
<html lang="en"     class="pb-page"  data-request-id="d56c529b-216d-4268-990c-0d9ee5084820"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.1c00631;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-13;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer" /></meta><meta name="dc.Creator" content="Qiuyue  Zhang" /></meta><meta name="dc.Creator" content="Zhongjiao  Fan" /></meta><meta name="dc.Creator" content="Lianshan  Zhang" /></meta><meta name="dc.Creator" content="Qidong  You" /></meta><meta name="dc.Creator" content="Lei  Wang" /></meta><meta name="dc.Description" content="Among numerous posttranslational regulation patterns, phosphorylation is reversibly controlled by the balance of kinases and phosphatases. The major form of cellular signaling involves the reversib..." /></meta><meta name="Description" content="Among numerous posttranslational regulation patterns, phosphorylation is reversibly controlled by the balance of kinases and phosphatases. The major form of cellular signaling involves the reversib..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 22, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00631" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00631" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00631" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00631" /></link>
        
    
    

<title>Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00631" /></meta><meta property="og:title" content="Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0014.jpeg" /></meta><meta property="og:description" content="Among numerous posttranslational regulation patterns, phosphorylation is reversibly controlled by the balance of kinases and phosphatases. The major form of cellular signaling involves the reversible phosphorylation of proteins on tyrosine, serine, or threonine residues. However, altered phosphorylation levels are found in diverse diseases, including cancer, making kinases and phosphatases ideal drug targets. In contrast to the success of prosperous kinase inhibitors, design of small molecules targeting phosphatase is struggling due to past bias and difficulty. This is especially true for serine/threonine phosphatases, one of the largest phosphatase families. From this perspective, we aim to provide insights into serine/threonine phosphatases and the small molecules targeting these proteins for drug development, especially in cancer. Through highlighting the modulation strategies, we aim to provide basic principles for the design of small molecules and future perspectives for the application of drugs targeting serine/threonine phosphatases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00631"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00631">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00631&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00631&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00631&amp;href=/doi/10.1021/acs.jmedchem.1c00631" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 8916-8938</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00629" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.1c00983" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Qiuyue Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qiuyue Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qiuyue++Zhang">Qiuyue Zhang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhongjiao Fan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhongjiao Fan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhongjiao++Fan">Zhongjiao Fan</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lianshan Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lianshan Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai 200245, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lianshan++Zhang">Lianshan Zhang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qidong You</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qidong You</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +86 025 83271351. Email: <a href="/cdn-cgi/l/email-protection#5c2533292d381c6d6a6f723f3331"><span class="__cf_email__" data-cfemail="d4adbba1a5b094e5e2e7fab7bbb9">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qidong++You">Qidong You</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8587-0122" title="Orcid link">https://orcid.org/0000-0002-8587-0122</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Lei Wang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lei Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +86-15261483858. Email: <a href="/cdn-cgi/l/email-protection#ee828b87998f8089c0d7dfae8d9e9bc08b8a9bc08d80"><span class="__cf_email__" data-cfemail="e9858c809e88878ec7d0d8a98a999cc78c8d9cc78a87">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Wang">Lei Wang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8181-5644" title="Orcid link">https://orcid.org/0000-0002-8181-5644</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00631&amp;href=/doi/10.1021%2Facs.jmedchem.1c00631" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 8916–8938</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 22, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 April 2021</li><li><span class="item_label"><b>Published</b> online</span>22 June 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 July 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00631" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00631</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8916%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DQiuyue%2BZhang%252C%2BZhongjiao%2BFan%252C%2BLianshan%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D13%26contentID%3Dacs.jmedchem.1c00631%26title%3DStrategies%2Bfor%2BTargeting%2BSerine%252FThreonine%2BProtein%2BPhosphatases%2Bwith%2BSmall%2BMolecules%2Bin%2BCancer%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8938%26publicationDate%3DJuly%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00631"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1085</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00631" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Qiuyue&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Zhongjiao&quot;,&quot;last_name&quot;:&quot;Fan&quot;},{&quot;first_name&quot;:&quot;Lianshan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Qidong&quot;,&quot;last_name&quot;:&quot;You&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;8916-8938&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00631&quot;},&quot;abstract&quot;:&quot;Among numerous posttranslational regulation patterns, phosphorylation is reversibly controlled by the balance of kinases and phosphatases. The major form of cellular signaling involves the reversible phosphorylation of proteins on tyrosine, serine, or threonine residues. However, altered phosphorylation levels are found in diverse diseases, including cancer, making kinases and phosphatases ideal drug targets. In contrast to the success of prosperous kinase inhibitors, design of small molecules targeting phosphatase is struggling due to past bias and difficulty. This is especially true for serine/threonine phosphatases, one of the largest phosphatase families. From this perspective, we aim to provide insights into serine/threonine phosphatases and the small molecules targeting these proteins for drug development, especially in cancer. Through highlighting the modulation strategies, we aim to provide basic principles for the design of small molecules and future perspectives for the application of drugs targetin&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00631&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00631" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00631&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00631" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00631&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00631" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00631&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00631&amp;href=/doi/10.1021/acs.jmedchem.1c00631" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00631" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00631" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (10 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00631%26sid%3Dliteratum%253Aachs%26pmid%3D34156850%26genre%3Darticle%26aulast%3DZhang%26date%3D2021%26atitle%3DStrategies%2Bfor%2BTargeting%2BSerine%252FThreonine%2BProtein%2BPhosphatases%2Bwith%2BSmall%2BMolecules%2Bin%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D13%26spage%3D8916%26epage%3D8938%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292276" title="Small molecules">Small molecules</a>,</li><li><a href="/action/doSearch?ConceptID=292544" title="Targeting">Targeting</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Among numerous posttranslational regulation patterns, phosphorylation is reversibly controlled by the balance of kinases and phosphatases. The major form of cellular signaling involves the reversible phosphorylation of proteins on tyrosine, serine, or threonine residues. However, altered phosphorylation levels are found in diverse diseases, including cancer, making kinases and phosphatases ideal drug targets. In contrast to the success of prosperous kinase inhibitors, design of small molecules targeting phosphatase is struggling due to past bias and difficulty. This is especially true for serine/threonine phosphatases, one of the largest phosphatase families. From this perspective, we aim to provide insights into serine/threonine phosphatases and the small molecules targeting these proteins for drug development, especially in cancer. Through highlighting the modulation strategies, we aim to provide basic principles for the design of small molecules and future perspectives for the application of drugs targeting serine/threonine phosphatases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phosphatases and kinases are enzymes that control the balance of the phosphorylation and dephosphorylation process (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). Kinases transfer a phosphate group from adenosine triphosphate (ATP) to the substrate protein. Phosphatases remove the negatively charged phosphate groups from the target proteins through a water molecule. The addition or removal of a phosphate group, usually on tyrosine (Tyr), serine (Ser), or threonine (Thr) residues, activates or inactivates a protein through a conformational change.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> This fundamental mechanism in eukaryotic organisms regulates multiple biological functions, including DNA replication, cell cycle progression, energy metabolism, and cell differentiation and development.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> In this manner, most of them are involved in central processes in cancer and many other diseases.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Considering the fundamental role of reversible protein phosphorylation, protein kinases are regarded as promising drug targets, contributing to a large number of drug discovery programs by pharmaceutical manufacturers. Up to 2020, more than 60 different protein kinase inhibitors were launched on the market (<a href="http://www.brimr.org/PKI/PKIs.htm" class="extLink">www.brimr.org/PKI/PKIs.htm</a>), which made kinases one of the most attractive drug targets (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). Additionally, numerous clinical and preclinical processes are being developed, resulting in many views in the development of kinase inhibitors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Although both kinases and phosphatases are equally important in pathological scenarios, rational design for phosphatase modulators faces tremendous challenges. As the majority of kinase inhibitors are designed to target ATP binding sites, initial efforts to develop phosphatase modulators were focused on targeting the catalytic active sites.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> However, due to the highly conserved character of active sites on phosphatases and the negative charges are required to guarantee the tight binding, it is difficult to achieve ideal selectivity and bioavailability for phosphatase modulators. Thus, for a long time, phosphatases were regarded as “undruggable” targets of small molecules.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Research progress on kinases and phosphatases. (A) Balanced regulation cycle of phosphorylation and dephosphorylation. (B) The number of launched protein kinase inhibitors versus the number of clinical protein phosphatase inhibitors (<a href="http://www.brimr.org/PKI/PKIs.htm" class="extLink">www.brimr.org/PKI/PKIs.htm</a>; <a href="https://clinicaltrials.gov" class="extLink">https://clinicaltrials.gov</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recent evidence with successful cases provides possibilities for the rational design of small molecules targeting phosphatases (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B, <a href="https://clinicaltrials.gov" class="extLink">https://clinicaltrials.gov</a>).<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> According to the substrate features, most phosphatases are tyrosine and serine/threonine phosphatases.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> For tyrosine phosphatases, targeting nonreceptor type 11, <i>ptpn</i>11, commonly called SHP2 for SH2-domain containing phosphatase-2, with small molecules (represented by SHP2 inhibitor TNO155 by Novartis) has received great interest in KRAS-driven cancers (NCT03114319).<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> Targeting protein tyrosine phosphatase 1B (PTP1B) with trodusquemine (MSI-1436 developed by Genaera Corporation) showed efficacy for obesity and type 2 diabetes (NCT00606112) and breast cancer (NCT02524951).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Notably, these inhibitors work in an allosteric binding manner rather than blocking the active sites, indicating that directly targeting the catalytic sites of phosphatases might not be an optimal method and that new methods are emerging. Considering that the small molecules targeting tyrosine phosphatases have been nicely introduced in previous reviews,<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28">(23−28)</a> herein, we will focus on serine/threonine phosphatases, which are composed of a large number of family members with different regulatory mechanisms to provide opportunities for the design of small molecules with new concepts. In eukaryotic cells, more than 97% of all protein phosphorylation sites occur on serine/threonine residues.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Serine/threonine phosphatases are mainly composed of phosphoprotein phosphatases (PPPases) and metal-dependent protein phosphatases.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Notably, the PPPases family plays an essential role, as its members are responsible for 90% of serine/threonine dephosphorylation events.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In this review, we aim to mainly introduce PPPases as representative serine/threonine phosphatases. PPPases can be further divided into seven subfamilies, including protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A), calcineurin (Cn, also known as PP2B or PP3), protein phosphatase 4 (PP4), protein phosphatase 5 (PP5), protein phosphatase 6 (PP6), and protein phosphatase 7 (PP7, also known as PPEF).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Although they share a common mechanism of metal-catalyzed dephosphorylation through highly conserved catalytic active sites, different PPPases exhibit specificity according to their diverse regulatory subunits or unique structural features, which provides potential opportunities for the rational design of small molecules.</div><div class="NLM_p">Among PPPases subfamilies, PP5 and PP7 work in monomeric enzyme form, while others work in holoenzyme form with the help of catalytic subunits, regulatory subunits, and/or scaffold subunits. Diverse compounds are under evaluation for their antiproliferation activity with different regulatory mechanisms, including targeting catalytic subunits, targeting noncatalytic subunits/domains, and targeting holoenzymes, which make PPPases potential drug targets in cancer. Among them, LB-100 (<b>1</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) shows antitumor effects against multiple types of cancer cells, such as hepatocellular carcinoma, pancreatic cancer, and ovarian cancer, by binding to the catalytic active sites of the PP2A catalytic subunit.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40">(31−40)</a> FTY720 (<b>2</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) exhibits antitumor activity in acute myeloid leukemia cells by combining with SET, an endogenous inhibitor of PP2A, to disrupt the PP2AC-SET interaction and selectively activate PP2A.<a onclick="showRef(event, 'ref41 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44 ref45">(41−45)</a> Both DT-061 and iHAP1 (respectively, <b>3</b> and <b>4</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) work as “molecular glue” to selectively active PP2A by interacting with different PP2A holoenzymes with distinct B56 subunits and induce their antitumor activity against cancer cells.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Cyclosporine A and tacrolimus (respectively, <b>5</b> and <b>6</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) selectively inhibit PP3 by targeting holoenzymes, showing antitumor effects against diverse cancer cells, including colorectal cancer, breast cancer, and bladder cancer cells.<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46−48)</a> In this review, we briefly introduce the structural characteristics and cancer-related biological functions of PPPases. According to the structural features of PPPases and the action mechanisms of modulators, the representative small-molecule modulators of PPPases are classified into three groups: (1) small molecules targeting catalytic subunits, (2) small molecules targeting noncatalytic subunits/domains, and (3) small molecules targeting holoenzymes. All of the current evidence demonstrates feasible approaches for the rational design of small molecules targeting PPPases with distinct patterns for cancer therapy, making these “undruggable” targets reborn.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. List of the Representative PPPase Modulators</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">activity<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">type and mechanism</th><th class="colsep0 rowsep0" align="center">targeted pathology</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Targeting Catalytic Subunits</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" valign="middle">cantharidin (<b>13</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" valign="middle">PP1</td><td class="colsep0 rowsep0" valign="middle">1.7 × 10<sup>3</sup> nM</td><td class="colsep0 rowsep0" rowspan="6" valign="middle">inhibitor binds to catalytic subunit</td><td class="colsep0 rowsep0" rowspan="6" valign="middle">hepatocellular carcinoma, breast cancer</td><td class="colsep0 rowsep0" rowspan="6" valign="middle"><a onclick="showRef(event, 'ref49 ref50 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref91 ref92">(49,50,91,92)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">160 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP3</td><td class="colsep0 rowsep0" valign="middle">>5 × 10<sup>5</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP4</td><td class="colsep0 rowsep0" valign="middle">50 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">600 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP6</td><td class="colsep0 rowsep0" valign="middle">8 × 10<sup>3</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" valign="middle">norcantharidin (<b>16</b>)</td><td class="colsep0 rowsep0" valign="middle">PP1</td><td class="colsep0 rowsep0" valign="middle">9 × 10<sup>3</sup> nM</td><td class="colsep0 rowsep0" rowspan="3" valign="middle">inhibitor binds to catalytic subunit</td><td class="colsep0 rowsep0" rowspan="3" valign="middle">liver cancer, gastric cancer, leukemia, cholangiocarcinoma, nasopharyngeal carcinoma, lung cancer, rectal cancer, esophageal cancer, esophageal cancer, breast cancer</td><td class="colsep0 rowsep0" rowspan="3" valign="middle"><a onclick="showRef(event, 'ref93 ref94 ref95 ref96 ref97 ref98 ref99 ref100 ref101 ref102 ref103 ref104 ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref93 ref94 ref95 ref96 ref97 ref98 ref99 ref100 ref101 ref102 ref103 ref104 ref105 ref106">(93−106)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">3 × 10<sup>3</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">970 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" valign="middle">LB-100 (<b>1</b>)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (phase II)</td><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">400 nM</td><td class="colsep0 rowsep0" rowspan="2" valign="middle">inhibitor binds to catalytic subunit</td><td class="colsep0 rowsep0" rowspan="2" valign="middle">glioblastoma, sarcoma, pheochromocytoma, breast cancer, nasopharyngeal carcinoma, hepatocellular carcinoma, pancreatic cancer, ovarian cancer, myelodysplastic syndromes</td><td class="colsep0 rowsep0" rowspan="2" valign="middle"><a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40">(31−40)</a>, <a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">1.8 × 10<sup>3</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" valign="middle">nodularin R (<b>10</b>)</td><td class="colsep0 rowsep0" valign="middle">PP1</td><td class="colsep0 rowsep0" valign="middle">2.4 nM</td><td class="colsep0 rowsep0" rowspan="5" valign="middle">inhibitor binds to catalytic subunit</td><td class="colsep0 rowsep0" rowspan="5" valign="middle">–</td><td class="colsep0 rowsep0" rowspan="5" valign="middle"><a onclick="showRef(event, 'ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref108 ref109">(108,109)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">0.3 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP3</td><td class="colsep0 rowsep0" valign="middle">>1 × 10<sup>3</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">4 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP7</td><td class="colsep0 rowsep0" valign="middle">>1 × 10<sup>3</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" valign="middle">microcystin-LR (<b>9</b>)</td><td class="colsep0 rowsep0" valign="middle">PP1</td><td class="colsep0 rowsep0" valign="middle">1.7 nM</td><td class="colsep0 rowsep0" rowspan="6" valign="middle">inhibitor binds to catalytic subunit</td><td class="colsep0 rowsep0" rowspan="6" valign="middle">–</td><td class="colsep0 rowsep0" rowspan="6" valign="middle"><a onclick="showRef(event, 'ref49 ref50 ref51 ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref110 ref111">(49−51,110,111)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">0.04 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP3</td><td class="colsep0 rowsep0" valign="middle">200 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP4</td><td class="colsep0 rowsep0" valign="middle">0.15 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">1 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP6</td><td class="colsep0 rowsep0" valign="middle">1 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="7" valign="middle">okadaic acid (<b>8</b>)</td><td class="colsep0 rowsep0" valign="middle">PP1</td><td class="colsep0 rowsep0" valign="middle">10–15 nM</td><td class="colsep0 rowsep0" rowspan="7" valign="middle">inhibitor binds to catalytic subunit</td><td class="colsep0 rowsep0" rowspan="7" valign="middle">–</td><td class="colsep0 rowsep0" rowspan="7" valign="middle"><a onclick="showRef(event, 'ref49 ref50 ref51 ref112'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref112">(49−51,112)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">0.1–0.3 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP3</td><td class="colsep0 rowsep0" valign="middle">>1 × 10<sup>7</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP4</td><td class="colsep0 rowsep0" valign="middle">0.1 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">3.5 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP6</td><td class="colsep0 rowsep0" valign="middle">1.0 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP7</td><td class="colsep0 rowsep0" valign="middle">>1 × 10<sup>3</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" valign="middle">tautomycin (<b>11</b>)</td><td class="colsep0 rowsep0" valign="middle">PP1</td><td class="colsep0 rowsep0" valign="middle">0.23–22 nM</td><td class="colsep0 rowsep0" rowspan="5" valign="middle">inhibitor binds to catalytic subunit</td><td class="colsep0 rowsep0" rowspan="5" valign="middle">medullary thyroid cancer</td><td class="colsep0 rowsep0" rowspan="5" valign="middle"><a onclick="showRef(event, 'ref49 ref51 ref113'); return false;" href="javascript:void(0);" class="ref ref49 ref51 ref113">(49,51,113)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">0.94–32 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP3</td><td class="colsep0 rowsep0" valign="middle">>1 × 10<sup>3</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP4</td><td class="colsep0 rowsep0" valign="middle">0.4 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">10 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" valign="middle">tautomycetin (<b>19</b>)</td><td class="colsep0 rowsep0" valign="middle">PP1</td><td class="colsep0 rowsep0" valign="middle">0.038 nM</td><td class="colsep0 rowsep0" rowspan="5" valign="middle">inhibitor binds to catalytic subunit</td><td class="colsep0 rowsep0" rowspan="5" valign="middle">medullary thyroid cancer</td><td class="colsep0 rowsep0" rowspan="5" valign="middle"><a onclick="showRef(event, 'ref113 ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref113 ref114 ref115">(113−115)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">5.3 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP3</td><td class="colsep0 rowsep0" valign="middle">17500 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP4</td><td class="colsep0 rowsep0" valign="middle">44.4 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">11.9 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="7" valign="middle">calyculin A (<b>7</b>)</td><td class="colsep0 rowsep0" valign="middle">PP1</td><td class="colsep0 rowsep0" valign="middle">0.4 nM</td><td class="colsep0 rowsep0" rowspan="7" valign="middle">inhibitor binds to catalytic subunit</td><td class="colsep0 rowsep0" rowspan="7" valign="middle">oral cancer, breast cancer</td><td class="colsep0 rowsep0" rowspan="7" valign="middle"><a onclick="showRef(event, 'ref49 ref50 ref51 ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref116 ref117">(49−51,116,117)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">0.25 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP3</td><td class="colsep0 rowsep0" valign="middle">>1 × 10<sup>3</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP4</td><td class="colsep0 rowsep0" valign="middle">0.2 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">3 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP6</td><td class="colsep0 rowsep0" valign="middle">10 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP7</td><td class="colsep0 rowsep0" valign="middle">>1 × 10<sup>3</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" valign="middle">fostriecin (<b>12</b>)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (phase I)</td><td class="colsep0 rowsep0" valign="middle">PP1</td><td class="colsep0 rowsep0" valign="middle">>1 × 10<sup>5</sup> nM</td><td class="colsep0 rowsep0" rowspan="5" valign="middle">inhibitor covalently binds to catalytic subunit</td><td class="colsep0 rowsep0" rowspan="5" valign="middle">leukemia, lung cancer, breast cancer, ovarian cancer</td><td class="colsep0 rowsep0" rowspan="5" valign="middle"><a onclick="showRef(event, 'ref49 ref51 ref118 ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref49 ref51 ref118 ref119 ref120">(49,51,118−120)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">1.5–5.5 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP3</td><td class="colsep0 rowsep0" valign="middle">>1 × 10<sup>5</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP4</td><td class="colsep0 rowsep0" valign="middle">3 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">>1 × 10<sup>4</sup> nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Targeting Noncatalytic Subunits/Domains</td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" valign="middle">P5SA-2 (<b>22</b>)</td><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">4-fold @ >1 × 10<sup>5</sup> nM</td><td class="colsep0 rowsep0" valign="middle">activator binds to allosteric sites</td><td class="colsep0 rowsep0" valign="middle">–</td><td class="colsep0 rowsep0" valign="middle"><a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" valign="middle">Ro 90-7501 (<b>15</b>)</td><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">>40% inhibition @ 1 × 10<sup>6</sup> nM</td><td class="colsep0 rowsep0" valign="middle">inhibitor binds to PP5 in a TPR-dependent manner</td><td class="colsep0 rowsep0" valign="middle">–</td><td class="colsep0 rowsep0" valign="middle"><a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" valign="middle">arachidonic acid (<b>23</b>)</td><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">EC<sub>50</sub> = 7.8 × 10<sup>4</sup> nM</td><td class="colsep0 rowsep0" valign="middle">activator binds to TPR domain</td><td class="colsep0 rowsep0" valign="middle">–</td><td class="colsep0 rowsep0" valign="middle"><a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" valign="middle">chaulmoogric acid (<b>24</b>)</td><td class="colsep0 rowsep0" valign="middle">PP5</td><td class="colsep0 rowsep0" valign="middle">EC<sub>50</sub> = 1.3 × 10<sup>5</sup> nM</td><td class="colsep0 rowsep0" valign="middle">activator binds to TPR domain</td><td class="colsep0 rowsep0" valign="middle">–</td><td class="colsep0 rowsep0" valign="middle"><a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" valign="middle">FTY720 (<b>2</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">175%@ 1 × 10<sup>3</sup> nM</td><td class="colsep0 rowsep0" valign="middle">activator binds to SET (PP2A endogenous inhibitor)</td><td class="colsep0 rowsep0" valign="middle">breast cancer, bladder cancer, prostate cancer, glioma, liver cancer, colorectal cancer, gastric cancer, pancreatic cancer, leukemia</td><td class="colsep0 rowsep0" valign="middle"><a onclick="showRef(event, 'ref124 ref125 ref126 ref127 ref128 ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref124 ref125 ref126 ref127 ref128 ref129 ref130">(124−130)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Targeting Holoenzymes</td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" valign="middle">perphenazine (<b>25</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">ND<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" valign="middle">activator with unknown binding site</td><td class="colsep0 rowsep0" valign="middle">T-cell acute lymphoblastic leukemia</td><td class="colsep0 rowsep0" valign="middle"><a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" valign="middle">DT-061(<b>3</b>)</td><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">GI<sub>50</sub> = 5 × 10<sup>3</sup> nM</td><td class="colsep0 rowsep0" valign="middle">activator binds to three subunits of B56α containing PP2A holoenzyme</td><td class="colsep0 rowsep0" valign="middle">lung cancer</td><td class="colsep0 rowsep0" valign="middle"><a onclick="showRef(event, 'ref14 ref132'); return false;" href="javascript:void(0);" class="ref ref14 ref132">(14,132)</a></td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" valign="middle">iHAP1(<b>4</b>)</td><td class="colsep0 rowsep0" valign="middle">PP2A</td><td class="colsep0 rowsep0" valign="middle">ND<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" valign="middle">activator binds to three subunits of B56ε containing PP2A holoenzyme</td><td class="colsep0 rowsep0" valign="middle">leukemia, neuroblastoma</td><td class="colsep0 rowsep0" valign="middle"><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" valign="middle">cyclosporine A (<b>5</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" valign="middle">PP3</td><td class="colsep0 rowsep0" valign="middle">7 nM</td><td class="colsep0 rowsep0" valign="middle">inhibitor binds to both two subunits of PP3 holoenzyme</td><td class="colsep0 rowsep0" valign="middle">colorectal cancer, bladder cancer, prostate cancer, lung cancer, oral squamous cell carcinoma, breast cancer</td><td class="colsep0 rowsep0" valign="middle"><a onclick="showRef(event, 'ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref133 ref134">(133,134)</a></td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" valign="middle">tacrolimus (<b>6</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" valign="middle">PP3</td><td class="colsep0 rowsep0" valign="middle">0.4 nM</td><td class="colsep0 rowsep0" valign="middle">inhibitor binds to both two subunits of PP3 holoenzyme</td><td class="colsep0 rowsep0" valign="middle">leukemia, lymphoma, multiple myeloma, kidney cancer</td><td class="colsep0 rowsep0" valign="middle"><a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The activity of inhibitor refers to inhibitory activity (IC<sub>50</sub>), and the activity of activator refers to activation activity.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">New use of old drugs.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">In clinical trials.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">ND: not determined.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Structure and Biological Function</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.1.  Sequences and Structural Features of PPPases</h3><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, the catalytic subunits of the PPPases superfamily are highly conserved in the sequence alignment. Especially, the catalytic cores in the catalytic subunits contain nine strictly conserved amino acids: Six amino acids (three His, two Asp, and one Asn) coordinate with a metal ion (including Mg<sup>2+</sup>, Mn<sup>2+</sup>, Fe<sup>2+</sup>, or Zn<sup>2+</sup>), and three of these amino acids (two Arg and one His) are responsible for the binding of the phosphate group. Additionally, all members of the PPPases family share a common catalytic mechanism that is dominated by two metal ions closely attached to the catalytic center. All the characteristics shown above imply a challenge for the design of selective small molecules by targeting catalytic sites. For example, calyculin A, okadaic acid, and microcystin-LR (respectively, <b>7</b>, <b>8</b>, and <b>9</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) are PPPase inhibitors with high binding affinity, but they are not selective for PPPases.<a onclick="showRef(event, 'ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51">(49−51)</a> Although PPPase members share common features, they can be distinguished by certain sequence characteristics and distinct regulatory subunits, which indicate the potential for the design of selective small molecules.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Sequences and structural features of PPPases. (A) The PPPases family contains seven subfamilies: PP1, PP2A, PP3, PP4, PP5, PP6, and PP7. The catalytic cores in the catalytic subunits (PP1C, PP2AC, PP4C, PP6C, PP3C, PP5C, and PP7/PPEF) are highly conserved (blue). In the catalytic core, several small sequence fragments (G, glycine; D, aspartic acid; x, any amino acid; H, histidine; V, valine; R, arginine; N, asparagine; E, glutamic acid) are strictly conserved, and the amino acids involving in metal ion coordination and phosphate group binding are indicated by green and red letters, respectively. The colors indicate the following components: The calcineurin B (CnB) binding domain (orange), the Ca<sup>2+</sup>-calmodulin (CaM) binding domain (brown), the autoinhibitory (AI) domain (plum red), the tetratricopeptide repeat (TPR) domain involved in autoinhibitory regulation (light green), an αJ helix with 9 amino acids involved in autoinhibitory regulation (pink), the EF-hand motifs (yellow-green) [a diverse motif class containing approximately 30 amino acids that fold into a helix–loop–helix structure (α-helix E (forefinger), a loop around the Ca<sup>2+</sup> ion (clenched middle finger), and α-helix F (thumb)) and are responsible for Ca<sup>2+</sup> binding], and the IQ calmodulin-binding motif (purple). The catalytic subunit of each subfamily is represented by PP1Cα (accession code: P62136), PP2ACα (accession code: P67775), PP4C (accession code: P60510), PP6C (accession code: O00743), PP3Cα (accession code: Q08209), PP5 (accession code: P53041), and PPEF1 (accession code: O14829), respectively. All proteins here come from <i>Homo sapiens</i> (<a href="https://www.uniprot.org" class="extLink">https://www.uniprot.org</a>). (B) Structure of PPPases family. PP5 and PP7 work in monomeric enzyme form, while others work in holoenzyme form with the help of catalytic subunits, regulatory subunits, and/or scaffold subunits.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In term of sequences, PP3, PP5, and PP7 can be distinguished from others by the unique N- and C-terminus of their catalytic subunits (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). PP5 contains a tetratricopeptide repeat (TPR) domain (composed of three consecutive TPR motifs) in the N-terminus and an αJ helix in the C-terminus.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The TPR domain cooperates with the αJ helix and works as a switch together to control the activity of PP5.<a onclick="showRef(event, 'ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55">(53−55)</a> Interestingly, both PP3 and PP7 are Ca<sup>2+</sup>-related PPPases with Ca<sup>2+</sup>-calmodulin binding motifs in their N- or C-terminal regions.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> PP3 has three functional domains in the C-terminal region, including the calcineurin B (CnB) binding domain which interacts with the regulatory subunit, the Ca<sup>2+</sup>-calmodulin (CaM) binding domain which interacts with calcium and calmodulin (a calcium sensing protein), and the autoinhibitory (AI) domain which forms an α helix to block the substrates from entering the catalytic center.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The N-terminal CaM binding motif of PP7 is also named the IQ motif. Additionally, five noncontiguous Ca<sup>2+</sup>-binding EF-hand motifs in the C-terminus are a typical feature of PP7. The presence of Ca<sup>2+</sup>-calmodulin binding and EF-hand motifs implies that PP7 is under dual control.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> In term of the structures, regulatory subunits and/or scaffold subunits make PPPases different from each other (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). PP3 is a dimeric holoenzyme that consists of a catalytic subunit with three isoforms (PP3Cα, PP3Cβ, and PP3Cδ) and a Ca<sup>2+</sup>-binding regulatory subunit (calcineurin B) that contains four noncontiguous Ca<sup>2+</sup> binding EF-hand domains, corresponding to the EF-hand motifs in PP7.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Similar to PP3, PP4 also works in a dimeric holoenzyme formed with one isoform of catalytic subunit.<a onclick="showRef(event, 'ref29 ref60'); return false;" href="javascript:void(0);" class="ref ref29 ref60">(29,60)</a> The regulatory subunits of PP4 have five members, namely, PP4R1, PP4R2, PP4R3α, PP4R3β, and PP4R4. PP1 is a dimeric or trimeric holoenzyme that consists of a catalytic subunit with four isoforms (PP1Cα, PP1Cβ, PP1Cγ1, and PP1Cγ2) and one or two regulatory subunits. Currently, more than 200 regulatory subunits are identified as regulatory interactors of protein phosphatase one (RIPPOs), which provides the specificity for a large number of substrates.<a onclick="showRef(event, 'ref30 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref30 ref61 ref62">(30,61,62)</a> PP2A and PP6 are trimeric holoenzymes. In addition to the catalytic subunit and regulatory subunit, they also have a scaffold subunit that mediates the interaction between catalytic subunit and regulatory subunit. PP2A consists of a catalytic subunit with two isoforms (PP2ACα and PP2ACβ), a regulatory subunit (at least 18 subunits have been discovered), and a scaffold subunit with two members (PP2AAα and PP2AAβ).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> PP6 has one type of catalytic subunit, three types of regulatory subunits (PPP6R1, PPP6R2, and PPP6R3), and three types of scaffold subunits (ANR28, ANR44, and ANR52).<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63,64)</a></div><div class="NLM_p last">Although it is challenging to design small molecules directly targeting the catalytic cores, based on the sequences and structural features, it is ideal to regulate the functions of PPPases with different mechanisms. Specific functional domains and regulatory subunits are the determinants of the functional diversity and specificity of each PPPase, thereby making it possible to target these regulatory subunits or specific functional domains for the design of selective small molecules.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.2.  Cancer-Related Biological Functions</h3><div class="NLM_p">PPPases participate in the regulation of diverse cellular signaling pathways, such as RNA splicing, the DNA damage response, protein synthesis, cell cycle progression, mitosis, proliferation, migration, and apoptosis.<a onclick="showRef(event, 'ref30 ref70 ref71 ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref30 ref70 ref71 ref72 ref73">(30,70−73)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, more than 200 proteins have been identified as the substrates of PPPases (depod.bioss.unifreiburg.de/br_net.php).<a onclick="showRef(event, 'ref56 ref65 ref66 ref67 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref56 ref65 ref66 ref67 ref68 ref69">(56,65−69)</a> Although a majority of the substrates have a one-to-one relationship with PPPases, this is just the current knowledge. In reality, this is even much more complicated, as only a few substrates have been directly assigned to one phosphatase, forming a complex dephosphorylation network. PPPases are closely related to the pathogenesis and development of many cancers. At the early stage, PPPases were simply identified as tumor suppressor proteins or oncogenic proteins. In recent years, accumulating evidence has indicated that PPPases play different roles in distinct cancers, which may be due to the diversity of regulatory subunits of PPPases.<a onclick="showRef(event, 'ref74 ref75 ref76 ref77 ref78 ref79 ref80 ref81 ref82 ref83 ref84 ref85 ref86 ref87 ref88 ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref77 ref78 ref79 ref80 ref81 ref82 ref83 ref84 ref85 ref86 ref87 ref88 ref89 ref90">(74−90)</a> Here, we list a few examples, mainly involving PP1, PP2A, and PP4 to illustrate that PPPases could act as both tumor promoters and tumor suppressors in specific cancers (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Substrates and biological functions of PPPases. (A) Substrates of PPPases. More than 200 proteins have been identified as the substrates of PPPases (depod.bioss.unifreiburg.de/br_net.php) and a complex dephosphorylation network is formed in which many substrates are regulated by multiple PPPases.<a onclick="showRef(event, 'ref56 ref65 ref66 ref67 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref56 ref65 ref66 ref67 ref68 ref69">(56,65−69)</a> (B) PPPases could act as both tumor promoters and tumor suppressors in specific cancers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There is still a debate on the classification of PP1 as a tumor suppressor protein or an oncogenic protein. The different PP1C isoforms were rarely discriminated in early tumor studies, and they were considered to play overlapping roles. To date, growing evidence has indicated that different isoforms of PP1C have individual functions or even antagonizing functions. For example, knockdown of different isoforms of PP1C induced distinct cell phenotypes in HeLa cervical carcinoma cells.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> PP1Cα knockdown induced cell rounding and increased proliferation inhibition; PP1Cβ knockdown led to cell flattening and enlargement, with enrichment of lamellipodia; and PP1Cγ1 knockdown changed the distribution of cell cycle phases. PP1Cα and PP1Cγ1 play antagonizing roles and display different functions in lung cancer cells.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> For more details about the underlying mechanism, see the review by Felgueiras et al.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> PP2A is another well-studied PPPase subfamily that was previously generally defined as a tumor suppressor.<a onclick="showRef(event, 'ref77 ref78 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref79 ref80">(77−80)</a> Its two completely different roles in cancer were uncovered by later studies. For example, PR55α (a regulatory subunit) containing PP2A acts as a tumor promoter in pancreatic cancer by sustaining hyperactive tumor promoters, including YAP, AKT, ERK and Wnt;<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81,82)</a> PR61γ1 or PR61γ3 (PP2A regulatory subunit) containing PP2A acts as a tumor suppressor to stabilize p53 by dephosphorylating at either Ser37 or Thr55.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83,84)</a> PP4 is also well-studied, and it play the opposite role in different cancers with different regulatory subunits. PPP4R1, a regulatory subunit of PP4, is overexpressed in many cancers, such as breast cancer,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> lung cancer,<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> and hepatocellular carcinoma.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> PPP4R1 knockdown induces cancer cell proliferation inhibition by downregulating cell cycle activators.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> PPP4R1-containing PP4 accelerates cell proliferation, which may be regulated by the p38 and c-Jun N-terminal kinase (JNK) pathways.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> PP4C is overexpressed in pancreatic ductal adenocarcinoma.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> PPP4R2, another regulatory subunit of PP4, is recurrently deleted in acute myeloid leukemia, which induces the DNA damage repair (DDR) impairment by blocking the dephosphorylation of DDR-related proteins, including KRAB domain-associated protein 1 (KAP-1), histone variant H2AX (γH2AX), tumor protein p53 (TP53), and replication protein A2 (RPA2).<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88,89)</a> As shown above, PPPases cannot be simply identified as tumor promoters or tumor suppressors, and their role in cancer depends on their structure and the type of tumor.</div><div class="NLM_p last">Considering the significant and changeable roles of PPPases in cancers, designing small-molecule activators or inhibitors targeting them provides chances to regulate cell growth, differentiation, migration and proliferation, which might be potential strategies for cancer therapy. Furthermore, selective small molecules targeting specific PPPases or even specific isoforms and regulatory subunits are necessary. Hence, effective strategies for identifying potential modulators are urgently needed.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">3.  Small-Molecule Modulators of PPPases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For a long time, phosphatases have been regarded as “undruggable” targets as they have highly conserved catalytic sites with negative charges and unspecific profiles. However, in the past few decades, several natural compounds targeting PPPases, including cyclosporine A,<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> tacrolimus,<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> nodularin R (<b>10</b>),<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> microcystin-LR,<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> okadaic acid,<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> tautomycin (<b>11</b>),<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> calyculin A,<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> fostriecin (<b>12</b>),<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> cantharidin (<b>13</b>),<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> and endothall (<b>14</b>),<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> have been reported, which supports the feasibility of the rational design of small molecules targeting PPPases (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Interestingly, most of them bind to the catalytic active sites of PPPases and act as pan inhibitors with nanomolar to micromolar inhibitory activity to all PPPases subfamilies (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Notably, among these natural products, cyclosporine A and tacrolimus selectively inhibit PP3 by working as “molecular glue” that bind to all subunits of the holoenzyme and interact with noncatalytic sites. These natural products lay the foundation for the subsequent development of small molecules targeting PPPases, indicating that in addition to targeting the catalytic sites, targeting the specific functional domains or the unique subunits of PPPases could be other promising strategies. This viewpoint seems to be supported by several small molecules reported in recent years, such as Ro 90-7501 (a TPR-dependent PP5 inhibitor, <b>15</b>),<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> and FTY720 (a PP2A activator, disrupting the PP2AC-SET interaction).<a onclick="showRef(event, 'ref41 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44 ref45">(41−45)</a> Additionally, targeting holoenzymes with the “molecular glue” (DT-061, iHAP1) have also been identified as a feasible strategy.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Here, based on the structural features of PPPases and the action mechanisms of modulators, the representative small-molecule modulators of PPPases are classified into three groups: (1) small molecules targeting catalytic subunits, (2) small molecules targeting noncatalytic subunits/domains, and (3) small molecules targeting holoenzymes. We briefly introduce the binding modes and the anticancer mechanisms of the representative compounds, which might provide potential clues for the subsequent development of selective small molecules targeting PPPases for cancer therapy.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of the representative PPPase modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.1.  Small Molecules Targeting the Catalytic Subunits</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">3.1.1.  Cantharidin and Its Derivatives</h4><div class="NLM_p">Cantharidin is a natural product extracted from Chinese blister beetles, and it is originally used to treat skin-related diseases in traditional Chinese medicine.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Recently, cantharidin was found to exhibit strong antitumor activity both <i>in vitro</i> and <i>in vivo</i> against various cancer cells, such as hepatocellular carcinoma cells and breast cancer cells.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Subsequently, Li and Casida first identified PP2A as a potential target for cantharidin, and Honkanen et al. reported its inhibitory activities against PP1 (IC<sub>50</sub> = 1700 nM), PP2A (IC<sub>50</sub> = 160 nM) and PP3 (lower inhibition).<a onclick="showRef(event, 'ref92 ref143'); return false;" href="javascript:void(0);" class="ref ref92 ref143">(92,143)</a> As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, current studies have identified cantharidin as a pan inhibitor of PPPases (including PP1, PP2A, PP4, PP5, and PP6) with submicromolar inhibitory activity, and its underlying antitumor mechanism is mainly involved in the DNA damage and apoptosis.<a onclick="showRef(event, 'ref49 ref50 ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref144 ref145">(49,50,144,145)</a> Unfortunately, the unavoidable side effects of cantharidin on the gastrointestinal tract, ureter, heart, lungs, skin, kidney, and blood limit its further application.<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146,147)</a> Although cantharidin was not applied as a drug in cancer treatment, it guided the subsequent development of cantharidin-derived small molecules targeting PPPases.</div><div class="NLM_p">Norcantharidin (<b>16</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), a demethylated form of cantharidin, is easier to synthesize and had less cytotoxicity and comparable inhibitory activities against PP1 (IC<sub>50</sub> = 9000 nM) and PP2A (IC<sub>50</sub> = 3000 nM). Norcantharidin exhibits antitumor activities in many tumors (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and has been used as a folk anticancer agent since 1984 in China.<a onclick="showRef(event, 'ref93 ref96 ref97 ref98 ref99 ref100 ref101 ref102 ref103 ref104 ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref93 ref96 ref97 ref98 ref99 ref100 ref101 ref102 ref103 ref104 ref105 ref106">(93,96−106)</a> Currently, norcantharidin has received increasing attention and a phase I trial is ongoing to evaluate the pharmacokinetics (PKs), safety, and tolerance of norcantharidin in the treatment of solid tumors (NCT04673396).</div><div class="NLM_p">Based on the inspiration of cantharidin and norcantharidin, a first-in-class small-molecule inhibitor targeting PP2A, LB-100, was discovered to have favorable membrane permeability properties and good tolerance <i>in vivo</i>.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Subsequently, LB-100 was proven to have stronger PP2A (IC<sub>50</sub> = 400 nM) and PP5 (IC<sub>50</sub> = 180 nM) inhibitory activities than norcantharidin.<a onclick="showRef(event, 'ref13 ref107'); return false;" href="javascript:void(0);" class="ref ref13 ref107">(13,107)</a> LB-100 exhibited antitumor activities against a variety of cancer cells (for more details, see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40">(31−40)</a> Many preclinical studies have shown that LB-100 acts as both a chemo- and radio-sensitizer that synergistically assists in enhancing the therapeutic effect of chemotherapy and radiotherapy on tumors without significant systemic toxicity.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> In 2013, LB-100 successfully entered into a clinical study (NCT01837667) in combination with docetaxel and showed promising safety, tolerability, and antitumor profiles in patients with advanced solid tumors.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Currently, two phase II trials are ongoing to assess the safety and efficacy of LB-100 in the treatment of myelodysplastic syndromes (NCT03886662) and glioblastoma (NCT03027388).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The new mechanism and satisfactory preliminary clinical results support the further development of LB-100 as well as in combination with other therapies.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Although LB-100 inhibits both PP2A and PP5, the antitumor mechanism of LB-100 by inhibiting PP2A has been elucidated more comprehensively. PP2A inhibition by LB-100 regulates its downstream signaling pathways, including the Akt, homologous recombination repair (HRR) and hypoxia inducible factor-1α (HIF-1α) related signaling pathways, thus inhibiting the proliferation of cancer cells by promoting progenitor cells differentiation, drug penetration, mitotic mutation and apoptosis (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A).<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Aberrant cell cycle progression promotes cancer cell sensitivity to chemotherapeutic agents. In the Akt pathway, PP2A inhibition can increase the level of phosphorylated Akt (pAkt), which represses the formation of the nuclear receptor corepressor (N-CoR) complex and increases the protein level of murine double (MDM2). Therefore, the N-CoR complex blocks the differentiation of astrocytes by inhibiting the transcription of related genes, thus resulting in cell differentiation.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The enhanced pAkt level induces a significant increase in the level of pMDM2, further suppressing p53, and induces mitotic catastrophe of cancer cells.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> In addition, mitotic catastrophe is also observed after radiation therapy combined with LB-100. In radiated cells which are pretreated with LB-100, the levels of phosphorylated polo-like kinase 1 (PlK1) and cell division cycle 25c (Cdc25c) are increased and accumulate in G2/M cell cycle progression.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> LB-100 improves chemotherapeutic agents for penetrating into the bulk of the tumor by increasing tumor angiogenesis and perfusion.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> In the HIF-1α pathway, the inhibition of PP2A increases HIF-1α and induces vascular endothelial growth factor (VEGF) secretion. HRR is one of the main DNA protection mechanisms that acts by inducing the apoptosis of DNA damaged cells. PP2A has also been demonstrated to upregulate the HRR pathway activity.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> The radio-sensitizing potential of LB-100 is achieved by inhibiting PP2A and decreasing the HRR repair.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. LB-100 binds to the catalytic sites of PPPases and shows antitumor activity by inhibiting PP2A. (A) The antitumor mechanism of LB-100 mediated by PP2A. (B) The superposes of PP5-LB-100 complex and PP5-phosphate complex. LB-100 tightly coordinates within the catalytic pocket through multitype interactions (including ionic interactions (red dotted line), hydrogen bonds (green dotted line), hydrophobic and dipole–dipole stacking interactions (yellow dotted line)), blocking the access of the phosphate group of the substrate to the catalytic mentals. The protein colored green and LB-100 colored yellow in the PP5-LB-100 complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WG8">5WG8</a>)<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> and the protein colored cyan and phosphate colored orange in the PP5-phosphate complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1S95">1S95</a>).<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> M and W represent Mn<sup>2+</sup> and water, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although no cocrystal structure of PP2A-LB-100 has been reported, a cocrystal structure of PP5-LB-100 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WG8">5WG8</a>)<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> was solved at 1.65 Å in 2019.<a onclick="showRef(event, 'ref13 ref107'); return false;" href="javascript:void(0);" class="ref ref13 ref107">(13,107)</a> It shows that LB-100 coordinates tightly within the catalytic pocket through multitype interactions (including ionic interactions, hydrogen bonds, hydrophobic and dipole–dipole stacking interactions) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Compared with the PP5-phosphates complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1S95">1S95</a>),<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> the O7 bridging oxygen of LB-100 replaces the active water molecule and the hydroxide of phosphates to coordinate with M2, blocking the access of phosphate group. The side chains of Arg275 and Tyr451 are shifted away from the catalytic metals to accommodate the inhibitor. Therefore, all the evidence proved that LB-100 inhibits PP5 and PP2A by competitively occupying the substrate-binding sites. The binding mode of LB-100 indicates possible features of PPPases catalytic sites that can be occupied by small molecule and it will provide a valuable reference for further design of small molecules targeting PPPases.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">3.1.2.  Fostriecin</h4><div class="NLM_p">Fostriecin is an active extract of <i>Streptomyces pulveraceus</i> that exhibits antitumor activities against leukemia, lung cancer, breast cancer, and ovarian cancer.<a onclick="showRef(event, 'ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref119 ref120">(119,120)</a> In the early stage, DNA topoisomerase II was considered the target of fostriecin, but its inhibitory activity (IC<sub>50</sub> = 40 μM) was weak.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Unlike other topoisomerase II inhibitors, G2 arrest in the cell cycle was not observed after treatment with fostriecin.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Subsequently, fostriecin was found to prevent the mitotic entry checkpoint by inhibiting PPPases, which was considered to be a more reliable antitumor mechanism. To date, the inhibitory activities of fostriecin against PP1, PP2A, PP3, PP4, and PP5 have been determined (IC<sub>50</sub> = 45–58 μM, 1.5–5.5 nM, >100 μM, 3.0 nM, and 50–70 μM, respectively).<a onclick="showRef(event, 'ref49 ref139 ref157 ref158'); return false;" href="javascript:void(0);" class="ref ref49 ref139 ref157 ref158">(49,139,157,158)</a> As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, fostriecin inhibits PP2A/PP4 more 10000-fold than other PPPases.</div><div class="NLM_p">In 2004, a preliminary phase I clinical study of fostriecin was conducted in patients with refractory advanced or metastatic cancer to evaluate maximum-tolerated dose (MTD), toxicity, and PK profiles. Unfortunately, this study was terminated before reaching the MTD due to instability in storage and unpredictable purity.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Nowadays, although the synthesis problem of fostriecin has been solved, the storage stability of fostriecin is still a problem that urgently needs to be addressed.<a onclick="showRef(event, 'ref159 ref160 ref161'); return false;" href="javascript:void(0);" class="ref ref159 ref160 ref161">(159−161)</a> When combined with carboplatin in ovarian cancer therapy, fostriecin can increase chemosensitivity, DNA damage, and micronuclei formation.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> The underlying antitumor mechanism includes the regulation of the DDR pathway mediated by PP4.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Generally, the inhibition of PP4 will promote the activation of signal transducer and activator of transcription 1 (STAT1), thereby increasing the expression of proinflammatory cytokines and triggering an antitumor immune response (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Fostriecin covalently binds to Cys269 on the PP2A catalytic subunit and shows antitumor activity. (A) The antiovarian cancer mechanism of fostriecin. The inhibition of PP4 promotes the activation of STAT1, thereby increasing the expression of proinflammatory cytokines and triggering an antitumor immune response. (B) The binding features offostriecin. Fostriecin covalently binds to Cys269 on the PP2A catalytic subunit (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IE3">2IE3</a>).<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although there is currently no cocrystal structure of the fostriecin-PPPases complex, Toshifumi Takeuchi et al. demonstrated that fostriecin acts as a covalent-binding inhibitor of PP2A/PP4 by mass spectrometry analysis.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> The electrophilic α,β-unsaturated δ-lactone moiety of fostriecin is nucleophilically attacked by Cys269 of PP2A (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Notably, Cys269 is a highly conserved amino acid among PP2A, PP4, and PP6, which may explain the weak inhibition of fostriecin to PP1, PP3, and PP5.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">3.1.3.  Microcystins</h4><div class="NLM_p">Microcystins (MCs) are cyclic peptide toxins extracted from cyanotoxins, and they are widely distributing in drinkable water, which is a growing environmental and health concern.<a onclick="showRef(event, 'ref165 ref166 ref167'); return false;" href="javascript:void(0);" class="ref ref165 ref166 ref167">(165−167)</a> MCs exposure will induce long-term carcinogenic toxicity, hepatotoxicity, or even acute poisoning based on different dosages.<a onclick="showRef(event, 'ref168 ref169 ref170 ref171 ref172'); return false;" href="javascript:void(0);" class="ref ref168 ref169 ref170 ref171 ref172">(168−172)</a> The toxicity mechanism mainly involves PP1 and PP2A inhibition with high affinities.<a onclick="showRef(event, 'ref173 ref174'); return false;" href="javascript:void(0);" class="ref ref173 ref174">(173,174)</a> Additionally, MCs also inhibit other PPPases subfamilies, including PP3, PP4, PP5, and PP6, with fewer studies.<a onclick="showRef(event, 'ref51 ref175'); return false;" href="javascript:void(0);" class="ref ref51 ref175">(51,175)</a> Cocrystal structures of microcystin-LR (a congener of MCs) with PP1C (PDB ID:<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FJM">1FJM</a>)<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> and PP2AC (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IE3">2IE3</a>)<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> have been reported, which revealed the binding feature and inhibitory mechanism of MCs. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, microcystin-LR attaches to the catalytic subunits of PPPases through multiple interactions, involving hydrophobic interactions, hydrogen bonds, and covalent bonds. Microcystin-LR forms a covalent bond with Cys273 in PP1 and Cys269 in PP2A, which are conserved in PPPases attributing to the high affinities and the lack of selectivity of MCs.<a onclick="showRef(event, 'ref164 ref176 ref177 ref178 ref179'); return false;" href="javascript:void(0);" class="ref ref164 ref176 ref177 ref178 ref179">(164,176−179)</a> Subsequently, based on an SAR study and rational modifications of MCs, Aggen et al. identified a selective PP1 inhibitor, compound 1 (<b>17</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), that has 7-fold selectivity toward PP1.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> In 2018, Köhn’s group identified a highly selective submicromolar PP2A inhibitor, compound 2 (<b>18</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), over PP1 (282-fold selectivity) based on MCs.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> In the future, after clarifying the relationship between toxicity and structure, MCs scaffolds may be used to develop specific inhibitors to treat PP1/PP2A-related cancers.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. The binding modes of microcystin-LR on PP1 and PP2A. Microcystin-LR covalently binds to the catalytic subunits of PP1 (PDB ID:<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FJM">1FJM</a>)<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> and PP2A (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IE3">2IE3</a>).<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> PP1 is colored blue, and PP2A is colored green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">3.1.4.  Tautomycetin</h4><div class="NLM_p">Tautomycetin (TTN, <b>19</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and tautomycin (TTM) are natural compounds isolated from bacteria and show antitumor and immunosuppressive activities.<a onclick="showRef(event, 'ref183 ref184 ref185'); return false;" href="javascript:void(0);" class="ref ref183 ref184 ref185">(183−185)</a> Both of them share similar structures and show PP1/PP2A inhibitory activities.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> In 2017, Honkanen’s group tested the inhibitory activity of TTN toward PPPases (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and revealed the PP1 specificity mechanism through a cocrystal structure of PP1-TTN (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ALZ">6ALZ</a>).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> The result of PPPases inhibition shows that TTN selectively inhibits PP1 at the picomolar level (IC<sub>50</sub> = 38 pM), while the inhibitory activities on other PPPases are at nanomolar levels (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, a complex interaction network is formed, including salt bridges, hydrophobic interactions, hydrogen bonds, and covalent bonds. The diacid head of TTN binds the PP1 active sites, and the diene/alkene group tail extends to the hydrophobic groove and forms a covalent bond with Cys127. According to a cocrystal constructure of PP1-TTM (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7B">3E7B</a>),<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> although TTM adapts a similar conformation to bind PP1, it does not form a covalent bond because the diene/alkene group in TTN is replaced with the spiroketal group in TTM. The Cys127 (corresponding to the Cys153 in PP3) specifically exists in PP1 and PP3, while the formation of covalent bonds is blocked by the steric hindrance of His155 and Val253 side chain of PP3, which explains the specific inhibition of PP1 by TTN.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. The binding modes of tautomycetin and tautomycin on PP1. Tautomycetin and tautomycin adapt similar conformations to bind PP1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ALZ">6ALZ</a>,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7B">3E7B</a><a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a>), but tautomycin does not form a covalent bond because the diene/alkene group in tautomycetin is replaced with the spiroketal group in tautomycin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the small molecules mentioned above, there are many other compounds have been reported as PPPase inhibitors, such as nodularin R,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> okadaic acid,<a onclick="showRef(event, 'ref49 ref50 ref51 ref112'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref112">(49−51,112)</a> and calyculin A,<a onclick="showRef(event, 'ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51">(49−51)</a> that target the catalytic active sites. Most of them have reported cocrystal structures with PPPases, supporting many details in binding features with catalytic regions on different PPPases.</div><div class="NLM_p last">In summary, many small molecules have been reported to modulate PPPases by binding to the catalytic subunits, and it has been turned out that targeting catalytic subunits is a feasible way for cancer therapy with some of these molecules have entered clinical studies. Even so, there are still many issues that need to be addressed, such as storage stability and selectivity. Fostriecin is a potential PP2A/PP4 inhibitor for cancer therapy, but the problem of storage instability blocks further clinical study and urgently needs to be addressed. Most of the modulators mentioned above act as pan-inhibitors and may cause unpredictable toxicities due to the complex biological functions of PPPases (for more details, see <a class="ref internalNav" href="#sec2_2" aria-label="Section 2.2">Section 2.2</a>). Fortunately, abundant cocrystal structure data have been reported that may provide some clues for the development of selective inhibitors by targeting the catalytic active sites of PPPases. For instance, by aligning their sequences and analyzing the key binding sites based on the known cocrystal structures to find specific amino residues, small molecules can be designed by targeting these specific amino residues. This might be a direct and promising strategy for developing selective small-molecule modulators.</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">3.2.  Small Molecules Targeting Noncatalytic Subunits/Domains</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">3.2.1.  FTY720</h4><div class="NLM_p">FTY720 (also known as fingolimod) is a synthetic compound modified from myriocin (ISP-1, <b>20</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), a metabolite from <i>Isaria sinclairii</i>.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Initially, FTY720 was developed as an immunosuppressive agent for the treatment of multiple sclerosis and approved by the FDA in 2010.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> In the past few years, FTY720 was reported to induce apoptosis in various cancers, such as breast cancer, bladder cancer, prostate cancer, glioma, and leukemia.<a onclick="showRef(event, 'ref124 ref125 ref126 ref127 ref128 ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref124 ref125 ref126 ref127 ref128 ref129 ref130">(124−130)</a> Matsuoka et al. demonstrated that the apoptotic effects of FTY720 are achieved by activating PP2A (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> They determined that FTY720 activates PP2A to 175% of its basal activity at a 10 μM concentration and has no effects on PP1. The PP2A activation mechanism of FTY720 is identified to involve PP2AC-SET interaction disruption.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> FTY720 activates PP2A by directly binding with the C-terminus (177–277 aminos) of SET, which is a known oncoprotein and an endogenous inhibitor of PP2A (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A).<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> The immunosuppressive property of FTY720 is induced by a phosphorylated form that activates sphingosine 1-phosphate receptors.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Subsequently, AAL(S) (<b>21</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), an analog of FTY720, is identified with no immunosuppressive properties through structural optimization.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> AAL(S) shows antitumor activity in acute myeloid leukemia cells and PP2A activation activity, which further supports the former PP2A activation antitumor mechanism of FTY720.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> After PP2A is activated, the downstream signal factors of PP2A (pAkt, p70<sup>S6k</sup>/p85<sup>S6k</sup>, pRb) are significantly decreased, which induces G0/G1 cell cycle arrest in the cell cycle and finally results in apoptosis (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. FTY720 activates PP2A by disrupting the PP2AC-SET interaction and shows antitumor activity. (A) The discovery process and PP2A activation mechanism of FTY720. (B) The mechanism of cancer cell apoptosis induced by FTY720.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">3.2.2.  Ro 90-7051</h4><div class="NLM_p">In 2017, Hong et al. discovered Ro 90-7051 as a PP5 inhibitor with a unique TPR-dependent inhibitory mechanism.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>, they performed high-throughput screening of the Library of Pharmacologically Active Compounds (LOPAC1280) through the <i>p</i>-nitrophenyl phosphate assay. Then, they designed different PP5 deletion constructs to explore the potential functional mechanism of Ro 90-7051. The results showed that Ro 90-7051 strongly inhibits PP5 when the TPR domain is intact and seemingly acts as a “molecular glue” to bind the TPR domain, thus maintaining the autoinhibitory conformation of PP5.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Due to the similar features among the catalytic sites of PPPases, targeting the TPR domain may be a prerequisite property for the development of PP5-specific phosphatase inhibitors. Ro 90-7051 is a promising lead compound for cancer therapy that acts in a TPR-dependent inhibition manner on PP5.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Discovery process and mechanistic study of Ro 90-7051. Ro 90-7051 is discovered by high-throughput screening and identified as a TPR-dependent inhibitor by studying deletion constructs of PP5. The TPR domain is colored marine, the αJ helix is colored purple and catalytic sites are colored red (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA9">4JA9</a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">3.2.3.  P5SA-2</h4><div class="NLM_p">In 2015, Haslbeck et al. identified P5SA-2 (<b>22</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) as an allosteric PP5 activator by high-throughput screening.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>, they screened a compound library with 10000 compounds using a chromogenic phosphatase assay.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> By the characterization of enzyme kinetic parameters and NMR analysis, P5SA-2 was identified as an allosteric activator of PP5. At a concentration of 100 μM, P5SA-2 increased the activity of PP5 over 4-fold higher than the basal activity. In contrast to other reported activators, such as arachidonic acid<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and chaulmoogric acid<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> (respectively, <b>23</b> and <b>24</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), P5SA-2 activates PP5 in a TPR-independent manner. Although P5SA-2 is failed to modeled with PP5, the X-ray structure and mutation studies imply the binding sites for P5SA-2.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> A 10° tilt of the TPR domain and a rearrangement of the αJ helix are observed when P5SA-2 binds to PP5 (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). The complete loss of activation effect of P5SA-2 is observed with amino acids mutation, including M455A, N457A, E428A, V429A, and K430A, implying the potential binding sites of the activator. Although the comprehensive activation mechanism of P5SA-2 is still unclear, it provides a new mechanism for the development of small molecules by allosterically targeting PPPases and might open a door to treat diseases triggered by hyperphosphorylation.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. The allosteric activator P5SA-2 is identified through high-throughput screening. The binding of P5SA-2 induces conformational change in PP5: A 10° tilt of the TPR domain and a rearrangement of the αJ helix (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA7">4JA7</a>,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> P5SA-2 binding PP5 is colored blue; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA9">4JA9</a>,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> apo PP5 is colored light blue). The potential P5SA-2 binding sites on PP5 are colored yellow, and catalytic sites on PP5 are colored red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In brief, these noncatalytic functional domains, regulatory subunits, or other regulatory proteins together determine the diverse structures and specific biological functions of PPPases, and targeting noncatalytic subunits/domains is another potential strategy for cancer therapy. The discovery of FTY720, Ro 90-7051, and P5SA-2 has indicated the feasibility of this strategy. There are still some difficulties in this strategy, including a lack of adequate knowledge of PPPases structures and biological functions. For example, PP5 adopts an autoinhibitory mechanism through the TPR domain and αJ helix to regulate its activity, but the conformational changes and the specific amino residues involved in the activity transition are still unclear, which hinders the development of selective small molecules targeting the unique domain of PP5. Thus, more in-depth studies on the regulation of PPPase activity are needed.</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">3.3.  Small Molecules Targeting Holoenzymes</h3><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">3.3.1.  Perphenazine and Its Analogs</h4><div class="NLM_p">Perphenazine (PPZ, <b>25</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) is a phenothiazine antipsychotic drug that targets dopamine and related receptors in the cerebral cortex and was approved by the Food and Drug Administration (FDA) in 1956. Furthermore, it is a well-known multitarget compound and requires more comprehensive study.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a></div><div class="NLM_p">In 2014, Gutierrez et al. identified PP2A as a potential target for PPZ. PPZ activates PP2A to promote the dephosphorylation of downstream substrates (p-Akt, p-p70<sup>S6K</sup>, p-BAD) and induces the apoptosis of T cell acute lymphoblastic leukemia (T-ALL) cells.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Unfortunately, the inevitable extrapyramidal and anticholinergic effects involved in antipsychotic mechanisms preclude its further clinical research as an antitumor drug. In 2020, their group reported a small molecule, iHAP1 (a PPZ analog), that specifically activates PP2A and shows no inhibition on dopamine receptor.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> To achieve this goal, 91 compounds containing PPZ, PPZ analogs (5 FDA approved compounds and 81 commercially available compounds), and 4 dopamine receptor D2 (DRD2) inhibitors (not related to the PPZ structure) were screened by KOPT-K1 cell antiproliferation, PP2A activation, and DRD2 inhibition assays. Compared with PPZ, the analog iHAP1 exhibits stronger PP2A activation activity (over 10-fold), undetectable DRD2 inhibitory activity, and improved antiproliferation effects. iHAP1 specifically activates the PP2A holoenzyme, which contains B56ε regulatory subunit (PP2A-B56ε), to promote dephosphorylation of MYBL2 (v-myb avian myeloblastosis viral oncogene homologue-like 2) at Ser241, finally causing cancer cells apoptosis by arresting the cell cycle in prometaphase. Thus, iHAP1 shows marked antiproliferative activities in leukemia cells and neuroblastoma cells (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>A). Unfortunately, the binding mode of iHAP1 remains unclear.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Allosteric activators of PP2A. (A) DT-061 and iHAP1 activate different PP2A holoenzymes with different B56 regulatory subunits and regulate different signaling pathways. (B) The binding mode of DT-061 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NTS">6NTS</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> DT-061 works as a “molecular glue” located in a pocket formed by the intersection interface of three PP2A subunits (the scaffold Aα subunit (A subunit), catalytic Cα subunit (C subunit), and B56α regulatory subunit (B subunit)) and forms multiple types of interactions with all three subunits to stabilize the PP2A heterotrimers. The binding pocket is far away from the catalytic sites. The A subunit, B subunit, C subunit, catalytic sites, and DT-061 are colored light magenta, violet purple, marine, red, and yellow, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In 2015, Kastrinsky et al. adapted another method to avoid the dopamine receptor-mediated antipsychotic activity of PPZ. They probed the anticancer pharmacophores of PPZ by deleting and replacing central nervous systems (CNS) pharmacophores.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> They evaluated those compounds by MTT cell viability assay and obtained a series of potent compounds that were later named SMAPs (small-molecule activators of PP2A).<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> They also uncovered that PPZ directly binds to the scaffold Aα subunit of PP2A and revealed a novel antitumor mechanism by which PPZ activates PP2A to inhibit the PI3K-AKT and RAS-ERK signaling pathways. In 2017, their group utilized KRAS mutant lung cancer mouse xenografts and transgenic models to demonstrate that SMAP (also named DT-061) inhibits the growth of these types cancer cells.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> A mutation study also demonstrated that DT-061 activates PP2A by binding to the scaffold Aα subunit and inducing a conformational change in PP2A. Due to its unique regulatory mechanism, DT-061 selectively stabilizes PP2A-B56α trimers, thus dephosphorylating specific substrates.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In contrast to iHAP1, which activates the B56ε-containing PP2A and dephosphorylates MYBL2, SMAPs activate the B56α-containing PP2A, induce the dephosphorylation of c-MYC and ERK, and arrest the cell cycle in G0/G1 phase (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>A). Thus, SMAPs show antitumor activities against MYC-driven cancers (T-ALL, Burkitt lymphoma, KRAS-driven nonsmall-cell lung cancer, and triple-negative breast cancer) and EGFR-driven cancer (lung adenocarcinoma).<a onclick="showRef(event, 'ref14 ref193 ref195'); return false;" href="javascript:void(0);" class="ref ref14 ref193 ref195">(14,193,195)</a> Importantly, a cocrystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NTS">6NTS</a>)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> of the PP2A-DT-061 complex was solved at 3.6 Å in 2020 by single-particle cryo-electron microscopy (cryo-EM). As shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>B, DT-061 works as a “molecular glue” that is located in a pocket formed by the intersection interface of three PP2A subunits (including the scaffold Aα subunit (A subunit), catalytic Cα subunit (C subunit), and B56α regulatory subunit (B subunit)) and forms multiple types of interactions with all three subunits to stabilize the PP2A heterotrimers. The trifluoromethoxy part inserts into a pocket and forms electrostatic interactions with both the A subunit through Glu100 and Glu101 and the B subunit through Lys316. The benzene ring is buried in a hydrophobic region composed of Ile237, Tyr238, and Phe317 of the B subunit and Phe308 of the C subunit. The sulfonyl group interacts with Lys283 of the B subunit through electrostatic interactions. The phenoxazine moiety is exposed to the solvent region and forms hydrophobic interactions with Thr102 and Val103 of the A subunit and electrostatic interactions with Pro305 and Tyr307 of the B subunit. The C-tail of the A subunit is swinging freely before DT-061 attachment, and it is fixed in the crack between A subunit and B subunit after the interaction formed between the phenoxazine moiety of DT-061 and AB subunits.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">3.3.2.  Macrolide Inhibitors</h4><div class="NLM_p">Cyclosporine A (CsA) is a cyclic peptide (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A) extracted from the fungus <i>Tolypocladium inflatum</i>, which is initially named “ovalicin” and manufactured by Novartis (previously known as Sandoz).<a onclick="showRef(event, 'ref197 ref198'); return false;" href="javascript:void(0);" class="ref ref197 ref198">(197,198)</a> Tacrolimus (also known as FK-506 or fujimycin) is isolated from <i>Streptomyces tsukubaensis</i> and originally developed by Astellas Pharma. Both of them are initially developed as immunosuppressants to reduce the risk of organ rejection after organ transplantation. CsA and FK-506 have similar biological properties and mechanisms.<a onclick="showRef(event, 'ref199 ref200'); return false;" href="javascript:void(0);" class="ref ref199 ref200">(199,200)</a> CsA and FK-506 were approved by the FDA in 1983 and 1994, respectively. In the process of exploring their mechanisms, PP3 is identified as a target.<a onclick="showRef(event, 'ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref133 ref134">(133,134)</a> Before combining with PP3, CsA and FK-506 first form a binary complex with immunophilins, their specific carrier protein. Immunophilins are highly conserved and ubiquitously expressed with peptidylprolyl isomerase activity, and they are mainly divided into two types: cyclophilins (Cyp, for CsA binding) and FK-506 binding proteins (FKBPs).<a onclick="showRef(event, 'ref201 ref202 ref203 ref204'); return false;" href="javascript:void(0);" class="ref ref201 ref202 ref203 ref204">(201−204)</a> Recently, they were found to exhibit antitumor effects in cancers, including colorectal cancer,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> breast cancer,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> bladder cancer,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> lung cancer,<a onclick="showRef(event, 'ref205 ref206'); return false;" href="javascript:void(0);" class="ref ref205 ref206">(205,206)</a> oral squamous cell carcinoma,<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> and other cancers.<a onclick="showRef(event, 'ref47 ref205 ref206 ref207 ref208'); return false;" href="javascript:void(0);" class="ref ref47 ref205 ref206 ref207 ref208">(47,205−208)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Macrolide inhibitors selectively inhibit PP3 and block the proliferation of diverse cancer cells. (A) Structure of CsA. (B) Antitumor mechanism of CsA and FK-506. (C) Binding mode of the Cn-CsA-Cyp complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MF8">1MF8</a>):<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> The CsA-Cyp complex interacts with both CnA and CnB mainly through hydrophobic interactions and hydrogen bonds. CsA hydrogen bonds are indicated by green dotted line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">CsA and FK-506 selectively inhibit PP3 with comparable inhibitory activities (the IC<sub>50</sub> value were 7 nM and 0.4 nM, respectively) and show no effects on other PPPases.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Masuo et al. investigated the role of PP3 in the development of cancers and found that PP3 promotes cancer cells proliferation through the NFAT pathway.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In colorectal cancer, PP3 promotes cancer cell proliferation probably by regulating the levels of c-Myc, the proliferating cell nuclear antigen (PCNA), and p21 (WAF1/CIP1).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B, the proliferation of colon cancer cells is blocked after CsA treatment, and the expression of c-Myc and PCNA is decreased, while that of p21 (WAF1/CIP1) is increased. In bladder cancer and prostate cancer, CsA and FK-506 attenuate NFAT transcriptional activity and decrease the expression of NFATc1 and the downstream proteins cyclooxygenase-2 (COX-2) and c-Myc. In addition, several tumor suppressor genes, such as p53, p21, and p27, are upregulated, and some oncogenic genes are downregulated, including cyclin D1, cyclin D3, and cyclin E.<a onclick="showRef(event, 'ref48 ref209'); return false;" href="javascript:void(0);" class="ref ref48 ref209">(48,209)</a> CsA and FK-506 retard tumor growth by inhibiting proliferation, migration, and invasion and promoting apoptosis. In addition to evidence from the Masuo group, other evidence also revealed the antitumor activities of CsA and FK-506 on other cancers.<a onclick="showRef(event, 'ref47 ref205 ref206 ref207 ref208'); return false;" href="javascript:void(0);" class="ref ref47 ref205 ref206 ref207 ref208">(47,205−208)</a> In a breast cancer model, pyruvate kinase M2 (PKM2) is overexpressed which is closely related to the usage of glycolytic intermediates for macromolecular biosynthesis and tumor growth. Treatment with CsA can significantly downregulate the expression of PKM2 and reduce ATP synthesis, which induces cancer cell necrosis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Other cancers, including lung cancer and oral squamous cell carcinoma, are also response to CsA.<a onclick="showRef(event, 'ref205 ref206 ref207 ref208'); return false;" href="javascript:void(0);" class="ref ref205 ref206 ref207 ref208">(205−208)</a></div><div class="NLM_p">The cocrystal structures of both CsA-immunophilin complex and FK-506-immunophilin complex revealed similar binding sites on PP3.<a onclick="showRef(event, 'ref196 ref210'); return false;" href="javascript:void(0);" class="ref ref196 ref210">(196,210)</a> Here, we just take CsA as an example to introduce its potential regulation mechanism and binding mode (PDB code:<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MF8">1MF8</a>).<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B, the binding sites are far away from the catalytic sites of CnA (catalytic subunit of PP3). The CsA-Cyp complex interacts with both CnA and CnB (Calcineurin B) mainly through hydrophobic interactions and hydrogen bonds.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> There are two hydrophobic surfaces in PP3: hydrophobic surface A (HSA) is composed of CnALeu343, CnAPro344, CnATrp352, CnASer353, CnAPhe356, CnBMet118, CnBVal119, CnBAsn122, and CnBLeu123; and hydrophobic surface B (HSB) is composed of CnALeu312 and CnAVal314. HSA forms primary hydrophobic interactions with Sar3, MeLeu4, Val5, MeLeu6, and Ala7 of CsA. HSB interacts with Ala8 and MeLeu9 of CsA. Among them, the side chain of CsAMeLeu4 inserts into a hydrophobic pocket composed of CnATrp352, CnASer353, CnAPhe356, CnBMet118, and CnBVal119. There are two hydrogen bonds formed by the carbonyl of CsAVal5 and indole NH of CnATrp352 and the amine NH of CsAVal7 and phenolic hydroxyl of CnATyr341. In short, the CsA-Cyp complex interacts with both the catalytic subunit and regulatory subunits of PP3 and covers the active sites of PP3 catalytic subunit to block access to the substrate protein.</div><div class="NLM_p">As shown above, small molecules targeting holoenzymes are another promising strategy to selectively modulate different PPPases or even different holoenzymes of one PPPase subfamily. iHAP1 and DT-061 interact with different B56-containing PP2A holoenzymes and specifically dephosphorylate different substrates of PP2A, thus inducing cancer cell apoptosis through different mechanisms. CsA and FK-506 selectively inhibit PP3 by binding to the heterodimer and retard proliferation of diverse cancer cells. As mentioned in <a class="ref internalNav" href="#sec3_2" aria-label="Section 3.2">Section 3.2</a>, the challenge in developing small molecules targeting holoenzymes also is the lack of the knowledge of the conformational changes in the activity transition of PPPases.</div><div class="NLM_p last">With so many reported compounds targeting PPPases, PPPases have broken the prejudice of undruggability and have gradually attracted the attention of medicinal chemists.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> Based on the current research results, small molecules targeting catalytic subunits, targeting noncatalytic subunits/domains, or targeting holoenzymes are all feasible ways to develop antitumor drugs by modulating PPPases. Compared with strategies targeting noncatalytic subunits/domains and holoenzymes, targeting catalytic subunits is easier with many reported ligand-PPPase cocrystal structures, which provides many essential clues to design small molecules. None of the existing small molecules targeting catalytic subunits are selective, which is the main difficulty in optimizing current small molecules or developing new small molecules with new scaffolds. It is easier to achieve selectivity by targeting noncatalytic subunits/domains or holoenzymes, but the lack of knowledge of the conformational changes in the activity transitions of PPPases is an obstacle hindering the development of these two strategies. Fortunately, many small molecules have been reported, which could provide guidance and references for the development of new candidates for cancer therapy.</div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">4.  Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">It is exciting to witness those possible ways of the development of the small molecules targeting PPPases in recent years. In this review, we summarize not only the structural features of different PPPases but also the related small molecules with disparate regulation mechanisms. With the accumulated evidence, it could be speculated that PPPases are highly involved in cancers. Thus, the rational design of small molecules targeting PPPases with high potency and specificity has become an urgent mission. Among all the potential strategies, directly targeting the catalytic subunits of PPPases remains an effective approach, although challenges still exist for the negatively charged binding domain and the lack of subtype specificity. Interestingly, targeting specific conserved cysteine residues on the surface of PPPases catalytic subunits makes covalent binding available and increases the selectivity of small molecules, which might provide another feasible way for developing PPPase modulators with improved binding potency and specificity. Targeting noncatalytic subunits/domains or holoenzymes is another promising way to design small molecules with better druggability and selectivity. Although the full scope of PPPases activity regulation has not been revealed, the success of the above-mentioned small molecules could provide guidance and references for the development of subsequent small molecules for cancer therapy. Notably, many small molecules originate from the new repurposing of old drugs, such as PPZ, FK-506, CsA, and FTY720, which may become a source of PPPase modulators screening. Taken together, these findings indicate that developing PPPase modulators is a promising strategy for cancer therapy, and it is foreseeable that PPPase modulators will occupy an important position in the development of antitumor drugs.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00631" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qidong You</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8587-0122" title="Orcid link">https://orcid.org/0000-0002-8587-0122</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#126b7d676376522324213c717d7f"><span class="__cf_email__" data-cfemail="433a2c363227037275706d202c2e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Wang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8181-5644" title="Orcid link">https://orcid.org/0000-0002-8181-5644</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fc9099958b9d929bd2c5cdbc9f8c89d2999889d29f92"><span class="__cf_email__" data-cfemail="0b676e627c6a656c25323a4b687b7e256e6f7e256865">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiuyue Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongjiao Fan</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lianshan Zhang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Hengrui Pharmaceutical Co., Ltd., Shanghai 200245, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Qiuyue Zhang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=BIO-d7e2770-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Qiuyue Zhang</b> received her Master’s degree from China Pharmaceutical University in 2019. She is currently a Ph.D. candidate at the Department of Medicinal Chemistry, China Pharmaceutical University and the Jiangsu Key Laboratory of Drug Design and Optimization, under the supervision of Professor Qi-Dong You. Her research interests mainly focus on the following: (i) discovery and development of first-in-class small-molecule inhibitors targeting the Hsp90-Cdc37-kinase related system and (ii) discovery and development of first-in-class small-molecule regulators targeting serine/threonine protein phosphatase.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Zhongjiao Fan</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=BIO-d7e2775-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zhongjiao Fan</b> received her Bachelor’s degree from China Pharmaceutical University in 2021. She is currently working on her Master’s degree at the School of Pharmacy, Fudan University.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Lianshan Zhang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=BIO-d7e2780-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lianshan Zhang</b> received his Ph.D. degree from Eberhard Karls Universität Tübingen in 1992. Currently, he is a professor of Medicinal Chemistry in the Department of Medicinal Chemistry, China Pharmaceutical University, the industry professor of Jiangsu Province, and the deputy general manager and the president of global research and development of Jiangsu Hengrui Pharmaceutical Co., Ltd. His research interests mainly focus on innovative drug research for major diseases.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Qidong You</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=BIO-d7e2785-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Qidong You</b> graduated from China Pharmaceutical University and received his Master’s degree in 1985. He received his Ph.D. degree from the Shanghai Institute of Pharmaceutical Industry in 1989. Currently, he is a professor in the Department of Medicinal Chemistry, China Pharmaceutical University and the director of Jiangsu Key Laboratory of Drug Design and Optimization. His research interests mainly focus on small-molecule inhibitors of protein–protein interactions, antitumor natural products, and targeted anticancer drugs.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Lei Wang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=BIO-d7e2790-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lei Wang</b> received his Ph.D. degree in 2018 from China Pharmaceutical University under the supervision of Prof. You. Currently, he is an associate professor at the Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University. His main research topics focus on the following: (i) discovery and development of first-in-class small-molecule inhibitors targeting the Hsp90-Cdc37-kinase related system, (ii) chemical biology study of molecule chaperone cycles, and (iii) discovery and development of first-in-class small-molecule regulators targeting serine/threonine protein phosphatase.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31548" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31548" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by projects 82003582 and 81930100 of the National Natural Science Foundation of China, BK20190559 of the Natural Science Foundation of Jiangsu Province of China, CPU2018GY02 of the Double First Class Innovation Team of China Pharmaceutical University, the National Science and Technology Major Project “Key New Drug Creation and Manufacturing Program”, China (nos: 2018ZX09711002, 2017ZX09302003 and 2015ZX09101032), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (nos. SKLNMZZ202003 and SKLNMZZ202003), and the Priority Academic Program Development of Jiangsu Higher Education Institutions.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BAD</td><td class="NLM_def"><p class="first last">Bcl-2-associated death promoter</p></td></tr><tr><td class="NLM_term">CaM</td><td class="NLM_def"><p class="first last">Ca<sup>2+</sup>-calmodulin</p></td></tr><tr><td class="NLM_term">AI</td><td class="NLM_def"><p class="first last">autoinhibitory domain</p></td></tr><tr><td class="NLM_term">Cn</td><td class="NLM_def"><p class="first last">calcineurin</p></td></tr><tr><td class="NLM_term">Cdc25c</td><td class="NLM_def"><p class="first last">cell division cycle 25c</p></td></tr><tr><td class="NLM_term">CsA</td><td class="NLM_def"><p class="first last">cyclosporine A</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous systems</p></td></tr><tr><td class="NLM_term">Cyp</td><td class="NLM_def"><p class="first last">cyclophilins</p></td></tr><tr><td class="NLM_term">CnA</td><td class="NLM_def"><p class="first last">subunit A of calcineurin, CnB, subunit B of calcineurin</p></td></tr><tr><td class="NLM_term">CIP1</td><td class="NLM_def"><p class="first last">CDK (cyclin-dependent kinase)-interacting protein 1</p></td></tr><tr><td class="NLM_term">COX-2</td><td class="NLM_def"><p class="first last">cyclooxygenase-2</p></td></tr><tr><td class="NLM_term">DDR</td><td class="NLM_def"><p class="first last">DNA damage repair</p></td></tr><tr><td class="NLM_term">DRD2</td><td class="NLM_def"><p class="first last">dopamine receptor D2</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular-signal regulated kinase</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">the Food and Drug Administration</p></td></tr><tr><td class="NLM_term">γH2AX</td><td class="NLM_def"><p class="first last">phosphorylated H2A histone family member X</p></td></tr><tr><td class="NLM_term">HRR</td><td class="NLM_def"><p class="first last">homologous recombination repair</p></td></tr><tr><td class="NLM_term">HIF-1α</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor-1α</p></td></tr><tr><td class="NLM_term">HSA</td><td class="NLM_def"><p class="first last">hydrophobic surface A</p></td></tr><tr><td class="NLM_term">HSB</td><td class="NLM_def"><p class="first last">hydrophobic surface B</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">MDM2</td><td class="NLM_def"><p class="first last">murine double minute 2</p></td></tr><tr><td class="NLM_term">MYBL2</td><td class="NLM_def"><p class="first last">v-myb avian myeloblastosis viral oncogene homologue-like 2</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximum-tolerated dose</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">N-CoR</td><td class="NLM_def"><p class="first last">nuclear receptor corepressor</p></td></tr><tr><td class="NLM_term">PlK1</td><td class="NLM_def"><p class="first last">polo-like kinase 1</p></td></tr><tr><td class="NLM_term">PPPases</td><td class="NLM_def"><p class="first last">phosphoprotein phosphatases</p></td></tr><tr><td class="NLM_term">PP1</td><td class="NLM_def"><p class="first last">protein phosphatase 1</p></td></tr><tr><td class="NLM_term">PP2A</td><td class="NLM_def"><p class="first last">protein phosphatase 2A</p></td></tr><tr><td class="NLM_term">PP2B</td><td class="NLM_def"><p class="first last">protein phosphatase 2B</p></td></tr><tr><td class="NLM_term">PP3</td><td class="NLM_def"><p class="first last">protein phosphatase 3</p></td></tr><tr><td class="NLM_term">PP4</td><td class="NLM_def"><p class="first last">protein phosphatase 4</p></td></tr><tr><td class="NLM_term">PP5</td><td class="NLM_def"><p class="first last">protein phosphatase 5</p></td></tr><tr><td class="NLM_term">PP6</td><td class="NLM_def"><p class="first last">protein phosphatase 6</p></td></tr><tr><td class="NLM_term">PP7</td><td class="NLM_def"><p class="first last">protein phosphatase 7</p></td></tr><tr><td class="NLM_term">PPEF</td><td class="NLM_def"><p class="first last">protein phosphatases with EF-hand domains</p></td></tr><tr><td class="NLM_term">PIPs</td><td class="NLM_def"><p class="first last">PP1-interacting proteins</p></td></tr><tr><td class="NLM_term">pRb</td><td class="NLM_def"><p class="first last">phosphorylated retinoblastoma</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PPZ</td><td class="NLM_def"><p class="first last">phenothiazine</p></td></tr><tr><td class="NLM_term">PCNA</td><td class="NLM_def"><p class="first last">the proliferating cell nuclear antigen</p></td></tr><tr><td class="NLM_term">PKM2</td><td class="NLM_def"><p class="first last">pyruvate kinase M2</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">Rb</td><td class="NLM_def"><p class="first last">retinoblastoma</p></td></tr><tr><td class="NLM_term">RAS</td><td class="NLM_def"><p class="first last">reticular activating system</p></td></tr><tr><td class="NLM_term">SMAPs</td><td class="NLM_def"><p class="first last">small-molecule activators of PP2A</p></td></tr><tr><td class="NLM_term">SET</td><td class="NLM_def"><p class="first last">SET domain containing protein (domain containing is a 130–140 amino acid, evolutionary well conserved sequence motif that was initially characterized in the Drosophila proteins Su (var.)3-9, Enhancer-of-zeste and Trithorax)</p></td></tr><tr><td class="NLM_term">STAT1</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 1</p></td></tr><tr><td class="NLM_term">TPR</td><td class="NLM_def"><p class="first last">tetratricopeptide repeat</p></td></tr><tr><td class="NLM_term">T-ALL</td><td class="NLM_def"><p class="first last">lymphoblastic leukemia</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36620" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36620" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 211 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagoev, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortensen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, M.</span></span> <span> </span><span class="NLM_article-title">Global, in Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2006.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17081983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WgtbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=635-648&author=J.+V.+Olsenauthor=B.+Blagoevauthor=F.+Gnadauthor=B.+Macekauthor=C.+Kumarauthor=P.+Mortensenauthor=M.+Mann&title=Global%2C+in+Vivo%2C+and+Site-Specific+Phosphorylation+Dynamics+in+Signaling+Networks&doi=10.1016%2Fj.cell.2006.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global, in vivo, and site-specific phosphorylation dynamics in signaling networks</span></div><div class="casAuthors">Olsen, Jesper V.; Blagoev, Blagoy; Gnad, Florian; Macek, Boris; Kumar, Chanchai; Mortensen, Peter; Mann, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">635-648</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cell signaling mechanisms often transmit information via posttranslational protein modifications, most importantly reversible protein phosphorylation.  Here we develop and apply a general mass spectrometric technol. for identification and quantitation of phosphorylation sites as a function of stimulus, time, and subcellular location.  We have detected 6600 phosphorylation sites on 2244 proteins and have detd. their temporal dynamics after stimulating HeLa cells with epidermal growth factor (EGF) and recorded them in the Phosida database.  Fourteen percent of phosphorylation sites are modulated at least 2-fold by EG, and these were classified by their temporal profiles.  Surprisingly, a majority of proteins contain multiple phosphorylation sites showing different kinetics, suggesting that they serve as platforms for integrating signals.  In addn. to protein kinase cascades, the targets of reversible phosphorylation include ubiquitin ligases, guanine nucleotide exchange factors, and at least 46 different transcriptional regulators.  The dynamic phosphoproteome provides a missing link in a global, integrative view of cellular regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2fanpqTJaa7Vg90H21EOLACvtfcHk0lg1dICGf39vOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WgtbzO&md5=c8f9ef184663cabfda0db5958549166c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DBlagoev%26aufirst%3DB.%26aulast%3DGnad%26aufirst%3DF.%26aulast%3DMacek%26aufirst%3DB.%26aulast%3DKumar%26aufirst%3DC.%26aulast%3DMortensen%26aufirst%3DP.%26aulast%3DMann%26aufirst%3DM.%26atitle%3DGlobal%252C%2520in%2520Vivo%252C%2520and%2520Site-Specific%2520Phosphorylation%2520Dynamics%2520in%2520Signaling%2520Networks%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D635%26epage%3D648%26doi%3D10.1016%2Fj.cell.2006.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holt, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuch, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gygi, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. O.</span></span> <span> </span><span class="NLM_article-title">Global Analysis of Cdk1 Substrate Phosphorylation Sites Provides Insights into Evolution</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">1682</span>– <span class="NLM_lpage">1686</span>, <span class="refDoi"> DOI: 10.1126/science.1172867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1126%2Fscience.1172867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19779198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGqt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=1682-1686&author=L.+J.+Holtauthor=B.+B.+Tuchauthor=J.+Villenauthor=A.+D.+Johnsonauthor=S.+P.+Gygiauthor=D.+O.+Morgan&title=Global+Analysis+of+Cdk1+Substrate+Phosphorylation+Sites+Provides+Insights+into+Evolution&doi=10.1126%2Fscience.1172867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Global Analysis of Cdk1 Substrate Phosphorylation Sites Provides Insights into Evolution</span></div><div class="casAuthors">Holt, Liam J.; Tuch, Brian B.; Villen, Judit; Johnson, Alexander D.; Gygi, Steven P.; Morgan, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5948</span>),
    <span class="NLM_cas:pages">1682-1686</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">To explore the mechanisms and evolution of cell-cycle control, we analyzed the position and conservation of large nos. of phosphorylation sites for the cyclin-dependent kinase Cdk1 in the budding yeast Saccharomyces cerevisiae.  We combined specific chem. inhibition of Cdk1 with quant. mass spectrometry to identify the positions of 547 phosphorylation sites on 308 Cdk1 substrates in vivo.  Comparisons of these substrates with orthologs throughout the ascomycete lineage revealed that the position of most phosphorylation sites is not conserved in evolution; instead, clusters of sites shift position in rapidly evolving disordered regions.  We propose that the regulation of protein function by phosphorylation often depends on simple nonspecific mechanisms that disrupt or enhance protein-protein interactions.  The gain or loss of phosphorylation sites in rapidly evolving regions could facilitate the evolution of kinase signaling circuits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi1JZunrkk8LVg90H21EOLACvtfcHk0lg1dICGf39vOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGqt7%252FP&md5=27178a3c1791d046fa801e47cac844be</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1172867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1172867%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DL.%2BJ.%26aulast%3DTuch%26aufirst%3DB.%2BB.%26aulast%3DVillen%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BD.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26atitle%3DGlobal%2520Analysis%2520of%2520Cdk1%2520Substrate%2520Phosphorylation%2520Sites%2520Provides%2520Insights%2520into%2520Evolution%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D1682%26epage%3D1686%26doi%3D10.1126%2Fscience.1172867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serber, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrell, J. E.</span></span> <span> </span><span class="NLM_article-title">Tuning Bulk Electrostatics to Regulate Protein Function</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.01.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2007.01.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17289565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1Wlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=441-444&author=Z.+Serberauthor=J.+E.+Ferrell&title=Tuning+Bulk+Electrostatics+to+Regulate+Protein+Function&doi=10.1016%2Fj.cell.2007.01.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tuning bulk electrostatics to regulate protein function</span></div><div class="casAuthors">Serber, Zach; Ferrell, James E., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-444</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinase activation can prevent yeast cells from responding to mating pheromone.  Strickfaden et al. (2007) now show that this block arises from the multisite phosphorylation of Ste5.  This provides a beautiful example of how phosphorylation can produce decisive changes in protein function through bulk electrostatics, without the necessity of intricate conformational changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqoROeBePwprVg90H21EOLACvtfcHk0lg1dICGf39vOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1Wlt7s%253D&md5=7c5c434214d2b0722fbc656592b8dee2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DSerber%26aufirst%3DZ.%26aulast%3DFerrell%26aufirst%3DJ.%2BE.%26atitle%3DTuning%2520Bulk%2520Electrostatics%2520to%2520Regulate%2520Protein%2520Function%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D441%26epage%3D444%26doi%3D10.1016%2Fj.cell.2007.01.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruvolo, P. P.</span></span> <span> </span><span class="NLM_article-title">Role of Protein Phosphatases in the Cancer Microenvironment</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1866</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2018.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bbamcr.2018.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30026077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCltLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1866&publication_year=2019&pages=144-152&author=P.+P.+Ruvolo&title=Role+of+Protein+Phosphatases+in+the+Cancer+Microenvironment&doi=10.1016%2Fj.bbamcr.2018.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Role of protein phosphatases in the cancer microenvironment</span></div><div class="casAuthors">Ruvolo, Peter P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1866</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer cells depend on a supportive niche (the tumor microenvironment) that promotes tumor cell survival while protecting the malignant cells from therapeutic challenges and the host's defense systems.  Cancer cells and the support cells in the tumor microenvironment communicate via cytokines/chemokines, cell:cell contact, or alterations in the metabolic state of the niche (e.g. hypoxia) that promote growth and survival of the tumor cell, influence metastasis, and defeat immune surveillance.  These signaling pathways involve dysregulation of not only protein kinases but also protein phosphatases as normal signal transduction processes require both activation and deactivation.  For instance, aberrant receptor signaling can result from constitutive activation of a tyrosine kinase such as FLT3 or inactivation of a tyrosine protein phosphatase such as SHP-2 (PTPN11).  Activation of serine/threonine kinases such as AKT and ERK are often obsd. during the development of drug resistance while genomic and non-genomic suppression of serine/threonine protein phosphatases such as PP2A achieve similar results.  It is fairly clear that the various protein phosphatases will impact processes that support drug resistance.  Of growing interest is the emerging model whereby the support cells in the tumor microenvironment actually serve as drivers of tumorigenesis.  This phenomenon has been most prominently obsd. in osteoblast cells in leukemic niches.  At least one protein phosphatase, PTPN11, has emerged as a crit. driver of this process in juvenile myelomonocytic leukemia.  This review will cover the role of various serine/threonine and tyrosine protein phosphatases in processes that are central to tumor microenvironment function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo3SXsQ76b47Vg90H21EOLACvtfcHk0lg1dICGf39vOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCltLjI&md5=fed1fbf4b19c201807dd3193fe835df9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2018.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2018.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DRuvolo%26aufirst%3DP.%2BP.%26atitle%3DRole%2520of%2520Protein%2520Phosphatases%2520in%2520the%2520Cancer%2520Microenvironment%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2019%26volume%3D1866%26spage%3D144%26epage%3D152%26doi%3D10.1016%2Fj.bbamcr.2018.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, C.</span></span> <span> </span><span class="NLM_article-title">Phosphatases in Mitosis: Roles and Regulation</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">55</span>, <span class="refDoi"> DOI: 10.3390/biom9020055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3390%2Fbiom9020055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvVehsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=55&author=M.+Mouraauthor=C.+Conde&title=Phosphatases+in+Mitosis%3A+Roles+and+Regulation&doi=10.3390%2Fbiom9020055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatases in mitosis: roles and regulation</span></div><div class="casAuthors">Moura, Margarida; Conde, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">55/1-55/51</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Mitosis requires extensive rearrangement of cellular architecture and of subcellular structures so that replicated chromosomes can bind correctly to spindle microtubules and segregate towards opposite poles.  This process originates two new daughter nuclei with equal genetic content and relies on highly-dynamic and tightly regulated phosphorylation of numerous cell cycle proteins.  A burst in protein phosphorylation orchestrated by several conserved kinases occurs as cells go into and progress through mitosis.  The opposing dephosphorylation events are catalyzed by a small set of protein phosphatases, whose importance for the accuracy of mitosis is becoming increasingly appreciated.  This review will focus on the established and emerging roles of mitotic phosphatases, describe their structural and biochem. properties, and discuss recent advances in understanding the regulation of phosphatase activity and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMQfiW6qA8Y7Vg90H21EOLACvtfcHk0lhvZ_5eAY9RrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvVehsL8%253D&md5=d42a0ee9edc8b35dd656b20b33a9a742</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fbiom9020055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom9020055%26sid%3Dliteratum%253Aachs%26aulast%3DMoura%26aufirst%3DM.%26aulast%3DConde%26aufirst%3DC.%26atitle%3DPhosphatases%2520in%2520Mitosis%253A%2520Roles%2520and%2520Regulation%26jtitle%3DBiomolecules%26date%3D2019%26volume%3D9%26spage%3D55%26doi%3D10.3390%2Fbiom9020055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenolikar, S.</span></span> <span> </span><span class="NLM_article-title">Protein Serine/Threonine Phosphatases: Keys to Unlocking Regulators and Substrates</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">964</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-062917-012332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1146%2Fannurev-biochem-062917-012332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29925267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=921-964&author=D.+L.+Brautiganauthor=S.+Shenolikar&title=Protein+Serine%2FThreonine+Phosphatases%3A+Keys+to+Unlocking+Regulators+and+Substrates&doi=10.1146%2Fannurev-biochem-062917-012332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Serine/Threonine Phosphatases: Keys to Unlocking Regulators and Substrates</span></div><div class="casAuthors">Brautigan, David L.; Shenolikar, Shirish</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">921-964</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Protein serine/threonine phosphatases (PPPs) are ancient enzymes, with distinct types conserved across eukaryotic evolution.  PPPs are segregated into types primarily on the basis of the unique interactions of PPP catalytic subunits with regulatory proteins.  The resulting holoenzymes dock substrates distal to the active site to enhance specificity.  This review focuses on the subunit and substrate interactions for PPP that depend on short linear motifs.  Insights about these motifs from structures of holoenzymes open new opportunities for computational biol. approaches to elucidate PPP networks.  There is an expanding knowledge base of posttranslational modifications of PPP catalytic and regulatory subunits, as well as of their substrates, including phosphorylation, acetylation, and ubiquitination.  Cross talk between these posttranslational modifications creates PPP-based signaling.  Knowledge of PPP complexes, signaling clusters, as well as how PPPs communicate with each other in response to cellular signals should unlock the doors to PPP networks and signaling "clouds" that orchestrate and coordinate different aspects of cell physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH392q45tGO7Vg90H21EOLACvtfcHk0lhvZ_5eAY9RrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrrL&md5=dc58f68ce05dd5535e8ce0c7e1d5036d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-062917-012332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-062917-012332%26sid%3Dliteratum%253Aachs%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26aulast%3DShenolikar%26aufirst%3DS.%26atitle%3DProtein%2520Serine%252FThreonine%2520Phosphatases%253A%2520Keys%2520to%2520Unlocking%2520Regulators%2520and%2520Substrates%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2018%26volume%3D87%26spage%3D921%26epage%3D964%26doi%3D10.1146%2Fannurev-biochem-062917-012332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Munter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">Challenges and Opportunities in the Development of Protein Phosphatase-Directed Therapeutics</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1021/cb300597g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300597g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSjurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=36-45&author=S.+De%0AMunterauthor=M.+K%C3%B6hnauthor=M.+Bollen&title=Challenges+and+Opportunities+in+the+Development+of+Protein+Phosphatase-Directed+Therapeutics&doi=10.1021%2Fcb300597g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities in the Development of Protein Phosphatase-Directed Therapeutics</span></div><div class="casAuthors">De Munter, Sofie; Kohn, Maja; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-45</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Protein phosphatases have both protective and promoting roles in the etiol. of diseases.  A prominent example is the existence of oncogenic as well as tumor-suppressing protein phosphatases.  A few protein phosphatase activity modulators are already applied in therapies.  These were however not developed in target-directed approaches, and the recent discovery of phosphatase involvement followed their application in therapy.  Nevertheless, these examples demonstrate that small mols. can be generated that modulate the activity of protein phosphatases and are beneficial for the treatment of protein phosphorylation diseases.  We describe here strategies for the development of activators and inhibitors of protein phosphatases and clarify some long-standing misconceptions concerning the drug ability of these enzymes.  Recent developments suggest that it is feasible to design potent and selective protein phosphatase modulators with a therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTwo-BD9sHS7Vg90H21EOLACvtfcHk0lhvZ_5eAY9RrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSjurrF&md5=a6bccc84309271ecdec328d6b1b84294</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcb300597g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300597g%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMunter%26aufirst%3DS.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DChallenges%2520and%2520Opportunities%2520in%2520the%2520Development%2520of%2520Protein%2520Phosphatase-Directed%2520Therapeutics%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D36%26epage%3D45%26doi%3D10.1021%2Fcb300597g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roskoski, R.</span></span> <span> </span><span class="NLM_article-title">Properties of Fda-Approved Small Molecule Protein Kinase Inhibitors</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2019.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.phrs.2019.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30877063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntVGnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=19-50&author=R.+Roskoski&title=Properties+of+Fda-Approved+Small+Molecule+Protein+Kinase+Inhibitors&doi=10.1016%2Fj.phrs.2019.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of FDA-approved small molecule protein kinase inhibitors</span></div><div class="casAuthors">Roskoski, Robert Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-50</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Because mutations, overexpression, and dysregulation of protein kinases play essential roles in the pathogenesis of many illnesses, this enzyme family has become one of the most important drug targets in the past 20 years.  The US FDA has approved 48 small mol. protein kinase inhibitors, nearly all of which are orally effective with the exceptions of netarsudil (which is given as an eye drop) and temsirolimus (which is given i.v.).  Of the 48 approved drugs, the majority (25) target receptor protein-tyrosine kinases, ten target non-receptor protein-tyrosine kinases, and 13 target protein-serine/threonine protein kinases.  The data indicate that 43 of these drugs are used in the treatment of malignancies (36 against solid tumors including lymphomas and seven against non-solid tumors, e.g., leukemias).  Seven drugs are used in the treatment of non-malignancies: baricitinib, rheumatoid arthritis; fostamatinib, chronic immune thrombocytopenia; ruxolitinib, myelofibrosis and polycythemia vera; nintedanib, idiopathic pulmonary fibrosis; sirolimus, renal graft vs. host disease; netarsudil, glaucoma; tofacitinib, rheumatoid arthritis, Crohn disease, and ulcerative colitis.  Moreover, ibrutinib and sirolimus are used for the treatment of both malignant and non-malignant diseases.  The most common drug targets include ALK, B-Raf, BCR-Abl, epidermal growth factor receptor (EGFR), and vascular endothelial growth factor receptor (VEGFR).  Most of the small mol. inhibitors (45) interact directly with the protein kinase domain.  In contrast, sirolimus, temsirolimus, and everolimus are larger mols. (MW ≈ 1000) that bind to FKBP-12 to generate a complex that inhibits mTOR (mammalian target of rapamycin).  This review presents the available drug-enzyme X-ray crystal structures for 27 of the approved drugs as well as the chem. structures and physicochem. properties of all of the FDA-approved small mol. protein kinase antagonists.  Six of the drugs bind covalently and irreversibly to their target.  Twenty of the 48 drugs have mol. wts. greater than 500, exceeding a Lipinski rule of five criterion.  Excluding the macrolides (everolimus, sirolimus, temsirolimus), the av. mol. wt. of drugs is 480 with a range of 306 (ruxolitinib) to 615 (trametinib).  Nearly half of the antagonists (23) have a lipophilic efficiency with values of less than five while the recommended optima range from 5-10.  One of the vexing problems is the near universal development of resistance that is assocd. with the use of small mol. protein kinase inhibitors for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLum_hDK00hbVg90H21EOLACvtfcHk0lgQ0F8rm6sJ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntVGnurg%253D&md5=a24dee87603bc4ea12bd34616e46f53d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2019.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DRoskoski%26aufirst%3DR.%26atitle%3DProperties%2520of%2520Fda-Approved%2520Small%2520Molecule%2520Protein%2520Kinase%2520Inhibitors%26jtitle%3DPharmacol.%2520Res.%26date%3D2019%26volume%3D144%26spage%3D19%26epage%3D50%26doi%3D10.1016%2Fj.phrs.2019.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCluskey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, A. T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakoff, J. A.</span></span> <span> </span><span class="NLM_article-title">Serine-Threonine Protein Phosphatase Inhibitors: Development of Potential Therapeutic Strategies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1151</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1021/jm010066k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010066k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Grsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1151-1175&author=A.+McCluskeyauthor=A.+T.+R.+Simauthor=J.+A.+Sakoff&title=Serine-Threonine+Protein+Phosphatase+Inhibitors%3A+Development+of+Potential+Therapeutic+Strategies&doi=10.1021%2Fjm010066k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Serine-Threonine Protein Phosphatase Inhibitors: Development of Potential Therapeutic Strategies</span></div><div class="casAuthors">McCluskey, Adam; Sim, Alistair T. R.; Sakoff, Jennette A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1151-1175</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include classification of protein phosphatases, natural phosphatase inhibitors, structural features of protein phosphatase inhibition and therapeutic use of protein phosphatase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1v3fejhgFHLVg90H21EOLACvtfcHk0lgQ0F8rm6sJ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Grsrw%253D&md5=911e087a9986fb7fb4c49e5cb03ddfc1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm010066k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010066k%26sid%3Dliteratum%253Aachs%26aulast%3DMcCluskey%26aufirst%3DA.%26aulast%3DSim%26aufirst%3DA.%2BT.%2BR.%26aulast%3DSakoff%26aufirst%3DJ.%2BA.%26atitle%3DSerine-Threonine%2520Protein%2520Phosphatase%2520Inhibitors%253A%2520Development%2520of%2520Potential%2520Therapeutic%2520Strategies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1151%26epage%3D1175%26doi%3D10.1021%2Fjm010066k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhullar, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagaron, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupasinghe, H. P. V.</span></span> <span> </span><span class="NLM_article-title">Kinase-Targeted Cancer Therapies: Progress, Challenges and Future Directions</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">48</span>, <span class="refDoi"> DOI: 10.1186/s12943-018-0804-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1186%2Fs12943-018-0804-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29455673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitF2nt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=48&author=K.+S.+Bhullarauthor=N.+O.+Lagaronauthor=E.+M.+McGowanauthor=I.+Parmarauthor=A.+Jhaauthor=B.+P.+Hubbardauthor=H.+P.+V.+Rupasinghe&title=Kinase-Targeted+Cancer+Therapies%3A+Progress%2C+Challenges+and+Future+Directions&doi=10.1186%2Fs12943-018-0804-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase-targeted cancer therapies: progress, challenges and future directions</span></div><div class="casAuthors">Bhullar, Khushwant S.; Lagaron, Naiara Orrego; McGowan, Eileen M.; Parmar, Indu; Jha, Amitabh; Hubbard, Basil P.; Rupasinghe, H. P. Vasantha</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48/1-48/20</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The human genome encodes 538 protein kinases that transfer a γ-phosphate group from ATP to serine, threonine, or tyrosine residues.  Many of these kinases are assocd. with human cancer initiation and progression.  The recent development of small-mol. kinase inhibitors for the treatment of diverse types of cancer has proven successful in clin. therapy.  Significantly, protein kinases are the second most targeted group of drug targets, after the G-proteincoupled receptors.  Since the development of the first protein kinase inhibitor, in the early 1980s, 37 kinase inhibitors have received FDA approval for treatment of malignancies such as breast and lung cancer.  Furthermore, about 150 kinase-targeted drugs are in clin. phase trials, and many kinase-specific inhibitors are in the preclin. stage of drug development.  Nevertheless, many factors confound the clin. efficacy of these mols.  Specific tumor genetics, tumor microenvironment, drug resistance, and pharmacogenomics det. how useful a compd. will be in the treatment of a given cancer.  This review provides an overview of kinase-targeted drug discovery and development in relation to oncol. and highlights the challenges and future potential for kinase-targeted cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb-edOGHyJPbVg90H21EOLACvtfcHk0lgQ0F8rm6sJ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitF2nt7fP&md5=30811747f13749327d998c5dadd2161d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2Fs12943-018-0804-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12943-018-0804-2%26sid%3Dliteratum%253Aachs%26aulast%3DBhullar%26aufirst%3DK.%2BS.%26aulast%3DLagaron%26aufirst%3DN.%2BO.%26aulast%3DMcGowan%26aufirst%3DE.%2BM.%26aulast%3DParmar%26aufirst%3DI.%26aulast%3DJha%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DB.%2BP.%26aulast%3DRupasinghe%26aufirst%3DH.%2BP.%2BV.%26atitle%3DKinase-Targeted%2520Cancer%2520Therapies%253A%2520Progress%252C%2520Challenges%2520and%2520Future%2520Directions%26jtitle%3DMol.%2520Cancer%26date%3D2018%26volume%3D17%26spage%3D48%26doi%3D10.1186%2Fs12943-018-0804-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fahs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lujan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Approaches to Study Phosphatases</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2944</span>– <span class="NLM_lpage">2961</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00570</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00570" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SjsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2944-2961&author=S.+Fahsauthor=P.+Lujanauthor=M.+K%C3%B6hn&title=Approaches+to+Study+Phosphatases&doi=10.1021%2Facschembio.6b00570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Approaches to Study Phosphatases</span></div><div class="casAuthors">Fahs, Sara; Lujan, Pablo; Koehn, Maja</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2944-2961</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Phosphatases play key roles in normal physiol. and diseases.  Studying phosphatases has been both essential and challenging, and the application of conventional genetic and biochem. methods has led to crucial but still limited understanding of their mechanisms, substrates, and exclusive functions within highly intricate networks.  With the advances in technologies such as cellular imaging and mol. and chem. biol. in terms of sensitive tools and methods, the phosphatase field has thrived in the past years and has set new insights for cell signaling studies and for therapeutic development.  In this review, we give an overview of the existing interdisciplinary tools for phosphatases, give examples on how they have been applied to increase our understanding of these enzymes, and suggest how they - and other tools yet barely used in the phosphatase field - might be adapted to address future questions and challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD5m8vT2LKKbVg90H21EOLACvtfcHk0lgQ0F8rm6sJ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SjsLjF&md5=91dd769625fcdc1d0d06937800630c94</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00570%26sid%3Dliteratum%253Aachs%26aulast%3DFahs%26aufirst%3DS.%26aulast%3DLujan%26aufirst%3DP.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DApproaches%2520to%2520Study%2520Phosphatases%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D2944%26epage%3D2961%26doi%3D10.1021%2Facschembio.6b00570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonks, N. K.</span></span> <span> </span><span class="NLM_article-title">Protein Tyrosine Phosphatases-from Housekeeping Enzymes to Master Regulators of Signal Transduction</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1111/febs.12077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1111%2Ffebs.12077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23176256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=346-378&author=N.+K.+Tonks&title=Protein+Tyrosine+Phosphatases-from+Housekeeping+Enzymes+to+Master+Regulators+of+Signal+Transduction&doi=10.1111%2Ffebs.12077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases - from housekeeping enzymes to master regulators of signal transduction</span></div><div class="casAuthors">Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">346-378</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  There are many misconceptions surrounding the roles of protein phosphatases in the regulation of signal transduction, perhaps the most damaging of which is the erroneous view that these enzymes exert their effects merely as constitutively active housekeeping enzymes.  On the contrary, the phosphatases are crit., specific regulators of signalling in their own right and serve an essential function, in a coordinated manner with the kinases, to det. the response to a physiol. stimulus.  This review is a personal perspective on the development of our understanding of the protein tyrosine phosphatase family of enzymes.  I have discussed various aspects of the structure, regulation and function of the protein tyrosine phosphatase family, which I hope will illustrate the fundamental importance of these enzymes in the control of signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ_gy-gS52MbVg90H21EOLACvtfcHk0ljEk9bSdBIN0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7s%253D&md5=3c14e627b0291ff2e601a71b8b39874e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12077%26sid%3Dliteratum%253Aachs%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DProtein%2520Tyrosine%2520Phosphatases-from%2520Housekeeping%2520Enzymes%2520to%2520Master%2520Regulators%2520of%2520Signal%2520Transduction%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D346%26epage%3D378%26doi%3D10.1111%2Ffebs.12077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Targeting Phosphatases in Cancer: Suppression of Many Versus the Ablation of One</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">6543</span>– <span class="NLM_lpage">6545</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.27201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.18632%2Foncotarget.27201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31762936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BB3Mfislejug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=6543-6545&author=B.+M.+D%E2%80%99Arcyauthor=A.+Prakashauthor=R.+E.+Honkanen&title=Targeting+Phosphatases+in+Cancer%3A+Suppression+of+Many+Versus+the+Ablation+of+One&doi=10.18632%2Foncotarget.27201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phosphatases in cancer: suppression of many versus the ablation of one</span></div><div class="casAuthors">D'Arcy Brandon M; D'Arcy Brandon M; Prakash Aishwarya; Honkanen Richard E</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">61</span>),
    <span class="NLM_cas:pages">6543-6545</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDllt95OKW9FHFYivNCdPRfW6udTcc2easqEDHoGIF47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mfislejug%253D%253D&md5=9fdb1e26b5f10b175c064d931a59931e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.27201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.27201%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DB.%2BM.%26aulast%3DPrakash%26aufirst%3DA.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DTargeting%2520Phosphatases%2520in%2520Cancer%253A%2520Suppression%2520of%2520Many%2520Versus%2520the%2520Ablation%2520of%2520One%26jtitle%3DOncotarget%26date%3D2019%26volume%3D10%26spage%3D6543%26epage%3D6545%26doi%3D10.18632%2Foncotarget.27201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiredja, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaware, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatzer, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasireddi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schüchner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perl, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galsky, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogris, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, G.</span></span> <span> </span><span class="NLM_article-title">Selective Pp2a Enhancement through Biased Heterotrimer Stabilization</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.03.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2020.03.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=32315618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvFeitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=688-701&author=D.+Leonardauthor=W.+Huangauthor=S.+Izadmehrauthor=C.+M.+O%E2%80%99Connorauthor=D.+D.+Wiredjaauthor=Z.+Wangauthor=N.+Zawareauthor=Y.+Chenauthor=D.+M.+Schlatzerauthor=J.+Kiselarauthor=N.+Vasireddiauthor=S.+Sch%C3%BCchnerauthor=A.+L.+Perlauthor=M.+D.+Galskyauthor=W.+Xuauthor=D.+L.+Brautiganauthor=E.+Ogrisauthor=D.+J.+Taylorauthor=G.+Narla&title=Selective+Pp2a+Enhancement+through+Biased+Heterotrimer+Stabilization&doi=10.1016%2Fj.cell.2020.03.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Selective PP2A enhancement through biased heterotrimer stabilization</span></div><div class="casAuthors">Leonard, Daniel; Huang, Wei; Izadmehr, Sudeh; O'Connor, Caitlin M.; Wiredja, Danica D.; Wang, Zhizhi; Zaware, Nilesh; Chen, Yinghua; Schlatzer, Daniela M.; Kiselar, Janna; Vasireddi, Nikhil; Schuchner, Stefan; Perl, Abbey L.; Galsky, Matthew D.; Xu, Wenqing; Brautigan, David L.; Ogris, Egon; Taylor, Derek J.; Narla, Goutham</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">688-701.e16</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Impairment of protein phosphatases, including the family of serine/threonine phosphatases designated PP2A, is essential for the pathogenesis of many diseases, including cancer.  The ability of PP2A to dephosphorylate hundreds of proteins is regulated by over 40 specificity-detg. regulatory "B" subunits that compete for assembly and activation of heterogeneous PP2A heterotrimers.  Here, we reveal how a small mol., DT-061, specifically stabilizes the B56α-PP2A holoenzyme in a fully assembled, active state to dephosphorylate selective substrates, such as its well-known oncogenic target, c-Myc.  Our 3.6 Å structure identifies mol. interactions between DT-061 and all three PP2A subunits that prevent dissocn. of the active enzyme and highlight inherent mechanisms of PP2A complex assembly.  Thus, our findings provide fundamental insights into PP2A complex assembly and regulation, identify a unique interfacial stabilizing mode of action for therapeutic targeting, and aid in the development of phosphatase-based therapeutics tailored against disease specific phospho-protein targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu4CUPqLYpQrVg90H21EOLACvtfcHk0ljEk9bSdBIN0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvFeitL4%253D&md5=baeee6ee120e38c807e69ad60845cf58</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.03.038%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DC.%2BM.%26aulast%3DWiredja%26aufirst%3DD.%2BD.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZaware%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSchlatzer%26aufirst%3DD.%2BM.%26aulast%3DKiselar%26aufirst%3DJ.%26aulast%3DVasireddi%26aufirst%3DN.%26aulast%3DSch%25C3%25BCchner%26aufirst%3DS.%26aulast%3DPerl%26aufirst%3DA.%2BL.%26aulast%3DGalsky%26aufirst%3DM.%2BD.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26aulast%3DOgris%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DD.%2BJ.%26aulast%3DNarla%26aufirst%3DG.%26atitle%3DSelective%2520Pp2a%2520Enhancement%2520through%2520Biased%2520Heterotrimer%2520Stabilization%26jtitle%3DCell%26date%3D2020%26volume%3D181%26spage%3D688%26epage%3D701%26doi%3D10.1016%2Fj.cell.2020.03.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durbin, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martel, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prutsch, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, A. T.</span></span> <span> </span><span class="NLM_article-title">Allosteric Activators of Protein Phosphatase 2a Display Broad Antitumor Activity Mediated by Dephosphorylation of Mybl2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">702</span>– <span class="NLM_lpage">715</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.03.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2020.03.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=32315619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvFeitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=702-715&author=K.+Moritaauthor=S.+Heauthor=R.+P.+Nowakauthor=J.+Wangauthor=M.+W.+Zimmermanauthor=C.+Fuauthor=A.+D.+Durbinauthor=M.+W.+Martelauthor=N.+Prutschauthor=N.+S.+Grayauthor=E.+S.+Fischerauthor=A.+T.+Look&title=Allosteric+Activators+of+Protein+Phosphatase+2a+Display+Broad+Antitumor+Activity+Mediated+by+Dephosphorylation+of+Mybl2&doi=10.1016%2Fj.cell.2020.03.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2</span></div><div class="casAuthors">Morita, Ken; He, Shuning; Nowak, Radoslaw P.; Wang, Jinhua; Zimmerman, Mark W.; Fu, Cong; Durbin, Adam D.; Martel, Megan W.; Prutsch, Nicole; Gray, Nathanael S.; Fischer, Eric S.; Look, A. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">702-715.e20</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Protein phosphatase 2A (PP2A) enzymes can suppress tumors, but they are often inactivated in human cancers overexpressing inhibitory proteins.  Here, we identify a class of small-mol. iHAPs (improved heterocyclic activators of PP2A) that kill leukemia cells by allosterically assembling a specific heterotrimeric PP2A holoenzyme consisting of PPP2R1A (scaffold), PPP2R5E (B56ε, regulatory), and PPP2CA (catalytic) subunits.  One compd., iHAP1, activates this complex but does not inhibit dopamine receptor D2, a mediator of neurol. toxicity induced by perphenazine and related neuroleptics.  The PP2A complex activated by iHAP1 dephosphorylates the MYBL2 transcription factor on Ser241, causing irreversible arrest of leukemia and other cancer cells in prometaphase.  In contrast, SMAPs, a sep. class of compds., activate PP2A holoenzymes contg. a different regulatory subunit, do not dephosphorylate MYBL2, and arrest tumor cells in G1 phase.  Our findings demonstrate that small mols. can serve as allosteric switches to activate distinct PP2A complexes with unique substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPVLhVVAc5VbVg90H21EOLACvtfcHk0lhGWOGw-bWZjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvFeitLg%253D&md5=b872bcc33d03742b9a2d69cb8fdbbb27</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.03.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.03.051%26sid%3Dliteratum%253Aachs%26aulast%3DMorita%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DNowak%26aufirst%3DR.%2BP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZimmerman%26aufirst%3DM.%2BW.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DDurbin%26aufirst%3DA.%2BD.%26aulast%3DMartel%26aufirst%3DM.%2BW.%26aulast%3DPrutsch%26aufirst%3DN.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DFischer%26aufirst%3DE.%2BS.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DAllosteric%2520Activators%2520of%2520Protein%2520Phosphatase%25202a%2520Display%2520Broad%2520Antitumor%2520Activity%2520Mediated%2520by%2520Dephosphorylation%2520of%2520Mybl2%26jtitle%3DCell%26date%3D2020%26volume%3D181%26spage%3D702%26epage%3D715%26doi%3D10.1016%2Fj.cell.2020.03.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, G.</span></span> <span> </span><span class="NLM_article-title">Genomics and Evolution of Protein Phosphatases</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">eaag1796</span> <span class="refDoi"> DOI: 10.1126/scisignal.aag1796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1126%2Fscisignal.aag1796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28400531" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&author=M.+J.+Chenauthor=J.+E.+Dixonauthor=G.+Manning&title=Genomics+and+Evolution+of+Protein+Phosphatases&doi=10.1126%2Fscisignal.aag1796"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aag1796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aag1796%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%2BJ.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26aulast%3DManning%26aufirst%3DG.%26atitle%3DGenomics%2520and%2520Evolution%2520of%2520Protein%2520Phosphatases%26jtitle%3DSci.%2520Signaling%26date%3D2017%26volume%3D10%26doi%3D10.1126%2Fscisignal.aag1796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilmanns, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Elucidating Human Phosphatase-Substrate Networks</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">rs10</span> <span class="refDoi"> DOI: 10.1126/scisignal.2003203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1126%2Fscisignal.2003203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23674824" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&author=X.+Liauthor=M.+Wilmannsauthor=J.+Thorntonauthor=M.+K%C3%B6hn&title=Elucidating+Human+Phosphatase-Substrate+Networks&doi=10.1126%2Fscisignal.2003203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2003203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2003203%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWilmanns%26aufirst%3DM.%26aulast%3DThornton%26aufirst%3DJ.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DElucidating%2520Human%2520Phosphatase-Substrate%2520Networks%26jtitle%3DSci.%2520Signaling%26date%3D2013%26volume%3D6%26doi%3D10.1126%2Fscisignal.2003203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heynen, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciecielski, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berninger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabacaoglu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Görgülü, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dantes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wörmann, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diakopoulos, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpathaki, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaya-Aksoy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Laan, E. A. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Alberca, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazaré, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saur, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erkan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopt, U. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sainz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algül, H.</span></span> <span> </span><span class="NLM_article-title">Mutant Kras-Driven Cancers Depend on Ptpn11/Shp2 Phosphatase</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">960</span>, <span class="refDoi"> DOI: 10.1038/s41591-018-0024-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fs41591-018-0024-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29808009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=954-960&author=D.+A.+Ruessauthor=G.+J.+Heynenauthor=K.+J.+Ciecielskiauthor=J.+Aiauthor=A.+Berningerauthor=D.+Kabacaogluauthor=K.+G%C3%B6rg%C3%BCl%C3%BCauthor=Z.+Dantesauthor=S.+M.+W%C3%B6rmannauthor=K.+N.+Diakopoulosauthor=A.+F.+Karpathakiauthor=M.+Kowalskaauthor=E.+Kaya-Aksoyauthor=L.+Songauthor=E.+A.+Z.+van+der+Laanauthor=M.+P.+L%C3%B3pez-Albercaauthor=M.+Nazar%C3%A9author=M.+Reichertauthor=D.+Saurauthor=M.+M.+Erkanauthor=U.+T.+Hoptauthor=B.+Sainzauthor=W.+Birchmeierauthor=R.+M.+Schmidauthor=M.+Lesinaauthor=H.+Alg%C3%BCl&title=Mutant+Kras-Driven+Cancers+Depend+on+Ptpn11%2FShp2+Phosphatase&doi=10.1038%2Fs41591-018-0024-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase</span></div><div class="casAuthors">Ruess, Dietrich A.; Heynen, Guus J.; Ciecielski, Katrin J.; Ai, Jiaoyu; Berninger, Alexandra; Kabacaoglu, Derya; Goerguelue, Kivanc; Dantes, Zahra; Woermann, Sonja M.; Diakopoulos, Kalliope N.; Karpathaki, Angeliki F.; Kowalska, Marlena; Kaya-Aksoy, Ezgi; Song, Liang; van der Laan, Eveline A. Zeeuw; Lopez-Alberca, Maria P.; Nazare, Marc; Reichert, Maximilian; Saur, Dieter; Erkan, Mert M.; Hopt, Ulrich T.; Sainz, Jr, Bruno; Birchmeier, Walter; Schmid, Roland M.; Lesina, Marina; Alguel, Hana</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">954-960</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The ubiquitously expressed non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, is involved in signal transduction downstream of multiple growth factor, cytokine and integrin receptors1.  Its requirement for complete RAS-MAPK activation and its role as a neg. regulator of JAK-STAT signaling have established SHP2 as an essential player in oncogenic signaling pathways1-7.  Recently, a novel potent allosteric SHP2 inhibitor was presented as a viable therapeutic option for receptor tyrosine kinase-driven cancers, but was shown to be ineffective in KRAS-mutant tumor cell lines in vitro8.  Here, we report a central and indispensable role for SHP2 in oncogenic KRAS-driven tumors.  Genetic deletion of Ptpn11 profoundly inhibited tumor development in mutant KRAS-driven murine models of pancreatic ductal adenocarcinoma and non-small-cell lung cancer.  We provide evidence for a crit. dependence of mutant KRAS on SHP2 during carcinogenesis.  Deletion or inhibition of SHP2 in established tumors delayed tumor progression but was not sufficient to achieve tumor regression.  However, SHP2 was necessary for resistance mechanisms upon blockade of MEK.  Synergy was obsd. when both SHP2 and MEK were targeted, resulting in sustained tumor growth control in murine and human patient-derived organoids and xenograft models of pancreatic ductal adenocarcinoma and non-small-cell lung cancer.  Our data indicate the clin. utility of dual SHP2/MEK inhibition as a targeted therapy approach for KRAS-mutant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoepq09hU77abVg90H21EOLACvtfcHk0lhGWOGw-bWZjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvF&md5=cc09897c2c4b8e32b035b991e5032f32</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fs41591-018-0024-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-018-0024-8%26sid%3Dliteratum%253Aachs%26aulast%3DRuess%26aufirst%3DD.%2BA.%26aulast%3DHeynen%26aufirst%3DG.%2BJ.%26aulast%3DCiecielski%26aufirst%3DK.%2BJ.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DBerninger%26aufirst%3DA.%26aulast%3DKabacaoglu%26aufirst%3DD.%26aulast%3DG%25C3%25B6rg%25C3%25BCl%25C3%25BC%26aufirst%3DK.%26aulast%3DDantes%26aufirst%3DZ.%26aulast%3DW%25C3%25B6rmann%26aufirst%3DS.%2BM.%26aulast%3DDiakopoulos%26aufirst%3DK.%2BN.%26aulast%3DKarpathaki%26aufirst%3DA.%2BF.%26aulast%3DKowalska%26aufirst%3DM.%26aulast%3DKaya-Aksoy%26aufirst%3DE.%26aulast%3DSong%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BLaan%26aufirst%3DE.%2BA.%2BZ.%26aulast%3DL%25C3%25B3pez-Alberca%26aufirst%3DM.%2BP.%26aulast%3DNazar%25C3%25A9%26aufirst%3DM.%26aulast%3DReichert%26aufirst%3DM.%26aulast%3DSaur%26aufirst%3DD.%26aulast%3DErkan%26aufirst%3DM.%2BM.%26aulast%3DHopt%26aufirst%3DU.%2BT.%26aulast%3DSainz%26aufirst%3DB.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DSchmid%26aufirst%3DR.%2BM.%26aulast%3DLesina%26aufirst%3DM.%26aulast%3DAlg%25C3%25BCl%26aufirst%3DH.%26atitle%3DMutant%2520Kras-Driven%2520Cancers%2520Depend%2520on%2520Ptpn11%252FShp2%2520Phosphatase%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D954%26epage%3D960%26doi%3D10.1038%2Fs41591-018-0024-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunkl, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazic-Legueux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchado, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brachmann, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerman, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caponigro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.-X.</span></span> <span> </span><span class="NLM_article-title">Shp2 Inhibition Overcomes Rtk-Mediated Pathway Reactivation in Kras-Mutant Tumors Treated with Mek Inhibitors</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1323</span>– <span class="NLM_lpage">1334</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-18-0852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1535-7163.MCT-18-0852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31068384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Kjsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=1323-1334&author=H.+Luauthor=C.+Liuauthor=R.+Velazquezauthor=H.+Wangauthor=L.+M.+Dunklauthor=M.+Kazic-Legueuxauthor=A.+Haberkornauthor=E.+Billyauthor=E.+Manchadoauthor=S.+M.+Brachmannauthor=S.+E.+Moodyauthor=J.+A.+Engelmanauthor=P.+S.+Hammermanauthor=G.+Caponigroauthor=M.+Mohseniauthor=H.-X.+Hao&title=Shp2+Inhibition+Overcomes+Rtk-Mediated+Pathway+Reactivation+in+Kras-Mutant+Tumors+Treated+with+Mek+Inhibitors&doi=10.1158%2F1535-7163.MCT-18-0852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS-mutant tumors treated with MEK inhibitors</span></div><div class="casAuthors">Lu, Hengyu; Liu, Chen; Velazquez, Roberto; Wang, Hongyun; Dunkl, Lukas Manuel; Kazic-Legueux, Malika; Haberkorn, Anne; Billy, Eric; Manchado, Eusebio; Brachmann, Saskia M.; Moody, Susan E.; Engelman, Jeffrey A.; Hammerman, Peter S.; Caponigro, Giordano; Mohseni, Morvarid; Hao, Huai-Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1323-1334</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">FGFR1 was recently shown to be activated as part of a compensatory response to prolonged treatment with the MEK inhibitor trametinib in several KRAS-mutant lung and pancreatic cancer cell lines.  We hypothesize that other receptor tyrosine kinases (RTK) are also feedback-activated in this context.  Herein, we profile a large panel of KRAS-mutant cancer cell lines for the contribution of RTKs to the feedback activation of phospho-MEK following MEK inhibition, using an SHP2 inhibitor (SHP099) that blocks RAS activation mediated by multiple RTKs.  We find that RTK-driven feedback activation widely exists in KRAS-mutant cancer cells, to a less extent in those harboring the G13D variant, and involves several RTKs, including EGFR, FGFR, and MET.  We further demonstrate that this pathway feedback activation is mediated through mutant KRAS, at least for the G12C, G12D, and G12V variants, and wild-type KRAS can also contribute significantly to the feedback activation.  Finally, SHP099 and MEK inhibitors exhibit combination benefits inhibiting KRAS-mutant cancer cell proliferation in vitro and in vivo.  These findings provide a rationale for exploration of combining SHP2 and MAPK pathway inhibitors for treating KRAS-mutant cancers in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLezgYOaDKL7Vg90H21EOLACvtfcHk0lgH5OPDWDyyQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Kjsb7I&md5=24d487c279126d146ed9515e5c5c3e10</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-18-0852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-18-0852%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DVelazquez%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDunkl%26aufirst%3DL.%2BM.%26aulast%3DKazic-Legueux%26aufirst%3DM.%26aulast%3DHaberkorn%26aufirst%3DA.%26aulast%3DBilly%26aufirst%3DE.%26aulast%3DManchado%26aufirst%3DE.%26aulast%3DBrachmann%26aufirst%3DS.%2BM.%26aulast%3DMoody%26aufirst%3DS.%2BE.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DHammerman%26aufirst%3DP.%2BS.%26aulast%3DCaponigro%26aufirst%3DG.%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DH.-X.%26atitle%3DShp2%2520Inhibition%2520Overcomes%2520Rtk-Mediated%2520Pathway%2520Reactivation%2520in%2520Kras-Mutant%2520Tumors%2520Treated%2520with%2520Mek%2520Inhibitors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2019%26volume%3D18%26spage%3D1323%26epage%3D1334%26doi%3D10.1158%2F1535-7163.MCT-18-0852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchdunger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanning, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lydon, N. B.</span></span> <span> </span><span class="NLM_article-title">Effects of a Selective Inhibitor of the Abl Tyrosine Kinase on the Growth of Bcr–Abl Positive Cells</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1038/nm0596-561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fnm0596-561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8616716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK28Xislyhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=561-566&author=B.+J.+Drukerauthor=S.+Tamuraauthor=E.+Buchdungerauthor=S.+Ohnoauthor=G.+M.+Segalauthor=S.+Fanningauthor=J.+Zimmermannauthor=N.+B.+Lydon&title=Effects+of+a+Selective+Inhibitor+of+the+Abl+Tyrosine+Kinase+on+the+Growth+of+Bcr%E2%80%93Abl+Positive+Cells&doi=10.1038%2Fnm0596-561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells</span></div><div class="casAuthors">Druker, Brian J.; Tamura, Shu; Buchdunger, Elisabeth; Ohno, Sayuri; Segal, Gerald M.; Fanning, Shane; Zimmermann, Jurg; Lydon, Nicholas B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-566</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">The Bcr-Abl oncogene, present in 95% of patients with chronic myelogenous leukemia (CML), has been implicated as the cause of this disease.  A compd., designed to inhibit the Abl protein tyrosine kinase (CGP 57148), was evaluated for its effects on cells contg. the Bcr-Abl fusion protein.  Cellular proliferation and tumor formation by Bcr-Abl-expressing cells were specifically inhibited by this compd.  In colony-forming assays of peripheral blood or bone marrow from patients with CML, there was a 92-98% decrease in the no. of Bcr-Abl colonies formed but no inhibition of normal colony formation.  This compd. may be useful in the treatment of Bcr-Abl-pos. leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjzXj-25AHOrVg90H21EOLACvtfcHk0lgH5OPDWDyyQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xislyhs70%253D&md5=1dc111cc883a1ed29964ae2c88c88cb9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnm0596-561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0596-561%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTamura%26aufirst%3DS.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DSegal%26aufirst%3DG.%2BM.%26aulast%3DFanning%26aufirst%3DS.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26atitle%3DEffects%2520of%2520a%2520Selective%2520Inhibitor%2520of%2520the%2520Abl%2520Tyrosine%2520Kinase%2520on%2520the%2520Growth%2520of%2520Bcr%25E2%2580%2593Abl%2520Positive%2520Cells%26jtitle%3DNat.%2520Med.%26date%3D1996%26volume%3D2%26spage%3D561%26epage%3D566%26doi%3D10.1038%2Fnm0596-561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koveal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akshinthala, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kragelj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackledge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthuswamy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonks, N. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the Disordered C Terminus of Ptp1b with an Allosteric Inhibitor</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fnchembio.1528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24845231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=558-566&author=N.+Krishnanauthor=D.+Kovealauthor=D.+H.+Millerauthor=B.+Xueauthor=S.+D.+Akshinthalaauthor=J.+Krageljauthor=M.+R.+Jensenauthor=C.+M.+Gaussauthor=R.+Pageauthor=M.+Blackledgeauthor=S.+K.+Muthuswamyauthor=W.+Petiauthor=N.+K.+Tonks&title=Targeting+the+Disordered+C+Terminus+of+Ptp1b+with+an+Allosteric+Inhibitor&doi=10.1038%2Fnchembio.1528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the disordered C terminus of PTP1B with an allosteric inhibitor</span></div><div class="casAuthors">Krishnan, Navasona; Koveal, Dorothy; Miller, Daniel H.; Xue, Bin; Akshinthala, Sai Dipikaa; Kragelj, Jaka; Jensen, Malene Ringkjoebing; Gauss, Carla-Maria; Page, Rebecca; Blackledge, Martin; Muthuswamy, Senthil K.; Peti, Wolfgang; Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">558-566</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">PTP1B, a validated therapeutic target for diabetes and obesity, has a crit. pos. role in HER2 signaling in breast tumorigenesis.  Efforts to develop therapeutic inhibitors of PTP1B have been frustrated by the chem. properties of the active site.  We define a new mechanism of allosteric inhibition that targets the C-terminal, noncatalytic segment of PTP1B.  We present what is to our knowledge the first ensemble structure of PTP1B contg. this intrinsically disordered segment, within which we identified a binding site for the small-mol. inhibitor MSI-1436.  We demonstrate binding to a second site close to the catalytic domain, with cooperative effects between the two sites locking PTP1B in an inactive state.  MSI-1436 antagonized HER2 signaling, inhibited tumorigenesis in xenografts and abrogated metastasis in the NDL2 mouse model of breast cancer, validating inhibition of PTP1B as a therapeutic strategy in breast cancer.  This new approach to inhibition of PTP1B emphasizes the potential of disordered segments of proteins as specific binding sites for therapeutic small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo526if7ja9XbVg90H21EOLACvtfcHk0lgH5OPDWDyyQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D&md5=10a460f3a5deafb9f7c206246d67a29b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1528%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DN.%26aulast%3DKoveal%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DD.%2BH.%26aulast%3DXue%26aufirst%3DB.%26aulast%3DAkshinthala%26aufirst%3DS.%2BD.%26aulast%3DKragelj%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DBlackledge%26aufirst%3DM.%26aulast%3DMuthuswamy%26aufirst%3DS.%2BK.%26aulast%3DPeti%26aufirst%3DW.%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DTargeting%2520the%2520Disordered%2520C%2520Terminus%2520of%2520Ptp1b%2520with%2520an%2520Allosteric%2520Inhibitor%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D558%26epage%3D566%26doi%3D10.1038%2Fnchembio.1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lantz, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, S. G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planey, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roitman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-White, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLane, M. P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Ptp1b by Trodusquemine (Msi-1436) Causes Fat-Specific Weight Loss in Diet-Induced Obese Mice</span>. <i>Obesity</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1516</span>– <span class="NLM_lpage">1523</span>, <span class="refDoi"> DOI: 10.1038/oby.2009.444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Foby.2009.444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20075852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlymsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1516-1523&author=K.+A.+Lantzauthor=S.+G.+E.+Hartauthor=S.+L.+Planeyauthor=M.+F.+Roitmanauthor=I.+A.+Ruiz-Whiteauthor=H.+R.+Wolfeauthor=M.+P.+McLane&title=Inhibition+of+Ptp1b+by+Trodusquemine+%28Msi-1436%29+Causes+Fat-Specific+Weight+Loss+in+Diet-Induced+Obese+Mice&doi=10.1038%2Foby.2009.444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PTP1B by Trodusquemine (MSI-1436) Causes Fat-specific Weight Loss in Diet-induced Obese Mice</span></div><div class="casAuthors">Lantz, Kristen A.; Emeigh Hart, Susan G.; Planey, Sonia L.; Roitman, Mitchell F.; Ruiz-White, Inez A.; Wolfe, Henry R.; McLane, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1516-1523</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Trodusquemine (MSI-1436) causes rapid and reversible wt. loss in genetic models of obesity.  To better predict the potential effects of trodusquemine in the clinic, we investigated the effects of trodusquemine treatment in a murine model of diet-induced obesity (DIO).  Trodusquemine suppressed appetite, reduced body wt. (BW) in a fat-specific manner, and improved plasma insulin and leptin levels in mice.  Screening assays revealed that trodusquemine selectively inhibited protein-tyrosine phosphatase 1B (PTP1B), a key enzyme regulating insulin and leptin signaling.  Trodusquemine significantly enhanced insulin-stimulated tyrosine phosphorylation of insulin receptor (IR) β and STAT3, direct targets of PTP1B, in HepG2 cells in vitro and/or hypothalamic tissue in vivo.  These data establish trodusquemine as an effective central and peripheral PTP1B inhibitor with the potential to elicit noncachectic fat-sp. wt. loss and improve insulin and leptin levels.  Obesity (2010) 18 8, 1516-1523. doi:10.1038/oby.2009.444.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpztdwe-fhYL7Vg90H21EOLACvtfcHk0lipisdK13bnvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlymsbY%253D&md5=9ead7eec1559f2b33631472b018d47fe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Foby.2009.444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foby.2009.444%26sid%3Dliteratum%253Aachs%26aulast%3DLantz%26aufirst%3DK.%2BA.%26aulast%3DHart%26aufirst%3DS.%2BG.%2BE.%26aulast%3DPlaney%26aufirst%3DS.%2BL.%26aulast%3DRoitman%26aufirst%3DM.%2BF.%26aulast%3DRuiz-White%26aufirst%3DI.%2BA.%26aulast%3DWolfe%26aufirst%3DH.%2BR.%26aulast%3DMcLane%26aufirst%3DM.%2BP.%26atitle%3DInhibition%2520of%2520Ptp1b%2520by%2520Trodusquemine%2520%2528Msi-1436%2529%2520Causes%2520Fat-Specific%2520Weight%2520Loss%2520in%2520Diet-Induced%2520Obese%2520Mice%26jtitle%3DObesity%26date%3D2010%26volume%3D18%26spage%3D1516%26epage%3D1523%26doi%3D10.1038%2Foby.2009.444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanford, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottini, N.</span></span> <span> </span><span class="NLM_article-title">Targeting Tyrosine Phosphatases: Time to End the Stigma</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2017.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.tips.2017.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28412041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFWrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=524-540&author=S.+M.+Stanfordauthor=N.+Bottini&title=Targeting+Tyrosine+Phosphatases%3A+Time+to+End+the+Stigma&doi=10.1016%2Fj.tips.2017.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Tyrosine Phosphatases: Time to End the Stigma</span></div><div class="casAuthors">Stanford, Stephanie M.; Bottini, Nunzio</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">524-540</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTPs) are a family of enzymes essential for numerous cellular processes, and several PTPs have been validated as therapeutic targets for human diseases.  Historically, the development of drugs targeting PTPs has been highly challenging, leading to stigmatization of these enzymes as undruggable targets.  Despite these difficulties, efforts to drug PTPs have persisted, and recent years have seen an influx of new probes providing opportunities for biol. examn. of old and new PTP targets.  Here we discuss progress towards drugging PTPs with special emphasis on the development of selective probes with biol. activity.  We describe the development of new small-mol. orthosteric, allosteric, and oligomerization-inhibiting PTP inhibitors and discuss new studies targeting the receptor PTP (RPTP) subfamily with biologics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodaLAks9bm7LVg90H21EOLACvtfcHk0lipisdK13bnvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFWrtbc%253D&md5=539153cbe8845849b542a6d92bf2e7ed</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2017.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2017.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DStanford%26aufirst%3DS.%2BM.%26aulast%3DBottini%26aufirst%3DN.%26atitle%3DTargeting%2520Tyrosine%2520Phosphatases%253A%2520Time%2520to%2520End%2520the%2520Stigma%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2017%26volume%3D38%26spage%3D524%26epage%3D540%26doi%3D10.1016%2Fj.tips.2017.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frankson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Targeting of Oncogenic Tyrosine Phosphatases</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">5701</span>– <span class="NLM_lpage">5705</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-17-1510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F0008-5472.CAN-17-1510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28855209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOlur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=5701-5705&author=R.+Franksonauthor=Z.+H.+Yuauthor=Y.+P.+Baiauthor=Q.+L.+Liauthor=R.+Y.+Zhangauthor=Z.+Y.+Zhang&title=Therapeutic+Targeting+of+Oncogenic+Tyrosine+Phosphatases&doi=10.1158%2F0008-5472.CAN-17-1510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Targeting of Oncogenic Tyrosine Phosphatases</span></div><div class="casAuthors">Frankson, Rochelle; Yu, Zhi-Hong; Bai, Yunpeng; Li, Qinglin; Zhang, Ruo-Yu; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5701-5705</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTP) are exciting and novel targets for cancer drug discovery that work in concert with protein tyrosine kinases (PTK) in controlling cellular homeostasis.  Given the activating role that some PTKs play in initiating growth factor-mediated cellular processes, PTPs are usually perceived as the neg. regulators of these events and therefore tumor suppressive in nature.  However, mounting evidence indicate that PTPs do not always antagonize the activity of PTKs in regulating tyrosine phosphorylation, but can also play dominant roles in the initiation and progression of signaling cascades that regulate cell functions.  It follows, therefore, that PTP malfunction can actively contribute to a host of human disorders, in particular, cancer, metabolic syndromes, and autoimmune diseases.  The Src homol. domain contg. phosphatase 2 (SHP2) and the three-membered family of phosphatases of regenerating liver (PRL) are infamously oncogenic members of the PTP superfamily.  Both are established regulators of major cancer pathways such as Ras/ERK1/2, Src, JAK/STAT, JNK, NF-κB, and PTEN/PI3K/AKT.  Furthermore, upregulation, mutation, or other dysregulation of these PTPs has been pos. correlated with cancer initiation and progression.  This review will provide topical coverage of target validation and drug discovery efforts made in targeting these oncogenic PTPs as compelling candidates for cancer therapy.  Cancer Res; 77(21); 5701-5. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrASNrPP4qCHbVg90H21EOLACvtfcHk0ljyzsXDxeB3WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOlur%252FI&md5=93f036dce3366a7f109d7ee0fc3fed9e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-17-1510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-17-1510%26sid%3Dliteratum%253Aachs%26aulast%3DFrankson%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DZ.%2BH.%26aulast%3DBai%26aufirst%3DY.%2BP.%26aulast%3DLi%26aufirst%3DQ.%2BL.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DTherapeutic%2520Targeting%2520of%2520Oncogenic%2520Tyrosine%2520Phosphatases%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D5701%26epage%3D5705%26doi%3D10.1158%2F0008-5472.CAN-17-1510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span> <span> </span><span class="NLM_article-title">Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">1069</span>– <span class="NLM_lpage">1091</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00105</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00105" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlyku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2018&pages=1069-1091&author=Z.+H.+Yuauthor=Z.+Y.+Zhang&title=Regulatory+Mechanisms+and+Novel+Therapeutic+Targeting+Strategies+for+Protein+Tyrosine+Phosphatases&doi=10.1021%2Facs.chemrev.7b00105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases</span></div><div class="casAuthors">Yu, Zhi-Hong; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1069-1091</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An appropriate level of protein phosphorylation on tyrosine is essential for cells to react to extracellular stimuli and maintain cellular homeostasis.  Faulty operation of signal pathways mediated by protein tyrosine phosphorylation causes numerous human diseases, which presents enormous opportunities for therapeutic intervention.  While the importance of protein tyrosine kinases in orchestrating the tyrosine phosphorylation networks and in target-based drug discovery has long been recognized, the significance of protein tyrosine phosphatases (PTPs) in cellular signaling and disease biol. has historically been underappreciated, due to a large extent to an erroneous assumption that they are largely constitutive and housekeeping enzymes.  Here, we provide a comprehensive examn. of a no. of regulatory mechanisms, including redox modulation, allosteric regulation, and protein oligomerization, that control PTP activity.  These regulatory mechanisms are integral to the myriad PTP-mediated biochem. events and reinforce the concept that PTPs are indispensable and specific modulators of cellular signaling.  We also discuss how disruption of these PTP regulatory mechanisms can cause human diseases and how these diverse regulatory mechanisms can be exploited for novel therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_-ydQ7-hJcbVg90H21EOLACvtfcHk0ljyzsXDxeB3WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlyku7k%253D&md5=7f3dd74cb0572214e98554613297863b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00105%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.%2BH.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DRegulatory%2520Mechanisms%2520and%2520Novel%2520Therapeutic%2520Targeting%2520Strategies%2520for%2520Protein%2520Tyrosine%2520Phosphatases%26jtitle%3DChem.%2520Rev.%26date%3D2018%26volume%3D118%26spage%3D1069%26epage%3D1091%26doi%3D10.1021%2Facs.chemrev.7b00105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bialy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Protein Tyrosine Phosphatases: Next-Generation Drugs?</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3814</span>– <span class="NLM_lpage">3839</span>, <span class="refDoi"> DOI: 10.1002/anie.200461517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fanie.200461517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFGisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=3814-3839&author=L.+Bialyauthor=H.+Waldmann&title=Inhibitors+of+Protein+Tyrosine+Phosphatases%3A+Next-Generation+Drugs%3F&doi=10.1002%2Fanie.200461517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of protein tyrosine phosphatases: Next-generation drugs?</span></div><div class="casAuthors">Bialy, Laurent; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3814-3839</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatases (PTPs) constitute a family of closely related key regulatory enzymes that dephosphorylate phosphotyrosine residues in their protein substrates.  Malfunctions in PTP activity are linked to various diseases, ranging from cancer to neurol. disorders and diabetes.  Consequently, PTPs have emerged as promising targets for therapeutic intervention in recent years.  In this review, general aspects of PTPs and the development of small-mol. inhibitors of PTPs by both academic research groups and pharmaceutical companies are discussed.  Different strategies have been successfully applied to identify potent and selective inhibitors.  These studies constitute the basis for the future development of PTP inhibitors as drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9K3DIu_xX_LVg90H21EOLACvtfcHk0ljyzsXDxeB3WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFGisr8%253D&md5=a8bcd03851b638cc6d3e6ab2466eb97b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fanie.200461517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200461517%26sid%3Dliteratum%253Aachs%26aulast%3DBialy%26aufirst%3DL.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DInhibitors%2520of%2520Protein%2520Tyrosine%2520Phosphatases%253A%2520Next-Generation%2520Drugs%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D3814%26epage%3D3839%26doi%3D10.1002%2Fanie.200461517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoeger, B.</span>; <span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Strategies for Designing Specific Protein Tyrosine Phosphatase Inhibitors and Their Intracellular Activation</span>. In  <i>Concepts and Case Studies in Chemical Biology</i><span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2F9783527687503.ch3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+Hoeger&author=M.+K%C3%B6hn&title=Concepts+and+Case+Studies+in+Chemical+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2F9783527687503.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527687503.ch3%26sid%3Dliteratum%253Aachs%26aulast%3DHoeger%26aufirst%3DB.%26atitle%3DStrategies%2520for%2520Designing%2520Specific%2520Protein%2520Tyrosine%2520Phosphatase%2520Inhibitors%2520and%2520Their%2520Intracellular%2520Activation%26btitle%3DConcepts%2520and%2520Case%2520Studies%2520in%2520Chemical%2520Biology%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontanillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Phosphatases: Their Roles in Cancer and Their Chemical Modulators</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>917</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-32805-8_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2F978-3-319-32805-8_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=27236558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVehs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=917&publication_year=2016&pages=209-240&author=M.+Fontanilloauthor=M.+K%C3%B6hn&title=Phosphatases%3A+Their+Roles+in+Cancer+and+Their+Chemical+Modulators&doi=10.1007%2F978-3-319-32805-8_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatases: Their Roles in Cancer and Their Chemical Modulators</span></div><div class="casAuthors">Fontanillo, Miriam; Koehn, Maja</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">917</span>
        (<span class="NLM_cas:issue">Protein Targeting Compounds</span>),
    <span class="NLM_cas:pages">209-240</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Phosphatases are involved in basically all cellular processes by dephosphorylating cellular components such as proteins, phospholipids and second messengers.  They counteract kinases of which many are established oncogenes, and therefore kinases are one of the most important drug targets for targeted cancer therapy.  Due to this relationship between kinases and phosphatases, phosphatases are traditionally assumed to be tumor suppressors.  However, research findings over the last years prove that this simplification is incorrect, as bona-fide and putative phosphatase oncogenes have been identified.  We describe here the role of phosphatases in cancer, tumor suppressors and oncogenes, and their chem. modulators, and discuss new approaches and opportunities for phosphatases as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq07q6dxJ1XmrVg90H21EOLACvtfcHk0ljyzsXDxeB3WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVehs78%253D&md5=221f76689dc44b9341947ab518b7ddee</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-32805-8_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-32805-8_10%26sid%3Dliteratum%253Aachs%26aulast%3DFontanillo%26aufirst%3DM.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DPhosphatases%253A%2520Their%2520Roles%2520in%2520Cancer%2520and%2520Their%2520Chemical%2520Modulators%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2016%26volume%3D917%26spage%3D209%26epage%3D240%26doi%3D10.1007%2F978-3-319-32805-8_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2634</span>– <span class="NLM_lpage">2660</span>, <span class="refDoi"> DOI: 10.2174/0929867325666180508095242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F0929867325666180508095242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29737249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFCitbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=2634-2660&author=M.+R.+Swingleauthor=R.+E.+Honkanen&title=Inhibitors+of+Serine%2FThreonine+Protein+Phosphatases%3A+Biochemical+and+Structural+Studies+Provide+Insight+for+Further+Development&doi=10.2174%2F0929867325666180508095242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development</span></div><div class="casAuthors">Swingle, Mark R.; Honkanen, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2634-2660</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: The reversible phosphorylation of proteins regulates many key functions in eukaryotic cells.  Phosphorylation is catalyzed by protein kinases, with the majority of phosphorylation occurring on side chains of serine and threonine residues.  The phosphomonoesters generated by protein kinases are hydrolyzed by protein phosphatases.  In the absence of a phosphatase, the half-time for the hydrolysis of alkyl phosphate dianions at 25° C is over 1 trillion years; knon ∼2 x 10-20 sec-1.  Therefore, ser/thr phosphatases are crit. for processes controlled by reversible phosphorylation.  Methods: This review is based on the literature searched in available databases.  We compare the catalytic mechanism of PPP-family phosphatases (PPPases) and the interactions of inhibitors that target these enzymes.  Results: PPPases are metal-dependent hydrolases that enhance the rate of hydrolysis ([kcat/kM]/knon ) by a factor of ∼1021, placing them among the most powerful known catalysts on earth.  Biochem. and structural studies indicate that the remarkable catalytic proficiencies of PPPases are achieved by 10 conserved amino acids, DXH(X)∼26DXXDR(X)∼20- 26NH(X)∼50H(X)∼25-45R(X)∼30-40H.  Six act as metal-coordinating residues.  Four position and orient the substrate phosphate.  Together, two metal ions and the 10 catalytic residues position the phosphoryl group and an activated bridging water/hydroxide nucleophile for an inline attack upon the substrate phosphorous atom.  The PPPases are conserved among species, and many structurally diverse natural toxins co-evolved to target these enzymes.  Conclusion: Although the catalytic site is conserved, opportunities for the development of selective inhibitors of this important group of metalloenzymes exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG3RBU0ksB2bVg90H21EOLACvtfcHk0lhqXAO8ZDUj_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFCitbnK&md5=23dadab0a8d685bf506c09c14be8d64b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F0929867325666180508095242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867325666180508095242%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DInhibitors%2520of%2520Serine%252FThreonine%2520Protein%2520Phosphatases%253A%2520Biochemical%2520and%2520Structural%2520Studies%2520Provide%2520Insight%2520for%2520Further%2520Development%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2019%26volume%3D26%26spage%3D2634%26epage%3D2660%26doi%3D10.2174%2F0929867325666180508095242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heroes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesage, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Görnemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beullens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Meervelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">The Pp1 Binding Code: A Molecular-Lego Strategy That Governs Specificity</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2012.08547.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1111%2Fj.1742-4658.2012.08547.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22360570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFClsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=584-595&author=E.+Heroesauthor=B.+Lesageauthor=J.+G%C3%B6rnemannauthor=M.+Beullensauthor=L.+Van+Meerveltauthor=M.+Bollen&title=The+Pp1+Binding+Code%3A+A+Molecular-Lego+Strategy+That+Governs+Specificity&doi=10.1111%2Fj.1742-4658.2012.08547.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The PP1 binding code: a molecular-lego strategy that governs specificity</span></div><div class="casAuthors">Heroes, Ewald; Lesage, Bart; Goernemann, Janina; Beullens, Monique; Van Meervelt, Luc; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">584-595</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Ser/Thr protein phosphatase 1 (PP1) is a single-domain hub protein with nearly 200 validated interactors in vertebrates.  PP1-interacting proteins (PIPs) are ubiquitously expressed but show an exceptional diversity in brain, testis, and white blood cells.  The binding of PIPs is mainly mediated by short motifs that dock to surface grooves of PP1.  Although PIPs often contain variants of the same PP1 binding motifs, they differ in the no. and combination of docking sites.  This mol.-lego strategy for binding to PP1 creates holoenzymes with unique properties.  The PP1 binding code can be described as specific, universal, degenerate, nonexclusive, and dynamic.  PIPs control assocd. PP1 by interference with substrate recruitment or access to the active site.  In addn., some PIPs have a subcellular targeting domain that promotes dephosphorylation by increasing the local concn. of PP1.  The diversity of the PP1 interactome and the properties of the PP1 binding code account for the exquisite specificity of PP1 in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONNHLs4pYSLVg90H21EOLACvtfcHk0lhqXAO8ZDUj_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFClsbY%253D&md5=775a3fd2534221da3bb84fbd0ae044ad</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2012.08547.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2012.08547.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeroes%26aufirst%3DE.%26aulast%3DLesage%26aufirst%3DB.%26aulast%3DG%25C3%25B6rnemann%26aufirst%3DJ.%26aulast%3DBeullens%26aufirst%3DM.%26aulast%3DVan%2BMeervelt%26aufirst%3DL.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DThe%2520Pp1%2520Binding%2520Code%253A%2520A%2520Molecular-Lego%2520Strategy%2520That%2520Governs%2520Specificity%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D584%26epage%3D595%26doi%3D10.1111%2Fj.1742-4658.2012.08547.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, G. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejiri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mushlin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonser, R. R.</span></span> <span> </span><span class="NLM_article-title">The Effect of a Pp2a Inhibitor on the Nuclear Receptor Corepressor Pathway in Glioma</span>. <i>J. Neurosurg.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.3171/2009.11.JNS091272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3171%2F2009.11.JNS091272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20001590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2010&pages=225-233&author=J.+Luauthor=Z.+Zhuangauthor=D.+K.+Songauthor=G.+U.+Mehtaauthor=B.+Ikejiriauthor=H.+Mushlinauthor=D.+M.+Parkauthor=R.+R.+Lonser&title=The+Effect+of+a+Pp2a+Inhibitor+on+the+Nuclear+Receptor+Corepressor+Pathway+in+Glioma&doi=10.3171%2F2009.11.JNS091272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma</span></div><div class="casAuthors">Lu, Jie; Zhuang, Zhengping; Song, Debbie K.; Mehta, Gautam U.; Ikejiri, Barbara; Mushlin, Harry; Park, Deric M.; Lonser, Russell R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurosurgery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-233</span>CODEN:
                <span class="NLM_cas:coden">JONSAC</span>;
        ISSN:<span class="NLM_cas:issn">0022-3085</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neurosurgeons</span>)
        </div><div class="casAbstract">Objective: Nuclear receptor corepressor (N-CoR) forms a complex that maintains neural stem cells in an undifferentiated state through transcriptional repression.  Recently, it has been shown that N-CoR is overexpressed in glioblastoma multiforme (GBM) tumor stem cells and has a putative role in maintaining these cells in an undifferentiated immortal state.  To det. the effects of disruption of N-CoR complex function by serine/threonine protein phosphatase 2A (PP2A) inhibition on GBM tumor cell differentiation and proliferation, the authors developed and investigated a competitive small mol. inhibitor (LB1) or PP2A in GBM.  Methods: The authors investigated the effects of LB1 on GBM proliferation and mol. differentiation pathways using in vitro and in vivo studies.  Results: The LB1 inhibited PP2A, leading to increased levels of phosphorylated Akt kinase and decreased N-CoR expression, as well as dose-dependent antiproliferative activity in cultured U87 and U251 malignant glioma cells (dose range 1-10 μM).  Systemic LB1 treatment (1.5 mg/kg/day for 21 days) had significant tumor antiproliferative effects in mice harboring U87 glioma xenografts (73% mean redn. in tumor vol. compared with controls; p < 0.001).  Moreover, a redn. in PP2A expression and activity after LB1 treatment in vivo correlated with increased Akt phosphorylation, reduced nuclear N-CoR expression and N-CoR cytoplasmic translocation, and increased accumulation of acetylated core histones, which coincided with the appearance of glial fibrillary acidic protein-expressing tumor cells.  Conclusions: These findings indicate that PP2A inhibition effectively disrupts N-CoR complex function/expression and leads to cytoplasmic translocation of N-CoR with subsequent tumor cell differentiation and/or death.  Therapeutic paradigms that target N-CoR function in the cancer stem cell component of malignant gliomas may have treatment utility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqh6O7KGnUVLVg90H21EOLACvtfcHk0lhqXAO8ZDUj_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbvI&md5=f728c00797d35473e32d8475db7f3776</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3171%2F2009.11.JNS091272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3171%252F2009.11.JNS091272%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DD.%2BK.%26aulast%3DMehta%26aufirst%3DG.%2BU.%26aulast%3DIkejiri%26aufirst%3DB.%26aulast%3DMushlin%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DD.%2BM.%26aulast%3DLonser%26aufirst%3DR.%2BR.%26atitle%3DThe%2520Effect%2520of%2520a%2520Pp2a%2520Inhibitor%2520on%2520the%2520Nuclear%2520Receptor%2520Corepressor%2520Pathway%2520in%2520Glioma%26jtitle%3DJ.%2520Neurosurg.%26date%3D2010%26volume%3D113%26spage%3D225%26epage%3D233%26doi%3D10.3171%2F2009.11.JNS091272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovach, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Serine/Threonine Phosphatase Pp2a Enhances Cancer Chemotherapy by Blocking DNA Damage Induced Defense Mechanisms</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">11697</span>– <span class="NLM_lpage">11702</span>, <span class="refDoi"> DOI: 10.1073/pnas.0905930106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.0905930106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19564615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVWitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=11697-11702&author=J.+Luauthor=J.+S.+Kovachauthor=F.+Johnsonauthor=J.+Chiangauthor=R.+Hodesauthor=R.+Lonserauthor=Z.+Zhuang&title=Inhibition+of+Serine%2FThreonine+Phosphatase+Pp2a+Enhances+Cancer+Chemotherapy+by+Blocking+DNA+Damage+Induced+Defense+Mechanisms&doi=10.1073%2Fpnas.0905930106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms</span></div><div class="casAuthors">Lu, Jie; Kovach, John S.; Johnson, Francis; Chiang, Jeffrey; Hodes, Richard; Lonser, Russell; Zhuang, Zhengping</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">11697-11702</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A variety of mechanisms maintain the integrity of the genome in the face of cell stress.  Cancer cell response to chemotherapeutic and radiation-induced DNA damage is mediated by multiple defense mechanisms including polo-like kinase 1 (Plk-1), protein kinase B (Akt-1), and/or p53 pathways leading to either apoptosis or cell cycle arrest.  Subsequently, a subpopulation of arrested viable cancer cells may remain and recur despite aggressive and repetitive therapy.  Here, we show that modulation (activation of Akt-1 and Plk-1 and repression of p53) of these pathways simultaneously results in paradoxical enhancement of the effectiveness of cytotoxic chemotherapy.  We demonstrate that a small mol. inhibitor, LB-1.2, of protein phosphatase 2A (PP2A) activates Plk-1 and Akt-1 and decreases p53 abundance in tumor cells.  Combined with temozolomide (TMZ; a DNA-methylating chemotherapeutic drug), LB-1.2 causes complete regression of glioblastoma multiforme (GBM) xenografts without recurrence in 50% of animals (up to 28 wk) and complete inhibition of growth of neuroblastoma (NB) xenografts.  Treatment with either drug alone results in only short-term inhibition/regression with all xenografts resuming rapid growth.  Combined with another widely used anticancer drug, Doxorubicin (DOX, a DNA intercalating agent), LB-1.2 also causes marked GBM xenograft regression, whereas DOX alone only slows growth.  Inhibition of PP2A by LB-1.2 blocks cell-cycle arrest and increases progression of cell cycle in the presence of TMZ or DOX.  Pharmacol. inhibition of PP2A may be a general method for enhancing the effectiveness of cancer treatments that damage DNA or disrupt components of cell replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3B6AfwowkHrVg90H21EOLACvtfcHk0lhiSOi09EwgJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVWitr0%253D&md5=890dab814ffd430da246034c3d4beb53</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0905930106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0905930106%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DKovach%26aufirst%3DJ.%2BS.%26aulast%3DJohnson%26aufirst%3DF.%26aulast%3DChiang%26aufirst%3DJ.%26aulast%3DHodes%26aufirst%3DR.%26aulast%3DLonser%26aufirst%3DR.%26aulast%3DZhuang%26aufirst%3DZ.%26atitle%3DInhibition%2520of%2520Serine%252FThreonine%2520Phosphatase%2520Pp2a%2520Enhances%2520Cancer%2520Chemotherapy%2520by%2520Blocking%2520DNA%2520Damage%2520Induced%2520Defense%2520Mechanisms%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D11697%26epage%3D11702%26doi%3D10.1073%2Fpnas.0905930106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, B.</span></span> <span> </span><span class="NLM_article-title">New Medical Treatment Options and Strategies to Assess Clinical Outcome in Soft-Tissue Sarcoma</span>. <i>Expert Rev. Anticancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.1586/era.09.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1586%2Fera.09.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19671035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvF2qu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1159-1167&author=T.+Schmittauthor=B.+Kasper&title=New+Medical+Treatment+Options+and+Strategies+to+Assess+Clinical+Outcome+in+Soft-Tissue+Sarcoma&doi=10.1586%2Fera.09.64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma</span></div><div class="casAuthors">Schmitt, Thomas; Kasper, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1159-1167</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Soft-tissue sarcomas (STSs) are a heterogeneous group of rare malignant tumors predominantly arising from the embryonic mesoderm.  The mainstay of curative therapy is the complete surgical resection of all tumor manifestations with neg. histol. margins.  However, up to 50% of patients will develop distant metastases during the course of their disease.  The prognosis for those patients is grim with a 5-yr overall survival of less than 10%.  First-line systemic therapy with ifosfamide and doxorubicin results in overall response rates of only 20% by conventional response evaluation criteria in solid tumors (RECIST).  However, stabilization of disease can be seen in a greater proportion.  Therefore, the role of the RECIST criteria has been questioned and the implementation of new imaging studies (e.g., FDG-PET) has shown promising results in assessing early tumor response to therapy.  Furthermore, a broader insight into the mol. pathways of sarcomagenesis has been gained in recent years, revealing intriguing targets for new therapeutic approaches (e.g., VEGF, VEGF receptor, IGF receptor, EGF receptor, mTOR and cyclin-dependent kinases).  In addn., a growing body of evidence is linking specific genetic aberrations with clin. outcome (e.g., SYT-SXX translocation in synovial sarcoma).  With further insight into the biol. of STS and the combination of new treatment options with modern imaging techniques, we will most certainly be able to improve clin. outcome in patients with STS in the upcoming years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofmSAbovIz7bVg90H21EOLACvtfcHk0lhiSOi09EwgJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvF2qu7g%253D&md5=0c5aac3d30ce1f38d633e4bf32de1860</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1586%2Fera.09.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.09.64%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DT.%26aulast%3DKasper%26aufirst%3DB.%26atitle%3DNew%2520Medical%2520Treatment%2520Options%2520and%2520Strategies%2520to%2520Assess%2520Clinical%2520Outcome%2520in%2520Soft-Tissue%2520Sarcoma%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2009%26volume%3D9%26spage%3D1159%26epage%3D1167%26doi%3D10.1586%2Fera.09.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holcomb, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neblett, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oates, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abumrad, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, H. W.</span></span> <span> </span><span class="NLM_article-title">Clinical Experience over 48 Years with Pheochromocytoma</span>. <i>Ann. Surg.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>229</i></span>,  <span class="NLM_fpage">755</span>, <span class="refDoi"> DOI: 10.1097/00000658-199906000-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1097%2F00000658-199906000-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10363888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADyaK1M3ptVGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1999&pages=755&author=R.+E.+Goldsteinauthor=J.+A.+O%E2%80%99Neillauthor=G.+W.+Holcombauthor=W.+M.+Morganauthor=W.+W.+Neblettauthor=J.+A.+Oatesauthor=N.+Brownauthor=J.+Nadeauauthor=B.+Smithauthor=D.+L.+Pageauthor=N.+N.+Abumradauthor=H.+W.+Scott&title=Clinical+Experience+over+48+Years+with+Pheochromocytoma&doi=10.1097%2F00000658-199906000-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical experience over 48 years with pheochromocytoma</span></div><div class="casAuthors">Goldstein R E; O'Neill J A Jr; Holcomb G W 3rd; Morgan W M 3rd; Neblett W W 3rd; Oates J A; Brown N; Nadeau J; Smith B; Page D L; Abumrad N N; Scott H W Jr</div><div class="citationInfo"><span class="NLM_cas:title">Annals of surgery</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-64; discussion 764-6</span>
        ISSN:<span class="NLM_cas:issn">0003-4932</span>.
    </div><div class="casAbstract">OBJECTIVE:  To analyze the presentation, localization, surgical management, pathology, and long-term outcome of a large series of patients with pheochromocytomas.  SUMMARY BACKGROUND DATA:  There are several areas of controversy pertaining to pheochromocytomas.  Although many studies report a higher rate of malignancy for extraadrenal pheochromocytomas than for adrenal pheochromocytomas, the number of patients with the former tumor are small and statistical analysis is lacking.  There has also been recent debate as to whether microscopic features of the tumor may be predictive of future behavior.  METHODS:  From 1950 to 1998, the authors observed 108 pheochromocytomas in 104 patients.  The outcome of these patients has been followed prospectively.  The medical records of these patients were reviewed for data on the presentation, localization, surgical management, pathology, and outcome.  Patient survival was analyzed using Kaplan-Meier survival distributions.  RESULTS:  This study included 66 female patients and 38 male patients.  The average age at surgery was 42.3 years.  Sporadic cases accounted for 84% of the patients; the other 16% had multiple endocrine neoplasia type 2, von Recklinghausen's disease, von Hippel-Lindau disease, or Carney's syndrome.  Of 64 adrenal tumors, 55 were initially considered benign, 6 had microscopic malignant features, and 3 had malignant disease.  Mean patient follow-up was 12.6 years.  To date, in five additional patients (none with microscopic disease) malignant disease developed (13% overall rate of malignancy).  Recurrence occurred as late as 15 years after resection.  Of 26 extraadrenal pheochromocytomas, 14 were initially considered benign, 8 had microscopic malignant features, and 4 had malignant disease.  Thus, 46% of patients had either malignant disease or tumors with malignant features.  Mean patient follow-up was 11.5 years.  In one patient with benign disease and in one patient with malignant features, malignant disease developed (23% overall rate of malignancy).  The difference in the rate of malignancy was not statistically significant between adrenal and extraadrenal pheochromocytomas.  Patients with adrenal and extraadrenal pheochromocytomas also had similar rates of survival (p = NS).  CONCLUSIONS:  The data suggest that patients with extraadrenal pheochromocytomas have the same risk of malignancy and the same overall survival as patients with adrenal pheochromocytomas.  Lifelong follow-up of these patients is mandatory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQKfpWMElvIZrBItaL1WaVAfW6udTcc2eYDq47XU6ZM1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3ptVGmtA%253D%253D&md5=8f9525f3adda7b1865c7c4d45cabed40</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1097%2F00000658-199906000-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000658-199906000-00001%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DR.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BA.%26aulast%3DHolcomb%26aufirst%3DG.%2BW.%26aulast%3DMorgan%26aufirst%3DW.%2BM.%26aulast%3DNeblett%26aufirst%3DW.%2BW.%26aulast%3DOates%26aufirst%3DJ.%2BA.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DNadeau%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DPage%26aufirst%3DD.%2BL.%26aulast%3DAbumrad%26aufirst%3DN.%2BN.%26aulast%3DScott%26aufirst%3DH.%2BW.%26atitle%3DClinical%2520Experience%2520over%252048%2520Years%2520with%2520Pheochromocytoma%26jtitle%3DAnn.%2520Surg.%26date%3D1999%26volume%3D229%26spage%3D755%26doi%3D10.1097%2F00000658-199906000-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eichhorn, P. J. A</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creyghton, M. P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelmsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernards, R.</span></span> <span> </span><span class="NLM_article-title">A Rna Interference Screen Identifies the Protein Phosphatase 2a Subunit Pr55γ as a Stress-Sensitive Inhibitor of C-Src</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e218</span>, <span class="refDoi"> DOI: 10.1371/journal.pgen.0030218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1371%2Fjournal.pgen.0030218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=18069897" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=e218&author=P.+J.+A+Eichhornauthor=M.+P+Creyghtonauthor=K.+Wilhelmsenauthor=H.+van+Damauthor=R.+Bernards&title=A+Rna+Interference+Screen+Identifies+the+Protein+Phosphatase+2a+Subunit+Pr55%CE%B3+as+a+Stress-Sensitive+Inhibitor+of+C-Src&doi=10.1371%2Fjournal.pgen.0030218"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.0030218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.0030218%26sid%3Dliteratum%253Aachs%26aulast%3DEichhorn%26aufirst%3DP.%2BJ.%2BA%26aulast%3DCreyghton%26aufirst%3DM.%2BP%26aulast%3DWilhelmsen%26aufirst%3DK.%26aulast%3Dvan%2BDam%26aufirst%3DH.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DA%2520Rna%2520Interference%2520Screen%2520Identifies%2520the%2520Protein%2520Phosphatase%25202a%2520Subunit%2520Pr55%25CE%25B3%2520as%2520a%2520Stress-Sensitive%2520Inhibitor%2520of%2520C-Src%26jtitle%3DPLoS%2520Genet.%26date%3D2007%26volume%3D3%26spage%3De218%26doi%3D10.1371%2Fjournal.pgen.0030218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.-m.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.-l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.-r.</span></span> <span> </span><span class="NLM_article-title">Effectiveness and Toxicities of Intensity-Modulated Radiotherapy for Patients with Locally Recurrent Nasopharyngeal Carcinoma</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e73918</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0073918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1371%2Fjournal.pone.0073918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24040115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyrsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e73918&author=H.-y.+Chenauthor=X.-m.+Maauthor=M.+Yeauthor=Y.-l.+Houauthor=H.-Y.+Xieauthor=Y.-r.+Bai&title=Effectiveness+and+Toxicities+of+Intensity-Modulated+Radiotherapy+for+Patients+with+Locally+Recurrent+Nasopharyngeal+Carcinoma&doi=10.1371%2Fjournal.pone.0073918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma</span></div><div class="casAuthors">Chen, Hai-Yan; Ma, Xiu-Mei; Ye, Ming; Hou, Yan-Li; Xie, Hua-Ying; Bai, Yong-Rui</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e73918</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Purpose: To analyze the effectiveness and toxicities in the re-irradn. of locally recurrent nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT).  Methods: This is a retrospective anal. of 54 NPC patients with local recurrence re-irradiated with IMRT.  The re-staging for rT1, rT2, rT3, rT4 were 3 (5.6%), 8 (14.8%), 9 (16.7%), 34 (63%) resp.  The av. dose to GTV was 69.95 Gy (49.8-76.58 Gy), the av. BED3Gy was 116.8 Gy (83.5-127.9 Gy).  V95 was 96%, and D95 was 65.75Gy.  33.3% of them received concurrent chemoradiotherapy.  Results: Median overall survival (OS) was 21 mo (1-93 mon).  The 1-,2-yr local progression free survival (LPFS) rate was 84.5%, 64% and OS rate was 71.7%, 44.3%.  Severe late adverse events (SLAE) occurred in 48.1% of patients, including 31.5% with ulcer or necrosis of the nasopharyngeal mucosa, 20.4% with difficulty in feeding, 18.5% with temporal lobe necrosis, 11.1% with massive hemorrhage.  15.4% died of local regional progression, 5.8% died of distant metastasis, 25% died of SLAE, 9.6% died of both local regional progression and SLAE that could not be differentiated, 5.8% died of other medical complications.  Concurrent chemoradiotherapy was the independent neg. prognostic factors for LPFS; PTV>100 mL was a predictive factor of poor OS; patients with invasion of post-styloid space were at higher risk of SLAE.  Conclusions: The present study demonstrated that IMRT with 70Gy was efficient for local tumor control.  However, we obsd. a high frequency of serious late complications.  More optimized combination treatment and patient selection are required to achieve excellent local control without significant late morbidities in locally recurrent NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu-N4tCebGxbVg90H21EOLACvtfcHk0lipobNI5S9WcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyrsLjP&md5=474c37fb444106846eb0d8a0528c006a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073918%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.-y.%26aulast%3DMa%26aufirst%3DX.-m.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DHou%26aufirst%3DY.-l.%26aulast%3DXie%26aufirst%3DH.-Y.%26aulast%3DBai%26aufirst%3DY.-r.%26atitle%3DEffectiveness%2520and%2520Toxicities%2520of%2520Intensity-Modulated%2520Radiotherapy%2520for%2520Patients%2520with%2520Locally%2520Recurrent%2520Nasopharyngeal%2520Carcinoma%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De73918%26doi%3D10.1371%2Fjournal.pone.0073918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. L.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic Effects of Cantharidin on the Growth of Normal and Carcinoma Cells</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/S0300-483X(00)00185-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0300-483X%2800%2900185-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10874155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlKmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2000&pages=77-87&author=C.+C.+Wangauthor=C.+H.+Wuauthor=K.+J.+Hsiehauthor=K.+Y.+Yenauthor=L.+L.+Yang&title=Cytotoxic+Effects+of+Cantharidin+on+the+Growth+of+Normal+and+Carcinoma+Cells&doi=10.1016%2FS0300-483X%2800%2900185-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells</span></div><div class="casAuthors">Wang, C.-C.; Wu, C.-H.; Hsieh, K.-J.; Yen, K.-Y.; Yang, L.-L.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-87</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Cantharidin is isolated from Mylabris phalerata Pallas and is a potent inhibitor of hepatocellular carcinoma cells (Hep 3B cells).  In the present study, the IC50 values of cantharidin on Hep 3B cells and normal Chang liver cells were 2.2 and 30.2 μM for 36 h, resp.  Furthermore, cantharidin-treated Hep 3B cells induced cell death within 1 h (IC50=52.8 μM), suggesting that cantharidin is an acute cytotoxic agent.  We found that although cantharidin could induce cell death, it could not directly inhibit the activity of nucleic acid biosynthesis by the cellular incorporation of 3H-thymidine, 3H-uridine or 3H-leucine.  Cantharidin-treated Hep 3B cells showed no evidence of major alterations in the cell cycle distribution within 1 h.  However, examn. of cells after treatment for 36 h showed that cantharidin regulated the cell cycle at the G2/M phase.  Moreover, the treated Hep 3B cells had a rounded and shrunken appearance.  The microvilli of treated Hep 3B cells were reduced in no. and replaced by numerous blebs.  Other ultrastructural changes following cantharidin treatment included the presence of lipid droplets, swelling of the mitochondria and accumulation of glycogen particles.  The findings of damaged mitochondria in the cantharidin treated Hep 3B cells in this study suggest that cantharidin can induce acute and lethal toxic effects on Hep 3B cells by inhibiting the mitochondria energy system.  In conclusion, this study had demonstrated that cantharidin could inhibit progression of all phases of the Hep 3B cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Nb5pDQWAbbVg90H21EOLACvtfcHk0lipobNI5S9WcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlKmtbo%253D&md5=dc1524496cef501de343e88138c173d3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0300-483X%2800%2900185-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0300-483X%252800%252900185-2%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DHsieh%26aufirst%3DK.%2BJ.%26aulast%3DYen%26aufirst%3DK.%2BY.%26aulast%3DYang%26aufirst%3DL.%2BL.%26atitle%3DCytotoxic%2520Effects%2520of%2520Cantharidin%2520on%2520the%2520Growth%2520of%2520Normal%2520and%2520Carcinoma%2520Cells%26jtitle%3DToxicology%26date%3D2000%26volume%3D147%26spage%3D77%26epage%3D87%26doi%3D10.1016%2FS0300-483X%2800%2900185-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z. K.</span></span> <span> </span><span class="NLM_article-title">Growth of the Pancreatic Cancer Cell Line Panc-1 Is Inhibited by Protein Phosphatase 2a Inhibitors through Overactivation of the C-Jun N-Terminal Kinase Pathway</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2654</span>– <span class="NLM_lpage">2664</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2011.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.ejca.2011.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=21958460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOjsb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=2654-2664&author=W.+Liauthor=Z.+Chenauthor=F.+R.+Gongauthor=Y.+Zongauthor=K.+Chenauthor=D.+M.+Liauthor=H.+Yinauthor=W.+M.+Duanauthor=Y.+Miaoauthor=M.+Taoauthor=X.+Hanauthor=Z.+K.+Xu&title=Growth+of+the+Pancreatic+Cancer+Cell+Line+Panc-1+Is+Inhibited+by+Protein+Phosphatase+2a+Inhibitors+through+Overactivation+of+the+C-Jun+N-Terminal+Kinase+Pathway&doi=10.1016%2Fj.ejca.2011.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway</span></div><div class="casAuthors">Li, Wei; Chen, Zheng; Gong, Fei-Ran; Zong, Yang; Chen, Kai; Li, Dao-Ming; Yin, Hong; Duan, Wei-Ming; Miao, Yi; Tao, Min; Han, Xiao; Xu, Ze-Kuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2654-2664</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Protein phosphatase 2A (PP2A) is a multimeric serine/threonine phosphatase that can dephosphorylate multiple kinases.  It is generally considered to be a cancer suppressor as its inhibition can induce phosphorylation and activation of substrate kinases that mainly accelerate growth.  We previously reported that cantharidin, an active constituent of a traditional Chinese medicine, potently and selectively inhibited PP2A, yet efficiently repressed the growth of pancreatic cancer cells through activation of the c-Jun N-terminal kinase (JNK) pathway.  This suggested that activation of kinase pathways might also be a potential strategy for cancer therapy.  In this study, we have confirmed that the basal activity of the phospatidylinositol 3-kinase (PI3K)/JNK/activator protein 1 (AP-1) pathway promoted pancreatic cancer cell growth when stimulated by growth factors.  Interestingly, although treatment with the PP2A inhibitors, cantharidin or okadaic acid (OA), amplified the PI3K-dependent activation of JNK, cell growth was repressed.  We therefore hypothesised that a specific level of activity of the JNK pathway might be required to maintain the promitogenic function, as both repression and overactivation of JNK could inhibit cell proliferation.  It was found that the JNK-dependent growth inhibition was independent of the activation of AP-1, but dependent on the repression of Akt.  Although the PP2A inhibitors triggered overactivation of JNK and inhibited cell growth, excessively activated protein kinase C (PKC) improved cell survival.  Combined treatment with a PP2A inhibitor and a PKC inhibitor produced a synergistic effect, which indicates a potentially promising therapeutic approach to pancreatic cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY-5FefWvHIrVg90H21EOLACvtfcHk0lipobNI5S9WcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOjsb%252FF&md5=b38257a3f43d8478fbb17bb4e80e556f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2011.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2011.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DF.%2BR.%26aulast%3DZong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DD.%2BM.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DDuan%26aufirst%3DW.%2BM.%26aulast%3DMiao%26aufirst%3DY.%26aulast%3DTao%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DZ.%2BK.%26atitle%3DGrowth%2520of%2520the%2520Pancreatic%2520Cancer%2520Cell%2520Line%2520Panc-1%2520Is%2520Inhibited%2520by%2520Protein%2520Phosphatase%25202a%2520Inhibitors%2520through%2520Overactivation%2520of%2520the%2520C-Jun%2520N-Terminal%2520Kinase%2520Pathway%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2011%26volume%3D47%26spage%3D2654%26epage%3D2664%26doi%3D10.1016%2Fj.ejca.2011.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrucki, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernatchez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinusas, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shulman, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sessa, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarovinsky, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, J. R.</span></span> <span> </span><span class="NLM_article-title">Ceramide-Activated Phosphatase Mediates Fatty Acid-Induced Endothelial Vegf Resistance and Impaired Angiogenesis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">1562</span>– <span class="NLM_lpage">1576</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2014.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.ajpath.2014.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24606881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVemtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2014&pages=1562-1576&author=V.+C.+Mehraauthor=E.+Jacksonauthor=X.+M.+Zhangauthor=X.+C.+Jiangauthor=L.+W.+Dobruckiauthor=J.+Yuauthor=P.+Bernatchezauthor=A.+J.+Sinusasauthor=G.+I.+Shulmanauthor=W.+C.+Sessaauthor=T.+O.+Yarovinskyauthor=J.+R.+Bender&title=Ceramide-Activated+Phosphatase+Mediates+Fatty+Acid-Induced+Endothelial+Vegf+Resistance+and+Impaired+Angiogenesis&doi=10.1016%2Fj.ajpath.2014.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide-Activated Phosphatase Mediates Fatty Acid-Induced Endothelial VEGF Resistance and Impaired Angiogenesis</span></div><div class="casAuthors">Mehra, Vishal C.; Jackson, Elias; Zhang, Xian M.; Jiang, Xian-Cheng; Dobrucki, Lawrence W.; Yu, Jun; Bernatchez, Pascal; Sinusas, Albert J.; Shulman, Gerald I.; Sessa, William C.; Yarovinsky, Timur O.; Bender, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1562-1576</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Endothelial dysfunction, including endothelial hyporesponsiveness to prototypical angiogenic growth factors and eNOS agonists, underlies vascular pathol. in many dysmetabolic states.  We investigated effects of a satd. free fatty acid, palmitic acid (PA), on endothelial cell responses to VEGF.  PA-pretreated endothelial cells had markedly diminished Akt, eNOS, and ERK activation responses to VEGF, despite normal VEGFR2 phosphorylation.  PA inhibited VEGF-induced angiogenic cord formation in Matrigel, and PA-treated endothelial cells accumulated early species (C16) ceramide.  The serine palmitoyltransferase inhibitor myriocin reversed these defects.  Protein phosphatase 2A (PP2A) became more eNOS-assocd. in PA-treated cells; the PP2A inhibitor okadaic acid reversed PA-induced signaling defects.  Mice fed a diet high in satd. fat for 2 to 3 wk had impaired i) aortic Akt and eNOS phosphorylation to infused VEGF, ii) ear angiogenic responses to intradermal adenoviral-VEGF injection, and iii) vascular flow recovery to hindlimb ischemia as indicated by laser Doppler and αVβ3 SPECT imaging.  High-fat feeding did not impair VEGF-induced signaling or angiogenic responses in mice with reduced serine palmitoyltransferase expression.  Thus, de novo ceramide synthesis is required for these detrimental PA effects.  The findings demonstrate an endothelial VEGF resistance mechanism conferred by PA, which comprises ceramide-induced, PP2A-mediated dephosphorylation of crit. activation sites on enzymes central to vascular homeostasis and angiogenesis.  This study defines potential mol. targets for preservation of endothelial function in metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgG6GyltXqD7Vg90H21EOLACvtfcHk0lh5QC68ypnfrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVemtLk%253D&md5=0ab893f099774af919a778489ba9ed35</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2014.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2014.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DMehra%26aufirst%3DV.%2BC.%26aulast%3DJackson%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%2BM.%26aulast%3DJiang%26aufirst%3DX.%2BC.%26aulast%3DDobrucki%26aufirst%3DL.%2BW.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DBernatchez%26aufirst%3DP.%26aulast%3DSinusas%26aufirst%3DA.%2BJ.%26aulast%3DShulman%26aufirst%3DG.%2BI.%26aulast%3DSessa%26aufirst%3DW.%2BC.%26aulast%3DYarovinsky%26aufirst%3DT.%2BO.%26aulast%3DBender%26aufirst%3DJ.%2BR.%26atitle%3DCeramide-Activated%2520Phosphatase%2520Mediates%2520Fatty%2520Acid-Induced%2520Endothelial%2520Vegf%2520Resistance%2520and%2520Impaired%2520Angiogenesis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2014%26volume%3D184%26spage%3D1562%26epage%3D1576%26doi%3D10.1016%2Fj.ajpath.2014.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKeage, M. J.</span></span> <span> </span><span class="NLM_article-title">New-Generation Platinum Drugs in the Treatment of Cisplatin-Resistant Cancers</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1046</span>, <span class="refDoi"> DOI: 10.1517/13543784.14.8.1033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1517%2F13543784.14.8.1033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=16050795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFelsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1033-1046&author=M.+J.+McKeage&title=New-Generation+Platinum+Drugs+in+the+Treatment+of+Cisplatin-Resistant+Cancers&doi=10.1517%2F13543784.14.8.1033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">New-generation platinum drugs in the treatment of cisplatin-resistant cancers</span></div><div class="casAuthors">McKeage, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1033-1046</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Platinum drugs with altered stable ligands, such as oxaliplatin and satraplatin, produce a different DNA-adduct profile to cisplatin.  This results in a distinct therapeutic profile, and clin. trials with these agents demonstrate significant anticancer activity in diseases with inherent or acquired resistance to cisplatin, such as colorectal and prostate cancers as well as previously treated ovarian and germ-cell cancer.  An alternative approach to increasing the efficacy assocd. with platinum therapy is to enhance tumor delivery by coupling platinum drugs with a polymer or encapsulating the agent in a liposome.  The early clin. trials of these novel delivery formulations are promising but, as yet, have not confirmed that the delivery of platinum to the tumor cell DNA is increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVke4wqJPl4bVg90H21EOLACvtfcHk0lh5QC68ypnfrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFelsrw%253D&md5=e95d7e5cd02b5bba3e4202ebc6c77f62</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.8.1033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.8.1033%26sid%3Dliteratum%253Aachs%26aulast%3DMcKeage%26aufirst%3DM.%2BJ.%26atitle%3DNew-Generation%2520Platinum%2520Drugs%2520in%2520the%2520Treatment%2520of%2520Cisplatin-Resistant%2520Cancers%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D1033%26epage%3D1046%26doi%3D10.1517%2F13543784.14.8.1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toop, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dun, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrills, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span> <span> </span><span class="NLM_article-title">Development of Novel Pp2a Activators for Use in the Treatment of Acute Myeloid Leukaemia</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4605</span>– <span class="NLM_lpage">4616</span>, <span class="refDoi"> DOI: 10.1039/C6OB00556J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1039%2FC6OB00556J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=27102578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsF2ntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=4605-4616&author=H.+D.+Toopauthor=M.+D.+Dunauthor=B.+K.+Rossauthor=H.+M.+Flanaganauthor=N.+M.+Verrillsauthor=J.+C.+Morris&title=Development+of+Novel+Pp2a+Activators+for+Use+in+the+Treatment+of+Acute+Myeloid+Leukaemia&doi=10.1039%2FC6OB00556J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel PP2A activators for use in the treatment of acute myeloid leukemia</span></div><div class="casAuthors">Toop, Hamish D.; Dun, Matthew D.; Ross, Bryony K.; Flanagan, Hayley M.; Verrills, Nicole M.; Morris, Jonathan C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4605-4616</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">AAL(S), the chiral deoxy analog of the FDA approved drug FTY720, has been shown to inhibit proliferation and apoptosis in several cancer cell lines.  It has been suggested that it does this by activating protein phosphatase 2A (PP2A).  The authors show that these analogs activate PP2A in these cells supporting the suggested mechanism for their cytotoxic properties.  The authors' findings identify key structural motifs required for anti-cancer effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4bXSci2sQNbVg90H21EOLACvtfcHk0lh5QC68ypnfrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsF2ntb0%253D&md5=1804e9ffc4c08747ee59161d333aaba4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1039%2FC6OB00556J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6OB00556J%26sid%3Dliteratum%253Aachs%26aulast%3DToop%26aufirst%3DH.%2BD.%26aulast%3DDun%26aufirst%3DM.%2BD.%26aulast%3DRoss%26aufirst%3DB.%2BK.%26aulast%3DFlanagan%26aufirst%3DH.%2BM.%26aulast%3DVerrills%26aufirst%3DN.%2BM.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26atitle%3DDevelopment%2520of%2520Novel%2520Pp2a%2520Activators%2520for%2520Use%2520in%2520the%2520Treatment%2520of%2520Acute%2520Myeloid%2520Leukaemia%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D4605%26epage%3D4616%26doi%3D10.1039%2FC6OB00556J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatchwell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrills, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wark, P. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Siqueira, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooze, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett Nathan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothenberg, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, J.</span></span> <span> </span><span class="NLM_article-title">The E3 Ubiquitin Ligase Midline 1 Promotes Allergen and Rhinovirus-Induced Asthma by Inhibiting Protein Phosphatase 2a Activity</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1038/nm.3049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fnm.3049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23334847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=232-237&author=A.+Collisonauthor=L.+Hatchwellauthor=N.+Verrillsauthor=P.+A.+B.+Warkauthor=A.+P.+de%0ASiqueiraauthor=M.+Toozeauthor=H.+Carpenterauthor=A.+S.+Donauthor=J.+C.+Morrisauthor=N.+Zimmermannauthor=W.+Bartlett+Nathanauthor=M.+E.+Rothenbergauthor=S.+L.+Johnstonauthor=P.+S.+Fosterauthor=J.+Mattes&title=The+E3+Ubiquitin+Ligase+Midline+1+Promotes+Allergen+and+Rhinovirus-Induced+Asthma+by+Inhibiting+Protein+Phosphatase+2a+Activity&doi=10.1038%2Fnm.3049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity</span></div><div class="casAuthors">Collison, Adam; Hatchwell, Luke; Verrills, Nicole; Wark, Peter A. B.; de Siqueira, Ana Pereira; Tooze, Melinda; Carpenter, Helen; Don, Anthony S.; Morris, Jonathan C.; Zimmermann, Nives; Bartlett, Nathan W.; Rothenberg, Marc E.; Johnston, Sebastian L.; Foster, Paul S.; Mattes, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">232-237</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Allergic airway inflammation is assocd. with activation of innate immune pathways by allergens.  Acute exacerbations of asthma are commonly assocd. with rhinovirus infection.  Here we show that, after exposure to house dust mite (HDM) or rhinovirus infection, the E3 ubiquitin ligase midline 1 (MID1) is upregulated in mouse bronchial epithelium.  HDM regulates MID1 expression in a Toll-like receptor 4 (TLR4)- and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent manner.  MID1 decreases protein phosphatase 2A (PP2A) activity through assocn. with its catalytic subunit PP2Ac. siRNA-mediated knockdown of MID1 or pharmacol. activation of PP2A using a nonphosphorylatable FTY720 analog in mice exposed to HDM reduces airway hyperreactivity and inflammation, including the expression of interleukin-25 (IL-25), IL-33 and CCL20, IL-5 and IL-13 release, nuclear factor (NF)κB activity, p38 mitogen-activated protein kinase (MAPK) phosphorylation, accumulation of eosinophils, T lymphocytes and myeloid dendritic cells, and the no. of mucus-producing cells.  MID1 inhibition also limited rhinovirus-induced exacerbation of allergic airway disease.  We found that MID1 was upregulated in primary human bronchial epithelial cells upon HDM or rhinovirus exposure, and this correlated with TRAIL and CCL20 expression.  Together, these findings identify a key role of MID1 in allergic airway inflammation and links innate immune pathway activation to the development and exacerbation of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDuz_MDUgBT7Vg90H21EOLACvtfcHk0lgSYttJ6jmpPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSjtLo%253D&md5=1978d6cb499352e5c91e393173d0828b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnm.3049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3049%26sid%3Dliteratum%253Aachs%26aulast%3DCollison%26aufirst%3DA.%26aulast%3DHatchwell%26aufirst%3DL.%26aulast%3DVerrills%26aufirst%3DN.%26aulast%3DWark%26aufirst%3DP.%2BA.%2BB.%26aulast%3Dde%2BSiqueira%26aufirst%3DA.%2BP.%26aulast%3DTooze%26aufirst%3DM.%26aulast%3DCarpenter%26aufirst%3DH.%26aulast%3DDon%26aufirst%3DA.%2BS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DZimmermann%26aufirst%3DN.%26aulast%3DBartlett%2BNathan%26aufirst%3DW.%26aulast%3DRothenberg%26aufirst%3DM.%2BE.%26aulast%3DJohnston%26aufirst%3DS.%2BL.%26aulast%3DFoster%26aufirst%3DP.%2BS.%26aulast%3DMattes%26aufirst%3DJ.%26atitle%3DThe%2520E3%2520Ubiquitin%2520Ligase%2520Midline%25201%2520Promotes%2520Allergen%2520and%2520Rhinovirus-Induced%2520Asthma%2520by%2520Inhibiting%2520Protein%2520Phosphatase%25202a%2520Activity%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D232%26epage%3D237%26doi%3D10.1038%2Fnm.3049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Switzer, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitek, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitek, M. P.</span></span> <span> </span><span class="NLM_article-title">Targeting Set/I(2)Pp2a Oncoprotein Functions as a Multi-Pathway Strategy for Cancer Therapy</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2504</span>– <span class="NLM_lpage">2513</span>, <span class="refDoi"> DOI: 10.1038/onc.2010.622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fonc.2010.622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=21297667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2504-2513&author=C.+H.+Switzerauthor=R.+Y.+S.+Chengauthor=T.+M.+Vitekauthor=D.+J.+Christensenauthor=D.+A.+Winkauthor=M.+P.+Vitek&title=Targeting+Set%2FI%282%29Pp2a+Oncoprotein+Functions+as+a+Multi-Pathway+Strategy+for+Cancer+Therapy&doi=10.1038%2Fonc.2010.622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy</span></div><div class="casAuthors">Switzer, C. H.; Cheng, R. Y. S.; Vitek, T. M.; Christensen, D. J.; Wink, D. A.; Vitek, M. P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2504-2513</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The SET oncoprotein participates in cancer progression by affecting multiple cellular processes, inhibiting the tumor suppressor protein phosphatase 2A (PP2A), and inhibiting the metastasis suppressor nm23-H1.  On the basis of these multiple activities, we hypothesized that targeted inhibition of SET would have multiple discrete and measurable effects on cancer cells.  Here, the effects of inhibiting SET oncoprotein function on intracellular signaling and proliferation of human cancer cell lines was investigated.  We obsd. the effects of COG112, a novel SET interacting peptide, on PP2A activity, Akt signaling, nm23-H1 activity and cellular migration/invasion in human U87 glioblastoma and MDA-MB-231 breast adenocarcinoma cancer cell lines.  We found that COG112 interacted with SET protein and inhibited the assocn. between SET and PP2A catalytic subunit (PP2A-c) and nm23-H1.  The interaction between COG112 and SET caused PP2A phosphatase and nm23-H1 exonuclease activities to increase.  COG112-mediated increases in PP2A activity resulted in the inhibition of Akt signaling and cellular proliferation.  Addnl., COG112 inhibited SET assocn. with Ras-related C3 botulinum toxin substrate 1 (Rac1), leading to decreased cellular migration and invasion.  COG112 treatment releases the SET-mediated inhibition of the tumor suppressor PP2A, as well as the metastasis suppressor nm23-H1.  These results establish SET as a novel mol. target and that the inhibition of SET may have beneficial effects in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNLfUOr4nkNrVg90H21EOLACvtfcHk0lgSYttJ6jmpPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqtLs%253D&md5=5297b9597daa0e745fbd80ccb711872d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fonc.2010.622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2010.622%26sid%3Dliteratum%253Aachs%26aulast%3DSwitzer%26aufirst%3DC.%2BH.%26aulast%3DCheng%26aufirst%3DR.%2BY.%2BS.%26aulast%3DVitek%26aufirst%3DT.%2BM.%26aulast%3DChristensen%26aufirst%3DD.%2BJ.%26aulast%3DWink%26aufirst%3DD.%2BA.%26aulast%3DVitek%26aufirst%3DM.%2BP.%26atitle%3DTargeting%2520Set%252FI%25282%2529Pp2a%2520Oncoprotein%2520Functions%2520as%2520a%2520Multi-Pathway%2520Strategy%2520for%2520Cancer%2520Therapy%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2504%26epage%3D2513%26doi%3D10.1038%2Fonc.2010.622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saddoughi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gencer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oaks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szulc, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvam, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senkal, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett-Mayer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Palma, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedarovich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habib, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahelin, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrotti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogretmen, B.</span></span> <span> </span><span class="NLM_article-title">Sphingosine Analogue Drug Fty720 Targets I2pp2a/Set and Mediates Lung Tumour Suppression Via Activation of Pp2a-Ripk1-Dependent Necroptosis</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1002/emmm.201201283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Femmm.201201283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23180565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFWq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=105-121&author=S.+A.+Saddoughiauthor=S.+Gencerauthor=Y.+K.+Petersonauthor=K.+E.+Wardauthor=A.+Mukhopadhyayauthor=J.+Oaksauthor=J.+Bielawskiauthor=Z.+M.+Szulcauthor=R.+J.+Thomasauthor=S.+P.+Selvamauthor=C.+E.+Senkalauthor=E.+Garrett-Mayerauthor=R.+M.+De+Palmaauthor=D.+Fedarovichauthor=A.+Liuauthor=A.+A.+Habibauthor=R.+V.+Stahelinauthor=D.+Perrottiauthor=B.+Ogretmen&title=Sphingosine+Analogue+Drug+Fty720+Targets+I2pp2a%2FSet+and+Mediates+Lung+Tumour+Suppression+Via+Activation+of+Pp2a-Ripk1-Dependent+Necroptosis&doi=10.1002%2Femmm.201201283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis</span></div><div class="casAuthors">Saddoughi, Sahar A.; Gencer, Salih; Peterson, Yuri K.; Ward, Katherine E.; Mukhopadhyay, Archana; Oaks, Joshua; Bielawski, Jacek; Szulc, Zdzislaw M.; Thomas, Raquela J.; Selvam, Shanmugam P.; Senkal, Can E.; Garrett-Mayer, Elizabeth; De Palma, Ryan M.; Fedarovich, Dzmitry; Liu, Angen; Habib, Amyn A.; Stahelin, Robert V.; Perrotti, Danilo; Ogretmen, Besim</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Mechanisms that alter protein phosphatase 2A (PP2A)-dependent lung tumor suppression via the I2PP2A/SET oncoprotein are unknown.  We show here that the tumor suppressor ceramide binds I2PP2A/SET selectively in the nucleus and including its K209 and Y122 residues as detd. by mol. modeling/simulations and site-directed mutagenesis.  Because I2PP2A/SET was found overexpressed, whereas ceramide was downregulated in lung tumors, a sphingolipid analog drug, FTY720, was identified to mimick ceramide for binding and targeting I2PP2A/SET, leading to PP2A reactivation, lung cancer cell death, and tumor suppression in vivo.  Accordingly, while mol. targeting of I2PP2A/SET by stable knockdown prevented further tumor suppression by FTY720, reconstitution of WT-I2PP2A/SET expression restored this process.  Mechanistically, targeting I2PP2A/SET by FTY720 mediated PP2A/RIPK1-dependent programmed necrosis (necroptosis), but not by apoptosis.  The RIPK1 inhibitor necrostatin and knockdown or genetic loss of RIPK1 prevented growth inhibition by FTY720.  Expression of WT- or death-domain-deleted (DDD)-RIPK1, but not the kinase-domain-deleted (KDD)-RIPK1, restored FTY720-mediated necroptosis in RIPK1-/- MEFs.  Thus, these data suggest that targeting I2PP2A/SET by FTY720 suppresses lung tumor growth, at least in part, via PP2A activation and necroptosis mediated by the kinase domain of RIPK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRYK04JuK_OrVg90H21EOLACvtfcHk0lgSYttJ6jmpPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFWq&md5=d51f3eac9f81dfd3668567f9cc9de8ab</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201283%26sid%3Dliteratum%253Aachs%26aulast%3DSaddoughi%26aufirst%3DS.%2BA.%26aulast%3DGencer%26aufirst%3DS.%26aulast%3DPeterson%26aufirst%3DY.%2BK.%26aulast%3DWard%26aufirst%3DK.%2BE.%26aulast%3DMukhopadhyay%26aufirst%3DA.%26aulast%3DOaks%26aufirst%3DJ.%26aulast%3DBielawski%26aufirst%3DJ.%26aulast%3DSzulc%26aufirst%3DZ.%2BM.%26aulast%3DThomas%26aufirst%3DR.%2BJ.%26aulast%3DSelvam%26aufirst%3DS.%2BP.%26aulast%3DSenkal%26aufirst%3DC.%2BE.%26aulast%3DGarrett-Mayer%26aufirst%3DE.%26aulast%3DDe%2BPalma%26aufirst%3DR.%2BM.%26aulast%3DFedarovich%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DHabib%26aufirst%3DA.%2BA.%26aulast%3DStahelin%26aufirst%3DR.%2BV.%26aulast%3DPerrotti%26aufirst%3DD.%26aulast%3DOgretmen%26aufirst%3DB.%26atitle%3DSphingosine%2520Analogue%2520Drug%2520Fty720%2520Targets%2520I2pp2a%252FSet%2520and%2520Mediates%2520Lung%2520Tumour%2520Suppression%2520Via%2520Activation%2520of%2520Pp2a-Ripk1-Dependent%2520Necroptosis%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D105%26epage%3D121%26doi%3D10.1002%2Femmm.201201283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pippa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Miralles, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Prieto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitek, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odero, M. D.</span></span> <span> </span><span class="NLM_article-title">Effect of Fty720 on the Set-Pp2a Complex in Acute Myeloid Leukemia; Set Binding Drugs Have Antagonistic Activity</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1915</span>– <span class="NLM_lpage">1918</span>, <span class="refDoi"> DOI: 10.1038/leu.2014.141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fleu.2014.141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24781014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslCgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1915-1918&author=R.+Pippaauthor=A.+Dominguezauthor=D.+J.+Christensenauthor=I.+Moreno-Mirallesauthor=M.+J.+Blanco-Prietoauthor=M.+P.+Vitekauthor=M.+D.+Odero&title=Effect+of+Fty720+on+the+Set-Pp2a+Complex+in+Acute+Myeloid+Leukemia%3B+Set+Binding+Drugs+Have+Antagonistic+Activity&doi=10.1038%2Fleu.2014.141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity</span></div><div class="casAuthors">Pippa, R.; Dominguez, A.; Christensen, D. J.; Moreno-Miralles, I.; Blanco-Prieto, M. J.; Vitek, M. P.; Odero, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1915-1918</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To study the mechanism of FTY720 restoration of PP2A activity in AML, we first analyzed the interaction between endogenous SET and PP2Ac proteins in the AML cell line HL-60.  Treatment with FTY720 at a concn. that reduced proliferation by 50% induced PP2A activity by 30%, and effectively disrupted the assocn. between SET and PP2Ac in HL-60 cells.  In conclusion, we show that SET forms an inhibitory complex with PP2Ac in AML, impairing the activity of PP2A, and that the whole structure of SET (amino terminus and carboxy terminus) is involved in the binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYLZ7kTICdJrVg90H21EOLACvtfcHk0lgLCpDoMkWFfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslCgsLw%253D&md5=679876e36bf1316ff06502d83499438e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fleu.2014.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2014.141%26sid%3Dliteratum%253Aachs%26aulast%3DPippa%26aufirst%3DR.%26aulast%3DDominguez%26aufirst%3DA.%26aulast%3DChristensen%26aufirst%3DD.%2BJ.%26aulast%3DMoreno-Miralles%26aufirst%3DI.%26aulast%3DBlanco-Prieto%26aufirst%3DM.%2BJ.%26aulast%3DVitek%26aufirst%3DM.%2BP.%26aulast%3DOdero%26aufirst%3DM.%2BD.%26atitle%3DEffect%2520of%2520Fty720%2520on%2520the%2520Set-Pp2a%2520Complex%2520in%2520Acute%2520Myeloid%2520Leukemia%253B%2520Set%2520Binding%2520Drugs%2520Have%2520Antagonistic%2520Activity%26jtitle%3DLeukemia%26date%3D2014%26volume%3D28%26spage%3D1915%26epage%3D1918%26doi%3D10.1038%2Fleu.2014.141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a Inhibits Colorectal Cancer Proliferation Probably by Regulating Expression Levels of C-Myc, P21waf1/Cip1 and Proliferating Cell Nuclear Antigen</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2009.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.canlet.2009.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19481339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFyqs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2009&pages=66-72&author=T.+Masuoauthor=S.+Okamuraauthor=Y.+Zhangauthor=M.+Mori&title=Cyclosporine+a+Inhibits+Colorectal+Cancer+Proliferation+Probably+by+Regulating+Expression+Levels+of+C-Myc%2C+P21waf1%2FCip1+and+Proliferating+Cell+Nuclear+Antigen&doi=10.1016%2Fj.canlet.2009.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21WAF1/CIP1 and proliferating cell nuclear antigen</span></div><div class="casAuthors">Masuo, Takashige; Okamura, Shinichi; Zhang, Yajing; Mori, Masatomo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-72</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The present study investigated the role of Calcineurin (CaN) in the proliferation of human colorectal cancers.  CaN activity and protein expression were increased in human colorectal cancers.  Nuclear transcription factor NFAT, a physiol. substrate for CaN, was activated in human colon cancer specimen as well as in the human colon cancer cell lines.  CaN inhibitor cyclosporine A (CsA) reduced cell growth in these cell lines.  CsA decreased the expressions of c-Myc and the proliferating cell nuclear antigen (PCNA) but also increased p21WAF1/CIP1 expression.  These results suggest that CaN promotes colorectal cancer proliferation probably by regulating levels of c-Myc, p21WAF1/CIP1, and PCNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5x0M0PqjXjLVg90H21EOLACvtfcHk0lgLCpDoMkWFfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFyqs7fE&md5=0f1129621c42de2ab5aae35efed1e564</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2009.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2009.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DMasuo%26aufirst%3DT.%26aulast%3DOkamura%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26atitle%3DCyclosporine%2520a%2520Inhibits%2520Colorectal%2520Cancer%2520Proliferation%2520Probably%2520by%2520Regulating%2520Expression%2520Levels%2520of%2520C-Myc%252C%2520P21waf1%252FCip1%2520and%2520Proliferating%2520Cell%2520Nuclear%2520Antigen%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D285%26spage%3D66%26epage%3D72%26doi%3D10.1016%2Fj.canlet.2009.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, K. A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a Inhibits Breast Cancer Cell Growth by Downregulating the Expression of Pyruvate Kinase Subtype M2</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2012.989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3892%2Fijmm.2012.989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22580449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ajtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=302-308&author=K.+A.+I.+Jiangauthor=B.+Heauthor=L.+Laiauthor=Q.+Chenauthor=Y.+Liuauthor=Q.+Guoauthor=Q.+Wang&title=Cyclosporine+a+Inhibits+Breast+Cancer+Cell+Growth+by+Downregulating+the+Expression+of+Pyruvate+Kinase+Subtype+M2&doi=10.3892%2Fijmm.2012.989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2</span></div><div class="casAuthors">Jiang, Kai; He, Baoming; Lai, Lihua; Chen, Qingyun; Liu, Yang; Guo, Qingming; Wang, Qingqing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">302-308</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">The high proliferative rate of tumor cells leads to metabolic needs distinct from those of their normal counterparts.  An embryonic- and tumor-specific isoform of the enzyme pyruvate kinase M2 (PKM2) is overexpressed in cancer cells to increase the use of glycolytic intermediates for macromol. biosynthesis and tumor growth.  We report that Cyclosporin A (CsA) can regulate the expression and activity of PKM2 in breast cancer cell lines MCF-7, MDA-MB-435 and MDA-MB-231.  PKM2 was found to be highly expressed in the three breast cancer cell lines compared to normal primary breast cells.  Treatment with CsA inhibited the viability of breast cancer cells in a time- and dose-dependent manner.  CsA significantly downregulated the expression of PKM2 in breast cancer cells and decreased ATP (ATP) synthesis, which induced cancer cells to undergo necrosis.  Furthermore, the growth suppression effect of CsA was impaired in MCF-7 cells when they were transfected with the PKM2 overexpression plasmid, suggesting that CsA was an effective inhibitor of PKM2-dependent proliferation of breast cancer cells.  These results may provide new insights into the mechanism of CsA in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmv8SetAhEbVg90H21EOLACvtfcHk0lgLCpDoMkWFfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ajtL7K&md5=0af5ee226bcb6e821ad9a41b490d02f2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2012.989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2012.989%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DK.%2BA.%2BI.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DCyclosporine%2520a%2520Inhibits%2520Breast%2520Cancer%2520Cell%2520Growth%2520by%2520Downregulating%2520the%2520Expression%2520of%2520Pyruvate%2520Kinase%2520Subtype%2520M2%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2012%26volume%3D30%26spage%3D302%26epage%3D308%26doi%3D10.3892%2Fijmm.2012.989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawahara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwagi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netto, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, H.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a and Tacrolimus Inhibit Bladder Cancer Growth through Down-Regulation of Nfatc1</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1582</span>– <span class="NLM_lpage">1593</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.18632%2Foncotarget.2750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25638160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC2Mrht1OrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1582-1593&author=T.+Kawaharaauthor=E.+Kashiwagiauthor=H.+Ideauthor=Y.+Liauthor=Y.+Zhengauthor=Y.+Miyamotoauthor=G.+J.+Nettoauthor=H.+Ishiguroauthor=H.+Miyamoto&title=Cyclosporine+a+and+Tacrolimus+Inhibit+Bladder+Cancer+Growth+through+Down-Regulation+of+Nfatc1&doi=10.18632%2Foncotarget.2750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1</span></div><div class="casAuthors">Kawahara Takashi; Kashiwagi Eiji; Ide Hiroki; Zheng Yichun; Netto George J; Ishiguro Hitoshi; Miyamoto Hiroshi; Kawahara Takashi; Li Yi; Zheng Yichun; Miyamoto Yurina; Ishiguro Hitoshi; Miyamoto Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1582-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The functional role of nuclear factor of activated T-cells (NFAT), a key regulator of the immune response, in bladder cancer progression remains uncertain.  In this study, we assessed biological significance of NFAT in human bladder cancer.  Immunohistochemistry detected nuclear/cytoplasmic NFATc1 signals in 14 (21.5%)/34 (52.3%), respectively, of 65 muscle-invasive bladder carcinomas and showed that patients with nuclear NFATc1-positive tumor had a significantly higher risk of disease progression (P = 0.006).  In bladder cancer cell lines, cyclosporine A (CsA) and tacrolimus (FK506), immunosuppressant drugs/non-selective NFAT inhibitors, attenuated NFATc1 expression and its nuclear translocation, NFAT transcriptional activity, and the expression of cyclooxygenase-2 and c-myc, downstream targets of NFATc1.  NFAT inhibition via NFATc1-small interfering RNA (siRNA) or treatment with these NFAT inhibitors resulted in decreases in cell viability/colony formation, cell migration/invasion, and the expression/activity of MMP-2 and MMP-9, as well as an increase in apoptosis, in the parental/control lines.  No significant additional inhibition in the viability and invasion of NFATc1-siRNA cells was seen.  In xenograft-bearing mice, CsA and FK506 significantly retarded tumor growth.  These results suggest that NFATc1 plays an important role in bladder cancer outgrowth.  Thus, NFATc1 inactivation, especially using CsA and FK506, has the potential of being a therapeutic approach for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOAG3KUOIPiH6oPH0mYWL1fW6udTcc2eaSghOQzATZcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mrht1OrsQ%253D%253D&md5=4ef8c68f7ed5ae66cea68e19c8877959</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2750%26sid%3Dliteratum%253Aachs%26aulast%3DKawahara%26aufirst%3DT.%26aulast%3DKashiwagi%26aufirst%3DE.%26aulast%3DIde%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DNetto%26aufirst%3DG.%2BJ.%26aulast%3DIshiguro%26aufirst%3DH.%26aulast%3DMiyamoto%26aufirst%3DH.%26atitle%3DCyclosporine%2520a%2520and%2520Tacrolimus%2520Inhibit%2520Bladder%2520Cancer%2520Growth%2520through%2520Down-Regulation%2520of%2520Nfatc1%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D1582%26epage%3D1593%26doi%3D10.18632%2Foncotarget.2750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P. T. W.</span></span> <span> </span><span class="NLM_article-title">Purification of Protein Phosphatase 4 Catalytic Subunit: Inhibition by the Antitumour Drug Fostriecin and Other Tumour Suppressors and Promoters</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>431</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(98)00775-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0014-5793%2898%2900775-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9714542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK1cXltFWrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=1998&pages=357-361&author=C.+J.+Hastieauthor=P.+T.+W.+Cohen&title=Purification+of+Protein+Phosphatase+4+Catalytic+Subunit%3A+Inhibition+by+the+Antitumour+Drug+Fostriecin+and+Other+Tumour+Suppressors+and+Promoters&doi=10.1016%2FS0014-5793%2898%2900775-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumor drug fostriecin and other tumor suppressors and promoters</span></div><div class="casAuthors">Hastie, C. James; Cohen, Patricia T. W.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">431</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-361</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Protein phosphatase 4 (PP4) is a protein serine/threonine phosphatase that predominantly localizes to centrosomes and plays a role in microtubule organization at centrosomes.  Here, PP4 catalytic subunit has been purified from porcine testis to near homogeneity and a specific activity of 680 mU/mg against phosphorylase a.  The antitumor drug, fostriecin, inhibits PP4 catalytic subunit (IC50 3 nM) with similar potency to PP2A catalytic subunit (IC50 1.5 nM).  PP4 is also inhibited in the nanomolar range by several naturally occurring tumor promoters and toxins, with similar IC50 values to those obtained for PP2A. The gene for human PP4 catalytic subunit localizes to 16p11.2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmkTsiBvA8PLVg90H21EOLACvtfcHk0lgVWaLypdXTtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFWrsb0%253D&md5=6a38bd64aeddc9e73877aa73745f7dbd</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2898%2900775-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252898%252900775-3%26sid%3Dliteratum%253Aachs%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%2BT.%2BW.%26atitle%3DPurification%2520of%2520Protein%2520Phosphatase%25204%2520Catalytic%2520Subunit%253A%2520Inhibition%2520by%2520the%2520Antitumour%2520Drug%2520Fostriecin%2520and%2520Other%2520Tumour%2520Suppressors%2520and%2520Promoters%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D431%26spage%3D357%26epage%3D361%26doi%3D10.1016%2FS0014-5793%2898%2900775-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prickett, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span> <span> </span><span class="NLM_article-title">The A4 Regulatory Subunit Exerts Opposing Allosteric Effects on Protein Phosphatases Pp6 and Pp2a</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">30503</span>– <span class="NLM_lpage">30511</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601054200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M601054200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=16895907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCrsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=30503-30511&author=T.+D.+Prickettauthor=D.+L.+Brautigan&title=The+A4+Regulatory+Subunit+Exerts+Opposing+Allosteric+Effects+on+Protein+Phosphatases+Pp6+and+Pp2a&doi=10.1074%2Fjbc.M601054200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The α4 Regulatory Subunit Exerts Opposing Allosteric Effects on Protein Phosphatases PP6 and PP2A</span></div><div class="casAuthors">Prickett, Todd D.; Brautigan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">30503-30511</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protein Ser/Thr phosphatase family contains three enzymes called PP2A, PP4, and PP6 with sep. biol. functions inferred from genetics of the yeast homologues Pph21/22, Pph3, and Sit4.  These catalytic subunits assoc. with a common subunit called α4 (related to yeast Tap42).  Here, we characterized recombinant PP6 and PP2A catalytic monomers and α4·phosphatase heterodimers.  Monomeric PP6 and PP2A showed identical kinetics using either p-nitrophenyl phosphate (pNPP) or 32P-myelin basic protein (MBP) as substrates, with matching Km and Vmax values.  Using pNPP as substrate, PP6 and PP2A gave the same IC50 with active site inhibitors okadaic acid, microcystin-LR, calyculin A, and cantharidin.  However, with MBP as substrate, PP6 was inhibited at 5-fold lower concns. of toxins relative to PP2A, suggesting PP6 might be a preferred in vivo target of toxins.  Heterodimeric α4·PP6 and α4·PP2A were starkly different.  With MBP as substrate the α4·PP2A heterodimer had a 100-fold higher Vmax than α4·PP6, and neither heterodimer was active with pNPP.  Thus, these phosphatases are distinguished by their different responses to allosteric binding of the common regulatory subunit α4.  Transient expression of α4 differentially increased or decreased phosphorylation of endogenous phosphoproteins, consistent with opposing effects on PP2A and PP6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqpOx4uHDms7Vg90H21EOLACvtfcHk0lgVWaLypdXTtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCrsL3K&md5=857da17a92103bf12b845e6cf4a3fe77</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601054200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601054200%26sid%3Dliteratum%253Aachs%26aulast%3DPrickett%26aufirst%3DT.%2BD.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26atitle%3DThe%2520A4%2520Regulatory%2520Subunit%2520Exerts%2520Opposing%2520Allosteric%2520Effects%2520on%2520Protein%2520Phosphatases%2520Pp6%2520and%2520Pp2a%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D30503%26epage%3D30511%26doi%3D10.1074%2Fjbc.M601054200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of Ser/Thr Protein Phosphatases: Specificity, Use and Common Forms of Abuse</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1385/1-59745-267-X:23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1385%2F1-59745-267-X%3A23" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2006&pages=23-38&author=M.+Swingleauthor=L.+Niauthor=R.+E.+Honkanen&title=Small-Molecule+Inhibitors+of+Ser%2FThr+Protein+Phosphatases%3A+Specificity%2C+Use+and+Common+Forms+of+Abuse&doi=10.1385%2F1-59745-267-X%3A23"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1385%2F1-59745-267-X%3A23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59745-267-X%253A23%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DM.%26aulast%3DNi%26aufirst%3DL.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520Ser%252FThr%2520Protein%2520Phosphatases%253A%2520Specificity%252C%2520Use%2520and%2520Common%2520Forms%2520of%2520Abuse%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2006%26volume%3D365%26spage%3D23%26epage%3D38%26doi%3D10.1385%2F1-59745-267-X%3A23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinclair, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charbonneau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossie, S.</span></span> <span> </span><span class="NLM_article-title">Purification of a Fatty Acid-Stimulated Protein-Serine/Threonine Phosphatase from Bovine Brain and Its Identification as a Homolog of Protein Phosphatase 5</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">22464</span>– <span class="NLM_lpage">22471</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.36.22464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.272.36.22464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9278397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2sXlvFGitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=22464-22471&author=J.+Skinnerauthor=C.+Sinclairauthor=C.+Romeoauthor=D.+Armstrongauthor=H.+Charbonneauauthor=S.+Rossie&title=Purification+of+a+Fatty+Acid-Stimulated+Protein-Serine%2FThreonine+Phosphatase+from+Bovine+Brain+and+Its+Identification+as+a+Homolog+of+Protein+Phosphatase+5&doi=10.1074%2Fjbc.272.36.22464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of a fatty acid-stimulated protein-serine/threonine phosphatase from bovine brain and its identification as a homolog of protein phosphatase 5</span></div><div class="casAuthors">Skinner, Jeffrey; Sinclair, Christopher; Romeo, Charles; Armstrong, David; Charbonneau, Harry; Rossie, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">22464-22471</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">An arachidonic acid-stimulated Ser/Thr phosphatase activity was detected in sol. exts. prepd. from rat pituitary clonal GH4C1 cells, rat or bovine brain, and bovine heart.  The enzyme activity was purified to homogeneity from bovine brain as a monomer with a Mr of 63,000 and a specific activity of 32 nmol of Pi released per min/mg of protein when assayed in the presence of 10 μM phosphocasein in the absence of lipid.  Arachidonic acid stimulated activity 4-14-fold, with half-maximal stimulation at 50-100 μM, when assayed in the presence of a variety of phosphosubstrates including casein, reduced carboxamidomethylated and maleylated lysozyme, myelin basic protein, and histone.  Oleic acid, linoleic acid, and palmitoleic acid also stimulated activity; however, satd. fatty acids and alc. or Me ester derivs. of fatty acids did not significantly affect activity.  The lipid-stimulated phosphatase was identified as the bovine equiv. of protein phosphatase 5 or a closely related homolog by sequence anal. of proteolytic fragments generated from the purified enzyme.  When recombinant rat protein phosphatase 5 was expressed as a cleavable glutathione S-transferase fusion protein, the affinity-purified thrombin-cleaved enzyme exhibited a specific activity and sensitivity to arachidonic acid similar to those of the purified bovine brain enzyme.  These results suggest that protein phosphatase 5 may be regulated in vivo by a lipid second messenger or another endogenous activator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEHnC4BDZiGLVg90H21EOLACvtfcHk0lhTqNhE4ASQig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvFGitr0%253D&md5=cda30d1c70bf65da6448a27ccafeb550</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.36.22464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.36.22464%26sid%3Dliteratum%253Aachs%26aulast%3DSkinner%26aufirst%3DJ.%26aulast%3DSinclair%26aufirst%3DC.%26aulast%3DRomeo%26aufirst%3DC.%26aulast%3DArmstrong%26aufirst%3DD.%26aulast%3DCharbonneau%26aufirst%3DH.%26aulast%3DRossie%26aufirst%3DS.%26atitle%3DPurification%2520of%2520a%2520Fatty%2520Acid-Stimulated%2520Protein-Serine%252FThreonine%2520Phosphatase%2520from%2520Bovine%2520Brain%2520and%2520Its%2520Identification%2520as%2520a%2520Homolog%2520of%2520Protein%2520Phosphatase%25205%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D22464%26epage%3D22471%26doi%3D10.1074%2Fjbc.272.36.22464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Serine/Threonine Phosphatases: Mechanism through Structure</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2009.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19879837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFKltL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2009&pages=468-484&author=Y.+Shi&title=Serine%2FThreonine+Phosphatases%3A+Mechanism+through+Structure&doi=10.1016%2Fj.cell.2009.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Serine/threonine phosphatases: mechanism through structure</span></div><div class="casAuthors">Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">468-484</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The reversible phosphorylation of proteins is accomplished by opposing activities of kinases and phosphatases.  Relatively few protein serine/threonine phosphatases (PSPs) control the specific dephosphorylation of thousands of phosphoprotein substrates.  Many PSPs, exemplified by protein phosphatase 1 (PP1) and PP2A, achieve substrate specificity and regulation through combinatorial interactions between conserved catalytic subunits and a large no. of regulatory subunits.  Other PSPs, represented by PP2C and TFIIF-assocg. component of RNA polymerase II C-terminal domain (CTD) phosphatase/small CTD phosphatase (FCP/SCP), contain both catalytic and regulatory domains within the same polypeptide chain.  Here, the authors discuss biochem. and structural investigations that advance the mechanistic understanding of the 3 major classes of PSPs, with a focus on PP2A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrS0iZKM4I_bVg90H21EOLACvtfcHk0lhTqNhE4ASQig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFKltL%252FK&md5=8a0892323688d6774c8448b69d389b8d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26atitle%3DSerine%252FThreonine%2520Phosphatases%253A%2520Mechanism%2520through%2520Structure%26jtitle%3DCell%26date%3D2009%26volume%3D139%26spage%3D468%26epage%3D484%26doi%3D10.1016%2Fj.cell.2009.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P. T. W.</span></span> <span> </span><span class="NLM_article-title">Activation of Protein Phosphatase 5 by Limited Proteolysis or the Binding of Polyunsaturated Fatty Acids to the Tpr Domain</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(96)01427-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0014-5793%2896%2901427-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9000529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK28XnsFSmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1997&pages=136-140&author=M.+X.+Chenauthor=P.+T.+W.+Cohen&title=Activation+of+Protein+Phosphatase+5+by+Limited+Proteolysis+or+the+Binding+of+Polyunsaturated+Fatty+Acids+to+the+Tpr+Domain&doi=10.1016%2FS0014-5793%2896%2901427-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of protein phosphatase 5 by limited proteolysis or the binding of polyunsaturated fatty acids to the TPR domain</span></div><div class="casAuthors">Chen, Mao Xiang; Cohen, Patricia T. W.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">136-140</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Protein phosphatase 5 (PP5) exhibits very low phosphatase activity, which can be stimulated >25-fold by proteolysis.  Since proteolysis cleaves the N-terminal tetratricopeptide repeat (TPR) domain from the catalytic domain, these results indicate that the TPR domain shields the active site.  Polyunsatd. fatty acids, such as arachidonic acid, and lipids contg. polyunsatd. fatty acids, such as phosphatidylinositol, stimulate both bacterially expressed human and native rabbit PP5 activity >25-fold toward casein and myelin basic protein.  Phosphatidylinositol binds to the TPR domain, and not to the catalytic domain, indicating that activation by polyunsatd. fatty acids is allosteric and that it may occur by movement of the TPR domain to allow substrate access.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQhPrOeuhk37Vg90H21EOLACvtfcHk0lhTqNhE4ASQig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsFSmt7k%253D&md5=53fbece8e1449adc8cd867ea3634bd30</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2896%2901427-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252896%252901427-5%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%2BX.%26aulast%3DCohen%26aufirst%3DP.%2BT.%2BW.%26atitle%3DActivation%2520of%2520Protein%2520Phosphatase%25205%2520by%2520Limited%2520Proteolysis%2520or%2520the%2520Binding%2520of%2520Polyunsaturated%2520Fatty%2520Acids%2520to%2520the%2520Tpr%2520Domain%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D400%26spage%3D136%26epage%3D140%26doi%3D10.1016%2FS0014-5793%2896%2901427-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayner, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinkers, M.</span></span> <span> </span><span class="NLM_article-title">Identification of Amino Acids in the Tetratricopeptide Repeat and C-Terminal Domains of Protein Phosphatase 5 Involved in Autoinhibition and Lipid Activation†</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">10485</span>– <span class="NLM_lpage">10490</span>, <span class="refDoi"> DOI: 10.1021/bi010999i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi010999i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFGmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10485-10490&author=H.+Kangauthor=S.+L.+Saynerauthor=K.+L.+Grossauthor=L.+C.+Russellauthor=M.+Chinkers&title=Identification+of+Amino+Acids+in+the+Tetratricopeptide+Repeat+and+C-Terminal+Domains+of+Protein+Phosphatase+5+Involved+in+Autoinhibition+and+Lipid+Activation%E2%80%A0&doi=10.1021%2Fbi010999i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Amino Acids in the Tetratricopeptide Repeat and C-Terminal Domains of Protein Phosphatase 5 Involved in Autoinhibition and Lipid Activation</span></div><div class="casAuthors">Kang, Hyeog; Sayner, Sarah L.; Gross, Katherine L.; Russell, Lance C.; Chinkers, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10485-10490</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein phosphatase 5 (PP5) exhibits low basal activity due to the autoinhibitory properties of its N-terminal and C-terminal domains but can be activated approx. 40-fold in vitro by polyunsatd. fatty acids.  To identify residues involved in regulating PP5 activity, we performed scanning mutagenesis of its N-terminal tetratricopeptide repeat (TPR) domain and deletion mutagenesis of its C-terminal domain.  Mutating residues in a groove of the TPR domain that binds to heat shock protein 90 had no effect on basal phosphatase activity.  Mutation of Glu-76, however, whose side chain projects away from this groove, resulted in a 10-fold elevation of basal activity without affecting arachidonic acid-stimulated activity.  Thus, the interface of the TPR domain involved in PP5 autoinhibition appears to be different from that involved in heat shock protein 90 binding.  We also obsd. a 10-fold elevation of basal phosphatase activity upon removing the C-terminal 13 amino acids of PP5, with a concomitant 50% decrease in arachidonic acid-stimulated activity.  These two effects were accounted for by two distinct amino acid deletions: deleting the four C-terminal residues (496-499) of PP5 had no effect on its activity, but removing Gln-495 elevated basal activity 10-fold.  Removal of a further three amino acids had no addnl. effect, but deleting Asn-491 resulted in a 50% redn. in arachidonic acid-stimulated activity.  Thus, Glu-76 in the TPR domain and Gln-495 at the C-terminus were implicated in maintaining the low basal activity of PP5.  While the TPR domain alone has been thought to mediate fatty acid activation of PP5, our data suggest that Asn-491, near its C-terminus, may also be involved in this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Ebu1Rlv0grVg90H21EOLACvtfcHk0lglviI7f0bzUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFGmtbo%253D&md5=d0ff0800f3d8a481c43d8162dc291ed5</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fbi010999i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi010999i%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DH.%26aulast%3DSayner%26aufirst%3DS.%2BL.%26aulast%3DGross%26aufirst%3DK.%2BL.%26aulast%3DRussell%26aufirst%3DL.%2BC.%26aulast%3DChinkers%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Amino%2520Acids%2520in%2520the%2520Tetratricopeptide%2520Repeat%2520and%2520C-Terminal%2520Domains%2520of%2520Protein%2520Phosphatase%25205%2520Involved%2520in%2520Autoinhibition%2520and%2520Lipid%2520Activation%25E2%2580%25A0%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10485%26epage%3D10490%26doi%3D10.1021%2Fbi010999i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andreeva, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutuzov, M. A.</span></span> <span> </span><span class="NLM_article-title">Ppef/Pp7 Protein Ser/Thr Phosphatases</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">3103</span>– <span class="NLM_lpage">3110</span>, <span class="refDoi"> DOI: 10.1007/s00018-009-0110-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs00018-009-0110-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19662497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCitrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=3103-3110&author=A.+V.+Andreevaauthor=M.+A.+Kutuzov&title=Ppef%2FPp7+Protein+Ser%2FThr+Phosphatases&doi=10.1007%2Fs00018-009-0110-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">PPEF/PP7 protein Ser/Thr phosphatases</span></div><div class="casAuthors">Andreeva, Alexandra V.; Kutuzov, Mikhail A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3103-3110</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  PPEF/PP7 represents one of the five subfamilies of the PPP protein Ser/Thr phosphatases.  Studies published in recent years point to a role of plant PP7 at a crossroad of different pathways of light and stress signalling.  In animals, PPEFs are highly expressed in sensory neurons, and Drosophila PPEF phosphatase, rdgC, is essential for dephosphorylation of rhodopsin.  Expression profiling suggests that mammalian PPEF may play a role in stress-protective responses, cell survival, growth, proliferation, and oncogenesis.  Despite structural similarities of the catalytic domains and the fact that some of these phosphatases are involved in light perception both in animals and in plants, the plant and non-plant representatives of this group have distinct domain architecture and appear not to be orthologues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoza2FZtBa9X7Vg90H21EOLACvtfcHk0lglviI7f0bzUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCitrvE&md5=51fcdaa7424693fa40cc9d9636584273</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-0110-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-0110-7%26sid%3Dliteratum%253Aachs%26aulast%3DAndreeva%26aufirst%3DA.%2BV.%26aulast%3DKutuzov%26aufirst%3DM.%2BA.%26atitle%3DPpef%252FPp7%2520Protein%2520Ser%252FThr%2520Phosphatases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26spage%3D3103%26epage%3D3110%26doi%3D10.1007%2Fs00018-009-0110-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rusnak, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertz, P.</span></span> <span> </span><span class="NLM_article-title">Calcineurin: Form and Function</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1521</span>, <span class="refDoi"> DOI: 10.1152/physrev.2000.80.4.1483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1152%2Fphysrev.2000.80.4.1483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11015619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVKisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2000&pages=1483-1521&author=F.+Rusnakauthor=P.+Mertz&title=Calcineurin%3A+Form+and+Function&doi=10.1152%2Fphysrev.2000.80.4.1483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Calcineurin: form and function</span></div><div class="casAuthors">Rusnak, Frank; Mertz, Pamela</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1483-1521</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review with 487 refs.  Calcineurin is a eukaryotic Ca2+/calmodulin-dependent serine/threonine phosphoprotein phosphatase.  It is a heterodimeric protein consisting of a catalytic subunit, calcineurin A, which contains an active site dinuclear metal center, and a tightly assocd., myristoylated, Ca2+-binding subunit, calcineurin B.  The primary sequence of both subunits and heterodimeric quaternary structure is highly conserved from yeast to mammals.  As a serine/threonine protein phosphatase, calcineurin participates in a no. of cellular processes and Ca2+-dependent signal transduction pathways.  Calcineurin is potently inhibited by immunosuppressant drugs, cyclosporin A and FK 506, in the presence of their resp. cytoplasmic immunophilin proteins, cyclophilin and FK 506-binding protein.  Many studies have used these immunosuppressant drugs and/or modern genetic techniques to disrupt calcineurin in model organisms such as yeast, filamentous fungi, plants, vertebrates, and mammals to explore its biol. function.  Recent advances regarding calcineurin structure include the detn. of its 3-dimensional structure.  In addn., biochem. and spectroscopic studies are beginning to unravel aspects of the mechanism of phosphate ester hydrolysis including the importance of the dinuclear metal ion cofactor and metal ion redox chem., studies which may lead to new calcineurin inhibitors.  This review provides a comprehensive examn. of the biol. roles of calcineurin and reviews aspects related to its structure and catalytic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb_f4SIemYHbVg90H21EOLACvtfcHk0lglviI7f0bzUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVKisLk%253D&md5=34321bdba3efaed2600666ad9fe9429b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2000.80.4.1483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2000.80.4.1483%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DF.%26aulast%3DMertz%26aufirst%3DP.%26atitle%3DCalcineurin%253A%2520Form%2520and%2520Function%26jtitle%3DPhysiol.%2520Rev.%26date%3D2000%26volume%3D80%26spage%3D1483%26epage%3D1521%26doi%3D10.1152%2Fphysrev.2000.80.4.1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kissinger, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parge, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knighton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempczyk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalish, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moomaw, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastinel, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habuka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacquet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villafranca, J. E.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of Human Calcineurin and the Human Fkbp12–Fk506–Calcineurin Complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1038/378641a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2F378641a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8524402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2MXpvVChsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=1995&pages=641-644&author=C.+R.+Kissingerauthor=H.+E.+Pargeauthor=D.+R.+Knightonauthor=C.+T.+Lewisauthor=L.+A.+Pelletierauthor=A.+Tempczykauthor=V.+J.+Kalishauthor=K.+D.+Tuckerauthor=R.+E.+Showalterauthor=E.+W.+Moomawauthor=L.+N.+Gastinelauthor=N.+Habukaauthor=X.+Chenauthor=F.+Maldonadoauthor=J.+E.+Barkerauthor=R.+Bacquetauthor=J.+E.+Villafranca&title=Crystal+Structures+of+Human+Calcineurin+and+the+Human+Fkbp12%E2%80%93Fk506%E2%80%93Calcineurin+Complex&doi=10.1038%2F378641a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex</span></div><div class="casAuthors">Kissinger, Charles R.; Parge, Hans E.; Knighton, Daniel R.; Lewis, Cristina T.; Pelletier, Laura A.; Tempczyk, Anna; Kalish, Vincent J.; Tucker, Kathleen D.; Showalter, Richard E.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">6557</span>),
    <span class="NLM_cas:pages">641-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Calcineurin (CaN) is a calcium- and calmodulin-dependent protein serine/threonine phosphatase which is crit. for several important cellular processes, including T-cell activation.  CaN is the target of the immunosuppressive drugs cyclosporin A and FK506, which inhibit CaN after forming complexes with cytoplasmic binding proteins (cyclophilin and FKBP12, resp.).  The authors report here the crystal structures of full-length human CaN at 2.1 Å resoln. and of the complex of human CaN with FKBP12-FK506 at 3.5 Å resoln.  In the native CaN structure, an autoinhibitory element binds at the Zn/Fe-contg. active site.  The site of binding of FKBP12-FK506 appears to be shared by other non-competitive inhibitors of calcineurin, including a natural anchoring protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIlai2HUv_4rVg90H21EOLACvtfcHk0lglviI7f0bzUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpvVChsbc%253D&md5=7410673e0cedc4bb5d12ea9961ef2153</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2F378641a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F378641a0%26sid%3Dliteratum%253Aachs%26aulast%3DKissinger%26aufirst%3DC.%2BR.%26aulast%3DParge%26aufirst%3DH.%2BE.%26aulast%3DKnighton%26aufirst%3DD.%2BR.%26aulast%3DLewis%26aufirst%3DC.%2BT.%26aulast%3DPelletier%26aufirst%3DL.%2BA.%26aulast%3DTempczyk%26aufirst%3DA.%26aulast%3DKalish%26aufirst%3DV.%2BJ.%26aulast%3DTucker%26aufirst%3DK.%2BD.%26aulast%3DShowalter%26aufirst%3DR.%2BE.%26aulast%3DMoomaw%26aufirst%3DE.%2BW.%26aulast%3DGastinel%26aufirst%3DL.%2BN.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMaldonado%26aufirst%3DF.%26aulast%3DBarker%26aufirst%3DJ.%2BE.%26aulast%3DBacquet%26aufirst%3DR.%26aulast%3DVillafranca%26aufirst%3DJ.%2BE.%26atitle%3DCrystal%2520Structures%2520of%2520Human%2520Calcineurin%2520and%2520the%2520Human%2520Fkbp12%25E2%2580%2593Fk506%25E2%2580%2593Calcineurin%2520Complex%26jtitle%3DNature%26date%3D1995%26volume%3D378%26spage%3D641%26epage%3D644%26doi%3D10.1038%2F378641a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santikarn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calder, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klee, C. B.</span></span> <span> </span><span class="NLM_article-title">Identification of the Nh2-Terminal Blocking Group of Calcineurin B as Myristic Acid</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(82)80759-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0014-5793%2882%2980759-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=7160476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL3sXht1Wqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=1982&pages=314-318&author=A.+Aitkenauthor=P.+Cohenauthor=S.+Santikarnauthor=D.+H.+Williamsauthor=A.+G.+Calderauthor=A.+Smithauthor=C.+B.+Klee&title=Identification+of+the+Nh2-Terminal+Blocking+Group+of+Calcineurin+B+as+Myristic+Acid&doi=10.1016%2F0014-5793%2882%2980759-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the amino-terminal blocking group of calcineurin B as myristic acid</span></div><div class="casAuthors">Aitken, Alastair; Cohen, Philip; Santikarn, Sitthivet; Williams, Dudley H.; Calder, A. Graham; Smith, Alistair; Klee, Claude B.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">314-18</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The N-terminal blocking group of the Ca2+-binding B-subunit of calcineurin (protein phosphatase-2B) was identified as myristic acid by fast atom bombardment mass spectrometry and gas chromatog.  The sequence, myristyl-Gly-Asn-Glu-Ala-, is very similar to that of the catalytic subunit of cAMP-dependent kinase, the only other protein known to contain this fatty acid.  This finding, and the elution of all myristyl peptides at 57% MeCN on reverse-phase high-performance liq. chromatog. may facilitate the identification of other proteins with this blocking group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDkGubhzoIGbVg90H21EOLACvtfcHk0likr-kdf44Ltg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXht1Wqu74%253D&md5=de5baba84d8c84252eca4cb1745a6f26</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2882%2980759-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252882%252980759-X%26sid%3Dliteratum%253Aachs%26aulast%3DAitken%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DSantikarn%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DCalder%26aufirst%3DA.%2BG.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DKlee%26aufirst%3DC.%2BB.%26atitle%3DIdentification%2520of%2520the%2520Nh2-Terminal%2520Blocking%2520Group%2520of%2520Calcineurin%2520B%2520as%2520Myristic%2520Acid%26jtitle%3DFEBS%2520Lett.%26date%3D1982%26volume%3D150%26spage%3D314%26epage%3D318%26doi%3D10.1016%2F0014-5793%2882%2980759-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P. T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Martin, C.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 4-from Obscurity to Vital Functions</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>579</i></span>,  <span class="NLM_fpage">3278</span>– <span class="NLM_lpage">3286</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2005.04.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.febslet.2005.04.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15913612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFSqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=3278-3286&author=P.+T.+W.+Cohenauthor=A.+Philpauthor=C.+V%C3%A1zquez-Martin&title=Protein+Phosphatase+4-from+Obscurity+to+Vital+Functions&doi=10.1016%2Fj.febslet.2005.04.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 4 - from obscurity to vital functions</span></div><div class="casAuthors">Cohen, Patricia T. W.; Philp, Amanda; Vazquez-Martin, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3278-3286</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein phosphatase 4 (Ppp4) is a ubiquitous protein serine/threonine phosphatase in the PPP family that is now recognized to regulate a variety of cellular functions independently of protein phosphatase 2A (PP2A).  Regulatory subunits (R1 and R2) have been identified in mammals that interact with the catalytic subunit of Ppp4 (Ppp4c) and control its activity.  Ppp4c-R2 complexes play roles in organelle assembly; not only are they essential for maturation of the centrosome, but they are also involved in spliceosomal assembly via interaction with the survival of motor neurons (SMNs) complex.  Several cellular signaling routes, including NF-κB and the target of rapamycin (TOR) pathways appear to be regulated by Ppp4.  Emerging evidence indicates that Ppp4 may play a role in the DNA damage response and that Ppp4c-R1 complexes decrease the activity of a histone deacetylase, implicating Ppp4 in the regulation of chromatin activities.  Antitumor agents, cantharidin and fostriecin, potently inhibit the activity of Ppp4.  Orthologs of mammalian Ppp4 subunits in Saccharomyces cerevisiae confer resistance to the anticancer, DNA-binding drugs, cisplatin and oxaliplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJh9_WaRLkXbVg90H21EOLACvtfcHk0likr-kdf44Ltg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFSqu78%253D&md5=45d31e4cd30f9616a3c1f7f86a455b94</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2005.04.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2005.04.070%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%2BT.%2BW.%26aulast%3DPhilp%26aufirst%3DA.%26aulast%3DV%25C3%25A1zquez-Martin%26aufirst%3DC.%26atitle%3DProtein%2520Phosphatase%25204-from%2520Obscurity%2520to%2520Vital%2520Functions%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D3278%26epage%3D3286%26doi%3D10.1016%2Fj.febslet.2005.04.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragusa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beullens, M.</span></span> <span> </span><span class="NLM_article-title">The Extended Pp1 Toolkit: Designed to Create Specificity</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2010.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.tibs.2010.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20399103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=450-458&author=M.+Bollenauthor=W.+Petiauthor=M.+J.+Ragusaauthor=M.+Beullens&title=The+Extended+Pp1+Toolkit%3A+Designed+to+Create+Specificity&doi=10.1016%2Fj.tibs.2010.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The extended PP1 toolkit: Designed to create specificity</span></div><div class="casAuthors">Bollen, Mathieu; Peti, Wolfgang; Ragusa, Michael J.; Beullens, Monique</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">450-458</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein Ser/Thr phosphatase-1 (PP1) catalyzes the majority of eukaryotic protein dephosphorylation reactions in a highly regulated and selective manner. Recent studies have identified an unusually diversified PP1 interactome with the properties of a regulatory toolkit.  PP1-interacting proteins (PIPs) function as targeting subunits, substrates and/or inhibitors.  As targeting subunits, PIPs contribute to substrate selection by bringing PP1 into the vicinity of specific substrates and by modulating substrate specificity via addnl. substrate docking sites or blocking substrate-binding channels.  Many of the nearly 200 established mammalian PIPs are predicted to be intrinsically disordered, a property that facilitates their binding to a large surface area of PP1 via multiple docking motifs.  These novel insights offer perspectives for the therapeutic targeting of PP1 by interfering with the binding of PIPs or substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCSyMKukyPxrVg90H21EOLACvtfcHk0likr-kdf44Ltg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKqsL4%253D&md5=960aa0dff84b136f7f3d03ed06f4b6c1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2010.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2010.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DBollen%26aufirst%3DM.%26aulast%3DPeti%26aufirst%3DW.%26aulast%3DRagusa%26aufirst%3DM.%2BJ.%26aulast%3DBeullens%26aufirst%3DM.%26atitle%3DThe%2520Extended%2520Pp1%2520Toolkit%253A%2520Designed%2520to%2520Create%2520Specificity%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2010%26volume%3D35%26spage%3D450%26epage%3D458%26doi%3D10.1016%2Fj.tibs.2010.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Wever, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derua, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beullens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Eynde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">A Substrate-Trapping Strategy for Protein Phosphatase Pp1 Holoenzymes Using Hypoactive Subunit Fusions</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">15152</span>– <span class="NLM_lpage">15162</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA118.004132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.RA118.004132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30115685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWhu7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=15152-15162&author=D.+Wuauthor=V.+De+Weverauthor=R.+Deruaauthor=C.+Winklerauthor=M.+Beullensauthor=A.+Van+Eyndeauthor=M.+Bollen&title=A+Substrate-Trapping+Strategy+for+Protein+Phosphatase+Pp1+Holoenzymes+Using+Hypoactive+Subunit+Fusions&doi=10.1074%2Fjbc.RA118.004132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A substrate-trapping strategy for protein phosphatase PP1 holoenzymes using hypoactive subunit fusions</span></div><div class="casAuthors">Wu, Dan; De Wever, Veerle; Derua, Rita; Winkler, Claudia; Beullens, Monique; Van Eynde, Aleyde; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">15152-15162</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protein Ser/Thr phosphatase PP1 catalyzes an important fraction of protein dephosphorylation events and forms highly specific holoenzymes through an assocn. with regulatory interactors of protein phosphatase one (RIPPOs).  The functional characterization of individual PP1 holoenzymes is hampered by the lack of straightforward strategies for substrate mapping.  Because efficient substrate recruitment often involves binding to both PP1 and its assocd. RIPPO, here we examd. whether PP1-RIPPO fusions can be used to trap substrates for further anal.  Fusions of an hypoactive point mutant of PP1 and either of four tested RIPPOs accumulated in HEK293T cells with their assocd. substrates and were co-immunopptd. for subsequent identification of the substrates by immunoblotting or MS anal.  Hypoactive fusions were also used to study RIPPOs themselves as substrates for assocd. PP1.  In contrast, substrate trapping was barely detected with active PP1-RIPPO fusions or with nonfused PP1 or RIPPO subunits.  Our results suggest that hypoactive fusions of PP1 subunits represent an easy-to-use tool for substrate identification of individual holoenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowtnZJ1lGt97Vg90H21EOLACvtfcHk0lh_fVpMwIjxeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWhu7zP&md5=2b1c2c0e617f15785f47cd086d3e8c31</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA118.004132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA118.004132%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDe%2BWever%26aufirst%3DV.%26aulast%3DDerua%26aufirst%3DR.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DBeullens%26aufirst%3DM.%26aulast%3DVan%2BEynde%26aufirst%3DA.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DA%2520Substrate-Trapping%2520Strategy%2520for%2520Protein%2520Phosphatase%2520Pp1%2520Holoenzymes%2520Using%2520Hypoactive%2520Subunit%2520Fusions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D15152%26epage%3D15162%26doi%3D10.1074%2Fjbc.RA118.004132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 6 Subunit with Conserved Sit4-Associated Protein Domain Targets Iκbϵ</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">22624</span>– <span class="NLM_lpage">22634</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601772200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M601772200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=16769727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVWjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=22624-22634&author=B.+Stefanssonauthor=D.+L.+Brautigan&title=Protein+Phosphatase+6+Subunit+with+Conserved+Sit4-Associated+Protein+Domain+Targets+I%CE%BAb%CF%B5&doi=10.1074%2Fjbc.M601772200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IκBε</span></div><div class="casAuthors">Stefansson, Bjarki; Brautigan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">22624-22634</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Protein Ser/Thr phosphatases compose a PPP family that includes type-2 PP2A, PP4, and PP6, each with essential functions.  The human PP6 gene rescues sit4ts mutants of Saccharomyces cerevisiae, and Sit4 phosphatase function depends on multiple Sit4-assocd. protein (SAP) subunits.  The authors report here finding a SAPS sequence domain encoded in only a single gene each in Schizosaccharomyces pombe, Caenorhabditis elegans, and Drosophila but in three distinct open reading frames in Xenopus, Mus musculus, and Homo sapiens.  The SAPS proteins are more divergent in sequence than PP6.  Northern hybridization showed differential distribution of the human SAPS-related mRNA in multiple human tissues, named as PP6R1, PP6R2, and PP6R3.  Antibodies were generated, distribution of endogenous PP6, PP6R1, PP6R2, and PP6R3 proteins was examd. by immunoblotting, and the abundance of mRNA and protein in various tissues did not match.  FLAG-tagged PP6R1 and PP6R2 expressed in HEK293 cells co-pptd. endogenous PP6, but not PP2A or PP4, showing specificity for recognition of phosphatases.  The SAPS domain of PP6R1 alone was sufficient for assocn. with PP6, and this predicts that conserved sequence motifs in the SAPS domain accounts for the specificity.  FLAG-PP6R1 and FLAG-PP6R2 co-pptd. HA-IκBε.  Knockdown of PP6 or PP6R1 but not PP6R3 with siRNA significantly enhanced degrdn. of endogenous IκBε in response to tumor necrosis factor-α.  The results show SAPS domain subunits recruit substrates such as IκBε as one way to det. specific functions for PP6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUt_ittCRdGrVg90H21EOLACvtfcHk0lh_fVpMwIjxeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVWjsrk%253D&md5=a737096150473184a74379499d674b17</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601772200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601772200%26sid%3Dliteratum%253Aachs%26aulast%3DStefansson%26aufirst%3DB.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26atitle%3DProtein%2520Phosphatase%25206%2520Subunit%2520with%2520Conserved%2520Sit4-Associated%2520Protein%2520Domain%2520Targets%2520I%25CE%25BAb%25CF%25B5%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D22624%26epage%3D22634%26doi%3D10.1074%2Fjbc.M601772200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugherty, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 6 Regulatory Subunits Composed of Ankyrin Repeat Domains†</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1442</span>– <span class="NLM_lpage">1451</span>, <span class="refDoi"> DOI: 10.1021/bi7022877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi7022877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksV2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1442-1451&author=B.+Stefanssonauthor=T.+Ohamaauthor=A.+E.+Daughertyauthor=D.+L.+Brautigan&title=Protein+Phosphatase+6+Regulatory+Subunits+Composed+of+Ankyrin+Repeat+Domains%E2%80%A0&doi=10.1021%2Fbi7022877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Phosphatase 6 Regulatory Subunits Composed of Ankyrin Repeat Domains</span></div><div class="casAuthors">Stefansson, Bjarki; Ohama, Takashi; Daugherty, Abbi E.; Brautigan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1442-1451</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein phosphatase 6 (PP6) is an essential Ser/Thr phosphatase conserved among eukaryotes.  The Saccharomyces cerevisiae homolog of PP6 called Sit4 depends on assocn. with SAPS domain subunits.  This study used a human SAPS domain subunit FLAG-PP6R1 to identify endogenous interacting proteins.  Mass spectrometry identified copptg. proteins as PP6 catalytic subunit and three ankyrin repeat proteins (Ankrd28, Ankrd44, and Ankrd52).  These proteins have extensive sequence identity to one another but segregate into sep. branches on a phylogenetic tree for vertebrate species, suggesting individual biol. functions.  Tagged Ankrd28 (ARS-A) copptd. with PP6, not with PP2A or PP4, and with SAPS domain subunits PP6R1 and PP6R3.  Tagged PP6 copptd. endogenous SAPS domain subunits and Ankrd28.  The C-terminal region of PP6R1 was sufficient to coppt. Ankrd28, but not PP6, demonstrating that PP6R1 acts as a scaffold with sep. regions for binding to PP6 and to Ankrd28.  Endogenous PP6 holoenzymes with PP6R1 and PP6R3 subunits were resolved by DEAE chromatog. and eluted together with Ankrd28 at Mr > 440 kDa from Superose 12.  Knockdown of PP6R1 or Ankrd28, but not PP6R3, produced equiv. enhancement of IκBε degrdn. in response to TNFα.  The results suggest that PP6 functions as a heterotrimer, composed of the PP6 catalytic subunit bound to a SAPS domain scaffold subunit that assocs. with Ankrd28.  We propose that the SAPS and ankyrin repeat regulatory subunits det. the function and specificity of PP6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfYTLHdSp5AbVg90H21EOLACvtfcHk0lh_fVpMwIjxeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksV2juw%253D%253D&md5=dc7460d9036c16a4e138e7c0a4fda704</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fbi7022877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7022877%26sid%3Dliteratum%253Aachs%26aulast%3DStefansson%26aufirst%3DB.%26aulast%3DOhama%26aufirst%3DT.%26aulast%3DDaugherty%26aufirst%3DA.%2BE.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26atitle%3DProtein%2520Phosphatase%25206%2520Regulatory%2520Subunits%2520Composed%2520of%2520Ankyrin%2520Repeat%2520Domains%25E2%2580%25A0%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D1442%26epage%3D1451%26doi%3D10.1021%2Fbi7022877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Damle, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">The Human Dephosphorylation Database Depod: 2019 Update</span>. <i>Database</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">baz133</span>, <span class="refDoi"> DOI: 10.1093/database/baz133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1093%2Fdatabase%2Fbaz133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31836896" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=baz133&author=N.+P.+Damleauthor=M.+K%C3%B6hn&title=The+Human+Dephosphorylation+Database+Depod%3A+2019+Update&doi=10.1093%2Fdatabase%2Fbaz133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1093%2Fdatabase%2Fbaz133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fdatabase%252Fbaz133%26sid%3Dliteratum%253Aachs%26aulast%3DDamle%26aufirst%3DN.%2BP.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DThe%2520Human%2520Dephosphorylation%2520Database%2520Depod%253A%25202019%2520Update%26jtitle%3DDatabase%26date%3D2019%26volume%3D2019%26spage%3Dbaz133%26doi%3D10.1093%2Fdatabase%2Fbaz133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohama, T.</span></span> <span> </span><span class="NLM_article-title">The Multiple Functions of Protein Phosphatase 6</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1866</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2018.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bbamcr.2018.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30036567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWhtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1866&publication_year=2019&pages=74-82&author=T.+Ohama&title=The+Multiple+Functions+of+Protein+Phosphatase+6&doi=10.1016%2Fj.bbamcr.2018.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The multiple functions of protein phosphatase 6</span></div><div class="casAuthors">Ohama, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1866</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-82</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review presents the accumulating evidence for the roles of protein phosphatase 6 (PP6) in cell cycle, DNA damage repair, inflammatory signaling, lymphocyte development, virus infection, tumor formation/progression, cell/tissue size, and non-coding RNA-mediated regulation.  PP6 is an evolutionarily conserved and ubiquitously expressed Ser/Thr protein phosphatase most closely related to protein phosphatase 2A (PP2A) and protein phosphatase 4 (PP4).  Although abundantly expressed in cells with multiple roles in cellular signaling, PP6 has received less attention than its close relative PP2A.  Many studies used okadaic acid as "PP2A" inhibitor, even though these toxins also inhibit PP6 activity, so effects of the inhibitor could have been due to inhibition of both phosphatases.  PP6 has its own dedicated subunits that assemble into heterotrimers that presumably fulfill its discrete functions in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwZcpMbVAD5LVg90H21EOLACvtfcHk0lhn1HUepdvMuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWhtLvF&md5=7317d761a17efe42b0f8c27c4310b750</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2018.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2018.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DOhama%26aufirst%3DT.%26atitle%3DThe%2520Multiple%2520Functions%2520of%2520Protein%2520Phosphatase%25206%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2019%26volume%3D1866%26spage%3D74%26epage%3D82%26doi%3D10.1016%2Fj.bbamcr.2018.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naguro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span> <span> </span><span class="NLM_article-title">A Pp6-Ask3Module Coordinates the Bidirectional Cell Volume Regulation under Osmotic Stress</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2809</span>– <span class="NLM_lpage">2817</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2018.02.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.celrep.2018.02.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29539411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslSgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=2809-2817&author=K.+Watanabeauthor=T.+Umedaauthor=K.+Niwaauthor=I.+Naguroauthor=H.+Ichijo&title=A+Pp6-Ask3Module+Coordinates+the+Bidirectional+Cell+Volume+Regulation+under+Osmotic+Stress&doi=10.1016%2Fj.celrep.2018.02.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A PP6-ASK3 Module Coordinates the Bidirectional Cell Volume Regulation under Osmotic Stress</span></div><div class="casAuthors">Watanabe, Kengo; Umeda, Tsuyoshi; Niwa, Kuniyoshi; Naguro, Isao; Ichijo, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2809-2817</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cell vol. regulation is a vital system for cellular activities.  When perturbed by hypoosmotic or hyperosmotic stress, cells immediately induce the cell vol. recovery system, regulatory vol. decrease (RVD) or regulatory vol. increase (RVI), resp.  In contrast to the knowledge about effector mols., the mol. mechanisms linking osmosensing to RVD/RVI induction remain unknown.  Addnl., few reciprocal responders in the bidirectional osmotic stress response have been identified.  We previously reported that ASK3 bidirectionally switches its kinase activity under osmotic stress.  Herein we demonstrate that ASK3 controls both RVD and RVI under osmotic stress.  Using a high-content genome-wide small interfering RNA (siRNA) screen, we identify PP6 as a direct ASK3 inactivator.  Furthermore, PP6 rapidly interacts with ASK3 in an osmolality-dependent manner, and it inactivates ASK3 to induce RVI and, thereby, cell survival under hyperosmotic stress.  These findings suggest that the PP6-ASK3 interaction is a core module in the bidirectional osmotic stress response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEyvmh_hzGdrVg90H21EOLACvtfcHk0lhn1HUepdvMuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslSgtrc%253D&md5=ab1dca1377664d9478ecb133ab437e4f</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2018.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2018.02.045%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DUmeda%26aufirst%3DT.%26aulast%3DNiwa%26aufirst%3DK.%26aulast%3DNaguro%26aufirst%3DI.%26aulast%3DIchijo%26aufirst%3DH.%26atitle%3DA%2520Pp6-Ask3Module%2520Coordinates%2520the%2520Bidirectional%2520Cell%2520Volume%2520Regulation%2520under%2520Osmotic%2520Stress%26jtitle%3DCell%2520Rep.%26date%3D2018%26volume%3D22%26spage%3D2809%26epage%3D2817%26doi%3D10.1016%2Fj.celrep.2018.02.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kutuzov, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreeva, A. V.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase with Ef-Hand Domains 2 (Ppef2) Is a Potent Negative Regulator of Apoptosis Signal Regulating Kinase-1 (Ask1)</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1816</span>– <span class="NLM_lpage">1822</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2010.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.biocel.2010.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20674765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ClsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=1816-1822&author=M.+A.+Kutuzovauthor=N.+Bennettauthor=A.+V.+Andreeva&title=Protein+Phosphatase+with+Ef-Hand+Domains+2+%28Ppef2%29+Is+a+Potent+Negative+Regulator+of+Apoptosis+Signal+Regulating+Kinase-1+%28Ask1%29&doi=10.1016%2Fj.biocel.2010.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase with EF-hand domains 2 (PPEF2) is a potent negative regulator of apoptosis signal regulating kinase-1 (ASK1)</span></div><div class="casAuthors">Kutuzov, Mikhail A.; Bennett, Nelly; Andreeva, Alexandra V.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1816-1822</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The function of protein phosphatases with EF-hand domains (PPEF) in mammals is not known.  Large-scale expression profiling expts. suggest that PPEF expression may correlate with stress protective responses, cell survival, growth, proliferation, or neoplastic transformation.  Apoptosis signal regulating kinase-1 (ASK1) is a MAP kinase kinase kinase implicated in cancer, cardiovascular and neurodegenerative diseases.  ASK1 is activated by oxidative stress and induces pro-apoptotic or inflammatory signalling, largely via sustained activation of MAP kinases p38 and/or JNK.  We identify human PPEF2 as a novel interacting partner and a neg. regulator of ASK1.  In COS-7 or HEK 293A cells treated with H2O2, expression of PPEF2 abrogated sustained activation of p38 and one of the JNK p46 isoforms, and prevented ASK1-dependent caspase-3 cleavage and activation.  PPEF2 efficiently suppressed H2O2-induced activation of ASK1.  Overexpessed as well as endogenous ASK1 co-immunopptd. with PPEF2.  PPEF2 was considerably more potent both as a suppressor of ASK1 activation and as its interacting partner as compared to protein phosphatase 5 (PP5), a well-known neg. regulator of ASK1.  PPEF2 was found to form complexes with endogenous Hsp70 and to a lesser extent Hsp90, which are also known interacting partners of PP5.  These data identify, for the first time, a possible downstream signalling partner of a mammalian PPEF phosphatase, and suggest that, despite structural divergence, PPEF and PP5 phosphatases may share common interacting partners and functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3rd5CybTzMbVg90H21EOLACvtfcHk0lhn1HUepdvMuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ClsrjK&md5=7e5b8c3f1453e7d75c4551e7e63828f6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2010.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2010.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DKutuzov%26aufirst%3DM.%2BA.%26aulast%3DBennett%26aufirst%3DN.%26aulast%3DAndreeva%26aufirst%3DA.%2BV.%26atitle%3DProtein%2520Phosphatase%2520with%2520Ef-Hand%2520Domains%25202%2520%2528Ppef2%2529%2520Is%2520a%2520Potent%2520Negative%2520Regulator%2520of%2520Apoptosis%2520Signal%2520Regulating%2520Kinase-1%2520%2528Ask1%2529%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2010%26volume%3D42%26spage%3D1816%26epage%3D1822%26doi%3D10.1016%2Fj.biocel.2010.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. G.</span></span> <span> </span><span class="NLM_article-title">Protein Serine/Threonine Phosphatase Ppef-1 Suppresses Genotoxic Stress Response Via Dephosphorylation of Pdcd5</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">39222</span>, <span class="refDoi"> DOI: 10.1038/srep39222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsrep39222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28051100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=39222&author=S.+Y.+Parkauthor=J.+Seoauthor=H.+K.+Choiauthor=H.+J.+Ohauthor=G.+Gukauthor=Y.+H.+Leeauthor=J.+Leeauthor=W.+J.+Junauthor=K.+C.+Choiauthor=H.+G.+Yoon&title=Protein+Serine%2FThreonine+Phosphatase+Ppef-1+Suppresses+Genotoxic+Stress+Response+Via+Dephosphorylation+of+Pdcd5&doi=10.1038%2Fsrep39222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Protein serine/threonine phosphatase PPEF-1 suppresses genotoxic stress response via dephosphorylation of PDCD5</span></div><div class="casAuthors">Park, Soo-Yeon; Seo, Jaesung; Choi, Hyo-Kyoung; Oh, Hye-Jeong; Guk, Garam; Lee, Yoo-Hyun; Lee, Jeongmin; Jun, Woo Jin; Choi, Kyung-Chul; Yoon, Ho-Geun</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39222</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Programmed cell death 5 (PDCD5) is believed to play a crucial role in p53 activation; however, the underlying mechanism of how PDCD5 function is regulated during apoptosis remains obscure.  Here, we report that the serine/threonine phosphatase PPEF-1 interacts with and dephosphorylates PDCD5 at Ser-119, which leads to PDCD5 destabilization.  Overexpression of wild-type PPEF-1, but not inactive PPEF-1D172N, efficiently suppressed CK2α-mediated stabilization of PDCD5 and p53-mediated apoptosis in response to etoposide (ET).  Conversely, PPEF-1 knockdown further enhanced genotoxic stress responses.  Notably, PPEF-1 suppressed p53-mediated genotoxic stress response via neg. regulation of PDCD5.  We also detd. that overexpression of wild-type PPEF-1, but not inactive PPEF-1D172N, significantly increased tumorigenic growth and chemoresistance of A549 human lung carcinoma cells.  Collectively, these data demonstrate that PPEF-1 plays a pivotal role in tumorigenesis of lung cancer cells by reducing PDCD5-mediated genotoxic stress responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogWbSCz9_3rLVg90H21EOLACvtfcHk0lhn1HUepdvMuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKmsw%253D%253D&md5=b6685132f75b39ed83c6a4d9ae00d23a</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fsrep39222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep39222%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DOh%26aufirst%3DH.%2BJ.%26aulast%3DGuk%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJun%26aufirst%3DW.%2BJ.%26aulast%3DChoi%26aufirst%3DK.%2BC.%26aulast%3DYoon%26aufirst%3DH.%2BG.%26atitle%3DProtein%2520Serine%252FThreonine%2520Phosphatase%2520Ppef-1%2520Suppresses%2520Genotoxic%2520Stress%2520Response%2520Via%2520Dephosphorylation%2520of%2520Pdcd5%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D39222%26doi%3D10.1038%2Fsrep39222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ceulemans, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">Functional Diversity of Protein Phosphatase-1, a Cellular Economizer and Reset Button</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1152/physrev.00013.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1152%2Fphysrev.00013.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=14715909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotl2rtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=1-39&author=H.+Ceulemansauthor=M.+Bollen&title=Functional+Diversity+of+Protein+Phosphatase-1%2C+a+Cellular+Economizer+and+Reset+Button&doi=10.1152%2Fphysrev.00013.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Functional diversity of protein phosphatase-1, a cellular economizer and reset button</span></div><div class="casAuthors">Ceulemans, Hugo; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-39</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Protein phosphatase-1 (PP1) is a ubiquitous eukaryotic enzyme that regulates a variety of cellular processes through the dephosphorylation of dozens of substrates.  This multifunctionality of PP1 relies on its assocn. with a host of function-specific targeting and substrate-specifying proteins.  Here, the authors discuss how PP1 affects the biochem. and physiol. of eukaryotic cells.  The picture of PP1 that emerges from this anal. is that of a "green" enzyme that promotes the rational use of energy, the recycling of protein factors, and a reversal of the cell to a basal and/or energy-conserving state.  Thus, PP1 promotes a shift to more energy-efficient fuels when nutrients are abundant and stimulates the storage of energy in the form of glycogen.  PP1 also enables the relaxation of actomyosin fibers, the return to basal patterns of protein synthesis, and the recycling of transcription and splicing factors.  In addn., PP1 plays a key role in the recovery from stress, but promotes apoptosis when cells are damaged beyond repair.  Furthermore, PP1 down-regulates ion pumps and transporters in various tissues and ion channels that are involved in the excitation of neurons.  Finally, PP1 promotes the exit from mitosis and maintains cells in the G1 or G2 phases of the cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS5CZMahU7vrVg90H21EOLACvtfcHk0lgj2k3UJrI7uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotl2rtw%253D%253D&md5=e3ef8c05db14f1d2d34bf9027d82b477</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00013.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00013.2003%26sid%3Dliteratum%253Aachs%26aulast%3DCeulemans%26aufirst%3DH.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DFunctional%2520Diversity%2520of%2520Protein%2520Phosphatase-1%252C%2520a%2520Cellular%2520Economizer%2520and%2520Reset%2520Button%26jtitle%3DPhysiol.%2520Rev.%26date%3D2004%26volume%3D84%26spage%3D1%26epage%3D39%26doi%3D10.1152%2Fphysrev.00013.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rebelo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Cruz e Silva, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Cruz e Silva, O. A. B.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 1 Is a Key Player in Nuclear Events</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2589</span>– <span class="NLM_lpage">2598</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2015.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cellsig.2015.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26275498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVyit7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=2589-2598&author=S.+Rebeloauthor=M.+Santosauthor=F.+Martinsauthor=E.+F.+da+Cruz+e+Silvaauthor=O.+A.+B.+da+Cruz+e+Silva&title=Protein+Phosphatase+1+Is+a+Key+Player+in+Nuclear+Events&doi=10.1016%2Fj.cellsig.2015.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 1 is a key player in nuclear events</span></div><div class="casAuthors">Rebelo, Sandra; Santos, Mariana; Martins, Filipa; da Cruz e Silva, Edgar F.; da Cruz e Silva, Odete A. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2589-2598</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Reversible protein phosphorylation at serine (Ser), threonine (Thr) and tyrosine (Tyr) residues is among the major regulatory mechanism in eukaryotic cells.  The eukaryotic genome encodes many protein kinases and protein phosphatases.  However, the localization, activity and specificity towards phosphatase substrates are dictated by a large array of phosphatase binding and regulatory subunits.  For protein phosphatase 1 (PP1) more than 200 binding subunits have been described.  The various PP1 isoforms and the binding subunits can be located throughout the cell, including in the nucleus.  It follows that several nuclear specific PP1 binding proteins (PIPs) have been described and these will be discussed.  Among them are PNUTS (phosphatase 1 nuclear targeting subunit), NIPP1 (nuclear inhibitor of PP1) and CREB (cAMP-responsive element-binding protein), which have all been assocd. with transcription.  In fact PP1 can assoc. with transcription factors fulfilling an important regulatory function, in this respect it can bind to Hox11, human factor C1 (HCF1) and myocyte enhancer factor-2 (MEF2).  PP1 also regulates cell cycle progression and centrosome maturation and splitting, again by binding to specific regulatory proteins.  Moreover, PP1 together with other protein phosphatases control the entry into mitosis by regulating the activity of mitotic kinases.  Thus, PP1, its binding proteins and/or the phosphorylation states of both, directly control a vast array of cell nucleus assocd. functions, many of which are starting to be unraveled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdEWDyzihjXrVg90H21EOLACvtfcHk0lgj2k3UJrI7uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVyit7fK&md5=108d25b14f3f3245078f09016faeb14f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2015.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2015.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DRebelo%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DMartins%26aufirst%3DF.%26aulast%3Dda%2BCruz%2Be%2BSilva%26aufirst%3DE.%2BF.%26aulast%3Dda%2BCruz%2Be%2BSilva%26aufirst%3DO.%2BA.%2BB.%26atitle%3DProtein%2520Phosphatase%25201%2520Is%2520a%2520Key%2520Player%2520in%2520Nuclear%2520Events%26jtitle%3DCell.%2520Signalling%26date%3D2015%26volume%3D27%26spage%3D2589%26epage%3D2598%26doi%3D10.1016%2Fj.cellsig.2015.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenolikar, S.</span></span> <span> </span><span class="NLM_article-title">From Promiscuity to Precision: Protein Phosphatases Get a Makeover</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2009.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.molcel.2009.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19285938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=537-545&author=D.+M.+Virshupauthor=S.+Shenolikar&title=From+Promiscuity+to+Precision%3A+Protein+Phosphatases+Get+a+Makeover&doi=10.1016%2Fj.molcel.2009.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">From promiscuity to precision: protein phosphatases get a makeover</span></div><div class="casAuthors">Virshup, David M.; Shenolikar, Shirish</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">537-545</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The control of biol. events requires strict regulation using complex protein phosphorylation and dephosphorylation strategies.  The bulk of Ser/Thr residue dephosphorylations are catalyzed by a handful of protein phosphatase (PP) catalytic subunits, giving rise to the misconception that these phosphatases are promiscuous and unregulated enzymes in vivo.  The reality is much more nuanced: PP1 and PP2A, the most abundant Ser/Thr-PPs, are, in fact, families of hundreds of protein Ser/Thr-PPs, assembled from a few catalytic subunits in combination with a highly diverse array of regulators.  As recent publications illustrate, these regulatory subunits confer specificity, selectivity, localization, and regulation on these important enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpCaDeYAzyZbVg90H21EOLACvtfcHk0lgj2k3UJrI7uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSmsr4%253D&md5=db62c4123ce7b9871f2a162d556a571c</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DShenolikar%26aufirst%3DS.%26atitle%3DFrom%2520Promiscuity%2520to%2520Precision%253A%2520Protein%2520Phosphatases%2520Get%2520a%2520Makeover%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D33%26spage%3D537%26epage%3D545%26doi%3D10.1016%2Fj.molcel.2009.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lesage, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">Spindle Checkpoint Silencing: Pp1 Tips the Balance</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">R898</span>– <span class="NLM_lpage">R903</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2011.08.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cub.2011.08.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22075433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKmurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=R898-R903&author=B.+Lesageauthor=J.+Qianauthor=M.+Bollen&title=Spindle+Checkpoint+Silencing%3A+Pp1+Tips+the+Balance&doi=10.1016%2Fj.cub.2011.08.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Spindle Checkpoint Silencing: PP1 Tips the Balance</span></div><div class="casAuthors">Lesage, Bart; Qian, Junbin; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">R898-R903</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The spindle checkpoint is a mitotic surveillance mechanism that delays anaphase until all sister chromatids are correctly attached to microtubules from opposite poles.  Recent studies reveal that protein kinase Aurora B is a key regulator of spindle checkpoint activation, whereas protein phosphatase PP1 antagonizes Aurora B and induces checkpoint silencing.  Chromosome biorientation stretches the kinetochores and spatially separates centromeric Aurora B from its kinetochore substrates, comprising several PP1-interacting proteins (PIPs).  The ensuing dephosphorylation of these PIPs creates docking sites for the bulk recruitment of PP1 to the kinetochores.  We propose that this tension-induced targeting of PP1 triggers checkpoint silencing by the dephosphorylation of kinetochore and checkpoint components, including Aurora B substrates.  In addn., PP1 also directly inactivates a kinetochore-assocd. pool of Aurora B and silences checkpoint signaling by opposing the centromeric targeting of Aurora B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqMytVf7Wph7Vg90H21EOLACvtfcHk0lgS7b8X8wLlww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKmurbK&md5=b98f9d817ffa9e61dbf4832782bf5208</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2011.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2011.08.063%26sid%3Dliteratum%253Aachs%26aulast%3DLesage%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DSpindle%2520Checkpoint%2520Silencing%253A%2520Pp1%2520Tips%2520the%2520Balance%26jtitle%3DCurr.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3DR898%26epage%3DR903%26doi%3D10.1016%2Fj.cub.2011.08.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanuma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuhashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, K.</span></span> <span> </span><span class="NLM_article-title">Analysis of Isoform Specific Function of Pp1 Catalytic Subunits in Mammalian Cells Using Sirna</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1383</span>– <span class="NLM_lpage">1388</span>, <span class="refDoi"> DOI: 10.3892/ijo.25.5.1383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3892%2Fijo.25.5.1383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15492829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSktbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1383-1388&author=T.+Okadaauthor=T.+Fujiiauthor=N.+Tanumaauthor=S.+Mitsuhashiauthor=T.+Uranoauthor=Y.+Arakiauthor=H.+Shimaauthor=K.+Kikuchi&title=Analysis+of+Isoform+Specific+Function+of+Pp1+Catalytic+Subunits+in+Mammalian+Cells+Using+Sirna&doi=10.3892%2Fijo.25.5.1383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of isoform specific function of PP1 catalytic subunits in mammalian cells using siRNA</span></div><div class="casAuthors">Okada, Tadashi; Fujii, Tsubasa; Tanuma, Nobuhiro; Mitsuhashi, Shinya; Urano, Takeshi; Araki, Yoshio; Shima, Hiroshi; Kikuchi, Kunimi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1383-1388</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Protein phosphatase type 1 (PP1) is involved in the regulation of numerous cell functions in mammalian cells.  The major isoforms of PP1 catalytic subunit (PP1C)α, γ1 and δ have nearly identical catalytic domain, but they vary in sequences at the amino and carboxyl termini.  We previously showed that PP1Cα is highly expressed in rat hepatoma cells.  To examine isoform specific function of PP1C, each isoform was depleted from HeLa cells by RNA interference.  The PP1Cα-depleted cells rounded up and showed increased cell death, indicating that PP1Cα is essential in cell proliferation.  PP1Cγ1-depleted cells slightly rounded up and have decreased G1 phase population and increased S phase population.  The PP1Cδ-depleted cells were enlarged, and appeared flat and rich in lamellipodia.  These data suggested that each PP1C isoform has non-redundant function in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSNqdgB_pE-bVg90H21EOLACvtfcHk0lgS7b8X8wLlww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSktbnP&md5=f8ec7542c6775fe49b911f68ad2afe85</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3892%2Fijo.25.5.1383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.25.5.1383%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DTanuma%26aufirst%3DN.%26aulast%3DMitsuhashi%26aufirst%3DS.%26aulast%3DUrano%26aufirst%3DT.%26aulast%3DAraki%26aufirst%3DY.%26aulast%3DShima%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DK.%26atitle%3DAnalysis%2520of%2520Isoform%2520Specific%2520Function%2520of%2520Pp1%2520Catalytic%2520Subunits%2520in%2520Mammalian%2520Cells%2520Using%2520Sirna%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2004%26volume%3D25%26spage%3D1383%26epage%3D1388%26doi%3D10.3892%2Fijo.25.5.1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. W. C.</span></span> <span> </span><span class="NLM_article-title">Pp-1α and Pp-1γ Display Antagonism and Differential Roles in Tumorigenicity of Lung Cancer Cells</span>. <i>Curr. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.2174/156652413804486205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F156652413804486205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23176181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=220-227&author=P.+C.+Chenauthor=C.+Liauthor=D.+Wangauthor=Z.+W.+Luoauthor=S.+J.+Fuauthor=X.+Liauthor=Z.+L.+Liauthor=X.+W.+Chenauthor=L.+Liauthor=Z.+X.+Huangauthor=W.+K.+Jiauthor=W.+F.+Huauthor=X.+H.+Huauthor=M.+Dengauthor=L.+Gongauthor=H.+G.+Chenauthor=J.+P.+Liuauthor=D.+W.+C.+Li&title=Pp-1%CE%B1+and+Pp-1%CE%B3+Display+Antagonism+and+Differential+Roles+in+Tumorigenicity+of+Lung+Cancer+Cells&doi=10.2174%2F156652413804486205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells</span></div><div class="casAuthors">Chen, P.-C.; Li, C.; Wang, D.; Luo, Z.-W.; Fu, S.-J.; Li, X.; Li, Z.-L.; Chen, X.-W.; Li, L.; Huang, Z.-X.; Ji, W.-K.; Hu, W.-F.; Hu, X.-H.; Deng, M.; Gong, L.; Chen, H.-G.; Liu, J.-P.; Li, D. W.-C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">220-227</span>CODEN:
                <span class="NLM_cas:coden">CMMUBP</span>;
        ISSN:<span class="NLM_cas:issn">1566-5240</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Protein serine/threonine phosphatases are important cellular signaling mols. and play major roles in regulating many different functions including cell proliferation, senescence, programmed cell death, and oncogenic cell transformation.  Among different serine/threonine phosphatases, PP-1 and PP-2A contribute to more than 90% phosphatase activities in eukaryotes.  While the functions of PP-2A in cell transformation and tumorigenesis have been well established, the role of PP-1 in carcinogenesis remains to be further explored.  Moreover, PP-1 exists in different isoforms, whether these isoforms have differential functions in tumorigenesis remains to be examd.  In the present study, we demonstrated that in lung cancer 1299 cells, PP1α and PP1γ exist in an antagonizing balance.  In the parent H1299 cells, PP-1γ is dominant, about 4-fold higher than that of PP-1α.  Overexpression of PP-1α significantly down-regulates PP-1γ at both mRNA and protein levels.  In contrast, knockdown of PP-1α leads to upregulation of PP-1γ.  Moreover, overexpression of PP-1α significantly attenuates the ability of the H1299 cells in promoting tumorigenicity as tested in immuno-deficient nude mice.  This attenuation is derived from the halted cell cycle progression, which is largely attributed by the changed RB-E2F activity.  Together, our results demonstrate that PP-1α and PP-1γ not only antagonize each other in lung cancer cells, but also display differential functions in tumorigenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWHqpOXAPAnbVg90H21EOLACvtfcHk0liQdNCb9FfioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeqtb0%253D&md5=01e4f6b2e2b5c6d5c9f387b1091faa29</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.2174%2F156652413804486205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156652413804486205%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DZ.%2BW.%26aulast%3DFu%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%2BL.%26aulast%3DChen%26aufirst%3DX.%2BW.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%2BX.%26aulast%3DJi%26aufirst%3DW.%2BK.%26aulast%3DHu%26aufirst%3DW.%2BF.%26aulast%3DHu%26aufirst%3DX.%2BH.%26aulast%3DDeng%26aufirst%3DM.%26aulast%3DGong%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DH.%2BG.%26aulast%3DLiu%26aufirst%3DJ.%2BP.%26aulast%3DLi%26aufirst%3DD.%2BW.%2BC.%26atitle%3DPp-1%25CE%25B1%2520and%2520Pp-1%25CE%25B3%2520Display%2520Antagonism%2520and%2520Differential%2520Roles%2520in%2520Tumorigenicity%2520of%2520Lung%2520Cancer%2520Cells%26jtitle%3DCurr.%2520Mol.%2520Med.%26date%3D2013%26volume%3D13%26spage%3D220%26epage%3D227%26doi%3D10.2174%2F156652413804486205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felgueiras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerónimo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fardilha, M.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 1 in Tumorigenesis: Is It Worth a Closer Look?</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>1874</i></span>,  <span class="NLM_fpage">188433</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2020.188433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bbcan.2020.188433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=32956763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVKgtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1874&publication_year=2020&pages=188433&author=J.+Felgueirasauthor=C.+Jer%C3%B3nimoauthor=M.+Fardilha&title=Protein+Phosphatase+1+in+Tumorigenesis%3A+Is+It+Worth+a+Closer+Look%3F&doi=10.1016%2Fj.bbcan.2020.188433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 1 in tumorigenesis: is it worth a closer look?</span></div><div class="casAuthors">Felgueiras, Juliana; Jeronimo, Carmen; Fardilha, Margarida</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">1874</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188433</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cancer cells take advantage of signaling cascades to meet their requirements for sustained growth and survival.  Cell signaling is tightly controlled by reversible protein phosphorylation mechanisms, which require the counterbalanced action of protein kinases and protein phosphatases.  Imbalances on this system are assocd. with cancer development and progression.  Protein phosphatase 1 (PP1) is one of the most relevant protein phosphatases in eukaryotic cells.  Despite the widely recognized involvement of PP1 in key biol. processes, both in health and disease, its relevance in cancer has been largely neglected.  Here, we provide compelling evidence that support major roles for PP1 in tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJmrEm9Ugv07Vg90H21EOLACvtfcHk0liQdNCb9FfioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVKgtrrE&md5=ab52757ccf2bf84b1970079687d583df</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2020.188433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2020.188433%26sid%3Dliteratum%253Aachs%26aulast%3DFelgueiras%26aufirst%3DJ.%26aulast%3DJer%25C3%25B3nimo%26aufirst%3DC.%26aulast%3DFardilha%26aufirst%3DM.%26atitle%3DProtein%2520Phosphatase%25201%2520in%2520Tumorigenesis%253A%2520Is%2520It%2520Worth%2520a%2520Closer%2520Look%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2020%26volume%3D1874%26spage%3D188433%26doi%3D10.1016%2Fj.bbcan.2020.188433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bialojan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, A.</span></span> <span> </span><span class="NLM_article-title">Inhibitory Effect of a Marine-Sponge Toxin, Okadaic Acid, on Protein Phosphatases. Specificity and Kinetics</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1042/bj2560283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1042%2Fbj2560283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2851982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL1MXitVequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1988&pages=283-290&author=C.+Bialojanauthor=A.+Takai&title=Inhibitory+Effect+of+a+Marine-Sponge+Toxin%2C+Okadaic+Acid%2C+on+Protein+Phosphatases.+Specificity+and+Kinetics&doi=10.1042%2Fbj2560283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases.  Specificity and kinetics</span></div><div class="casAuthors">Bialojan, Corinna; Takai, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-90</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">The inhibitory effect of a marine sponge toxin, okadaic acid, was examd. on type 1, type 2A, type 2B, and type 2C protein phosphatases as well as on a polycation-modulated (PCM) phosphatase.  Of the protein phosphatases examd., the catalytic subunit of type 2A phosphatase from rabbit skeletal muscle was most potently inhibited.  For the phosphorylated myosin light-chain (PMLC) phosphatase activity of the enzyme, the concn. of okadaic acid required to obtain 50% inhibition (ID50) was ∼1 nM.  The PMLC phosphatase activities of type 1 and PCM phosphatase were also strongly inhibited (ID50 0.1-0.5 μM).  The PMLC phosphatase activity of type 2B phosphatase (calcineurin) was inhibited to a lesser extent (ID50 4-5 μM).  Similar results were obtained for the phosphorylase a phosphatase activity of type 1 and PCM phosphatases and for the p-nitrophenyl phosphate phosphatase activity of calcineurin.  The following phosphatases were not affected by ≤10 μM okadaic acid: type 2C phosphatase, phosphotyrosyl phosphatase, inositol 1,4,5-trisphosphate phosphatase, acid phosphatases, and alk. phosphatases.  Thus okadaic acid had a relatively high specificity for type 2A, type 1, and PCM phosphatases.  Kinetic studies showed that okadaic acid acts as a noncompetitive or mixed inhibitor on the okadaic acid-sensitive enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDRX40cIwTiLVg90H21EOLACvtfcHk0liQdNCb9FfioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXitVequg%253D%253D&md5=0303a70deb82c0c087e4585ac180c5d8</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1042%2Fbj2560283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2560283%26sid%3Dliteratum%253Aachs%26aulast%3DBialojan%26aufirst%3DC.%26aulast%3DTakai%26aufirst%3DA.%26atitle%3DInhibitory%2520Effect%2520of%2520a%2520Marine-Sponge%2520Toxin%252C%2520Okadaic%2520Acid%252C%2520on%2520Protein%2520Phosphatases.%2520Specificity%2520and%2520Kinetics%26jtitle%3DBiochem.%2520J.%26date%3D1988%26volume%3D256%26spage%3D283%26epage%3D290%26doi%3D10.1042%2Fbj2560283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suganuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suguri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayasu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojika, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakamatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimura, T.</span></span> <span> </span><span class="NLM_article-title">Okadaic Acid: An Additional Non-Phorbol-12-Tetradecanoate-13-Acetate-Type Tumor Promoter</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">1768</span>– <span class="NLM_lpage">1771</span>, <span class="refDoi"> DOI: 10.1073/pnas.85.6.1768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.85.6.1768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=3126494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL1cXktVaitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=1768-1771&author=M.+Suganumaauthor=H.+Fujikiauthor=H.+Suguriauthor=S.+Yoshizawaauthor=M.+Hirotaauthor=M.+Nakayasuauthor=M.+Ojikaauthor=K.+Wakamatsuauthor=K.+Yamadaauthor=T.+Sugimura&title=Okadaic+Acid%3A+An+Additional+Non-Phorbol-12-Tetradecanoate-13-Acetate-Type+Tumor+Promoter&doi=10.1073%2Fpnas.85.6.1768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Okadaic acid: an additional non-phorbol-12-tetradecanoate 13-acetate-type tumor promoter</span></div><div class="casAuthors">Suganuma, Masami; Fujiki, Hirota; Suguri, Hiroko; Yoshizawa, Shigeru; Hirota, Mitsuru; Nakayasu, Michie; Ojika, Makoto; Wakamatsu, Kazumasa; Yamada, Kiyoyuki; Sugimura, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1768-71</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A 2-stage carcinogenesis expt. in mouse skin initiated by a single application of 100 μg of DMBA and followed by application of 10 μg of okadaic acid (a polyether compd. of C38 fatty acid) twice a week revealed that the latter is a potent addnl. tumor promoter: tumors developed in 93% of the mice treated with DMBA and okadaic acid by week 16.  In contrast, tumors were found in only 1 mouse each in the groups treated with DMBA alone or okadaic acid alone.  An av. of 2.6 tumors/mouse was found in week 30 in the group treated with DMBA and okadaic acid.  Unlike TPA, teleocidin, and aplysiatoxin, okadaic acid did not inhibit the specific binding of [3H]TPA to a mouse skin particulate fraction when added up to 100 μM or activate Ca-activated, phospholipid-dependent protein kinase (protein kinase C) in vitro when added up to 1.2 μM.  Therefore, the actions of okadaic acid and phorbol ester may be mediated in different ways.  These results show that okadaic acid is a non-TPA-type tumor promoter in mouse skin carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTZJGIsBydTbVg90H21EOLACvtfcHk0lg_jSTE70hIlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXktVaitrw%253D&md5=9aa530e2a6fa72ef04baa1146d024417</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.6.1768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.6.1768%26sid%3Dliteratum%253Aachs%26aulast%3DSuganuma%26aufirst%3DM.%26aulast%3DFujiki%26aufirst%3DH.%26aulast%3DSuguri%26aufirst%3DH.%26aulast%3DYoshizawa%26aufirst%3DS.%26aulast%3DHirota%26aufirst%3DM.%26aulast%3DNakayasu%26aufirst%3DM.%26aulast%3DOjika%26aufirst%3DM.%26aulast%3DWakamatsu%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DSugimura%26aufirst%3DT.%26atitle%3DOkadaic%2520Acid%253A%2520An%2520Additional%2520Non-Phorbol-12-Tetradecanoate-13-Acetate-Type%2520Tumor%2520Promoter%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D1768%26epage%3D1771%26doi%3D10.1073%2Fpnas.85.6.1768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suganuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuya-Suguri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fusetani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimura, T.</span></span> <span> </span><span class="NLM_article-title">Calyculin a, an Inhibitor of Protein Phosphatases, a Potent Tumor Promoter on Cd-1 Mouse Skin</span>. <i>Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3521</span>– <span class="NLM_lpage">3525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=3521-3525&author=M.+Suganumaauthor=H.+Fujikiauthor=H.+Furuya-Suguriauthor=S.+Yoshizawaauthor=S.+Yasumotoauthor=Y.+Katoauthor=N.+Fusetaniauthor=T.+Sugimura&title=Calyculin+a%2C+an+Inhibitor+of+Protein+Phosphatases%2C+a+Potent+Tumor+Promoter+on+Cd-1+Mouse+Skin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuganuma%26aufirst%3DM.%26aulast%3DFujiki%26aufirst%3DH.%26aulast%3DFuruya-Suguri%26aufirst%3DH.%26aulast%3DYoshizawa%26aufirst%3DS.%26aulast%3DYasumoto%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DFusetani%26aufirst%3DN.%26aulast%3DSugimura%26aufirst%3DT.%26atitle%3DCalyculin%2520a%252C%2520an%2520Inhibitor%2520of%2520Protein%2520Phosphatases%252C%2520a%2520Potent%2520Tumor%2520Promoter%2520on%2520Cd-1%2520Mouse%2520Skin%26jtitle%3DCancer%2520Res.%2520Treat.%26date%3D1990%26volume%3D50%26spage%3D3521%26epage%3D3525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suganuma, M.</span></span> <span> </span><span class="NLM_article-title">Tumor Promotion by Inhibitors of Protein Phosphatases 1 and 2a: The Okadaic Acid Class of Compounds</span>. <i>Adv. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/S0065-230X(08)60958-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0065-230X%2808%2960958-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8394044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFensLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1993&pages=143-194&author=H.+Fujikiauthor=M.+Suganuma&title=Tumor+Promotion+by+Inhibitors+of+Protein+Phosphatases+1+and+2a%3A+The+Okadaic+Acid+Class+of+Compounds&doi=10.1016%2FS0065-230X%2808%2960958-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor promotion by inhibitors of protein phosphatases 1 and 2A: The okadaic acid class of compounds</span></div><div class="casAuthors">Fujiki, Hirota; Suganuma, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-94</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    </div><div class="casAbstract">A review with many refs. on okadaic acid compds., calyculins, microcystins, nodularin, tautomycin and human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokprynlqNJ3rVg90H21EOLACvtfcHk0lg_jSTE70hIlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFensLk%253D&md5=81c71b978764ef1b6d9152934c51865b</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2808%2960958-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252808%252960958-6%26sid%3Dliteratum%253Aachs%26aulast%3DFujiki%26aufirst%3DH.%26aulast%3DSuganuma%26aufirst%3DM.%26atitle%3DTumor%2520Promotion%2520by%2520Inhibitors%2520of%2520Protein%2520Phosphatases%25201%2520and%25202a%253A%2520The%2520Okadaic%2520Acid%2520Class%2520of%2520Compounds%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D1993%26volume%3D61%26spage%3D143%26epage%3D194%26doi%3D10.1016%2FS0065-230X%2808%2960958-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hein, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandquist, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshacharyulu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span> <span> </span><span class="NLM_article-title">Pr55α Regulatory Subunit of Pp2a Inhibits the Mob1/Lats Cascade and Activates Yap in Pancreatic Cancer Cells</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">63</span>, <span class="refDoi"> DOI: 10.1038/s41389-019-0172-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fs41389-019-0172-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31659153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BB3MjisVWjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=63&author=A.+L.+Heinauthor=N.+D.+Brandquistauthor=C.+Y.+Ouelletteauthor=P.+Seshacharyuluauthor=C.+A.+Enkeauthor=M.+M.+Ouelletteauthor=S.+K.+Batraauthor=Y.+Yan&title=Pr55%CE%B1+Regulatory+Subunit+of+Pp2a+Inhibits+the+Mob1%2FLats+Cascade+and+Activates+Yap+in+Pancreatic+Cancer+Cells&doi=10.1038%2Fs41389-019-0172-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells</span></div><div class="casAuthors">Hein Ashley L; Brandquist Nichole D; Ouellette Caroline Y; Enke Charles A; Yan Ying; Seshacharyulu Parthasarathy; Ouellette Michel M; Batra Surinder K; Yan Ying; Ouellette Michel M</div><div class="citationInfo"><span class="NLM_cas:title">Oncogenesis</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">63</span>
        ISSN:<span class="NLM_cas:issn">2157-9024</span>.
    </div><div class="casAbstract">PP2A holoenzyme complexes are responsible for the majority of Ser/Thr phosphatase activities in human cells.  Each PP2A consists of a catalytic subunit (C), a scaffold subunit (A), and a regulatory subunit (B).  While the A and C subunits each exists only in two highly conserved isoforms, a large number of B subunits share no homology, which determines PP2A substrate specificity and cellular localization.  It is anticipated that different PP2A holoenzymes play distinct roles in cellular signaling networks, whereas PP2A has only generally been defined as a putative tumor suppressor, which is mostly based on the loss-of-function studies using pharmacological or biological inhibitors for the highly conserved A or C subunit of PP2A.  Recent studies of specific pathways indicate that some PP2A complexes also possess tumor-promoting functions.  We have previously reported an essential role of PR55α, a PP2A regulatory subunit, in the support of oncogenic phenotypes, including in vivo tumorigenicity/metastasis of pancreatic cancer cells.  In this report, we have elucidated a novel role of PR55α-regulated PP2A in the activation of YAP oncoprotein, whose function is required for anchorage-independent growth during oncogenesis of solid tumors.  Our data show two lines of YAP regulation by PR55α: (1) PR55α inhibits the MOB1-triggered autoactivation of LATS1/2 kinases, the core member of the Hippo pathway that inhibits YAP by inducing its proteasomal degradation and cytoplasmic retention and (2) PR55α directly interacts with and regulates YAP itself.  Accordingly, PR55α is essential for YAP-promoted gene transcriptions, as well as for anchorage-independent growth, in which YAP plays a key role.  In summary, current findings demonstrate a novel YAP activation mechanism based on the PR55α-regulated PP2A phosphatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR2TUtaXPf8uKNc3HjJRoFAfW6udTcc2ebEOyG5NQwunrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjisVWjtg%253D%253D&md5=e387c69ef4990ee2a6ef1b1fc13b0b50</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fs41389-019-0172-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41389-019-0172-9%26sid%3Dliteratum%253Aachs%26aulast%3DHein%26aufirst%3DA.%2BL.%26aulast%3DBrandquist%26aufirst%3DN.%2BD.%26aulast%3DOuellette%26aufirst%3DC.%2BY.%26aulast%3DSeshacharyulu%26aufirst%3DP.%26aulast%3DEnke%26aufirst%3DC.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BM.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26aulast%3DYan%26aufirst%3DY.%26atitle%3DPr55%25CE%25B1%2520Regulatory%2520Subunit%2520of%2520Pp2a%2520Inhibits%2520the%2520Mob1%252FLats%2520Cascade%2520and%2520Activates%2520Yap%2520in%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DOncogenesis%26date%3D2019%26volume%3D8%26spage%3D63%26doi%3D10.1038%2Fs41389-019-0172-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hein, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshacharyulu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachagani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheinin, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnusamy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumby, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span> <span> </span><span class="NLM_article-title">Pr55α Subunit of Protein Phosphatase 2a Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">2243</span>– <span class="NLM_lpage">2253</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-2119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F0008-5472.CAN-15-2119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26893480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVagsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=2243-2253&author=A.+L.+Heinauthor=P.+Seshacharyuluauthor=S.+Rachaganiauthor=Y.+M.+Sheininauthor=M.+M.+Ouelletteauthor=M.+P.+Ponnusamyauthor=M.+C.+Mumbyauthor=S.+K.+Batraauthor=Y.+Yan&title=Pr55%CE%B1+Subunit+of+Protein+Phosphatase+2a+Supports+the+Tumorigenic+and+Metastatic+Potential+of+Pancreatic+Cancer+Cells+by+Sustaining+Hyperactive+Oncogenic+Signaling&doi=10.1158%2F0008-5472.CAN-15-2119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling</span></div><div class="casAuthors">Hein, Ashley L.; Seshacharyulu, Parthasarathy; Rachagani, Satyanarayana; Sheinin, Yuri M.; Ouellette, Michel M.; Ponnusamy, Moorthy P.; Mumby, Marc C.; Batra, Surinder K.; Yan, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2243-2253</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The protein phosphatase 2 (PP2A) holoenzyme consists of a catalytic subunit, a scaffold subunit, and a regulatory subunit.  Based on loss-of-function anal. using PP2A catalytic inhibitors or inhibition via tumor viral antigens, limited studies suggest that PP2A is a putative tumor suppressor.  However, PP2A has also been shown to facilitate the activation of oncogenic signaling pathways when assocd. with specific regulatory subunits.  In this study, we investigated the possible oncogenic role of PP2A in pancreatic cancer.  We found a striking increase in the expression of PR55α (PPP2R2A), a PP2A regulatory subunit, in pancreatic cancer cells compared with normal pancreatic epithelial cells.  Consistently, PR55α expression was markedly elevated in pancreatic ductal adenocarcinoma tissues compared with adjacent normal pancreatic tissues (P < 0.0001) and correlated with poor survival of pancreatic cancer patients (P < 0.0003).  RNAi-mediated depletion of PR55α in pancreatic cancer cell lines resulted in diminished phosphorylation of both AKT and ERK1/2 (MAPK3/1) and decreased protein levels of β-catenin (CTNNB1).  Accordingly, pancreatic cancer cells with reduced PR55α expression exhibited significantly impaired properties of transformation, including attenuated cell growth, clonogenicity, mobility, and anchorage-independent growth.  Moreover, orthotopic implantation of PR55α-depleted pancreatic cancer cells into nude mice resulted in markedly reduced tumorigenicity (P < 0.001) and distant metastases.  Together, these results suggest that PR55α promotes pancreatic cancer development by sustaining hyperactivity of multiple oncogenic signaling pathways, including AKT, ERK, and Wnt.  These studies also provide a basis for exploring PR55α as a diagnostic or therapeutic target in pancreatic cancer.  Cancer Res; 76(8); 2243-53. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpctfLsB_OWHbVg90H21EOLACvtfcHk0lh6JS76YTzG_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVagsr4%253D&md5=0c6e0ef27c8db5734572cdd14d4d98ba</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-2119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-2119%26sid%3Dliteratum%253Aachs%26aulast%3DHein%26aufirst%3DA.%2BL.%26aulast%3DSeshacharyulu%26aufirst%3DP.%26aulast%3DRachagani%26aufirst%3DS.%26aulast%3DSheinin%26aufirst%3DY.%2BM.%26aulast%3DOuellette%26aufirst%3DM.%2BM.%26aulast%3DPonnusamy%26aufirst%3DM.%2BP.%26aulast%3DMumby%26aufirst%3DM.%2BC.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26aulast%3DYan%26aufirst%3DY.%26atitle%3DPr55%25CE%25B1%2520Subunit%2520of%2520Protein%2520Phosphatase%25202a%2520Supports%2520the%2520Tumorigenic%2520and%2520Metastatic%2520Potential%2520of%2520Pancreatic%2520Cancer%2520Cells%2520by%2520Sustaining%2520Hyperactive%2520Oncogenic%2520Signaling%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D2243%26epage%3D2253%26doi%3D10.1158%2F0008-5472.CAN-15-2119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dohoney, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillerm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteford, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hager, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, J. N.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of P53 at Serine 37 Is Important for Transcriptional Activity and Regulation in Response to DNA Damage</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1207005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsj.onc.1207005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=14712210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=49-57&author=K.+M.+Dohoneyauthor=C.+Guillermauthor=C.+Whitefordauthor=C.+Elbiauthor=P.+F.+Lambertauthor=G.+L.+Hagerauthor=J.+N.+Brady&title=Phosphorylation+of+P53+at+Serine+37+Is+Important+for+Transcriptional+Activity+and+Regulation+in+Response+to+DNA+Damage&doi=10.1038%2Fsj.onc.1207005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage</span></div><div class="casAuthors">Dohoney, Kathleen M.; Guillerm, Claire; Whiteford, Craig; Elbi, Cem; Lambert, Paul F.; Hager, Gordon L.; Brady, John N.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-57</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The p53 tumor suppressor protein plays a crit. role in mediating cellular response to stress.  Upon DNA damage, post-translational modifications stabilize and activate this nuclear phosphoprotein.  To det. the effect of phosphorylation site mutants in the context of the whole p53 protein, we performed reporter assays in p53 and MDM2 knockout mouse embryonic fibroblasts transfected with full-length p53 constructs.  We show that mutation of S37 causes a decrease in p53 transcriptional activity compared to wild-type p53.  Our data further suggest that the dephosphorylation of p53 at S37 is a regulated event involving protein phosphatase 2A (PP2A).  Coimmunopptn. and immunofluorescence microscopy studies demonstrate that PP2A and p53 assoc. with one another in vivo following γ-irradn.  Consistent with these observations, phosphorylated S37 accumulates in cell exts. prepd. from γ-irradiated Molt-4 cells in the presence of okadaic acid.  Furthermore, in vitro phosphatase assays show that PP2A dephosphorylates p53 at S37.  These results suggest that dephosphorylation of p53 at S37 plays a role in the transcriptional regulation of the p53 protein in response to DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-PeB-y_VrLVg90H21EOLACvtfcHk0lh6JS76YTzG_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKgsg%253D%253D&md5=e191cae86f3cf566409740c505d3b830</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207005%26sid%3Dliteratum%253Aachs%26aulast%3DDohoney%26aufirst%3DK.%2BM.%26aulast%3DGuillerm%26aufirst%3DC.%26aulast%3DWhiteford%26aufirst%3DC.%26aulast%3DElbi%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DP.%2BF.%26aulast%3DHager%26aufirst%3DG.%2BL.%26aulast%3DBrady%26aufirst%3DJ.%2BN.%26atitle%3DPhosphorylation%2520of%2520P53%2520at%2520Serine%252037%2520Is%2520Important%2520for%2520Transcriptional%2520Activity%2520and%2520Regulation%2520in%2520Response%2520to%2520DNA%2520Damage%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D49%26epage%3D57%26doi%3D10.1038%2Fsj.onc.1207005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shouse, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piluso, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">A Specific Pp2a Regulatory Subunit, B56gamma, Mediates DNA Damage-Induced Dephosphorylation of P53 at Thr55</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsj.emboj.7601519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17245430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFKnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=402-411&author=H.+H.+Liauthor=X.+Caiauthor=G.+P.+Shouseauthor=L.+G.+Pilusoauthor=X.+Liu&title=A+Specific+Pp2a+Regulatory+Subunit%2C+B56gamma%2C+Mediates+DNA+Damage-Induced+Dephosphorylation+of+P53+at+Thr55&doi=10.1038%2Fsj.emboj.7601519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">A specific PP2A regulatory subunit, B56γ, mediates DNA damage-induced dephosphorylation of p53 at Thr55</span></div><div class="casAuthors">Li, Heng-Hong; Cai, Xin; Shouse, Geoffrey P.; Piluso, Landon G.; Liu, Xuan</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">402-411</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein phosphatase 2A (PP2A) has been implicated to exert its tumor suppressive function via a small subset of regulatory subunits.  In this study, we reported that the specific B regulatory subunits of PP2A B56γ1 and B56γ3 mediate dephosphorylation of p53 at Thr55.  Ablation of the B56γ protein by RNAi, which abolishes the Thr55 dephosphorylation in response to DNA damage, reduces p53 stabilization, Bax expression and cell apoptosis.  To investigate the mol. mechanisms, we have shown that the endogenous B56γ protein level and assocn. with p53 increase after DNA damage.  Finally, we demonstrate that Thr55 dephosphorylation is required for B56γ3-mediated inhibition of cell proliferation and cell transformation.  These results suggest a mol. mechanism for B56γ-mediated tumor suppression and provide a potential route for regulation of B56γ-specific PP2A complex function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogpCl1lcVVR7Vg90H21EOLACvtfcHk0lh6JS76YTzG_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFKnug%253D%253D&md5=cd8d5524ac3afc35f6aa9eed449c299f</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601519%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%2BH.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DShouse%26aufirst%3DG.%2BP.%26aulast%3DPiluso%26aufirst%3DL.%2BG.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DA%2520Specific%2520Pp2a%2520Regulatory%2520Subunit%252C%2520B56gamma%252C%2520Mediates%2520DNA%2520Damage-Induced%2520Dephosphorylation%2520of%2520P53%2520at%2520Thr55%26jtitle%3DEMBO%2520J.%26date%3D2007%26volume%3D26%26spage%3D402%26epage%3D411%26doi%3D10.1038%2Fsj.emboj.7601519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span> <span> </span><span class="NLM_article-title">Knockdown of Protein Phosphatase 4 Regulatory Subunit 1 Inhibits Growth of Lung Cancer Cells in Vitro</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">10513</span>– <span class="NLM_lpage">10520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXms1WqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=10513-10520&author=Y.+Zhuauthor=Y.+Wuauthor=J.+Wangauthor=F.+Lvauthor=X.+Shen&title=Knockdown+of+Protein+Phosphatase+4+Regulatory+Subunit+1+Inhibits+Growth+of+Lung+Cancer+Cells+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Knockdown of protein phosphatase 4 regulatory subunit 1 inhibits growth of lung cancer cells in vitro</span></div><div class="casAuthors">Zhu, Yanping; Wu, Yun; Wang, Jialei; Lv, Fanzhen; Shen, Xiaoyong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">10513-10520</span>CODEN:
                <span class="NLM_cas:coden">IJCEFA</span>;
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Lung cancer is the leading cause of death from cancer around the world.  Cancer patients undertaking chemotherapy or radiotherapy would experience a wide range of distressing side effects.  Hence, exploring a promising new and safe therapeutic strategy to fight against cancer was urgent.  Protein phosphatase 4 catalytic subunit (PP4c) is a member of the Protein phosphatase 2 (PP2A) family and play an essential role in biol. processes of microtubule (MT) growth/organization, apoptosis, and tumor necrosis factor signaling.  Protein phosphatase 4 regulatory subunit 1 (PPP4R1), a protein that co-purifying with PP4c from bovine testis exts., has been reported to be involved in tumor progression.  However, its functional role in lung cancer remains unclear.  In this study, we firstly evaluated the expression levels of PPP4R1 in three lung cancer cell lines by quant. real-time PCR (qRT-PCR) anal. and found that PPP4R1 was expressed highest in 95D cells.  Then PPP4R1 was knocked down by lentivirus-based system in 95D cells.  Proliferation and colony nos. were evaluated in lung cancer 95D cells by tetrazolium (MTT) and colony formation assay, resp.  As a result, stable knockdown of PPP4R1 led to suppression of proliferation and colony-forming ability in 95D cells.  Subsequently, the cell cycle anal. showed knockdown of PPP4R1 arrested cell cycle at G0/G1 phase in 95D cells.  Further investigation indicated that knockdown of PPP4R1 down-regulated cell-cycle activators, including CDK2, CDK4 and CDK6, as detd. by western blot.  Our results suggest that PPP4R1 knockdown inhibited lung cancer cell proliferation via down regulating cell-cycle activators.  The identification of PPP4R1 may provide a potential therapeutic strategy for lung cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyc-f7XRj_grVg90H21EOLACvtfcHk0lgH9WjqgfHXug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXms1WqurY%253D&md5=0c3e12202dbbe3a2976c2f61b7ea6aa2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLv%26aufirst%3DF.%26aulast%3DShen%26aufirst%3DX.%26atitle%3DKnockdown%2520of%2520Protein%2520Phosphatase%25204%2520Regulatory%2520Subunit%25201%2520Inhibits%2520Growth%2520of%2520Lung%2520Cancer%2520Cells%2520in%2520Vitro%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2016%26volume%3D9%26spage%3D10513%26epage%3D10520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Pp4r1 Accelerates Cell Growth and Proliferation in Hepg2 Hepatocellular Carcinoma</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2067</span>– <span class="NLM_lpage">2074</span>, <span class="refDoi"> DOI: 10.2147/OTT.S77709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2147%2FOTT.S77709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26300649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFegtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=2067-2074&author=G.+Wuauthor=Z.+Maauthor=J.+Qianauthor=B.+Liu&title=Pp4r1+Accelerates+Cell+Growth+and+Proliferation+in+Hepg2+Hepatocellular+Carcinoma&doi=10.2147%2FOTT.S77709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">PP4R1 accelerates cell growth and proliferation in HepG2 hepatocellular carcinoma</span></div><div class="casAuthors">Wu, Gang; Ma, Zhenyu; Qian, Jianmin; Liu, Bin</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2067-2074</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC), as the fifth most common cancer worldwide, has become the third leading cause of cancer-related deaths.  It is reported that protein phosphatase 4 (PP4) is an essential protein for nucleation, growth, and stabilization of microtubules in centrosomes/spindle bodies during cell division.  Besides, previous studies have identified protein phosphatase 4 regulatory subunit 1 (PP4R1) as a constitutive interaction partner of PP4 catalytic subunit PP4C.  The PP4C-PP4R1 PP4 complex plays a role in dephosphorylation, regulation of histone acetylation, and NF-κB activation.  However, little is known about the pathol. functions of PP4R1 in human cancers.  Thus, in order to investigate how PP4R1 functions in human HCC, two common hepatocarcinogenesis HCC cell lines HepG2 and SMMC-7721 were employed, transduced with recombinant lentivirus expressing PP4R1 short hairpin RNA.  Compared with the controls, the cells treated with Lv-shPP4R1 showed a significant decrease in cell proliferation and colony formation.  The results of flow cytometry showed that the knockdown of PP4R1 caused HepG2 cells arrest at G2/M phase in the cell cycle.  Furthermore, the transduction of Lv-shPP4R1 into HepG2 cells led to the inactivation of two major mitogen-activated protein kinase signaling cascades: p38 and c-Jun N-terminal kinase (JNK), indicating that PP4R1 could promote cell proliferation, which might be regulated by p38 and c-Jun N-terminal kinase pathways.  In a word, this study highlights the crucial role of PP4R1 in promoting HCC cell growth, which might elucidate the pathol. mechanism of HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW3WgqxNrntrVg90H21EOLACvtfcHk0lgH9WjqgfHXug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFegtLg%253D&md5=9b200f429892e43711a554fd7da65e63</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2147%2FOTT.S77709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S77709%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DPp4r1%2520Accelerates%2520Cell%2520Growth%2520and%2520Proliferation%2520in%2520Hepg2%2520Hepatocellular%2520Carcinoma%26jtitle%3DOncoTargets%2520Ther.%26date%3D2015%26volume%3D8%26spage%3D2067%26epage%3D2074%26doi%3D10.2147%2FOTT.S77709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisters, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbruzzese, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage Ii Pancreatic Ductal Adenocarcinoma</span>. <i>Cancer Epidemiol., Biomarkers Prev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1336</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1158/1055-9965.EPI-12-0223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1055-9965.EPI-12-0223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22665577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOhs73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=1336-1343&author=S.+Wengauthor=H.+Wangauthor=W.+Chenauthor=M.+H.+Katzauthor=D.+Chatterjeeauthor=J.+E.+Leeauthor=P.+W.+Pistersauthor=H.+F.+Gomezauthor=J.+L.+Abbruzzeseauthor=J.+B.+Flemingauthor=H.+Wang&title=Overexpression+of+Protein+Phosphatase+4+Correlates+with+Poor+Prognosis+in+Patients+with+Stage+Ii+Pancreatic+Ductal+Adenocarcinoma&doi=10.1158%2F1055-9965.EPI-12-0223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Weng, Shaofan; Wang, Hua; Chen, Weihong; Katz, Matthew H.; Chatterjee, Deyali; Lee, Jeffrey E.; Pisters, Peter W.; Gomez, Henry F.; Abbruzzese, James L.; Fleming, Jason B.; Wang, Huamin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Epidemiology, Biomarkers & Prevention</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1336-1343</span>CODEN:
                <span class="NLM_cas:coden">CEBPE4</span>;
        ISSN:<span class="NLM_cas:issn">1055-9965</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Protein phosphatase 4 (PP4) has been reported to be overexpressed in breast and lung cancers.  PP4 plays an important role in the regulation of centrosome maturation, DNA repair, NF-κB, and c-jun-NH2-kinase (JNK) signaling pathways.  However, the expression and functions of PP4 in pancreatic cancer have not been studied.  Exptl. Design: We examd. the expression of PP4 catalytic subunit (PP4C) protein in 133 patients with stage II pancreatic ductal adenocarcinoma (PDAC) and their paired benign pancreatic samples (N = 113) by immunohistochem.  To confirm the immunohistochem. results, we measured PP4C protein and mRNA levels by Western blotting and real-time reverse transcriptase PCR.  Using univariate and multivariate anal., we correlated PP4C expression with survival and other clinicopathol. features.  Results: PP4C was overexpressed in 75 of 133 (56.4%) stage II PDAC samples, which was significantly higher than the paired benign pancreatic tissue (15%, 17 of 113).  PP4C mRNA expression levels were also higher in PDAC samples than the paired benign pancreatic tissue.  Overexpression of PP4C in PDAC samples was assocd. with higher frequencies of distant metastasis (P = 0.02) and poor disease-free and overall survivals in patients with stage II PDAC (P = 0.006 and 0.02) independent of tumor size, margin status, and lymph node status (stage).  Conclusions: Our study showed that PP4C is overexpressed in PDAC.  Overexpression of PP4C in PDAC samples is assocd. with poor prognosis in patients with stage II PDAC.  Therefore, targeting PP4 signaling pathway may represent a new approach for the treatment of PDAC.  Impact: Our study showed that PP4C is an independent prognostic factor in patients with stage II PDAC.  Cancer Epidemiol Biomarkers Prev; 21(8); 1336-43. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUDVHHguAIMLVg90H21EOLACvtfcHk0lgH9WjqgfHXug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOhs73J&md5=63a2d4d4ce6c702c9febe3b6e12cf607</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1158%2F1055-9965.EPI-12-0223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1055-9965.EPI-12-0223%26sid%3Dliteratum%253Aachs%26aulast%3DWeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DKatz%26aufirst%3DM.%2BH.%26aulast%3DChatterjee%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DPisters%26aufirst%3DP.%2BW.%26aulast%3DGomez%26aufirst%3DH.%2BF.%26aulast%3DAbbruzzese%26aufirst%3DJ.%2BL.%26aulast%3DFleming%26aufirst%3DJ.%2BB.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DOverexpression%2520of%2520Protein%2520Phosphatase%25204%2520Correlates%2520with%2520Poor%2520Prognosis%2520in%2520Patients%2520with%2520Stage%2520Ii%2520Pancreatic%2520Ductal%2520Adenocarcinoma%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2012%26volume%3D21%26spage%3D1336%26epage%3D1343%26doi%3D10.1158%2F1055-9965.EPI-12-0223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herzig, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullinger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasdogan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teleanu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rücker, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paschka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchenbauer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidel, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buske, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döhner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döhner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidzik, V. I.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 4 Regulatory Subunit 2 (Ppp4r2) Is Recurrently Deleted in Acute Myeloid Leukemia and Required for Efficient DNA Double Strand Break Repair</span>. <i>Onco Targets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">95038</span>– <span class="NLM_lpage">95053</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.21119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.18632%2Foncotarget.21119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=95038-95053&author=J.+K.+Herzigauthor=L.+Bullingerauthor=A.+Tasdoganauthor=P.+Zimmermannauthor=M.+Schlegelauthor=V.+Teleanuauthor=D.+Weberauthor=F.+G.+R%C3%BCckerauthor=P.+Paschkaauthor=A.+Dolnikauthor=E.+Schneiderauthor=F.+Kuchenbauerauthor=F.+H.+Heidelauthor=C.+Buskeauthor=H.+D%C3%B6hnerauthor=K.+D%C3%B6hnerauthor=V.+I.+Gaidzik&title=Protein+Phosphatase+4+Regulatory+Subunit+2+%28Ppp4r2%29+Is+Recurrently+Deleted+in+Acute+Myeloid+Leukemia+and+Required+for+Efficient+DNA+Double+Strand+Break+Repair&doi=10.18632%2Foncotarget.21119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.21119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.21119%26sid%3Dliteratum%253Aachs%26aulast%3DHerzig%26aufirst%3DJ.%2BK.%26aulast%3DBullinger%26aufirst%3DL.%26aulast%3DTasdogan%26aufirst%3DA.%26aulast%3DZimmermann%26aufirst%3DP.%26aulast%3DSchlegel%26aufirst%3DM.%26aulast%3DTeleanu%26aufirst%3DV.%26aulast%3DWeber%26aufirst%3DD.%26aulast%3DR%25C3%25BCcker%26aufirst%3DF.%2BG.%26aulast%3DPaschka%26aufirst%3DP.%26aulast%3DDolnik%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DKuchenbauer%26aufirst%3DF.%26aulast%3DHeidel%26aufirst%3DF.%2BH.%26aulast%3DBuske%26aufirst%3DC.%26aulast%3DD%25C3%25B6hner%26aufirst%3DH.%26aulast%3DD%25C3%25B6hner%26aufirst%3DK.%26aulast%3DGaidzik%26aufirst%3DV.%2BI.%26atitle%3DProtein%2520Phosphatase%25204%2520Regulatory%2520Subunit%25202%2520%2528Ppp4r2%2529%2520Is%2520Recurrently%2520Deleted%2520in%2520Acute%2520Myeloid%2520Leukemia%2520and%2520Required%2520for%2520Efficient%2520DNA%2520Double%2520Strand%2520Break%2520Repair%26jtitle%3DOnco%2520Targets%2520Ther.%26date%3D2017%26volume%3D8%26spage%3D95038%26epage%3D95053%26doi%3D10.18632%2Foncotarget.21119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mirna, M. M.</span>; <span class="NLM_string-name">Robert, H.</span>; <span class="NLM_string-name">Cyntura, S.</span>; <span class="NLM_string-name">Alicja, L.</span></span> <span> </span><span class="NLM_article-title">Role of Protein Phosphatase 4 Regulatory Subunits in Myeloid Leukaemia</span>. In  <i>NCRI Cancer Conference</i>, November 6–9, 2016, Liverpool, UK; <span class="NLM_publisher-name">NCRI</span>: <span class="NLM_publisher-loc">London</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+M.+Mirna&author=H.+Robert&author=S.+Cyntura&author=L.+Alicja&title=Role+of+Protein+Phosphatase+4+Regulatory+Subunits+in+Myeloid+Leukaemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMirna%26aufirst%3DM.%2BM.%26atitle%3DRole%2520of%2520Protein%2520Phosphatase%25204%2520Regulatory%2520Subunits%2520in%2520Myeloid%2520Leukaemia%26jtitle%3DNCRI%2520Cancer%2520Conference%26pub%3DNCRI%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span> <span> </span><span class="NLM_article-title">Lentivirus-Mediated Short-Hairpin Rna Targeting Protein Phosphatase 4 Regulatory Subunit 1 Inhibits Growth in Breast Cancer</span>. <i>Journal of breast cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.4048/jbc.2015.18.3.218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.4048%2Fjbc.2015.18.3.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26472971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC28zisF2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=218-224&author=Y.+Qiauthor=T.+Huauthor=K.+Liauthor=R.+Yeauthor=Z.+Ye&title=Lentivirus-Mediated+Short-Hairpin+Rna+Targeting+Protein+Phosphatase+4+Regulatory+Subunit+1+Inhibits+Growth+in+Breast+Cancer&doi=10.4048%2Fjbc.2015.18.3.218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Lentivirus-Mediated Short-Hairpin RNA Targeting Protein Phosphatase 4 Regulatory Subunit 1 Inhibits Growth in Breast Cancer</span></div><div class="casAuthors">Qi Yuying; Ye Renqing; Ye Zuodong; Hu Tinghui; Li Kai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of breast cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">218-24</span>
        ISSN:<span class="NLM_cas:issn">1738-6756</span>.
    </div><div class="casAbstract">PURPOSE:  Protein phosphatase 4 regulatory subunit 1 (PP4R1), as an interaction partner of the catalytic serine/threonine-protein phosphatase 4 catalytic subunit has been shown to involve in cellular processes and nuclear factor κB signaling.  However, the functions of PP4R1 in human breast cancers remain unclear.  This study is designed to explore the effect of PP4R1 knockdown on the biological characteristics of breast cancer cells.  METHODS:  A lentivirus-mediated short hairpin RNA (shRNA) was designed to knockdown the expression of PP4R1 in ZR-75-30 breast cancer cells.  The efficiency of lentivirus-mediated shRNA infection was determined using fluorescence microscopy to observe lentivirus-mediated green fluorescent protein expression and confirmed to be over 80%.  PP4R1 expression in infected ZR-75-30 cells was detected by quantitative real-time polymerase chain reaction and western blot analysis.  Cell proliferation and colony formation ability were measured by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay and colony formation assay, respectively.  Flow cytometry was used to measure cell cycle progression and cell apoptosis.  In addition, apoptosis makers, including poly-ADP-ribose polymerase (PARP) and caspase-3, were investigated in PP4R1-silenced ZR-75-30 cells by western blot assay.  RESULTS:  We successfully constructed lentivirus-mediated shRNA to target PP4R1 in ZR-75-30 cells.  MTT assay and colony formation assay showed the loss of PP4R1 suppressed the proliferation of ZR-75-30 cells.  Flow cytometry analysis indicated cell cycle arrest and increased cell apoptosis in PP4R1 knockdown cells.  Further, the apoptosis response in cells depleted of PP4R1 was illustrated by downregulation of PARP and upregulation of caspase-3.  CONCLUSION:  Our results suggest that PP4R1 could promote breast cancer cell proliferation and might play a vital role in breast cancer occurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTg6XDPcrotG7jnyZkbE8yXfW6udTcc2eaGBBNx7jf5f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zisF2jsA%253D%253D&md5=cc7a755d5808686c5e092c34b934b7d8</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.4048%2Fjbc.2015.18.3.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4048%252Fjbc.2015.18.3.218%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DR.%26aulast%3DYe%26aufirst%3DZ.%26atitle%3DLentivirus-Mediated%2520Short-Hairpin%2520Rna%2520Targeting%2520Protein%2520Phosphatase%25204%2520Regulatory%2520Subunit%25201%2520Inhibits%2520Growth%2520in%2520Breast%2520Cancer%26jtitle%3DJournal%2520of%2520breast%2520cancer%26date%3D2015%26volume%3D18%26spage%3D218%26epage%3D224%26doi%3D10.4048%2Fjbc.2015.18.3.218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span> <span> </span><span class="NLM_article-title">Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1166</span>– <span class="NLM_lpage">1176</span>, <span class="refDoi"> DOI: 10.2174/1389557511313080005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F1389557511313080005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23373656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslyrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1166-1176&author=L.+P.+Dengauthor=J.+Dongauthor=W.+Wang&title=Exploiting+Protein+Phosphatase+Inhibitors+Based+on+Cantharidin+Analogues+for+Cancer+Drug+Discovery&doi=10.2174%2F1389557511313080005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting protein phosphatase inhibitors based on cantharidin analogues for cancer drug discovery</span></div><div class="casAuthors">Deng, Liping; Dong, Jian; Wang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1166-1176</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cantharidin (CTD), a natural toxin, can inhibit a variety of tumor cell lines, esp. hepatocellular carcinoma cells.  It is a strong inhibitor of protein phosphatase type 1 (PP1) and type 2A (PP2A).  Because of the cytotoxicity, the clin. application of CDT is limited.  Here, we review the structure-activity relationships of CDT analogs, including norcantharidin (NCTD), cantharimides and related derivs. of CTDs, which have more powerful antitumor activity but less cytotoxicity than CDT itself.  Important advances in the design of the CTD-based inhibitors achieved recently are outlined here in order to establish principles for synthesis, screening, and the applications of promising anti-cancer drug candidates.  In addn., efforts to ameliorate the intrinsic cytotoxicity through the use of drug carriers are also discussed.  It is conceivable that rational design of the protein phosphatase inhibitors based on cantharidin analogs can be facilitated by studies of mechanism of the protein-inhibitor interactions and the related structural biol. in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSSUpGh8KMe7Vg90H21EOLACvtfcHk0lj6dTwOdiz-tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslyrtLY%253D&md5=1294bf70bdddc356ee08f6d061720d03</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.2174%2F1389557511313080005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557511313080005%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%2BP.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DExploiting%2520Protein%2520Phosphatase%2520Inhibitors%2520Based%2520on%2520Cantharidin%2520Analogues%2520for%2520Cancer%2520Drug%2520Discovery%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1166%26epage%3D1176%26doi%3D10.2174%2F1389557511313080005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Cantharidin, Another Natural Toxin That Inhibits the Activity of Serine/Threonine Protein Phosphatases Types 1 and 2a</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(93)80889-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0014-5793%2893%2980889-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8397101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3sXmtF2gtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=1993&pages=283-286&author=R.+E.+Honkanen&title=Cantharidin%2C+Another+Natural+Toxin+That+Inhibits+the+Activity+of+Serine%2FThreonine+Protein+Phosphatases+Types+1+and+2a&doi=10.1016%2F0014-5793%2893%2980889-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A</span></div><div class="casAuthors">Honkanen, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-6</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">Cantharidin, a natural toxicant of blister beetles, is a strong inhibitor of protein phosphatases types 1(PP1) and 2A (PP2A).  Like okadaic acid, cantharidin inhibits the activity of the purified catalytic subunit of PP2A (IC50 = 0.16 μM) at a lower concn. than that of PP1 (IC50 = 1.7 μM) and only inhibits the activity of protein phosphatase type 2B (PP2B) at high concns.  Dose-inhibition studies conducted with whole cell homogenates indicate that cantharidin also inhibits the native forms of these enzymes.  Thus, cantharidin, which is economical and readily available, may be useful as an addnl. probe for studying the functions of serine/threonine protein phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCTexjtZgU8LVg90H21EOLACvtfcHk0lj6dTwOdiz-tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmtF2gtrk%253D&md5=fe0aed4fcaa215b56456a530316695de</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2893%2980889-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252893%252980889-3%26sid%3Dliteratum%253Aachs%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DCantharidin%252C%2520Another%2520Natural%2520Toxin%2520That%2520Inhibits%2520the%2520Activity%2520of%2520Serine%252FThreonine%2520Protein%2520Phosphatases%2520Types%25201%2520and%25202a%26jtitle%3DFEBS%2520Lett.%26date%3D1993%26volume%3D330%26spage%3D283%26epage%3D286%26doi%3D10.1016%2F0014-5793%2893%2980889-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kok, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, M. Y. P.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin-Induced Apoptosis in Oral Cancer Cells Is Associated with an Increase of Proapoptotic to Antiapoptotic Protein Ratio</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2004.07.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.canlet.2004.07.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15596295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKksbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2005&pages=43-52&author=S.+H.+Kokauthor=S.+J.+Chengauthor=C.+Y.+Hongauthor=J.+J.+Leeauthor=S.+K.+Linauthor=Y.+S.+Kuoauthor=C.+P.+Chiangauthor=M.+Y.+P.+Kuo&title=Norcantharidin-Induced+Apoptosis+in+Oral+Cancer+Cells+Is+Associated+with+an+Increase+of+Proapoptotic+to+Antiapoptotic+Protein+Ratio&doi=10.1016%2Fj.canlet.2004.07.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio</span></div><div class="casAuthors">Kok, Sang-Heng; Cheng, Shih-Jung; Hong, Chi-Yuan; Lee, Jang-Jaer; Lin, Sze-Kwan; Kuo, Ying-Shiung; Chiang, Chun-Pin; Kuo, Mark Yen-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-52</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Norcantharidin (NCTD), the demethylated analog of cantharidin, was used to treat human cancers in China since 1984.  It was recently found to be capable of inducing apoptosis in human colon carcinoma, hepatoma and glioblastoma cells by way of an elusive mechanism.  In this study, the authors demonstrated that NCTD also induces apoptosis in human oral cancer cell lines SAS (p53 wild-type phenotype) and Ca9-22 (p53 mutant) as evidenced by nuclear condensation, TUNEL labeling, DNA fragmentation and cleavage of PARP.  Apoptosis induced by NCTD was both dose- and time-dependent.  The authors found NCTD did not induce Fas and FasL, implying that it activated other apoptosis pathways.  The authors' data showed that NCTD caused accumulation of cytosolic cytochrome c and activation of caspase-9, suggesting that apoptosis occurred via the mitochondria mediated pathway.  NCTD enhanced the expression of Bax in SAS cells consistent with their p53 status.  Moreover, the authors showed that NCTD downregulated the expression of Bcl-2 in Ca9-22 and Bcl-XL in SAS.  The authors' results suggest that NCTD-induced apoptosis in oral cancer cells may be mediated by an increase in the ratios of proapoptotic to antiapoptotic proteins.  Since oral cancer cells with mutant p53 or elevated Bcl-XL levels showed resistance to multiple chemotherapeutic agents, NCTD may overcome the chemoresistance of these cells and provide potential new avenues for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0t5WMeg_eLVg90H21EOLACvtfcHk0litkJWkwiJl3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKksbfJ&md5=505b03d726bd7a687c2daacc4a0d8dd2</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.07.045%26sid%3Dliteratum%253Aachs%26aulast%3DKok%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DS.%2BJ.%26aulast%3DHong%26aufirst%3DC.%2BY.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DLin%26aufirst%3DS.%2BK.%26aulast%3DKuo%26aufirst%3DY.%2BS.%26aulast%3DChiang%26aufirst%3DC.%2BP.%26aulast%3DKuo%26aufirst%3DM.%2BY.%2BP.%26atitle%3DNorcantharidin-Induced%2520Apoptosis%2520in%2520Oral%2520Cancer%2520Cells%2520Is%2520Associated%2520with%2520an%2520Increase%2520of%2520Proapoptotic%2520to%2520Antiapoptotic%2520Protein%2520Ratio%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D217%26spage%3D43%26epage%3D52%26doi%3D10.1016%2Fj.canlet.2004.07.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin: Research Advances in Pharmaceutical Activities and Derivatives in Recent Years</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">110755</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2020.110755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.biopha.2020.110755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=33152920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVClsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2020&pages=110755&author=J.+Zhouauthor=Y.+Renauthor=L.+Tanauthor=X.+Songauthor=M.+Wangauthor=Y.+Liauthor=Z.+Caoauthor=C.+Guo&title=Norcantharidin%3A+Research+Advances+in+Pharmaceutical+Activities+and+Derivatives+in+Recent+Years&doi=10.1016%2Fj.biopha.2020.110755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years</span></div><div class="casAuthors">Zhou, Jianbo; Ren, Yali; Tan, Lu; Song, Xiaominting; Wang, Miao; Li, Yuzhi; Cao, Zhixing; Guo, Chuanjie</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110755</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Cantharidin (CTD) is the main bioactive component of Cantharides, which is called Banmao in Traditional Chinese Medicine (TCM).  Norcantharidin (NCTD) is a structural modifier of CTD.  To compare with CTD, NCTD has lighter side effects and stronger bioactivity in anti-cancer through inhibiting cell proliferation, causing apoptosis and autophagy, overwhelming migration and metastasis, affecting immunity as well as lymphangiogenesis.  Examples of these effects include suppressing Protein Phosphatase 2A and modulating Wnt/beta catenin signal, with Caspase family proteins, AMPK pathway and c-Met/EGFR pathway involving resp.  Moreover, NCTD has the effects of immune enhancement, anti-platelet aggregation and inhibition of renal interstitial fibrosis with distinct signaling pathways.  The immunol. effects induced by NCTD are related to the regulation of macrophage polarization and LPS-mediated immune response.  The antiplatelet activity that NCTD induced is relevant to the inhibition of platelet signaling and the downregulation of α2 integrin.  Furthermore, some of novel derivs. designed and synthesized artificially show stronger biol. activities (e.g., anticancer effect, enzyme inhibition effect, antioxidant effect) and lower toxicity than NCTD itself.  Plenty of literatures have reported various pharmacol. effects of NCTD, particularly the anticancer effect, which has been widely concerned in clin. application and lab. research.  In this review, the pharmaceutical activities and derivs. of NCTD are discussed, which can be ref. for further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNm6z-HAVWs7Vg90H21EOLACvtfcHk0litkJWkwiJl3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVClsbvE&md5=ed227404d8b9d59674af74cf8632a735</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2020.110755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2020.110755%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DC.%26atitle%3DNorcantharidin%253A%2520Research%2520Advances%2520in%2520Pharmaceutical%2520Activities%2520and%2520Derivatives%2520in%2520Recent%2520Years%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2020%26volume%3D131%26spage%3D110755%26doi%3D10.1016%2Fj.biopha.2020.110755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackland, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakoff, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCluskey, A.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Substituted Cantharidin and Norcantharidin Analogues—Synthesis, Protein Phosphatase (1 and 2a) Inhibition, and Anti-Cancer Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3392</span>– <span class="NLM_lpage">3397</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bmcl.2007.03.093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17451951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVals7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3392-3397&author=T.+A.+Hillauthor=S.+G.+Stewartauthor=B.+Sauerauthor=J.+Gilbertauthor=S.+P.+Acklandauthor=J.+A.+Sakoffauthor=A.+McCluskey&title=Heterocyclic+Substituted+Cantharidin+and+Norcantharidin+Analogues%E2%80%94Synthesis%2C+Protein+Phosphatase+%281+and+2a%29+Inhibition%2C+and+Anti-Cancer+Activity&doi=10.1016%2Fj.bmcl.2007.03.093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic substituted cantharidin and norcantharidin analogues-synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity</span></div><div class="casAuthors">Hill, Timothy A.; Stewart, Scott G.; Sauer, Benjamin; Gilbert, Jayne; Ackland, Stephen P.; Sakoff, Jennette A.; McCluskey, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3392-3397</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Norcantharidin is a potent PP1 (IC50 = 9.0 ± 1.4 μM) and PP2A (IC50 = 3.0 ± 0.4 μM) inhibitor with 3-fold PP2A selectivity and induces growth inhibition (GI50 ∼45 μM) across a range of human cancer cell lines including those of colorectal (HT29, SW480), breast (MCF-7), ovarian (A2780), lung (H460), skin (A431), prostate (DU145), neuroblastoma (BE2-C), and glioblastoma (SJ-G2) origin.  Until now limited modifications to the parent compd. have been tolerated.  Surprisingly, simple heterocyclic half-acid norcantharidin analogs are more active than the original lead compd., with the morphilino-substituted I being a more potent (IC50 = 2.8 ± 0.10 μM) and selective (4.6-fold) PP2A inhibitor with greater in vitro cytotoxicity (GI50 ∼9.6 μM) relative to norcantharidin.  The analogous thiomorpholine-substituted II displays increased PP1 inhibition (IC50 = 3.2 ± 0 μM) and reduced PP2A inhibition (IC50 = 5.1 ± 0.41 μM), to norcantharidin.  Synthesis of the analogous cantharidin analog III with incorporation of the amine nitrogen into the heterocycle further increases PP1 (IC50 = 5.9 ± 2.2 μM) and PP2A (IC50 = 0.79 ± 0.1 μM) inhibition and cell cytotoxicity (GI50 ∼3.3 μM).  These analogs represent the most potent cantharidin analogs thus reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7h1jE0eU50rVg90H21EOLACvtfcHk0litkJWkwiJl3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVals7g%253D&md5=a97b9fa408a2486f1285084ed230eaff</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.093%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DT.%2BA.%26aulast%3DStewart%26aufirst%3DS.%2BG.%26aulast%3DSauer%26aufirst%3DB.%26aulast%3DGilbert%26aufirst%3DJ.%26aulast%3DAckland%26aufirst%3DS.%2BP.%26aulast%3DSakoff%26aufirst%3DJ.%2BA.%26aulast%3DMcCluskey%26aufirst%3DA.%26atitle%3DHeterocyclic%2520Substituted%2520Cantharidin%2520and%2520Norcantharidin%2520Analogues%25E2%2580%2594Synthesis%252C%2520Protein%2520Phosphatase%2520%25281%2520and%25202a%2529%2520Inhibition%252C%2520and%2520Anti-Cancer%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3392%26epage%3D3397%26doi%3D10.1016%2Fj.bmcl.2007.03.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarleton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakoff, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCluskey, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Anticancer Activity of a Series of Norcantharidin Analogues</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.ejmech.2012.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22796041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWntLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2012&pages=573-581&author=M.+Tarletonauthor=J.+Gilbertauthor=J.+A.+Sakoffauthor=A.+McCluskey&title=Synthesis+and+Anticancer+Activity+of+a+Series+of+Norcantharidin+Analogues&doi=10.1016%2Fj.ejmech.2012.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticancer activity of a series of norcantharidin analogues</span></div><div class="casAuthors">Tarleton, Mark; Gilbert, Jayne; Sakoff, Jennette A.; McCluskey, Adam</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">573-581</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Cantharidin (I) and norcantharidin (II) display high levels of anticancer activity against a broad range of tumor cell lines.  Synthetic manipulation of norcantharidin yields (3S,3aR,4S,7R,7aS)-3-hydroxyhexahydro-4,7-epoxyisobenzofuran-1(3H)-one III (R = H), which also displays a high level of anticancer activity against tumor cells but interestingly, shows selectivity towards HT29 (colon; GI50 = 14 μM) and SJ-G2 (glioblastoma; GI50 = 15 μM) cell lines.  Substitution at the hydroxyl group of the cyclic lactone within III (R = H) produces a diastereomeric pair of products that have no difference in cytotoxicity over the cell lines tested.  Incorporation of an iso-Pr tail at this position, giving III (R = OCHMe2), produced the most promising compd. of this series to date, with strong selectivity towards HT29 (colon; GI50 = 19 μM) and SJ-G2 (glioblastoma; GI50 = 21 μM) cell lines but completely void of any activity against the remaining tumor cell lines (GI50 > 100 μM), as per the parent mol.  We also discovered that the introduction of a terminal phosphate moiety, to give IV, at the same position produced a different trend in cytotoxicity with strong activity in BE2-C (neuroblastoma; GI50 = 9 μM) cells; suggestive of an alternate mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7fXI0hNBoy7Vg90H21EOLACvtfcHk0liGJw7NmMbD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWntLfE&md5=0d00855b5afc8b1e15f5e83968fc1b82</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DTarleton%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DJ.%26aulast%3DSakoff%26aufirst%3DJ.%2BA.%26aulast%3DMcCluskey%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Anticancer%2520Activity%2520of%2520a%2520Series%2520of%2520Norcantharidin%2520Analogues%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D54%26spage%3D573%26epage%3D581%26doi%3D10.1016%2Fj.ejmech.2012.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, B.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Inhibits Il-6-Induced Epithelial-Mesenchymal Transition Via the Jak2/Stat3/Twist Signaling Pathway in Hepatocellular Carcinoma Cells</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1224</span>– <span class="NLM_lpage">1232</span>, <span class="refDoi"> DOI: 10.3892/or.2017.5775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3892%2For.2017.5775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28677802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVSnu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=1224-1232&author=Y.+Gaoauthor=W.+Liauthor=R.+Liuauthor=Q.+Guoauthor=J.+Liauthor=Y.+Baoauthor=H.+Zhengauthor=S.+Jiangauthor=B.+Hua&title=Norcantharidin+Inhibits+Il-6-Induced+Epithelial-Mesenchymal+Transition+Via+the+Jak2%2FStat3%2FTwist+Signaling+Pathway+in+Hepatocellular+Carcinoma+Cells&doi=10.3892%2For.2017.5775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin inhibits IL-6-induced epithelial-mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells</span></div><div class="casAuthors">Gao, Yebo; Li, Weidong; Liu, Rui; Guo, Qiujun; Li, Jie; Bao, Yanju; Zheng, Honggang; Jiang, Shulong; Hua, Baojin</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1224-1232</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Epithelial-mesenchymal transition (EMT), plays a vital role in hepatocellular carcinoma (HCC) development and metastasis.  Norcantharidin (NCTD; 7-oxabicyclo (2.2.1) heptane-2,3-dicarboxylic anhydride) plays anticancer roles in the regulation of tumor cell proliferation, apoptosis and migra- tion.  However, the mol. mechanism of HCC EMT and the effects of NCTD in the HCC EMT process have been either poorly elucidated or not studied.  In this study, HCC EMT was induced by the treatment of IL-6 and various concns. of NCTD (0, 30, 60 and 120 μM) were treated with HCC cell lines, HCCLM3 and SMMC-7721.  We investigated the effect of NCTD on the invasion of HCC cells by using Transwell assay.  Immunofluorescence staining, western blot anal. and quant. RT-PCR were performed to evaluate the protein and mRNA expression levels of HCC cells.  Here, using cell line models, our data demonstrated that interleukin 6 (IL-6) induced EMT through the JAK/STAT3/TWIST pathway in HCC.  Moreover, our studies revealed that NCTD markedly inhibited IL-6-induced EMT and cell invasiveness.  Signaling studies revealed that NCTD sufficiently suppressed JAK/ STAT3/TWIST signaling to reverse the IL-6-promoting effects.  Collectively, these data provide evidence for the use of NCTD as a potential anticancer drug in HCC metastatic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVlXR6BJlgLbVg90H21EOLACvtfcHk0liGJw7NmMbD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVSnu7nF&md5=beb7e71b25cfa7c180e4e55462965d87</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.3892%2For.2017.5775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2017.5775%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DHua%26aufirst%3DB.%26atitle%3DNorcantharidin%2520Inhibits%2520Il-6-Induced%2520Epithelial-Mesenchymal%2520Transition%2520Via%2520the%2520Jak2%252FStat3%252FTwist%2520Signaling%2520Pathway%2520in%2520Hepatocellular%2520Carcinoma%2520Cells%26jtitle%3DOncol.%2520Rep.%26date%3D2017%26volume%3D38%26spage%3D1224%26epage%3D1232%26doi%3D10.3892%2For.2017.5775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. G.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin-Induced Apoptosis of Ags Human Gastric Cancer Cells through Reactive Oxygen Species Production, and Caspase- and Mitochondria-Dependent Signaling Pathways</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">6031</span>– <span class="NLM_lpage">6042</span>, <span class="refDoi"> DOI: 10.21873/anticanres.11192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.21873%2Fanticanres.11192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=27793930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFahsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=6031-6042&author=L.+C.+Zhengauthor=M.+D.+Yangauthor=C.+L.+Kuoauthor=C.+H.+Linauthor=M.+J.+Fanauthor=Y.+C.+Chouauthor=H.+F.+Luauthor=W.+W.+Huangauthor=S.+F.+Pengauthor=J.+G.+Chung&title=Norcantharidin-Induced+Apoptosis+of+Ags+Human+Gastric+Cancer+Cells+through+Reactive+Oxygen+Species+Production%2C+and+Caspase-+and+Mitochondria-Dependent+Signaling+Pathways&doi=10.21873%2Fanticanres.11192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin-induced apoptosis of AGS human gastric cancer cells through reactive oxygen species production, and caspase- and mitochondria-dependent signaling pathways</span></div><div class="casAuthors">Zheng, Li-Cheng; Yang, Mei-Due; Chao-Lin, Kuo; Lin, Chia-Hsin; Fan, Ming-Jen; Yu-Cheng, Chou; Lu, Hsu-Feng; Huang, Wen-Wen; Peng, Shu-Fen; Chung, Jing-Gung</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6031-6042</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Norcantharidin (NCTD) was purified from mylabris, the dried body of the Chinese blister beetle.  NCTD has been shown to exhibit anticancer activities in many human cancer cell lines, but there are no reports to show whether it induces apoptosis of human gastric cancer cells.  Therefore, in the present study, we investigated NCTD-induced cell death and assocd. protein expression in human gastric cancer AGS cells in vitro.  Cell morphol. changes, viability and cell-cycle distribution were examd. and analyzed by phase-contrast microscopy and flow cytometric assays.  Flow cytometry was also used to measure the levels of reactive oxygen species (ROS), Ca2+, mitochondrial membrane potential (Vm) and activity of caspases.  The results indicated that NCTD induced cell morphol. changes, reduced total viable cell no. and induced G0/G1 phase arrest.  NCTD also increased ROS prodn. and reduced the Vm and increased caspase-9 activity in AGS cells.  Western blotting also found that NCTD increased the pro-apoptotic proteins such as BCL2-assocd. X protein (BAX) and BH3 interacting-domain death agonist (BID) and increased the release of cytochrome c, apoptosis inducing factor (AIF) and endonuclease G (Endo G) release from mitochondria in AGS cells.  NCTD also significantly increased the expression of active forms of caspase-3 and -8 and -9 and reduced the expression of caspase-4 and -12 in AGS cells.  Based on these observations, we suggest that NCTD-induced apoptotic cell death may be through mitochondria- and caspase-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_rZz_7L6ZDrVg90H21EOLACvtfcHk0liGJw7NmMbD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFahsr0%253D&md5=2bf794d0f154d2d35387b780a1cd378d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.21873%2Fanticanres.11192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fanticanres.11192%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DL.%2BC.%26aulast%3DYang%26aufirst%3DM.%2BD.%26aulast%3DKuo%26aufirst%3DC.%2BL.%26aulast%3DLin%26aufirst%3DC.%2BH.%26aulast%3DFan%26aufirst%3DM.%2BJ.%26aulast%3DChou%26aufirst%3DY.%2BC.%26aulast%3DLu%26aufirst%3DH.%2BF.%26aulast%3DHuang%26aufirst%3DW.%2BW.%26aulast%3DPeng%26aufirst%3DS.%2BF.%26aulast%3DChung%26aufirst%3DJ.%2BG.%26atitle%3DNorcantharidin-Induced%2520Apoptosis%2520of%2520Ags%2520Human%2520Gastric%2520Cancer%2520Cells%2520through%2520Reactive%2520Oxygen%2520Species%2520Production%252C%2520and%2520Caspase-%2520and%2520Mitochondria-Dependent%2520Signaling%2520Pathways%26jtitle%3DAnticancer%2520Res.%26date%3D2016%26volume%3D36%26spage%3D6031%26epage%3D6042%26doi%3D10.21873%2Fanticanres.11192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. D.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Induces Cell Cycle Arrest and Inhibits Progression of Human Leukemic Jurkat T Cells through Mitogen-Activated Protein Kinase-Mediated Regulation of Interleukin-2 Production</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2010.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.tiv.2010.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=21075198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1agsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=206-212&author=H.+F.+Liaoauthor=Y.+J.+Chenauthor=C.+H.+Chouauthor=F.+W.+Wangauthor=C.+D.+Kuo&title=Norcantharidin+Induces+Cell+Cycle+Arrest+and+Inhibits+Progression+of+Human+Leukemic+Jurkat+T+Cells+through+Mitogen-Activated+Protein+Kinase-Mediated+Regulation+of+Interleukin-2+Production&doi=10.1016%2Fj.tiv.2010.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production</span></div><div class="casAuthors">Liao, Hui-Fen; Chen, Yu-Jen; Chou, Chin-Hung; Wang, Fang-Wei; Kuo, Cheng-Deng</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology in Vitro</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">206-212</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Norcantharidin (NCTD) is a potential anti-cancer agent that inhibits proliferation and induces cell death through regulation of mitogen-activated protein kinases (MAPK).  This study examd. the effect of NCTD on tumor cells by using a model of phorbol 12-myristate 13-acetate plus ionomycin (PMAI)-activated leukemia Jurkat T cells.  The results showed that NCTD significantly inhibited the viability of cells with and without PMAI treatment.  NCTD induced cell cycle arrest at G2/M phase, down-regulated the expression of calcineurin and, by itself or in combination with Cyclosporine A, reduced calcineurin phosphatase activity.  Furthermore, NCTD up-regulates the expression of phosphorylated (p)-P38 and p-ERK1/2, but not JNK in PMAI-activated Jurkat T cells, in accordance with the alteration in viability.  Regarding major cytokine and chemokine secretion profile, NCTD attenuates PMAI-augmented prodn. of IL-2, but slightly increases or has no effect on TNF-α and IL-8.  By blockade of various MAPK, NCTD regulates PMAI-augmented IL-2 prodn. through activation of P38 and ERK1/2, in accordance with the aforementioned MAPK expression.  In conclusion, NCTD inhibited IL-2 prodn. in PMAI-activated human leukemia Jurkat T cells through activation of P38 and ERK1/2, suggesting that NCTD might have the potential of being used as a chemopreventive agent to inhibit tumor progression in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobvijPSQqGlLVg90H21EOLACvtfcHk0liGJw7NmMbD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1agsLnL&md5=3e8e59fd6d94d1887c4fb728785897ea</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2010.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2010.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DH.%2BF.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DChou%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DF.%2BW.%26aulast%3DKuo%26aufirst%3DC.%2BD.%26atitle%3DNorcantharidin%2520Induces%2520Cell%2520Cycle%2520Arrest%2520and%2520Inhibits%2520Progression%2520of%2520Human%2520Leukemic%2520Jurkat%2520T%2520Cells%2520through%2520Mitogen-Activated%2520Protein%2520Kinase-Mediated%2520Regulation%2520of%2520Interleukin-2%2520Production%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2011%26volume%3D25%26spage%3D206%26epage%3D212%26doi%3D10.1016%2Fj.tiv.2010.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Nanocapsules Inhibit the Invasion and Metastasis of Esophageal Cancer by Inhibiting Microrna-206 Via Igf1r-Pi3k-Akt Pathway</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">7249</span>– <span class="NLM_lpage">7256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVaqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=7249-7256&author=Z.+H.+Luauthor=K.+Guauthor=Y.+F.+Yunauthor=Y.+T.+Tangauthor=X.+J.+Luauthor=Y.+Ouauthor=X.+F.+Zhouauthor=Y.+Tian&title=Norcantharidin+Nanocapsules+Inhibit+the+Invasion+and+Metastasis+of+Esophageal+Cancer+by+Inhibiting+Microrna-206+Via+Igf1r-Pi3k-Akt+Pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin nanocapsules inhibit the invasion and metastasis of esophageal cancer by inhibiting microRNA-206 via IGF1R-PI3K-AKT pathway</span></div><div class="casAuthors">Lu, Zhonghua; Gu, Ke; Yun, Yifei; Tang, Yiting; Lu, Xujing; Ou, Yao; Zhou, Xifa; Tian, Ye</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">7249-7256</span>CODEN:
                <span class="NLM_cas:coden">IJCEFA</span>;
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">To investigate the effect of norcantharidin nanocapsules (NCTD-NPs) on the growth of esophageal cancer EC109 cells by inhibiting miR-206-mediated IGF1R-PI3K-Akt signaling pathway.  Esophageal cancer (ESCA) cell line EC109 was cultured.  Proliferative, invasive and metastatic capacities of EC109 cells were detected by cell counting kit-8 (CCK-8), would healing and transwell assay, resp.  Cell apoptosis was detected by flow cytometry.  Western blot and quant. real time-polymerase chain reaction (qRT-PCR) were conducted to det. expressions of relative genes.  The model of in situ transplantation tumor of ESCA in nude mice was established.  Meanwhile, fluorescence in vivo imaging was obsd.  Proliferative capacity of microRNA-206 overexpressing EC109 cells remarkably decreased after NCTD-NPs treatment in time- and dose-dependent manners.  NCTD-NPs treatment increased apoptotic rate of microRNA-206 overexpressing EC109 cells compared with that of EC109 cells.  After treatment with different doses of NCTD-NPs or NCTD, the migratory capacity of microRNA-206 overexpressing EC109 cells remarkably decreased than that of EC109 cells.  Transwell assay indicated that 25 nmol/L NCTD-NPs could markedly inhibit invasion of microRNA-206 overexpressing EC109 cells.  Western blot results elucidated downregulation of p-AKT (Ser473) and p-AKT (Thr308) in EC109 cells and microRNA-206 overexpressing EC109 cells.  Fluorescence in vivo imaging showed better inhibitory effect of NCTD-NPs on ESCA metastasis than NCTD in nude mice.  NCTD-NPs inhibited invasion and metastasis of ESCA both in vitro and in vivo.  The inhibitory effect of NCTD-NPs on ESCA development is related to IGF1R-PI3K-AKT pathway regulated by microRNA-206.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB0asi9JIE2bVg90H21EOLACvtfcHk0ljkXzEX_QgV7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVaqsbk%253D&md5=3430a3bb97397e5a0c488938436fa727</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DZ.%2BH.%26aulast%3DGu%26aufirst%3DK.%26aulast%3DYun%26aufirst%3DY.%2BF.%26aulast%3DTang%26aufirst%3DY.%2BT.%26aulast%3DLu%26aufirst%3DX.%2BJ.%26aulast%3DOu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%2BF.%26aulast%3DTian%26aufirst%3DY.%26atitle%3DNorcantharidin%2520Nanocapsules%2520Inhibit%2520the%2520Invasion%2520and%2520Metastasis%2520of%2520Esophageal%2520Cancer%2520by%2520Inhibiting%2520Microrna-206%2520Via%2520Igf1r-Pi3k-Akt%2520Pathway%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2019%26volume%3D12%26spage%3D7249%26epage%3D7256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Autophagy Suppression Accelerates Apoptosis Induced by Norcantharidin in Cholangiocarcinoma</span>. <i>Pathol. Oncol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1697</span>– <span class="NLM_lpage">1707</span>, <span class="refDoi"> DOI: 10.1007/s12253-019-00719-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs12253-019-00719-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31612378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFKjsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&pages=1697-1707&author=Y.+Wangauthor=W.+Jiangauthor=C.+Liauthor=X.+Xiongauthor=H.+Guoauthor=Q.+Tianauthor=X.+Li&title=Autophagy+Suppression+Accelerates+Apoptosis+Induced+by+Norcantharidin+in+Cholangiocarcinoma&doi=10.1007%2Fs12253-019-00719-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy Suppression Accelerates Apoptosis Induced by Norcantharidin in Cholangiocarcinoma</span></div><div class="casAuthors">Wang, Yun; Jiang, Wangjie; Li, Cunjiang; Xiong, Xuanxuan; Guo, Hao; Tian, Qingzhong; Li, Xiangcheng</div><div class="citationInfo"><span class="NLM_cas:title">Pathology & Oncology Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1697-1707</span>CODEN:
                <span class="NLM_cas:coden">POREFR</span>;
        ISSN:<span class="NLM_cas:issn">1219-4956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Norcantharidin is a cantharidin demethylated analog with antitumor effects in many tumors, including cholangiocarcinoma.  Autophagy suppression is known to increase chemosensitivity in cholangiocarcinoma.  This study aimed to det. whether autophagy suppression accelerates apoptosis induced by norcantharidin in human cholangiocarcinoma cells.  The human cholangiocarcinoma cell line QBC939 was incubated in RPMI 1640 medium with or without norcantharidin.  Autophagy was induced using HBSS media with Ca2+ and Mg2+ supported by 10 mM HEPES or suppressed by treatment with 3-MA or transfection with siRNA against Atg5.  The comparison was drawn between these conditions in mitochondrial membrane potential disturbance, the levels of reactive oxygen species (ROS), apoptotic proteins, and apoptosis.  Cholangiocarcinoma cell apoptosis was accelerated by norcantharidin.  Autophagy suppression up-regulated norcantharidins pro-apoptotic effect, but autophagy induction weakened it.  As apoptosis was accelerated, ROS prodn. was up-regulated.  Bax protein expression, cytochrome c levels and localization, mitochondrial membrane disturbance, and the levels of caspase-9, caspase-3, and cleaved PARP were higher when autophagy was suppressed, and all of those were down-regulated when autophagy was induced.  To sum up, it was found that norcantharidin induced cholangiocarcinoma cell death, and autophagy suppression enhanced the pro-apoptotic action of norcantharidin, which appears to involve the mitochondrial apoptosis pathway activation and ROS generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7l-1H940697Vg90H21EOLACvtfcHk0ljkXzEX_QgV7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFKjsbvK&md5=c04e46712fb3b338da0c5ee44c20d5ef</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1007%2Fs12253-019-00719-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12253-019-00719-9%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DAutophagy%2520Suppression%2520Accelerates%2520Apoptosis%2520Induced%2520by%2520Norcantharidin%2520in%2520Cholangiocarcinoma%26jtitle%3DPathol.%2520Oncol.%2520Res.%26date%3D2020%26volume%3D26%26spage%3D1697%26epage%3D1707%26doi%3D10.1007%2Fs12253-019-00719-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsi, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. K.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Induce Apoptosis in Human Nasopharyngeal Carcinoma through Caspase and Mitochondrial Pathway</span>. <i>Environ. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1002/tox.22521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Ftox.22521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29193574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOrtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=343-350&author=A.+W.+G.+Chenauthor=Y.+S.+Tsengauthor=C.+C.+Linauthor=Y.+T.+Hsiauthor=Y.+S.+Loauthor=Y.+C.+Chuangauthor=S.+H.+Linauthor=C.+Y.+Yuauthor=M.+J.+Hsiehauthor=M.+K.+Chen&title=Norcantharidin+Induce+Apoptosis+in+Human+Nasopharyngeal+Carcinoma+through+Caspase+and+Mitochondrial+Pathway&doi=10.1002%2Ftox.22521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin induce apoptosis in human nasopharyngeal carcinoma through caspase and mitochondrial pathway</span></div><div class="casAuthors">Chen, Andy Wei-Ge; Tseng, Yen-Shuo; Lin, Chia-Chieh; Hsi, Yi-Ting; Lo, Yu-Sheng; Chuang, Yi-Ching; Lin, Shu-Hui; Yu, Chia-Yun; Hsieh, Ming-Ju; Chen, Mu-Kuan</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-350</span>CODEN:
                <span class="NLM_cas:coden">ETOXFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-4081</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">While Nasopharyngeal carcinoma (NPC) is uncommon in western countries, it is endemic in Southeast Asia and Southern China.  Previous study of norcantharidin (NCTD), isolated from blister beetles, has proved its anticancer effect on various tumors.  However, the effect of NCTD in NPC has never been studied.  The purpose of this study is to inspect the suppression activity of NCTD on NPC, along with the underlying mechanism.  NPC cell line NPC-BM was treated with NCTD.  NCTD remarkably inhibited proliferation and induce apoptosis in NPC-BM cell.  Activation of caspase-3, -8, -9 was obsd. through western blotting.  The expression of antiapoptotic protein Bcl-XL was significantly reduced, but expression of proapoptotic protein Bak was increased after treatment of NCTD.  The cytotoxic effect of NCTD on NPC-BM cell is mainly due to apoptosis, mediated by caspase and mitochondrial pathway.  These results suggested that NCTD could be a potential anticancer agent for NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_k5HvygfIhrVg90H21EOLACvtfcHk0lijEl0IDZ40rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOrtL%252FK&md5=39f02f149cc6ecd2702506e31890564c</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Ftox.22521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Ftox.22521%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DA.%2BW.%2BG.%26aulast%3DTseng%26aufirst%3DY.%2BS.%26aulast%3DLin%26aufirst%3DC.%2BC.%26aulast%3DHsi%26aufirst%3DY.%2BT.%26aulast%3DLo%26aufirst%3DY.%2BS.%26aulast%3DChuang%26aufirst%3DY.%2BC.%26aulast%3DLin%26aufirst%3DS.%2BH.%26aulast%3DYu%26aufirst%3DC.%2BY.%26aulast%3DHsieh%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DM.%2BK.%26atitle%3DNorcantharidin%2520Induce%2520Apoptosis%2520in%2520Human%2520Nasopharyngeal%2520Carcinoma%2520through%2520Caspase%2520and%2520Mitochondrial%2520Pathway%26jtitle%3DEnviron.%2520Toxicol.%26date%3D2018%26volume%3D33%26spage%3D343%26epage%3D350%26doi%3D10.1002%2Ftox.22521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein Phosphatase 5 Suppresses Non-Small Cell Lung Cancer through Amp-Activated Kinase Activation</span>. <i>Lung Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.lungcan.2017.07.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.lungcan.2017.07.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29191605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC1M3msFyqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2017&pages=81-89&author=F.+S.+Hsiehauthor=M.+H.+Hungauthor=C.+Y.+Wangauthor=Y.+L.+Chenauthor=Y.+J.+Hsiaoauthor=M.+H.+Tsaiauthor=J.+R.+Liauthor=L.+J.+Chenauthor=C.+T.+Shihauthor=T.+I.+Chaoauthor=K.+F.+Chen&title=Inhibition+of+Protein+Phosphatase+5+Suppresses+Non-Small+Cell+Lung+Cancer+through+Amp-Activated+Kinase+Activation&doi=10.1016%2Fj.lungcan.2017.07.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation</span></div><div class="casAuthors">Hsieh Feng-Shu; Hsiao Yung-Jen; Tsai Ming-Hsien; Li Jia-Rong; Chen Li-Ju; Shih Chih-Ting; Hung Man-Hsin; Wang Cheng-Yi; Chen Yen-Lin; Chao Tzu-I; Chen Kuen-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Lung cancer (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-89</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Non-small cell lung cancer (NSCLC) continues to be the top cause of cancer death.  To improve the treatment of lung cancer, there is necessity to identify novel oncogenes and investigate their effects on lung carcinogenesis.  Protein phosphatase 5 (PP5) has long been known to regulate stress-induced apoptosis and cell proliferation.  Recently, PP5 has been found overexpressed and emerged as a viable therapeutic target in various human cancers, but its role in NSCLC remains elusive.  MATERIALS AND METHODS:  The expression of PP5 in NSCLC cell lines (A549, H358, and H460) and human tumor samples were examined.  Protein phosphatase inhibitors, cantharidin and norcantharidin, were used as proof-of-concept compounds to investigate the pathological function of PP5 in NSCLC.  Apoptosis and cellular signaling were analyzed.  In vivo efficacy was determined in nude mice with H460 xenograft.  RESULTS AND CONCLUSION:  We found that PP5 was more highly expressed in human lung tumor samples than in adjacent normal tissues.  Overexpression of PP5 promoted cell proliferation, colony formation, and sphere-forming ability of A549 cells.  Inhibition of PP5 phosphatase activity by cantharidin induced significant apoptosis and upregulated AMP-activated protein kinase (AMPK) signaling.  Importantly, we found that PP5-mediated dephosphorylation of AMPK determines the in vitro anti-NSCLC effects of cantharidin.  Consistent with our in vitro data, PP5 inhibition suppressed H460 tumor growth and upregulated p-AMPK in tumor samples.  Our results demonstrate that PP5 inhibition suppresses tumor growth via activating AMPK signaling.  Targeting oncogenic PP5 represents an attractive therapeutic strategy for treating lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCA6xgGlThsr9KldV63DuefW6udTcc2eYgjELmQjn8Nbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3msFyqtg%253D%253D&md5=537b67e55d6c63e8ed3e4839f8cceeec</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2017.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2017.07.040%26sid%3Dliteratum%253Aachs%26aulast%3DHsieh%26aufirst%3DF.%2BS.%26aulast%3DHung%26aufirst%3DM.%2BH.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DHsiao%26aufirst%3DY.%2BJ.%26aulast%3DTsai%26aufirst%3DM.%2BH.%26aulast%3DLi%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DL.%2BJ.%26aulast%3DShih%26aufirst%3DC.%2BT.%26aulast%3DChao%26aufirst%3DT.%2BI.%26aulast%3DChen%26aufirst%3DK.%2BF.%26atitle%3DInhibition%2520of%2520Protein%2520Phosphatase%25205%2520Suppresses%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520through%2520Amp-Activated%2520Kinase%2520Activation%26jtitle%3DLung%2520Cancer%26date%3D2017%26volume%3D112%26spage%3D81%26epage%3D89%26doi%3D10.1016%2Fj.lungcan.2017.07.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Inhibits Cell Growth by Suppressing the Expression and Phosphorylation of Both Egfr and C-Met in Human Colon Cancer Cells</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">55</span>, <span class="refDoi"> DOI: 10.1186/s12885-016-3039-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1186%2Fs12885-016-3039-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28086832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs12ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=55&author=P.+Qiuauthor=S.+Wangauthor=M.+Liuauthor=H.+Maauthor=X.+Zengauthor=M.+Zhangauthor=L.+Xuauthor=Y.+Cuiauthor=H.+Xuauthor=Y.+Tangauthor=Y.+Heauthor=L.+Zhang&title=Norcantharidin+Inhibits+Cell+Growth+by+Suppressing+the+Expression+and+Phosphorylation+of+Both+Egfr+and+C-Met+in+Human+Colon+Cancer+Cells&doi=10.1186%2Fs12885-016-3039-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells</span></div><div class="casAuthors">Qiu, Peiju; Wang, Siwen; Liu, Ming; Ma, He; Zeng, Xuan; Zhang, Meng; Xu, Lingling; Cui, Yidi; Xu, Huixin; Tang, Yang; He, Yanli; Zhang, Lijuan</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55/1-55/7</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Norcantharidin (NCTD) is a Chinese FDA approved, chem. synthesized drug for cancer treatment.  The effect of NCTD on signaling proteins of EGFR and c-Met was systematically elucidated in current study.  Methods: Two human colon cancer cell lines, HCT116 and HT29, were used as model systems to investigate the anti-cancer mol. mechanism of NCTD.  Cell cycle arrest and early/late apoptosis were analyzed by flow cytometry.  The levels of EGFR, phospho-EGFR, c-Met, phospho-c-Met and other related proteins were quantified by western blot anal.  Results: NCTD induced cell cycle arrest at G2/M phase in both cell lines.  The early and late apoptosis was also obsd.  Further investigation indicated that NCTD suppressed not only the expression of the total EGFR and the phosphorylated EGFR but also the expression of the total c-Met and the phosphorylated c-Met in colon cancer cells.  Moreover, EGFR expression could be mostly restored by co-treatment with MG132, a proteasome inhibitor.  In addn., NCTD-induced cell death was comparable to that of the anti-cancer drug gefitinib, a tyrosine kinase inhibitor for EGFR, based on the immunoblot anal. of the expressed proteins after the drug treatment.  Conclusions: NCTD might be a useful and inexpensive drug candidate to substitute for gefitinib to serve the treatment needs of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolo43L-3UDf7Vg90H21EOLACvtfcHk0ljhxU8P8MOi9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs12ntbo%253D&md5=b903120dc626f56b9961f876b1de0896</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1186%2Fs12885-016-3039-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-016-3039-x%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DNorcantharidin%2520Inhibits%2520Cell%2520Growth%2520by%2520Suppressing%2520the%2520Expression%2520and%2520Phosphorylation%2520of%2520Both%2520Egfr%2520and%2520C-Met%2520in%2520Human%2520Colon%2520Cancer%2520Cells%26jtitle%3DBMC%2520Cancer%26date%3D2017%26volume%3D17%26spage%3D55%26doi%3D10.1186%2Fs12885-016-3039-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, B.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Regulates Erα Signaling and Tamoxifen Resistance Via Targeting Mir-873/Cdk3 in Breast Cancer Cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">e0217181</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0217181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1371%2Fjournal.pone.0217181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31120927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht12jsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=e0217181&author=X.+Zhangauthor=B.+Zhangauthor=P.+Zhangauthor=L.+Lianauthor=L.+Liauthor=Z.+Qiuauthor=K.+Qianauthor=A.+Chenauthor=Q.+Liuauthor=Y.+Jiangauthor=J.+Cuiauthor=B.+Qi&title=Norcantharidin+Regulates+Er%CE%B1+Signaling+and+Tamoxifen+Resistance+Via+Targeting+Mir-873%2FCdk3+in+Breast+Cancer+Cells&doi=10.1371%2Fjournal.pone.0217181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells</span></div><div class="casAuthors">Zhang, Xiumei; Zhang, Bingfeng; Zhang, Panhong; Lian, Lihui; Li, Lianlian; Qiu, Zhihong; Qian, Kai; Chen, An; Liu, Qiongqing; Jiang, Yinjie; Cui, Jiajun; Qi, Bing</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0217181</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">MiR-873/CDK3 has been shown to play a crit. role in ERα signaling and tamoxifen resistance.  Thus, targeting this pathway may be a potential therapeutic approach for the treatment of ER pos. breast cancer esp. tamoxifen resistant subtype.  Here we report that Norcantharidin (NCTD), currently used clin. as an ani-cancer drug in China, regulates miR-873/CDK3 axis in breast cancer cells.  NCTD decreases the transcriptional activity of ERα but not ERβ through the modulation of miR-873/CDK3 axis.  We also found that NCTD inhibits cell proliferation and tumor growth and miR-873/CDK3 axis mediates cell proliferation suppression of NCTD.  More important, we found that NCTD sensitizes resistant cells to tamoxifen.  NCTD inhibits tamoxifen induced the transcriptional activity as well ERα downstream gene expressions in tamoxifen resistant breast cancer cells.  In addn., we found that NCTD restores tamoxifen induced recruitments of ERα co-repressors N-CoR and SMRT.  Knockdown of miR-873 and overexpression of CDK3 diminish the effect of NCTD on tamoxifen resistance.  Our data shows that NCTD regulates ERα signaling and tamoxifen resistance by targeting miR-873/CDK3 axis in breast cancer cells.  This study may provide an alternative therapy strategy for tamoxifen resistant breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorKXr5qYN-YLVg90H21EOLACvtfcHk0ljhxU8P8MOi9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht12jsbbK&md5=303c872eddd1b83478811e8584642962</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0217181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0217181%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DLian%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DZ.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DB.%26atitle%3DNorcantharidin%2520Regulates%2520Er%25CE%25B1%2520Signaling%2520and%2520Tamoxifen%2520Resistance%2520Via%2520Targeting%2520Mir-873%252FCdk3%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DPLoS%2520One%26date%3D2019%26volume%3D14%26spage%3De0217181%26doi%3D10.1371%2Fjournal.pone.0217181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. F.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 5 Promotes Hepatocarcinogenesis through Interaction with Amp-Activated Protein Kinase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bcp.2017.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28528695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotF2qsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=49-60&author=Y.+L.+Chenauthor=M.+H.+Hungauthor=P.+Y.+Chuauthor=T.+I.+Chaoauthor=M.+H.+Tsaiauthor=L.+J.+Chenauthor=Y.+J.+Hsiaoauthor=C.+T.+Shihauthor=F.+S.+Hsiehauthor=K.+F.+Chen&title=Protein+Phosphatase+5+Promotes+Hepatocarcinogenesis+through+Interaction+with+Amp-Activated+Protein+Kinase&doi=10.1016%2Fj.bcp.2017.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase</span></div><div class="casAuthors">Chen, Yao-Li; Hung, Man-Hsin; Chu, Pei-Yi; Chao, Tzu-I.; Tsai, Ming-Hsien; Chen, Li-Ju; Hsiao, Yung-Jen; Shih, Chih-Ting; Hsieh, Feng-Shu; Chen, Kuen-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The serine-threonine protein phosphatase family members are known as crit. regulators of various cellular functions, such as survival and transformation.  Growing evidence suggests that pharmacol. manipulation of phosphatase activity exhibits therapeutic benefits.  Ser/Thr protein phosphatase 5 (PP5) is known to participate in glucocorticoid receptor (GR) and stress-induced signaling cascades that regulate cell growth and apoptosis, and has been shown to be overexpressed in various human malignant diseases.  However, the role of PP5 in hepatocellular carcinoma (HCC) and whether PP5 may be a viable therapeutic target for HCC treatment are unknown.  Here, by analyzing HCC clin. samples obtained from 215 patients, we found that overexpression of PP5 is tumor specific and assocd. with worse clin. outcomes.  We further characterized the oncogenic properties of PP5 in HCC cells.  Importantly, both silencing of PP5 with lentiviral-mediated short hairpin RNA (shRNA) and chem. inhibition of PP5 phosphatase activity using the natural compd. cantharidin/norcantharidin markedly suppressed the growth of HCC cells and tumors in vitro and in vivo.  Moreover, we identified AMP-activated protein kinase (AMPK) as a novel downstream target of oncogenic PP5 and demonstrated that the antitumor mechanisms underlying PP5 inhibition involve activation of AMPK signaling.  Overall, our results establish a pathol. function of PP5 in hepatocarcinogenesis via affecting AMPK signaling and suggest that PP5 inhibition is an attractive therapeutic approach for HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopo4vKvhpeebVg90H21EOLACvtfcHk0lh5iwxdaX7RGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotF2qsbo%253D&md5=c5c7dff475271b7986de3cfeb1d25e2d</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DHung%26aufirst%3DM.%2BH.%26aulast%3DChu%26aufirst%3DP.%2BY.%26aulast%3DChao%26aufirst%3DT.%2BI.%26aulast%3DTsai%26aufirst%3DM.%2BH.%26aulast%3DChen%26aufirst%3DL.%2BJ.%26aulast%3DHsiao%26aufirst%3DY.%2BJ.%26aulast%3DShih%26aufirst%3DC.%2BT.%26aulast%3DHsieh%26aufirst%3DF.%2BS.%26aulast%3DChen%26aufirst%3DK.%2BF.%26atitle%3DProtein%2520Phosphatase%25205%2520Promotes%2520Hepatocarcinogenesis%2520through%2520Interaction%2520with%2520Amp-Activated%2520Protein%2520Kinase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2017%26volume%3D138%26spage%3D49%26epage%3D60%26doi%3D10.1016%2Fj.bcp.2017.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papke, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abney, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">The Antitumor Drug Lb-100 Is a Catalytic Inhibitor of Protein Phosphatase 2a (Ppp2ca) and 5 (Ppp5c) Coordinating with the Active-Site Catalytic Metals in Ppp5c</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-1143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1535-7163.MCT-17-1143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30679389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFGgs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=556-566&author=B.+M.+D%E2%80%99Arcyauthor=M.+R.+Swingleauthor=C.+M.+Papkeauthor=K.+A.+Abneyauthor=E.+S.+Bouskaauthor=A.+Prakashauthor=R.+E.+Honkanen&title=The+Antitumor+Drug+Lb-100+Is+a+Catalytic+Inhibitor+of+Protein+Phosphatase+2a+%28Ppp2ca%29+and+5+%28Ppp5c%29+Coordinating+with+the+Active-Site+Catalytic+Metals+in+Ppp5c&doi=10.1158%2F1535-7163.MCT-17-1143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">The antitumor drug LB-100 is a catalytic inhibitor of protein phosphatase 2A (PPP2CA) and 5 (PPP5C) coordinating with the active-site catalytic metals in PPP5C</span></div><div class="casAuthors">D'Arcy, Brandon M.; Swingle, Mark R.; Papke, Cinta M.; Abney, Kevin A.; Bouska, Erin S.; Prakash, Aishwarya; Honkanen, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">556-566</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The first phase I trial (NCT01837667) evaluating LB-100 recently concluded that safety and efficacy parameters are favorable for further clin. testing.  Although LB-100 is widely reported as a specific inhibitor of serine/threonine phosphatase 2A (PP2AC/PPP2CA:PPP2CB), we could find no exptl. evidence in the published literature demonstrating the specific engagement of LB-100 with PP2A in vitro, in cultured cells, or in animals.  Rather, the premise for LB-100 targeting PP2AC is derived from studies that measure phosphate released from a phosphopeptide (K-R-pT-I-R-R) or inferred from the ability of LB-100 to mimic activity previously reported to result from the inhibition of PP2AC by other means.  PP2AC and PPP5C share a common catalytic mechanism.  Here, we demonstrate that the phosphopeptide used to ascribe LB-100 specificity for PP2A is also a substrate for PPP5C.  Inhibition assays using purified enzymes demonstrate that LB-100 is a catalytic inhibitor of both PP2AC and PPP5C.  The structure of PPP5C cocrystd. with LB-100 was solved to a resoln. of 1.65Å, revealing that the 7-oxabicyclo[2.2.1]heptane-2,3-dicarbonyl moiety coordinates with the metal ions and key residues that are conserved in both PP2AC and PPP5C.  These data demonstrate that LB-100 is a catalytic inhibitor of both PP2AC and PPP5C and suggest that the obsd. antitumor activity might be due to an additive effect achieved by suppressing both PP2A and PPP5C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnejVjep6twLVg90H21EOLACvtfcHk0lh5iwxdaX7RGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFGgs7bL&md5=d0abf7737094643ebf06547cecce574d</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-1143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-1143%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DB.%2BM.%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DPapke%26aufirst%3DC.%2BM.%26aulast%3DAbney%26aufirst%3DK.%2BA.%26aulast%3DBouska%26aufirst%3DE.%2BS.%26aulast%3DPrakash%26aufirst%3DA.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DThe%2520Antitumor%2520Drug%2520Lb-100%2520Is%2520a%2520Catalytic%2520Inhibitor%2520of%2520Protein%2520Phosphatase%25202a%2520%2528Ppp2ca%2529%2520and%25205%2520%2528Ppp5c%2529%2520Coordinating%2520with%2520the%2520Active-Site%2520Catalytic%2520Metals%2520in%2520Ppp5c%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2019%26volume%3D18%26spage%3D556%26epage%3D566%26doi%3D10.1158%2F1535-7163.MCT-17-1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golden, T.</span></span> <span> </span><span class="NLM_article-title">Regulators of Serine/Threonine Protein Phosphatases at the Dawn of a Clinical Era?</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2055</span>– <span class="NLM_lpage">2075</span>, <span class="refDoi"> DOI: 10.2174/0929867023368836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F0929867023368836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=12369870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlCnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=2055-2075&author=R.+E.+Honkanenauthor=T.+Golden&title=Regulators+of+Serine%2FThreonine+Protein+Phosphatases+at+the+Dawn+of+a+Clinical+Era%3F&doi=10.2174%2F0929867023368836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Regulators of serine/threonine protein phosphatases at the dawn of a clinical era?</span></div><div class="casAuthors">Honkanen, R. E.; Golden, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2055-2075</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Reversible phosphorylation is a key mechanism for regulating the biol. activity of many human proteins that affect a diverse array of cellular processes, including protein-protein interactions, gene transcription, cell-cycle progression and apoptosis.  Once viewed as simple house keeping enzymes, recent studies have made it eminently clear that, like their kinase counterparts, protein phosphatases are dynamic and highly regulated enzymes.  Therefore, the development of compds. that alter the activity of specific phosphatases is rapidly emerging as an important area in drug discovery.  Because >98% of protein phosphorylation occurs on serine and threonine residues, the identification of agents that alter the activity of specific serine/threonine phosphatases seems esp. promising for drug development in the future.  This review is focused on the enzymes encoded by the PPP-gene family, which includes PP1, PP2A, PP2B, PP4, PP5, PP6 and PP7.  The structure/functions of human phosphatases will be addressed briefly, as will the natural product inhibitors of PP1-PP6 (e.g. okadaic acid, microcystins, nodularin, cantharidin, calyculin A, tautomycin, and fostriecin).  The development of chimeric antisense oligonucleotides that support RNase H mediated degrdn. of the targeted mRNA has resulted in compds. capable of specifically suppressing the expression of PP5 (ISIS 15534) and PP1gamma 1 (ISIS 14435) in human cells.  Such compds. have already proven useful for the validation of drug targets, and if difficulties assocd. with systemic delivery of antisense oligonucleotides can be overcome, antisense is poised to have a major impact on the clin. management of many human disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjDFkVtCb1obVg90H21EOLACvtfcHk0lh5iwxdaX7RGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlCnsbc%253D&md5=ea4cd9c1cee79fb1e43d2e64e333755b</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.2174%2F0929867023368836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867023368836%26sid%3Dliteratum%253Aachs%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DGolden%26aufirst%3DT.%26atitle%3DRegulators%2520of%2520Serine%252FThreonine%2520Protein%2520Phosphatases%2520at%2520the%2520Dawn%2520of%2520a%2520Clinical%2520Era%253F%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D2055%26epage%3D2075%26doi%3D10.2174%2F0929867023368836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of Ser/Thr Protein Phosphatases: Specificity, Use and Common Forms of Abuse</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1385/1-59745-267-X:23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1385%2F1-59745-267-X%3A23" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2006&pages=23-38&author=M.+Swingleauthor=L.+Niauthor=R.+E.+Honkanen&title=Small-Molecule+Inhibitors+of+Ser%2FThr+Protein+Phosphatases%3A+Specificity%2C+Use+and+Common+Forms+of+Abuse&doi=10.1385%2F1-59745-267-X%3A23"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1385%2F1-59745-267-X%3A23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59745-267-X%253A23%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DM.%26aulast%3DNi%26aufirst%3DL.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520Ser%252FThr%2520Protein%2520Phosphatases%253A%2520Specificity%252C%2520Use%2520and%2520Common%2520Forms%2520of%2520Abuse%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2006%26volume%3D365%26spage%3D23%26epage%3D38%26doi%3D10.1385%2F1-59745-267-X%3A23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R E</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwiller, J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, R E</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daily, S L</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatra, B S</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukelow, M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boynton, A L</span></span> <span> </span><span class="NLM_article-title">Characterization of Microcystin-Lr, a Potent Inhibitor of Type 1 and Type 2a Protein Phosphatases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>265</i></span>,  <span class="NLM_fpage">19401</span>– <span class="NLM_lpage">19404</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(17)45384-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0021-9258%2817%2945384-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2174036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXlvVOisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=19401-19404&author=R+E+Honkanenauthor=J+Zwillerauthor=R+E+Mooreauthor=S+L+Dailyauthor=B+S+Khatraauthor=M+Dukelowauthor=A+L+Boynton&title=Characterization+of+Microcystin-Lr%2C+a+Potent+Inhibitor+of+Type+1+and+Type+2a+Protein+Phosphatases&doi=10.1016%2FS0021-9258%2817%2945384-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases</span></div><div class="casAuthors">Honkanen, Richard E.; Zwiller, Jean; Moore, Richard E.; Daily, Sharon L.; Khatra, Balwant S.; Dukelow, Michael; Boynton, Alton L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">19401-4</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The level of protein phosphorylation is dependent on the relative activities of both protein kinases and protein phosphatases.  By comparison with protein kinases, however, there have been considerably fewer studies on the functions of serine/threonine protein phosphatases.  This is partly due to a lack of specific protein phosphatase inhibitors that can be used as probes.  The present study is a characterization of the inhibitory effects of microcystin-LR, a hepatotoxic cyclic peptide assocd. with most strains of the blue-green algae Microcystis aeruginosa found in the Northern hemisphere, that proves to be a potent inhibitor of type 1 (IC50 = 1.7 nM) and type 2A (IC50 = 0.04 nM) protein phosphatases.  Microcystin-LR inhibited the activity of both type 1 and type 2A phosphatases >10-fold more potently than okadaic acid under the same conditions.  Type 2A protein phosphatases in dil. mammalian cell exts. were found to be completely inhibited by 0.5 nM microcystin-LR while type I protein phosphatases were only slightly affected at this concn.  Thus, microcystin-LR may prove to be a useful probe for the study and identification of cellular processes which are mediated by protein phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTSf9UHioQjLVg90H21EOLACvtfcHk0livtF5Pjogz6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlvVOisrc%253D&md5=dca914b3af519bf6d0e97d2e5415184b</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2817%2945384-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252817%252945384-1%26sid%3Dliteratum%253Aachs%26aulast%3DHonkanen%26aufirst%3DR%2BE%26aulast%3DZwiller%26aufirst%3DJ%26aulast%3DMoore%26aufirst%3DR%2BE%26aulast%3DDaily%26aufirst%3DS%2BL%26aulast%3DKhatra%26aufirst%3DB%2BS%26aulast%3DDukelow%26aufirst%3DM%26aulast%3DBoynton%26aufirst%3DA%2BL%26atitle%3DCharacterization%2520of%2520Microcystin-Lr%252C%2520a%2520Potent%2520Inhibitor%2520of%2520Type%25201%2520and%2520Type%25202a%2520Protein%2520Phosphatases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D19401%26epage%3D19404%26doi%3D10.1016%2FS0021-9258%2817%2945384-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacKintosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beattie, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klumpp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codd, G. A.</span></span> <span> </span><span class="NLM_article-title">Cyanobacterial Microcystin-Lr Is a Potent and Specific Inhibitor of Protein Phosphatases 1 and 2a from Both Mammals and Higher Plants</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(90)80245-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0014-5793%2890%2980245-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2162782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXlsVOjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1990&pages=187-192&author=C.+MacKintoshauthor=K.+A.+Beattieauthor=S.+Klumppauthor=P.+Cohenauthor=G.+A.+Codd&title=Cyanobacterial+Microcystin-Lr+Is+a+Potent+and+Specific+Inhibitor+of+Protein+Phosphatases+1+and+2a+from+Both+Mammals+and+Higher+Plants&doi=10.1016%2F0014-5793%2890%2980245-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants</span></div><div class="casAuthors">MacKintosh, Carol; Beattie, Kenneth A.; Klumpp, Susanne; Cohen, Philip; Codd, Geoffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-92</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The cyclic heptapeptide, microcystin-LR (I), inhibits protein phosphatases 1 (PP1) and 2A (PP2A) with Ki values >0.1 nM.  Protein phosphatase 2B is inhibited 1000-fold less potently, whereas 6 other phosphatases and 8 protein kinases tested are unaffected.  These results are strikingly similar to those obtained with the tumor promoter okadaic acid.  Okadaic acid prevents the binding of microcystin-LR to PP2A, and the protein inhibitors 1 and 2 prevent the binding of microcystin-LR to PP1.  The possibility that inhibition of PP1 and PP2A accounts for the extreme toxicity of microcystin-LR, and indicate its potential value in the detection and anal. of protein kinases and phosphatases was also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY9x8OhseK07Vg90H21EOLACvtfcHk0livtF5Pjogz6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlsVOjs74%253D&md5=ba374e02bd0233ca76986bd375bc7ae7</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2890%2980245-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252890%252980245-E%26sid%3Dliteratum%253Aachs%26aulast%3DMacKintosh%26aufirst%3DC.%26aulast%3DBeattie%26aufirst%3DK.%2BA.%26aulast%3DKlumpp%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCodd%26aufirst%3DG.%2BA.%26atitle%3DCyanobacterial%2520Microcystin-Lr%2520Is%2520a%2520Potent%2520and%2520Specific%2520Inhibitor%2520of%2520Protein%2520Phosphatases%25201%2520and%25202a%2520from%2520Both%2520Mammals%2520and%2520Higher%2520Plants%26jtitle%3DFEBS%2520Lett.%26date%3D1990%26volume%3D264%26spage%3D187%26epage%3D192%26doi%3D10.1016%2F0014-5793%2890%2980245-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppeck, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlin, A. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the Ser-Thr Phosphatases Pp1 and Pp2a by Naturally Occurring Toxins</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(97)00146-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0968-0896%2897%2900146-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9354230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2sXntVOmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=1739-1750&author=J.+E.+Sheppeckauthor=C.+M.+Gaussauthor=A.+R.+Chamberlin&title=Inhibition+of+the+Ser-Thr+Phosphatases+Pp1+and+Pp2a+by+Naturally+Occurring+Toxins&doi=10.1016%2FS0968-0896%2897%2900146-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins</span></div><div class="casAuthors">Sheppeck, James E., II; Gauss, Carla-Maria; Chamberlin, A. Richard</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1739-1750</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 112 refs., of PP1 and PP2A phosphatases and their inhibition by endogenous protein inhibitors and okadaic acid class inhibitors.  Site-directed mutagenesis studies of the enzymes are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJAM7FgXBGdrVg90H21EOLACvtfcHk0liRel2ApgNobA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXntVOmtbo%253D&md5=6ab1a2f7c9cbee2f0434e6d3e93d3627</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2897%2900146-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252897%252900146-6%26sid%3Dliteratum%253Aachs%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DChamberlin%26aufirst%3DA.%2BR.%26atitle%3DInhibition%2520of%2520the%2520Ser-Thr%2520Phosphatases%2520Pp1%2520and%2520Pp2a%2520by%2520Naturally%2520Occurring%2520Toxins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1997%26volume%3D5%26spage%3D1739%26epage%3D1750%26doi%3D10.1016%2FS0968-0896%2897%2900146-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adler, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitt, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunnimalaiyaan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Tautomycetin and Tautomycin Suppress the Growth of Medullary Thyroid Cancer Cells Via Inhibition of Glycogen Synthase Kinase-3β</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">914</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1535-7163.MCT-08-0712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19372564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1amtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=914-920&author=J.+T.+Adlerauthor=M.+Cookauthor=Y.+Luoauthor=S.+C.+Pittauthor=J.+Juauthor=W.+Liauthor=B.+Shenauthor=M.+Kunnimalaiyaanauthor=H.+Chen&title=Tautomycetin+and+Tautomycin+Suppress+the+Growth+of+Medullary+Thyroid+Cancer+Cells+Via+Inhibition+of+Glycogen+Synthase+Kinase-3%CE%B2&doi=10.1158%2F1535-7163.MCT-08-0712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3β</span></div><div class="casAuthors">Adler, Joel T.; Cook, Mackenzie; Luo, Yinggang; Pitt, Susan C.; Ju, Jianhua; Li, Wenli; Shen, Ben; Kunnimalaiyaan, Muthusamy; Chen, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">914-920</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Medullary thyroid cancer (MTC) is a relatively uncommon neuroendocrine tumor that arises from the calcitonin-secreting parafollicular cells of the thyroid gland.  Unfortunately, MTC frequently metastasizes, precluding curative surgical resection and causing significant morbidity.  Thus, there is an urgent need for new treatment modalities.  Tautomycin and tautomycetin are antifungal antibiotics isolated from Streptomyces spiroverticillatus and Streptomyces griseochromogens, resp.  Glycogen synthase kinase-3β is a serine/threonine protein kinase that regulates multiple cellular processes and is important in various cancers, including MTC.  Treatment with tautomycin and tautomycetin decreased neuroendocrine markers, suppressed hormonal secretion, and inhibited growth through apoptosis in MTC cells.  Importantly, we describe a novel action of these compds.: inhibition of glycogen synthase kinase-3β.[Mol Cancer Ther 2009;8(4):914-20].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsbyEBzq3K-rVg90H21EOLACvtfcHk0liRel2ApgNobA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1amtrc%253D&md5=8c61808108510fcd0d675ba54ba3ca4d</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0712%26sid%3Dliteratum%253Aachs%26aulast%3DAdler%26aufirst%3DJ.%2BT.%26aulast%3DCook%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DPitt%26aufirst%3DS.%2BC.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DKunnimalaiyaan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DTautomycetin%2520and%2520Tautomycin%2520Suppress%2520the%2520Growth%2520of%2520Medullary%2520Thyroid%2520Cancer%2520Cells%2520Via%2520Inhibition%2520of%2520Glycogen%2520Synthase%2520Kinase-3%25CE%25B2%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D914%26epage%3D920%26doi%3D10.1158%2F1535-7163.MCT-08-0712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choy, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettenbach, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span> <span> </span><span class="NLM_article-title">Pp1:Tautomycetin Complex Reveals a Path toward the Development of Pp1-Specific Inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">17703</span>– <span class="NLM_lpage">17706</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b09368</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b09368" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=17703-17706&author=M.+S.+Choyauthor=M.+Swingleauthor=B.+D%E2%80%99Arcyauthor=K.+Abneyauthor=S.+F.+Rusinauthor=A.+N.+Kettenbachauthor=R.+Pageauthor=R.+E.+Honkanenauthor=W.+Peti&title=Pp1%3ATautomycetin+Complex+Reveals+a+Path+toward+the+Development+of+Pp1-Specific+Inhibitors&doi=10.1021%2Fjacs.7b09368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">PP1:Tautomycetin Complex Reveals a Path toward the Development of PP1-Specific Inhibitors</span></div><div class="casAuthors">Choy, Meng S.; Swingle, Mark; D'Arcy, Brandon; Abney, Kevin; Rusin, Scott F.; Kettenbach, Arminja N.; Page, Rebecca; Honkanen, Richard E.; Peti, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17703-17706</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors for each serine/threonine phosphatase (PPP) are essential to investigate the biol. actions of PPPs and to guide drug development.  Biol. diverse organisms (e.g., cyanobacteria, dinoflagellates, beetles) produce structurally distinct toxins that are catalytic inhibitors of PPPs.  However, most toxins exhibit little selectivity, typically inhibiting multiple family members with similar potencies.  Thus, the use of these toxins as chem. tools to study the relationship between individual PPPs and their biol. substrates, and how disruptions in these relationships contributes to human disease, is severely limited.  Here, the authors show that tautomycetin (TTN) is highly selective for a single PPP, protein phosphatase 1 (PP1/PPP1C).  The structure of the PP1:TTN complex reveals that PP1 selectivity is defined by a covalent bond between TTN and a PP1-specific cysteine residue, Cys127.  Together, these data provide key mol. insights needed for the development of novel probes targeting single PPPs, esp. PP1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpALzQw5bYdb7Vg90H21EOLACvtfcHk0liRel2ApgNobA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbI&md5=d84b7f918040f64c3733e61383b3240c</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b09368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b09368%26sid%3Dliteratum%253Aachs%26aulast%3DChoy%26aufirst%3DM.%2BS.%26aulast%3DSwingle%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DB.%26aulast%3DAbney%26aufirst%3DK.%26aulast%3DRusin%26aufirst%3DS.%2BF.%26aulast%3DKettenbach%26aufirst%3DA.%2BN.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DPeti%26aufirst%3DW.%26atitle%3DPp1%253ATautomycetin%2520Complex%2520Reveals%2520a%2520Path%2520toward%2520the%2520Development%2520of%2520Pp1-Specific%2520Inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D17703%26epage%3D17706%26doi%3D10.1021%2Fjacs.7b09368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuhashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubukata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oikawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, K.</span></span> <span> </span><span class="NLM_article-title">Tautomycetin Is a Novel and Specific Inhibitor of Serine/Threonine Protein Phosphatase Type 1, Pp1</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2001.5596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1006%2Fbbrc.2001.5596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11554729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms12rtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2001&pages=328-331&author=S.+Mitsuhashiauthor=N.+Matsuuraauthor=M.+Ubukataauthor=H.+Oikawaauthor=H.+Shimaauthor=K.+Kikuchi&title=Tautomycetin+Is+a+Novel+and+Specific+Inhibitor+of+Serine%2FThreonine+Protein+Phosphatase+Type+1%2C+Pp1&doi=10.1006%2Fbbrc.2001.5596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Tautomycetin Is a Novel and Specific Inhibitor of Serine/Threonine Protein Phosphatase Type 1, PP1</span></div><div class="casAuthors">Mitsuhashi, Shinya; Matsuura, Nobuyasu; Ubukata, Makoto; Oikawa, Hideaki; Shima, Hiroshi; Kikuchi, Kunimi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-331</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Here we isolated tautomycetin, TC, and examd. its phosphatase inhibitory activity.  Recently we have reported that the left-hand moiety of tautomycin, TM, and the right one contg. the spiroketal are essentially required for inhibition of protein phosphatase, PP, and induction of apoptosis, resp.  TC is structurally almost identical to TM except that TC is lacking the spiroketal, which has the potential apoptosis-inducing activity.  TC specifically inhibited PP1 activity, IC50 values for purified PP1 and PP2A enzymes being 1.6 and 62 nM, resp., whereas the IC50 values of TM were 0.21 and 0.94 nM, resp.  These results demonstrate that TC is the most specific PP1 inhibitor out of over 40 species of natural phosphatase inhibitors reported, strongly suggesting that TC is a novel powerful tool to elucidate the physiol. roles of PP1 in various biol. events.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriOZircsC4mbVg90H21EOLACvtfcHk0lj_6XjsOfnzUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms12rtLk%253D&md5=71a0e3a172f3da73003d35f2c0f0d992</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.5596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.5596%26sid%3Dliteratum%253Aachs%26aulast%3DMitsuhashi%26aufirst%3DS.%26aulast%3DMatsuura%26aufirst%3DN.%26aulast%3DUbukata%26aufirst%3DM.%26aulast%3DOikawa%26aufirst%3DH.%26aulast%3DShima%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DK.%26atitle%3DTautomycetin%2520Is%2520a%2520Novel%2520and%2520Specific%2520Inhibitor%2520of%2520Serine%252FThreonine%2520Protein%2520Phosphatase%2520Type%25201%252C%2520Pp1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D287%26spage%3D328%26epage%3D331%26doi%3D10.1006%2Fbbrc.2001.5596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velmurugan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, Y. C.</span></span> <span> </span><span class="NLM_article-title">Combination of Celecoxib and Calyculin-a Inhibits Epithelial-Mesenchymal Transition in Human Oral Cancer Cells</span>. <i>Biotech. Histochem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1080/10520295.2019.1700429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1080%2F10520295.2019.1700429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31937145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2nsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2020&pages=341-348&author=B.+K.+Velmuruganauthor=C.+H.+Huaauthor=M.+H.+Tsaiauthor=C.+P.+Leeauthor=C.+M.+Chungauthor=Y.+C.+Ko&title=Combination+of+Celecoxib+and+Calyculin-a+Inhibits+Epithelial-Mesenchymal+Transition+in+Human+Oral+Cancer+Cells&doi=10.1080%2F10520295.2019.1700429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of celecoxib and calyculin-A inhibits epithelial-mesenchymal transition in human oral cancer cells</span></div><div class="casAuthors">Velmurugan, Bharath Kumar; Hua, Chun-Hung; Tsai, Ming-Hsui; Lee, Chi-Pin; Chung, Chia-Min; Ko, Ying-Chin</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnic & Histochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">341-348</span>CODEN:
                <span class="NLM_cas:coden">BIHIEU</span>;
        ISSN:<span class="NLM_cas:issn">1052-0295</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Expression of cyclo-oxygenase-2 (COX-2) and protein phosphatase 2A (PP2A) deactivation occurs frequently in oral squamous cell carcinoma (OSCC).  We initially assessed COX-2 and PP2A protein expression in OSCC specimens using immunohistochem. (IHC) staining and western blot anal.  We found strong COX-2 and phosphorylated PP2A (p-PP2A) expression in OSCC samples.  No significant difference in total PP2A expression was obsd. between cancer and nontumor tissues.  The effect of combining COX-2 inhibitor and celecoxib (CXB) with the PP2A inhibitor, calyculin-A (CLA) on the OSCC cell line, HSC3, was evaluated in vitro.  We found that a combination of 1 nM CLA and 50μM CXB significantly inhibited cell viability, and migration and invasion of HSC3 cells.  Western blots for AKT, p-AKT, ERK, p-ERK, E-cadherin, vimentin and β-catenin were conducted after treatment with CXB and/or CLA.  Increased E-cadherin and decreased β-catenin expression were found in CXB or CLA treated hsc-3 cells, whereas the combined CXB and CLA treatment showed no difference in E-cadherin or β-catenin expression.  Our findings suggest that CLA alone was more effective than CXB alone, but not in the combined drug treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmKsicr0G907Vg90H21EOLACvtfcHk0lj_6XjsOfnzUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2nsr4%253D&md5=894bf17776e9a22aaf5e08d58e38eff4</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1080%2F10520295.2019.1700429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10520295.2019.1700429%26sid%3Dliteratum%253Aachs%26aulast%3DVelmurugan%26aufirst%3DB.%2BK.%26aulast%3DHua%26aufirst%3DC.%2BH.%26aulast%3DTsai%26aufirst%3DM.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BP.%26aulast%3DChung%26aufirst%3DC.%2BM.%26aulast%3DKo%26aufirst%3DY.%2BC.%26atitle%3DCombination%2520of%2520Celecoxib%2520and%2520Calyculin-a%2520Inhibits%2520Epithelial-Mesenchymal%2520Transition%2520in%2520Human%2520Oral%2520Cancer%2520Cells%26jtitle%3DBiotech.%2520Histochem.%26date%3D2020%26volume%3D95%26spage%3D341%26epage%3D348%26doi%3D10.1080%2F10520295.2019.1700429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edelson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span> <span> </span><span class="NLM_article-title">The Discodermia Calyx Toxin Calyculin a Enhances Cyclin D1 Phosphorylation and Degradation, and Arrests Cell Cycle Progression in Human Breast Cancer Cells</span>. <i>Toxins</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.3390/toxins3010105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3390%2Ftoxins3010105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22069692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVSqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=105-119&author=J.+R.+Edelsonauthor=D.+L.+Brautigan&title=The+Discodermia+Calyx+Toxin+Calyculin+a+Enhances+Cyclin+D1+Phosphorylation+and+Degradation%2C+and+Arrests+Cell+Cycle+Progression+in+Human+Breast+Cancer+Cells&doi=10.3390%2Ftoxins3010105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">The Discodermia calyx toxin calyculin A enhances cyclin D1 phosphorylation and degradation, and arrests cell cycle progression in human breast cancer cells</span></div><div class="casAuthors">Edelson, Jessica R.; Brautigan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Toxins</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-119</span>CODEN:
                <span class="NLM_cas:coden">TOXIB7</span>;
        ISSN:<span class="NLM_cas:issn">2072-6651</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Cyclin D1 is a key regulator of the cell cycle that is over expressed in more than half of breast cancer patients.  The levels of cyclin D1 are controlled primarily through post-translational mechanisms and phosphorylation of cyclin D1 at T286 induces its proteasomal degrdn.  To date, no studies have explored the involvement of phosphatases in this process.  Here we treated human breast cancer cells with the structurally distinct toxins calyculin A, okadaic acid, and cantharidin, which are known to inhibit Ser/Thr phosphatases of the PPP family.  At low nanomolar concns. calyculin A induced T286 phosphorylation and degrdn. of cyclin D1 via the proteosome in MDA-MB-468 and MDA-MB-231 cells.  Cyclin D1 degrdn. also was dose-dependently induced by okadaic acid and catharidin, implicating a neg. regulatory role for type-2A phosphatases.  These effects occurred without increasing phosphorylation of p70S6K, cyclin D3, or myosin light chain that were used as endogenous reporters of cellular PP2A and PP1 activity.  A reverse phase phosphoprotein array anal. revealed increased phosphorylation of only 6 out of 33 Ser/Thr phosphosites, indicating selective inhibition of phosphatases by calyculin A.  Calyculin A treatment induced cell cycle arrest in MDA-MB-468 and MCF-7 breast cancer cells.  These findings suggest that a specific pool of type-2A phosphatase is inhibited by calyculin A leading to the degrdn. of cyclin D1 in human breast cancer cells.  The results highlight the utility of toxins as pharmacol. probes and points to the T286 cyclin D1 phosphatase inhibited by calyculin A as a possible target for chemotherapy to treat triple neg. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8BWDOyU65SbVg90H21EOLACvtfcHk0lj_6XjsOfnzUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVSqsL0%253D&md5=be584d29f5225f6f219bca8cfa94ef46</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.3390%2Ftoxins3010105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Ftoxins3010105%26sid%3Dliteratum%253Aachs%26aulast%3DEdelson%26aufirst%3DJ.%2BR.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Discodermia%2520Calyx%2520Toxin%2520Calyculin%2520a%2520Enhances%2520Cyclin%2520D1%2520Phosphorylation%2520and%2520Degradation%252C%2520and%2520Arrests%2520Cell%2520Cycle%2520Progression%2520in%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DToxins%26date%3D2011%26volume%3D3%26spage%3D105%26epage%3D119%26doi%3D10.3390%2Ftoxins3010105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lê, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlichman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiessen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhauer, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M. J.</span></span> <span> </span><span class="NLM_article-title">Phase I and Pharmacokinetic Study of Fostriecin Given as an Intravenous Bolus Daily for Five Consecutive Days</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1023/B:DRUG.0000011792.13160.b0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1023%2FB%3ADRUG.0000011792.13160.b0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=14739664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisleisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=159-167&author=L.+H.+L%C3%AAauthor=C.+Erlichmanauthor=L.+Pillonauthor=J.+J.+Thiessenauthor=A.+Dayauthor=N.+Wainmanauthor=E.+A.+Eisenhauerauthor=M.+J.+Moore&title=Phase+I+and+Pharmacokinetic+Study+of+Fostriecin+Given+as+an+Intravenous+Bolus+Daily+for+Five+Consecutive+Days&doi=10.1023%2FB%3ADRUG.0000011792.13160.b0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and Pharmacokinetic Study of Fostriecin given as an Intravenous Bolus Daily for Five Consecutive Days</span></div><div class="casAuthors">Le, Lyly H.; Erlichman, Charles; Pillon, Linda; Thiessen, Jake J.; Day, Andrew; Wainman, Nancy; Eisenhauer, Elizabeth A.; Moore, Malcolm J.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-167</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Fostriecin (CI-920) is a potent inhibitor of protein phosphatase 2A (PP2A) and protein phosphatase 4(PP4) found to have anticancer activity in preclin. testing.  A phase I study was conducted to evaluate the max.-tolerated dose (MTD), toxicity profile, and pharmacokinetics (PK) of this drug.  Forty-six patients were treated with escalating doses of fostriecin (2-47 mg/m2) administered as a daily bolus infusion for five consecutive days.  PK studies were performed at different time points following administration of fostriecin.  Dose-limiting toxicities included: elevation of creatinine, bilirubin, and hepatic transaminases; nausea, anorexia, lethargy, and hypotension.  PK studies were compatible with a two-compartment model.  Regression anal. revealed a significant relationship between dose and clearance; however, the r2 value was only 0.168 indicating a low predictive value for the model.  No significant difference was seen in PK parameters with repeated dosing during the same cycle.  Although no tumor responses were seen, 16 patients had stable disease with a median duration response of 2.6 mo.  The study was closed before reaching MTD due to problems with the supply of fostriecin from the National Cancer Institute of the United States (NCI US).  New methods for synthesizing fostriecin have recently been described and therefore further development of this unique anticancer agent may be warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGCDycMl34ErVg90H21EOLACvtfcHk0lh7WEoP_DEIzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisleisQ%253D%253D&md5=1439c0b7a0c9d9a072a15e1573163c8a</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1023%2FB%3ADRUG.0000011792.13160.b0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253ADRUG.0000011792.13160.b0%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25AA%26aufirst%3DL.%2BH.%26aulast%3DErlichman%26aufirst%3DC.%26aulast%3DPillon%26aufirst%3DL.%26aulast%3DThiessen%26aufirst%3DJ.%2BJ.%26aulast%3DDay%26aufirst%3DA.%26aulast%3DWainman%26aufirst%3DN.%26aulast%3DEisenhauer%26aufirst%3DE.%2BA.%26aulast%3DMoore%26aufirst%3DM.%2BJ.%26atitle%3DPhase%2520I%2520and%2520Pharmacokinetic%2520Study%2520of%2520Fostriecin%2520Given%2520as%2520an%2520Intravenous%2520Bolus%2520Daily%2520for%2520Five%2520Consecutive%2520Days%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2004%26volume%3D22%26spage%3D159%26epage%3D167%26doi%3D10.1023%2FB%3ADRUG.0000011792.13160.b0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tunac, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, W. E.</span></span> <span> </span><span class="NLM_article-title">Novel Antitumor Agents Ci-920, Pd113,270 and Pd113,271. I. Taxonomy, Fermentation and Biological Properties</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1595</span>– <span class="NLM_lpage">1600</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.36.1595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.7164%2Fantibiotics.36.1595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=6689323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL2cXhtlOhur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1983&pages=1595-1600&author=J.+B.+Tunacauthor=B.+D.+Grahamauthor=W.+E.+Dobson&title=Novel+Antitumor+Agents+Ci-920%2C+Pd113%2C270+and+Pd113%2C271.+I.+Taxonomy%2C+Fermentation+and+Biological+Properties&doi=10.7164%2Fantibiotics.36.1595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Novel antitumor agents CI-920, PD 113,270 and PD 113,271.  I.  Taxonomy, fermentation and biological properties</span></div><div class="casAuthors">Tunac, J. B.; Graham, B. D.; Dobson, W. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1595-600</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">CI-920 (PD 110,161)  [87810-56-8] and 2 analogs (PD 113,270  [87860-37-5] and PD 113,271  [87810-56-8]) are novel antitumor compds. produced by a new actinomycete characterized as Streptomyces pulveraceus subspecies fostreus ATCC 31906.  The antitumor compds. are predominantly produced during the stationary (idiophase) growth phase of the organism.  CI-920 is active against the murine P388 lymphocytic and L1210 lymphoid leukemia with T/C values of 246 and 207, resp.  This compd. has no significant antimicrobial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJnwOMEqsDLrVg90H21EOLACvtfcHk0lh7WEoP_DEIzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtlOhur8%253D&md5=4eea14d04a03e9c44325f3b30dced9a1</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.36.1595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.36.1595%26sid%3Dliteratum%253Aachs%26aulast%3DTunac%26aufirst%3DJ.%2BB.%26aulast%3DGraham%26aufirst%3DB.%2BD.%26aulast%3DDobson%26aufirst%3DW.%2BE.%26atitle%3DNovel%2520Antitumor%2520Agents%2520Ci-920%252C%2520Pd113%252C270%2520and%2520Pd113%252C271.%2520I.%2520Taxonomy%252C%2520Fermentation%2520and%2520Biological%2520Properties%26jtitle%3DJ.%2520Antibiot.%26date%3D1983%26volume%3D36%26spage%3D1595%26epage%3D1600%26doi%3D10.7164%2Fantibiotics.36.1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stampwala, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunge, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willmer, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brankiewicz, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smitka, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, J. C.</span></span> <span> </span><span class="NLM_article-title">Novel Antitumor Agents Ci-920, Pd113,270 and Pd113,271. Ii. Isolation and Characterization</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1605</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.36.1601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.7164%2Fantibiotics.36.1601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=6689324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL2cXhtlGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1983&pages=1601-1605&author=S.+S.+Stampwalaauthor=R.+H.+Bungeauthor=T.+R.+Hurleyauthor=N.+E.+Willmerauthor=A.+J.+Brankiewiczauthor=C.+E.+Steinmanauthor=T.+A.+Smitkaauthor=J.+C.+French&title=Novel+Antitumor+Agents+Ci-920%2C+Pd113%2C270+and+Pd113%2C271.+Ii.+Isolation+and+Characterization&doi=10.7164%2Fantibiotics.36.1601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Novel antitumor agents CI-920, PD 113,270 and PD 113,271.  II.  Isolation and characterization</span></div><div class="casAuthors">Stampwala, S. S.; Bunge, R. H.; Hurley, T. R.; Willmer, N. E.; Brankiewicz, A. J.; Steinman, C. E.; Smitka, T. A.; French, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1601-5</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">A complex of structurally related compds. that exhibit in vivo antileukemic activity was isolated from fermn. broths of a new streptomycete.  The components of this complex are water sol. phosphate esters contg. a conjugated triene system.  The isolation and characterization of 3 of these components are described: CI-920 (I), PD 113,270 (II), and PD 11,271 (III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxZWINg6gZLVg90H21EOLACvtfcHk0lh7WEoP_DEIzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtlGltL8%253D&md5=513f2bc9f77918073e5636c743bd0ab5</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.36.1601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.36.1601%26sid%3Dliteratum%253Aachs%26aulast%3DStampwala%26aufirst%3DS.%2BS.%26aulast%3DBunge%26aufirst%3DR.%2BH.%26aulast%3DHurley%26aufirst%3DT.%2BR.%26aulast%3DWillmer%26aufirst%3DN.%2BE.%26aulast%3DBrankiewicz%26aufirst%3DA.%2BJ.%26aulast%3DSteinman%26aufirst%3DC.%2BE.%26aulast%3DSmitka%26aufirst%3DT.%2BA.%26aulast%3DFrench%26aufirst%3DJ.%2BC.%26atitle%3DNovel%2520Antitumor%2520Agents%2520Ci-920%252C%2520Pd113%252C270%2520and%2520Pd113%252C271.%2520Ii.%2520Isolation%2520and%2520Characterization%26jtitle%3DJ.%2520Antibiot.%26date%3D1983%26volume%3D36%26spage%3D1601%26epage%3D1605%26doi%3D10.7164%2Fantibiotics.36.1601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haslbeck, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drazic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckl, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alte, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popowicz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemmecker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Striggow, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, K.</span></span> <span> </span><span class="NLM_article-title">Selective Activators of Protein Phosphatase 5 Target the Auto-Inhibitory Mechanism</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">e00210</span>, <span class="refDoi"> DOI: 10.1042/BSR20150042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1042%2FBSR20150042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26182372" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=e00210&author=V.+Haslbeckauthor=A.+Drazicauthor=J.+M.+Ecklauthor=F.+Alteauthor=M.+Helmuthauthor=G.+Popowiczauthor=W.+Schmidtauthor=F.+Braunauthor=M.+Weiwadauthor=G.+Fischerauthor=G.+Gemmeckerauthor=M.+Sattlerauthor=F.+Striggowauthor=M.+Grollauthor=K.+Richter&title=Selective+Activators+of+Protein+Phosphatase+5+Target+the+Auto-Inhibitory+Mechanism&doi=10.1042%2FBSR20150042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1042%2FBSR20150042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20150042%26sid%3Dliteratum%253Aachs%26aulast%3DHaslbeck%26aufirst%3DV.%26aulast%3DDrazic%26aufirst%3DA.%26aulast%3DEckl%26aufirst%3DJ.%2BM.%26aulast%3DAlte%26aufirst%3DF.%26aulast%3DHelmuth%26aufirst%3DM.%26aulast%3DPopowicz%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DW.%26aulast%3DBraun%26aufirst%3DF.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DGemmecker%26aufirst%3DG.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DStriggow%26aufirst%3DF.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DK.%26atitle%3DSelective%2520Activators%2520of%2520Protein%2520Phosphatase%25205%2520Target%2520the%2520Auto-Inhibitory%2520Mechanism%26jtitle%3DBiosci.%2520Rep.%26date%3D2015%26volume%3D35%26spage%3De00210%26doi%3D10.1042%2FBSR20150042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, J. S.</span></span> <span> </span><span class="NLM_article-title">Ro 90-7501 Inhibits Pp5 through a Novel, Tpr-Dependent Mechanism</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>482</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.11.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bbrc.2016.11.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=27840051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKgtrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2017&pages=215-220&author=T.+J.+Hongauthor=K.+Parkauthor=E.+W.+Choiauthor=J.+S.+Hahn&title=Ro+90-7501+Inhibits+Pp5+through+a+Novel%2C+Tpr-Dependent+Mechanism&doi=10.1016%2Fj.bbrc.2016.11.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Ro 90-7501 inhibits PP5 through a novel, TPR-dependent mechanism</span></div><div class="casAuthors">Hong, Tae-Joon; Park, Kwanghyun; Choi, Eun-Wook; Hahn, Ji-Sook</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein phosphatase 5 (PP5) is a serine/threonine phosphatase that belongs to the PPP family phosphatases.  PP5 and the other phosphatases of the PPP family share significantly similar catalytic domain structure.  Due to this structural similarity, natural competitive inhibitors such as okadaic acid and cantharidin exhibit broad specificity over the PPP family phosphatases.  In this study, we report the identification of three PP5 inhibitors, Ro 90-7501, aurothioglucose, and N-oleoyldopamine, along with a novel inhibitory mechanism of Ro 90-7501.  Unlike other inhibitors binding to the phosphatase domain, Ro 90-7501 inhibited PP5 in a TPR-dependent manner.  This TPR-dependent PP5 inhibition shown by Ro 90-7501 is a unique and novel inhibitory mechanism, which might be a useful tool for studies of PP5 on both regulatory mechanism and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7kSCE7SCq4bVg90H21EOLACvtfcHk0lgow_z9tQZH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKgtrfO&md5=e6145b85c9ecfe377f05340331625b94</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.11.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.11.043%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DT.%2BJ.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DE.%2BW.%26aulast%3DHahn%26aufirst%3DJ.%2BS.%26atitle%3DRo%252090-7501%2520Inhibits%2520Pp5%2520through%2520a%2520Novel%252C%2520Tpr-Dependent%2520Mechanism%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D482%26spage%3D215%26epage%3D220%26doi%3D10.1016%2Fj.bbrc.2016.11.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung
Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">Identification of Chaulmoogric Acid as a Small Molecule Activator of Protein Phosphatase 5</span>. <i>Appl. Biochem. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">1450</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.1007/s12010-009-8647-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs12010-009-8647-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19404779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivVSmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=1450-1459&author=C.+Cherauthor=M.-H.+Tremblayauthor=J.+R.+Barberauthor=S.+Chung%0ANgauthor=B.+Zhang&title=Identification+of+Chaulmoogric+Acid+as+a+Small+Molecule+Activator+of+Protein+Phosphatase+5&doi=10.1007%2Fs12010-009-8647-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of chaulmoogric acid as a small molecule activator of protein phosphatase 5</span></div><div class="casAuthors">Cher, Charmian; Tremblay, Marie-Helene; Barber, Jack R.; Ng, Shi Chung; Zhang, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Applied Biochemistry and Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1450-1459</span>CODEN:
                <span class="NLM_cas:coden">ABIBDL</span>;
        ISSN:<span class="NLM_cas:issn">0273-2289</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protein phosphatase 5 (PP5) is an important protein phosphatase that is abundantly expressed in the central nervous system.  Recent studies showed that PP5 activity in the neocortex from patients with Alzheimer's disease (AD) is decreased significantly, suggesting that small mol. PP5 activators may have therapeutic potential for AD.  Here, the authors performed a biochem. screening for PP5 activators with the microsource compd. library.  Chaulmoogric acid (I) was identified to be an effective activator with EC50 value of 134.5 μM.  Importantly, results from CD and limited proteolysis studies showed that I bound to a region of the tetratricopeptide repeat (TPR) domain of PP5 resulting in complete loss of helical content.  These results demonstrated a different mechanism of action from that of arachidonic acid, a known activator for PP5 dephosphorylation activity.  Synergistic activation of PP5 enzymic activity was also obsd. with combined application of both compds. at relatively low concns.  Therefore, a further structure-activity relation study of I may facilitate the discovery of small mols. that can synergize with endogenous arachidonic acid for PP5 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8yRVAxHEbELVg90H21EOLACvtfcHk0lgow_z9tQZH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivVSmtbs%253D&md5=3d4afccc38de95524d20fe77d34b3e18</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1007%2Fs12010-009-8647-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12010-009-8647-3%26sid%3Dliteratum%253Aachs%26aulast%3DCher%26aufirst%3DC.%26aulast%3DTremblay%26aufirst%3DM.-H.%26aulast%3DBarber%26aufirst%3DJ.%2BR.%26aulast%3DChung%2BNg%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520Chaulmoogric%2520Acid%2520as%2520a%2520Small%2520Molecule%2520Activator%2520of%2520Protein%2520Phosphatase%25205%26jtitle%3DAppl.%2520Biochem.%2520Biotechnol.%26date%3D2010%26volume%3D160%26spage%3D1450%26epage%3D1459%26doi%3D10.1007%2Fs12010-009-8647-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikekita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinomiya, T.</span></span> <span> </span><span class="NLM_article-title">A Novel Immunosuppressive Agent Fty720 Induced Akt Dephosphorylation in Leukemia Cells</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1312</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0705182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsj.bjp.0705182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=12711631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFGiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2003&pages=1303-1312&author=Y.+Matsuokaauthor=Y.+Nagaharaauthor=M.+Ikekitaauthor=T.+Shinomiya&title=A+Novel+Immunosuppressive+Agent+Fty720+Induced+Akt+Dephosphorylation+in+Leukemia+Cells&doi=10.1038%2Fsj.bjp.0705182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells</span></div><div class="casAuthors">Matsuoka, Yumiko; Nagahara, Yukitoshi; Ikekita, Masahiko; Shinomiya, Takahisa</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1303-1312</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Our previous studies revealed that the immunosuppressive agent, FTY720, mainly induces mitochondria-involved apoptosis in some types of cancer cells, since Bcl-2 overexpression prevents the FTY720-induction of apoptotic stimuli.  Furthermore, FTY720 induces G0/G1 cell cycle arrest.  The present study further examines the correlation between intracellular signaling kinases with FTY720-induced mitochondria-involved apoptosis.  Human T cell leukemia Jurkat was exposed to FTY720.  Dephosphorylation of Akt occurred in a time- and concn.-dependent manner.  FTY720 also induced Bad (Ser136) and ribosomal p70S6 kinase (p7056k) (Thr389) dephosphorylation.  FTY720-induced Akt dephosphorylation was not because of Akt upstream phosphatidylinositol 3'-kinase (PI 3-kinase) pathway inhibition.  FTY720 also induced Akt dephosphorylation in human B cell leukemia BALL-1.  BALL-1 cells were resistant to FTY720-induced apoptosis.  Okadaic acid (OA) inhibited the FTY720-induced dephosphorylation of Akt and p70S6k, suggesting that FTY720 promotes Ser/Thr protein phosphatase (PP) activity.  OA partially inhibited FTY720-induced caspase-3 activation.  PP2A or PP2A-like phosphatase was temporarily activated in cells exposed to FTY720.  In addn., FTY720 activated purified PP2A (ABC).  Overall, the results suggest that FTY720 activated PP2A or PP2A-like phosphatase and dephosphorylated Akt pathway factors resulting in the enhancement of apoptosis via mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB5BFOyJHN8rVg90H21EOLACvtfcHk0lgow_z9tQZH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFGiu74%253D&md5=b49a304112e81d5c254f5803f5c70cac</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705182%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DY.%26aulast%3DNagahara%26aufirst%3DY.%26aulast%3DIkekita%26aufirst%3DM.%26aulast%3DShinomiya%26aufirst%3DT.%26atitle%3DA%2520Novel%2520Immunosuppressive%2520Agent%2520Fty720%2520Induced%2520Akt%2520Dephosphorylation%2520in%2520Leukemia%2520Cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D138%26spage%3D1303%26epage%3D1312%26doi%3D10.1038%2Fsj.bjp.0705182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mudhakir, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalil, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harashima, H.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic Analysis of the Tissue Distribution of Octaarginine Modified Liposomes in Mice</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.2133/dmpk.20.275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2133%2Fdmpk.20.275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=16141607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWitrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=275-281&author=D.+Mudhakirauthor=H.+Akitaauthor=I.+A.+Khalilauthor=S.+Futakiauthor=H.+Harashima&title=Pharmacokinetic+Analysis+of+the+Tissue+Distribution+of+Octaarginine+Modified+Liposomes+in+Mice&doi=10.2133%2Fdmpk.20.275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic analysis of the tissue distribution of octaarginine modified liposomes in mice</span></div><div class="casAuthors">Mudhakir, Diky; Akita, Hidetaka; Khalil, Ikramy A.; Futaki, Shiroh; Harashima, Hideyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">275-281</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">We recently found that octaarginine modified liposomes (R8-Lip) can be efficiently internalized by cultured cells.  The purpose of the present study was to quant. det. the effect of R8-d. on the tissue distribution of R8-Lip in mice, using their clearance as an index.  R8 was introduced in the form of stearylated R8 (STR-R8).  The liposomes were composed of cholesterol and egg phosphatidylcholine and were labeled with [3H]cholesteryl hexadecyl ether.  Various densities of R8 (3%, 10% and 30%) contg. liposomes were prepd. with a diam. of approx. 70-80 nm.  The tissue distribution of R8-Lip was detd. after their i.v. administration into mice and the effect of R8-d. on tissue distribution was compared with uptake clearance, the calcd. tissue distribution divided by the area under the blood concn.-time course.  As results, R8-Lip were more rapidly eliminated from circulating blood and distributed to many tissues, esp. liver depending on the R8-d.  However, the tissue uptake clearance represented similar value to that of pos. charge liposomes.  Based on these results, we conclude that the R8-dependent increase in R8-Lip in various tissues tested indicates that pos. charge, but not PTD function derived from R8 predominantly responsible for the enhancement of tissue distribution.  Therefore, it is suggested that topol. control of R8 is important to exhibit the PTD function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWHEEeoxWEWrVg90H21EOLACvtfcHk0lhGFCZdcqg-xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWitrnF&md5=3423e90977c4c239f214ac2e33bad919</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.20.275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.20.275%26sid%3Dliteratum%253Aachs%26aulast%3DMudhakir%26aufirst%3DD.%26aulast%3DAkita%26aufirst%3DH.%26aulast%3DKhalil%26aufirst%3DI.%2BA.%26aulast%3DFutaki%26aufirst%3DS.%26aulast%3DHarashima%26aufirst%3DH.%26atitle%3DPharmacokinetic%2520Analysis%2520of%2520the%2520Tissue%2520Distribution%2520of%2520Octaarginine%2520Modified%2520Liposomes%2520in%2520Mice%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2005%26volume%3D20%26spage%3D275%26epage%3D281%26doi%3D10.2133%2Fdmpk.20.275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Permpongkosol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumiya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongkanand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuyama, A.</span></span> <span> </span><span class="NLM_article-title">Anticarcinogenic Effect of Fty720 in Human Prostate Carcinoma Du145 Cells: Modulation of Mitogenic Signaling, Fak, Cell-Cycle Entry and Apoptosis</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1002/ijc.10178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fijc.10178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11857403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2002&pages=167-172&author=S.+Permpongkosolauthor=J.+D.+Wangauthor=S.+Takaharaauthor=K.+Matsumiyaauthor=N.+Nonomuraauthor=K.+Nishimuraauthor=A.+Tsujimuraauthor=A.+Kongkanandauthor=A.+Okuyama&title=Anticarcinogenic+Effect+of+Fty720+in+Human+Prostate+Carcinoma+Du145+Cells%3A+Modulation+of+Mitogenic+Signaling%2C+Fak%2C+Cell-Cycle+Entry+and+Apoptosis&doi=10.1002%2Fijc.10178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis</span></div><div class="casAuthors">Permpongkosol, Sompol; Wang, Jing-Ding; Takahara, Shiro; Matsumiya, Kiyomi; Nonomura, Norio; Nishimura, Kazuo; Tsujimura, Akira; Kongkanand, Apichat; Okuyama, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-172</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Despite the high frequency of prostate cancer, therapeutic options for advanced disease are limited to chemotherapy, radiation or hormonal therapy and eventually fail in all patients.  Therefore, alternative approaches need to be developed.  We previously reported that FTY720, a metabolite from Isaria sinclairii, is a unique antitumor agent for an androgen-independent prostate cancer cell line and requires caspase-3 activation in apoptosis.  In our study, we have evaluated the effect of FTY720 on a family of mitogen-activated protein kinases (MAPKs), focal adhesion kinase (FAK), mitochondrial transmembrane potential, caspase-9 and caspase-8 and analyzed the expression of some cell-cycle regulator proteins in DU145 cells to understand the various antitumor effects of FTY720.  Apoptosis was quantified by phosphatidylserine exposure.  Activation of MAPKs, cleavage of caspase-9 and caspase-8, status of cyclin-dependent kinases (CDKs) and Cip1/p21, a cyclin-dependent kinase inhibitor, were evaluated by Western blot anal., in addn. to FAK and phospho-FAK immunopptn. and cell-cycle anal. by FAC Scan.  We found that in DU145 cells, 40 μM FTY720 caused activation of p38 MAPK and the upstream kinase MKK3/MKK6 but not SAPK/JNK.  Mitochondrial transmembrane potential, FAK and ERK1/2 were reduced while caspase-9 and caspase-8 were cleaved.  The p38-specific inhibitor had no effect on apoptosis induced by FTY720, whereas z-VAD.FMK, a broad-spectrum caspase inhibitor, did not inhibit the p38 MAPK activation.  An amt. of 20 μM FTY720 resulted in G1 arrest and a decrease of CDK2 as well as CDK4, whereas it induced Cip1/p21.  FTY720 may exert anticarcinogenic effects against prostate cancer cells possibly involving modulation of mitogenic signaling, cell-cycle regulators, induction of G1 arrest and apoptotic death in DU145 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYNohycZVKrrVg90H21EOLACvtfcHk0lhGFCZdcqg-xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVSktb8%253D&md5=18bac0de77ae125c2fdca91164b0f9c5</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2Fijc.10178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.10178%26sid%3Dliteratum%253Aachs%26aulast%3DPermpongkosol%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BD.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DMatsumiya%26aufirst%3DK.%26aulast%3DNonomura%26aufirst%3DN.%26aulast%3DNishimura%26aufirst%3DK.%26aulast%3DTsujimura%26aufirst%3DA.%26aulast%3DKongkanand%26aufirst%3DA.%26aulast%3DOkuyama%26aufirst%3DA.%26atitle%3DAnticarcinogenic%2520Effect%2520of%2520Fty720%2520in%2520Human%2520Prostate%2520Carcinoma%2520Du145%2520Cells%253A%2520Modulation%2520of%2520Mitogenic%2520Signaling%252C%2520Fak%252C%2520Cell-Cycle%2520Entry%2520and%2520Apoptosis%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2002%26volume%3D98%26spage%3D167%26epage%3D172%26doi%3D10.1002%2Fijc.10178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otsuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuoka, Y.</span></span> <span> </span><span class="NLM_article-title">Induction of Apoptosis in Human Bladder Cancer Cells in Vitro and in Vivo Caused by Fty720 Treatment</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">2372</span>– <span class="NLM_lpage">2377</span>, <span class="refDoi"> DOI: 10.1097/01.ju.0000064938.32318.91</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1097%2F01.ju.0000064938.32318.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=12771800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlOisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2003&pages=2372-2377&author=H.+Azumaauthor=S.+Takaharaauthor=S.+Horieauthor=S.+Mutoauthor=Y.+Otsukiauthor=Y.+Katsuoka&title=Induction+of+Apoptosis+in+Human+Bladder+Cancer+Cells+in+Vitro+and+in+Vivo+Caused+by+Fty720+Treatment&doi=10.1097%2F01.ju.0000064938.32318.91"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of Apoptosis in Human Bladder Cancer Cells In Vitro and In Vivo Caused by FTY720 Treatment</span></div><div class="casAuthors">Azuma, Haruhito; Takahara, Shiro; Horie, Shigeo; Muto, Satoru; Otsuki, Yoshinori; Katsuoka, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2372-2377</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">FTY720 is a unique immunosuppressant that induces apoptosis in activated lymphocytes but not in other hematopoietic cells.  We examd. whether FTY720 has anticancer effects on human bladder cancer cells by inducing apoptosis and we investigated its mol. pathway.  MATERIALS AND METHODS We used the 3 human bladder cancer cell lines T24, UMUC3 and HT1197, and the human fibroblast derived cell line CRL-2096 (American Type Tissue Collection, Rockville, Maryland) in this study.  The difference in drug susceptibility to FTY720 in cancer cells and fibroblasts was examd. by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and cell growth assays.  FTY720 induced apoptosis was detd. by morphol. anal. under light and electron microscopy, and DNA electrophoresis, and its mol. pathway was evaluated by Western blot anal. focusing on the p42/p44 mitogen activated protein kinase pathway.  We then tested the in vivo effect of this agent using 2 mouse models of human bladder cancer xenograft.  RESULTS FTY720 treatment in vitro induced selective apoptosis in cancer cells at a concn. of less than 10 μM. Morphol. anal. revealed features characteristic of apoptosis, including small cytoplasm with fragmented nuclei and condensed chromatin.  DNA electrophoresis confirmed apoptosis, as evidenced by a distinct oligosomal ladder.  Western blot anal. revealed that the agent significantly inhibited hepatocyte growth factor induced p42/p44 mitogen activated protein kinase activity.  The in vivo anticancer effect was clearly confirmed by significantly decreased tumor growth without notable side effects in the 2 xenograft models.  CONCLUSIONS FTY720 treatment may induce selective apoptosis in vitro as well as in vivo in cancer cells.  We suggest that FTY720 is a potent and clin. applicable anticancer agent for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLUVoMc3LO8rVg90H21EOLACvtfcHk0lhGFCZdcqg-xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlOisLY%253D&md5=48b7aff671b4fcb1f64117dd3b62614c</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1097%2F01.ju.0000064938.32318.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.ju.0000064938.32318.91%26sid%3Dliteratum%253Aachs%26aulast%3DAzuma%26aufirst%3DH.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DHorie%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DS.%26aulast%3DOtsuki%26aufirst%3DY.%26aulast%3DKatsuoka%26aufirst%3DY.%26atitle%3DInduction%2520of%2520Apoptosis%2520in%2520Human%2520Bladder%2520Cancer%2520Cells%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Caused%2520by%2520Fty720%2520Treatment%26jtitle%3DJ.%2520Urol.%26date%3D2003%26volume%3D169%26spage%3D2372%26epage%3D2377%26doi%3D10.1097%2F01.ju.0000064938.32318.91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sonoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizu-Yokota, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momoi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, T.</span></span> <span> </span><span class="NLM_article-title">Fty720, a Novel Immunosuppressive Agent, Induces Apoptosis in Human Glioma Cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2001.4352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1006%2Fbbrc.2001.4352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11181042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1aitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2001&pages=282-288&author=Y.+Sonodaauthor=D.+Yamamotoauthor=S.+Sakuraiauthor=M.+Hasegawaauthor=E.+Aizu-Yokotaauthor=T.+Momoiauthor=T.+Kasahara&title=Fty720%2C+a+Novel+Immunosuppressive+Agent%2C+Induces+Apoptosis+in+Human+Glioma+Cells&doi=10.1006%2Fbbrc.2001.4352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720, a Novel Immunosuppressive Agent, Induces Apoptosis in Human Glioma Cells</span></div><div class="casAuthors">Sonoda, Yoshiko; Yamamoto, Daisuke; Sakurai, Shinya; Hasegawa, Maki; Aizu-Yokota, Eriko; Momoi, Takashi; Kasahara, Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">282-288</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">FTY720, a metabolite from Isaria sinclairii, has been developed to be a potent immunosuppressive drug with induction of apoptosis in T cells and several cell lines.  We investigated whether FTY720 induces apoptosis in human glioma cell lines, since they are relatively resistant to multiple apoptotic stimuli.  In human glioma cells including T98G, FTY720 induced apoptosis with ED50 between 1 to 10 μg/mL, while etoposide did not induce apoptosis at the same doses.  Among the caspase family proteases, mainly caspase-6 was activated during the apoptosis by FTY720 but not etoposide.  In addn., FTY720 caused tyrosine dephosphorylation of FAK and did not activate a FAK-PI3-kinase survival pathway.  This was confirmed also by the observation that orthovanadate prevented FTY720-induced dephosphorylation of FAK and inhibited FTY720-induced cell death.  We assumed that FTY720 induced FAK dephosphorylation and cut off the FAK-PI3-kinase pathway resulting in the induction of apoptosis via caspase-6 activation in these glioma cells.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgnarZ8uvwVbVg90H21EOLACvtfcHk0lg1-f9fKF7XLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1aitLY%253D&md5=54a9a89c87911ee6f4e6a0f3d701b4ff</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.4352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.4352%26sid%3Dliteratum%253Aachs%26aulast%3DSonoda%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DD.%26aulast%3DSakurai%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DAizu-Yokota%26aufirst%3DE.%26aulast%3DMomoi%26aufirst%3DT.%26aulast%3DKasahara%26aufirst%3DT.%26atitle%3DFty720%252C%2520a%2520Novel%2520Immunosuppressive%2520Agent%252C%2520Induces%2520Apoptosis%2520in%2520Human%2520Glioma%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D281%26spage%3D282%26epage%3D288%26doi%3D10.1006%2Fbbrc.2001.4352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrestha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, E.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baek, D. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Fty720 (Fingolimod) Derivatives with Aromatic Head Group as Anticancer Agents</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1015</span>– <span class="NLM_lpage">1018</span>, <span class="refDoi"> DOI: 10.1248/cpb.c18-00065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1248%2Fcpb.c18-00065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30270236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltF2qtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=1015-1018&author=T.+Leeauthor=H.+S.+Moonauthor=S.+W.+Kimauthor=J.+Shresthaauthor=S.+M.+Shinauthor=J.-Y.+Leeauthor=S.+Kimauthor=E.-Y.+Parkauthor=D.+J.+Baek&title=Synthesis+and+Biological+Evaluation+of+Fty720+%28Fingolimod%29+Derivatives+with+Aromatic+Head+Group+as+Anticancer+Agents&doi=10.1248%2Fcpb.c18-00065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of FTY720 (fingolimod) derivatives with aromatic head group as anticancer agents</span></div><div class="casAuthors">Lee, Taeho; Moon, Hong Seop; Kim, Seon Woong; Shrestha, Jitendra; Shin, Sang Mi; Lee, Joo-Youn; Kim, Sanghee; Park, Eun-Young; Baek, Dong Jae</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1015-1018</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">FTY720 is employed for the treatment of multiple sclerosis and exerts apoptotic effects on various cancers through protein phosphatase 2A (PP2A) activation.  In compd. I (R = 2,6-(OH)2C6H3), the dihydroxy head group of FTY720 was modified into dihydroxy Ph group.  The cell survival in I treated colorectal and gastric cancer cells was significantly reduced as compared with control, 34.6 and 25.1%, resp.  The docking study of I showed that the arom. head group effectively binds to PP2A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKotwPi-v_LVg90H21EOLACvtfcHk0lg1-f9fKF7XLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltF2qtrg%253D&md5=ef00753b12ce5459fe936d7e76cfc29f</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c18-00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c18-00065%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%26aulast%3DMoon%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DShrestha%26aufirst%3DJ.%26aulast%3DShin%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DJ.-Y.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DE.-Y.%26aulast%3DBaek%26aufirst%3DD.%2BJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Fty720%2520%2528Fingolimod%2529%2520Derivatives%2520with%2520Aromatic%2520Head%2520Group%2520as%2520Anticancer%2520Agents%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2018%26volume%3D66%26spage%3D1015%26epage%3D1018%26doi%3D10.1248%2Fcpb.c18-00065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S. S.</span></span> <span> </span><span class="NLM_article-title">Fty720, a Synthetic Compound from Isaria Sinclairii, Inhibits Proliferation and Induces Apoptosis in Pancreatic Cancer Cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2007.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.canlet.2007.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17462818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFKjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2007&pages=288-297&author=Y.+Shenauthor=M.+X.+Caiauthor=W.+L.+Xiaauthor=J.+W.+Liuauthor=Q.+Y.+Zhangauthor=H.+Y.+Xieauthor=C.+Wangauthor=X.+H.+Wangauthor=S.+S.+Zheng&title=Fty720%2C+a+Synthetic+Compound+from+Isaria+Sinclairii%2C+Inhibits+Proliferation+and+Induces+Apoptosis+in+Pancreatic+Cancer+Cells&doi=10.1016%2Fj.canlet.2007.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells</span></div><div class="casAuthors">Shen, Yan; Cai, Minxia; Xia, Weiliang; Liu, Junwei; Zhang, Qiyi; Xie, Haiyang; Wang, Chen; Wang, Xiaohui; Zheng, Shusen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">288-297</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">FTY720, a synthetic compd. produced by modification of a metabolite from Isaria sinclairii, is known as a unique immunosuppressive agent that exerts its activity by inducing apoptosis of lymphocytes [S. Suzuki, FTY720: Mechanisms of action and its effect on organ transplantation, Transplant. Proc. 31 (1999) 2779-2782].  Addnl., it has been found that FTY720 has inhibitory effects on various cancer growth and metastasis [J.D. Wang, S. Takahara, N. Nonomura, Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation, Prostate 40 (1999) 50-55].  To investigate its effect on the growth and metastasis of pancreatic cancer, FTY720 was used to treat three pancreatic cancer cell lines (BxPC-3, AsPC-1, and PANC-1).  The MTT assay and flow cytometry were used to evaluate the cell death after FTY720 treatment; the wound closure assay, three-dimensional (3D) Matrigel assay, and invasive assay were used to evaluate the migration, colony formation and invasion abilities after FTY720 treatment, resp.  Protein expression in BxPC-3, AsPC-1, and PANC-1 cells after FTY720 treatment was detected by Western blotting.  The MTT assay indicated that the growth of pancreatic cancer cells could be inhibited by FTY720 at various concns. between 0 and 17 μM in a dose-dependent manner, which was also confirmed by flow cytometry.  The wound closure assay, 3D Matrigel assay and cell invasion assay all showed that FTY720 significantly suppressed migration, colony formation and invasion ability of cancer cells at concns. from 5 to 17 μM.  After FTY720 treatment, the phospho-Akt, Bcl-2, pro-caspase-3 expression were down-regulated while the caspase-9 protein expression was increased.  In conclusion, FTY720 can inhibit the growth, migration and invasion of pancreatic cancer cells.  Our study provides a preclin. support for chemotherapeutic approach with FTY720 for the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq91TuouUYBILVg90H21EOLACvtfcHk0lg1-f9fKF7XLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFKjsLw%253D&md5=d89f995c7acbd5fae6256468734008bc</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2007.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2007.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DM.%2BX.%26aulast%3DXia%26aufirst%3DW.%2BL.%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DZhang%26aufirst%3DQ.%2BY.%26aulast%3DXie%26aufirst%3DH.%2BY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%2BH.%26aulast%3DZheng%26aufirst%3DS.%2BS.%26atitle%3DFty720%252C%2520a%2520Synthetic%2520Compound%2520from%2520Isaria%2520Sinclairii%252C%2520Inhibits%2520Proliferation%2520and%2520Induces%2520Apoptosis%2520in%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D254%26spage%3D288%26epage%3D297%26doi%3D10.1016%2Fj.canlet.2007.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groen, R. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baleydier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kentsis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marineau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grebliunaite, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozakewich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pflumio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poglio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VerPlank, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolliday, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aster, J. C.</span></span> <span> </span><span class="NLM_article-title">Phenothiazines Induce Pp2a-Mediated Apoptosis in T Cell Acute Lymphoblastic Leukemia</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1172/JCI65093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1172%2FJCI65093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24401270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1ertLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=644-655&author=A.+Gutierrezauthor=L.+Panauthor=R.+W.+J.+Groenauthor=F.+Baleydierauthor=A.+Kentsisauthor=J.+Marineauauthor=R.+Grebliunaiteauthor=E.+Kozakewichauthor=C.+Reedauthor=F.+Pflumioauthor=S.+Poglioauthor=B.+Uzanauthor=P.+Clemonsauthor=L.+VerPlankauthor=F.+Anauthor=J.+Burbankauthor=S.+Nortonauthor=N.+Tollidayauthor=H.+Steenauthor=A.+P.+Wengauthor=H.+Yuanauthor=J.+E.+Bradnerauthor=C.+Mitsiadesauthor=A.+T.+Lookauthor=J.+C.+Aster&title=Phenothiazines+Induce+Pp2a-Mediated+Apoptosis+in+T+Cell+Acute+Lymphoblastic+Leukemia&doi=10.1172%2FJCI65093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia</span></div><div class="casAuthors">Gutierrez, Alejandro; Pan, Li; Groen, Richard W. J.; Baleydier, Frederic; Kentsis, Alex; Marineau, Jason; Grebliunaite, Ruta; Kozakewich, Elena; Reed, Casie; Pflumio, Francoise; Poglio, Sandrine; Uzan, Benjamin; Clemons, Paul; VerPlank, Lynn; An, Frank; Burbank, Jason; Norton, Stephanie; Tolliday, Nicola; Steen, Hanno; Weng, Andrew P.; Yuan, Huipin; Bradner, James E.; Mitsiades, Constantine; Look, A. Thomas; Aster, Jon C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">644-655</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">T cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer that is frequently assocd. with activating mutations in NOTCH1 and dysregulation of MYC.  Here, we performed 2 complementary screens to identify FDA-approved drugs and drug-like small mols. with activity against T-ALL.  We developed a zebrafish system to screen small mols. for toxic activity toward MYC-overexpressing thymocytes and used a human T-ALL cell line to screen for small mols. that synergize with Notch inhibitors.  We identified the antipsychotic drug perphenazine in both screens due to its ability to induce apoptosis in fish, mouse, and human T-ALL cells.  Using ligand-affinity chromatog. coupled with mass spectrometry, we identified protein phosphatase 2A (PP2A) as a perphenazine target.  T-ALL cell lines treated with perphenazine exhibited rapid dephosphorylation of multiple PP2A substrates and subsequent apoptosis.  Moreover, shRNA knockdown of specific PP2A subunits attenuated perphenazine activity, indicating that PP2A mediates the drug's antileukemic activity.  Finally, human T-ALLs treated with perphenazine exhibited suppressed cell growth and dephosphorylation of PP2A targets in vitro and in vivo.  Our findings provide a mechanistic explanation for the recurring identification of phenothiazines as a class of drugs with anticancer effects.  Furthermore, these data suggest that pharmacol. PP2A activation in T-ALL and other cancers driven by hyperphosphorylated PP2A substrates has therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9Qi2TciNj57Vg90H21EOLACvtfcHk0lhzxPh1LWEP-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1ertLo%253D&md5=5f1136790da37d215708aeae37af3085</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1172%2FJCI65093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI65093%26sid%3Dliteratum%253Aachs%26aulast%3DGutierrez%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DGroen%26aufirst%3DR.%2BW.%2BJ.%26aulast%3DBaleydier%26aufirst%3DF.%26aulast%3DKentsis%26aufirst%3DA.%26aulast%3DMarineau%26aufirst%3DJ.%26aulast%3DGrebliunaite%26aufirst%3DR.%26aulast%3DKozakewich%26aufirst%3DE.%26aulast%3DReed%26aufirst%3DC.%26aulast%3DPflumio%26aufirst%3DF.%26aulast%3DPoglio%26aufirst%3DS.%26aulast%3DUzan%26aufirst%3DB.%26aulast%3DClemons%26aufirst%3DP.%26aulast%3DVerPlank%26aufirst%3DL.%26aulast%3DAn%26aufirst%3DF.%26aulast%3DBurbank%26aufirst%3DJ.%26aulast%3DNorton%26aufirst%3DS.%26aulast%3DTolliday%26aufirst%3DN.%26aulast%3DSteen%26aufirst%3DH.%26aulast%3DWeng%26aufirst%3DA.%2BP.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DLook%26aufirst%3DA.%2BT.%26aulast%3DAster%26aufirst%3DJ.%2BC.%26atitle%3DPhenothiazines%2520Induce%2520Pp2a-Mediated%2520Apoptosis%2520in%2520T%2520Cell%2520Acute%2520Lymphoblastic%2520Leukemia%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D644%26epage%3D655%26doi%3D10.1172%2FJCI65093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kauko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulesskiy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangodkar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aakula, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yetukuri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padzik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laajala, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haapaniemi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momeny, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varila, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aittokallio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennerberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westermarck, J.</span></span> <span> </span><span class="NLM_article-title">Pp2a Inhibition Is a Druggable Mek Inhibitor Resistance Mechanism in Kras-Mutant Lung Cancer Cells</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">eaaq1093</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aaq1093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1126%2Fscitranslmed.aaq1093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30021885" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=eaaq1093&author=O.+Kaukoauthor=C.+M.+O%E2%80%99Connorauthor=E.+Kulesskiyauthor=J.+Sangodkarauthor=A.+Aakulaauthor=S.+Izadmehrauthor=L.+Yetukuriauthor=B.+Yadavauthor=A.+Padzikauthor=T.+D.+Laajalaauthor=P.+Haapaniemiauthor=M.+Momenyauthor=T.+Varilaauthor=M.+Ohlmeyerauthor=T.+Aittokallioauthor=K.+Wennerbergauthor=G.+Narlaauthor=J.+Westermarck&title=Pp2a+Inhibition+Is+a+Druggable+Mek+Inhibitor+Resistance+Mechanism+in+Kras-Mutant+Lung+Cancer+Cells&doi=10.1126%2Fscitranslmed.aaq1093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaq1093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaq1093%26sid%3Dliteratum%253Aachs%26aulast%3DKauko%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DC.%2BM.%26aulast%3DKulesskiy%26aufirst%3DE.%26aulast%3DSangodkar%26aufirst%3DJ.%26aulast%3DAakula%26aufirst%3DA.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DYetukuri%26aufirst%3DL.%26aulast%3DYadav%26aufirst%3DB.%26aulast%3DPadzik%26aufirst%3DA.%26aulast%3DLaajala%26aufirst%3DT.%2BD.%26aulast%3DHaapaniemi%26aufirst%3DP.%26aulast%3DMomeny%26aufirst%3DM.%26aulast%3DVarila%26aufirst%3DT.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DAittokallio%26aufirst%3DT.%26aulast%3DWennerberg%26aufirst%3DK.%26aulast%3DNarla%26aufirst%3DG.%26aulast%3DWestermarck%26aufirst%3DJ.%26atitle%3DPp2a%2520Inhibition%2520Is%2520a%2520Druggable%2520Mek%2520Inhibitor%2520Resistance%2520Mechanism%2520in%2520Kras-Mutant%2520Lung%2520Cancer%2520Cells%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2018%26volume%3D10%26spage%3Deaaq1093%26doi%3D10.1126%2Fscitranslmed.aaq1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Calcineurin Is a Common Target of Cyclophilin-Cyclosporin a and Fkbp-Fk506 Complexes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(91)90124-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0092-8674%2891%2990124-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1715244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1991&pages=807-815&author=J.+Liuauthor=J.+D.+Farmerauthor=W.+S.+Laneauthor=J.+Friedmanauthor=I.+Weissmanauthor=S.+L.+Schreiber&title=Calcineurin+Is+a+Common+Target+of+Cyclophilin-Cyclosporin+a+and+Fkbp-Fk506+Complexes&doi=10.1016%2F0092-8674%2891%2990124-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</span></div><div class="casAuthors">Liu, Jun; Farmer, Jesse D., Jr.; Lane, Willam S.; Friedman, Jeff; Weissman, Irving; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">807-15</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Although the immediate receptors (immunophilins) of the immunosuppressants cyclosporin A (CsA) and FK506 are distinct, their similar mechanisms of inhibition of cell signaling suggest that their assocd. immunophilin complexes interact with a common target.  The authors report that the complexes cyclophilin-CsA and FKBP-FK506 (but not cyclophilin, FKBP, FKBP-rapamycin, or FKBP-506BD) competitively bind to and inhibit the Ca2+- and calmodulin-dependent phosphatase calcineurin, although the binding and inhibition of calcineurin do not require calmodulin.  These results suggest that calcineurin is involved in a common step assocd. with T cell receptor and IgE receptor signaling pathways and that cyclophilin and FKBP mediate the actions of CsA and FK506, resp., by forming drug-dependent complexes with and altering the activity of calcineurin-calmodulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfN8mg-hNhLVg90H21EOLACvtfcHk0lhzxPh1LWEP-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D&md5=00c4883ea86e6b2c554f8f72ed717ac9</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2891%2990124-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252891%252990124-H%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFarmer%26aufirst%3DJ.%2BD.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DWeissman%26aufirst%3DI.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DCalcineurin%2520Is%2520a%2520Common%2520Target%2520of%2520Cyclophilin-Cyclosporin%2520a%2520and%2520Fkbp-Fk506%2520Complexes%26jtitle%3DCell%26date%3D1991%26volume%3D66%26spage%3D807%26epage%3D815%26doi%3D10.1016%2F0092-8674%2891%2990124-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fruman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burakoff, S.</span></span> <span> </span><span class="NLM_article-title">Calcineurin Phosphatase Activity in T Lymphocytes Is Inhibited by Fk 506 and Cyclosporin A</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">3686</span>– <span class="NLM_lpage">3690</span>, <span class="refDoi"> DOI: 10.1073/pnas.89.9.3686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.89.9.3686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1373887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1SisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=3686-3690&author=D.+Frumanauthor=C.+Kleeauthor=B.+Biererauthor=S.+Burakoff&title=Calcineurin+Phosphatase+Activity+in+T+Lymphocytes+Is+Inhibited+by+Fk+506+and+Cyclosporin+A&doi=10.1073%2Fpnas.89.9.3686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A</span></div><div class="casAuthors">Fruman, David A.; Klee, Claude B.; Bierer, Barbara E.; Burakoff, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3686-90</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The immunosuppressive agents cyclosporin A (CsA) and FK 506 bind to distinct families of intracellular proteins (immunophilins) termed cyclophilins and FK 506-binding proteins (FKBPs).  Recently, it has been shown that, in vitro, the complexes of CsA-cyclophilin and FK 506-FKBP-12 bind to and inhibit the activity of calcineurin, a calcium-dependent serine/threonine phosphatase.  The authors have investigated the effects of drug treatment on phosphatase activity in T lymphocytes.  Calcineurin is expressed in T cells, and its activity can be measured in cell lysates.  Both CsA and FK 506 specifically inhibit cellular calcineurin at drug concns. that inhibit interleukin 2 prodn. in activated T cells.  Rapamycin, which binds to FKBPs but exhibits different activities than FK 506, has no effect on calcineurin activity.  Furthermore, excess concns. of rapamycin prevent the effects of FK 506, apparently by displacing FK 506 from FKBPs.  These results show that calcineurin is a target of drug-immunophilin complexes in vivo and establish a physiol. role for calcineurin in T-cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnX1PJSpEhorVg90H21EOLACvtfcHk0lhBTCQiizJwMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1SisLo%253D&md5=c0c5457bc8f333a2d0efd6bfd99994d2</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.9.3686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.9.3686%26sid%3Dliteratum%253Aachs%26aulast%3DFruman%26aufirst%3DD.%26aulast%3DKlee%26aufirst%3DC.%26aulast%3DBierer%26aufirst%3DB.%26aulast%3DBurakoff%26aufirst%3DS.%26atitle%3DCalcineurin%2520Phosphatase%2520Activity%2520in%2520T%2520Lymphocytes%2520Is%2520Inhibited%2520by%2520Fk%2520506%2520and%2520Cyclosporin%2520A%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26spage%3D3686%26epage%3D3690%26doi%3D10.1073%2Fpnas.89.9.3686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelker, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of Protein Phosphatase-1 Bound to Nodularin-R and Tautomycin: A Novel Scaffold for Structure-Based Drug Design of Serine/Threonine Phosphatase Inhibitors</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>385</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.10.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.jmb.2008.10.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=18992256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=11-21&author=M.+S.+Kelkerauthor=R.+Pageauthor=W.+Peti&title=Crystal+Structures+of+Protein+Phosphatase-1+Bound+to+Nodularin-R+and+Tautomycin%3A+A+Novel+Scaffold+for+Structure-Based+Drug+Design+of+Serine%2FThreonine+Phosphatase+Inhibitors&doi=10.1016%2Fj.jmb.2008.10.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Protein Phosphatase-1 Bound to Nodularin-R and Tautomycin: A Novel Scaffold for Structure-based Drug Design of Serine/Threonine Phosphatase Inhibitors</span></div><div class="casAuthors">Kelker, Matthew S.; Page, Rebecca; Peti, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-21</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Protein phosphatase 1 (PP1) occurs in all tissues and regulates many pathways, ranging from cell-cycle progression to carbohydrate metab.  Many naturally occurring, mol. toxins modulate PP1 activity, though the exact mechanism of this differential regulation is not understood.  A detailed elucidation of these interactions is crucial for understanding the cellular basis of phosphatase function and signaling pathways but more importantly, they can serve as the basis for highly specific therapeutics, e.g. against cancer.  We report the crystal structures of PP1 in complex with nodularin-R at 1.63 Å and tautomycin at 1.70 Å resoln.  The PP1:nodularin-R complex was used to demonstrate the utility of our improved PP1 prodn. technique, which produces highly active, sol. PP1.  Tautomycin is one of the few toxins that reportedly preferentially binds PP1 > PP2A.  Therefore, the PP1:tautomycin structure is the first complex structure with a toxin with preferred PP1 specificity.  Furthermore, since tautomycin is a linear non-peptide-based toxin, our reported structure will aid the design of lead compds. for novel PP1-specific pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6lYsXVoX1jrVg90H21EOLACvtfcHk0lhBTCQiizJwMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsbrF&md5=c6d5fb0be88de9ea584aecfa5e04d57b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.10.053%26sid%3Dliteratum%253Aachs%26aulast%3DKelker%26aufirst%3DM.%2BS.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DPeti%26aufirst%3DW.%26atitle%3DCrystal%2520Structures%2520of%2520Protein%2520Phosphatase-1%2520Bound%2520to%2520Nodularin-R%2520and%2520Tautomycin%253A%2520A%2520Novel%2520Scaffold%2520for%2520Structure-Based%2520Drug%2520Design%2520of%2520Serine%252FThreonine%2520Phosphatase%2520Inhibitors%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D385%26spage%3D11%26epage%3D21%26doi%3D10.1016%2Fj.jmb.2008.10.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwiller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daily, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatra, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukelow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boynton, A. L.</span></span> <span> </span><span class="NLM_article-title">Characterization of Microcystin-Lr, a Potent Inhibitor of Type 1 and Type 2a Protein Phosphatases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>265</i></span>,  <span class="NLM_fpage">19401</span>– <span class="NLM_lpage">19404</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(17)45384-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0021-9258%2817%2945384-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2174036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXlvVOisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=19401-19404&author=R.+E.+Honkanenauthor=J.+Zwillerauthor=R.+E.+Mooreauthor=S.+L.+Dailyauthor=B.+S.+Khatraauthor=M.+Dukelowauthor=A.+L.+Boynton&title=Characterization+of+Microcystin-Lr%2C+a+Potent+Inhibitor+of+Type+1+and+Type+2a+Protein+Phosphatases&doi=10.1016%2FS0021-9258%2817%2945384-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases</span></div><div class="casAuthors">Honkanen, Richard E.; Zwiller, Jean; Moore, Richard E.; Daily, Sharon L.; Khatra, Balwant S.; Dukelow, Michael; Boynton, Alton L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">19401-4</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The level of protein phosphorylation is dependent on the relative activities of both protein kinases and protein phosphatases.  By comparison with protein kinases, however, there have been considerably fewer studies on the functions of serine/threonine protein phosphatases.  This is partly due to a lack of specific protein phosphatase inhibitors that can be used as probes.  The present study is a characterization of the inhibitory effects of microcystin-LR, a hepatotoxic cyclic peptide assocd. with most strains of the blue-green algae Microcystis aeruginosa found in the Northern hemisphere, that proves to be a potent inhibitor of type 1 (IC50 = 1.7 nM) and type 2A (IC50 = 0.04 nM) protein phosphatases.  Microcystin-LR inhibited the activity of both type 1 and type 2A phosphatases >10-fold more potently than okadaic acid under the same conditions.  Type 2A protein phosphatases in dil. mammalian cell exts. were found to be completely inhibited by 0.5 nM microcystin-LR while type I protein phosphatases were only slightly affected at this concn.  Thus, microcystin-LR may prove to be a useful probe for the study and identification of cellular processes which are mediated by protein phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTSf9UHioQjLVg90H21EOLACvtfcHk0lhBTCQiizJwMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlvVOisrc%253D&md5=dca914b3af519bf6d0e97d2e5415184b</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2817%2945384-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252817%252945384-1%26sid%3Dliteratum%253Aachs%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DZwiller%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DR.%2BE.%26aulast%3DDaily%26aufirst%3DS.%2BL.%26aulast%3DKhatra%26aufirst%3DB.%2BS.%26aulast%3DDukelow%26aufirst%3DM.%26aulast%3DBoynton%26aufirst%3DA.%2BL.%26atitle%3DCharacterization%2520of%2520Microcystin-Lr%252C%2520a%2520Potent%2520Inhibitor%2520of%2520Type%25201%2520and%2520Type%25202a%2520Protein%2520Phosphatases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D19401%26epage%3D19404%26doi%3D10.1016%2FS0021-9258%2817%2945384-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bialojan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, A.</span></span> <span> </span><span class="NLM_article-title">Inhibitory Effect of a Marine-Sponge Toxin, Okadaic Acid, on Protein Phosphatases. Specificity and Kinetics</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1042/bj2560283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1042%2Fbj2560283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2851982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL1MXitVequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1988&pages=283-290&author=C.+Bialojanauthor=A.+Takai&title=Inhibitory+Effect+of+a+Marine-Sponge+Toxin%2C+Okadaic+Acid%2C+on+Protein+Phosphatases.+Specificity+and+Kinetics&doi=10.1042%2Fbj2560283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases.  Specificity and kinetics</span></div><div class="casAuthors">Bialojan, Corinna; Takai, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-90</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">The inhibitory effect of a marine sponge toxin, okadaic acid, was examd. on type 1, type 2A, type 2B, and type 2C protein phosphatases as well as on a polycation-modulated (PCM) phosphatase.  Of the protein phosphatases examd., the catalytic subunit of type 2A phosphatase from rabbit skeletal muscle was most potently inhibited.  For the phosphorylated myosin light-chain (PMLC) phosphatase activity of the enzyme, the concn. of okadaic acid required to obtain 50% inhibition (ID50) was ∼1 nM.  The PMLC phosphatase activities of type 1 and PCM phosphatase were also strongly inhibited (ID50 0.1-0.5 μM).  The PMLC phosphatase activity of type 2B phosphatase (calcineurin) was inhibited to a lesser extent (ID50 4-5 μM).  Similar results were obtained for the phosphorylase a phosphatase activity of type 1 and PCM phosphatases and for the p-nitrophenyl phosphate phosphatase activity of calcineurin.  The following phosphatases were not affected by ≤10 μM okadaic acid: type 2C phosphatase, phosphotyrosyl phosphatase, inositol 1,4,5-trisphosphate phosphatase, acid phosphatases, and alk. phosphatases.  Thus okadaic acid had a relatively high specificity for type 2A, type 1, and PCM phosphatases.  Kinetic studies showed that okadaic acid acts as a noncompetitive or mixed inhibitor on the okadaic acid-sensitive enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDRX40cIwTiLVg90H21EOLACvtfcHk0lhGQRtGmnLMxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXitVequg%253D%253D&md5=0303a70deb82c0c087e4585ac180c5d8</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1042%2Fbj2560283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2560283%26sid%3Dliteratum%253Aachs%26aulast%3DBialojan%26aufirst%3DC.%26aulast%3DTakai%26aufirst%3DA.%26atitle%3DInhibitory%2520Effect%2520of%2520a%2520Marine-Sponge%2520Toxin%252C%2520Okadaic%2520Acid%252C%2520on%2520Protein%2520Phosphatases.%2520Specificity%2520and%2520Kinetics%26jtitle%3DBiochem.%2520J.%26date%3D1988%26volume%3D256%26spage%3D283%26epage%3D290%26doi%3D10.1042%2Fbj2560283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span> <span> </span><span class="NLM_article-title">Calyculin a, Protein Phosphatase Inhibitor, Enhances Capacitation of Human Sperm*</span>. <i>Fertil. Steril.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1016/S0015-0282(16)55642-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0015-0282%2816%2955642-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8380391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADyaK3s7it1ahtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1993&pages=216-222&author=S.+Furuyaauthor=Y.+Endoauthor=K.+Osumiauthor=M.+Obaauthor=S.+Nozawaauthor=S.+Suzuki&title=Calyculin+a%2C+Protein+Phosphatase+Inhibitor%2C+Enhances+Capacitation+of+Human+Sperm*&doi=10.1016%2FS0015-0282%2816%2955642-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Calyculin A, protein phosphatase inhibitor, enhances capacitation of human sperm</span></div><div class="casAuthors">Furuya S; Endo Y; Osumi K; Oba M; Nozawa S; Suzuki S</div><div class="citationInfo"><span class="NLM_cas:title">Fertility and sterility</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">216-22</span>
        ISSN:<span class="NLM_cas:issn">0015-0282</span>.
    </div><div class="casAbstract">OBJECTIVE:  To examine the effects of protein phosphatase inhibitors on capacitation and protein phosphorylation in human sperm.  DESIGN:  The chlortetracycline (CTC) fluorescence assay was used to monitor capacitated sperm treated with or without protein phosphatase inhibitors.  Capacitation was confirmed by the ability of sperm to undergo the acrosome reaction in response to Ca++ ionophore A23187 or mouse zonae pellucidae. 32P-labeled sperm phosphoproteins were analyzed by one-dimensional gel electrophoresis to detect the effects of protein phosphatase inhibitors on protein phosphorylation.  RESULTS:  The treatment of sperm with calyculin A resulted in the following: [1] the rapid appearance of the clear perimeter pattern, specifically, distribution of fluorescence over the entire head exhibiting a bright perimeter and bright midpiece, in a dose-dependent manner in the 1 to 100 nM range; [2] an accelerated ability to undergo the acrosome reaction; and [3] an enhanced phosphorylation of sperm phosphoproteins in a dose-related fashion in the 1 to 100 nM range.  A similar stimulatory effect was observed only with a 100-fold higher concentrations of okadaic acid, another protein phosphatase inhibitor.  CONCLUSION:  Our results strongly suggest that protein phosphorylation and dephosphorylation may be involved in the regulation of human sperm capacitation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSh7hPk4cJ4JjAEfvC7EH1LfW6udTcc2eZAkRBssiKHJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s7it1ahtA%253D%253D&md5=c2743bf5364f67aa2e493b3726b8baa6</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2FS0015-0282%2816%2955642-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0015-0282%252816%252955642-8%26sid%3Dliteratum%253Aachs%26aulast%3DFuruya%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DOsumi%26aufirst%3DK.%26aulast%3DOba%26aufirst%3DM.%26aulast%3DNozawa%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26atitle%3DCalyculin%2520a%252C%2520Protein%2520Phosphatase%2520Inhibitor%252C%2520Enhances%2520Capacitation%2520of%2520Human%2520Sperm%252A%26jtitle%3DFertil.%2520Steril.%26date%3D1993%26volume%3D59%26spage%3D216%26epage%3D222%26doi%3D10.1016%2FS0015-0282%2816%2955642-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Fostriecin, an Antitumor Antibiotic with Inhibitory Activity against Serine/Threonine Protein Phosphatases Types 1 (Pp1) and 2a (Pp2a), Is Highly Selective for Pp2a</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>416</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(97)01210-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0014-5793%2897%2901210-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9373158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2sXmvFWjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=1997&pages=230-234&author=A.+H.+Walshauthor=A.+Chengauthor=R.+E.+Honkanen&title=Fostriecin%2C+an+Antitumor+Antibiotic+with+Inhibitory+Activity+against+Serine%2FThreonine+Protein+Phosphatases+Types+1+%28Pp1%29+and+2a+%28Pp2a%29%2C+Is+Highly+Selective+for+Pp2a&doi=10.1016%2FS0014-5793%2897%2901210-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A</span></div><div class="casAuthors">Walsh, Aimee H.; Cheng, Aiyang; Honkanen, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">416</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-234</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Fostriecin, an antitumor antibiotic produced by Streptomyces pulveraceus, is a strong inhibitor of type 2A (PP2A; IC50 3.2 nM) and a weak inhibitor of type 1 (PP1; IC50 131 μM) serine/threonine protein phosphatases.  Fostriecin has no apparent effect on the activity of PP2B, and dose-inhibition studies conducted with whole cell homogenates indicate that fostriecin also inhibits the native forms of PP1 and PP2A.  Studies with recombinant PP1/PP2A chimeras indicate that okadaic acid and fostriecin have different binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdJTXuBKPEvbVg90H21EOLACvtfcHk0ljyTZ51za755w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvFWjsLs%253D&md5=c1d1b15eda708b2f87e5dee740214827</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2897%2901210-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252897%252901210-6%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DA.%2BH.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DFostriecin%252C%2520an%2520Antitumor%2520Antibiotic%2520with%2520Inhibitory%2520Activity%2520against%2520Serine%252FThreonine%2520Protein%2520Phosphatases%2520Types%25201%2520%2528Pp1%2529%2520and%25202a%2520%2528Pp2a%2529%252C%2520Is%2520Highly%2520Selective%2520for%2520Pp2a%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D416%26spage%3D230%26epage%3D234%26doi%3D10.1016%2FS0014-5793%2897%2901210-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackintosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 2a and Its [3h]Cantharidin/[3h] Endothall Thioanhydride Binding Site</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1443</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(93)90109-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0006-2952%2893%2990109-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8240393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2cXpvVKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=1435-1443&author=Y.+M.+Liauthor=C.+Mackintoshauthor=J.+E.+Casida&title=Protein+Phosphatase+2a+and+Its+%5B3h%5DCantharidin%2F%5B3h%5D+Endothall+Thioanhydride+Binding+Site&doi=10.1016%2F0006-2952%2893%2990109-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogs</span></div><div class="casAuthors">Li, Yue Ming; Mackintosh, Carol; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1435-43</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The target site for cantharidin (CA) (I) and its analogs was isolated recently from mouse liver and identified as protein phosphatase 2A (PP2A) in the heterodimeric form known as PP2A2.  The most toxic CA analog, endothall thioanhydride (ETA) (mouse i.p. LD50 0.3 mg/kg), appears to have the same binding site in mouse liver and brain based on studies comparing [3H]ETA and [3H]CA.  ATP and its nonhydrolyzable analogs and pyrophosphate and related compds. including phosphonoformic acid inhibited both [3H]CA and [3H]ETA binding with IC50 values ranging from 2 to 81 μM.  As with CA itself, the most potent inhibitors have two neg. charged groups in close proximity to each other.  Inhibition of [3H]CA binding by 5,5'-dithiobis(2-nitrobenzoic acid) and stimulation by N-ethylmaleimide indicated the involvement of a thiol site in the CA-binding domain.  CA and three analogs (cantharidic acid, palasonin and endothall) inhibited PP2A and protein phosphatase 1 (PP1) but not PP2B or PP2C.  The catalytic subunit of PP2A was 5- to 12-fold more sensitive to these CA analogs than the catalytic subunit of PP1.  CA and the herbicide endothall also inhibited spinach leaf PP1 and PP2A and, at 50 μM, decreased the PP2A-mediated light-induced activation of nitrate reductase in intact spinach leaves by 62 and 56%, resp.  This is consistent with PP2A as their site of action in plants, and indicates that potential use of CA analogs as pharmacol. probes to investigate cellular processes that are regulated by reversible protein phosphorylation in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjHd2be-nKP7Vg90H21EOLACvtfcHk0ljyTZ51za755w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXpvVKlsg%253D%253D&md5=357fb1e34a8c6943f61f8348cd0e5889</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2893%2990109-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252893%252990109-A%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DMackintosh%26aufirst%3DC.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DProtein%2520Phosphatase%25202a%2520and%2520Its%2520%255B3h%255DCantharidin%252F%255B3h%255D%2520Endothall%2520Thioanhydride%2520Binding%2520Site%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D46%26spage%3D1435%26epage%3D1443%26doi%3D10.1016%2F0006-2952%2893%2990109-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciszak, E. M.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for the Catalytic Activity of Human Serine/Threonine Protein Phosphatase-5</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">33992</span>– <span class="NLM_lpage">33999</span>, <span class="refDoi"> DOI: 10.1074/jbc.M402855200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M402855200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15155720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=33992-33999&author=M.+R.+Swingleauthor=R.+E.+Honkanenauthor=E.+M.+Ciszak&title=Structural+Basis+for+the+Catalytic+Activity+of+Human+Serine%2FThreonine+Protein+Phosphatase-5&doi=10.1074%2Fjbc.M402855200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Catalytic Activity of Human Serine/Threonine Protein Phosphatase-5</span></div><div class="casAuthors">Swingle, Mark R.; Honkanen, Richard E.; Ciszak, Ewa M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">33992-33999</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Serine/threonine protein phosphatase-5 (PP5) affects many signaling networks that regulate cell growth and cellular responses to stress.  Here we report the crystal structure of the PP5 catalytic domain (PP5c) at a resoln. of 1.6 Å.  From this structure we propose a mechanism for PP5-mediated hydrolysis of phosphoprotein substrates, which requires the precise positioning of two metal ions within a conserved Asp271-M1:M2-W1-His427-His304-Asp274 catalytic motif (where M1 and M2 are metals and W1 is a water mol.).  The structure of PP5c provides a structural basis for explaining the exceptional catalytic proficiency of protein phosphatases, which are among the most powerful known catalysts.  Resoln. of the entire C terminus revealed a novel subdomain, and the structure of the PP5c should also aid development of type-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg1iBbzyxsibVg90H21EOLACvtfcHk0ljyTZ51za755w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs7Y%253D&md5=7e302ecc9f581181f7e52d766cf78b7e</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M402855200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M402855200%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DCiszak%26aufirst%3DE.%2BM.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Catalytic%2520Activity%2520of%2520Human%2520Serine%252FThreonine%2520Protein%2520Phosphatase-5%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D33992%26epage%3D33999%26doi%3D10.1074%2Fjbc.M402855200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. S.</span></span> <span> </span><span class="NLM_article-title">Medical Uses of Mylabris in Ancient China and Recent Studies</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/0378-8741(89)90062-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0378-8741%2889%2990062-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2689797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXptFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1989&pages=147-162&author=G.+S.+Wang&title=Medical+Uses+of+Mylabris+in+Ancient+China+and+Recent+Studies&doi=10.1016%2F0378-8741%2889%2990062-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Medical uses of Mylabris in ancient China and recent studies</span></div><div class="casAuthors">Wang, Guangsheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-62</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    </div><div class="casAbstract">A review with 56 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtR_mIS1cynLVg90H21EOLACvtfcHk0lg2359AzTdlFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXptFSitg%253D%253D&md5=ac51dbf89c0fbb622bb0939b7d4a9f27</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2F0378-8741%2889%2990062-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-8741%252889%252990062-7%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BS.%26atitle%3DMedical%2520Uses%2520of%2520Mylabris%2520in%2520Ancient%2520China%2520and%2520Recent%2520Studies%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D1989%26volume%3D26%26spage%3D147%26epage%3D162%26doi%3D10.1016%2F0378-8741%2889%2990062-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Cantharidin-Binding Protein: Identification as Protein Phosphatase 2a</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">11867</span>– <span class="NLM_lpage">11870</span>, <span class="refDoi"> DOI: 10.1073/pnas.89.24.11867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.89.24.11867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1334551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3sXps12isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=11867-11870&author=Y.+M.+Liauthor=J.+E.+Casida&title=Cantharidin-Binding+Protein%3A+Identification+as+Protein+Phosphatase+2a&doi=10.1073%2Fpnas.89.24.11867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Cantharidin-binding protein:  Identification as protein phosphatase 2A</span></div><div class="casAuthors">Li, Yue Ming; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11867-70</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The toxic effects of cantharidin from blister beetles and its analogs, including the herbicide endothall, are attributable to their high affinity and specificity for a cantharidin-binding protein (CBP).  An ammonium sulfate ppt. of mouse liver cytosol was purified by five chromatog. steps to isolate CBP in 14% yield and >99% purity as monitored by [3H]cantharidin-binding activity.  The purifn. factor of 2230-fold corresponds to a CBP content of 0.045% of the liver cytosolic protein.  CBP is a heterodimer consisting of a 61-kDa α subunit and a 30-kDa β subunit.  Amino acid sequences of four peptides from CBP-α and three peptides from CBP-β are identical with deduced amino acid sequences for the Aα regulatory and Cβ catalytic subunits, resp., of protein phosphatase 2A (PP2A).  This assignment of CBP as PP2A-AC from structural evidence is supported by biochem. studies with selective substrates and inhibitors.  CBP dephosphorylation of phosphorylase a is sensitive not only to okadaic acid, as with PP2A, but also to cantharidin and its analogs, consistent with their potency in blocking the radioligand binding site of CBP.  Okadaic acid is a potent inhibitor of [3H]cantharidin binding to CBP.  PP2A is present in many mammalian tissues and in plants and is involved in regulatory phosphorylation-dephosphorylation events which modulate multiple cellular functions.  Inhibition of PP2A activity may account for the diverse effects and toxicity of cantharidin and its analogs, including the herbicide endothall, in mammals and possibly plants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_hQQbwUrdybVg90H21EOLACvtfcHk0lg2359AzTdlFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXps12isg%253D%253D&md5=ed879675d31ff91e40123a9821695e6c</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.24.11867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.24.11867%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DCantharidin-Binding%2520Protein%253A%2520Identification%2520as%2520Protein%2520Phosphatase%25202a%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26spage%3D11867%26epage%3D11870%26doi%3D10.1073%2Fpnas.89.24.11867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norbury, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span> <span> </span><span class="NLM_article-title">DNA Damage-Induced Apoptosis</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2797</span>– <span class="NLM_lpage">2808</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1207532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsj.onc.1207532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15077143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=2797-2808&author=C.+J.+Norburyauthor=B.+Zhivotovsky&title=DNA+Damage-Induced+Apoptosis&doi=10.1038%2Fsj.onc.1207532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">DNA damage-induced apoptosis</span></div><div class="casAuthors">Norbury, Chris J.; Zhivotovsky, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2797-2808</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Unicellular organisms respond to the presence of DNA lesions by activating cell cycle checkpoint and repair mechanisms, while multi-cellular animals have acquired the further option of eliminating damaged cells by triggering apoptosis.  Defects in DNA damage-induced apoptosis contribute to tumorigenesis and to the resistance of cancer cells to a variety of therapeutic agents.  The intranuclear mechanisms that signal apoptosis after DNA damage overlap with those that initiate cell cycle arrest and DNA repair, and the early events in these pathways are highly conserved.  In addn., multiple independent routes have recently been traced by which nuclear DNA damage can be signaled to the mitochondria, tipping the balance in favor of cell death rather than repair and survival.  Here, we review current knowledge of nuclear DNA damage signaling, giving particular attention to interactions between these nuclear events and apoptotic processes in other intracellular compartments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlYE0yPuxqDbVg90H21EOLACvtfcHk0lg2359AzTdlFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLY%253D&md5=f7e5152debef32edeaee0bed090eff8b</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207532%26sid%3Dliteratum%253Aachs%26aulast%3DNorbury%26aufirst%3DC.%2BJ.%26aulast%3DZhivotovsky%26aufirst%3DB.%26atitle%3DDNA%2520Damage-Induced%2520Apoptosis%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D2797%26epage%3D2808%26doi%3D10.1038%2Fsj.onc.1207532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomicic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böchzelt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tome, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briehl, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaina, B.</span></span> <span> </span><span class="NLM_article-title">Molecular Modes of Action of Cantharidin in Tumor Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">811</span>– <span class="NLM_lpage">818</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2004.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bcp.2004.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15710358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2005&pages=811-818&author=T.+Efferthauthor=R.+Rauhauthor=S.+Kahlauthor=M.+Tomicicauthor=H.+B%C3%B6chzeltauthor=M.+E.+Tomeauthor=M.+M.+Briehlauthor=R.+Bauerauthor=B.+Kaina&title=Molecular+Modes+of+Action+of+Cantharidin+in+Tumor+Cells&doi=10.1016%2Fj.bcp.2004.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modes of action of cantharidin in tumor cells</span></div><div class="casAuthors">Efferth, Thomas; Rauh, Rolf; Kahl, Stefan; Tomicic, Maja; Boechzelt, Herbert; Tome, Margaret E.; Briehl, Margaret M.; Bauer, Rudolf; Kaina, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">811-818</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer chemotherapy is often limited by patient's toxicity and tumor drug resistance indicating that new drug development and modification of existing drugs is crit. for improving the therapeutic response.  Traditional Chinese medicine is a rich source of potential anticancer agents.  In particular, cantharidin (CAN), the active principle ingredient from the blister beetle, Mylabris, has antitumor activity, but the cytotoxic mechanism is unknown.  In leukemia cells, cantharidin induces apoptosis by a p53-dependent mechanism.  Cantharidin causes both DNA single- and double-strand breaks.  Colony-forming assays with knockout and transfectant cells lines showed that DNA polymerase β, but not ERCC1, conferred increased cell survival after cantharidin treatment, indicating that base excision repair (BER), rather than nucleotide excision repair (NER), is important for CAN-induced DNA lesions.  Oxidative stress-resistant thymic lymphoma-derived WEHI7.2 variants are also more resistant to cantharidin.  These data suggest that cantharidin treatment causes oxidative stress that provokes DNA damage and p53-dependent apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6EwUQMINvirVg90H21EOLACvtfcHk0lg6C9hkM4R11A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCrsb0%253D&md5=7765e60d2ea2140273645730d420da65</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DEfferth%26aufirst%3DT.%26aulast%3DRauh%26aufirst%3DR.%26aulast%3DKahl%26aufirst%3DS.%26aulast%3DTomicic%26aufirst%3DM.%26aulast%3DB%25C3%25B6chzelt%26aufirst%3DH.%26aulast%3DTome%26aufirst%3DM.%2BE.%26aulast%3DBriehl%26aufirst%3DM.%2BM.%26aulast%3DBauer%26aufirst%3DR.%26aulast%3DKaina%26aufirst%3DB.%26atitle%3DMolecular%2520Modes%2520of%2520Action%2520of%2520Cantharidin%2520in%2520Tumor%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D69%26spage%3D811%26epage%3D818%26doi%3D10.1016%2Fj.bcp.2004.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadioglu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kermani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiebig, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span> <span> </span><span class="NLM_article-title">Pharmacogenomics of Cantharidin in Tumor Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2013.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bcp.2013.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24231507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlGr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=399-409&author=O.+Kadiogluauthor=N.+S.+Kermaniauthor=G.+Kelterauthor=U.+Schumacherauthor=H.-H.+Fiebigauthor=H.+J.+Gretenauthor=T.+Efferth&title=Pharmacogenomics+of+Cantharidin+in+Tumor+Cells&doi=10.1016%2Fj.bcp.2013.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenomics of cantharidin in tumor cells</span></div><div class="casAuthors">Kadioglu, Onat; Kermani, Navid Salehi; Kelter, Gerhard; Schumacher, Udo; Fiebig, Heinz-Herbert; Greten, Henry Johannes; Efferth, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-409</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cantharis vesicatoria (blister beetle) is used in Chinese medicine and has been categorized as highly toxic in the Chinese pharmacopeia.  In Europe, Cantharis patches have been used since ages to treat various skin-related diseases.  We investigated the cytotoxicity of the Cantharis ingredient, cantharidin, in 41 tumor cell lines (Oncotest panel) and compared the results with those of 60 cell lines of the National Cancer Institute, USA.  We found profound activity at low micromolar concns. (log10IC50 values between -6.980 and 5.009 M).  Cantharidin bound to protein phosphatase 2A (PP2A) with higher affinity (-8.12 kcal/mol) than to PP1 (-6.25 kcal/mol) in mol. docking analyses.  Using a PCR array for 84 apoptosis genes, cantharidin treatment upregulated gene expression of caspase-1 and nerve growth factor receptor, but downregulated mRNA expression of Bcl-2 like protein 10, Fas ligand, and tumor necrosis factor-α.  By using COMPARE anal. of microarray-based transcriptome-wide mRNA expressions, 21 genes were found to significantly correlate with response of 60 tumor cell lines to cantharidin.  As shown by hierarchical cluster anal. and chi-squared test, the distribution of cell lines in the dendrogram according to their gene expression profiles predicted sensitivity or resistance to cantharidin (P = 6.482 × 10-5).  The compassionate use of Cantharis patches in two patients suffering from basalioma and Mycosis fungoides, resp., considerably improved the diseases without signs of toxicity.  In conclusion, these results indicate that cantharidin may be a useful candidate to develop novel strategies for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5v3KSTltV77Vg90H21EOLACvtfcHk0lg6C9hkM4R11A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlGr&md5=6253a9c33e6ca5cee8f85a076ace1ce4</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DKadioglu%26aufirst%3DO.%26aulast%3DKermani%26aufirst%3DN.%2BS.%26aulast%3DKelter%26aufirst%3DG.%26aulast%3DSchumacher%26aufirst%3DU.%26aulast%3DFiebig%26aufirst%3DH.-H.%26aulast%3DGreten%26aufirst%3DH.%2BJ.%26aulast%3DEfferth%26aufirst%3DT.%26atitle%3DPharmacogenomics%2520of%2520Cantharidin%2520in%2520Tumor%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2014%26volume%3D87%26spage%3D399%26epage%3D409%26doi%3D10.1016%2Fj.bcp.2013.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span> <span> </span><span class="NLM_article-title">Overview of Cantharidin and Its Analogues</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2034</span>– <span class="NLM_lpage">2044</span>, <span class="refDoi"> DOI: 10.2174/0929867324666170414165253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F0929867324666170414165253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28413963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVGns7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=2034-2044&author=G.+Wangauthor=J.+Dongauthor=L.+Deng&title=Overview+of+Cantharidin+and+Its+Analogues&doi=10.2174%2F0929867324666170414165253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of Cantharidin and its Analogues</span></div><div class="casAuthors">Wang, Guofang; Dong, Jian; Deng, Liping</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2034-2044</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Cantharidin has been categorized as highly toxicant in Chinese medicine.  But cantharidin can efficiently treat different types of diseases, such as molluscum contagiosum.  While cantharidin is quite useful, unfortunately, due to its side effects, increasing regulations have limited access to this useful therapeutic option.  Cantharidin&#39;s toxic effects have caused it to fall into disuse for most legitimate medical purposes.  Although cantharidin generates effects and its advantages must be realized.  Recently, cancer affects people's life more and more.  Because cantharidin can treat some cancers, so solns. must be used to reduce side effects.  This review aims to describe some its analogs, several efficient methods to inhibit the side effects of cantharidin and pharmacogenomics of cantharidin.  Methods: We searched for research about cantharidin by entering the database.  Then evaluated these papers and analyzed their founding, soln., mechanism, etc., and targeted to screen the papers related to the content of our research, and then sorted them out in accordance with the soln., mechanism research and other content.  Finally, these content was unified into a framework.  Results: Some cantharidin&#39;s analogs were found that they show some similar functions to cantharidin and we found that norcantharidin, acylthiourea derivs., cantharidinamides, anhydride-modified derivs. and other derivs. have less side effects.  The modified cantharidin analogs reduce toxicity in hepatocytes.  Cantharidin consists of a six-ring and a five-ring, the moiety of oxygen on the six-ring and the anhydride section exhibit biochem. activity.  Protein phosphatases are assocd. with many cellular processes including apoptosis, cell cycle progression and so on.  Cantharidin can cause apoptosis and double-stand breakage of DNA.  Cantharidin and norcantharidin can efficiently inhibit the activity of mammalian and plant protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) in vivo.  Cantharidin inhibits PP5 at the nanomolar level with an IC50 value of 600 nM.  PP5 can manage the cellular survival, death, proliferation and other some intracellular biol. activities in mammals.  After cantharidin's treatment, the level of EtPP5 mRNA expression was downregulated.  Their also can be used to inhibit the Glutathione S-transferases (GSTs), angiogenesis and the expression of A549 human lung cancer cells, trigger eryptosis and induced bladder cancer cell apoptosis.  We found that using Vitamin C and ginsenosides and translating cantharidin into nanoparticles can minimize the cantharidin side effects in the patients.  Conclusion: Cantharidin can inhibit various tumor cell lines.  Cantharidin causes both DNA single- and double- strand breaks and induces apoptosis.  Although cantharidin shows some toxicity for human, its anti-cancer effects should be taken seriously.  Several viable methods can help solve this problem.  The most important pharmacogenomics of cantharidin is that cantharidin can inhibit PPs, because PPs are assocd. with many cellular processes.  This prospect is very broad and needs to continue studying.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLehivCxkC5rVg90H21EOLACvtfcHk0lg6C9hkM4R11A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVGns7nO&md5=527b7f06d39155cf19ca27c346a23319</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.2174%2F0929867324666170414165253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867324666170414165253%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DL.%26atitle%3DOverview%2520of%2520Cantharidin%2520and%2520Its%2520Analogues%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2018%26volume%3D25%26spage%3D2034%26epage%3D2044%26doi%3D10.2174%2F0929867324666170414165253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elder, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span> <span> </span><span class="NLM_article-title">Lb100, a Small Molecule Inhibitor of Pp2a with Potent Chemo- and Radio-Sensitizing Potential</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">833</span>, <span class="refDoi"> DOI: 10.1080/15384047.2015.1040961</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1080%2F15384047.2015.1040961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25897893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWlsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=821-833&author=C.+S.+Hongauthor=W.+Hoauthor=C.+Zhangauthor=C.+Yangauthor=J.+B.+Elderauthor=Z.+Zhuang&title=Lb100%2C+a+Small+Molecule+Inhibitor+of+Pp2a+with+Potent+Chemo-+and+Radio-Sensitizing+Potential&doi=10.1080%2F15384047.2015.1040961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential</span></div><div class="casAuthors">Hong, Christopher S.; Ho, Winson; Zhang, Chao; Yang, Chunzhang; Elder, J. Bradley; Zhuang, Zhengping</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">821-833</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1555-8576</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase that plays a significant role in mitotic progression and cellular responses to DNA damage.  While traditionally viewed as a tumor suppressor, inhibition of PP2A has recently come to attention as a novel therapeutic means of driving senescent cancer cells into mitosis and promoting cell death via mitotic catastrophe.  These findings have been corroborated in numerous studies utilizing naturally produced compds. that selectively inhibit PP2A.  To overcome the known human toxicities assocd. with these compds., a water-sol. small mol. inhibitor, LB100, was recently developed to competitively inhibit the PP2A protein.  This review summarizes the pre-clin. studies to date that have demonstrated the anti-cancer activity of LB100 via its chemo- and radio-sensitizing properties.  These studies demonstrate the tremendous therapeutic potential of LB100 in a variety of cancer types.  The results of an ongoing phase 1 trial are eagerly anticipated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmlFnabEiiRrVg90H21EOLACvtfcHk0lj5Z9Kv2iWbSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWlsL%252FI&md5=dea6b6f986027fdfa49f51efa60a12f6</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1080%2F15384047.2015.1040961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15384047.2015.1040961%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DC.%2BS.%26aulast%3DHo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DElder%26aufirst%3DJ.%2BB.%26aulast%3DZhuang%26aufirst%3DZ.%26atitle%3DLb100%252C%2520a%2520Small%2520Molecule%2520Inhibitor%2520of%2520Pp2a%2520with%2520Potent%2520Chemo-%2520and%2520Radio-Sensitizing%2520Potential%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2015%26volume%3D16%26spage%3D821%26epage%3D833%26doi%3D10.1080%2F15384047.2015.1040961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansfield, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braiteh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durivage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ungerleider, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovach, J. S.</span></span> <span> </span><span class="NLM_article-title">Safety, Tolerability, and Preliminary Activity of Lb-100, an Inhibitor of Protein Phosphatase 2a, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3277</span>– <span class="NLM_lpage">3284</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-2299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1078-0432.CCR-16-2299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28039265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=3277-3284&author=V.+Chungauthor=A.+S.+Mansfieldauthor=F.+Braitehauthor=D.+Richardsauthor=H.+Durivageauthor=R.+S.+Ungerleiderauthor=F.+Johnsonauthor=J.+S.+Kovach&title=Safety%2C+Tolerability%2C+and+Preliminary+Activity+of+Lb-100%2C+an+Inhibitor+of+Protein+Phosphatase+2a%2C+in+Patients+with+Relapsed+Solid+Tumors%3A+An+Open-Label%2C+Dose+Escalation%2C+First-in-Human%2C+Phase+I+Trial&doi=10.1158%2F1078-0432.CCR-16-2299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial</span></div><div class="casAuthors">Chung, Vincent; Mansfield, Aaron S.; Braiteh, Fadi; Richards, Donald; Durivage, Henry; Ungerleider, Richard S.; Johnson, Francis; Kovach, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3277-3284</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To det. the MTD and to assess the safety, tolerability, and potential activity of LB-100, a first-in-class small-mol. inhibitor of protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors.  Exptl. Design: LB-100 was administered i.v. daily for 3 days in 21-day cycles in a 3 + 3 dose escalation design.  Results: There were 29 patient entries over 7 dose escalations.  One patient stopped treatment after one dose because of an acute infection and was reenrolled after recovery; each course was analyzed as a sep. patient entry.  Two patients had dose-limiting toxicity (reversible increases in serum creatinine or calcd. serum creatinine clearance) at the 3.1 mg/m2 level.  Probable or possible study drug-related grade 3 adverse events occurred in 6 (20.7%) patients [anemia (n = 2), decreased creatinine clearance, dyspnea, hyponatremia, and lymphopenia].  Ten (50%) of 20 response-evaluable patients had stable disease for four or more cycles.  One patient with pancreatic adenocarcinoma had a partial response noted after 10 cycles, which was maintained for five addnl. cycles.  The other patients achieving stable disease had one of the following: fibrosarcoma, chondrosarcoma, thymoma, atypical carcinoid of lung, or ovarian, testicular, breast (n = 2), and prostate cancer.  The recommended phase II dose of LB-100 is 2.33 mg/m2 daily for 3 days every 3 wk.  Conclusions: The safety, tolerability, preliminary evidence of antitumor activity, and novel mechanism of action of LB-100 support its continued development alone and in combination with other therapies.  Clin Cancer Res; 23(13); 3277-84. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmfD_3Ttra_bVg90H21EOLACvtfcHk0lj5Z9Kv2iWbSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurfM&md5=9df8e258b2a7034e268dc07db1eec751</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-2299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-2299%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DV.%26aulast%3DMansfield%26aufirst%3DA.%2BS.%26aulast%3DBraiteh%26aufirst%3DF.%26aulast%3DRichards%26aufirst%3DD.%26aulast%3DDurivage%26aufirst%3DH.%26aulast%3DUngerleider%26aufirst%3DR.%2BS.%26aulast%3DJohnson%26aufirst%3DF.%26aulast%3DKovach%26aufirst%3DJ.%2BS.%26atitle%3DSafety%252C%2520Tolerability%252C%2520and%2520Preliminary%2520Activity%2520of%2520Lb-100%252C%2520an%2520Inhibitor%2520of%2520Protein%2520Phosphatase%25202a%252C%2520in%2520Patients%2520with%2520Relapsed%2520Solid%2520Tumors%253A%2520An%2520Open-Label%252C%2520Dose%2520Escalation%252C%2520First-in-Human%252C%2520Phase%2520I%2520Trial%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D3277%26epage%3D3284%26doi%3D10.1158%2F1078-0432.CCR-16-2299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span> <span> </span><span class="NLM_article-title">A Synthetic Cantharidin Analog for the Enhancement of Doxorubicin Suppression of Stem Cell-Derived Aggressive Sarcoma</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">9535</span>– <span class="NLM_lpage">9543</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2010.08.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.biomaterials.2010.08.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20875681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlygt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=9535-9543&author=C.+Zhangauthor=Y.+Pengauthor=F.+Wangauthor=X.+Tanauthor=N.+Liuauthor=S.+Fanauthor=D.+Wangauthor=L.+Zhangauthor=D.+Liuauthor=T.+Wangauthor=S.+Wangauthor=Y.+Zhouauthor=Y.+Suauthor=T.+Chengauthor=Z.+Zhuangauthor=C.+Shi&title=A+Synthetic+Cantharidin+Analog+for+the+Enhancement+of+Doxorubicin+Suppression+of+Stem+Cell-Derived+Aggressive+Sarcoma&doi=10.1016%2Fj.biomaterials.2010.08.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">A synthetic cantharidin analog for the enhancement of doxorubicin suppression of stem cell-derived aggressive sarcoma</span></div><div class="casAuthors">Zhang, Chao; Peng, Yi; Wang, Fengchao; Tan, Xu; Liu, Nan; Fan, Song; Wang, Dechun; Zhang, Lilong; Liu, Dengqun; Wang, Tao; Wang, Shaojun; Zhou, Yue; Su, Yongping; Cheng, Tianmin; Zhuang, Zhengping; Shi, Chunmeng</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">9535-9543</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Failure to cure many cancers once they are disseminated has been attributed to the presence of resistant cancer stem cells.  Cantharidin, a natural compd. isolated from the beetles and other insects has been traditionally used as anticancer agent, but limited by its significant toxicity.  It has shown that cantharidin can force cancer cells prematurely into cell cycle and subsequently induce apoptotic cell death through the inhibition of protein phosphatase 2A (PP2A).  In this study, we showed that a synthesized analog of cantharidin, LB1, with significant PP2A inhibition activity but without apparent toxicity, greatly enhanced the effectiveness of the std. anti-sarcoma chemotherapeutic agent, doxorubicin (DOX), in the xenograft growth inhibition and lung metastases prevention of an aggressive sarcoma derived from transformed mesenchymal stem cells in syngeneic rats.  We report here on the possibility of, pharmacol. inhibition of PP2A with low toxicity cantharidin derivs. may be a useful strategy to enhance the effectiveness of DNA-damaged chemotherapeutic drugs against stem cell-derived cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNZMdCeWHDGLVg90H21EOLACvtfcHk0lj5Z9Kv2iWbSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlygt77P&md5=b1555bdcbdbc50ca86dadcf3cc25a3b2</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2010.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2010.08.059%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DShi%26aufirst%3DC.%26atitle%3DA%2520Synthetic%2520Cantharidin%2520Analog%2520for%2520the%2520Enhancement%2520of%2520Doxorubicin%2520Suppression%2520of%2520Stem%2520Cell-Derived%2520Aggressive%2520Sarcoma%26jtitle%3DBiomaterials%26date%3D2010%26volume%3D31%26spage%3D9535%26epage%3D9543%26doi%3D10.1016%2Fj.biomaterials.2010.08.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y.-X.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein Phosphatase 2a with a Small Molecule Lb100 Radiosensitizes Nasopharyngeal Carcinoma Xenografts by Inducing Mitotic Catastrophe and Blocking DNA Damage Repair</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">7512</span>– <span class="NLM_lpage">7524</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.18632%2Foncotarget.2258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25245035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC2M7js1agsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=7512-7524&author=P.+Lvauthor=Y.+Wangauthor=J.+Maauthor=Z.+Wangauthor=J.-L.+Liauthor=C.+S.+Hongauthor=Z.+Zhuangauthor=Y.-X.+Zeng&title=Inhibition+of+Protein+Phosphatase+2a+with+a+Small+Molecule+Lb100+Radiosensitizes+Nasopharyngeal+Carcinoma+Xenografts+by+Inducing+Mitotic+Catastrophe+and+Blocking+DNA+Damage+Repair&doi=10.18632%2Foncotarget.2258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair</span></div><div class="casAuthors">Lv Peng; Wang Yue; Li Jing-Li; Ma Jie; Wang Zheng; Hong Christopher S; Zhuang Zhengping; Zeng Yi-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7512-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nasopharyngeal carcinoma (NPC), while uncommon worldwide, is a major health problem in China.  Although local radiation and surgery provide good control of NPC, better treatments that permit reductions in radiation dosing are needed.  Inhibition of protein phosphatase 2A (PP2A), a ubiquitous multifunctional enzyme with critical roles in cell cycle regulation and DNA-damage response, reportedly sensitizes cancer cells to radiation and chemotherapy.  We studied PP2A inhibition with LB100, a small molecule currently in a Phase I clinical trial, on radiosensitization of two human nasopharyngeal cell lines: CNE1, which is reportedly radioresistant, and CNE2.  In both cell lines, LB100 exposure increased intracellular p-Plk1, TCTP, and Cdk1 and decreased p53, changes associated with cell cycle arrest, mitotic catastrophe and radio-inhibition of cell proliferation.  Mice bearing subcutaneous xenografts of either cell line were administered 1.5 mg/kg LB100 daily for three days and a single dose of 20 Gy radiation (day 3), which produced marked and prolonged tumor mass regression (dose enhancement factors of 2.98 and 2.27 for CNE1 and CNE2 xenografts, respectively).  Treatment with either LB100 or radiation alone only transiently inhibited xenograft growth.  Our results support further exploration of PP2A inhibition as part of radiotherapy regimens for NPC and potentially other solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2-dNSOMXQvuxsqfvU0ziafW6udTcc2eYREV-DFP0tErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7js1agsw%253D%253D&md5=44d7ff0a78dd6fa95ae62b81fea3c972</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2258%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.-L.%26aulast%3DHong%26aufirst%3DC.%2BS.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DZeng%26aufirst%3DY.-X.%26atitle%3DInhibition%2520of%2520Protein%2520Phosphatase%25202a%2520with%2520a%2520Small%2520Molecule%2520Lb100%2520Radiosensitizes%2520Nasopharyngeal%2520Carcinoma%2520Xenografts%2520by%2520Inducing%2520Mitotic%2520Catastrophe%2520and%2520Blocking%2520DNA%2520Damage%2520Repair%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D7512%26epage%3D7524%26doi%3D10.18632%2Foncotarget.2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein Phosphatase 2a Sensitizes Pancreatic Cancer to Chemotherapy by Increasing Drug Perfusion Via Hif-1α-Vegf Mediated Angiogenesis</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.canlet.2014.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25304380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslCisbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2014&pages=281-287&author=X.+Baiauthor=X.+Zhiauthor=Q.+Zhangauthor=F.+Liangauthor=W.+Chenauthor=C.+Liangauthor=Q.+Huauthor=X.+Sunauthor=Z.+Zhuangauthor=T.+Liang&title=Inhibition+of+Protein+Phosphatase+2a+Sensitizes+Pancreatic+Cancer+to+Chemotherapy+by+Increasing+Drug+Perfusion+Via+Hif-1%CE%B1-Vegf+Mediated+Angiogenesis&doi=10.1016%2Fj.canlet.2014.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis</span></div><div class="casAuthors">Bai, Xueli; Zhi, Xiao; Zhang, Qi; Liang, Feng; Chen, Wei; Liang, Chao; Hu, Qida; Sun, Xu; Zhuang, Zhengping; Liang, Tingbo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-287</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Pancreatic cancer is a malignant disease without efficient treatment.  Improved treatments are urgently needed to enhance or replace chemotherapy.  Here we used a small mol. compd. LB-100 to assess the effect of pharmacol. inhibition of protein phosphatase 2A (PP2A) in combination with doxorubicin on the proliferation of pancreatic cancer in cell lines and a xenograft model.  LB-100 moderately reduced PP2A activity and the growth of the cell lines but did not show chemosensitization in vitro.  In vivo, however, LB-100 synergistically enhanced the activity of doxorubicin.  This effect was assocd. with increased microvessel d., blood perfusion, and doxorubicin concns. within the xenografts.  Mech., LB-100 induced expression of hypoxia-induced factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF).  In an umbilical vein endothelial cell monolayer model for measuring changes in vascular permeability, increased VEGF secretion following exposure to LB-100 and doxorubicin was accompanied by increased amts. of doxorubicin penetrating the endothelial barrier.  In conclusion, PP2A inhibition by LB-100 enhanced the cytotoxicity of doxorubicin in vivo but not in vitro potentially via HIF-1α-VEGF mediated angiogenesis.  Combining inhibition of PP2A with chemotherapeutic regimens may enhance their effectiveness against pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXdjMXoSXSw7Vg90H21EOLACvtfcHk0lhoK72Morpjvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslCisbfE&md5=a2930a35970d9f6e0aa9fc113868453f</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.09.048%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DX.%26aulast%3DZhi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520Protein%2520Phosphatase%25202a%2520Sensitizes%2520Pancreatic%2520Cancer%2520to%2520Chemotherapy%2520by%2520Increasing%2520Drug%2520Perfusion%2520Via%2520Hif-1%25CE%25B1-Vegf%2520Mediated%2520Angiogenesis%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D355%26spage%3D281%26epage%3D287%26doi%3D10.1016%2Fj.canlet.2014.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalev, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simicek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablina, A.</span></span> <span> </span><span class="NLM_article-title">Loss of Ppp2r2a Inhibits Homologous Recombination DNA Repair and Predicts Tumor Sensitivity to Parp Inhibition</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">6414</span>– <span class="NLM_lpage">6424</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-1667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F0008-5472.CAN-12-1667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23087057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyns7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=6414-6424&author=P.+Kalevauthor=M.+Simicekauthor=I.+Vazquezauthor=S.+Munckauthor=L.+Chenauthor=T.+Soinauthor=N.+Dandaauthor=W.+Chenauthor=A.+Sablina&title=Loss+of+Ppp2r2a+Inhibits+Homologous+Recombination+DNA+Repair+and+Predicts+Tumor+Sensitivity+to+Parp+Inhibition&doi=10.1158%2F0008-5472.CAN-12-1667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of PPP2R2A Inhibits Homologous Recombination DNA Repair and Predicts Tumor Sensitivity to PARP Inhibition</span></div><div class="casAuthors">Kalev, Peter; Simicek, Michal; Vazquez, Iria; Munck, Sebastian; Chen, Liping; Soin, Thomas; Danda, Natasha; Chen, Wen; Sablina, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6414-6424</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Findings suggest that downregulation of a PP2A family phosphatase in tumors may predict therapeutic responses to a promising new class of anticancer agents currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3mqXzgrVh4LVg90H21EOLACvtfcHk0liC5w4pvytOvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyns7rK&md5=b93954d366c436b42e61d924466bc717</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-1667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-1667%26sid%3Dliteratum%253Aachs%26aulast%3DKalev%26aufirst%3DP.%26aulast%3DSimicek%26aufirst%3DM.%26aulast%3DVazquez%26aufirst%3DI.%26aulast%3DMunck%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSoin%26aufirst%3DT.%26aulast%3DDanda%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSablina%26aufirst%3DA.%26atitle%3DLoss%2520of%2520Ppp2r2a%2520Inhibits%2520Homologous%2520Recombination%2520DNA%2520Repair%2520and%2520Predicts%2520Tumor%2520Sensitivity%2520to%2520Parp%2520Inhibition%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D6414%26epage%3D6424%26doi%3D10.1158%2F0008-5472.CAN-12-1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsels, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsels, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maybaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein Phosphatase 2a Radiosensitizes Pancreatic Cancers by Modulating Cdc25c/Cdk1 and Homologous Recombination Repair</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4422</span>– <span class="NLM_lpage">4432</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-0788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1078-0432.CCR-13-0788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23780887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSitr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4422-4432&author=D.+Weiauthor=L.+A.+Parselsauthor=D.+Karnakauthor=M.+A.+Davisauthor=J.+D.+Parselsauthor=A.+C.+Marshauthor=L.+Zhaoauthor=J.+Maybaumauthor=T.+S.+Lawrenceauthor=Y.+Sunauthor=M.+A.+Morgan&title=Inhibition+of+Protein+Phosphatase+2a+Radiosensitizes+Pancreatic+Cancers+by+Modulating+Cdc25c%2FCdk1+and+Homologous+Recombination+Repair&doi=10.1158%2F1078-0432.CCR-13-0788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair</span></div><div class="casAuthors">Wei, Dongping; Parsels, Leslie A.; Karnak, David; Davis, Mary A.; Parsels, Joshua D.; Marsh, Amanda C.; Zhao, Lili; Maybaum, Jonathan; Lawrence, Theodore S.; Sun, Yi; Morgan, Meredith A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4422-4432</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To identify targets whose inhibition may enhance the efficacy of chemoradiation in pancreatic cancer and thus improve survival, we conducted an siRNA library screen in pancreatic cancer cells.  We investigated PPP2R1A, a scaffolding subunit of protein phosphatase 2A (PP2A) as a lead radiosensitizing target.  Exptl. Design: We detd. the effect of PP2A inhibition by genetic (PPP2R1A siRNA) and pharmacol. (LB100, a small mol. entering phase I clin. trials) approaches on radiosensitization of Panc-1 and MiaPaCa-2 pancreatic cancer cells both in vitro and in vivo.  Results: PPP2R1A depletion by siRNA radiosensitized Panc-1 and MiaPaCa-2 cells, with radiation enhancement ratios of 1.4 (P < 0.05).  Likewise, LB100 produced similar radiosensitization in pancreatic cancer cells, but minimal radiosensitization in normal small intestinal cells.  Mechanistically, PPP2R1A siRNA or LB100 caused aberrant CDK1 activation, likely resulting from accumulation of the active forms of PLK1 (pPLK1 T210) and CDC25C (pCDC25C T130).  Furthermore, LB100 inhibited radiation-induced Rad51 focus formation and homologous recombination repair (HRR), ultimately leading to persistent radiation-induced DNA damage, as reflected by γ-H2AX expression.  Finally, we identified CDC25C as a key PP2A substrate involved in LB100-mediated radiosensitization as depletion of CDC25C partially reversed LB100-mediated radiosensitization.  In a mouse xenograft model of human pancreatic cancer, LB100 produced significant radiosensitization with minimal wt. loss.  Conclusions: Collectively, our data show that PP2A inhibition radiosensitizes pancreatic cancer both in vitro and in vivo via activation of CDC25C/CDK1 and inhibition of HRR, and provide proof-of-concept evidence that PP2A is a promising target for the improvement of local therapy in pancreatic cancer.  Clin Cancer Res; 19(16); 4422-32. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB8m2W4oU8G7Vg90H21EOLACvtfcHk0liC5w4pvytOvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSitr%252FL&md5=e85c871a61505ec2480fbc00a9d002c1</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0788%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DD.%26aulast%3DParsels%26aufirst%3DL.%2BA.%26aulast%3DKarnak%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DM.%2BA.%26aulast%3DParsels%26aufirst%3DJ.%2BD.%26aulast%3DMarsh%26aufirst%3DA.%2BC.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DMaybaum%26aufirst%3DJ.%26aulast%3DLawrence%26aufirst%3DT.%2BS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26atitle%3DInhibition%2520of%2520Protein%2520Phosphatase%25202a%2520Radiosensitizes%2520Pancreatic%2520Cancers%2520by%2520Modulating%2520Cdc25c%252FCdk1%2520and%2520Homologous%2520Recombination%2520Repair%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D4422%26epage%3D4432%26doi%3D10.1158%2F1078-0432.CCR-13-0788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structure of Protein Phosphatase 2a Core Enzyme Bound to Tumor-Inducing Toxins</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.09.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2006.09.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17055435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=341-353&author=Y.+Xingauthor=Y.+Xuauthor=Y.+Chenauthor=P.+D.+Jeffreyauthor=Y.+Chaoauthor=Z.+Linauthor=Z.+Liauthor=S.+Strackauthor=J.+B.+Stockauthor=Y.+Shi&title=Structure+of+Protein+Phosphatase+2a+Core+Enzyme+Bound+to+Tumor-Inducing+Toxins&doi=10.1016%2Fj.cell.2006.09.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins</span></div><div class="casAuthors">Xing, Yongna; Xu, Yanhui; Chen, Yu; Jeffrey, Philip D.; Chao, Yang; Lin, Zheng; Li, Zhu; Strack, Stefan; Stock, Jeffry B.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">341-353</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The serine/threonine phosphatase protein phosphatase 2A (PP2A) plays an essential role in many aspects of cellular functions and has been shown to be an important tumor suppressor.  The core enzyme of PP2A comprises a 65 kDa scaffolding subunit and a 36 kDa catalytic subunit.  Here we report the crystal structures of the PP2A core enzyme bound to two of its inhibitors, the tumor-inducing agents okadaic acid and microcystin-LR, at 2.6 and 2.8 Å resoln., resp.  The catalytic subunit recognizes one end of the elongated scaffolding subunit by interacting with the conserved ridges of HEAT repeats 11-15.  Formation of the core enzyme forces the scaffolding subunit to undergo pronounced structural rearrangement.  The scaffolding subunit exhibits considerable conformational flexibility, which is proposed to play an essential role in PP2A function.  These structures, together with biochem. analyses, reveal significant insights into PP2A function and serve as a framework for deciphering the diverse roles of PP2A in cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaeKKPHPHlPbVg90H21EOLACvtfcHk0liC5w4pvytOvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73K&md5=b6bef7b8fbff156a1deda69e4443d338</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.09.025%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DChao%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DStrack%26aufirst%3DS.%26aulast%3DStock%26aufirst%3DJ.%2BB.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructure%2520of%2520Protein%2520Phosphatase%25202a%2520Core%2520Enzyme%2520Bound%2520to%2520Tumor-Inducing%2520Toxins%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D341%26epage%3D353%26doi%3D10.1016%2Fj.cell.2006.09.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uges, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleijfer, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höppener, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groen, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemse, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Graaf, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, E. G.</span></span> <span> </span><span class="NLM_article-title">Phase I and Pharmacokinetic Study of the Topoisomerase Ii Catalytic Inhibitor Fostriecin</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">882</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6690141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsj.bjc.6690141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10070885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK1MXhslCnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1999&pages=882-887&author=R.+S.+de+Jongauthor=N.+H.+Mulderauthor=D.+R.+Ugesauthor=D.+T.+Sleijferauthor=F.+J.+H%C3%B6ppenerauthor=H.+J.+Groenauthor=P.+H.+Willemseauthor=W.+T.+van+der%0AGraafauthor=E.+G.+de+Vries&title=Phase+I+and+Pharmacokinetic+Study+of+the+Topoisomerase+Ii+Catalytic+Inhibitor+Fostriecin&doi=10.1038%2Fsj.bjc.6690141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin</span></div><div class="casAuthors">De Jong, R. S.; Mulder, N. H.; Uges, D. R. A.; Sleijfer, D. Th; Hoppener, F. J. P.; Groen, H. J. M.; Willemse, P. H. B.; Van der Graaf, W. T. A.; De Vries, E. G. E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">882-887</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">We conducted a phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.  Fostriecin was administered i.v. over 60 min on days 1-5 at 4-wk intervals.  Dose was escalated from 2 mg m-2 day-1 to 20 mg m-2 day-1 in 20 patients.  Drug pharmacokinetics was analyzed with high performance liq. chromatog. with UV-detection.  Plasma collected during drug administration was tested in vitro for growth inhibition of a teniposide-resistant small-cell lung cancer (SCLC) cell line.  The predominant toxicities were elevated liver transaminases (max. common toxicity criteria (CTC) grade 4) and serum creatinine (max. CTC grade 2).  These showed only a limited increase with increasing doses, often recovered during drug administration and were fully reversible.  Duration of elevated alanine-amino transferase (ALT) was dose-limiting in one patient at 20 mg m-2.  Other frequent toxicities were grade 1-2 nausea/vomiting, fever and mild fatigue.  Mean fostriecin plasma half-life was 0.36 h (initial; 95% Cl, 0-0.76 h) and 1.51 h (terminal; 95% Cl, 0.41-2.61 h).  A metabolite, most probably dephosphorylated fostriecin, was detected in plasma and urine.  No tumor responses were obsd., but the plasma concns. reached in the patients were insufficient to induce significant growth inhibition in vitro.  The max. tolerated dose (MTD) has not been reached, because drug supply was stopped at the 20 mg m-2 dose level.  However, further escalation seems possible and is warranted to achieve potentially effective drug levels.  Fostriecin has a short plasma half-life and longer duration of infusion should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQHIU_LDw9QLVg90H21EOLACvtfcHk0lgY__tR_pWsBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhslCnsbs%253D&md5=aeb49bb8bdc77cc495eade5a905eb0d0</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6690141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6690141%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJong%26aufirst%3DR.%2BS.%26aulast%3DMulder%26aufirst%3DN.%2BH.%26aulast%3DUges%26aufirst%3DD.%2BR.%26aulast%3DSleijfer%26aufirst%3DD.%2BT.%26aulast%3DH%25C3%25B6ppener%26aufirst%3DF.%2BJ.%26aulast%3DGroen%26aufirst%3DH.%2BJ.%26aulast%3DWillemse%26aufirst%3DP.%2BH.%26aulast%3Dvan%2Bder%2BGraaf%26aufirst%3DW.%2BT.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BG.%26atitle%3DPhase%2520I%2520and%2520Pharmacokinetic%2520Study%2520of%2520the%2520Topoisomerase%2520Ii%2520Catalytic%2520Inhibitor%2520Fostriecin%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1999%26volume%3D79%26spage%3D882%26epage%3D887%26doi%3D10.1038%2Fsj.bjc.6690141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buck, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardouin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichikawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soenen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonness, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Fundamental Role of the Fostriecin Unsaturated Lactone and Implications for Selective Protein Phosphatase Inhibition</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">15694</span>– <span class="NLM_lpage">15695</span>, <span class="refDoi"> DOI: 10.1021/ja038672n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja038672n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=15694-15695&author=S.+B.+Buckauthor=C.+Hardouinauthor=S.+Ichikawaauthor=D.+R.+Soenenauthor=C.+M.+Gaussauthor=I.+Hwangauthor=M.+R.+Swingleauthor=K.+M.+Bonnessauthor=R.+E.+Honkanenauthor=D.+L.+Boger&title=Fundamental+Role+of+the+Fostriecin+Unsaturated+Lactone+and+Implications+for+Selective+Protein+Phosphatase+Inhibition&doi=10.1021%2Fja038672n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Fundamental Role of the Fostriecin Unsaturated Lactone and Implications for Selective Protein Phosphatase Inhibition</span></div><div class="casAuthors">Buck, Suzanne B.; Hardouin, Christophe; Ichikawa, Satoshi; Soenen, Danielle R.; Gauss, C.-M.; Hwang, Inkyu; Swingle, Mark R.; Bonness, Kathy M.; Honkanen, Richard E.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">15694-15695</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Key derivs. and analogs of fostriecin were prepd. and examd. that revealed a fundamental role for the unsatd. lactone and confirmed the essential nature of the phosphate monoester.  Thus, an identical 200-fold redn. in protein phosphatase 2A (PP2A) inhibition is obsd. with either the satd. lactone (7) or with an analog that lacks the entire lactone (15).  This 200-fold increase in PP2A inhibition attributable to the unsatd. lactone may be due to reversible C269 alkylation within the PP β12-β13 active site loop accounting for PP2A/4 potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruIuvHRt3367Vg90H21EOLACvtfcHk0lgY__tR_pWsBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGqurg%253D&md5=34d2fe8f857cb1d045111b45c96dfc46</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1021%2Fja038672n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja038672n%26sid%3Dliteratum%253Aachs%26aulast%3DBuck%26aufirst%3DS.%2BB.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DIchikawa%26aufirst%3DS.%26aulast%3DSoenen%26aufirst%3DD.%2BR.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DBonness%26aufirst%3DK.%2BM.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DFundamental%2520Role%2520of%2520the%2520Fostriecin%2520Unsaturated%2520Lactone%2520and%2520Implications%2520for%2520Selective%2520Protein%2520Phosphatase%2520Inhibition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D15694%26epage%3D15695%26doi%3D10.1021%2Fja038672n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amable, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationship Studies of Fostriecin, Cytostatin, and Key Analogs, with Pp1, Pp2a, Pp5, and (B12–B13)-Chimeras (Pp1/Pp2a and Pp5/Pp2a), Provide Further Insight into the Inhibitory Actions of Fostriecin Family Inhibitors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.155630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1124%2Fjpet.109.155630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19592665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Gjt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=45-53&author=M.+R.+Swingleauthor=L.+Amableauthor=B.+G.+Lawhornauthor=S.+B.+Buckauthor=C.+P.+Burkeauthor=P.+Rattiauthor=K.+L.+Fischerauthor=D.+L.+Bogerauthor=R.+E.+Honkanen&title=Structure-Activity+Relationship+Studies+of+Fostriecin%2C+Cytostatin%2C+and+Key+Analogs%2C+with+Pp1%2C+Pp2a%2C+Pp5%2C+and+%28B12%E2%80%93B13%29-Chimeras+%28Pp1%2FPp2a+and+Pp5%2FPp2a%29%2C+Provide+Further+Insight+into+the+Inhibitory+Actions+of+Fostriecin+Family+Inhibitors&doi=10.1124%2Fjpet.109.155630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and (β12-β13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors</span></div><div class="casAuthors">Swingle, Mark R.; Amable, Lauren; Lawhorn, Brian G.; Buck, Suzanne B.; Burke, Christopher P.; Ratti, Pukar; Fischer, Kimberly L.; Boger, Dale L.; Honkanen, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-53</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Fostriecin and cytostatin are structurally related natural inhibitors of serine/threonine phosphatases, with promising antitumor activity.  The total synthesis of these antitumor agents has enabled the prodn. of structural analogs, which are useful to explore the biol. significance of features contained in the parent compds.  Here, the inhibitory activity of fostriecin, cytostatin, and 10 key structural analogs were tested in side-by-side phosphatase assays to further characterize their inhibitory activity against PP1c (Ser/Thr protein phosphatase 1 catalytic subunit), PP2Ac (Ser/Thr protein phosphatase 2A catalytic subunit), PP5c (Ser/Thr protein phosphatase 5 catalytic subunit), and chimeras of PP1 (Ser/Thr protein phosphatase 1) and PP5 (Ser/Thr protein phosphatase 5), in which key residues predicted for inhibitor contact with PP2A (Ser/Thr protein phosphatase 2A) were introduced into PP1 and PP5 using site-directed mutagenesis.  The data confirm the importance of the C9-phosphate and C11-alc. for general inhibition and further demonstrate the importance of a predicted C3 interaction with a unique cysteine (Cys269) in the β12-β13 loop of PP2A.  The data also indicate that addnl. features beyond the unsatd. lactone contribute to inhibitory potency and selectivity.  Notably, a deriv. of fostriecin lacking the entire lactone subunit demonstrated marked potency and selectivity for PP2A, while having substantially reduced and similar activity against PP1 and PP1/PP2A- PP5/PP2A-chimeras that have greatly increased sensitivity to both fostriecin and cytostatin.  This suggests that other features [e.g., the (Z,Z,E)-triene] also contribute to inhibitory selectivity.  When considered together with previous data, these studies suggest that, despite the high structural conservation of the catalytic site in PP1, PP2A and PP5, the development of highly selective catalytic inhibitors should be feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofSHvvUev4N7Vg90H21EOLACvtfcHk0lgY__tR_pWsBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Gjt7fP&md5=632aa6f446f9c964048ce9b6badc9573</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.155630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.155630%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DAmable%26aufirst%3DL.%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DBuck%26aufirst%3DS.%2BB.%26aulast%3DBurke%26aufirst%3DC.%2BP.%26aulast%3DRatti%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DK.%2BL.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DStructure-Activity%2520Relationship%2520Studies%2520of%2520Fostriecin%252C%2520Cytostatin%252C%2520and%2520Key%2520Analogs%252C%2520with%2520Pp1%252C%2520Pp2a%252C%2520Pp5%252C%2520and%2520%2528B12%25E2%2580%2593B13%2529-Chimeras%2520%2528Pp1%252FPp2a%2520and%2520Pp5%252FPp2a%2529%252C%2520Provide%2520Further%2520Insight%2520into%2520the%2520Inhibitory%2520Actions%2520of%2520Fostriecin%2520Family%2520Inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D45%26epage%3D53%26doi%3D10.1124%2Fjpet.109.155630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Doherty, G. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Dehydro-Dephospho-Fostriecin and Formal Total Synthesis of Fostriecin</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">8334</span>– <span class="NLM_lpage">8338</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.9b03120</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.9b03120" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFShsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=8334-8338&author=D.+Gaoauthor=B.+Liauthor=G.+A.+O%E2%80%99Doherty&title=Synthesis+of+Dehydro-Dephospho-Fostriecin+and+Formal+Total+Synthesis+of+Fostriecin&doi=10.1021%2Facs.orglett.9b03120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Dehydro-Dephospho-Fostriecin and Formal Total Synthesis of Fostriecin</span></div><div class="casAuthors">Gao, Dong; Li, Bohui; O'Doherty, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8334-8338</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A formal synthesis of fostriecin and a total synthesis of its related congener dihydro-dephospho-fostriecin (I) have been achieved.  The route relies upon the use of the Sharpless dihydroxylation to set the abs. stereochem. at C-8/9 and Noyori transfer hydrogenation and Leighton allylation to set the C-11 and C-5 relative stereochem., resp.  Finally, the divergent functionalization of a C-12/13 alkyne was used to establish the Z,E-dienyne of dehydro-dephospho-fostriecin I and the Z,Z,E-triene of fostriecin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqae8JRXnq3rVg90H21EOLACvtfcHk0lhqQZiLYN47ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFShsbnO&md5=1692837e9d0eb16cf2a7ad0b29c4d10c</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.9b03120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.9b03120%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Doherty%26aufirst%3DG.%2BA.%26atitle%3DSynthesis%2520of%2520Dehydro-Dephospho-Fostriecin%2520and%2520Formal%2520Total%2520Synthesis%2520of%2520Fostriecin%26jtitle%3DOrg.%2520Lett.%26date%3D2019%26volume%3D21%26spage%3D8334%26epage%3D8338%26doi%3D10.1021%2Facs.orglett.9b03120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoshima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okado, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, M.</span></span> <span> </span><span class="NLM_article-title">Formal Total Synthesis of Fostriecin by 1,4-Asymmetric Induction with an Alkyne-Cobalt Complex</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">10150</span>– <span class="NLM_lpage">10159</span>, <span class="refDoi"> DOI: 10.1002/chem.201000795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fchem.201000795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20645347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2qsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=10150-10159&author=Y.+Hayashiauthor=H.+Yamaguchiauthor=M.+Toyoshimaauthor=K.+Okadoauthor=T.+Toyoauthor=M.+Shoji&title=Formal+Total+Synthesis+of+Fostriecin+by+1%2C4-Asymmetric+Induction+with+an+Alkyne-Cobalt+Complex&doi=10.1002%2Fchem.201000795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Formal Total Synthesis of Fostriecin by 1,4-Asymmetric Induction with an Alkyne-Cobalt Complex</span></div><div class="casAuthors">Hayashi, Yujiro; Yamaguchi, Hirofumi; Toyoshima, Maya; Okado, Kotaro; Toyo, Takumi; Shoji, Mitsuru</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">10150-10159, S10150/1-S10150/134</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The synthesis of a protected dephosphofostriecin, I, and thereby a formal synthesis of fostriecin, has been accomplished.  The synthetic challenges were the construction of four stereogenic centers and the conformationally labile cis-cis-trans-triene moiety.  Previous total syntheses have employed at least two asym. reactions that required the use of an external chiral auxiliary.  Although remote stereoinduction in a 1,4-relationship is considered difficult, we have developed a notable 1,4-asym. induction that utilizes an alkyne-cobalt complex for the control of C5 stereochem. by the C8 stereogenic center.  The stereochem. at C11 was established by 1,3-asym. induction with a higher-order alkynyl-zinc reagent.  Thus, only one asym. reaction requiring an external chiral auxiliary was employed in this route.  The labile cis-cis-trans-triene unit was constructed at a late stage of the synthesis by diastereoselective coupling of a dienyne and an aldehyde unit, followed by redn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6ws1u-rVjC7Vg90H21EOLACvtfcHk0lhqQZiLYN47ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2qsb%252FI&md5=61a25f41da7ee45ee6e924f2b0506a2b</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1002%2Fchem.201000795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201000795%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DToyoshima%26aufirst%3DM.%26aulast%3DOkado%26aufirst%3DK.%26aulast%3DToyo%26aufirst%3DT.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DFormal%2520Total%2520Synthesis%2520of%2520Fostriecin%2520by%25201%252C4-Asymmetric%2520Induction%2520with%2520an%2520Alkyne-Cobalt%2520Complex%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2010%26volume%3D16%26spage%3D10150%26epage%3D10159%26doi%3D10.1002%2Fchem.201000795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Doherty, G.</span></span> <span> </span><span class="NLM_article-title">Total and Formal Syntheses of Fostriecin</span>. <i>Org. Chem. Front.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3608</span>– <span class="NLM_lpage">3615</span>, <span class="refDoi"> DOI: 10.1039/D0QO01121E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1039%2FD0QO01121E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=33184589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVKgsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2020&pages=3608-3615&author=G.+Dongauthor=B.+Liauthor=G.+O%E2%80%99Doherty&title=Total+and+Formal+Syntheses+of+Fostriecin&doi=10.1039%2FD0QO01121E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Total and formal syntheses of fostriecin</span></div><div class="casAuthors">Dong, Gao; Li, Bohui; O'Doherty, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Chemistry Frontiers</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3608-3615</span>CODEN:
                <span class="NLM_cas:coden">OCFRA8</span>;
        ISSN:<span class="NLM_cas:issn">2052-4129</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Two formal syntheses and one total synthesis of fostriecin (1) have been achieved, as well as, the synthesis of its related congener dihydro-dephospho-fostriecin.  All the routes use the Sharpless dihydroxylation to set the abs. stereochem. at C-8/9 positions and a Leighton allylation to set the C-5 position of the natural product.  In the formal syntheses a Noyori transfer hydrogenation of an ynone was used to set the C-11 position while the total synthesis employed a combination of asym. dihydroxylation and Pd-π-allyl redn. to set the C-11 position.  Finally in the total synthesis, a trans-hydroboration of the C-12/13 alkyne was used in combination with a Suzuki cross coupling to establish the Z,Z,E-triene of fostriecin (1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxXBN_YFF83LVg90H21EOLACvtfcHk0lhqQZiLYN47ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVKgsr3M&md5=7c6f6db293bf26f6f744f93306ff81c3</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1039%2FD0QO01121E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0QO01121E%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Doherty%26aufirst%3DG.%26atitle%3DTotal%2520and%2520Formal%2520Syntheses%2520of%2520Fostriecin%26jtitle%3DOrg.%2520Chem.%2520Front.%26date%3D2020%26volume%3D7%26spage%3D3608%26epage%3D3615%26doi%3D10.1039%2FD0QO01121E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, M.</span></span> <span> </span><span class="NLM_article-title">Fostriecin Potentiates Genome Instability and Anti-Tumor Immunity in Ovarian Cancer</span>. <i>J. Immunother. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">A593</span>– <span class="NLM_lpage">A593</span>, <span class="refDoi"> DOI: 10.1136/jitc-2020-SITC2020.0559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1136%2Fjitc-2020-SITC2020.0559" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=A593-A593&author=R.+Rajaauthor=C.+Wuauthor=K.+Butlerauthor=M.+Curtis&title=Fostriecin+Potentiates+Genome+Instability+and+Anti-Tumor+Immunity+in+Ovarian+Cancer&doi=10.1136%2Fjitc-2020-SITC2020.0559"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1136%2Fjitc-2020-SITC2020.0559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjitc-2020-SITC2020.0559%26sid%3Dliteratum%253Aachs%26aulast%3DRaja%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DK.%26aulast%3DCurtis%26aufirst%3DM.%26atitle%3DFostriecin%2520Potentiates%2520Genome%2520Instability%2520and%2520Anti-Tumor%2520Immunity%2520in%2520Ovarian%2520Cancer%26jtitle%3DJ.%2520Immunother.%2520Cancer%26date%3D2020%26volume%3D8%26spage%3DA593%26epage%3DA593%26doi%3D10.1136%2Fjitc-2020-SITC2020.0559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusayanagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuramochi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, F.</span></span> <span> </span><span class="NLM_article-title">Antitumor Antibiotic Fostriecin Covalently Binds to Cysteine-269 Residue of Protein Phosphatase 2a Catalytic Subunit in Mammalian Cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">8113</span>– <span class="NLM_lpage">8122</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.09.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bmc.2009.09.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19857968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2js7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=8113-8122&author=T.+Takeuchiauthor=N.+Takahashiauthor=K.+Ishiauthor=T.+Kusayanagiauthor=K.+Kuramochiauthor=F.+Sugawara&title=Antitumor+Antibiotic+Fostriecin+Covalently+Binds+to+Cysteine-269+Residue+of+Protein+Phosphatase+2a+Catalytic+Subunit+in+Mammalian+Cells&doi=10.1016%2Fj.bmc.2009.09.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor antibiotic fostriecin covalently binds to cysteine-269 residue of protein phosphatase 2A catalytic subunit in mammalian cells</span></div><div class="casAuthors">Takeuchi, Toshifumi; Takahashi, Noriyuki; Ishi, Kazutomo; Kusayanagi, Tomoe; Kuramochi, Kouji; Sugawara, Fumio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8113-8122</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fostriecin is a phosphate monoester with excellent antitumor activity against mouse leukemia, and it is a potent inhibitor of protein phosphatase (PP) 2A.  This compd. has been predicted to covalently bind to the Cys269 residue of the PP2A catalytic subunit (PP2Ac) at the α,β-unsatd. lactone via a conjugate addn. reaction.  However, this binding has not yet been exptl. proven.  To confirm such binding, we synthesized biotin-labeled fostriecin (bio-Fos), which has an inhibitory activity against the proliferation of mouse leukemia cells.  We showed that fostriecin directly binds to PP2Ac in HeLa S3 cells by pull-down assays using bio-Fos.  Moreover, we directly demonstrated that fostriecin covalently binds to the Cys269 residue of PP2Ac by matrix assisted laser desorption/ionization time-of-flight mass spectrometry anal.  From these results, the inhibitory mechanism of fostriecin on PP2A activity is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFAMdpXt3_arVg90H21EOLACvtfcHk0lip0_e-Oi1dDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2js7fL&md5=7cd55788624efa257f9f635fd154976f</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.09.050%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DIshi%26aufirst%3DK.%26aulast%3DKusayanagi%26aufirst%3DT.%26aulast%3DKuramochi%26aufirst%3DK.%26aulast%3DSugawara%26aufirst%3DF.%26atitle%3DAntitumor%2520Antibiotic%2520Fostriecin%2520Covalently%2520Binds%2520to%2520Cysteine-269%2520Residue%2520of%2520Protein%2520Phosphatase%25202a%2520Catalytic%2520Subunit%2520in%2520Mammalian%2520Cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D8113%26epage%3D8122%26doi%3D10.1016%2Fj.bmc.2009.09.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greengard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nairn, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span> <span> </span><span class="NLM_article-title">Three-Dimensional Structure of the Catalytic Subunit of Protein Serine/Threonine Phosphatase-1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>376</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">753</span>, <span class="refDoi"> DOI: 10.1038/376745a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2F376745a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=7651533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFChs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=745-753&author=J.+Goldbergauthor=H.+B.+Huangauthor=Y.+G.+Kwonauthor=P.+Greengardauthor=A.+C.+Nairnauthor=J.+Kuriyan&title=Three-Dimensional+Structure+of+the+Catalytic+Subunit+of+Protein+Serine%2FThreonine+Phosphatase-1&doi=10.1038%2F376745a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1</span></div><div class="casAuthors">Goldberg, Jonathan; Huang, Hsien-bin; Kwon, Young-guen; Greengard, Paul; Nairn, Angus C.; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">6543</span>),
    <span class="NLM_cas:pages">745-53</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The crystal structure of mammalian (rabbit muscle) phosphoprotein phosphatase 1, complexed with the toxin, microcystin, and detd. at 2.1 Å resoln., revealed that it is a metalloenzyme unrelated in architecture to the phosphoprotein tyrosine phosphatases.  Two metal cations were positioned by a central β-α-β-α-β scaffold at the active site, from which emanate 3 surface grooves that are potential binding sites for substrates and inhibitors.  The C-terminus was positioned at the end of one of the grooves such that regulatory sequences following the domain might modulate function.  The fold of the catalytic domain was expected to be closely preserved in phosphoprotein phosphatases 2A and 2B (calcineurin).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3Ox1khdGU7Vg90H21EOLACvtfcHk0lip0_e-Oi1dDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFChs7w%253D&md5=05f1a525b89cb35161fde5af5edac860</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1038%2F376745a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376745a0%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DH.%2BB.%26aulast%3DKwon%26aufirst%3DY.%2BG.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DThree-Dimensional%2520Structure%2520of%2520the%2520Catalytic%2520Subunit%2520of%2520Protein%2520Serine%252FThreonine%2520Phosphatase-1%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D745%26epage%3D753%26doi%3D10.1038%2F376745a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Apeldoorn, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Egmond, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speijers, G. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, G. J. I.</span></span> <span> </span><span class="NLM_article-title">Toxins of Cyanobacteria</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1002/mnfr.200600185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fmnfr.200600185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17195276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFCrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=7-60&author=M.+E.+van%0AApeldoornauthor=H.+P.+van+Egmondauthor=G.+J.+A.+Speijersauthor=G.+J.+I.+Bakker&title=Toxins+of+Cyanobacteria&doi=10.1002%2Fmnfr.200600185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Toxins of cyanobacteria</span></div><div class="casAuthors">van Apeldoorn, Marian E.; van Egmond, Hans P.; Speijers, Gerrit J. A.; Bakker, Guido J. I.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Nutrition & Food Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-60</span>CODEN:
                <span class="NLM_cas:coden">MNFRCV</span>;
        ISSN:<span class="NLM_cas:issn">1613-4125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Blue-green algae are found in lakes, ponds, rivers and brackish waters throughout the world.  In case of excessive growth such as bloom formation, these bacteria can produce inherent toxins in quantities causing toxicity in mammals, including humans.  These cyanotoxins include cyclic peptides and alkaloids.  Among the cyclic peptides are the microcystins and the nodularins.  The alkaloids include anatoxin-a, anatoxin-a(S), cylindrospermopsin, saxitoxins (STXs), aplysiatoxins and lyngbyatoxin.  Both biol. and chem. methods are used to det. cyanotoxins.  Bioassays and biochem. assays are nonspecific, so they can only be used as screening methods.  HPLC has some good prospects.  For the subsequent detection of these toxins different detectors may be used, ranging from simple UV-spectrometry via fluorescence detection to various types of MS.  The main problem in the detn. of cyanobacterial toxins is the lack of ref. materials of all relevant toxins.  In general, toxicity data on cyanotoxins are rather scarce.  A majority of toxicity data are known to be of microcystin-LR.  For nodularins, data from a few animal studies are available.  For the alkaloids, limited toxicity data exist for anatoxin-a, cylindrospermopsin and STX.  Risk assessment for acute exposure could be relevant for some types of exposure.  Nevertheless, no acute ref. doses have formally been derived thus far.  For STX(s), many countries have established tolerance levels in bivalves, but these limits were set in view of STX(s) as biotoxins, accumulating in marine shellfish.  Official regulations for other cyanotoxins were not established, although some (provisional) guideline values were derived for microcystins in drinking water by WHO and several countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdcVqkbkPfb7Vg90H21EOLACvtfcHk0lip0_e-Oi1dDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFCrur8%253D&md5=a9ab88d7d63f4de718f1392f83b87b25</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.200600185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.200600185%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BApeldoorn%26aufirst%3DM.%2BE.%26aulast%3Dvan%2BEgmond%26aufirst%3DH.%2BP.%26aulast%3DSpeijers%26aufirst%3DG.%2BJ.%2BA.%26aulast%3DBakker%26aufirst%3DG.%2BJ.%2BI.%26atitle%3DToxins%2520of%2520Cyanobacteria%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2007%26volume%3D51%26spage%3D7%26epage%3D60%26doi%3D10.1002%2Fmnfr.200600185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwaghe, M. J.</span></span> <span> </span><span class="NLM_article-title">Microcystins Contamination of Surface Water Supply Sources in Zaria-Nigeria</span>. <i>Environ. Monit. Assess.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">606</span>, <span class="refDoi"> DOI: 10.1007/s10661-015-4829-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs10661-015-4829-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26329267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC287otlarug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2015&pages=606&author=M.+A.+Chiaauthor=M.+J.+Kwaghe&title=Microcystins+Contamination+of+Surface+Water+Supply+Sources+in+Zaria-Nigeria&doi=10.1007%2Fs10661-015-4829-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Microcystins contamination of surface water supply sources in Zaria-Nigeria</span></div><div class="casAuthors">Chia Mathias Ahii; Kwaghe Mndepawe Jonah</div><div class="citationInfo"><span class="NLM_cas:title">Environmental monitoring and assessment</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">606</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cyanobacterial contamination of public water supply systems is a worldwide problem.  The present study investigated water quality and microcystins (MCs) contamination of four public water supply systems in Zaria, Nigeria.  The water bodies were eutrophic in the rainy and dry season and supported high phytoplankton biomass with chlorophyll a concentrations generally higher than 20.0 μg/L.  The biomass of the predominant species (Microcystis aeruginosa and Anabaena subcylindrica) of cyanobacteria had a significant positive correlation with particulate and dissolved MCs.  Dissolved MCs concentrations were higher (>1.0 μg/L) than the maximum permissible limits for drinking water in all the water bodies in the dry season and three of them in the rainy season.  These results suggest that there is the need to have a regular monitoring program for these water bodies to prevent acute and chronic health hazards associated with MCs contamination of drinking and irrigation water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4DbdyGL01oNK0qsdY6Nc1fW6udTcc2eYkjld7OGWvBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287otlarug%253D%253D&md5=4687b954c4cf8e229b14033d4bc26e48</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1007%2Fs10661-015-4829-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10661-015-4829-3%26sid%3Dliteratum%253Aachs%26aulast%3DChia%26aufirst%3DM.%2BA.%26aulast%3DKwaghe%26aufirst%3DM.%2BJ.%26atitle%3DMicrocystins%2520Contamination%2520of%2520Surface%2520Water%2520Supply%2520Sources%2520in%2520Zaria-Nigeria%26jtitle%3DEnviron.%2520Monit.%2520Assess.%26date%3D2015%26volume%3D187%26spage%3D606%26doi%3D10.1007%2Fs10661-015-4829-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bittencourt-Oliveira, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hereman, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordeiro-Araújo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo-Silva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, F. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, A. N.</span></span> <span> </span><span class="NLM_article-title">Phytotoxicity Associated to Microcystins: A Review</span>. <i>Braz. J. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.1590/1519-6984.06213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1590%2F1519-6984.06213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25627583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC2Mrgt1OhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=753-760&author=M.+C.+Bittencourt-Oliveiraauthor=T.+C.+Heremanauthor=M.+K.+Cordeiro-Ara%C3%BAjoauthor=I.+Macedo-Silvaauthor=C.+T.+Diasauthor=F.+F.+C.+Sasakiauthor=A.+N.+Moura&title=Phytotoxicity+Associated+to+Microcystins%3A+A+Review&doi=10.1590%2F1519-6984.06213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Phytotoxicity associated to microcystins: a review</span></div><div class="casAuthors">Bittencourt-Oliveira M C; Hereman T C; Cordeiro-Araujo M K; Sasaki F F C; Macedo-Silva I; Dias C T; Moura A N</div><div class="citationInfo"><span class="NLM_cas:title">Brazilian journal of biology = Revista brasleira de biologia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Microcystins (MC) are the most studied toxins of cyanobacteria since they are widely distributed and account for several cases of human and animal poisoning, being potent inhibitors of the serine/threonine protein phosphatases 1 (PP1) and 2A (PP2A).  The phosphatases PP1 and PP2A are also present in plants, which may also suffer adverse effects due to the inhibition of these enzymes.  In aquatic plants, biomass reduction is usually observed after absorption of cyanotoxins, which can bioaccumulate in its tissues.  In terrestrial plants, the effects caused by microcystins vary from inhibition to stimulation as the individuals develop from seedling to adult, and include reduction of protein phosphatases 1 and 2A, oxidative stress, decreased photosynthetic activity and even cell apoptosis, as well as bioaccumulation in plant tissues.  Thus, the irrigation of crop plants by water contaminated with microcystins is not only an economic problem but becomes a public health issue because of the possibility of food contamination, and this route of exposure requires careful monitoring by the responsible authorities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdcE3_BMw2imhHGZei4OW9fW6udTcc2eYkjld7OGWvBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mrgt1OhtA%253D%253D&md5=41256c6643c5f17aed200e938f71df11</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1590%2F1519-6984.06213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252F1519-6984.06213%26sid%3Dliteratum%253Aachs%26aulast%3DBittencourt-Oliveira%26aufirst%3DM.%2BC.%26aulast%3DHereman%26aufirst%3DT.%2BC.%26aulast%3DCordeiro-Ara%25C3%25BAjo%26aufirst%3DM.%2BK.%26aulast%3DMacedo-Silva%26aufirst%3DI.%26aulast%3DDias%26aufirst%3DC.%2BT.%26aulast%3DSasaki%26aufirst%3DF.%2BF.%2BC.%26aulast%3DMoura%26aufirst%3DA.%2BN.%26atitle%3DPhytotoxicity%2520Associated%2520to%2520Microcystins%253A%2520A%2520Review%26jtitle%3DBraz.%2520J.%2520Biol.%26date%3D2014%26volume%3D74%26spage%3D753%26epage%3D760%26doi%3D10.1590%2F1519-6984.06213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Funari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testai, E.</span></span> <span> </span><span class="NLM_article-title">Human Health Risk Assessment Related to Cyanotoxins Exposure</span>. <i>Crit. Rev. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1080/10408440701749454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1080%2F10408440701749454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=18259982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Wlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=97-125&author=E.+Funariauthor=E.+Testai&title=Human+Health+Risk+Assessment+Related+to+Cyanotoxins+Exposure&doi=10.1080%2F10408440701749454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Human health risk assessment related to cyanotoxins exposure</span></div><div class="casAuthors">Funari, Enzo; Testai, Emanuela</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-125</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">1040-8444</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  This review focuses on the risk assessment assocd. with human exposure to cyanotoxins, secondary metabolites of an ubiquitous group of photosynthetic procariota.  Cyanobacteria occurr esp. in eutrophic inland and coastal surface waters, where under favorable conditions they attain high densities and may form blooms and scums.  Cyanotoxins can be grouped according to their biol. effects into hepatotoxins, neurotoxins, cytotoxins, and toxins with irritating potential, also acting on the gastrointestinal system.  The chem. and toxicol. properties of the main cyanotoxins, relevant for the evaluation of possible risks for human health, are presented.  Humans may be exposed to cyanotoxins via several routes, with the oral one being by far the most important, occurring by ingesting contaminated drinking water, food, some dietary supplements, or water during recreational activities.  Acute and short-term toxic effects have been assocd. in humans with exposure to high levels of cyanotoxins in drinking and bathing waters.  However, the chronic exposure to low cyanotoxin levels remains a crit. issue.  This article identifies the actual risky exposure scenarios, provides toxicol. derived ref. values, and discusses open issues and research needs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj3AszvQxfR7Vg90H21EOLACvtfcHk0lhtKEpF6keEcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Wlurk%253D&md5=dbe83c9af6215b25af04b3b01fa13528</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1080%2F10408440701749454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408440701749454%26sid%3Dliteratum%253Aachs%26aulast%3DFunari%26aufirst%3DE.%26aulast%3DTestai%26aufirst%3DE.%26atitle%3DHuman%2520Health%2520Risk%2520Assessment%2520Related%2520to%2520Cyanotoxins%2520Exposure%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D2008%26volume%3D38%26spage%3D97%26epage%3D125%26doi%3D10.1080%2F10408440701749454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jochimsen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmichael, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardo, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cookson, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filho, D. A. d. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyra, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreto, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azevedo, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, W. R.</span></span> <span> </span><span class="NLM_article-title">Liver Failure and Death after Exposure to Microcystins at a Hemodialysis Center in Brazil</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">878</span>, <span class="refDoi"> DOI: 10.1056/NEJM199803263381304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1056%2FNEJM199803263381304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9516222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADyaK1c7mslyisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1998&pages=873-878&author=E.+M.+Jochimsenauthor=W.+W.+Carmichaelauthor=J.+S.+Anauthor=D.+M.+Cardoauthor=S.+T.+Cooksonauthor=C.+E.+Holmesauthor=M.+B.+Antunesauthor=D.+A.+d.+M.+Filhoauthor=T.+M.+Lyraauthor=V.+S.+Barretoauthor=S.+M.+Azevedoauthor=W.+R.+Jarvis&title=Liver+Failure+and+Death+after+Exposure+to+Microcystins+at+a+Hemodialysis+Center+in+Brazil&doi=10.1056%2FNEJM199803263381304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil</span></div><div class="casAuthors">Jochimsen E M; Carmichael W W; An J S; Cardo D M; Cookson S T; Holmes C E; Antunes M B; de Melo Filho D A; Lyra T M; Barreto V S; Azevedo S M; Jarvis W R</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">873-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Hemodialysis is a common but potentially hazardous procedure.  From February 17 to 20, 1996, 116 of 130 patients (89 percent) at a dialysis center (dialysis center A) in Caruaru, Brazil, had visual disturbances, nausea, and vomiting associated with hemodialysis.  By March 24, 26 of the patients had died of acute liver failure.  METHODS:  A case patient was defined as any patient undergoing dialysis at dialysis center A or Caruaru's other dialysis center (dialysis center B) during February 1996 who had acute liver failure.  To determine the risk factors for and the source of the outbreak, we conducted a cohort study of the 130 patients at dialysis center A and the 47 patients at dialysis center B, reviewed the centers' water supplies, and collected water, patients' serum, and postmortem liver tissue for microcystin assays.  RESULTS:  One hundred one patients (all at dialysis center A) met the case definition, and 50 died.  Affected patients who died were older than those who survived (median age, 47 vs. 35 years, P<0.001).  Furthermore, all 17 patients undergoing dialysis on the Tuesday-, Thursday-, and Saturday-night schedule became ill, and 13 of them (76 percent) died.  Both centers received water from a nearby reservoir.  However, the water supplied to dialysis center B was treated, filtered, and chlorinated, whereas the water supplied to dialysis center A was not.  Microcystins produced by cyanobacteria were detected in water from the reservoir and from dialysis center A and in serum and liver tissue of case patients.  CONCLUSIONS:  Water used for hemodialysis can contain toxic materials, and its quality should therefore be carefully monitored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6uVwzPlrzozUE-swuRqsHfW6udTcc2eYkjld7OGWvBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7mslyisA%253D%253D&md5=02e75c15621b4a4946060f0a8ab2a958</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1056%2FNEJM199803263381304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199803263381304%26sid%3Dliteratum%253Aachs%26aulast%3DJochimsen%26aufirst%3DE.%2BM.%26aulast%3DCarmichael%26aufirst%3DW.%2BW.%26aulast%3DAn%26aufirst%3DJ.%2BS.%26aulast%3DCardo%26aufirst%3DD.%2BM.%26aulast%3DCookson%26aufirst%3DS.%2BT.%26aulast%3DHolmes%26aufirst%3DC.%2BE.%26aulast%3DAntunes%26aufirst%3DM.%2BB.%26aulast%3DFilho%26aufirst%3DD.%2BA.%2Bd.%2BM.%26aulast%3DLyra%26aufirst%3DT.%2BM.%26aulast%3DBarreto%26aufirst%3DV.%2BS.%26aulast%3DAzevedo%26aufirst%3DS.%2BM.%26aulast%3DJarvis%26aufirst%3DW.%2BR.%26atitle%3DLiver%2520Failure%2520and%2520Death%2520after%2520Exposure%2520to%2520Microcystins%2520at%2520a%2520Hemodialysis%2520Center%2520in%2520Brazil%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D338%26spage%3D873%26epage%3D878%26doi%3D10.1056%2FNEJM199803263381304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshikata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. C.</span></span> <span> </span><span class="NLM_article-title">Detection and Identification of Microcystins in the Drinking Water of Haimen City, China</span>. <i>Nat. Toxins</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1002/(SICI)(1996)4:6<277::AID-NT5>3.0.CO;2-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2F%28SICI%29%281996%294%3A6%3C277%3A%3AAID-NT5%3E3.0.CO%3B2-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9029553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2sXhsFeqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=277-283&author=K.+Haradaauthor=M.+Oshikataauthor=H.+Uchidaauthor=M.+Suzukiauthor=F.+Kondoauthor=K.+Satoauthor=Y.+Uenoauthor=S.+Z.+Yuauthor=G.+Chenauthor=G.+C.+Chen&title=Detection+and+Identification+of+Microcystins+in+the+Drinking+Water+of+Haimen+City%2C+China&doi=10.1002%2F%28SICI%29%281996%294%3A6%3C277%3A%3AAID-NT5%3E3.0.CO%3B2-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Detection and identification of microcystins in the drinking water of Haimen City, China</span></div><div class="casAuthors">Harada, Ken-Ichi; Oshikata, Motoji; Uchida, Hideaki; Suzuki, Makoto; Kondo, Fumio; Sato, Katsuhiko; Ueno, Yoshio; Yu, Shun-Zhang; Chen, Gang; Chen, Gong-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Natural Toxins</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">277-283</span>CODEN:
                <span class="NLM_cas:coden">NATOEE</span>;
        ISSN:<span class="NLM_cas:issn">1056-9014</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">Cyanobacterial toxins, microcystins, have a potent tumor-promoting activity.  We investigated the level of microcystins in drinking water collected from 1992 to 1994 in Haimen City, China, where people who drink pond ditch water usually incurred a high incidence rate of hepatocellular carcinoma as compared with those who drink well water.  HPLC, liq. chromatog./mass spectrometry (LC/MS), and protein phosphatase inhibition assay (pp assay) were used to identify and quantify the microcystins.  Microcystin LR and [D-Asp3]microcystin LR were detected in 2 of 50 samples at a concn. of less than 100 ng/L by LC/MS in 1992.  Although no microcystins were found by the chem. method in 1993, 6 of 7 samples, except for 3 tap water samples, showed approx. 100 ng/L by using the pp assay in 1994.  The results obtained supported the epidemiol. results reported by S. Z. Yu (1989, 1995).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Cen8oCjfB7Vg90H21EOLACvtfcHk0ljfuQfhuYW01g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsFeqtbg%253D&md5=374fa77175f43b4dfbd698e9b5461a38</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%29%281996%294%3A6%3C277%3A%3AAID-NT5%3E3.0.CO%3B2-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%2529%25281996%25294%253A6%253C277%253A%253AAID-NT5%253E3.0.CO%253B2-1%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DOshikata%26aufirst%3DM.%26aulast%3DUchida%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DKondo%26aufirst%3DF.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DS.%2BZ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DG.%2BC.%26atitle%3DDetection%2520and%2520Identification%2520of%2520Microcystins%2520in%2520the%2520Drinking%2520Water%2520of%2520Haimen%2520City%252C%2520China%26jtitle%3DNat.%2520Toxins%26date%3D1996%26volume%3D4%26spage%3D277%26epage%3D283%26doi%3D10.1002%2F%28SICI%29%281996%294%3A6%3C277%3A%3AAID-NT5%3E3.0.CO%3B2-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svircev, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krstic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miladinov-Mikov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidovic, M.</span></span> <span> </span><span class="NLM_article-title">Freshwater Cyanobacterial Blooms and Primary Liver Cancer Epidemiological Studies in Serbia</span>. <i>J. Environ. Sci. Heal C</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1080/10590500802668016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1080%2F10590500802668016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslShtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=36-55&author=Z.+Svircevauthor=S.+Krsticauthor=M.+Miladinov-Mikovauthor=V.+Balticauthor=M.+Vidovic&title=Freshwater+Cyanobacterial+Blooms+and+Primary+Liver+Cancer+Epidemiological+Studies+in+Serbia&doi=10.1080%2F10590500802668016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Freshwater Cyanobacterial Blooms and Primary Liver Cancer Epidemiological Studies in Serbia</span></div><div class="casAuthors">Svircev, Zorica; Krstic, Svetislav; Miladinov-Mokov, Marica; Baltic, Vladimir; Vidovic, Milka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis & Ecotoxicology Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-55</span>CODEN:
                <span class="NLM_cas:coden">JESHA2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A large part of Central Serbia experiences continual shortage of sufficient ground water resources.  For that reason, more than 20 reservoirs serve as drinking water suppliers.  Significant and persistent cyanobacterial "blooms" have been recognized in nine of them.  Samples for cyanotoxin analyses were taken during and after "blooms" in Celije Reservoir and from Krusevac town-supplied tap water from that reservoir two days later.  Concn. of microcystin-LR was 650 μ gL-1 in the reservoir, while the tap water contained 2.5 μ gL-1.  In the two investigated periods, the high primary liver cancer (PLC) mortality of 11.6 from 1980-1990 and extremely high PLC incidence of 34.7 from 2000-2002 were obsd. in the regions affected by heavy cyanobacterial blooms.  In contrast, PLC mortality and incidence rates were substantially lower in the regions not affected by cyanobacterial blooms: in 1980-1990 the rate of PLC mortality amounted to 2.7 in Kosovo, 7.6 in Vojvodina, and 8.3 in the non-affected regions of Central Serbia; while in 2000-2002 PLC incidence amounted to 4.1 in Kosovo, 5.2 in Vojvodina, and 13.6 in the non- or less-affected regions of Central Serbia.  Keeping in mind that the most affected PLC regions in Central Serbia (Toplicki, Niski, and Sumadijski regions) have the water supply systems based on six reservoirs found regularly in bloom during summer months and that some of the regions are also connected with two boundary "blooming" reservoirs, representing a total of eight of nine blooming reservoirs, it is easy to presume that the PLC incidence could be related to drinking water quality.  The uneven geog. distribution of liver cancer in Serbia is conspicuous and hot spots could be related to drinking water supply.  It is very clear that the high-risk regions for PLC occurrence correspond with drinking water reservoirs continually found with cyanobacterial blooms, and the low risk regions correspond with water supplies not affected by cyanobacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo27-h0lS6n2LVg90H21EOLACvtfcHk0ljfuQfhuYW01g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslShtrY%253D&md5=7899e2a89e6aa270cd6151a2df56ea87</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1080%2F10590500802668016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10590500802668016%26sid%3Dliteratum%253Aachs%26aulast%3DSvircev%26aufirst%3DZ.%26aulast%3DKrstic%26aufirst%3DS.%26aulast%3DMiladinov-Mikov%26aufirst%3DM.%26aulast%3DBaltic%26aufirst%3DV.%26aulast%3DVidovic%26aufirst%3DM.%26atitle%3DFreshwater%2520Cyanobacterial%2520Blooms%2520and%2520Primary%2520Liver%2520Cancer%2520Epidemiological%2520Studies%2520in%2520Serbia%26jtitle%3DJ.%2520Environ.%2520Sci.%2520Heal%2520C%26date%3D2009%26volume%3D27%26spage%3D36%26epage%3D55%26doi%3D10.1080%2F10590500802668016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. Z.</span></span> <span> </span><span class="NLM_article-title">Detection of Microcystins, a Blue-Green Algal Hepatotoxin, in Drinking Water Sampled in Haimen and Fusui, Endemic Areas of Primary Liver Cancer in China, by Highly Sensitive Immunoassay</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1317</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1093/carcin/17.6.1317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1093%2Fcarcin%2F17.6.1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8681449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK28XjvFegurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=1317-1321&author=Y.+Uenoauthor=S.+Nagataauthor=T.+Tsutsumiauthor=A.+Hasegawaauthor=M.+F.+Watanabeauthor=H.+D.+Parkauthor=G.+C.+Chenauthor=G.+Chenauthor=S.+Z.+Yu&title=Detection+of+Microcystins%2C+a+Blue-Green+Algal+Hepatotoxin%2C+in+Drinking+Water+Sampled+in+Haimen+and+Fusui%2C+Endemic+Areas+of+Primary+Liver+Cancer+in+China%2C+by+Highly+Sensitive+Immunoassay&doi=10.1093%2Fcarcin%2F17.6.1317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay</span></div><div class="casAuthors">Ueno, Yoshio; Nagata, Satoshi; Tsutsumi, Tomoaki; Hasegawa, Akihiro; Watanabe, Mariyo F.; Park, Ho-Dong; Chen, Gong-Chao; Chen, Gang; Yu, Shun-Zhang</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1317-1321</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">An epidemiol. survey to identify causes of a high incidence of primary liver cancer (PLC) in Haimen City, Jian-Su Province and Fusui County, Guangxi Province, China, found a close correlation between the incidence of PLC and consumption of pond and ditch water.  To clarify whether microcystin (MC), a hepatotoxic peptide produced by water bloom algae, pollute drinking water in PLC endemic areas in China, a highly sensitive ELISA with a detection limit of 50 pg/mL, was introduced to monitor MC.  Three drinking water surveys were conducted in 1993-1994.  A total of 1135 samples were collected from ponds, ditches, rivers, shallow wells, and deep wells in Haimen City.  The first survey, in Sept. 1993, found that 3 of 14 ditch water specimens were pos. for MC, in concns. of 90-460 pg/mL.  Several toxic algae such as Oscillatoria agardhii were present in some ditches.  In the second trial, samples were collected from 5 ponds/ditches, 2 rivers, 2 shallow wells, and 2 deep wells on a monthly basis throughout 1994.  These data showed that MC was highest in June-Sept., at concns. of 62-296 pg/mL.  A third trial of 989 samples collected from water sources in July 1994 showed that 17% of pond/ditch water, 32% of river water, and 4% of shallow well water were pos. for MC, with avs. of 101, 160, and 68 pg/mL, resp.  No MC was detected in deep well water.  A similar survey on 26 drinking water samples in Fusui, demonstrated a high MC contamination frequency in pond/ditch and river waters, but no MC in shallow and deep wells.  These data support a hypothesis that the blue-green algal toxin, MC, in pond/ditch and river waters used as drinking water is a risk factor for the high incidence of PLC in China.  Based on previous PLC epidemiol. findings and MC drinking water screening surveys, an advisory level of MC in drinking water of <0.01 μg/L was proposed.  The combined effect of a potent hepatocarcinogen, AFB1, and an intermittent intake of MC in drinking water in summer was discussed as an etiol. of PLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJLNHTWjvoULVg90H21EOLACvtfcHk0lj9kBExhOw7TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvFegurg%253D&md5=aa950c022ada24c2f88480b2735af1c5</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2F17.6.1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252F17.6.1317%26sid%3Dliteratum%253Aachs%26aulast%3DUeno%26aufirst%3DY.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DM.%2BF.%26aulast%3DPark%26aufirst%3DH.%2BD.%26aulast%3DChen%26aufirst%3DG.%2BC.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DS.%2BZ.%26atitle%3DDetection%2520of%2520Microcystins%252C%2520a%2520Blue-Green%2520Algal%2520Hepatotoxin%252C%2520in%2520Drinking%2520Water%2520Sampled%2520in%2520Haimen%2520and%2520Fusui%252C%2520Endemic%2520Areas%2520of%2520Primary%2520Liver%2520Cancer%2520in%2520China%252C%2520by%2520Highly%2520Sensitive%2520Immunoassay%26jtitle%3DCarcinogenesis%26date%3D1996%26volume%3D17%26spage%3D1317%26epage%3D1321%26doi%3D10.1093%2Fcarcin%2F17.6.1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Figueiredo, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azeiteiro, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteves, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, F. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, M. J.</span></span> <span> </span><span class="NLM_article-title">Microcystin-Producing Blooms—a Serious Global Public Health Issue</span>. <i>Ecotoxicol. Environ. Saf.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/j.ecoenv.2004.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.ecoenv.2004.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15327870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFCltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=151-163&author=D.+R.+de+Figueiredoauthor=U.+M.+Azeiteiroauthor=S.+M.+Estevesauthor=F.+J.+M.+Gon%C3%A7alvesauthor=M.+J.+Pereira&title=Microcystin-Producing+Blooms%E2%80%94a+Serious+Global+Public+Health+Issue&doi=10.1016%2Fj.ecoenv.2004.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Microcystin-producing blooms-a serious global public health issue</span></div><div class="casAuthors">de Figueiredo, Daniela R.; Azeiteiro, Ulisses M.; Esteves, Sonia M.; Goncalves, Fernando J. M.; Pereira, Mario J.</div><div class="citationInfo"><span class="NLM_cas:title">Ecotoxicology and Environmental Safety</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-163</span>CODEN:
                <span class="NLM_cas:coden">EESADV</span>;
        ISSN:<span class="NLM_cas:issn">0147-6513</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The investigation on microcystin topics is increasing due to the related ecol. and public health risks.  Recent investigation confirms a gap in establishing global patterns relating a particular environment to the bloom occurrence of a species and the prodn. of certain microcystin variants.  All the results concerning the environmental effects on the microcystin synthesis of one species must be checked in the light of genome diversity.  Thus, the poisoning risks of a bloom depend on the strain causing toxicity.  To be more effective, specific water treatment methods are required for blooms of different microcystin-producing species (such as colonial and filamentous cyanobacteria found in stratified and unstratified water bodies, resp.).  With the increasing no. of new microcystin variants discovered, the development of new rapid, inexpensive, and sensitive enough monitoring methods to promptly screen simultaneously a great diversity of toxins and also check their toxic effects is becoming necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNhcNFNBcdpLVg90H21EOLACvtfcHk0lj9kBExhOw7TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFCltbY%253D&md5=2d3079a71d6d4e13d869299fefc4d1ff</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2Fj.ecoenv.2004.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ecoenv.2004.04.006%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BFigueiredo%26aufirst%3DD.%2BR.%26aulast%3DAzeiteiro%26aufirst%3DU.%2BM.%26aulast%3DEsteves%26aufirst%3DS.%2BM.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DF.%2BJ.%2BM.%26aulast%3DPereira%26aufirst%3DM.%2BJ.%26atitle%3DMicrocystin-Producing%2520Blooms%25E2%2580%2594a%2520Serious%2520Global%2520Public%2520Health%2520Issue%26jtitle%3DEcotoxicol.%2520Environ.%2520Saf.%26date%3D2004%26volume%3D59%26spage%3D151%26epage%3D163%26doi%3D10.1016%2Fj.ecoenv.2004.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vareli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frillingos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briasoulis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sainis, I.</span></span> <span> </span><span class="NLM_article-title">Hepatotoxic Seafood Poisoning (Hsp) Due to Microcystins: A Threat from the Ocean?</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2751</span>– <span class="NLM_lpage">2768</span>, <span class="refDoi"> DOI: 10.3390/md11082751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3390%2Fmd11082751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23921721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSms7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=2751-2768&author=K.+Vareliauthor=W.+Jaegerauthor=A.+Toukaauthor=S.+Frillingosauthor=E.+Briasoulisauthor=I.+Sainis&title=Hepatotoxic+Seafood+Poisoning+%28Hsp%29+Due+to+Microcystins%3A+A+Threat+from+the+Ocean%3F&doi=10.3390%2Fmd11082751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatotoxic Seafood Poisoning (HSP) due to microcystins: a threat from the ocean?</span></div><div class="casAuthors">Vareli, Katerina; Jaeger, Walter; Touka, Anastasia; Frillingos, Stathis; Briasoulis, Evangelos; Sainis, Ioannis</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2751-2768, 18 pp.</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Cyanobacterial blooms are a major and growing problem for freshwater ecosystems worldwide that increasingly concerns public health, with an av. of 60% of blooms known to be toxic.  The most studied cyanobacterial toxins belong to a family of cyclic heptapeptide hepatotoxins, called microcystins.  The microcystins are stable hydrophilic cyclic heptapeptides with a potential to cause cell damage following cellular uptake via org. anion-transporting proteins (OATP).  Their intracellular biol. effects presumably involve inhibition of catalytic subunits of protein phosphatases (PP1 and PP2A) and glutathione depletion.  The microcystins produced by cyanobacteria pose a serious problem to human health, if they contaminate drinking water or food.  These toxins are collectively responsible for human fatalities, as well as continued and widespread poisoning of wild and domestic animals.  Although intoxications of aquatic organisms by microcystins have been widely documented for freshwater ecosystems, such poisonings in marine environments have only occasionally been reported.  Moreover, these poisonings have been attributed to freshwater cyanobacterial species invading seas of lower salinity (e.g., the Baltic) or to the discharge of freshwater microcystins into the ocean.  However, recent data suggest that microcystins are also being produced in the oceans by a no. of cosmopolitan marine species, so that Hepatotoxic Seafood Poisoning (HSP) is increasingly recognized as a major health risk that follows consumption of contaminated seafood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz2rT3uysozLVg90H21EOLACvtfcHk0lghy3XhivbC9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSms7bO&md5=136df3b9e7408a9d6259962bfcab56b1</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.3390%2Fmd11082751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd11082751%26sid%3Dliteratum%253Aachs%26aulast%3DVareli%26aufirst%3DK.%26aulast%3DJaeger%26aufirst%3DW.%26aulast%3DTouka%26aufirst%3DA.%26aulast%3DFrillingos%26aufirst%3DS.%26aulast%3DBriasoulis%26aufirst%3DE.%26aulast%3DSainis%26aufirst%3DI.%26atitle%3DHepatotoxic%2520Seafood%2520Poisoning%2520%2528Hsp%2529%2520Due%2520to%2520Microcystins%253A%2520A%2520Threat%2520from%2520the%2520Ocean%253F%26jtitle%3DMar.%2520Drugs%26date%3D2013%26volume%3D11%26spage%3D2751%26epage%3D2768%26doi%3D10.3390%2Fmd11082751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prickett, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span> <span> </span><span class="NLM_article-title">The A4 Regulatory Subunit Exerts Opposing Allosteric Effects on Protein Phosphatases Pp6 and Pp2a</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">30503</span>– <span class="NLM_lpage">30511</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601054200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M601054200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=16895907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCrsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=30503-30511&author=T.+D.+Prickettauthor=D.+L.+Brautigan&title=The+A4+Regulatory+Subunit+Exerts+Opposing+Allosteric+Effects+on+Protein+Phosphatases+Pp6+and+Pp2a&doi=10.1074%2Fjbc.M601054200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">The α4 Regulatory Subunit Exerts Opposing Allosteric Effects on Protein Phosphatases PP6 and PP2A</span></div><div class="casAuthors">Prickett, Todd D.; Brautigan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">30503-30511</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protein Ser/Thr phosphatase family contains three enzymes called PP2A, PP4, and PP6 with sep. biol. functions inferred from genetics of the yeast homologues Pph21/22, Pph3, and Sit4.  These catalytic subunits assoc. with a common subunit called α4 (related to yeast Tap42).  Here, we characterized recombinant PP6 and PP2A catalytic monomers and α4·phosphatase heterodimers.  Monomeric PP6 and PP2A showed identical kinetics using either p-nitrophenyl phosphate (pNPP) or 32P-myelin basic protein (MBP) as substrates, with matching Km and Vmax values.  Using pNPP as substrate, PP6 and PP2A gave the same IC50 with active site inhibitors okadaic acid, microcystin-LR, calyculin A, and cantharidin.  However, with MBP as substrate, PP6 was inhibited at 5-fold lower concns. of toxins relative to PP2A, suggesting PP6 might be a preferred in vivo target of toxins.  Heterodimeric α4·PP6 and α4·PP2A were starkly different.  With MBP as substrate the α4·PP2A heterodimer had a 100-fold higher Vmax than α4·PP6, and neither heterodimer was active with pNPP.  Thus, these phosphatases are distinguished by their different responses to allosteric binding of the common regulatory subunit α4.  Transient expression of α4 differentially increased or decreased phosphorylation of endogenous phosphoproteins, consistent with opposing effects on PP2A and PP6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqpOx4uHDms7Vg90H21EOLACvtfcHk0lghy3XhivbC9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCrsL3K&md5=857da17a92103bf12b845e6cf4a3fe77</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601054200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601054200%26sid%3Dliteratum%253Aachs%26aulast%3DPrickett%26aufirst%3DT.%2BD.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26atitle%3DThe%2520A4%2520Regulatory%2520Subunit%2520Exerts%2520Opposing%2520Allosteric%2520Effects%2520on%2520Protein%2520Phosphatases%2520Pp6%2520and%2520Pp2a%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D30503%26epage%3D30511%26doi%3D10.1074%2Fjbc.M601054200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maude, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Donnell, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehrotra, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gani, D.</span></span> <span> </span><span class="NLM_article-title">Design and Preparation of Serine–Threonine Protein Phosphatase Inhibitors Based Upon the Nodularin and Microcystin Toxin Structures. Part 3</span>. <i>J. Chem. Soc. Perkin Trans. 1</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1695</span>, <span class="refDoi"> DOI: 10.1039/b100401h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1039%2Fb100401h" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=1673-1695&author=K.+L.+Websterauthor=A.+B.+Maudeauthor=M.+E.+O%27Donnellauthor=A.+P.+Mehrotraauthor=D.+Gani&title=Design+and+Preparation+of+Serine%E2%80%93Threonine+Protein+Phosphatase+Inhibitors+Based+Upon+the+Nodularin+and+Microcystin+Toxin+Structures.+Part+3&doi=10.1039%2Fb100401h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1039%2Fb100401h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb100401h%26sid%3Dliteratum%253Aachs%26aulast%3DWebster%26aufirst%3DK.%2BL.%26aulast%3DMaude%26aufirst%3DA.%2BB.%26aulast%3DO%2527Donnell%26aufirst%3DM.%2BE.%26aulast%3DMehrotra%26aufirst%3DA.%2BP.%26aulast%3DGani%26aufirst%3DD.%26atitle%3DDesign%2520and%2520Preparation%2520of%2520Serine%25E2%2580%2593Threonine%2520Protein%2520Phosphatase%2520Inhibitors%2520Based%2520Upon%2520the%2520Nodularin%2520and%2520Microcystin%2520Toxin%2520Structures.%2520Part%25203%26jtitle%3DJ.%2520Chem.%2520Soc.%2520Perkin%2520Trans.%25201%26date%3D2001%26volume%3D1%26spage%3D1673%26epage%3D1695%26doi%3D10.1039%2Fb100401h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maynes, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, C. F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. N. G.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Tumor-Promoter Okadaic Acid Bound to Protein Phosphatase-1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">44078</span>– <span class="NLM_lpage">44082</span>, <span class="refDoi"> DOI: 10.1074/jbc.M107656200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M107656200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11535607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos12ntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=44078-44082&author=J.+T.+Maynesauthor=K.+S.+Batemanauthor=M.+M.+Cherneyauthor=A.+K.+Dasauthor=H.+A.+Luuauthor=C.+F.+B.+Holmesauthor=M.+N.+G.+James&title=Crystal+Structure+of+the+Tumor-Promoter+Okadaic+Acid+Bound+to+Protein+Phosphatase-1&doi=10.1074%2Fjbc.M107656200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tumor-promoter okadaic acid bound to protein phosphatase-1</span></div><div class="casAuthors">Maynes, Jason T.; Bateman, Katherine S.; Cherney, Maia M.; Das, Amit K.; Luu, Hue Anh; Holmes, Charles F. B.; James, Michael N. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">44078-44082</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Protein phosphatase-1 (PP1) plays a key role in dephosphorylation in numerous biol. processes such as glycogen metab., cell cycle regulation, smooth muscle contraction, and protein synthesis.  Microorganisms produce a variety of inhibitors of PP1, which include the microcystin class of inhibitors and okadaic acid, the latter being the major cause of diarrhetic shellfish poisoning and a powerful tumor promoter.  The authors have detd. the crystal structure of the mol. complex of okadaic acid bound to PP1 to a resoln. of 1.9 Å.  This structure reveals that the acid binds in a hydrophobic groove adjacent to the active site of the protein and interacts with basic residues within the active site.  Okadaic acid exhibits a cyclic structure, which is maintained via an intramol. hydrogen bond.  This is reminiscent of other macrocyclic protein phosphatase inhibitors.  The inhibitor-bound enzyme shows very little conformational change when compared with two other PP1 structures, except in the inhibitor-sensitive β12-β13 loop region.  The selectivity of okadaic acid for protein phosphatases-1 and -2A but not PP-2B (calcineurin) may be reassessed in light of this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7AMLpTLsFbbVg90H21EOLACvtfcHk0lghy3XhivbC9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos12ntb8%253D&md5=8b41e617072a2dde062fac26b42ec1da</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M107656200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M107656200%26sid%3Dliteratum%253Aachs%26aulast%3DMaynes%26aufirst%3DJ.%2BT.%26aulast%3DBateman%26aufirst%3DK.%2BS.%26aulast%3DCherney%26aufirst%3DM.%2BM.%26aulast%3DDas%26aufirst%3DA.%2BK.%26aulast%3DLuu%26aufirst%3DH.%2BA.%26aulast%3DHolmes%26aufirst%3DC.%2BF.%2BB.%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Tumor-Promoter%2520Okadaic%2520Acid%2520Bound%2520to%2520Protein%2520Phosphatase-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D44078%26epage%3D44082%26doi%3D10.1074%2Fjbc.M107656200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boga, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colby, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amable, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis and Evaluation of Cytostatin, Its C10-C11 Diastereomers, and Additional Key Analogues: Impact on Pp2a Inhibition</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">16720</span>– <span class="NLM_lpage">16732</span>, <span class="refDoi"> DOI: 10.1021/ja066477d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja066477d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSrsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=16720-16732&author=B.+G.+Lawhornauthor=S.+B.+Bogaauthor=S.+E.+Wolkenbergauthor=D.+A.+Colbyauthor=C.-M.+Gaussauthor=M.+R.+Swingleauthor=L.+Amableauthor=R.+E.+Honkanenauthor=D.+L.+Boger&title=Total+Synthesis+and+Evaluation+of+Cytostatin%2C+Its+C10-C11+Diastereomers%2C+and+Additional+Key+Analogues%3A+Impact+on+Pp2a+Inhibition&doi=10.1021%2Fja066477d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis and Evaluation of Cytostatin, Its C10-C11 Diastereomers, and Additional Key Analogues: Impact on PP2A Inhibition</span></div><div class="casAuthors">Lawhorn, Brian G.; Boga, Sobhana B.; Wolkenberg, Scott E.; Colby, David A.; Gauss, Carla-Maria; Swingle, Mark R.; Amable, Lauren; Honkanen, Richard E.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">16720-16732</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The total synthesis of cytostatin (I, R = H, R1 = OH), an antitumor agent belonging to the fostriecin family of natural products, is described in full detail.  The convergent approach relied on a key epoxide-opening reaction to join the two stereotriad units and a single-step late-stage stereoselective installation of the sensitive (Z,Z,E)-triene through a β-chelation-controlled nucleophilic addn.  The synthetic route provided rapid access to the C4-C6 stereoisomers of the cytostatin lactone, which were prepd. and used to define the C4-C6 relative stereochem. of the natural product.  In addn. to the natural product, each of the C10-C11 diastereomers of cytostatin was divergently prepd., e.g. I (R = OH, R1 = H), (11 steps from key convergence step) by this route and used to unequivocally confirm the relative and abs. stereochem. of cytostatin.  Each of the cytostatin diastereomers exhibited a reduced activity toward inhibition of PP2A (>100-fold), demonstrating the importance of the presence and stereochem. of the C10-Me and C11-hydroxy groups for potent PP2A inhibition.  Extensions of the studies provided dephosphocytostatin, sulfocytostatin (a key analog related to the natural product sultriecin), 11-deshydroxycytostatin, and an analog lacking the entire C12-C18 (Z,Z,E)-triene segment, which were used to define the magnitude of the C9-phosphate (>4000-fold), C11-alc. (250-fold), and triene (220-fold) contribution to PP2A inhibition.  A model of cytostatin bound to the active site of PP2A is presented, compared to that of fostriecin, which is also presented in detail for the first time, and used to provide insights into the role of the key substituents.  Notably, the α,β-unsatd. lactone of cytostatin, like that of fostriecin, is projected to serve as a key electrophile, providing a covalent adduct with Cys269 unique to PP2A, contributing to its potency (≥200-fold for fostriecin) and accounting for its selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeS-CWIkStBrVg90H21EOLACvtfcHk0lj_zU6N9tDhQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSrsr%252FO&md5=e2be848f74cd7b13dce3568d0ef8588c</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1021%2Fja066477d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja066477d%26sid%3Dliteratum%253Aachs%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DBoga%26aufirst%3DS.%2BB.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DColby%26aufirst%3DD.%2BA.%26aulast%3DGauss%26aufirst%3DC.-M.%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DAmable%26aufirst%3DL.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DTotal%2520Synthesis%2520and%2520Evaluation%2520of%2520Cytostatin%252C%2520Its%2520C10-C11%2520Diastereomers%252C%2520and%2520Additional%2520Key%2520Analogues%253A%2520Impact%2520on%2520Pp2a%2520Inhibition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D16720%26epage%3D16732%26doi%3D10.1021%2Fja066477d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambrecht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haesen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sents, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssens, V.</span></span> <span> </span><span class="NLM_article-title">Structure, Regulation, and Pharmacological Modulation of Pp2a Phosphatases</span>. <i>Methods Mol. Biol. (N. Y., NY, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1053</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1007/978-1-62703-562-0_17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2F978-1-62703-562-0_17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23860660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvVSjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1053&publication_year=2013&pages=283-305&author=C.+Lambrechtauthor=D.+Haesenauthor=W.+Sentsauthor=E.+Ivanovaauthor=V.+Janssens&title=Structure%2C+Regulation%2C+and+Pharmacological+Modulation+of+Pp2a+Phosphatases&doi=10.1007%2F978-1-62703-562-0_17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, Regulation, and Pharmacological Modulation of PP2A Phosphatases</span></div><div class="casAuthors">Lambrecht, Caroline; Haesen, Dorien; Sents, Ward; Ivanova, Elitsa; Janssens, Veerle</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1053</span>
        (<span class="NLM_cas:issue">Phosphatase Modulators</span>),
    <span class="NLM_cas:pages">283-305</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Protein phosphatases of the type 2A family (PP2A) represent a major fraction of cellular Ser/Thr phosphatase activity in any given human tissue.  In this review, we describe how the holoenzymic nature of PP2A and the existence of several distinct PP2A composing subunits allow for the generation of multiple structurally and functionally different PP2A complexes, explaining why PP2A is involved in the regulation of so many diverse cell biol. and physiol. processes.  Moreover, in human disease, most notably in several cancers and Alzheimer's Disease, PP2A expression and/or activity have been found significantly decreased, underscoring its important functions as a major tumor suppressor and tau phosphatase.  Hence, several recent preclin. studies have demonstrated that pharmacol. restoration of PP2A activity, as well as pharmacol. PP2A inhibition, under certain conditions, may be of significant future therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFqaa-GHtxarVg90H21EOLACvtfcHk0lj_zU6N9tDhQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvVSjsLY%253D&md5=7c84b163ba402ff91d9806ccdf345b98</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-562-0_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-562-0_17%26sid%3Dliteratum%253Aachs%26aulast%3DLambrecht%26aufirst%3DC.%26aulast%3DHaesen%26aufirst%3DD.%26aulast%3DSents%26aufirst%3DW.%26aulast%3DIvanova%26aufirst%3DE.%26aulast%3DJanssens%26aufirst%3DV.%26atitle%3DStructure%252C%2520Regulation%252C%2520and%2520Pharmacological%2520Modulation%2520of%2520Pp2a%2520Phosphatases%26jtitle%3DMethods%2520Mol.%2520Biol.%2520%2528N.%2520Y.%252C%2520NY%252C%2520U.%2520S.%2529%26date%3D2013%26volume%3D1053%26spage%3D283%26epage%3D305%26doi%3D10.1007%2F978-1-62703-562-0_17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aggen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nairn, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlin, A. R.</span></span> <span> </span><span class="NLM_article-title">The Design, Synthesis, and Biological Evaluation of Analogues of the Serine-Threonine Protein Phosphatase 1 and 2a Selective Inhibitor Microcystin La: Rational Modifications Imparting Pp1 Selectivity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(98)00254-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0968-0896%2898%2900254-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10220039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK1MXitlGktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=543-564&author=J.+B.+Aggenauthor=J.+M.+Humphreyauthor=C.+M.+Gaussauthor=H.+B.+Huangauthor=A.+C.+Nairnauthor=A.+R.+Chamberlin&title=The+Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Analogues+of+the+Serine-Threonine+Protein+Phosphatase+1+and+2a+Selective+Inhibitor+Microcystin+La%3A+Rational+Modifications+Imparting+Pp1+Selectivity&doi=10.1016%2FS0968-0896%2898%2900254-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">The design, synthesis, and biological evaluation of analogs of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivity</span></div><div class="casAuthors">Aggen, James B.; Humphrey, John M.; Gauss, Carla-Maria; Huang, Hsien-Bin; Nairn, Angus C.; Chamberlin, A. Richard</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">543-564</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Based on the results from previously reported mol. modeling analyses of the interactions between the inhibitor microcystin and the serine-threonine protein phosphatases 1 and 2A, the authors have designed analogs of microcystin LA (I) with structural modifications intended to impart PP1 selectivity.  The synthesis of several first generation analogs followed by inhibition assays revealed that all three are PP1-selective, as predicted.  Although the obsd. selectivities are modest, one of the designed analogs is more selective for PP1 than any known small mol. inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoirJVeATZ49bVg90H21EOLACvtfcHk0lilPyCl61IQ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitlGktbg%253D&md5=45a6a03ed8f3c9e11c9dc4f7e20297e2</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2898%2900254-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252898%252900254-5%26sid%3Dliteratum%253Aachs%26aulast%3DAggen%26aufirst%3DJ.%2BB.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DHuang%26aufirst%3DH.%2BB.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DChamberlin%26aufirst%3DA.%2BR.%26atitle%3DThe%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Analogues%2520of%2520the%2520Serine-Threonine%2520Protein%2520Phosphatase%25201%2520and%25202a%2520Selective%2520Inhibitor%2520Microcystin%2520La%253A%2520Rational%2520Modifications%2520Imparting%2520Pp1%2520Selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1999%26volume%3D7%26spage%3D543%26epage%3D564%26doi%3D10.1016%2FS0968-0896%2898%2900254-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontanillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemskov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhrig, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Highly Selective Submicromolar Microcystin-Based Inhibitors of Protein Phosphatase (Pp)2a over Pp1</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">13985</span>– <span class="NLM_lpage">13989</span>, <span class="refDoi"> DOI: 10.1002/anie.201606449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fanie.201606449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1CgtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=13985-13989&author=M.+Fontanilloauthor=I.+Zemskovauthor=M.+Hafnerauthor=U.+Uhrigauthor=F.+Salviauthor=B.+Simonauthor=V.+Wittmannauthor=M.+Kohn&title=Synthesis+of+Highly+Selective+Submicromolar+Microcystin-Based+Inhibitors+of+Protein+Phosphatase+%28Pp%292a+over+Pp1&doi=10.1002%2Fanie.201606449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of highly selective submicromolar microcystin-based inhibitors of protein phosphatase (PP)2A over PP1</span></div><div class="casAuthors">Fontanillo, Miriam; Zemskov, Ivan; Haefner, Maximilian; Uhrig, Ulrike; Salvi, Francesca; Simon, Bernd; Wittmann, Valentin; Koehn, Maja</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">13985-13989</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Research and therapeutic targeting of the phosphoserine/threonine phosphatases PP1 and PP2A is hindered by the lack of selective inhibitors.  The microcystin (MC) natural toxins target both phosphatases with equal potency, and their complex synthesis has complicated structure-activity relationship studies in the past.  We report herein the synthesis and biochem. evaluation of 11 MC analogs, which was accomplished through an efficient strategy combining solid- and soln.-phase approaches.  Our approach led to the first MC analog with submicromolar inhibitory potency that is strongly selective for PP2A over PP1 and does not require the complex lipophilic Adda group.  Through mutational and structural analyses, we identified a new key element for binding, as well as reasons for the selectivity.  This work gives unprecedented insight into how selectivity between these phosphatases can be achieved with MC analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9YGP8xoSFCbVg90H21EOLACvtfcHk0lilPyCl61IQ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1CgtLfI&md5=58eb29f37742812e41be89fd1918065f</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1002%2Fanie.201606449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201606449%26sid%3Dliteratum%253Aachs%26aulast%3DFontanillo%26aufirst%3DM.%26aulast%3DZemskov%26aufirst%3DI.%26aulast%3DHafner%26aufirst%3DM.%26aulast%3DUhrig%26aufirst%3DU.%26aulast%3DSalvi%26aufirst%3DF.%26aulast%3DSimon%26aufirst%3DB.%26aulast%3DWittmann%26aufirst%3DV.%26aulast%3DKohn%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520Highly%2520Selective%2520Submicromolar%2520Microcystin-Based%2520Inhibitors%2520of%2520Protein%2520Phosphatase%2520%2528Pp%25292a%2520over%2520Pp1%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D13985%26epage%3D13989%26doi%3D10.1002%2Fanie.201606449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontanillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Microcystins: Synthesis and Structure–Activity Relationship Studies toward Pp1 and Pp2a</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1118</span>– <span class="NLM_lpage">1126</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.08.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bmc.2017.08.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28893598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKlurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=1118-1126&author=M.+Fontanilloauthor=M.+K%C3%B6hn&title=Microcystins%3A+Synthesis+and+Structure%E2%80%93Activity+Relationship+Studies+toward+Pp1+and+Pp2a&doi=10.1016%2Fj.bmc.2017.08.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Microcystins: Synthesis and structure-activity relationship studies toward PP1 and PP2A</span></div><div class="casAuthors">Fontanillo, Miriam; Koehn, Maja</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1118-1126</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Microcystins are highly toxic cyanotoxins responsible for plant, animal and human poisoning.  Exposure to microcystins, mainly through drinkable water and contaminated food, is a current world health concern.  Although it is quite challenging, the synthesis of these potent cyanotoxins, analogs and derivs. helps to evaluate their toxicol. properties and to elucidate their binding mechanisms to their main targets Protein Phosphatase-1 (PP1) and -2A (PP2A).  This review focuses on synthetic approaches to prep. microcystins and analogs and compiles structure-activity relationship (SAR) studies that describe the unique features of microcystins that make them so potent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdqsA88KlWTbVg90H21EOLACvtfcHk0lilPyCl61IQ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKlurfF&md5=f0a944727d4103bd4c57e4f29dd827ce</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.08.040%26sid%3Dliteratum%253Aachs%26aulast%3DFontanillo%26aufirst%3DM.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DMicrocystins%253A%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Studies%2520toward%2520Pp1%2520and%2520Pp2a%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D1118%26epage%3D1126%26doi%3D10.1016%2Fj.bmc.2017.08.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snen, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isono, K.</span></span> <span> </span><span class="NLM_article-title">A New Antibiotic, Tautomycetin</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.42.141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.7164%2Fantibiotics.42.141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2921220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL1MXhsVOhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1989&pages=141-144&author=Y.+Kobayashiauthor=K.+Koauthor=I.+Yamaguchiauthor=Y.-C.+Snenauthor=K.+Isono&title=A+New+Antibiotic%2C+Tautomycetin&doi=10.7164%2Fantibiotics.42.141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">A new antibiotic, tautomycetin</span></div><div class="casAuthors">Cheng, Xing Chun; Kihara, Tsuyoshi; Ying, Xing; Uramoto, Masakazu; Osada, Hiroyuki; Kusakabe, Hiroo; Wang, Bao Nu; Kobayashi, Yumiko; Ko, Keido; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-4</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">The new antibiotic tautomycetin was isolated from Streptomyces griseochromogenes.  This compd. appeared as a tautomeric mixt. and had inhibitory activity against a series of fungi, but not against Gram pos. or neg. bacteria.  In human erythroid leukemia cells, the antibiotic at 3-100 μg/mL induced bleb formation, but it reversed the bleb formation induced by phorbol 12,13-dibutyrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTw_hyGXGm8rVg90H21EOLACvtfcHk0lilPyCl61IQ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhsVOhtrc%253D&md5=ebec46dd250df88956cb75554068e571</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.42.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.42.141%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKo%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DI.%26aulast%3DSnen%26aufirst%3DY.-C.%26aulast%3DIsono%26aufirst%3DK.%26atitle%3DA%2520New%2520Antibiotic%252C%2520Tautomycetin%26jtitle%3DJ.%2520Antibiot.%26date%3D1989%26volume%3D42%26spage%3D141%26epage%3D144%26doi%3D10.7164%2Fantibiotics.42.141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ubukata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isono, a. K.</span></span> <span> </span><span class="NLM_article-title">The Structure of Tautomycin, a Regulator of Eukaryotic Cell Growth</span>. <i>J. Chem. Soc., Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1039/c39900000244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1039%2Fc39900000244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXkslOqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=244-246&author=M.+Ubukataauthor=X.+C.+Chengauthor=a.+K.+Isono&title=The+Structure+of+Tautomycin%2C+a+Regulator+of+Eukaryotic+Cell+Growth&doi=10.1039%2Fc39900000244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of tautomycin, a regulator of eukaryotic cell growth</span></div><div class="casAuthors">Ubukata, Makoto; Cheng, Xing Chun; Isono, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Chemical Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">244-6</span>CODEN:
                <span class="NLM_cas:coden">JCCCAT</span>;
        ISSN:<span class="NLM_cas:issn">0022-4936</span>.
    </div><div class="casAbstract">Structure I is proposed for tautomycin produced by Streptomyces spiroverticillatus, on the basis of chem. degrdn. and spectroscopic evidences including 2D INADEQUATE of tautomycin labeled with [1,2-13C]acetate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18QToO9qtibVg90H21EOLACvtfcHk0ljmrQG28VV7rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslOqtbg%253D&md5=7bda344594d976ba2b9e659e8e98966d</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1039%2Fc39900000244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39900000244%26sid%3Dliteratum%253Aachs%26aulast%3DUbukata%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DX.%2BC.%26aulast%3DIsono%26aufirst%3Da.%2BK.%26atitle%3DThe%2520Structure%2520of%2520Tautomycin%252C%2520a%2520Regulator%2520of%2520Eukaryotic%2520Cell%2520Growth%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1990%26spage%3D244%26epage%3D246%26doi%3D10.1039%2Fc39900000244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myles, D. C.</span></span> <span> </span><span class="NLM_article-title">Novel Biologically Active Natural and Unnatural Products</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">633</span>, <span class="refDoi"> DOI: 10.1016/j.copbio.2003.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.copbio.2003.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=14662393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1OqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=627-633&author=D.+C.+Myles&title=Novel+Biologically+Active+Natural+and+Unnatural+Products&doi=10.1016%2Fj.copbio.2003.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Novel biologically active natural and unnatural products</span></div><div class="casAuthors">Myles, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-633</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Natural products have been used as medicinal agents for many years.  In addn., these compds. have served as the starting points for semisynthetic analogs with improved properties.  This review highlights work on several classes of natural products and their derivs., including both well established and emerging structural classes that are in, or nearing, clin. use for a variety of important indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXZqb8I12KtrVg90H21EOLACvtfcHk0ljmrQG28VV7rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1OqtLs%253D&md5=a1f2171645fc3383b60bd2039b04da76</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2003.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2003.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DMyles%26aufirst%3DD.%2BC.%26atitle%3DNovel%2520Biologically%2520Active%2520Natural%2520and%2520Unnatural%2520Products%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2003%26volume%3D14%26spage%3D627%26epage%3D633%26doi%3D10.1016%2Fj.copbio.2003.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubukata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isono, K.</span></span> <span> </span><span class="NLM_article-title">The Structure of Tautomycin, a Dialkylmaleic Anhydride Antibiotic</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">819</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.43.809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.7164%2Fantibiotics.43.809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2387775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXmtlWjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1990&pages=809-819&author=X.+C.+Chengauthor=M.+Ubukataauthor=K.+Isono&title=The+Structure+of+Tautomycin%2C+a+Dialkylmaleic+Anhydride+Antibiotic&doi=10.7164%2Fantibiotics.43.809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of tautomycin, a dialkylmaleic anhydride antibiotic</span></div><div class="casAuthors">Cheng, Xing Chun; Ubukata, Makoto; Isono, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">809-19</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">The chem. structure of tautomycin (C41H66O13) was detd. to be I by chem. degrdn., spectroscopic anal. and 2D INADEQUATE of tautomycin labeled with [1,2-13C]acetate.  Tautomycin exists in methanol-buffer soln. (1% Et2NH-HCO2H, pH 7.3) as an equil. mixt. of 2,3-dialkylmaleic anhydride and its dicarboxylic acid in a ratio of ∼5:4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrABMMVSDe5mLVg90H21EOLACvtfcHk0ljmrQG28VV7rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtlWjtrs%253D&md5=dd3defa0557b4506c05ac0d734c01d64</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.43.809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.43.809%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%2BC.%26aulast%3DUbukata%26aufirst%3DM.%26aulast%3DIsono%26aufirst%3DK.%26atitle%3DThe%2520Structure%2520of%2520Tautomycin%252C%2520a%2520Dialkylmaleic%2520Anhydride%2520Antibiotic%26jtitle%3DJ.%2520Antibiot.%26date%3D1990%26volume%3D43%26spage%3D809%26epage%3D819%26doi%3D10.7164%2Fantibiotics.43.809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkhof, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalban, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izquierdo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiel-Wilck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stites, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aradhye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappos, L.</span></span> <span> </span><span class="NLM_article-title">Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>362</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0907839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1056%2FNEJMoa0907839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20089954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVWrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=402-415&author=J.+A.+Cohenauthor=F.+Barkhofauthor=G.+Comiauthor=H.+P.+Hartungauthor=B.+O.+Khatriauthor=X.+Montalbanauthor=J.+Pelletierauthor=R.+Capraauthor=P.+Galloauthor=G.+Izquierdoauthor=K.+Tiel-Wilckauthor=A.+de+Veraauthor=J.+Jinauthor=T.+Stitesauthor=S.+Wuauthor=S.+Aradhyeauthor=L.+Kappos&title=Oral+Fingolimod+or+Intramuscular+Interferon+for+Relapsing+Multiple+Sclerosis&doi=10.1056%2FNEJMoa0907839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis</span></div><div class="casAuthors">Cohen, Jeffrey A.; Barkhof, Frederik; Comi, Giancarlo; Hartung, Hans-Peter; Khatri, Bhupendra O.; Montalban, Xavier; Pelletier, Jean; Capra, Ruggero; Gallo, Paolo; Izquierdo, Guillermo; Tiel-Wilck, Klaus; de Vera, Ana; Jin, James; Stites, Tracy; Wu, Stacy; Aradhye, Shreeram; Kappos, Ludwig</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">402-415</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyte egress from lymph nodes, showed clin. efficacy and improvement on imaging in a phase 2 study involving patients with multiple sclerosis.  METHODS: In this 12-mo, double-blind, double-dummy study, we randomly assigned 1292 patients with relapsing-remitting multiple sclerosis who had a recent history of at least one relapse to receive either oral fingolimod at a daily dose of either 1.25 or 0.5 mg or i.m. interferon beta-1a (an established therapy for multiple sclerosis) at a weekly dose of 30 μg.  The primary end point was the annualized relapse rate.  Key secondary end points were the no. of new or enlarged lesions on T2-weighted magnetic resonance imaging (MRI) scans at 12 mo and progression of disability that was sustained for at least 3 mo.  RESULTS: A total of 1153 patients (89%) completed the study.  The annualized relapse rate was significantly lower in both groups receiving fingolimod - 0.20 (95% confidence interval [CI], 0.16 to 0.26) in the 1.25-mg group and 0.16 (95% CI, 0.12 to 0.21) in the 0.5-mg group - than in the interferon group (0.33; 95% CI, 0.26 to 0.42; P < 0.001 for both comparisons).  MRI findings supported the primary results.  No significant differences were seen among the study groups with respect to progression of disability.  Two fatal infections occurred in the group that received the 1.25-mg dose of fingolimod: disseminated primary varicella zoster and herpes simplex encephalitis.  Other adverse events among patients receiving fingolimod were nonfatal herpesvirus infections, bradycardia and atrioventricular block, hypertension, macular edema, skin cancer, and elevated liver-enzyme levels.  CONCLUSIONS: This trial showed the superior efficacy of oral fingolimod with respect to relapse rates and MRI outcomes in patients with multiple sclerosis, as compared with i.m. interferon beta-1a.  Longer studies are needed to assess the safety and efficacy of treatment beyond 1 yr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2xFo108Gd0bVg90H21EOLACvtfcHk0liT2jL9U5O73Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVWrsbk%253D&md5=13b88619c4c0460c8920f0fb15a14fe7</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0907839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0907839%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%2BA.%26aulast%3DBarkhof%26aufirst%3DF.%26aulast%3DComi%26aufirst%3DG.%26aulast%3DHartung%26aufirst%3DH.%2BP.%26aulast%3DKhatri%26aufirst%3DB.%2BO.%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DCapra%26aufirst%3DR.%26aulast%3DGallo%26aufirst%3DP.%26aulast%3DIzquierdo%26aufirst%3DG.%26aulast%3DTiel-Wilck%26aufirst%3DK.%26aulast%3Dde%2BVera%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DStites%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DKappos%26aufirst%3DL.%26atitle%3DOral%2520Fingolimod%2520or%2520Intramuscular%2520Interferon%2520for%2520Relapsing%2520Multiple%2520Sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D402%26epage%3D415%26doi%3D10.1056%2FNEJMoa0907839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heise, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hof, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prieschl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumruker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiestand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span> <span> </span><span class="NLM_article-title">The Immune Modulator Fty720 Targets Sphingosine 1-Phosphate Receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">21453</span>– <span class="NLM_lpage">21457</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200176200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+Immune+Modulator+Fty720+Targets+Sphingosine+1-Phosphate+Receptors&doi=10.1074%2Fjbc.C200176200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0liT2jL9U5O73Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520Immune%2520Modulator%2520Fty720%2520Targets%2520Sphingosine%25201-Phosphate%2520Receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457%26doi%3D10.1074%2Fjbc.C200176200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proia, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, H.</span></span> <span> </span><span class="NLM_article-title">Essential Requirement for Sphingosine Kinase 2 in a Sphingolipid Apoptosis Pathway Activated by Fty720 Analogues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">15833</span>– <span class="NLM_lpage">15842</span>, <span class="refDoi"> DOI: 10.1074/jbc.M609124200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M609124200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17400555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=15833-15842&author=A.+S.+Donauthor=C.+Martinez-Lamencaauthor=W.+R.+Webbauthor=R.+L.+Proiaauthor=E.+Robertsauthor=H.+Rosen&title=Essential+Requirement+for+Sphingosine+Kinase+2+in+a+Sphingolipid+Apoptosis+Pathway+Activated+by+Fty720+Analogues&doi=10.1074%2Fjbc.M609124200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Essential Requirement for Sphingosine Kinase 2 in a Sphingolipid Apoptosis Pathway Activated by FTY720 Analogues</span></div><div class="casAuthors">Don, Anthony S.; Martinez-Lamenca, Carolina; Webb, William R.; Proia, Richard L.; Roberts, Ed; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">15833-15842</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The clin. immunosuppressant FTY720 is a sphingosine analog that, once phosphorylated by sphingosine kinase 2 (Sphk2), is an agonist of multiple receptor subtypes for sphingosine 1-phosphate.  Short exposures to FTY720 afford long term protection in lymphoproliferative and autoimmune disease models, presumably by inducing apoptosis in subsets of cells essential for pathogenesis.  Sphingosine itself is pro-apoptotic, and apoptosis induced with FTY720 or sphingosine is thought to proceed independently of their phosphorylation.  Following chem. mutagenesis of Jurkat cells we isolated mutants that are selectively resistant to FTY720 analog AAL(R), as well as natural sphingolipid bases, including sphingosine.  Cells lacking functional Sphk2 were resistant to apoptosis induced with AAL(R), indicating that apoptosis proceeds through AAL(R) phosphorylation.  Phosphorylation of AAL(R) was also required for induction of lymphocyte apoptosis in mice, as apoptosis was not induced with the non-phosphorylatable chiral analog, AAL(S).  Apoptosis was induced in the spleen but not the thymus of mice administered 1 mg/kg AAL(R), correlating with levels of AAL(R)-phosphate (AFD(R)) in organ exts.  AFD(R) did not induce apoptosis when added to the cell culture medium, indicating that it induces apoptosis through an intracellular target.  NBD-labeled AAL(R) localized to the endoplasmic reticulum, and AAL(R) treatment resulted in elevated cytosolic calcium, Bax redistribution from cytosol to mitochondrial and endoplasmic reticulum membranes, and caspase-independent mitochondrial permeabilization in Jurkat cells.  We therefore describe an apoptotic pathway triggered by intracellular accumulation of sphingolipid base phosphates and suggest that sphingoid base substrates for Sphk2 acting intracellularly could be useful in the treatment of lymphoproliferative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvCAjaLgvWeLVg90H21EOLACvtfcHk0liT2jL9U5O73Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7c%253D&md5=2c44863428e98ebc5e338b447b5d99c8</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609124200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609124200%26sid%3Dliteratum%253Aachs%26aulast%3DDon%26aufirst%3DA.%2BS.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DWebb%26aufirst%3DW.%2BR.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DEssential%2520Requirement%2520for%2520Sphingosine%2520Kinase%25202%2520in%2520a%2520Sphingolipid%2520Apoptosis%2520Pathway%2520Activated%2520by%2520Fty720%2520Analogues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D15833%26epage%3D15842%26doi%3D10.1074%2Fjbc.M609124200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung
Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">Identification of Chaulmoogric Acid as a Small Molecule Activator of Protein Phosphatase 5</span>. <i>Appl. Biochem. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">1450</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.1007/s12010-009-8647-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs12010-009-8647-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19404779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivVSmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=1450-1459&author=C.+Cherauthor=M.+H.+Tremblayauthor=J.+R.+Barberauthor=S.+Chung%0ANgauthor=B.+Zhang&title=Identification+of+Chaulmoogric+Acid+as+a+Small+Molecule+Activator+of+Protein+Phosphatase+5&doi=10.1007%2Fs12010-009-8647-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of chaulmoogric acid as a small molecule activator of protein phosphatase 5</span></div><div class="casAuthors">Cher, Charmian; Tremblay, Marie-Helene; Barber, Jack R.; Ng, Shi Chung; Zhang, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Applied Biochemistry and Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1450-1459</span>CODEN:
                <span class="NLM_cas:coden">ABIBDL</span>;
        ISSN:<span class="NLM_cas:issn">0273-2289</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protein phosphatase 5 (PP5) is an important protein phosphatase that is abundantly expressed in the central nervous system.  Recent studies showed that PP5 activity in the neocortex from patients with Alzheimer's disease (AD) is decreased significantly, suggesting that small mol. PP5 activators may have therapeutic potential for AD.  Here, the authors performed a biochem. screening for PP5 activators with the microsource compd. library.  Chaulmoogric acid (I) was identified to be an effective activator with EC50 value of 134.5 μM.  Importantly, results from CD and limited proteolysis studies showed that I bound to a region of the tetratricopeptide repeat (TPR) domain of PP5 resulting in complete loss of helical content.  These results demonstrated a different mechanism of action from that of arachidonic acid, a known activator for PP5 dephosphorylation activity.  Synergistic activation of PP5 enzymic activity was also obsd. with combined application of both compds. at relatively low concns.  Therefore, a further structure-activity relation study of I may facilitate the discovery of small mols. that can synergize with endogenous arachidonic acid for PP5 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8yRVAxHEbELVg90H21EOLACvtfcHk0lgxhtmhq6POnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivVSmtbs%253D&md5=3d4afccc38de95524d20fe77d34b3e18</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1007%2Fs12010-009-8647-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12010-009-8647-3%26sid%3Dliteratum%253Aachs%26aulast%3DCher%26aufirst%3DC.%26aulast%3DTremblay%26aufirst%3DM.%2BH.%26aulast%3DBarber%26aufirst%3DJ.%2BR.%26aulast%3DChung%2BNg%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520Chaulmoogric%2520Acid%2520as%2520a%2520Small%2520Molecule%2520Activator%2520of%2520Protein%2520Phosphatase%25205%26jtitle%3DAppl.%2520Biochem.%2520Biotechnol.%26date%3D2010%26volume%3D160%26spage%3D1450%26epage%3D1459%26doi%3D10.1007%2Fs12010-009-8647-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sager, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dushukyan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodford, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of the Co-Chaperone Protein Phosphatase 5 in Cancer</span>. <i>Cell Stress Chaperones</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1007/s12192-020-01091-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs12192-020-01091-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=32239474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtFygs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=383-394&author=R.+A.+Sagerauthor=N.+Dushukyanauthor=M.+Woodfordauthor=M.+Mollapour&title=Structure+and+Function+of+the+Co-Chaperone+Protein+Phosphatase+5+in+Cancer&doi=10.1007%2Fs12192-020-01091-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of the co-chaperone protein phosphatase 5 in cancer</span></div><div class="casAuthors">Sager, Rebecca A.; Dushukyan, Natela; Woodford, Mark; Mollapour, Mehdi</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress & Chaperones</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-394</span>CODEN:
                <span class="NLM_cas:coden">CSCHFG</span>;
        ISSN:<span class="NLM_cas:issn">1355-8145</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Abstr.: Protein phosphatase 5 (PP5) is a serine/threonine protein phosphatase that regulates many cellular functions including steroid hormone signaling, stress response, proliferation, apoptosis, and DNA repair.  PP5 is also a co-chaperone of the heat shock protein 90 mol. chaperone machinery that assists in regulation of cellular signaling pathways essential for cell survival and growth.  PP5 plays a significant role in survival and propagation of multiple cancers, which makes it a promising target for cancer therapy.  Though there are several naturally occurring PP5 inhibitors, none is specific for PP5.  Here, we review the roles of PP5 in cancer progression and survival and discuss the unique features of the PP5 structure that differentiate it from other phosphoprotein phosphatase (PPP) family members and make it an attractive therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrevQjbIKpaPLVg90H21EOLACvtfcHk0lgxhtmhq6POnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtFygs78%253D&md5=88975ea4fa2a889c5dce3d826660b6d1</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1007%2Fs12192-020-01091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12192-020-01091-3%26sid%3Dliteratum%253Aachs%26aulast%3DSager%26aufirst%3DR.%2BA.%26aulast%3DDushukyan%26aufirst%3DN.%26aulast%3DWoodford%26aufirst%3DM.%26aulast%3DMollapour%26aufirst%3DM.%26atitle%3DStructure%2520and%2520Function%2520of%2520the%2520Co-Chaperone%2520Protein%2520Phosphatase%25205%2520in%2520Cancer%26jtitle%3DCell%2520Stress%2520Chaperones%26date%3D2020%26volume%3D25%26spage%3D383%26epage%3D394%26doi%3D10.1007%2Fs12192-020-01091-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaszczyszyn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ga̧siorowski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Świa̧tek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malinka, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieślik-Boczula, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarnik-Matusewicz, B.</span></span> <span> </span><span class="NLM_article-title">Chemical Structure of Phenothiazines and Their Biological Activity</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/S1734-1140(12)70726-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS1734-1140%2812%2970726-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22580516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOqurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=16-23&author=A.+Jaszczyszynauthor=K.+Ga%CC%A7siorowskiauthor=P.+%C5%9Awia%CC%A7tekauthor=W.+Malinkaauthor=K.+Cie%C5%9Blik-Boczulaauthor=J.+Petrusauthor=B.+Czarnik-Matusewicz&title=Chemical+Structure+of+Phenothiazines+and+Their+Biological+Activity&doi=10.1016%2FS1734-1140%2812%2970726-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical structure of phenothiazines and their biological activity</span></div><div class="casAuthors">Jaszczyszyn, Agata; Gasiorowski, Kazimierz; Swiatek, Piotr; Malinka, Wieslaw; Cieslik-Boczula, Katarzyna; Petrus, Joanna; Czarnik-Matusewicz, Boguslawa</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-23</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">A review.  Phenothiazines belong to the oldest, synthetic antipsychotic drugs, which do not have their precursor in the world of natural compds.  Apart from their fundamental neuroleptic action connected with the dopaminergic receptors blockade, phenothiazine derivs. also exert diverse biol. activities, which account for their cancer chemopreventive-effect, as: calmodulin- and protein kinase C inhibitory-actions, anti-proliferative effect, inhibition of P-glycoprotein transport function and reversion of multidrug resistance.  According to literature data on relations between chem. structure of phenothiazines and their biol. effects, the main directions for further chem. modifications have been established.  They are provided and discussed in this review paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMdmAHZF4qbrVg90H21EOLACvtfcHk0liwk8Ia_KBe5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOqurnF&md5=6430e4be4856ee62dc8eaa9dc79731e9</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2812%2970726-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252812%252970726-0%26sid%3Dliteratum%253Aachs%26aulast%3DJaszczyszyn%26aufirst%3DA.%26aulast%3DGa%25CC%25A7siorowski%26aufirst%3DK.%26aulast%3D%25C5%259Awia%25CC%25A7tek%26aufirst%3DP.%26aulast%3DMalinka%26aufirst%3DW.%26aulast%3DCie%25C5%259Blik-Boczula%26aufirst%3DK.%26aulast%3DPetrus%26aufirst%3DJ.%26aulast%3DCzarnik-Matusewicz%26aufirst%3DB.%26atitle%3DChemical%2520Structure%2520of%2520Phenothiazines%2520and%2520Their%2520Biological%2520Activity%26jtitle%3DPharmacol.%2520Rep.%26date%3D2012%26volume%3D64%26spage%3D16%26epage%3D23%26doi%3D10.1016%2FS1734-1140%2812%2970726-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kastrinsky, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangodkar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaware, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhawan, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M.</span></span> <span> </span><span class="NLM_article-title">Reengineered Tricyclic Anti-Cancer Agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6528</span>– <span class="NLM_lpage">6534</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bmc.2015.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26372073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSitLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6528-6534&author=D.+B.+Kastrinskyauthor=J.+Sangodkarauthor=N.+Zawareauthor=S.+Izadmehrauthor=N.+S.+Dhawanauthor=G.+Narlaauthor=M.+Ohlmeyer&title=Reengineered+Tricyclic+Anti-Cancer+Agents&doi=10.1016%2Fj.bmc.2015.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Reengineered tricyclic anti-cancer agents</span></div><div class="casAuthors">Kastrinsky, David B.; Sangodkar, Jaya; Zaware, Nilesh; McClinch, Kimberly; Farrington, Caroline C.; Giannini, Heather M.; Izadmehr, Sudeh; Dhawan, Neil S.; Narla, Goutham; Ohlmeyer, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6528-6534</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The phenothiazine and dibenzazepine tricyclics are potent neurotropic drugs with a documented but underutilized anti-cancer side effect.  Reengineering these agents (TFP, CPZ, CIP) by replacing the basic amine with a neutral polar functional group (e.g., RTC-1, RTC-2) abrogated their CNS effects as demonstrated by in vitro pharmacol. assays and in vivo behavioral models.  Further optimization generated several phenothiazines and dibenzazepines with improved anti-cancer potency, exemplified by RTC-5.  This new lead demonstrated efficacy against a xenograft model of an EGFR driven cancer without the neurotropic effects exhibited by the parent mols.  Its effects were attributed to concomitant neg. regulation of PI3K-AKT and RAS-ERK signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF-IPrpK7hDLVg90H21EOLACvtfcHk0liwk8Ia_KBe5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSitLbI&md5=a76922484503f3651d39688139e8178b</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DKastrinsky%26aufirst%3DD.%2BB.%26aulast%3DSangodkar%26aufirst%3DJ.%26aulast%3DZaware%26aufirst%3DN.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DDhawan%26aufirst%3DN.%2BS.%26aulast%3DNarla%26aufirst%3DG.%26aulast%3DOhlmeyer%26aufirst%3DM.%26atitle%3DReengineered%2520Tricyclic%2520Anti-Cancer%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6528%26epage%3D6534%26doi%3D10.1016%2Fj.bmc.2015.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sangodkar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tohme, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastrinsky, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaware, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiredja, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhawan, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatzer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borczuk, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokulrangan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrington, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avelar, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gidwani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQuaid, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClinch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma’ayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiFeo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galsky, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannou, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chance, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, G.</span></span> <span> </span><span class="NLM_article-title">Activation of Tumor Suppressor Protein Pp2a Inhibits Kras-Driven Tumor Growth</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">2081</span>– <span class="NLM_lpage">2090</span>, <span class="refDoi"> DOI: 10.1172/JCI89548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1172%2FJCI89548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28504649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC1crntlagtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=2081-2090&author=J.+Sangodkarauthor=A.+Perlauthor=R.+Tohmeauthor=J.+Kiselarauthor=D.+B.+Kastrinskyauthor=N.+Zawareauthor=S.+Izadmehrauthor=S.+Mazharauthor=D.+D.+Wiredjaauthor=C.+M.+O%E2%80%99Connorauthor=D.+Hoonauthor=N.+S.+Dhawanauthor=D.+Schlatzerauthor=S.+Yaoauthor=D.+Leonardauthor=A.+C.+Borczukauthor=G.+Gokulranganauthor=L.+Wangauthor=E.+Svensonauthor=C.+C.+Farringtonauthor=E.+Yuanauthor=R.+A.+Avelarauthor=A.+Stachnikauthor=B.+Smithauthor=V.+Gidwaniauthor=H.+M.+Gianniniauthor=D.+McQuaidauthor=K.+McClinchauthor=Z.+Wangauthor=A.+C.+Levineauthor=R.+C.+Searsauthor=E.+Y.+Chenauthor=Q.+Duanauthor=M.+Dattauthor=S.+Haiderauthor=A.+Ma%E2%80%99ayanauthor=A.+DiFeoauthor=N.+Sharmaauthor=M.+D.+Galskyauthor=D.+L.+Brautiganauthor=Y.+A.+Ioannouauthor=W.+Xuauthor=M.+R.+Chanceauthor=M.+Ohlmeyerauthor=G.+Narla&title=Activation+of+Tumor+Suppressor+Protein+Pp2a+Inhibits+Kras-Driven+Tumor+Growth&doi=10.1172%2FJCI89548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth</span></div><div class="casAuthors">Sangodkar Jaya; Kastrinsky David B; Zaware Nilesh; Izadmehr Sudeh; Hoon Divya; Dhawan Neil S; Yao Shen; Stachnik Agnes; Smith Blake; Gidwani Vickram; Giannini Heather M; McQuaid Daniel; McClinch Kimberly; Levine Alice C; Chen Edward Y; Duan Qiaonan; Ma'ayan Avi; Galsky Matthew D; Ioannou Yiannis A; Ohlmeyer Michael; Perl Abbey; Tohme Rita; Kiselar Janna; Mazhar Sahar; Wiredja Danica D; O'Connor Caitlin M; Schlatzer Daniela; Leonard Daniel; Gokulrangan Giridharan; Svenson Elena; Farrington Caroline C; Yuan Eric; Avelar Rita A; DiFeo Analisa; Sharma Neelesh; Chance Mark R; Narla Goutham; Tohme Rita; Borczuk Alain C; Wang Lifu; Brautigan David L; Wang Zhizhi; Haider Shozeb; Xu Wenqing; Sears Rosalie C; Datt Manish; Haider Shozeb</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2081-2090</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Targeted cancer therapies, which act on specific cancer-associated molecular targets, are predominantly inhibitors of oncogenic kinases.  While these drugs have achieved some clinical success, the inactivation of kinase signaling via stimulation of endogenous phosphatases has received minimal attention as an alternative targeted approach.  Here, we have demonstrated that activation of the tumor suppressor protein phosphatase 2A (PP2A), a negative regulator of multiple oncogenic signaling proteins, is a promising therapeutic approach for the treatment of cancers.  Our group previously developed a series of orally bioavailable small molecule activators of PP2A, termed SMAPs.  We now report that SMAP treatment inhibited the growth of KRAS-mutant lung cancers in mouse xenografts and transgenic models.  Mechanistically, we found that SMAPs act by binding to the PP2A Aα scaffold subunit to drive conformational changes in PP2A.  These results show that PP2A can be activated in cancer cells to inhibit proliferation.  Our strategy of reactivating endogenous PP2A may be applicable to the treatment of other diseases and represents an advancement toward the development of small molecule activators of tumor suppressor proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSu8vjXvEHeHDAEfvC7EH1LfW6udTcc2eauCddQC9JhBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crntlagtg%253D%253D&md5=38e48e3438d12d2c2091f2eafdfc9a83</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1172%2FJCI89548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI89548%26sid%3Dliteratum%253Aachs%26aulast%3DSangodkar%26aufirst%3DJ.%26aulast%3DPerl%26aufirst%3DA.%26aulast%3DTohme%26aufirst%3DR.%26aulast%3DKiselar%26aufirst%3DJ.%26aulast%3DKastrinsky%26aufirst%3DD.%2BB.%26aulast%3DZaware%26aufirst%3DN.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DMazhar%26aufirst%3DS.%26aulast%3DWiredja%26aufirst%3DD.%2BD.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DC.%2BM.%26aulast%3DHoon%26aufirst%3DD.%26aulast%3DDhawan%26aufirst%3DN.%2BS.%26aulast%3DSchlatzer%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DLeonard%26aufirst%3DD.%26aulast%3DBorczuk%26aufirst%3DA.%2BC.%26aulast%3DGokulrangan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSvenson%26aufirst%3DE.%26aulast%3DFarrington%26aufirst%3DC.%2BC.%26aulast%3DYuan%26aufirst%3DE.%26aulast%3DAvelar%26aufirst%3DR.%2BA.%26aulast%3DStachnik%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DGidwani%26aufirst%3DV.%26aulast%3DGiannini%26aufirst%3DH.%2BM.%26aulast%3DMcQuaid%26aufirst%3DD.%26aulast%3DMcClinch%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLevine%26aufirst%3DA.%2BC.%26aulast%3DSears%26aufirst%3DR.%2BC.%26aulast%3DChen%26aufirst%3DE.%2BY.%26aulast%3DDuan%26aufirst%3DQ.%26aulast%3DDatt%26aufirst%3DM.%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DMa%25E2%2580%2599ayan%26aufirst%3DA.%26aulast%3DDiFeo%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DGalsky%26aufirst%3DM.%2BD.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26aulast%3DIoannou%26aufirst%3DY.%2BA.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DChance%26aufirst%3DM.%2BR.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DNarla%26aufirst%3DG.%26atitle%3DActivation%2520of%2520Tumor%2520Suppressor%2520Protein%2520Pp2a%2520Inhibits%2520Kras-Driven%2520Tumor%2520Growth%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2017%26volume%3D127%26spage%3D2081%26epage%3D2090%26doi%3D10.1172%2FJCI89548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrington, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen-Petersen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janghorban, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolczanski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangodkar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, G.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 2a Activation as a Therapeutic Strategy for Managing Myc-Driven Cancers</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>295</i></span>,  <span class="NLM_fpage">757</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(17)49933-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0021-9258%2817%2949933-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31822503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3MXmslKlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2020&pages=757-770&author=C.+C.+Farringtonauthor=E.+Yuanauthor=S.+Mazharauthor=S.+Izadmehrauthor=L.+Hurstauthor=B.+L.+Allen-Petersenauthor=M.+Janghorbanauthor=E.+Chungauthor=G.+Wolczanskiauthor=M.+Galskyauthor=R.+Searsauthor=J.+Sangodkarauthor=G.+Narla&title=Protein+Phosphatase+2a+Activation+as+a+Therapeutic+Strategy+for+Managing+Myc-Driven+Cancers&doi=10.1016%2FS0021-9258%2817%2949933-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers</span></div><div class="casAuthors">Farrington, Caroline C.; Yuan, Eric; Mazhar, Sahar; Izadmehr, Sudeh; Hurst, Lauren; Allen-Petersen, Brittany L.; Janghorban, Mahnaz; Chung, Eric; Wolczanski, Grace; Galsky, Matthew; Sears, Rosalie; Sangodkar, Jaya; Narla, Goutham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">757-770</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The tumor suppressor protein phosphatase 2A (PP2A) is a serine/threonine phosphatase whose activity is inhibited in most human cancers.  One of the best-characterized PP2A substrates is MYC proto-oncogene basic helix-loop-helix transcription factor (MYC), whose overexpression is commonly assocd. with aggressive forms of this disease.  PP2A directly dephosphorylates MYC, resulting in its degrdn.  To explore the therapeutic potential of direct PP2A activation in a diverse set of MYC-driven cancers, here we used biochem. assays, recombinant cell lines, gene expression analyses, and immunohistochem. to evaluate a series of first-in-class small-mol. activators of PP2A (SMAPs) in Burkitt lymphoma, KRAS-driven non-small cell lung cancer, and triple-neg. breast cancer.  In all tested models of MYC-driven cancer, the SMAP treatment rapidly and persistently inhibited MYC expression through proteasome-mediated degrdn., inhibition of MYC transcriptional activity, decreased cancer cell proliferation, and tumor growth inhibition.  Importantly, we generated a series of cell lines expressing PP2A-dependent phosphodegron variants of MYC and demonstrated that the antitumorigenic activity of SMAPs depends on MYC degrdn.  Collectively, the findings presented here indicate a pharmacol. tractable approach to drive MYC degrdn. by using SMAPs for the management of a broad range of MYC-driven cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK-i1WvbxTi7Vg90H21EOLACvtfcHk0liGGsDmK6mY8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXmslKlsLk%253D&md5=df2645d79fa6375819e19ad0c099c921</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2817%2949933-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252817%252949933-9%26sid%3Dliteratum%253Aachs%26aulast%3DFarrington%26aufirst%3DC.%2BC.%26aulast%3DYuan%26aufirst%3DE.%26aulast%3DMazhar%26aufirst%3DS.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DHurst%26aufirst%3DL.%26aulast%3DAllen-Petersen%26aufirst%3DB.%2BL.%26aulast%3DJanghorban%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DE.%26aulast%3DWolczanski%26aufirst%3DG.%26aulast%3DGalsky%26aufirst%3DM.%26aulast%3DSears%26aufirst%3DR.%26aulast%3DSangodkar%26aufirst%3DJ.%26aulast%3DNarla%26aufirst%3DG.%26atitle%3DProtein%2520Phosphatase%25202a%2520Activation%2520as%2520a%2520Therapeutic%2520Strategy%2520for%2520Managing%2520Myc-Driven%2520Cancers%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2020%26volume%3D295%26spage%3D757%26epage%3D770%26doi%3D10.1016%2FS0021-9258%2817%2949933-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, S. C.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of Human Calcineurin Complexed with Cyclosporin a and Human Cyclophilin</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">13522</span>– <span class="NLM_lpage">13526</span>, <span class="refDoi"> DOI: 10.1073/pnas.212504399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.212504399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=12357034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVKms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=13522-13526&author=L.+Jinauthor=S.+C.+Harrison&title=Crystal+Structure+of+Human+Calcineurin+Complexed+with+Cyclosporin+a+and+Human+Cyclophilin&doi=10.1073%2Fpnas.212504399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin</span></div><div class="casAuthors">Jin, Lei; Harrison, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13522-13526</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Calcineurin (Cn; protein phosphatase 2B), is an important participant in signaling pathways that activate T cells.  It is the target of the immunosuppressive drugs, cyclosporin A (CsA) and FK 506.  These drugs bind proteins known as cyclophilin (Cyp) and FK 506-binding protein, resp., and the drug-protein complexes in turn inhibit Cn.  Here, the authors report the crystal structure of a Cyp/CsA/Cn ternary complex, detd. to a resoln. of 3.1 Å.  Residues 3-9 of CsA, particularly N-methylleucine (Mle)-4 and Mle-6, and Trp-121 of Cyp were found to form a composite surface for interaction with Cn.  The hydrophobic interface buried 2 H-bonds.  The structure accounted clearly for the effects of mutations in Cn on CsA-resistance and for the way modifications of CsA alter immunosuppressive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqspopSI-iZLLVg90H21EOLACvtfcHk0ljosJzkYMkUew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVKms7c%253D&md5=cff5598bce80f7a372582156f9e8619b</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1073%2Fpnas.212504399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.212504399%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DL.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26atitle%3DCrystal%2520Structure%2520of%2520Human%2520Calcineurin%2520Complexed%2520with%2520Cyclosporin%2520a%2520and%2520Human%2520Cyclophilin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D13522%26epage%3D13526%26doi%3D10.1073%2Fpnas.212504399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazáry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stähelin, H.</span></span> <span> </span><span class="NLM_article-title">Immunosuppressive and Specific Antimitotic Effects of Ovalicin</span>. <i>Experientia</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1171</span>– <span class="NLM_lpage">1173</span>, <span class="refDoi"> DOI: 10.1007/BF02147835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2FBF02147835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=4889119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaF1MXhtVagsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1968&pages=1171-1173&author=S.+Laz%C3%A1ryauthor=H.+St%C3%A4helin&title=Immunosuppressive+and+Specific+Antimitotic+Effects+of+Ovalicin&doi=10.1007%2FBF02147835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppressive and specific antimitotic effects of ovalicin</span></div><div class="casAuthors">Lazary, S.; Staehelin, H.</div><div class="citationInfo"><span class="NLM_cas:title">Experientia</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1171-3</span>CODEN:
                <span class="NLM_cas:coden">EXPEAM</span>;
        ISSN:<span class="NLM_cas:issn">0014-4754</span>.
    </div><div class="casAbstract">The primary hemagglutinin response in mice 7 or 14 days after immunization with sheep red blood cells (SRBC) was strongly inhibited by ovalicin (600 and 1200 mg./kg., orally).  Partial tolerance to the standard secondary challenge with SRBC was found when the primary response was inhibited with 1200 mg./kg.  When animals were treated with the drug on the day of the 2nd challenge with SRBC only, there was but a slight inhibition of the response.  Survival of skin grafts in mice was prolonged by a single dose of ovalicin (300 mg./kg., i.p.), with max. effect 3-4 days after grafting.  High doses (300 mg./kg.) of ovalicin reduced the spleen wt. in immunized animals to a level close to that of nonimmunized mice.  Similarly, spleen wt. increased due to infiltration, and multiplication of leukemia L-1210 cells was repressed by ovalicin, in a hybrid host as well as in the isologous host.  High doses of ovalicin were required to depress the mitotic index in the spleens in nonstimulated mice, while in immunized mice lower doses were quite active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowsFIh4n5a_rVg90H21EOLACvtfcHk0ljosJzkYMkUew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXhtVagsw%253D%253D&md5=52f6a314f42179017874f605c24dae91</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1007%2FBF02147835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02147835%26sid%3Dliteratum%253Aachs%26aulast%3DLaz%25C3%25A1ry%26aufirst%3DS.%26aulast%3DSt%25C3%25A4helin%26aufirst%3DH.%26atitle%3DImmunosuppressive%2520and%2520Specific%2520Antimitotic%2520Effects%2520of%2520Ovalicin%26jtitle%3DExperientia%26date%3D1968%26volume%3D24%26spage%3D1171%26epage%3D1173%26doi%3D10.1007%2FBF02147835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Twentyman, P. R.</span></span> <span> </span><span class="NLM_article-title">Cyclosporins as Drug Resistance Modifiers</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(92)90668-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0006-2952%2892%2990668-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1346494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK38Xht1Shtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1992&pages=109-117&author=P.+R.+Twentyman&title=Cyclosporins+as+Drug+Resistance+Modifiers&doi=10.1016%2F0006-2952%2892%2990668-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporins as drug resistance modifiers</span></div><div class="casAuthors">Twentyman, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-17</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A review with 74 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYudtkPoUSN7Vg90H21EOLACvtfcHk0lg99B2U0rnGZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht1Shtrc%253D&md5=bebd650b92118463a5d91f4953cfa252</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2892%2990668-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252892%252990668-9%26sid%3Dliteratum%253Aachs%26aulast%3DTwentyman%26aufirst%3DP.%2BR.%26atitle%3DCyclosporins%2520as%2520Drug%2520Resistance%2520Modifiers%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1992%26volume%3D43%26spage%3D109%26epage%3D117%26doi%3D10.1016%2F0006-2952%2892%2990668-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÖLler, E.</span></span> <span> </span><span class="NLM_article-title">Evidence That the Immunosuppressive Effects of Fk506 and Cyclosporine Are Identical</span>. <i>Transplantation</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1001</span>– <span class="NLM_lpage">1007</span>, <span class="refDoi"> DOI: 10.1097/00007890-199012000-00021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1097%2F00007890-199012000-00021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1701570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3MXhvF2htbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=1001-1007&author=A.+Johanssonauthor=E.+M%C3%96Ller&title=Evidence+That+the+Immunosuppressive+Effects+of+Fk506+and+Cyclosporine+Are+Identical&doi=10.1097%2F00007890-199012000-00021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical</span></div><div class="casAuthors">Johansson, Anette; Moeller, Erna</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1001-7</span>CODEN:
                <span class="NLM_cas:coden">TRPLAU</span>;
        ISSN:<span class="NLM_cas:issn">0041-1337</span>.
    </div><div class="casAbstract">The in vitro immunol. properties of FK506 were studied in comparison and in combination with cyclosporin A (CsA), to evaluate the possibility that their mechanisms of action were identical or similar, in spite of their different mol. structures.  The ability to inhibit several responses of human peripheral blood lymphocytes to mitogenic and alloantigenic stimulation was explored.  Synergistic effects of the 2 drugs were extensively studied.  FK506 and CsA had very similar mechanisms of action and additive effects were recorded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDNeLAgMfRaLVg90H21EOLACvtfcHk0lg99B2U0rnGZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhvF2htbs%253D&md5=879f12c44dae74bec8fb7d0eda1b0b9b</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1097%2F00007890-199012000-00021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007890-199012000-00021%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DM%25C3%2596Ller%26aufirst%3DE.%26atitle%3DEvidence%2520That%2520the%2520Immunosuppressive%2520Effects%2520of%2520Fk506%2520and%2520Cyclosporine%2520Are%2520Identical%26jtitle%3DTransplantation%26date%3D1990%26volume%3D50%26spage%3D1001%26epage%3D1007%26doi%3D10.1097%2F00007890-199012000-00021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltz, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siekierka, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigal, N. H.</span></span> <span> </span><span class="NLM_article-title">Fk-506 and Cyclosporin a Inhibit Highly Similar Signal Transduction Pathways in Human T Lymphocytes</span>. <i>Cell. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1016/0008-8749(91)90103-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0008-8749%2891%2990103-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1707760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3MXhslyjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1991&pages=269-284&author=C.+S.+Linauthor=R.+C.+Boltzauthor=J.+J.+Siekierkaauthor=N.+H.+Sigal&title=Fk-506+and+Cyclosporin+a+Inhibit+Highly+Similar+Signal+Transduction+Pathways+in+Human+T+Lymphocytes&doi=10.1016%2F0008-8749%2891%2990103-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes</span></div><div class="casAuthors">Lin, C. Shirley; Boltz, Robert C.; Siekierka, John J.; Sigal, Nolan H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-84</span>CODEN:
                <span class="NLM_cas:coden">CLIMB8</span>;
        ISSN:<span class="NLM_cas:issn">0008-8749</span>.
    </div><div class="casAbstract">This report compares the ability of cyclosporin A and FK-506 to inhibit human T cell activation triggered via cell surface mols. that utilize different intracellular processes.  The authors stimulated highly purified peripheral blood T lymphocytes with mitogens (Con A and PHA), ionomycin + PMA, or monoclonal antibodies specific for cell surface antigens involved in activation (CD2, CD3, CD28) either in combination with each other or in conjunction with PMA.  Using measurements of the proliferative response, IL-2 prodn., and changes in intracellular Ca2+ ([Ca2+]i), the authors demonstrate that FK-506 exerts its inhibitory effect on early events of T-cell activation in a manner indistinguishable from that of CsA.  An important finding in this study is the strict correlation between those activation pathways that are inhibited by FK-506 and CsA and the requirement that the sensitive pathways induce a measurable rise in [Ca2+]i.  This correlation held even for the CD28/CD2 pathway which was previously shown to be calcium-independent; however by employing FACS anal. of [Ca2+]i within individual cells, a subset of cells activated via CD28/CD2 was found to respond with a measurable rise in [Ca2+]i.  The authors also noted that the proliferative response induced by certain stimuli, such as ionomycin + PMA and PHA + PMA, was partially resistant to FK-506 and CsA, while IL-2 prodn. was completely suppressed.  The partial FK-506/CsA-resistance of these responses was shown to be detd. by the amt. of PMA added to the cultures.  FK-506 and CsA inhibit highly similar signal transduction pathways in human T lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS11XBY_VeN7Vg90H21EOLACvtfcHk0lg99B2U0rnGZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslyjsbc%253D&md5=05eab8b7b126287ca9a386b72e517ca3</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2F0008-8749%2891%2990103-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0008-8749%252891%252990103-I%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%2BS.%26aulast%3DBoltz%26aufirst%3DR.%2BC.%26aulast%3DSiekierka%26aufirst%3DJ.%2BJ.%26aulast%3DSigal%26aufirst%3DN.%2BH.%26atitle%3DFk-506%2520and%2520Cyclosporin%2520a%2520Inhibit%2520Highly%2520Similar%2520Signal%2520Transduction%2520Pathways%2520in%2520Human%2520T%2520Lymphocytes%26jtitle%3DCell.%2520Immunol.%26date%3D1991%26volume%3D133%26spage%3D269%26epage%3D284%26doi%3D10.1016%2F0008-8749%2891%2990103-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondragon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of Calcineurin-Cyclophilin-Cyclosporin Shows Common but Distinct Recognition of Immunophilin-Drug Complexes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">12037</span>– <span class="NLM_lpage">12042</span>, <span class="refDoi"> DOI: 10.1073/pnas.192206699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.192206699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=12218175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlCltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=12037-12042&author=Q.+Huaiauthor=H.+Y.+Kimauthor=Y.+Liuauthor=Y.+Zhaoauthor=A.+Mondragonauthor=J.+O.+Liuauthor=H.+Ke&title=Crystal+Structure+of+Calcineurin-Cyclophilin-Cyclosporin+Shows+Common+but+Distinct+Recognition+of+Immunophilin-Drug+Complexes&doi=10.1073%2Fpnas.192206699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes</span></div><div class="casAuthors">Huai, Qing; Kim, Hwa-Young; Liu, Yudong; Zhao, Yingdong; Mondragon, Angelo; Liu, Jun O.; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">12037-12042</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the common target for two immunophilin-immunosuppressant complexes, cyclophilin A-cyclosporin A (CyPA-CsA) and FKBP-FK506.  How the two structurally distinct immunophilin-drug complexes bind the same target has remained unknown.  We report the crystal structure of calcineurin (CN) in complex with CyPA-CsA at 2.8-Å resoln.  The CyPA-CsA complex binds to a composite surface formed by the catalytic and regulatory subunits of CN, where the complex of FK506 and its binding protein FKBP also binds.  While the majority of the CN residues involved in the binding are common for both immunophilin-immunosuppressant complexes, a significant no. of the residues are distinct.  Unlike FKBP-FK506, CyPA-CsA interacts with Arg-122 at the active site of CN, implying direct involvement of CyPA-CsA in the regulation of CN catalysis.  The simultaneous interaction of CyPA with both the composite surface and the active site of CN suggests that the composite surface may serve as a substrate recognition site responsible for the narrow substrate specificity of CN.  The comparison of CyPA-CsA-CN with FKBP-FK506-CN significantly contributes to understanding the mol. basis of regulation of CN activity by the immunophilin-immunosuppressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSjhnlTGw4urVg90H21EOLACvtfcHk0liSypylMyyNcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlCltbk%253D&md5=9cc518ce524b0e84963cc891a9d1415d</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1073%2Fpnas.192206699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.192206699%26sid%3Dliteratum%253Aachs%26aulast%3DHuai%26aufirst%3DQ.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMondragon%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DCrystal%2520Structure%2520of%2520Calcineurin-Cyclophilin-Cyclosporin%2520Shows%2520Common%2520but%2520Distinct%2520Recognition%2520of%2520Immunophilin-Drug%2520Complexes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D12037%26epage%3D12042%26doi%3D10.1073%2Fpnas.192206699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sintchak, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgibbon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navia, M. A.</span></span> <span> </span><span class="NLM_article-title">X-Ray Structure of Calcineurin Inhibited by the Immunophilin-Immunosuppressant Fkbp12-Fk506 Complex</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(95)90439-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0092-8674%2895%2990439-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=7543369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFSgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1995&pages=507-522&author=J.+P.+Griffithauthor=J.+L.+Kimauthor=E.+E.+Kimauthor=M.+D.+Sintchakauthor=J.+A.+Thomsonauthor=M.+J.+Fitzgibbonauthor=M.+A.+Flemingauthor=P.+R.+Caronauthor=K.+Hsiaoauthor=M.+A.+Navia&title=X-Ray+Structure+of+Calcineurin+Inhibited+by+the+Immunophilin-Immunosuppressant+Fkbp12-Fk506+Complex&doi=10.1016%2F0092-8674%2895%2990439-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex</span></div><div class="casAuthors">Griffith, James P.; Kim, Joseph L.; Kim, Eunice E.; Sintchak, Michael D.; Thomson, John A.; Fitzgibbon, Matthew J.; Fleming, Mark A.; Caron, Paul R.; Hsiao, Kathy; Navia, Manuel A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">507-22</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The x-ray structure of the ternary complex of a calcineurin A fragment, calcineurin B, FKBP12, and the immunosuppressant drug FK506 (also known as tacrolimus) has been detd. at 2.5 Å resoln., providing a description of how FK506 functions at the at. level.  In the structure, FKBP-12-KF506 binary complex does not contact the phosphatase active site on calcineurin A that is more than 10 Å removed.  Instead, FKBP-12-FK506 is so positioned that it can inhibit the dephosphorylation of its macromol. substrates by phys. hindering their approach to the active site.  The ternary complex described here represents the three-dimensional structure of a Ser/Thr protein phosphatase and provides a structural basis for understanding calcineurin inhibition by FKBP-12-FK506.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLqpO9MqIX57Vg90H21EOLACvtfcHk0liSypylMyyNcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFSgtrY%253D&md5=bcb0f597be68fbb42888776700591d14</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990439-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990439-5%26sid%3Dliteratum%253Aachs%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DKim%26aufirst%3DE.%2BE.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DFitzgibbon%26aufirst%3DM.%2BJ.%26aulast%3DFleming%26aufirst%3DM.%2BA.%26aulast%3DCaron%26aufirst%3DP.%2BR.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DNavia%26aufirst%3DM.%2BA.%26atitle%3DX-Ray%2520Structure%2520of%2520Calcineurin%2520Inhibited%2520by%2520the%2520Immunophilin-Immunosuppressant%2520Fkbp12-Fk506%2520Complex%26jtitle%3DCell%26date%3D1995%26volume%3D82%26spage%3D507%26epage%3D522%26doi%3D10.1016%2F0092-8674%2895%2990439-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harikishore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sup Yoon, H.</span></span> <span> </span><span class="NLM_article-title">Immunophilins: Structures, Mechanisms and Ligands</span>. <i>Curr. Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.2174/1874467208666150519113427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F1874467208666150519113427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25986569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC2MfltVKitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=37-47&author=A.+Harikishoreauthor=H.+Sup+Yoon&title=Immunophilins%3A+Structures%2C+Mechanisms+and+Ligands&doi=10.2174%2F1874467208666150519113427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Immunophilins: Structures, Mechanisms and Ligands</span></div><div class="casAuthors">Harikishore Amaravadhi; Yoon Ho Sup</div><div class="citationInfo"><span class="NLM_cas:title">Current molecular pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Immunophilins consist of a family of highly conserved proteins which possess binding abilities to immunosuppressive drugs.  Cyclophilins (Cyps) and FK506-binding proteins (FKBP) are family proteins collectively referred as immunophilins.  Most Cyps and FKBP family members catalyse peptidyl-prolyl cis/trans isomerase (PPIase) mediated reactions and form binary complexes with their ligands cyclosporine A and FK506.  Immunophilins are also involved in key biochemical processes including protein folding, receptor signalling, protein trafficking, and transcription and exhibit versatile biological functions, when complexed with their ligands.  Therapeutic implications of immunophilins and effects of their ligands in neurodegenerative disorders, cancer, and infectious diseases have been accumulating in recent years.  This review focuses on molecular characteristics of the canonical and non-canonical immunophilin family members from human and Plasmodium falciparum and P. vivax, recent progress on immunophilin inhibitor development, and future perspectives of structure-based design of non-immunosuppressive immunophilin ligands with potential pharmacological activities against infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzpKzaquF5abJzI8owOhpDfW6udTcc2eZq4LwMHlTOIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfltVKitQ%253D%253D&md5=7bfe974952c55aac2dfd3da051158e97</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.2174%2F1874467208666150519113427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1874467208666150519113427%26sid%3Dliteratum%253Aachs%26aulast%3DHarikishore%26aufirst%3DA.%26aulast%3DSup%2BYoon%26aufirst%3DH.%26atitle%3DImmunophilins%253A%2520Structures%252C%2520Mechanisms%2520and%2520Ligands%26jtitle%3DCurr.%2520Mol.%2520Pharmacol.%26date%3D2015%26volume%3D9%26spage%3D37%26epage%3D47%26doi%3D10.2174%2F1874467208666150519113427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grigoriu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cossio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hummer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cyert, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span> <span> </span><span class="NLM_article-title">The Molecular Mechanism of Substrate Engagement and Immunosuppressant Inhibition of Calcineurin</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e1001492</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1001492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1371%2Fjournal.pbio.1001492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23468591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt1Wnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=e1001492&author=S.+Grigoriuauthor=R.+Bondauthor=P.+Cossioauthor=J.+A.+Chenauthor=N.+Lyauthor=G.+Hummerauthor=R.+Pageauthor=M.+S.+Cyertauthor=W.+Peti&title=The+Molecular+Mechanism+of+Substrate+Engagement+and+Immunosuppressant+Inhibition+of+Calcineurin&doi=10.1371%2Fjournal.pbio.1001492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanism of substrate engagement and immunosuppressant inhibition of calcineurin</span></div><div class="casAuthors">Grigoriu, Simina; Bond, Rachel; Cossio, Pilar; Chen, Jennifer A.; Ly, Nina; Hummer, Gerhard; Page, Rebecca; Cyert, Martha S.; Peti, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1001492</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Ser/Thr phosphatases dephosphorylate their targets with high specificity, yet the structural and sequence determinants of phosphosite recognition are poorly understood.  Calcineurin (CN) is a conserved Ca2+/calmodulin-dependent Ser/Thr phosphatase and the target of immunosuppressants, FK506 and cyclosporin A (CSA).  To investigate CN substrate recognition we used X-ray crystallog., biochem., modeling, and in vivo expts. to study A238L, a viral protein inhibitor of CN.  We show that A238L competitively inhibits CN by occupying a crit. substrate recognition site, while leaving the catalytic center fully accessible.  Critically, the 1.7 Å structure of the A238L-CN complex reveals how CN recognizes residues in A238L that are analogous to a substrate motif, "LxVP".  The structure enabled modeling of a peptide substrate bound to CN, which predicts substrate interactions beyond the catalytic center.  Finally, this study establishes that "LxVP" sequences and immunosuppressants bind to the identical site on CN.  Thus, FK506, CSA, and A238L all prevent "LxVP"-mediated substrate recognition by CN, highlighting the importance of this interaction for substrate dephosphorylation.  Collectively, this work presents the first integrated structural model for substrate selection and dephosphorylation by CN and lays the groundwork for structure-based development of new CN inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPKK_IkJPw7LVg90H21EOLACvtfcHk0ljEkINFIUvJ2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt1Wnu7s%253D&md5=2f0fd8d26bafc562c50a323648d23fb3</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1001492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1001492%26sid%3Dliteratum%253Aachs%26aulast%3DGrigoriu%26aufirst%3DS.%26aulast%3DBond%26aufirst%3DR.%26aulast%3DCossio%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%2BA.%26aulast%3DLy%26aufirst%3DN.%26aulast%3DHummer%26aufirst%3DG.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DCyert%26aufirst%3DM.%2BS.%26aulast%3DPeti%26aufirst%3DW.%26atitle%3DThe%2520Molecular%2520Mechanism%2520of%2520Substrate%2520Engagement%2520and%2520Immunosuppressant%2520Inhibition%2520of%2520Calcineurin%26jtitle%3DPLoS%2520Biol.%26date%3D2013%26volume%3D11%26spage%3De1001492%26doi%3D10.1371%2Fjournal.pbio.1001492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a Sensitizes Human Non-Small Cell Lung Cancer Cells to Gefitinib through Inhibition of Stat3</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.canlet.2016.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=27264264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28Xptl2msbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2016&pages=124-133&author=J.+Shouauthor=L.+Youauthor=J.+Yaoauthor=J.+Xieauthor=J.+Jingauthor=Z.+Jingauthor=L.+Jiangauthor=X.+Suiauthor=H.+Panauthor=W.+Han&title=Cyclosporine+a+Sensitizes+Human+Non-Small+Cell+Lung+Cancer+Cells+to+Gefitinib+through+Inhibition+of+Stat3&doi=10.1016%2Fj.canlet.2016.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3</span></div><div class="casAuthors">Shou, Jiawei; You, Liangkun; Yao, Junlin; Xie, Jiansheng; Jing, Jing; Jing, Zhao; Jiang, Liming; Sui, Xinbing; Pan, Hongming; Han, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-133</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have dramatically prolonged the overall survival of non-small cell lung cancer (NSCLC) patients with EGFR-activating mutation, but the presence of primary or acquired resistance eventually leads to therapeutic failure.  Thus, how to improve the efficacy and reverse the resistance to EGFR-TKIs remains a significant challenge.  In this study, we found that CsA significantly augmented the anti-cancer effect of gefitinib in EGFR-TKI-sensitive and -resistant NSCLC cells.  Mechanistically, CsA promoted gefitinib-induced apoptosis through inhibition of the STAT3 pathway.  Similar with the function of CsA, siRNAs against STAT3 also enhanced gefitinib-induced apoptosis in multiple lung cancer cells.  Xenograft studies further demonstrated that CsA promoted the anti-cancer activity of gefitinib on lung cancer cells through inhibition of STAT3.  Moreover, NSCLC patients with high levels of phosphorylated STAT3 (Y705) showed a significantly poorer therapeutic response to EGFR-TKIs.  This study provides preclin. evidence that the combination of CsA or a STAT3 inhibitor with EGFR-TKIs is a promising approach to improve the efficacy of EGFR-TKIs for the treatment of patients with advanced NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDFcLL-N9pZrVg90H21EOLACvtfcHk0lg70ZlCmkMbLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xptl2msbo%253D&md5=b77ae3609cbe1ba3612a4b3c01c08537</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DShou%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DJing%26aufirst%3DJ.%26aulast%3DJing%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSui%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DW.%26atitle%3DCyclosporine%2520a%2520Sensitizes%2520Human%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Cells%2520to%2520Gefitinib%2520through%2520Inhibition%2520of%2520Stat3%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D379%26spage%3D124%26epage%3D133%26doi%3D10.1016%2Fj.canlet.2016.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a Sensitizes Lung Cancer Cells to Crizotinib through Inhibition of the Ca2+/Calcineurin/Erk Pathway</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2019.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.ebiom.2019.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30879923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BB3cbkvFygsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2019&pages=326-339&author=Z.+Liuauthor=L.+Jiangauthor=Y.+Liauthor=B.+Xieauthor=J.+Xieauthor=Z.+Wangauthor=X.+Zhouauthor=H.+Jiangauthor=Y.+Fangauthor=H.+Panauthor=W.+Han&title=Cyclosporine+a+Sensitizes+Lung+Cancer+Cells+to+Crizotinib+through+Inhibition+of+the+Ca2%2B%2FCalcineurin%2FErk+Pathway&doi=10.1016%2Fj.ebiom.2019.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2(+)/calcineurin/Erk pathway</span></div><div class="casAuthors">Liu Zhen; Jiang Liming; Li Yiran; Xie Binbin; Fang Yong; Xie Jiansheng; Wang Zhanggui; Zhou Xiaoyun; Jiang Hanliang; Pan Hongming; Han Weidong</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">326-339</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Crizotinib has potent anti-tumor activity in patients with advanced MET-amplified non-small cell lung cancer (NSCLC).  However, the therapeutic effect is still not satisfying.  Thus, developing approaches that improve the efficacy of crizotinib remains a significant challenge.  METHODS:  MET-amplified NSCLC cell lines were treated with crizotinib and cyclosporine A (CsA).  Cell viability was determined by MTS assay.  The changes of apoptosis, cell cycle and calcineurin-Erk pathways were assessed by western blot.  Xenograft mouse model, primary human NSCLC cells and hollow fiber assays were utilized to confirm the effects of CsA.  FINDINGS:  We demonstrated that CsA significantly increased the anti-tumor effect of crizotinib on multiple MET-amplified NSCLC cells in vitro and in vivo.  Mechanistically, crizotinib treatment led to the activation of Ca(2+)-calcineurin (CaN)-Kinase suppressor of Ras 2 (KSR2) signaling, resulting in Erk1/2 activation and enhanced survival of cancer cells.  CsA effectively blocked CaN-KSR2-Erk1/2 signaling, promoting crizotinib-induced apoptosis and G2/M arrest.  Similarly, pharmacologic or genetic inhibition of Erk1/2 also enhanced crizotinib-induced growth inhibition in vitro.  Xenograft studies further confirmed that CsA or Erk1/2 inhibitor PD98059 enhanced the anti-cancer activity of crizotinib through inhibition of CaN-Erk1/2 axis.  The results were also validated by primary human NSCLC cells in vitro and hollow fiber assays in vivo.  INTERPRETATION:  This study provides preclinical evidences that combination therapy of CsA and crizotinib is a promising approach for targeted treatment of MET-amplified lung cancer patients.  FUND: This work was supported by the National Natural Science Foundation of China, the Key Projects of Natural Foundation of Zhejiang Province, the Ten thousand plan youth talent support program of Zhejiang Province, the Zhejiang Natural Sciences Foundation Grant, and the Zhejiang medical innovative discipline construction project-2016.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgn64dfaI-xP6xYuD7tu2XfW6udTcc2eaFFk6mqRWy2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbkvFygsA%253D%253D&md5=f3adbefaac0ecde03500f13d45b1b9d8</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2019.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2019.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DB.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DW.%26atitle%3DCyclosporine%2520a%2520Sensitizes%2520Lung%2520Cancer%2520Cells%2520to%2520Crizotinib%2520through%2520Inhibition%2520of%2520the%2520Ca2%252B%252FCalcineurin%252FErk%2520Pathway%26jtitle%3DEBioMedicine%26date%3D2019%26volume%3D42%26spage%3D326%26epage%3D339%26doi%3D10.1016%2Fj.ebiom.2019.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, K.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in Vitro</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.2174/1871520618666181029170605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F1871520618666181029170605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30378503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVKns77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=248-255&author=L.+Gaoauthor=J.+Dongauthor=N.+Zhangauthor=Z.+Leauthor=W.+Renauthor=S.+Liauthor=F.+Liauthor=J.+Songauthor=Q.+Wangauthor=Z.+Douauthor=S.+Y.+Parkauthor=K.+Zhi&title=Cyclosporine+a+Suppresses+the+Malignant+Progression+of+Oral+Squamous+Cell+Carcinoma+in+Vitro&doi=10.2174%2F1871520618666181029170605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro</span></div><div class="casAuthors">Gao, Ling; Dong, Jianwei; Zhang, Nanyang; Le, Zhanxian; Ren, Wenhao; Li, Shaoming; Li, Fan; Song, Jianzhong; Wang, Qibo; Dou, Zhichao; Park, Soo Y.; Zhi, Keqian</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">248-255</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The Oral Squamous Cell Carcinoma (OSCC) is one of the most frequent cancer types.  Failure of treatment of OSCC is potentially lethal because of local recurrence, regional lymph node metastasis, and distant metastasis.  Chemotherapy plays a vital role through suppression of tumorigenesis.  Cyclosporine A (CsA), an immunosuppressant drug, has been efficiently used in allograft organ transplant recipients to prevent rejection, and also has been used in a subset of patients with autoimmunity related disorders.  The present study aims to investigate novel and effective chemotherapeutic drugs to overcome drug-resistance in the treatment of OSCC.  Cells were incubated in the std. way.  Cell viability was assayed using the MTT assay.  Cell proliferation was detd. using colony formation assay.  The cell cycle assay was performed using flow cytometry.  Apoptosis was assessed using fluorescence-activated cell sorting after stained by the Annexin V-fluorescein isothiocyanate (FITC).  Cell migration and invasion were analyzed using wound healing assay and tranwell.  The effect of COX-2, c-Myc, MMP-9, MMP-2, and NFATc1 protein expression was detd. using Western blot anal. while NFATc1 mRNA expression was detd. by RT-PCR.  In vitro studies indicated that CsA inhibited partial OSCC growth by inducing cell cycle arrest, apoptosis, and the migration and invasion of OSCC cells.  We also demonstrated that CsA could inhibit the expression of NFATc1 and its downstream genes COX-2, c-Myc, MMP-9, and MMP-2 in OSCC cells.  Furthermore, we analyzed the expression of NFATc1 in head and neck cancer through the Oncomine database.  The data was consistent with the exptl. findings.  The present study initially demonstrated that CsA could inhibit the progression of OSCC cells and can mediate the signal mols. of NFATc1 signaling pathway, which has strong relationship with cancer development.  That explains us CsA has potential to explore the possibilities as a novel chemotherapeutic drug for the treatment of OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryTfyBLTiuA7Vg90H21EOLACvtfcHk0lgMkc4jU5usxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVKns77F&md5=f75a707fc004fb95f5c0cfd11f299ed3</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.2174%2F1871520618666181029170605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520618666181029170605%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLe%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DDou%26aufirst%3DZ.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DZhi%26aufirst%3DK.%26atitle%3DCyclosporine%2520a%2520Suppresses%2520the%2520Malignant%2520Progression%2520of%2520Oral%2520Squamous%2520Cell%2520Carcinoma%2520in%2520Vitro%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2019%26volume%3D19%26spage%3D248%26epage%3D255%26doi%3D10.2174%2F1871520618666181029170605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Metabolic Dependence of Cyclosporinea on Cell Proliferation of Human Non-Small Cell Lung Cancer A549 Cells and Its Implication in Post-Transplant Malignancy</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2997</span>– <span class="NLM_lpage">3004</span>, <span class="refDoi"> DOI: 10.3892/or.2019.7076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3892%2For.2019.7076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30896878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKitrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2019&pages=2997-3004&author=X.+Qinauthor=Z.+Chen&title=Metabolic+Dependence+of+Cyclosporinea+on+Cell+Proliferation+of+Human+Non-Small+Cell+Lung+Cancer+A549+Cells+and+Its+Implication+in+Post-Transplant+Malignancy&doi=10.3892%2For.2019.7076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic dependence of cyclosporine A on cell proliferation of human non-small cell lung cancer A549 cells and its implication in post-transplant malignancy</span></div><div class="casAuthors">Qin, Xinghua; Chen, Ziwei</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2997-3004</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Cyclosporine A (CsA), a widely used immunosuppressant to prevent organ transplant rejection, is assocd. with an increased cancer risk following transplantation, particularly in the lung.  However, the underlying mechanisms remain unclear.  In the present study, using human non-small cell lung cancer A549 cells, it was detd. that CsA (0.1 or 1μM) promoted cell proliferation with glucose alone as the energy source.  CsA treatment increased the phosphorylation of protein kinase B (Akt) and consequently the expression of Cyclin D1.  Inhibiting Akt signaling with the phosphatidylinositol 3-kinase inhibitor wortmannin prevented this effect.  Mechanistically, CsA treatment increased reactive oxygen species (ROS) generation, and the intracellular ROS scavenger N-acetyl-cysteine (NAC) attenuated CsA-induced cell proliferation as well as the activation of Akt/Cyclin D1 signaling.  However, notably, it was demonstrated that CsA treatment decreased cell proliferation and Akt phosphorylation under normal lipid loading.  Further investigation indicated that palmitic acid induced excessive generation of ROS, while CsA treatment further stimulated this ROS prodn.  Scavenging intracellular ROS with NAC attenuated the CsA-mediated inhibition of cell proliferation.  Collectively, the results indicated a pleiotropic effect of CsA in the regulation of A549 cell proliferation under different metabolic conditions.  This indicated that CsA administration may contribute to increased post-transplant cancer risk in organ recipients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEcyvtTsnL4rVg90H21EOLACvtfcHk0lgMkc4jU5usxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKitrzF&md5=05f37b2c45f7341a742d56f1e3e61c79</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.3892%2For.2019.7076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2019.7076%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DMetabolic%2520Dependence%2520of%2520Cyclosporinea%2520on%2520Cell%2520Proliferation%2520of%2520Human%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520A549%2520Cells%2520and%2520Its%2520Implication%2520in%2520Post-Transplant%2520Malignancy%26jtitle%3DOncol.%2520Rep.%26date%3D2019%26volume%3D41%26spage%3D2997%26epage%3D3004%26doi%3D10.3892%2For.2019.7076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawahara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwagi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netto, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, H.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a and Tacrolimus Inhibit Urothelial Tumorigenesis</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1002/mc.22265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fmc.22265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25594762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvV2isQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=161-169&author=T.+Kawaharaauthor=E.+Kashiwagiauthor=Y.+Liauthor=Y.+Zhengauthor=Y.+Miyamotoauthor=G.+J.+Nettoauthor=H.+Ishiguroauthor=H.+Miyamoto&title=Cyclosporine+a+and+Tacrolimus+Inhibit+Urothelial+Tumorigenesis&doi=10.1002%2Fmc.22265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis</span></div><div class="casAuthors">Kawahara, Takashi; Kashiwagi, Eiji; Li, Yi; Zheng, Yichun; Miyamoto, Yurina; Netto, George J.; Ishiguro, Hitoshi; Miyamoto, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-169</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The functional role of nuclear factor of activated T-cells (NFAT), while it has been extensively investigated in the immune system, remains uncertain in bladder cancer development.  We here aim to assess the effects of cyclosporine A (CsA) and tacrolimus (FK506), immunosuppressants known to specifically inactivate the NFAT pathway in immune cells, on neoplastic transformation of urothelial cells.  Immunohistochem. revealed that the expression levels of NFATc1, a NFAT isoform shown to function as an oncogene in a sarcoma model, were elevated in urothelial neoplasms, compared with non-neoplastic urothelial tissues, and in low-grade and high-grade papillary urothelial carcinomas, compared with papillary urothelial neoplasms of low malignant potential.  In an immortalized normal urothelial cell line SVHUC, CsA and FK506 reduced NFATc1 expression, NFAT transcriptional activity, and the expression of c-myc, a downstream target of NFATc1 signals.  Treatment with CsA or FK506 in the SVHUC cells undergoing neoplastic transformation induced by exposure to a chem. carcinogen 3-methylcholanthrene resulted in strong inhibition in colony formation in vitro as well as tumor formation in NOD-SCID mice.  CsA and FK506 were addnl. found to up-regulate the expression of several mols. that play a protective role in bladder tumorigenesis, including p53, p21, and p27, and down-regulate that of oncogenic genes, such as cyclin D1, cyclin D3, and cyclin E, in SVHUC cells with the carcinogen challenge.  Thus, CsA and FK506 likely inhibit urothelial tumorigenesis.  These findings offer a potential chemopreventive approach for urothelial tumors using NFAT inhibitors. © 2015 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_VwswJdNilrVg90H21EOLACvtfcHk0lgMkc4jU5usxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvV2isQ%253D%253D&md5=63927dc291af434d9d72c81e7de1bfc4</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1002%2Fmc.22265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22265%26sid%3Dliteratum%253Aachs%26aulast%3DKawahara%26aufirst%3DT.%26aulast%3DKashiwagi%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DNetto%26aufirst%3DG.%2BJ.%26aulast%3DIshiguro%26aufirst%3DH.%26aulast%3DMiyamoto%26aufirst%3DH.%26atitle%3DCyclosporine%2520a%2520and%2520Tacrolimus%2520Inhibit%2520Urothelial%2520Tumorigenesis%26jtitle%3DMol.%2520Carcinog.%26date%3D2016%26volume%3D55%26spage%3D161%26epage%3D169%26doi%3D10.1002%2Fmc.22265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juvvadi, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobay, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobeil, S. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venters, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Averette, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrington, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheaton, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciofani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spicer, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, W. J.</span></span> <span> </span><span class="NLM_article-title">Harnessing Calcineurin-Fk506-Fkbp12 Crystal Structures from Invasive Fungal Pathogens to Develop Antifungal Agents</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4275</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-12199-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fs41467-019-12199-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31537789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BB3MngsVaqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4275&author=P.+R.+Juvvadiauthor=D.+Foxauthor=B.+G.+Bobayauthor=M.+J.+Hoyauthor=S.+M.+C.+Gobeilauthor=R.+A.+Ventersauthor=Z.+Changauthor=J.+J.+Linauthor=A.+F.+Averetteauthor=D.+C.+Coleauthor=B.+C.+Barringtonauthor=J.+D.+Wheatonauthor=M.+Ciofaniauthor=M.+Trzossauthor=X.+M.+Liauthor=S.+C.+Leeauthor=Y.+L.+Chenauthor=M.+Mutzauthor=L.+D.+Spicerauthor=M.+A.+Schumacherauthor=J.+Heitmanauthor=W.+J.+Steinbach&title=Harnessing+Calcineurin-Fk506-Fkbp12+Crystal+Structures+from+Invasive+Fungal+Pathogens+to+Develop+Antifungal+Agents&doi=10.1038%2Fs41467-019-12199-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents</span></div><div class="casAuthors">Juvvadi Praveen R; Cole D Christopher; Barrington Blake C; Steinbach William J; Fox David 3rd; Fox David 3rd; Fox David 3rd; Bobay Benjamin G; Venters Ronald A; Spicer Leonard D; Bobay Benjamin G; Gobeil Sophie M C; Venters Ronald A; Spicer Leonard D; Schumacher Maria A; Bobay Benjamin G; Gobeil Sophie M C; Venters Ronald A; Spicer Leonard D; Hoy Michael J; Chang Zanetta; Lin Jackie J; Averette Anna Floyd; Heitman Joseph; Steinbach William J; Wheaton Joshua D; Ciofani Maria; Trzoss Michael; Li Xiaoming; Mutz Mitchell; Li Xiaoming; Lee Soo Chan; Chen Ying-Lien; Mutz Mitchell</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4275</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Calcineurin is important for fungal virulence and a potential antifungal target, but compounds targeting calcineurin, such as FK506, are immunosuppressive.  Here we report the crystal structures of calcineurin catalytic (CnA) and regulatory (CnB) subunits complexed with FK506 and the FK506-binding protein (FKBP12) from human fungal pathogens (Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans and Coccidioides immitis).  Fungal calcineurin complexes are similar to the mammalian complex, but comparison of fungal and human FKBP12 (hFKBP12) reveals conformational differences in the 40s and 80s loops.  NMR analysis, molecular dynamic simulations, and mutations of the A. fumigatus CnA/CnB-FK506-FKBP12-complex identify a Phe88 residue, not conserved in hFKBP12, as critical for binding and inhibition of fungal calcineurin.  These differences enable us to develop a less immunosuppressive FK506 analog, APX879, with an acetohydrazine substitution of the C22-carbonyl of FK506.  APX879 exhibits reduced immunosuppressive activity and retains broad-spectrum antifungal activity and efficacy in a murine model of invasive fungal infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAI0aDOrgWeKNc3HjJRoFAfW6udTcc2eYRx_tBU-PvTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MngsVaqtA%253D%253D&md5=c660da6ed31639ea01cee2910afd57e6</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-12199-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-12199-1%26sid%3Dliteratum%253Aachs%26aulast%3DJuvvadi%26aufirst%3DP.%2BR.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DBobay%26aufirst%3DB.%2BG.%26aulast%3DHoy%26aufirst%3DM.%2BJ.%26aulast%3DGobeil%26aufirst%3DS.%2BM.%2BC.%26aulast%3DVenters%26aufirst%3DR.%2BA.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DJ.%2BJ.%26aulast%3DAverette%26aufirst%3DA.%2BF.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DBarrington%26aufirst%3DB.%2BC.%26aulast%3DWheaton%26aufirst%3DJ.%2BD.%26aulast%3DCiofani%26aufirst%3DM.%26aulast%3DTrzoss%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DMutz%26aufirst%3DM.%26aulast%3DSpicer%26aufirst%3DL.%2BD.%26aulast%3DSchumacher%26aufirst%3DM.%2BA.%26aulast%3DHeitman%26aufirst%3DJ.%26aulast%3DSteinbach%26aufirst%3DW.%2BJ.%26atitle%3DHarnessing%2520Calcineurin-Fk506-Fkbp12%2520Crystal%2520Structures%2520from%2520Invasive%2520Fungal%2520Pathogens%2520to%2520Develop%2520Antifungal%2520Agents%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D4275%26doi%3D10.1038%2Fs41467-019-12199-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Turn and Face the Strange: A New View on Phosphatases</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1021/acscentsci.9b00909</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.9b00909" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BB38vgtlGlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=467-477&author=M.+K%C3%B6hn&title=Turn+and+Face+the+Strange%3A+A+New+View+on+Phosphatases&doi=10.1021%2Facscentsci.9b00909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Turn and Face the Strange: A New View on Phosphatases</span></div><div class="casAuthors">Kohn Maja; Kohn Maja</div><div class="citationInfo"><span class="NLM_cas:title">ACS central science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-477</span>
        ISSN:<span class="NLM_cas:issn">2374-7943</span>.
    </div><div class="casAbstract">Phosphorylation as a post-translational modification is critical for cellular homeostasis.  Kinases and phosphatases regulate phosphorylation levels by adding or removing, respectively, a phosphate group from proteins or other biomolecules.  Imbalances in phosphorylation levels are involved in a multitude of diseases.  Phosphatases are often thought of as the black sheep, the strangers, of phosphorylation-mediated signal transduction, particularly when it comes to drug discovery and development.  This is due to past difficulties to study them and unsuccessful attempts to target them; however, phosphatases have regained strong attention and are actively pursued now in clinical trials.  By giving examples for current hot topics in phosphatase biology and for new approaches to target them, it is illustrated here how and why phosphatases made their comeback, and what is envisioned to come in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuvWjnAOzzqBgd2Wuil24tfW6udTcc2eYRx_tBU-PvTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38vgtlGlsw%253D%253D&md5=2911d30a74e11a6fd18246c0d3350414</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.9b00909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.9b00909%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DTurn%2520and%2520Face%2520the%2520Strange%253A%2520A%2520New%2520View%2520on%2520Phosphatases%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2020%26volume%3D6%26spage%3D467%26epage%3D477%26doi%3D10.1021%2Facscentsci.9b00909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Research progress on kinases and phosphatases. (A) Balanced regulation cycle of phosphorylation and dephosphorylation. (B) The number of launched protein kinase inhibitors versus the number of clinical protein phosphatase inhibitors (<a href="http://www.brimr.org/PKI/PKIs.htm" class="extLink">www.brimr.org/PKI/PKIs.htm</a>; <a href="https://clinicaltrials.gov" class="extLink">https://clinicaltrials.gov</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Sequences and structural features of PPPases. (A) The PPPases family contains seven subfamilies: PP1, PP2A, PP3, PP4, PP5, PP6, and PP7. The catalytic cores in the catalytic subunits (PP1C, PP2AC, PP4C, PP6C, PP3C, PP5C, and PP7/PPEF) are highly conserved (blue). In the catalytic core, several small sequence fragments (G, glycine; D, aspartic acid; x, any amino acid; H, histidine; V, valine; R, arginine; N, asparagine; E, glutamic acid) are strictly conserved, and the amino acids involving in metal ion coordination and phosphate group binding are indicated by green and red letters, respectively. The colors indicate the following components: The calcineurin B (CnB) binding domain (orange), the Ca<sup>2+</sup>-calmodulin (CaM) binding domain (brown), the autoinhibitory (AI) domain (plum red), the tetratricopeptide repeat (TPR) domain involved in autoinhibitory regulation (light green), an αJ helix with 9 amino acids involved in autoinhibitory regulation (pink), the EF-hand motifs (yellow-green) [a diverse motif class containing approximately 30 amino acids that fold into a helix–loop–helix structure (α-helix E (forefinger), a loop around the Ca<sup>2+</sup> ion (clenched middle finger), and α-helix F (thumb)) and are responsible for Ca<sup>2+</sup> binding], and the IQ calmodulin-binding motif (purple). The catalytic subunit of each subfamily is represented by PP1Cα (accession code: P62136), PP2ACα (accession code: P67775), PP4C (accession code: P60510), PP6C (accession code: O00743), PP3Cα (accession code: Q08209), PP5 (accession code: P53041), and PPEF1 (accession code: O14829), respectively. All proteins here come from <i>Homo sapiens</i> (<a href="https://www.uniprot.org" class="extLink">https://www.uniprot.org</a>). (B) Structure of PPPases family. PP5 and PP7 work in monomeric enzyme form, while others work in holoenzyme form with the help of catalytic subunits, regulatory subunits, and/or scaffold subunits.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Substrates and biological functions of PPPases. (A) Substrates of PPPases. More than 200 proteins have been identified as the substrates of PPPases (depod.bioss.unifreiburg.de/br_net.php) and a complex dephosphorylation network is formed in which many substrates are regulated by multiple PPPases.<a onclick="showRef(event, 'ref56 ref65 ref66 ref67 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref56 ref65 ref66 ref67 ref68 ref69">(56,65−69)</a> (B) PPPases could act as both tumor promoters and tumor suppressors in specific cancers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of the representative PPPase modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. LB-100 binds to the catalytic sites of PPPases and shows antitumor activity by inhibiting PP2A. (A) The antitumor mechanism of LB-100 mediated by PP2A. (B) The superposes of PP5-LB-100 complex and PP5-phosphate complex. LB-100 tightly coordinates within the catalytic pocket through multitype interactions (including ionic interactions (red dotted line), hydrogen bonds (green dotted line), hydrophobic and dipole–dipole stacking interactions (yellow dotted line)), blocking the access of the phosphate group of the substrate to the catalytic mentals. The protein colored green and LB-100 colored yellow in the PP5-LB-100 complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WG8">5WG8</a>)<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> and the protein colored cyan and phosphate colored orange in the PP5-phosphate complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1S95">1S95</a>).<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> M and W represent Mn<sup>2+</sup> and water, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Fostriecin covalently binds to Cys269 on the PP2A catalytic subunit and shows antitumor activity. (A) The antiovarian cancer mechanism of fostriecin. The inhibition of PP4 promotes the activation of STAT1, thereby increasing the expression of proinflammatory cytokines and triggering an antitumor immune response. (B) The binding features offostriecin. Fostriecin covalently binds to Cys269 on the PP2A catalytic subunit (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IE3">2IE3</a>).<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. The binding modes of microcystin-LR on PP1 and PP2A. Microcystin-LR covalently binds to the catalytic subunits of PP1 (PDB ID:<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FJM">1FJM</a>)<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> and PP2A (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IE3">2IE3</a>).<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> PP1 is colored blue, and PP2A is colored green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. The binding modes of tautomycetin and tautomycin on PP1. Tautomycetin and tautomycin adapt similar conformations to bind PP1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ALZ">6ALZ</a>,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7B">3E7B</a><a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a>), but tautomycin does not form a covalent bond because the diene/alkene group in tautomycetin is replaced with the spiroketal group in tautomycin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. FTY720 activates PP2A by disrupting the PP2AC-SET interaction and shows antitumor activity. (A) The discovery process and PP2A activation mechanism of FTY720. (B) The mechanism of cancer cell apoptosis induced by FTY720.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Discovery process and mechanistic study of Ro 90-7051. Ro 90-7051 is discovered by high-throughput screening and identified as a TPR-dependent inhibitor by studying deletion constructs of PP5. The TPR domain is colored marine, the αJ helix is colored purple and catalytic sites are colored red (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA9">4JA9</a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. The allosteric activator P5SA-2 is identified through high-throughput screening. The binding of P5SA-2 induces conformational change in PP5: A 10° tilt of the TPR domain and a rearrangement of the αJ helix (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA7">4JA7</a>,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> P5SA-2 binding PP5 is colored blue; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA9">4JA9</a>,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> apo PP5 is colored light blue). The potential P5SA-2 binding sites on PP5 are colored yellow, and catalytic sites on PP5 are colored red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Allosteric activators of PP2A. (A) DT-061 and iHAP1 activate different PP2A holoenzymes with different B56 regulatory subunits and regulate different signaling pathways. (B) The binding mode of DT-061 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NTS">6NTS</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> DT-061 works as a “molecular glue” located in a pocket formed by the intersection interface of three PP2A subunits (the scaffold Aα subunit (A subunit), catalytic Cα subunit (C subunit), and B56α regulatory subunit (B subunit)) and forms multiple types of interactions with all three subunits to stabilize the PP2A heterotrimers. The binding pocket is far away from the catalytic sites. The A subunit, B subunit, C subunit, catalytic sites, and DT-061 are colored light magenta, violet purple, marine, red, and yellow, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/medium/jm1c00631_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Macrolide inhibitors selectively inhibit PP3 and block the proliferation of diverse cancer cells. (A) Structure of CsA. (B) Antitumor mechanism of CsA and FK-506. (C) Binding mode of the Cn-CsA-Cyp complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MF8">1MF8</a>):<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> The CsA-Cyp complex interacts with both CnA and CnB mainly through hydrophobic interactions and hydrogen bonds. CsA hydrogen bonds are indicated by green dotted line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00631/20210629/images/large/jm1c00631_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00631&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 211 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagoev, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortensen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, M.</span></span> <span> </span><span class="NLM_article-title">Global, in Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2006.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17081983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WgtbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=635-648&author=J.+V.+Olsenauthor=B.+Blagoevauthor=F.+Gnadauthor=B.+Macekauthor=C.+Kumarauthor=P.+Mortensenauthor=M.+Mann&title=Global%2C+in+Vivo%2C+and+Site-Specific+Phosphorylation+Dynamics+in+Signaling+Networks&doi=10.1016%2Fj.cell.2006.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global, in vivo, and site-specific phosphorylation dynamics in signaling networks</span></div><div class="casAuthors">Olsen, Jesper V.; Blagoev, Blagoy; Gnad, Florian; Macek, Boris; Kumar, Chanchai; Mortensen, Peter; Mann, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">635-648</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cell signaling mechanisms often transmit information via posttranslational protein modifications, most importantly reversible protein phosphorylation.  Here we develop and apply a general mass spectrometric technol. for identification and quantitation of phosphorylation sites as a function of stimulus, time, and subcellular location.  We have detected 6600 phosphorylation sites on 2244 proteins and have detd. their temporal dynamics after stimulating HeLa cells with epidermal growth factor (EGF) and recorded them in the Phosida database.  Fourteen percent of phosphorylation sites are modulated at least 2-fold by EG, and these were classified by their temporal profiles.  Surprisingly, a majority of proteins contain multiple phosphorylation sites showing different kinetics, suggesting that they serve as platforms for integrating signals.  In addn. to protein kinase cascades, the targets of reversible phosphorylation include ubiquitin ligases, guanine nucleotide exchange factors, and at least 46 different transcriptional regulators.  The dynamic phosphoproteome provides a missing link in a global, integrative view of cellular regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2fanpqTJaa7Vg90H21EOLACvtfcHk0lgW3w1d86uJHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WgtbzO&md5=c8f9ef184663cabfda0db5958549166c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DBlagoev%26aufirst%3DB.%26aulast%3DGnad%26aufirst%3DF.%26aulast%3DMacek%26aufirst%3DB.%26aulast%3DKumar%26aufirst%3DC.%26aulast%3DMortensen%26aufirst%3DP.%26aulast%3DMann%26aufirst%3DM.%26atitle%3DGlobal%252C%2520in%2520Vivo%252C%2520and%2520Site-Specific%2520Phosphorylation%2520Dynamics%2520in%2520Signaling%2520Networks%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D635%26epage%3D648%26doi%3D10.1016%2Fj.cell.2006.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holt, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuch, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gygi, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. O.</span></span> <span> </span><span class="NLM_article-title">Global Analysis of Cdk1 Substrate Phosphorylation Sites Provides Insights into Evolution</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">1682</span>– <span class="NLM_lpage">1686</span>, <span class="refDoi"> DOI: 10.1126/science.1172867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1126%2Fscience.1172867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19779198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGqt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=1682-1686&author=L.+J.+Holtauthor=B.+B.+Tuchauthor=J.+Villenauthor=A.+D.+Johnsonauthor=S.+P.+Gygiauthor=D.+O.+Morgan&title=Global+Analysis+of+Cdk1+Substrate+Phosphorylation+Sites+Provides+Insights+into+Evolution&doi=10.1126%2Fscience.1172867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Global Analysis of Cdk1 Substrate Phosphorylation Sites Provides Insights into Evolution</span></div><div class="casAuthors">Holt, Liam J.; Tuch, Brian B.; Villen, Judit; Johnson, Alexander D.; Gygi, Steven P.; Morgan, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5948</span>),
    <span class="NLM_cas:pages">1682-1686</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">To explore the mechanisms and evolution of cell-cycle control, we analyzed the position and conservation of large nos. of phosphorylation sites for the cyclin-dependent kinase Cdk1 in the budding yeast Saccharomyces cerevisiae.  We combined specific chem. inhibition of Cdk1 with quant. mass spectrometry to identify the positions of 547 phosphorylation sites on 308 Cdk1 substrates in vivo.  Comparisons of these substrates with orthologs throughout the ascomycete lineage revealed that the position of most phosphorylation sites is not conserved in evolution; instead, clusters of sites shift position in rapidly evolving disordered regions.  We propose that the regulation of protein function by phosphorylation often depends on simple nonspecific mechanisms that disrupt or enhance protein-protein interactions.  The gain or loss of phosphorylation sites in rapidly evolving regions could facilitate the evolution of kinase signaling circuits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi1JZunrkk8LVg90H21EOLACvtfcHk0lgW3w1d86uJHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGqt7%252FP&md5=27178a3c1791d046fa801e47cac844be</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1172867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1172867%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DL.%2BJ.%26aulast%3DTuch%26aufirst%3DB.%2BB.%26aulast%3DVillen%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BD.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26atitle%3DGlobal%2520Analysis%2520of%2520Cdk1%2520Substrate%2520Phosphorylation%2520Sites%2520Provides%2520Insights%2520into%2520Evolution%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D1682%26epage%3D1686%26doi%3D10.1126%2Fscience.1172867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serber, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrell, J. E.</span></span> <span> </span><span class="NLM_article-title">Tuning Bulk Electrostatics to Regulate Protein Function</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.01.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2007.01.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17289565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1Wlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=441-444&author=Z.+Serberauthor=J.+E.+Ferrell&title=Tuning+Bulk+Electrostatics+to+Regulate+Protein+Function&doi=10.1016%2Fj.cell.2007.01.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tuning bulk electrostatics to regulate protein function</span></div><div class="casAuthors">Serber, Zach; Ferrell, James E., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-444</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinase activation can prevent yeast cells from responding to mating pheromone.  Strickfaden et al. (2007) now show that this block arises from the multisite phosphorylation of Ste5.  This provides a beautiful example of how phosphorylation can produce decisive changes in protein function through bulk electrostatics, without the necessity of intricate conformational changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqoROeBePwprVg90H21EOLACvtfcHk0ljmIm9xWDFeJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1Wlt7s%253D&md5=7c5c434214d2b0722fbc656592b8dee2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DSerber%26aufirst%3DZ.%26aulast%3DFerrell%26aufirst%3DJ.%2BE.%26atitle%3DTuning%2520Bulk%2520Electrostatics%2520to%2520Regulate%2520Protein%2520Function%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D441%26epage%3D444%26doi%3D10.1016%2Fj.cell.2007.01.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruvolo, P. P.</span></span> <span> </span><span class="NLM_article-title">Role of Protein Phosphatases in the Cancer Microenvironment</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1866</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2018.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bbamcr.2018.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30026077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCltLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1866&publication_year=2019&pages=144-152&author=P.+P.+Ruvolo&title=Role+of+Protein+Phosphatases+in+the+Cancer+Microenvironment&doi=10.1016%2Fj.bbamcr.2018.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Role of protein phosphatases in the cancer microenvironment</span></div><div class="casAuthors">Ruvolo, Peter P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1866</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer cells depend on a supportive niche (the tumor microenvironment) that promotes tumor cell survival while protecting the malignant cells from therapeutic challenges and the host's defense systems.  Cancer cells and the support cells in the tumor microenvironment communicate via cytokines/chemokines, cell:cell contact, or alterations in the metabolic state of the niche (e.g. hypoxia) that promote growth and survival of the tumor cell, influence metastasis, and defeat immune surveillance.  These signaling pathways involve dysregulation of not only protein kinases but also protein phosphatases as normal signal transduction processes require both activation and deactivation.  For instance, aberrant receptor signaling can result from constitutive activation of a tyrosine kinase such as FLT3 or inactivation of a tyrosine protein phosphatase such as SHP-2 (PTPN11).  Activation of serine/threonine kinases such as AKT and ERK are often obsd. during the development of drug resistance while genomic and non-genomic suppression of serine/threonine protein phosphatases such as PP2A achieve similar results.  It is fairly clear that the various protein phosphatases will impact processes that support drug resistance.  Of growing interest is the emerging model whereby the support cells in the tumor microenvironment actually serve as drivers of tumorigenesis.  This phenomenon has been most prominently obsd. in osteoblast cells in leukemic niches.  At least one protein phosphatase, PTPN11, has emerged as a crit. driver of this process in juvenile myelomonocytic leukemia.  This review will cover the role of various serine/threonine and tyrosine protein phosphatases in processes that are central to tumor microenvironment function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo3SXsQ76b47Vg90H21EOLACvtfcHk0ljmIm9xWDFeJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCltLjI&md5=fed1fbf4b19c201807dd3193fe835df9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2018.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2018.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DRuvolo%26aufirst%3DP.%2BP.%26atitle%3DRole%2520of%2520Protein%2520Phosphatases%2520in%2520the%2520Cancer%2520Microenvironment%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2019%26volume%3D1866%26spage%3D144%26epage%3D152%26doi%3D10.1016%2Fj.bbamcr.2018.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, C.</span></span> <span> </span><span class="NLM_article-title">Phosphatases in Mitosis: Roles and Regulation</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">55</span>, <span class="refDoi"> DOI: 10.3390/biom9020055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3390%2Fbiom9020055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvVehsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=55&author=M.+Mouraauthor=C.+Conde&title=Phosphatases+in+Mitosis%3A+Roles+and+Regulation&doi=10.3390%2Fbiom9020055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatases in mitosis: roles and regulation</span></div><div class="casAuthors">Moura, Margarida; Conde, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">55/1-55/51</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Mitosis requires extensive rearrangement of cellular architecture and of subcellular structures so that replicated chromosomes can bind correctly to spindle microtubules and segregate towards opposite poles.  This process originates two new daughter nuclei with equal genetic content and relies on highly-dynamic and tightly regulated phosphorylation of numerous cell cycle proteins.  A burst in protein phosphorylation orchestrated by several conserved kinases occurs as cells go into and progress through mitosis.  The opposing dephosphorylation events are catalyzed by a small set of protein phosphatases, whose importance for the accuracy of mitosis is becoming increasingly appreciated.  This review will focus on the established and emerging roles of mitotic phosphatases, describe their structural and biochem. properties, and discuss recent advances in understanding the regulation of phosphatase activity and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMQfiW6qA8Y7Vg90H21EOLACvtfcHk0ljmIm9xWDFeJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvVehsL8%253D&md5=d42a0ee9edc8b35dd656b20b33a9a742</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fbiom9020055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom9020055%26sid%3Dliteratum%253Aachs%26aulast%3DMoura%26aufirst%3DM.%26aulast%3DConde%26aufirst%3DC.%26atitle%3DPhosphatases%2520in%2520Mitosis%253A%2520Roles%2520and%2520Regulation%26jtitle%3DBiomolecules%26date%3D2019%26volume%3D9%26spage%3D55%26doi%3D10.3390%2Fbiom9020055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenolikar, S.</span></span> <span> </span><span class="NLM_article-title">Protein Serine/Threonine Phosphatases: Keys to Unlocking Regulators and Substrates</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">964</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-062917-012332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1146%2Fannurev-biochem-062917-012332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29925267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=921-964&author=D.+L.+Brautiganauthor=S.+Shenolikar&title=Protein+Serine%2FThreonine+Phosphatases%3A+Keys+to+Unlocking+Regulators+and+Substrates&doi=10.1146%2Fannurev-biochem-062917-012332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Serine/Threonine Phosphatases: Keys to Unlocking Regulators and Substrates</span></div><div class="casAuthors">Brautigan, David L.; Shenolikar, Shirish</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">921-964</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Protein serine/threonine phosphatases (PPPs) are ancient enzymes, with distinct types conserved across eukaryotic evolution.  PPPs are segregated into types primarily on the basis of the unique interactions of PPP catalytic subunits with regulatory proteins.  The resulting holoenzymes dock substrates distal to the active site to enhance specificity.  This review focuses on the subunit and substrate interactions for PPP that depend on short linear motifs.  Insights about these motifs from structures of holoenzymes open new opportunities for computational biol. approaches to elucidate PPP networks.  There is an expanding knowledge base of posttranslational modifications of PPP catalytic and regulatory subunits, as well as of their substrates, including phosphorylation, acetylation, and ubiquitination.  Cross talk between these posttranslational modifications creates PPP-based signaling.  Knowledge of PPP complexes, signaling clusters, as well as how PPPs communicate with each other in response to cellular signals should unlock the doors to PPP networks and signaling "clouds" that orchestrate and coordinate different aspects of cell physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH392q45tGO7Vg90H21EOLACvtfcHk0ljmIm9xWDFeJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrrL&md5=dc58f68ce05dd5535e8ce0c7e1d5036d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-062917-012332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-062917-012332%26sid%3Dliteratum%253Aachs%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26aulast%3DShenolikar%26aufirst%3DS.%26atitle%3DProtein%2520Serine%252FThreonine%2520Phosphatases%253A%2520Keys%2520to%2520Unlocking%2520Regulators%2520and%2520Substrates%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2018%26volume%3D87%26spage%3D921%26epage%3D964%26doi%3D10.1146%2Fannurev-biochem-062917-012332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Munter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">Challenges and Opportunities in the Development of Protein Phosphatase-Directed Therapeutics</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1021/cb300597g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300597g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSjurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=36-45&author=S.+De%0AMunterauthor=M.+K%C3%B6hnauthor=M.+Bollen&title=Challenges+and+Opportunities+in+the+Development+of+Protein+Phosphatase-Directed+Therapeutics&doi=10.1021%2Fcb300597g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities in the Development of Protein Phosphatase-Directed Therapeutics</span></div><div class="casAuthors">De Munter, Sofie; Kohn, Maja; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-45</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Protein phosphatases have both protective and promoting roles in the etiol. of diseases.  A prominent example is the existence of oncogenic as well as tumor-suppressing protein phosphatases.  A few protein phosphatase activity modulators are already applied in therapies.  These were however not developed in target-directed approaches, and the recent discovery of phosphatase involvement followed their application in therapy.  Nevertheless, these examples demonstrate that small mols. can be generated that modulate the activity of protein phosphatases and are beneficial for the treatment of protein phosphorylation diseases.  We describe here strategies for the development of activators and inhibitors of protein phosphatases and clarify some long-standing misconceptions concerning the drug ability of these enzymes.  Recent developments suggest that it is feasible to design potent and selective protein phosphatase modulators with a therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTwo-BD9sHS7Vg90H21EOLACvtfcHk0lhteqspvpgk5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSjurrF&md5=a6bccc84309271ecdec328d6b1b84294</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcb300597g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300597g%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMunter%26aufirst%3DS.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DChallenges%2520and%2520Opportunities%2520in%2520the%2520Development%2520of%2520Protein%2520Phosphatase-Directed%2520Therapeutics%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D36%26epage%3D45%26doi%3D10.1021%2Fcb300597g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roskoski, R.</span></span> <span> </span><span class="NLM_article-title">Properties of Fda-Approved Small Molecule Protein Kinase Inhibitors</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2019.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.phrs.2019.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30877063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntVGnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=19-50&author=R.+Roskoski&title=Properties+of+Fda-Approved+Small+Molecule+Protein+Kinase+Inhibitors&doi=10.1016%2Fj.phrs.2019.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of FDA-approved small molecule protein kinase inhibitors</span></div><div class="casAuthors">Roskoski, Robert Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-50</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Because mutations, overexpression, and dysregulation of protein kinases play essential roles in the pathogenesis of many illnesses, this enzyme family has become one of the most important drug targets in the past 20 years.  The US FDA has approved 48 small mol. protein kinase inhibitors, nearly all of which are orally effective with the exceptions of netarsudil (which is given as an eye drop) and temsirolimus (which is given i.v.).  Of the 48 approved drugs, the majority (25) target receptor protein-tyrosine kinases, ten target non-receptor protein-tyrosine kinases, and 13 target protein-serine/threonine protein kinases.  The data indicate that 43 of these drugs are used in the treatment of malignancies (36 against solid tumors including lymphomas and seven against non-solid tumors, e.g., leukemias).  Seven drugs are used in the treatment of non-malignancies: baricitinib, rheumatoid arthritis; fostamatinib, chronic immune thrombocytopenia; ruxolitinib, myelofibrosis and polycythemia vera; nintedanib, idiopathic pulmonary fibrosis; sirolimus, renal graft vs. host disease; netarsudil, glaucoma; tofacitinib, rheumatoid arthritis, Crohn disease, and ulcerative colitis.  Moreover, ibrutinib and sirolimus are used for the treatment of both malignant and non-malignant diseases.  The most common drug targets include ALK, B-Raf, BCR-Abl, epidermal growth factor receptor (EGFR), and vascular endothelial growth factor receptor (VEGFR).  Most of the small mol. inhibitors (45) interact directly with the protein kinase domain.  In contrast, sirolimus, temsirolimus, and everolimus are larger mols. (MW ≈ 1000) that bind to FKBP-12 to generate a complex that inhibits mTOR (mammalian target of rapamycin).  This review presents the available drug-enzyme X-ray crystal structures for 27 of the approved drugs as well as the chem. structures and physicochem. properties of all of the FDA-approved small mol. protein kinase antagonists.  Six of the drugs bind covalently and irreversibly to their target.  Twenty of the 48 drugs have mol. wts. greater than 500, exceeding a Lipinski rule of five criterion.  Excluding the macrolides (everolimus, sirolimus, temsirolimus), the av. mol. wt. of drugs is 480 with a range of 306 (ruxolitinib) to 615 (trametinib).  Nearly half of the antagonists (23) have a lipophilic efficiency with values of less than five while the recommended optima range from 5-10.  One of the vexing problems is the near universal development of resistance that is assocd. with the use of small mol. protein kinase inhibitors for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLum_hDK00hbVg90H21EOLACvtfcHk0lhteqspvpgk5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntVGnurg%253D&md5=a24dee87603bc4ea12bd34616e46f53d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2019.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DRoskoski%26aufirst%3DR.%26atitle%3DProperties%2520of%2520Fda-Approved%2520Small%2520Molecule%2520Protein%2520Kinase%2520Inhibitors%26jtitle%3DPharmacol.%2520Res.%26date%3D2019%26volume%3D144%26spage%3D19%26epage%3D50%26doi%3D10.1016%2Fj.phrs.2019.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCluskey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, A. T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakoff, J. A.</span></span> <span> </span><span class="NLM_article-title">Serine-Threonine Protein Phosphatase Inhibitors: Development of Potential Therapeutic Strategies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1151</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1021/jm010066k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010066k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Grsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1151-1175&author=A.+McCluskeyauthor=A.+T.+R.+Simauthor=J.+A.+Sakoff&title=Serine-Threonine+Protein+Phosphatase+Inhibitors%3A+Development+of+Potential+Therapeutic+Strategies&doi=10.1021%2Fjm010066k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Serine-Threonine Protein Phosphatase Inhibitors: Development of Potential Therapeutic Strategies</span></div><div class="casAuthors">McCluskey, Adam; Sim, Alistair T. R.; Sakoff, Jennette A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1151-1175</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include classification of protein phosphatases, natural phosphatase inhibitors, structural features of protein phosphatase inhibition and therapeutic use of protein phosphatase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1v3fejhgFHLVg90H21EOLACvtfcHk0lhteqspvpgk5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Grsrw%253D&md5=911e087a9986fb7fb4c49e5cb03ddfc1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm010066k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010066k%26sid%3Dliteratum%253Aachs%26aulast%3DMcCluskey%26aufirst%3DA.%26aulast%3DSim%26aufirst%3DA.%2BT.%2BR.%26aulast%3DSakoff%26aufirst%3DJ.%2BA.%26atitle%3DSerine-Threonine%2520Protein%2520Phosphatase%2520Inhibitors%253A%2520Development%2520of%2520Potential%2520Therapeutic%2520Strategies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1151%26epage%3D1175%26doi%3D10.1021%2Fjm010066k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhullar, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagaron, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupasinghe, H. P. V.</span></span> <span> </span><span class="NLM_article-title">Kinase-Targeted Cancer Therapies: Progress, Challenges and Future Directions</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">48</span>, <span class="refDoi"> DOI: 10.1186/s12943-018-0804-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1186%2Fs12943-018-0804-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29455673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitF2nt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=48&author=K.+S.+Bhullarauthor=N.+O.+Lagaronauthor=E.+M.+McGowanauthor=I.+Parmarauthor=A.+Jhaauthor=B.+P.+Hubbardauthor=H.+P.+V.+Rupasinghe&title=Kinase-Targeted+Cancer+Therapies%3A+Progress%2C+Challenges+and+Future+Directions&doi=10.1186%2Fs12943-018-0804-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase-targeted cancer therapies: progress, challenges and future directions</span></div><div class="casAuthors">Bhullar, Khushwant S.; Lagaron, Naiara Orrego; McGowan, Eileen M.; Parmar, Indu; Jha, Amitabh; Hubbard, Basil P.; Rupasinghe, H. P. Vasantha</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48/1-48/20</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The human genome encodes 538 protein kinases that transfer a γ-phosphate group from ATP to serine, threonine, or tyrosine residues.  Many of these kinases are assocd. with human cancer initiation and progression.  The recent development of small-mol. kinase inhibitors for the treatment of diverse types of cancer has proven successful in clin. therapy.  Significantly, protein kinases are the second most targeted group of drug targets, after the G-proteincoupled receptors.  Since the development of the first protein kinase inhibitor, in the early 1980s, 37 kinase inhibitors have received FDA approval for treatment of malignancies such as breast and lung cancer.  Furthermore, about 150 kinase-targeted drugs are in clin. phase trials, and many kinase-specific inhibitors are in the preclin. stage of drug development.  Nevertheless, many factors confound the clin. efficacy of these mols.  Specific tumor genetics, tumor microenvironment, drug resistance, and pharmacogenomics det. how useful a compd. will be in the treatment of a given cancer.  This review provides an overview of kinase-targeted drug discovery and development in relation to oncol. and highlights the challenges and future potential for kinase-targeted cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb-edOGHyJPbVg90H21EOLACvtfcHk0ljItHRzsvzA8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitF2nt7fP&md5=30811747f13749327d998c5dadd2161d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2Fs12943-018-0804-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12943-018-0804-2%26sid%3Dliteratum%253Aachs%26aulast%3DBhullar%26aufirst%3DK.%2BS.%26aulast%3DLagaron%26aufirst%3DN.%2BO.%26aulast%3DMcGowan%26aufirst%3DE.%2BM.%26aulast%3DParmar%26aufirst%3DI.%26aulast%3DJha%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DB.%2BP.%26aulast%3DRupasinghe%26aufirst%3DH.%2BP.%2BV.%26atitle%3DKinase-Targeted%2520Cancer%2520Therapies%253A%2520Progress%252C%2520Challenges%2520and%2520Future%2520Directions%26jtitle%3DMol.%2520Cancer%26date%3D2018%26volume%3D17%26spage%3D48%26doi%3D10.1186%2Fs12943-018-0804-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fahs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lujan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Approaches to Study Phosphatases</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2944</span>– <span class="NLM_lpage">2961</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00570</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00570" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SjsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2944-2961&author=S.+Fahsauthor=P.+Lujanauthor=M.+K%C3%B6hn&title=Approaches+to+Study+Phosphatases&doi=10.1021%2Facschembio.6b00570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Approaches to Study Phosphatases</span></div><div class="casAuthors">Fahs, Sara; Lujan, Pablo; Koehn, Maja</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2944-2961</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Phosphatases play key roles in normal physiol. and diseases.  Studying phosphatases has been both essential and challenging, and the application of conventional genetic and biochem. methods has led to crucial but still limited understanding of their mechanisms, substrates, and exclusive functions within highly intricate networks.  With the advances in technologies such as cellular imaging and mol. and chem. biol. in terms of sensitive tools and methods, the phosphatase field has thrived in the past years and has set new insights for cell signaling studies and for therapeutic development.  In this review, we give an overview of the existing interdisciplinary tools for phosphatases, give examples on how they have been applied to increase our understanding of these enzymes, and suggest how they - and other tools yet barely used in the phosphatase field - might be adapted to address future questions and challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD5m8vT2LKKbVg90H21EOLACvtfcHk0ljItHRzsvzA8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SjsLjF&md5=91dd769625fcdc1d0d06937800630c94</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00570%26sid%3Dliteratum%253Aachs%26aulast%3DFahs%26aufirst%3DS.%26aulast%3DLujan%26aufirst%3DP.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DApproaches%2520to%2520Study%2520Phosphatases%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D2944%26epage%3D2961%26doi%3D10.1021%2Facschembio.6b00570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonks, N. K.</span></span> <span> </span><span class="NLM_article-title">Protein Tyrosine Phosphatases-from Housekeeping Enzymes to Master Regulators of Signal Transduction</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1111/febs.12077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1111%2Ffebs.12077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23176256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=346-378&author=N.+K.+Tonks&title=Protein+Tyrosine+Phosphatases-from+Housekeeping+Enzymes+to+Master+Regulators+of+Signal+Transduction&doi=10.1111%2Ffebs.12077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases - from housekeeping enzymes to master regulators of signal transduction</span></div><div class="casAuthors">Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">346-378</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  There are many misconceptions surrounding the roles of protein phosphatases in the regulation of signal transduction, perhaps the most damaging of which is the erroneous view that these enzymes exert their effects merely as constitutively active housekeeping enzymes.  On the contrary, the phosphatases are crit., specific regulators of signalling in their own right and serve an essential function, in a coordinated manner with the kinases, to det. the response to a physiol. stimulus.  This review is a personal perspective on the development of our understanding of the protein tyrosine phosphatase family of enzymes.  I have discussed various aspects of the structure, regulation and function of the protein tyrosine phosphatase family, which I hope will illustrate the fundamental importance of these enzymes in the control of signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ_gy-gS52MbVg90H21EOLACvtfcHk0ljItHRzsvzA8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7s%253D&md5=3c14e627b0291ff2e601a71b8b39874e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12077%26sid%3Dliteratum%253Aachs%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DProtein%2520Tyrosine%2520Phosphatases-from%2520Housekeeping%2520Enzymes%2520to%2520Master%2520Regulators%2520of%2520Signal%2520Transduction%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D346%26epage%3D378%26doi%3D10.1111%2Ffebs.12077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Targeting Phosphatases in Cancer: Suppression of Many Versus the Ablation of One</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">6543</span>– <span class="NLM_lpage">6545</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.27201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.18632%2Foncotarget.27201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31762936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BB3Mfislejug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=6543-6545&author=B.+M.+D%E2%80%99Arcyauthor=A.+Prakashauthor=R.+E.+Honkanen&title=Targeting+Phosphatases+in+Cancer%3A+Suppression+of+Many+Versus+the+Ablation+of+One&doi=10.18632%2Foncotarget.27201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phosphatases in cancer: suppression of many versus the ablation of one</span></div><div class="casAuthors">D'Arcy Brandon M; D'Arcy Brandon M; Prakash Aishwarya; Honkanen Richard E</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">61</span>),
    <span class="NLM_cas:pages">6543-6545</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDllt95OKW9FHFYivNCdPRfW6udTcc2eauYzshbpZporntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mfislejug%253D%253D&md5=9fdb1e26b5f10b175c064d931a59931e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.27201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.27201%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DB.%2BM.%26aulast%3DPrakash%26aufirst%3DA.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DTargeting%2520Phosphatases%2520in%2520Cancer%253A%2520Suppression%2520of%2520Many%2520Versus%2520the%2520Ablation%2520of%2520One%26jtitle%3DOncotarget%26date%3D2019%26volume%3D10%26spage%3D6543%26epage%3D6545%26doi%3D10.18632%2Foncotarget.27201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiredja, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaware, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatzer, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasireddi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schüchner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perl, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galsky, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogris, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, G.</span></span> <span> </span><span class="NLM_article-title">Selective Pp2a Enhancement through Biased Heterotrimer Stabilization</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.03.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2020.03.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=32315618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvFeitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=688-701&author=D.+Leonardauthor=W.+Huangauthor=S.+Izadmehrauthor=C.+M.+O%E2%80%99Connorauthor=D.+D.+Wiredjaauthor=Z.+Wangauthor=N.+Zawareauthor=Y.+Chenauthor=D.+M.+Schlatzerauthor=J.+Kiselarauthor=N.+Vasireddiauthor=S.+Sch%C3%BCchnerauthor=A.+L.+Perlauthor=M.+D.+Galskyauthor=W.+Xuauthor=D.+L.+Brautiganauthor=E.+Ogrisauthor=D.+J.+Taylorauthor=G.+Narla&title=Selective+Pp2a+Enhancement+through+Biased+Heterotrimer+Stabilization&doi=10.1016%2Fj.cell.2020.03.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Selective PP2A enhancement through biased heterotrimer stabilization</span></div><div class="casAuthors">Leonard, Daniel; Huang, Wei; Izadmehr, Sudeh; O'Connor, Caitlin M.; Wiredja, Danica D.; Wang, Zhizhi; Zaware, Nilesh; Chen, Yinghua; Schlatzer, Daniela M.; Kiselar, Janna; Vasireddi, Nikhil; Schuchner, Stefan; Perl, Abbey L.; Galsky, Matthew D.; Xu, Wenqing; Brautigan, David L.; Ogris, Egon; Taylor, Derek J.; Narla, Goutham</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">688-701.e16</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Impairment of protein phosphatases, including the family of serine/threonine phosphatases designated PP2A, is essential for the pathogenesis of many diseases, including cancer.  The ability of PP2A to dephosphorylate hundreds of proteins is regulated by over 40 specificity-detg. regulatory "B" subunits that compete for assembly and activation of heterogeneous PP2A heterotrimers.  Here, we reveal how a small mol., DT-061, specifically stabilizes the B56α-PP2A holoenzyme in a fully assembled, active state to dephosphorylate selective substrates, such as its well-known oncogenic target, c-Myc.  Our 3.6 Å structure identifies mol. interactions between DT-061 and all three PP2A subunits that prevent dissocn. of the active enzyme and highlight inherent mechanisms of PP2A complex assembly.  Thus, our findings provide fundamental insights into PP2A complex assembly and regulation, identify a unique interfacial stabilizing mode of action for therapeutic targeting, and aid in the development of phosphatase-based therapeutics tailored against disease specific phospho-protein targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu4CUPqLYpQrVg90H21EOLACvtfcHk0libti9Hj7s9Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvFeitL4%253D&md5=baeee6ee120e38c807e69ad60845cf58</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.03.038%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DC.%2BM.%26aulast%3DWiredja%26aufirst%3DD.%2BD.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZaware%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSchlatzer%26aufirst%3DD.%2BM.%26aulast%3DKiselar%26aufirst%3DJ.%26aulast%3DVasireddi%26aufirst%3DN.%26aulast%3DSch%25C3%25BCchner%26aufirst%3DS.%26aulast%3DPerl%26aufirst%3DA.%2BL.%26aulast%3DGalsky%26aufirst%3DM.%2BD.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26aulast%3DOgris%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DD.%2BJ.%26aulast%3DNarla%26aufirst%3DG.%26atitle%3DSelective%2520Pp2a%2520Enhancement%2520through%2520Biased%2520Heterotrimer%2520Stabilization%26jtitle%3DCell%26date%3D2020%26volume%3D181%26spage%3D688%26epage%3D701%26doi%3D10.1016%2Fj.cell.2020.03.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durbin, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martel, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prutsch, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, A. T.</span></span> <span> </span><span class="NLM_article-title">Allosteric Activators of Protein Phosphatase 2a Display Broad Antitumor Activity Mediated by Dephosphorylation of Mybl2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">702</span>– <span class="NLM_lpage">715</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.03.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2020.03.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=32315619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvFeitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=702-715&author=K.+Moritaauthor=S.+Heauthor=R.+P.+Nowakauthor=J.+Wangauthor=M.+W.+Zimmermanauthor=C.+Fuauthor=A.+D.+Durbinauthor=M.+W.+Martelauthor=N.+Prutschauthor=N.+S.+Grayauthor=E.+S.+Fischerauthor=A.+T.+Look&title=Allosteric+Activators+of+Protein+Phosphatase+2a+Display+Broad+Antitumor+Activity+Mediated+by+Dephosphorylation+of+Mybl2&doi=10.1016%2Fj.cell.2020.03.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2</span></div><div class="casAuthors">Morita, Ken; He, Shuning; Nowak, Radoslaw P.; Wang, Jinhua; Zimmerman, Mark W.; Fu, Cong; Durbin, Adam D.; Martel, Megan W.; Prutsch, Nicole; Gray, Nathanael S.; Fischer, Eric S.; Look, A. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">702-715.e20</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Protein phosphatase 2A (PP2A) enzymes can suppress tumors, but they are often inactivated in human cancers overexpressing inhibitory proteins.  Here, we identify a class of small-mol. iHAPs (improved heterocyclic activators of PP2A) that kill leukemia cells by allosterically assembling a specific heterotrimeric PP2A holoenzyme consisting of PPP2R1A (scaffold), PPP2R5E (B56ε, regulatory), and PPP2CA (catalytic) subunits.  One compd., iHAP1, activates this complex but does not inhibit dopamine receptor D2, a mediator of neurol. toxicity induced by perphenazine and related neuroleptics.  The PP2A complex activated by iHAP1 dephosphorylates the MYBL2 transcription factor on Ser241, causing irreversible arrest of leukemia and other cancer cells in prometaphase.  In contrast, SMAPs, a sep. class of compds., activate PP2A holoenzymes contg. a different regulatory subunit, do not dephosphorylate MYBL2, and arrest tumor cells in G1 phase.  Our findings demonstrate that small mols. can serve as allosteric switches to activate distinct PP2A complexes with unique substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPVLhVVAc5VbVg90H21EOLACvtfcHk0libti9Hj7s9Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvFeitLg%253D&md5=b872bcc33d03742b9a2d69cb8fdbbb27</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.03.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.03.051%26sid%3Dliteratum%253Aachs%26aulast%3DMorita%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DNowak%26aufirst%3DR.%2BP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZimmerman%26aufirst%3DM.%2BW.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DDurbin%26aufirst%3DA.%2BD.%26aulast%3DMartel%26aufirst%3DM.%2BW.%26aulast%3DPrutsch%26aufirst%3DN.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DFischer%26aufirst%3DE.%2BS.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DAllosteric%2520Activators%2520of%2520Protein%2520Phosphatase%25202a%2520Display%2520Broad%2520Antitumor%2520Activity%2520Mediated%2520by%2520Dephosphorylation%2520of%2520Mybl2%26jtitle%3DCell%26date%3D2020%26volume%3D181%26spage%3D702%26epage%3D715%26doi%3D10.1016%2Fj.cell.2020.03.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, G.</span></span> <span> </span><span class="NLM_article-title">Genomics and Evolution of Protein Phosphatases</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">eaag1796</span> <span class="refDoi"> DOI: 10.1126/scisignal.aag1796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1126%2Fscisignal.aag1796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28400531" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&author=M.+J.+Chenauthor=J.+E.+Dixonauthor=G.+Manning&title=Genomics+and+Evolution+of+Protein+Phosphatases&doi=10.1126%2Fscisignal.aag1796"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aag1796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aag1796%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%2BJ.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26aulast%3DManning%26aufirst%3DG.%26atitle%3DGenomics%2520and%2520Evolution%2520of%2520Protein%2520Phosphatases%26jtitle%3DSci.%2520Signaling%26date%3D2017%26volume%3D10%26doi%3D10.1126%2Fscisignal.aag1796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilmanns, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Elucidating Human Phosphatase-Substrate Networks</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">rs10</span> <span class="refDoi"> DOI: 10.1126/scisignal.2003203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1126%2Fscisignal.2003203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23674824" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&author=X.+Liauthor=M.+Wilmannsauthor=J.+Thorntonauthor=M.+K%C3%B6hn&title=Elucidating+Human+Phosphatase-Substrate+Networks&doi=10.1126%2Fscisignal.2003203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2003203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2003203%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWilmanns%26aufirst%3DM.%26aulast%3DThornton%26aufirst%3DJ.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DElucidating%2520Human%2520Phosphatase-Substrate%2520Networks%26jtitle%3DSci.%2520Signaling%26date%3D2013%26volume%3D6%26doi%3D10.1126%2Fscisignal.2003203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heynen, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciecielski, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berninger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabacaoglu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Görgülü, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dantes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wörmann, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diakopoulos, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpathaki, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaya-Aksoy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Laan, E. A. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Alberca, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazaré, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saur, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erkan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopt, U. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sainz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algül, H.</span></span> <span> </span><span class="NLM_article-title">Mutant Kras-Driven Cancers Depend on Ptpn11/Shp2 Phosphatase</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">960</span>, <span class="refDoi"> DOI: 10.1038/s41591-018-0024-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fs41591-018-0024-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29808009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=954-960&author=D.+A.+Ruessauthor=G.+J.+Heynenauthor=K.+J.+Ciecielskiauthor=J.+Aiauthor=A.+Berningerauthor=D.+Kabacaogluauthor=K.+G%C3%B6rg%C3%BCl%C3%BCauthor=Z.+Dantesauthor=S.+M.+W%C3%B6rmannauthor=K.+N.+Diakopoulosauthor=A.+F.+Karpathakiauthor=M.+Kowalskaauthor=E.+Kaya-Aksoyauthor=L.+Songauthor=E.+A.+Z.+van+der+Laanauthor=M.+P.+L%C3%B3pez-Albercaauthor=M.+Nazar%C3%A9author=M.+Reichertauthor=D.+Saurauthor=M.+M.+Erkanauthor=U.+T.+Hoptauthor=B.+Sainzauthor=W.+Birchmeierauthor=R.+M.+Schmidauthor=M.+Lesinaauthor=H.+Alg%C3%BCl&title=Mutant+Kras-Driven+Cancers+Depend+on+Ptpn11%2FShp2+Phosphatase&doi=10.1038%2Fs41591-018-0024-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase</span></div><div class="casAuthors">Ruess, Dietrich A.; Heynen, Guus J.; Ciecielski, Katrin J.; Ai, Jiaoyu; Berninger, Alexandra; Kabacaoglu, Derya; Goerguelue, Kivanc; Dantes, Zahra; Woermann, Sonja M.; Diakopoulos, Kalliope N.; Karpathaki, Angeliki F.; Kowalska, Marlena; Kaya-Aksoy, Ezgi; Song, Liang; van der Laan, Eveline A. Zeeuw; Lopez-Alberca, Maria P.; Nazare, Marc; Reichert, Maximilian; Saur, Dieter; Erkan, Mert M.; Hopt, Ulrich T.; Sainz, Jr, Bruno; Birchmeier, Walter; Schmid, Roland M.; Lesina, Marina; Alguel, Hana</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">954-960</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The ubiquitously expressed non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, is involved in signal transduction downstream of multiple growth factor, cytokine and integrin receptors1.  Its requirement for complete RAS-MAPK activation and its role as a neg. regulator of JAK-STAT signaling have established SHP2 as an essential player in oncogenic signaling pathways1-7.  Recently, a novel potent allosteric SHP2 inhibitor was presented as a viable therapeutic option for receptor tyrosine kinase-driven cancers, but was shown to be ineffective in KRAS-mutant tumor cell lines in vitro8.  Here, we report a central and indispensable role for SHP2 in oncogenic KRAS-driven tumors.  Genetic deletion of Ptpn11 profoundly inhibited tumor development in mutant KRAS-driven murine models of pancreatic ductal adenocarcinoma and non-small-cell lung cancer.  We provide evidence for a crit. dependence of mutant KRAS on SHP2 during carcinogenesis.  Deletion or inhibition of SHP2 in established tumors delayed tumor progression but was not sufficient to achieve tumor regression.  However, SHP2 was necessary for resistance mechanisms upon blockade of MEK.  Synergy was obsd. when both SHP2 and MEK were targeted, resulting in sustained tumor growth control in murine and human patient-derived organoids and xenograft models of pancreatic ductal adenocarcinoma and non-small-cell lung cancer.  Our data indicate the clin. utility of dual SHP2/MEK inhibition as a targeted therapy approach for KRAS-mutant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoepq09hU77abVg90H21EOLACvtfcHk0lhzpWPppSMu8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvF&md5=cc09897c2c4b8e32b035b991e5032f32</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fs41591-018-0024-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-018-0024-8%26sid%3Dliteratum%253Aachs%26aulast%3DRuess%26aufirst%3DD.%2BA.%26aulast%3DHeynen%26aufirst%3DG.%2BJ.%26aulast%3DCiecielski%26aufirst%3DK.%2BJ.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DBerninger%26aufirst%3DA.%26aulast%3DKabacaoglu%26aufirst%3DD.%26aulast%3DG%25C3%25B6rg%25C3%25BCl%25C3%25BC%26aufirst%3DK.%26aulast%3DDantes%26aufirst%3DZ.%26aulast%3DW%25C3%25B6rmann%26aufirst%3DS.%2BM.%26aulast%3DDiakopoulos%26aufirst%3DK.%2BN.%26aulast%3DKarpathaki%26aufirst%3DA.%2BF.%26aulast%3DKowalska%26aufirst%3DM.%26aulast%3DKaya-Aksoy%26aufirst%3DE.%26aulast%3DSong%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BLaan%26aufirst%3DE.%2BA.%2BZ.%26aulast%3DL%25C3%25B3pez-Alberca%26aufirst%3DM.%2BP.%26aulast%3DNazar%25C3%25A9%26aufirst%3DM.%26aulast%3DReichert%26aufirst%3DM.%26aulast%3DSaur%26aufirst%3DD.%26aulast%3DErkan%26aufirst%3DM.%2BM.%26aulast%3DHopt%26aufirst%3DU.%2BT.%26aulast%3DSainz%26aufirst%3DB.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DSchmid%26aufirst%3DR.%2BM.%26aulast%3DLesina%26aufirst%3DM.%26aulast%3DAlg%25C3%25BCl%26aufirst%3DH.%26atitle%3DMutant%2520Kras-Driven%2520Cancers%2520Depend%2520on%2520Ptpn11%252FShp2%2520Phosphatase%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D954%26epage%3D960%26doi%3D10.1038%2Fs41591-018-0024-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunkl, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazic-Legueux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchado, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brachmann, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerman, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caponigro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.-X.</span></span> <span> </span><span class="NLM_article-title">Shp2 Inhibition Overcomes Rtk-Mediated Pathway Reactivation in Kras-Mutant Tumors Treated with Mek Inhibitors</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1323</span>– <span class="NLM_lpage">1334</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-18-0852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1535-7163.MCT-18-0852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31068384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Kjsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=1323-1334&author=H.+Luauthor=C.+Liuauthor=R.+Velazquezauthor=H.+Wangauthor=L.+M.+Dunklauthor=M.+Kazic-Legueuxauthor=A.+Haberkornauthor=E.+Billyauthor=E.+Manchadoauthor=S.+M.+Brachmannauthor=S.+E.+Moodyauthor=J.+A.+Engelmanauthor=P.+S.+Hammermanauthor=G.+Caponigroauthor=M.+Mohseniauthor=H.-X.+Hao&title=Shp2+Inhibition+Overcomes+Rtk-Mediated+Pathway+Reactivation+in+Kras-Mutant+Tumors+Treated+with+Mek+Inhibitors&doi=10.1158%2F1535-7163.MCT-18-0852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS-mutant tumors treated with MEK inhibitors</span></div><div class="casAuthors">Lu, Hengyu; Liu, Chen; Velazquez, Roberto; Wang, Hongyun; Dunkl, Lukas Manuel; Kazic-Legueux, Malika; Haberkorn, Anne; Billy, Eric; Manchado, Eusebio; Brachmann, Saskia M.; Moody, Susan E.; Engelman, Jeffrey A.; Hammerman, Peter S.; Caponigro, Giordano; Mohseni, Morvarid; Hao, Huai-Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1323-1334</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">FGFR1 was recently shown to be activated as part of a compensatory response to prolonged treatment with the MEK inhibitor trametinib in several KRAS-mutant lung and pancreatic cancer cell lines.  We hypothesize that other receptor tyrosine kinases (RTK) are also feedback-activated in this context.  Herein, we profile a large panel of KRAS-mutant cancer cell lines for the contribution of RTKs to the feedback activation of phospho-MEK following MEK inhibition, using an SHP2 inhibitor (SHP099) that blocks RAS activation mediated by multiple RTKs.  We find that RTK-driven feedback activation widely exists in KRAS-mutant cancer cells, to a less extent in those harboring the G13D variant, and involves several RTKs, including EGFR, FGFR, and MET.  We further demonstrate that this pathway feedback activation is mediated through mutant KRAS, at least for the G12C, G12D, and G12V variants, and wild-type KRAS can also contribute significantly to the feedback activation.  Finally, SHP099 and MEK inhibitors exhibit combination benefits inhibiting KRAS-mutant cancer cell proliferation in vitro and in vivo.  These findings provide a rationale for exploration of combining SHP2 and MAPK pathway inhibitors for treating KRAS-mutant cancers in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLezgYOaDKL7Vg90H21EOLACvtfcHk0lhzpWPppSMu8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Kjsb7I&md5=24d487c279126d146ed9515e5c5c3e10</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-18-0852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-18-0852%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DVelazquez%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDunkl%26aufirst%3DL.%2BM.%26aulast%3DKazic-Legueux%26aufirst%3DM.%26aulast%3DHaberkorn%26aufirst%3DA.%26aulast%3DBilly%26aufirst%3DE.%26aulast%3DManchado%26aufirst%3DE.%26aulast%3DBrachmann%26aufirst%3DS.%2BM.%26aulast%3DMoody%26aufirst%3DS.%2BE.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DHammerman%26aufirst%3DP.%2BS.%26aulast%3DCaponigro%26aufirst%3DG.%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DH.-X.%26atitle%3DShp2%2520Inhibition%2520Overcomes%2520Rtk-Mediated%2520Pathway%2520Reactivation%2520in%2520Kras-Mutant%2520Tumors%2520Treated%2520with%2520Mek%2520Inhibitors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2019%26volume%3D18%26spage%3D1323%26epage%3D1334%26doi%3D10.1158%2F1535-7163.MCT-18-0852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchdunger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanning, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lydon, N. B.</span></span> <span> </span><span class="NLM_article-title">Effects of a Selective Inhibitor of the Abl Tyrosine Kinase on the Growth of Bcr–Abl Positive Cells</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1038/nm0596-561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fnm0596-561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8616716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK28Xislyhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=561-566&author=B.+J.+Drukerauthor=S.+Tamuraauthor=E.+Buchdungerauthor=S.+Ohnoauthor=G.+M.+Segalauthor=S.+Fanningauthor=J.+Zimmermannauthor=N.+B.+Lydon&title=Effects+of+a+Selective+Inhibitor+of+the+Abl+Tyrosine+Kinase+on+the+Growth+of+Bcr%E2%80%93Abl+Positive+Cells&doi=10.1038%2Fnm0596-561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells</span></div><div class="casAuthors">Druker, Brian J.; Tamura, Shu; Buchdunger, Elisabeth; Ohno, Sayuri; Segal, Gerald M.; Fanning, Shane; Zimmermann, Jurg; Lydon, Nicholas B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-566</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">The Bcr-Abl oncogene, present in 95% of patients with chronic myelogenous leukemia (CML), has been implicated as the cause of this disease.  A compd., designed to inhibit the Abl protein tyrosine kinase (CGP 57148), was evaluated for its effects on cells contg. the Bcr-Abl fusion protein.  Cellular proliferation and tumor formation by Bcr-Abl-expressing cells were specifically inhibited by this compd.  In colony-forming assays of peripheral blood or bone marrow from patients with CML, there was a 92-98% decrease in the no. of Bcr-Abl colonies formed but no inhibition of normal colony formation.  This compd. may be useful in the treatment of Bcr-Abl-pos. leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjzXj-25AHOrVg90H21EOLACvtfcHk0lhhuJ-jxAQ6qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xislyhs70%253D&md5=1dc111cc883a1ed29964ae2c88c88cb9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnm0596-561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0596-561%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTamura%26aufirst%3DS.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DSegal%26aufirst%3DG.%2BM.%26aulast%3DFanning%26aufirst%3DS.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26atitle%3DEffects%2520of%2520a%2520Selective%2520Inhibitor%2520of%2520the%2520Abl%2520Tyrosine%2520Kinase%2520on%2520the%2520Growth%2520of%2520Bcr%25E2%2580%2593Abl%2520Positive%2520Cells%26jtitle%3DNat.%2520Med.%26date%3D1996%26volume%3D2%26spage%3D561%26epage%3D566%26doi%3D10.1038%2Fnm0596-561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koveal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akshinthala, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kragelj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackledge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthuswamy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonks, N. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the Disordered C Terminus of Ptp1b with an Allosteric Inhibitor</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fnchembio.1528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24845231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=558-566&author=N.+Krishnanauthor=D.+Kovealauthor=D.+H.+Millerauthor=B.+Xueauthor=S.+D.+Akshinthalaauthor=J.+Krageljauthor=M.+R.+Jensenauthor=C.+M.+Gaussauthor=R.+Pageauthor=M.+Blackledgeauthor=S.+K.+Muthuswamyauthor=W.+Petiauthor=N.+K.+Tonks&title=Targeting+the+Disordered+C+Terminus+of+Ptp1b+with+an+Allosteric+Inhibitor&doi=10.1038%2Fnchembio.1528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the disordered C terminus of PTP1B with an allosteric inhibitor</span></div><div class="casAuthors">Krishnan, Navasona; Koveal, Dorothy; Miller, Daniel H.; Xue, Bin; Akshinthala, Sai Dipikaa; Kragelj, Jaka; Jensen, Malene Ringkjoebing; Gauss, Carla-Maria; Page, Rebecca; Blackledge, Martin; Muthuswamy, Senthil K.; Peti, Wolfgang; Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">558-566</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">PTP1B, a validated therapeutic target for diabetes and obesity, has a crit. pos. role in HER2 signaling in breast tumorigenesis.  Efforts to develop therapeutic inhibitors of PTP1B have been frustrated by the chem. properties of the active site.  We define a new mechanism of allosteric inhibition that targets the C-terminal, noncatalytic segment of PTP1B.  We present what is to our knowledge the first ensemble structure of PTP1B contg. this intrinsically disordered segment, within which we identified a binding site for the small-mol. inhibitor MSI-1436.  We demonstrate binding to a second site close to the catalytic domain, with cooperative effects between the two sites locking PTP1B in an inactive state.  MSI-1436 antagonized HER2 signaling, inhibited tumorigenesis in xenografts and abrogated metastasis in the NDL2 mouse model of breast cancer, validating inhibition of PTP1B as a therapeutic strategy in breast cancer.  This new approach to inhibition of PTP1B emphasizes the potential of disordered segments of proteins as specific binding sites for therapeutic small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo526if7ja9XbVg90H21EOLACvtfcHk0lhhuJ-jxAQ6qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D&md5=10a460f3a5deafb9f7c206246d67a29b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1528%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DN.%26aulast%3DKoveal%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DD.%2BH.%26aulast%3DXue%26aufirst%3DB.%26aulast%3DAkshinthala%26aufirst%3DS.%2BD.%26aulast%3DKragelj%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DBlackledge%26aufirst%3DM.%26aulast%3DMuthuswamy%26aufirst%3DS.%2BK.%26aulast%3DPeti%26aufirst%3DW.%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DTargeting%2520the%2520Disordered%2520C%2520Terminus%2520of%2520Ptp1b%2520with%2520an%2520Allosteric%2520Inhibitor%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D558%26epage%3D566%26doi%3D10.1038%2Fnchembio.1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lantz, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, S. G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planey, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roitman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-White, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLane, M. P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Ptp1b by Trodusquemine (Msi-1436) Causes Fat-Specific Weight Loss in Diet-Induced Obese Mice</span>. <i>Obesity</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1516</span>– <span class="NLM_lpage">1523</span>, <span class="refDoi"> DOI: 10.1038/oby.2009.444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Foby.2009.444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20075852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlymsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1516-1523&author=K.+A.+Lantzauthor=S.+G.+E.+Hartauthor=S.+L.+Planeyauthor=M.+F.+Roitmanauthor=I.+A.+Ruiz-Whiteauthor=H.+R.+Wolfeauthor=M.+P.+McLane&title=Inhibition+of+Ptp1b+by+Trodusquemine+%28Msi-1436%29+Causes+Fat-Specific+Weight+Loss+in+Diet-Induced+Obese+Mice&doi=10.1038%2Foby.2009.444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PTP1B by Trodusquemine (MSI-1436) Causes Fat-specific Weight Loss in Diet-induced Obese Mice</span></div><div class="casAuthors">Lantz, Kristen A.; Emeigh Hart, Susan G.; Planey, Sonia L.; Roitman, Mitchell F.; Ruiz-White, Inez A.; Wolfe, Henry R.; McLane, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1516-1523</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Trodusquemine (MSI-1436) causes rapid and reversible wt. loss in genetic models of obesity.  To better predict the potential effects of trodusquemine in the clinic, we investigated the effects of trodusquemine treatment in a murine model of diet-induced obesity (DIO).  Trodusquemine suppressed appetite, reduced body wt. (BW) in a fat-specific manner, and improved plasma insulin and leptin levels in mice.  Screening assays revealed that trodusquemine selectively inhibited protein-tyrosine phosphatase 1B (PTP1B), a key enzyme regulating insulin and leptin signaling.  Trodusquemine significantly enhanced insulin-stimulated tyrosine phosphorylation of insulin receptor (IR) β and STAT3, direct targets of PTP1B, in HepG2 cells in vitro and/or hypothalamic tissue in vivo.  These data establish trodusquemine as an effective central and peripheral PTP1B inhibitor with the potential to elicit noncachectic fat-sp. wt. loss and improve insulin and leptin levels.  Obesity (2010) 18 8, 1516-1523. doi:10.1038/oby.2009.444.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpztdwe-fhYL7Vg90H21EOLACvtfcHk0lhhuJ-jxAQ6qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlymsbY%253D&md5=9ead7eec1559f2b33631472b018d47fe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Foby.2009.444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foby.2009.444%26sid%3Dliteratum%253Aachs%26aulast%3DLantz%26aufirst%3DK.%2BA.%26aulast%3DHart%26aufirst%3DS.%2BG.%2BE.%26aulast%3DPlaney%26aufirst%3DS.%2BL.%26aulast%3DRoitman%26aufirst%3DM.%2BF.%26aulast%3DRuiz-White%26aufirst%3DI.%2BA.%26aulast%3DWolfe%26aufirst%3DH.%2BR.%26aulast%3DMcLane%26aufirst%3DM.%2BP.%26atitle%3DInhibition%2520of%2520Ptp1b%2520by%2520Trodusquemine%2520%2528Msi-1436%2529%2520Causes%2520Fat-Specific%2520Weight%2520Loss%2520in%2520Diet-Induced%2520Obese%2520Mice%26jtitle%3DObesity%26date%3D2010%26volume%3D18%26spage%3D1516%26epage%3D1523%26doi%3D10.1038%2Foby.2009.444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanford, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottini, N.</span></span> <span> </span><span class="NLM_article-title">Targeting Tyrosine Phosphatases: Time to End the Stigma</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2017.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.tips.2017.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28412041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFWrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=524-540&author=S.+M.+Stanfordauthor=N.+Bottini&title=Targeting+Tyrosine+Phosphatases%3A+Time+to+End+the+Stigma&doi=10.1016%2Fj.tips.2017.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Tyrosine Phosphatases: Time to End the Stigma</span></div><div class="casAuthors">Stanford, Stephanie M.; Bottini, Nunzio</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">524-540</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTPs) are a family of enzymes essential for numerous cellular processes, and several PTPs have been validated as therapeutic targets for human diseases.  Historically, the development of drugs targeting PTPs has been highly challenging, leading to stigmatization of these enzymes as undruggable targets.  Despite these difficulties, efforts to drug PTPs have persisted, and recent years have seen an influx of new probes providing opportunities for biol. examn. of old and new PTP targets.  Here we discuss progress towards drugging PTPs with special emphasis on the development of selective probes with biol. activity.  We describe the development of new small-mol. orthosteric, allosteric, and oligomerization-inhibiting PTP inhibitors and discuss new studies targeting the receptor PTP (RPTP) subfamily with biologics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodaLAks9bm7LVg90H21EOLACvtfcHk0lgdaI61DwFtRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFWrtbc%253D&md5=539153cbe8845849b542a6d92bf2e7ed</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2017.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2017.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DStanford%26aufirst%3DS.%2BM.%26aulast%3DBottini%26aufirst%3DN.%26atitle%3DTargeting%2520Tyrosine%2520Phosphatases%253A%2520Time%2520to%2520End%2520the%2520Stigma%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2017%26volume%3D38%26spage%3D524%26epage%3D540%26doi%3D10.1016%2Fj.tips.2017.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frankson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Targeting of Oncogenic Tyrosine Phosphatases</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">5701</span>– <span class="NLM_lpage">5705</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-17-1510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F0008-5472.CAN-17-1510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28855209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOlur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=5701-5705&author=R.+Franksonauthor=Z.+H.+Yuauthor=Y.+P.+Baiauthor=Q.+L.+Liauthor=R.+Y.+Zhangauthor=Z.+Y.+Zhang&title=Therapeutic+Targeting+of+Oncogenic+Tyrosine+Phosphatases&doi=10.1158%2F0008-5472.CAN-17-1510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Targeting of Oncogenic Tyrosine Phosphatases</span></div><div class="casAuthors">Frankson, Rochelle; Yu, Zhi-Hong; Bai, Yunpeng; Li, Qinglin; Zhang, Ruo-Yu; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5701-5705</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTP) are exciting and novel targets for cancer drug discovery that work in concert with protein tyrosine kinases (PTK) in controlling cellular homeostasis.  Given the activating role that some PTKs play in initiating growth factor-mediated cellular processes, PTPs are usually perceived as the neg. regulators of these events and therefore tumor suppressive in nature.  However, mounting evidence indicate that PTPs do not always antagonize the activity of PTKs in regulating tyrosine phosphorylation, but can also play dominant roles in the initiation and progression of signaling cascades that regulate cell functions.  It follows, therefore, that PTP malfunction can actively contribute to a host of human disorders, in particular, cancer, metabolic syndromes, and autoimmune diseases.  The Src homol. domain contg. phosphatase 2 (SHP2) and the three-membered family of phosphatases of regenerating liver (PRL) are infamously oncogenic members of the PTP superfamily.  Both are established regulators of major cancer pathways such as Ras/ERK1/2, Src, JAK/STAT, JNK, NF-κB, and PTEN/PI3K/AKT.  Furthermore, upregulation, mutation, or other dysregulation of these PTPs has been pos. correlated with cancer initiation and progression.  This review will provide topical coverage of target validation and drug discovery efforts made in targeting these oncogenic PTPs as compelling candidates for cancer therapy.  Cancer Res; 77(21); 5701-5. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrASNrPP4qCHbVg90H21EOLACvtfcHk0lgdaI61DwFtRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOlur%252FI&md5=93f036dce3366a7f109d7ee0fc3fed9e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-17-1510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-17-1510%26sid%3Dliteratum%253Aachs%26aulast%3DFrankson%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DZ.%2BH.%26aulast%3DBai%26aufirst%3DY.%2BP.%26aulast%3DLi%26aufirst%3DQ.%2BL.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DTherapeutic%2520Targeting%2520of%2520Oncogenic%2520Tyrosine%2520Phosphatases%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D5701%26epage%3D5705%26doi%3D10.1158%2F0008-5472.CAN-17-1510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span> <span> </span><span class="NLM_article-title">Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">1069</span>– <span class="NLM_lpage">1091</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00105</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00105" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlyku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2018&pages=1069-1091&author=Z.+H.+Yuauthor=Z.+Y.+Zhang&title=Regulatory+Mechanisms+and+Novel+Therapeutic+Targeting+Strategies+for+Protein+Tyrosine+Phosphatases&doi=10.1021%2Facs.chemrev.7b00105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases</span></div><div class="casAuthors">Yu, Zhi-Hong; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1069-1091</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An appropriate level of protein phosphorylation on tyrosine is essential for cells to react to extracellular stimuli and maintain cellular homeostasis.  Faulty operation of signal pathways mediated by protein tyrosine phosphorylation causes numerous human diseases, which presents enormous opportunities for therapeutic intervention.  While the importance of protein tyrosine kinases in orchestrating the tyrosine phosphorylation networks and in target-based drug discovery has long been recognized, the significance of protein tyrosine phosphatases (PTPs) in cellular signaling and disease biol. has historically been underappreciated, due to a large extent to an erroneous assumption that they are largely constitutive and housekeeping enzymes.  Here, we provide a comprehensive examn. of a no. of regulatory mechanisms, including redox modulation, allosteric regulation, and protein oligomerization, that control PTP activity.  These regulatory mechanisms are integral to the myriad PTP-mediated biochem. events and reinforce the concept that PTPs are indispensable and specific modulators of cellular signaling.  We also discuss how disruption of these PTP regulatory mechanisms can cause human diseases and how these diverse regulatory mechanisms can be exploited for novel therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_-ydQ7-hJcbVg90H21EOLACvtfcHk0lgdaI61DwFtRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlyku7k%253D&md5=7f3dd74cb0572214e98554613297863b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00105%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.%2BH.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DRegulatory%2520Mechanisms%2520and%2520Novel%2520Therapeutic%2520Targeting%2520Strategies%2520for%2520Protein%2520Tyrosine%2520Phosphatases%26jtitle%3DChem.%2520Rev.%26date%3D2018%26volume%3D118%26spage%3D1069%26epage%3D1091%26doi%3D10.1021%2Facs.chemrev.7b00105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bialy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Protein Tyrosine Phosphatases: Next-Generation Drugs?</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3814</span>– <span class="NLM_lpage">3839</span>, <span class="refDoi"> DOI: 10.1002/anie.200461517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fanie.200461517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFGisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=3814-3839&author=L.+Bialyauthor=H.+Waldmann&title=Inhibitors+of+Protein+Tyrosine+Phosphatases%3A+Next-Generation+Drugs%3F&doi=10.1002%2Fanie.200461517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of protein tyrosine phosphatases: Next-generation drugs?</span></div><div class="casAuthors">Bialy, Laurent; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3814-3839</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatases (PTPs) constitute a family of closely related key regulatory enzymes that dephosphorylate phosphotyrosine residues in their protein substrates.  Malfunctions in PTP activity are linked to various diseases, ranging from cancer to neurol. disorders and diabetes.  Consequently, PTPs have emerged as promising targets for therapeutic intervention in recent years.  In this review, general aspects of PTPs and the development of small-mol. inhibitors of PTPs by both academic research groups and pharmaceutical companies are discussed.  Different strategies have been successfully applied to identify potent and selective inhibitors.  These studies constitute the basis for the future development of PTP inhibitors as drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9K3DIu_xX_LVg90H21EOLACvtfcHk0lj5ncGQR4EinQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFGisr8%253D&md5=a8bcd03851b638cc6d3e6ab2466eb97b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fanie.200461517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200461517%26sid%3Dliteratum%253Aachs%26aulast%3DBialy%26aufirst%3DL.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DInhibitors%2520of%2520Protein%2520Tyrosine%2520Phosphatases%253A%2520Next-Generation%2520Drugs%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D3814%26epage%3D3839%26doi%3D10.1002%2Fanie.200461517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoeger, B.</span>; <span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Strategies for Designing Specific Protein Tyrosine Phosphatase Inhibitors and Their Intracellular Activation</span>. In  <i>Concepts and Case Studies in Chemical Biology</i><span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2F9783527687503.ch3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+Hoeger&author=M.+K%C3%B6hn&title=Concepts+and+Case+Studies+in+Chemical+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2F9783527687503.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527687503.ch3%26sid%3Dliteratum%253Aachs%26aulast%3DHoeger%26aufirst%3DB.%26atitle%3DStrategies%2520for%2520Designing%2520Specific%2520Protein%2520Tyrosine%2520Phosphatase%2520Inhibitors%2520and%2520Their%2520Intracellular%2520Activation%26btitle%3DConcepts%2520and%2520Case%2520Studies%2520in%2520Chemical%2520Biology%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontanillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Phosphatases: Their Roles in Cancer and Their Chemical Modulators</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>917</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-32805-8_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2F978-3-319-32805-8_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=27236558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVehs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=917&publication_year=2016&pages=209-240&author=M.+Fontanilloauthor=M.+K%C3%B6hn&title=Phosphatases%3A+Their+Roles+in+Cancer+and+Their+Chemical+Modulators&doi=10.1007%2F978-3-319-32805-8_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatases: Their Roles in Cancer and Their Chemical Modulators</span></div><div class="casAuthors">Fontanillo, Miriam; Koehn, Maja</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">917</span>
        (<span class="NLM_cas:issue">Protein Targeting Compounds</span>),
    <span class="NLM_cas:pages">209-240</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Phosphatases are involved in basically all cellular processes by dephosphorylating cellular components such as proteins, phospholipids and second messengers.  They counteract kinases of which many are established oncogenes, and therefore kinases are one of the most important drug targets for targeted cancer therapy.  Due to this relationship between kinases and phosphatases, phosphatases are traditionally assumed to be tumor suppressors.  However, research findings over the last years prove that this simplification is incorrect, as bona-fide and putative phosphatase oncogenes have been identified.  We describe here the role of phosphatases in cancer, tumor suppressors and oncogenes, and their chem. modulators, and discuss new approaches and opportunities for phosphatases as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq07q6dxJ1XmrVg90H21EOLACvtfcHk0lj5ncGQR4EinQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVehs78%253D&md5=221f76689dc44b9341947ab518b7ddee</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-32805-8_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-32805-8_10%26sid%3Dliteratum%253Aachs%26aulast%3DFontanillo%26aufirst%3DM.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DPhosphatases%253A%2520Their%2520Roles%2520in%2520Cancer%2520and%2520Their%2520Chemical%2520Modulators%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2016%26volume%3D917%26spage%3D209%26epage%3D240%26doi%3D10.1007%2F978-3-319-32805-8_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2634</span>– <span class="NLM_lpage">2660</span>, <span class="refDoi"> DOI: 10.2174/0929867325666180508095242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F0929867325666180508095242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29737249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFCitbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=2634-2660&author=M.+R.+Swingleauthor=R.+E.+Honkanen&title=Inhibitors+of+Serine%2FThreonine+Protein+Phosphatases%3A+Biochemical+and+Structural+Studies+Provide+Insight+for+Further+Development&doi=10.2174%2F0929867325666180508095242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development</span></div><div class="casAuthors">Swingle, Mark R.; Honkanen, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2634-2660</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: The reversible phosphorylation of proteins regulates many key functions in eukaryotic cells.  Phosphorylation is catalyzed by protein kinases, with the majority of phosphorylation occurring on side chains of serine and threonine residues.  The phosphomonoesters generated by protein kinases are hydrolyzed by protein phosphatases.  In the absence of a phosphatase, the half-time for the hydrolysis of alkyl phosphate dianions at 25° C is over 1 trillion years; knon ∼2 x 10-20 sec-1.  Therefore, ser/thr phosphatases are crit. for processes controlled by reversible phosphorylation.  Methods: This review is based on the literature searched in available databases.  We compare the catalytic mechanism of PPP-family phosphatases (PPPases) and the interactions of inhibitors that target these enzymes.  Results: PPPases are metal-dependent hydrolases that enhance the rate of hydrolysis ([kcat/kM]/knon ) by a factor of ∼1021, placing them among the most powerful known catalysts on earth.  Biochem. and structural studies indicate that the remarkable catalytic proficiencies of PPPases are achieved by 10 conserved amino acids, DXH(X)∼26DXXDR(X)∼20- 26NH(X)∼50H(X)∼25-45R(X)∼30-40H.  Six act as metal-coordinating residues.  Four position and orient the substrate phosphate.  Together, two metal ions and the 10 catalytic residues position the phosphoryl group and an activated bridging water/hydroxide nucleophile for an inline attack upon the substrate phosphorous atom.  The PPPases are conserved among species, and many structurally diverse natural toxins co-evolved to target these enzymes.  Conclusion: Although the catalytic site is conserved, opportunities for the development of selective inhibitors of this important group of metalloenzymes exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG3RBU0ksB2bVg90H21EOLACvtfcHk0lj5ncGQR4EinQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFCitbnK&md5=23dadab0a8d685bf506c09c14be8d64b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F0929867325666180508095242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867325666180508095242%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DInhibitors%2520of%2520Serine%252FThreonine%2520Protein%2520Phosphatases%253A%2520Biochemical%2520and%2520Structural%2520Studies%2520Provide%2520Insight%2520for%2520Further%2520Development%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2019%26volume%3D26%26spage%3D2634%26epage%3D2660%26doi%3D10.2174%2F0929867325666180508095242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heroes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesage, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Görnemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beullens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Meervelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">The Pp1 Binding Code: A Molecular-Lego Strategy That Governs Specificity</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2012.08547.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1111%2Fj.1742-4658.2012.08547.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22360570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFClsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=584-595&author=E.+Heroesauthor=B.+Lesageauthor=J.+G%C3%B6rnemannauthor=M.+Beullensauthor=L.+Van+Meerveltauthor=M.+Bollen&title=The+Pp1+Binding+Code%3A+A+Molecular-Lego+Strategy+That+Governs+Specificity&doi=10.1111%2Fj.1742-4658.2012.08547.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The PP1 binding code: a molecular-lego strategy that governs specificity</span></div><div class="casAuthors">Heroes, Ewald; Lesage, Bart; Goernemann, Janina; Beullens, Monique; Van Meervelt, Luc; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">584-595</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Ser/Thr protein phosphatase 1 (PP1) is a single-domain hub protein with nearly 200 validated interactors in vertebrates.  PP1-interacting proteins (PIPs) are ubiquitously expressed but show an exceptional diversity in brain, testis, and white blood cells.  The binding of PIPs is mainly mediated by short motifs that dock to surface grooves of PP1.  Although PIPs often contain variants of the same PP1 binding motifs, they differ in the no. and combination of docking sites.  This mol.-lego strategy for binding to PP1 creates holoenzymes with unique properties.  The PP1 binding code can be described as specific, universal, degenerate, nonexclusive, and dynamic.  PIPs control assocd. PP1 by interference with substrate recruitment or access to the active site.  In addn., some PIPs have a subcellular targeting domain that promotes dephosphorylation by increasing the local concn. of PP1.  The diversity of the PP1 interactome and the properties of the PP1 binding code account for the exquisite specificity of PP1 in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONNHLs4pYSLVg90H21EOLACvtfcHk0lj5ncGQR4EinQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFClsbY%253D&md5=775a3fd2534221da3bb84fbd0ae044ad</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2012.08547.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2012.08547.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeroes%26aufirst%3DE.%26aulast%3DLesage%26aufirst%3DB.%26aulast%3DG%25C3%25B6rnemann%26aufirst%3DJ.%26aulast%3DBeullens%26aufirst%3DM.%26aulast%3DVan%2BMeervelt%26aufirst%3DL.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DThe%2520Pp1%2520Binding%2520Code%253A%2520A%2520Molecular-Lego%2520Strategy%2520That%2520Governs%2520Specificity%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D584%26epage%3D595%26doi%3D10.1111%2Fj.1742-4658.2012.08547.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, G. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejiri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mushlin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonser, R. R.</span></span> <span> </span><span class="NLM_article-title">The Effect of a Pp2a Inhibitor on the Nuclear Receptor Corepressor Pathway in Glioma</span>. <i>J. Neurosurg.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.3171/2009.11.JNS091272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3171%2F2009.11.JNS091272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20001590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2010&pages=225-233&author=J.+Luauthor=Z.+Zhuangauthor=D.+K.+Songauthor=G.+U.+Mehtaauthor=B.+Ikejiriauthor=H.+Mushlinauthor=D.+M.+Parkauthor=R.+R.+Lonser&title=The+Effect+of+a+Pp2a+Inhibitor+on+the+Nuclear+Receptor+Corepressor+Pathway+in+Glioma&doi=10.3171%2F2009.11.JNS091272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma</span></div><div class="casAuthors">Lu, Jie; Zhuang, Zhengping; Song, Debbie K.; Mehta, Gautam U.; Ikejiri, Barbara; Mushlin, Harry; Park, Deric M.; Lonser, Russell R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurosurgery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-233</span>CODEN:
                <span class="NLM_cas:coden">JONSAC</span>;
        ISSN:<span class="NLM_cas:issn">0022-3085</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neurosurgeons</span>)
        </div><div class="casAbstract">Objective: Nuclear receptor corepressor (N-CoR) forms a complex that maintains neural stem cells in an undifferentiated state through transcriptional repression.  Recently, it has been shown that N-CoR is overexpressed in glioblastoma multiforme (GBM) tumor stem cells and has a putative role in maintaining these cells in an undifferentiated immortal state.  To det. the effects of disruption of N-CoR complex function by serine/threonine protein phosphatase 2A (PP2A) inhibition on GBM tumor cell differentiation and proliferation, the authors developed and investigated a competitive small mol. inhibitor (LB1) or PP2A in GBM.  Methods: The authors investigated the effects of LB1 on GBM proliferation and mol. differentiation pathways using in vitro and in vivo studies.  Results: The LB1 inhibited PP2A, leading to increased levels of phosphorylated Akt kinase and decreased N-CoR expression, as well as dose-dependent antiproliferative activity in cultured U87 and U251 malignant glioma cells (dose range 1-10 μM).  Systemic LB1 treatment (1.5 mg/kg/day for 21 days) had significant tumor antiproliferative effects in mice harboring U87 glioma xenografts (73% mean redn. in tumor vol. compared with controls; p < 0.001).  Moreover, a redn. in PP2A expression and activity after LB1 treatment in vivo correlated with increased Akt phosphorylation, reduced nuclear N-CoR expression and N-CoR cytoplasmic translocation, and increased accumulation of acetylated core histones, which coincided with the appearance of glial fibrillary acidic protein-expressing tumor cells.  Conclusions: These findings indicate that PP2A inhibition effectively disrupts N-CoR complex function/expression and leads to cytoplasmic translocation of N-CoR with subsequent tumor cell differentiation and/or death.  Therapeutic paradigms that target N-CoR function in the cancer stem cell component of malignant gliomas may have treatment utility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqh6O7KGnUVLVg90H21EOLACvtfcHk0liXdeAzCOQ8oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbvI&md5=f728c00797d35473e32d8475db7f3776</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3171%2F2009.11.JNS091272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3171%252F2009.11.JNS091272%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DD.%2BK.%26aulast%3DMehta%26aufirst%3DG.%2BU.%26aulast%3DIkejiri%26aufirst%3DB.%26aulast%3DMushlin%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DD.%2BM.%26aulast%3DLonser%26aufirst%3DR.%2BR.%26atitle%3DThe%2520Effect%2520of%2520a%2520Pp2a%2520Inhibitor%2520on%2520the%2520Nuclear%2520Receptor%2520Corepressor%2520Pathway%2520in%2520Glioma%26jtitle%3DJ.%2520Neurosurg.%26date%3D2010%26volume%3D113%26spage%3D225%26epage%3D233%26doi%3D10.3171%2F2009.11.JNS091272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovach, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Serine/Threonine Phosphatase Pp2a Enhances Cancer Chemotherapy by Blocking DNA Damage Induced Defense Mechanisms</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">11697</span>– <span class="NLM_lpage">11702</span>, <span class="refDoi"> DOI: 10.1073/pnas.0905930106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.0905930106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19564615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVWitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=11697-11702&author=J.+Luauthor=J.+S.+Kovachauthor=F.+Johnsonauthor=J.+Chiangauthor=R.+Hodesauthor=R.+Lonserauthor=Z.+Zhuang&title=Inhibition+of+Serine%2FThreonine+Phosphatase+Pp2a+Enhances+Cancer+Chemotherapy+by+Blocking+DNA+Damage+Induced+Defense+Mechanisms&doi=10.1073%2Fpnas.0905930106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms</span></div><div class="casAuthors">Lu, Jie; Kovach, John S.; Johnson, Francis; Chiang, Jeffrey; Hodes, Richard; Lonser, Russell; Zhuang, Zhengping</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">11697-11702</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A variety of mechanisms maintain the integrity of the genome in the face of cell stress.  Cancer cell response to chemotherapeutic and radiation-induced DNA damage is mediated by multiple defense mechanisms including polo-like kinase 1 (Plk-1), protein kinase B (Akt-1), and/or p53 pathways leading to either apoptosis or cell cycle arrest.  Subsequently, a subpopulation of arrested viable cancer cells may remain and recur despite aggressive and repetitive therapy.  Here, we show that modulation (activation of Akt-1 and Plk-1 and repression of p53) of these pathways simultaneously results in paradoxical enhancement of the effectiveness of cytotoxic chemotherapy.  We demonstrate that a small mol. inhibitor, LB-1.2, of protein phosphatase 2A (PP2A) activates Plk-1 and Akt-1 and decreases p53 abundance in tumor cells.  Combined with temozolomide (TMZ; a DNA-methylating chemotherapeutic drug), LB-1.2 causes complete regression of glioblastoma multiforme (GBM) xenografts without recurrence in 50% of animals (up to 28 wk) and complete inhibition of growth of neuroblastoma (NB) xenografts.  Treatment with either drug alone results in only short-term inhibition/regression with all xenografts resuming rapid growth.  Combined with another widely used anticancer drug, Doxorubicin (DOX, a DNA intercalating agent), LB-1.2 also causes marked GBM xenograft regression, whereas DOX alone only slows growth.  Inhibition of PP2A by LB-1.2 blocks cell-cycle arrest and increases progression of cell cycle in the presence of TMZ or DOX.  Pharmacol. inhibition of PP2A may be a general method for enhancing the effectiveness of cancer treatments that damage DNA or disrupt components of cell replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3B6AfwowkHrVg90H21EOLACvtfcHk0liXdeAzCOQ8oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVWitr0%253D&md5=890dab814ffd430da246034c3d4beb53</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0905930106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0905930106%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DKovach%26aufirst%3DJ.%2BS.%26aulast%3DJohnson%26aufirst%3DF.%26aulast%3DChiang%26aufirst%3DJ.%26aulast%3DHodes%26aufirst%3DR.%26aulast%3DLonser%26aufirst%3DR.%26aulast%3DZhuang%26aufirst%3DZ.%26atitle%3DInhibition%2520of%2520Serine%252FThreonine%2520Phosphatase%2520Pp2a%2520Enhances%2520Cancer%2520Chemotherapy%2520by%2520Blocking%2520DNA%2520Damage%2520Induced%2520Defense%2520Mechanisms%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D11697%26epage%3D11702%26doi%3D10.1073%2Fpnas.0905930106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, B.</span></span> <span> </span><span class="NLM_article-title">New Medical Treatment Options and Strategies to Assess Clinical Outcome in Soft-Tissue Sarcoma</span>. <i>Expert Rev. Anticancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.1586/era.09.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1586%2Fera.09.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19671035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvF2qu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1159-1167&author=T.+Schmittauthor=B.+Kasper&title=New+Medical+Treatment+Options+and+Strategies+to+Assess+Clinical+Outcome+in+Soft-Tissue+Sarcoma&doi=10.1586%2Fera.09.64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma</span></div><div class="casAuthors">Schmitt, Thomas; Kasper, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1159-1167</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Soft-tissue sarcomas (STSs) are a heterogeneous group of rare malignant tumors predominantly arising from the embryonic mesoderm.  The mainstay of curative therapy is the complete surgical resection of all tumor manifestations with neg. histol. margins.  However, up to 50% of patients will develop distant metastases during the course of their disease.  The prognosis for those patients is grim with a 5-yr overall survival of less than 10%.  First-line systemic therapy with ifosfamide and doxorubicin results in overall response rates of only 20% by conventional response evaluation criteria in solid tumors (RECIST).  However, stabilization of disease can be seen in a greater proportion.  Therefore, the role of the RECIST criteria has been questioned and the implementation of new imaging studies (e.g., FDG-PET) has shown promising results in assessing early tumor response to therapy.  Furthermore, a broader insight into the mol. pathways of sarcomagenesis has been gained in recent years, revealing intriguing targets for new therapeutic approaches (e.g., VEGF, VEGF receptor, IGF receptor, EGF receptor, mTOR and cyclin-dependent kinases).  In addn., a growing body of evidence is linking specific genetic aberrations with clin. outcome (e.g., SYT-SXX translocation in synovial sarcoma).  With further insight into the biol. of STS and the combination of new treatment options with modern imaging techniques, we will most certainly be able to improve clin. outcome in patients with STS in the upcoming years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofmSAbovIz7bVg90H21EOLACvtfcHk0liXdeAzCOQ8oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvF2qu7g%253D&md5=0c5aac3d30ce1f38d633e4bf32de1860</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1586%2Fera.09.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.09.64%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DT.%26aulast%3DKasper%26aufirst%3DB.%26atitle%3DNew%2520Medical%2520Treatment%2520Options%2520and%2520Strategies%2520to%2520Assess%2520Clinical%2520Outcome%2520in%2520Soft-Tissue%2520Sarcoma%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2009%26volume%3D9%26spage%3D1159%26epage%3D1167%26doi%3D10.1586%2Fera.09.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holcomb, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neblett, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oates, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abumrad, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, H. W.</span></span> <span> </span><span class="NLM_article-title">Clinical Experience over 48 Years with Pheochromocytoma</span>. <i>Ann. Surg.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>229</i></span>,  <span class="NLM_fpage">755</span>, <span class="refDoi"> DOI: 10.1097/00000658-199906000-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1097%2F00000658-199906000-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10363888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADyaK1M3ptVGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1999&pages=755&author=R.+E.+Goldsteinauthor=J.+A.+O%E2%80%99Neillauthor=G.+W.+Holcombauthor=W.+M.+Morganauthor=W.+W.+Neblettauthor=J.+A.+Oatesauthor=N.+Brownauthor=J.+Nadeauauthor=B.+Smithauthor=D.+L.+Pageauthor=N.+N.+Abumradauthor=H.+W.+Scott&title=Clinical+Experience+over+48+Years+with+Pheochromocytoma&doi=10.1097%2F00000658-199906000-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical experience over 48 years with pheochromocytoma</span></div><div class="casAuthors">Goldstein R E; O'Neill J A Jr; Holcomb G W 3rd; Morgan W M 3rd; Neblett W W 3rd; Oates J A; Brown N; Nadeau J; Smith B; Page D L; Abumrad N N; Scott H W Jr</div><div class="citationInfo"><span class="NLM_cas:title">Annals of surgery</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-64; discussion 764-6</span>
        ISSN:<span class="NLM_cas:issn">0003-4932</span>.
    </div><div class="casAbstract">OBJECTIVE:  To analyze the presentation, localization, surgical management, pathology, and long-term outcome of a large series of patients with pheochromocytomas.  SUMMARY BACKGROUND DATA:  There are several areas of controversy pertaining to pheochromocytomas.  Although many studies report a higher rate of malignancy for extraadrenal pheochromocytomas than for adrenal pheochromocytomas, the number of patients with the former tumor are small and statistical analysis is lacking.  There has also been recent debate as to whether microscopic features of the tumor may be predictive of future behavior.  METHODS:  From 1950 to 1998, the authors observed 108 pheochromocytomas in 104 patients.  The outcome of these patients has been followed prospectively.  The medical records of these patients were reviewed for data on the presentation, localization, surgical management, pathology, and outcome.  Patient survival was analyzed using Kaplan-Meier survival distributions.  RESULTS:  This study included 66 female patients and 38 male patients.  The average age at surgery was 42.3 years.  Sporadic cases accounted for 84% of the patients; the other 16% had multiple endocrine neoplasia type 2, von Recklinghausen's disease, von Hippel-Lindau disease, or Carney's syndrome.  Of 64 adrenal tumors, 55 were initially considered benign, 6 had microscopic malignant features, and 3 had malignant disease.  Mean patient follow-up was 12.6 years.  To date, in five additional patients (none with microscopic disease) malignant disease developed (13% overall rate of malignancy).  Recurrence occurred as late as 15 years after resection.  Of 26 extraadrenal pheochromocytomas, 14 were initially considered benign, 8 had microscopic malignant features, and 4 had malignant disease.  Thus, 46% of patients had either malignant disease or tumors with malignant features.  Mean patient follow-up was 11.5 years.  In one patient with benign disease and in one patient with malignant features, malignant disease developed (23% overall rate of malignancy).  The difference in the rate of malignancy was not statistically significant between adrenal and extraadrenal pheochromocytomas.  Patients with adrenal and extraadrenal pheochromocytomas also had similar rates of survival (p = NS).  CONCLUSIONS:  The data suggest that patients with extraadrenal pheochromocytomas have the same risk of malignancy and the same overall survival as patients with adrenal pheochromocytomas.  Lifelong follow-up of these patients is mandatory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQKfpWMElvIZrBItaL1WaVAfW6udTcc2eZTmrvn2ieP2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3ptVGmtA%253D%253D&md5=8f9525f3adda7b1865c7c4d45cabed40</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1097%2F00000658-199906000-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000658-199906000-00001%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DR.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BA.%26aulast%3DHolcomb%26aufirst%3DG.%2BW.%26aulast%3DMorgan%26aufirst%3DW.%2BM.%26aulast%3DNeblett%26aufirst%3DW.%2BW.%26aulast%3DOates%26aufirst%3DJ.%2BA.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DNadeau%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DPage%26aufirst%3DD.%2BL.%26aulast%3DAbumrad%26aufirst%3DN.%2BN.%26aulast%3DScott%26aufirst%3DH.%2BW.%26atitle%3DClinical%2520Experience%2520over%252048%2520Years%2520with%2520Pheochromocytoma%26jtitle%3DAnn.%2520Surg.%26date%3D1999%26volume%3D229%26spage%3D755%26doi%3D10.1097%2F00000658-199906000-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eichhorn, P. J. A</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creyghton, M. P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelmsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernards, R.</span></span> <span> </span><span class="NLM_article-title">A Rna Interference Screen Identifies the Protein Phosphatase 2a Subunit Pr55γ as a Stress-Sensitive Inhibitor of C-Src</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e218</span>, <span class="refDoi"> DOI: 10.1371/journal.pgen.0030218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1371%2Fjournal.pgen.0030218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=18069897" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=e218&author=P.+J.+A+Eichhornauthor=M.+P+Creyghtonauthor=K.+Wilhelmsenauthor=H.+van+Damauthor=R.+Bernards&title=A+Rna+Interference+Screen+Identifies+the+Protein+Phosphatase+2a+Subunit+Pr55%CE%B3+as+a+Stress-Sensitive+Inhibitor+of+C-Src&doi=10.1371%2Fjournal.pgen.0030218"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.0030218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.0030218%26sid%3Dliteratum%253Aachs%26aulast%3DEichhorn%26aufirst%3DP.%2BJ.%2BA%26aulast%3DCreyghton%26aufirst%3DM.%2BP%26aulast%3DWilhelmsen%26aufirst%3DK.%26aulast%3Dvan%2BDam%26aufirst%3DH.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DA%2520Rna%2520Interference%2520Screen%2520Identifies%2520the%2520Protein%2520Phosphatase%25202a%2520Subunit%2520Pr55%25CE%25B3%2520as%2520a%2520Stress-Sensitive%2520Inhibitor%2520of%2520C-Src%26jtitle%3DPLoS%2520Genet.%26date%3D2007%26volume%3D3%26spage%3De218%26doi%3D10.1371%2Fjournal.pgen.0030218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.-m.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.-l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.-r.</span></span> <span> </span><span class="NLM_article-title">Effectiveness and Toxicities of Intensity-Modulated Radiotherapy for Patients with Locally Recurrent Nasopharyngeal Carcinoma</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e73918</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0073918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1371%2Fjournal.pone.0073918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24040115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyrsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e73918&author=H.-y.+Chenauthor=X.-m.+Maauthor=M.+Yeauthor=Y.-l.+Houauthor=H.-Y.+Xieauthor=Y.-r.+Bai&title=Effectiveness+and+Toxicities+of+Intensity-Modulated+Radiotherapy+for+Patients+with+Locally+Recurrent+Nasopharyngeal+Carcinoma&doi=10.1371%2Fjournal.pone.0073918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma</span></div><div class="casAuthors">Chen, Hai-Yan; Ma, Xiu-Mei; Ye, Ming; Hou, Yan-Li; Xie, Hua-Ying; Bai, Yong-Rui</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e73918</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Purpose: To analyze the effectiveness and toxicities in the re-irradn. of locally recurrent nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT).  Methods: This is a retrospective anal. of 54 NPC patients with local recurrence re-irradiated with IMRT.  The re-staging for rT1, rT2, rT3, rT4 were 3 (5.6%), 8 (14.8%), 9 (16.7%), 34 (63%) resp.  The av. dose to GTV was 69.95 Gy (49.8-76.58 Gy), the av. BED3Gy was 116.8 Gy (83.5-127.9 Gy).  V95 was 96%, and D95 was 65.75Gy.  33.3% of them received concurrent chemoradiotherapy.  Results: Median overall survival (OS) was 21 mo (1-93 mon).  The 1-,2-yr local progression free survival (LPFS) rate was 84.5%, 64% and OS rate was 71.7%, 44.3%.  Severe late adverse events (SLAE) occurred in 48.1% of patients, including 31.5% with ulcer or necrosis of the nasopharyngeal mucosa, 20.4% with difficulty in feeding, 18.5% with temporal lobe necrosis, 11.1% with massive hemorrhage.  15.4% died of local regional progression, 5.8% died of distant metastasis, 25% died of SLAE, 9.6% died of both local regional progression and SLAE that could not be differentiated, 5.8% died of other medical complications.  Concurrent chemoradiotherapy was the independent neg. prognostic factors for LPFS; PTV>100 mL was a predictive factor of poor OS; patients with invasion of post-styloid space were at higher risk of SLAE.  Conclusions: The present study demonstrated that IMRT with 70Gy was efficient for local tumor control.  However, we obsd. a high frequency of serious late complications.  More optimized combination treatment and patient selection are required to achieve excellent local control without significant late morbidities in locally recurrent NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu-N4tCebGxbVg90H21EOLACvtfcHk0lii4ID7VftdMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyrsLjP&md5=474c37fb444106846eb0d8a0528c006a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073918%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.-y.%26aulast%3DMa%26aufirst%3DX.-m.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DHou%26aufirst%3DY.-l.%26aulast%3DXie%26aufirst%3DH.-Y.%26aulast%3DBai%26aufirst%3DY.-r.%26atitle%3DEffectiveness%2520and%2520Toxicities%2520of%2520Intensity-Modulated%2520Radiotherapy%2520for%2520Patients%2520with%2520Locally%2520Recurrent%2520Nasopharyngeal%2520Carcinoma%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De73918%26doi%3D10.1371%2Fjournal.pone.0073918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. L.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic Effects of Cantharidin on the Growth of Normal and Carcinoma Cells</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/S0300-483X(00)00185-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0300-483X%2800%2900185-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10874155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlKmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2000&pages=77-87&author=C.+C.+Wangauthor=C.+H.+Wuauthor=K.+J.+Hsiehauthor=K.+Y.+Yenauthor=L.+L.+Yang&title=Cytotoxic+Effects+of+Cantharidin+on+the+Growth+of+Normal+and+Carcinoma+Cells&doi=10.1016%2FS0300-483X%2800%2900185-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells</span></div><div class="casAuthors">Wang, C.-C.; Wu, C.-H.; Hsieh, K.-J.; Yen, K.-Y.; Yang, L.-L.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-87</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Cantharidin is isolated from Mylabris phalerata Pallas and is a potent inhibitor of hepatocellular carcinoma cells (Hep 3B cells).  In the present study, the IC50 values of cantharidin on Hep 3B cells and normal Chang liver cells were 2.2 and 30.2 μM for 36 h, resp.  Furthermore, cantharidin-treated Hep 3B cells induced cell death within 1 h (IC50=52.8 μM), suggesting that cantharidin is an acute cytotoxic agent.  We found that although cantharidin could induce cell death, it could not directly inhibit the activity of nucleic acid biosynthesis by the cellular incorporation of 3H-thymidine, 3H-uridine or 3H-leucine.  Cantharidin-treated Hep 3B cells showed no evidence of major alterations in the cell cycle distribution within 1 h.  However, examn. of cells after treatment for 36 h showed that cantharidin regulated the cell cycle at the G2/M phase.  Moreover, the treated Hep 3B cells had a rounded and shrunken appearance.  The microvilli of treated Hep 3B cells were reduced in no. and replaced by numerous blebs.  Other ultrastructural changes following cantharidin treatment included the presence of lipid droplets, swelling of the mitochondria and accumulation of glycogen particles.  The findings of damaged mitochondria in the cantharidin treated Hep 3B cells in this study suggest that cantharidin can induce acute and lethal toxic effects on Hep 3B cells by inhibiting the mitochondria energy system.  In conclusion, this study had demonstrated that cantharidin could inhibit progression of all phases of the Hep 3B cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Nb5pDQWAbbVg90H21EOLACvtfcHk0lii4ID7VftdMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlKmtbo%253D&md5=dc1524496cef501de343e88138c173d3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0300-483X%2800%2900185-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0300-483X%252800%252900185-2%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DHsieh%26aufirst%3DK.%2BJ.%26aulast%3DYen%26aufirst%3DK.%2BY.%26aulast%3DYang%26aufirst%3DL.%2BL.%26atitle%3DCytotoxic%2520Effects%2520of%2520Cantharidin%2520on%2520the%2520Growth%2520of%2520Normal%2520and%2520Carcinoma%2520Cells%26jtitle%3DToxicology%26date%3D2000%26volume%3D147%26spage%3D77%26epage%3D87%26doi%3D10.1016%2FS0300-483X%2800%2900185-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z. K.</span></span> <span> </span><span class="NLM_article-title">Growth of the Pancreatic Cancer Cell Line Panc-1 Is Inhibited by Protein Phosphatase 2a Inhibitors through Overactivation of the C-Jun N-Terminal Kinase Pathway</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2654</span>– <span class="NLM_lpage">2664</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2011.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.ejca.2011.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=21958460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOjsb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=2654-2664&author=W.+Liauthor=Z.+Chenauthor=F.+R.+Gongauthor=Y.+Zongauthor=K.+Chenauthor=D.+M.+Liauthor=H.+Yinauthor=W.+M.+Duanauthor=Y.+Miaoauthor=M.+Taoauthor=X.+Hanauthor=Z.+K.+Xu&title=Growth+of+the+Pancreatic+Cancer+Cell+Line+Panc-1+Is+Inhibited+by+Protein+Phosphatase+2a+Inhibitors+through+Overactivation+of+the+C-Jun+N-Terminal+Kinase+Pathway&doi=10.1016%2Fj.ejca.2011.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway</span></div><div class="casAuthors">Li, Wei; Chen, Zheng; Gong, Fei-Ran; Zong, Yang; Chen, Kai; Li, Dao-Ming; Yin, Hong; Duan, Wei-Ming; Miao, Yi; Tao, Min; Han, Xiao; Xu, Ze-Kuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2654-2664</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Protein phosphatase 2A (PP2A) is a multimeric serine/threonine phosphatase that can dephosphorylate multiple kinases.  It is generally considered to be a cancer suppressor as its inhibition can induce phosphorylation and activation of substrate kinases that mainly accelerate growth.  We previously reported that cantharidin, an active constituent of a traditional Chinese medicine, potently and selectively inhibited PP2A, yet efficiently repressed the growth of pancreatic cancer cells through activation of the c-Jun N-terminal kinase (JNK) pathway.  This suggested that activation of kinase pathways might also be a potential strategy for cancer therapy.  In this study, we have confirmed that the basal activity of the phospatidylinositol 3-kinase (PI3K)/JNK/activator protein 1 (AP-1) pathway promoted pancreatic cancer cell growth when stimulated by growth factors.  Interestingly, although treatment with the PP2A inhibitors, cantharidin or okadaic acid (OA), amplified the PI3K-dependent activation of JNK, cell growth was repressed.  We therefore hypothesised that a specific level of activity of the JNK pathway might be required to maintain the promitogenic function, as both repression and overactivation of JNK could inhibit cell proliferation.  It was found that the JNK-dependent growth inhibition was independent of the activation of AP-1, but dependent on the repression of Akt.  Although the PP2A inhibitors triggered overactivation of JNK and inhibited cell growth, excessively activated protein kinase C (PKC) improved cell survival.  Combined treatment with a PP2A inhibitor and a PKC inhibitor produced a synergistic effect, which indicates a potentially promising therapeutic approach to pancreatic cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY-5FefWvHIrVg90H21EOLACvtfcHk0lg8S5c5fbd_-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOjsb%252FF&md5=b38257a3f43d8478fbb17bb4e80e556f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2011.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2011.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DF.%2BR.%26aulast%3DZong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DD.%2BM.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DDuan%26aufirst%3DW.%2BM.%26aulast%3DMiao%26aufirst%3DY.%26aulast%3DTao%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DZ.%2BK.%26atitle%3DGrowth%2520of%2520the%2520Pancreatic%2520Cancer%2520Cell%2520Line%2520Panc-1%2520Is%2520Inhibited%2520by%2520Protein%2520Phosphatase%25202a%2520Inhibitors%2520through%2520Overactivation%2520of%2520the%2520C-Jun%2520N-Terminal%2520Kinase%2520Pathway%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2011%26volume%3D47%26spage%3D2654%26epage%3D2664%26doi%3D10.1016%2Fj.ejca.2011.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrucki, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernatchez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinusas, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shulman, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sessa, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarovinsky, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, J. R.</span></span> <span> </span><span class="NLM_article-title">Ceramide-Activated Phosphatase Mediates Fatty Acid-Induced Endothelial Vegf Resistance and Impaired Angiogenesis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">1562</span>– <span class="NLM_lpage">1576</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2014.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.ajpath.2014.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24606881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVemtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2014&pages=1562-1576&author=V.+C.+Mehraauthor=E.+Jacksonauthor=X.+M.+Zhangauthor=X.+C.+Jiangauthor=L.+W.+Dobruckiauthor=J.+Yuauthor=P.+Bernatchezauthor=A.+J.+Sinusasauthor=G.+I.+Shulmanauthor=W.+C.+Sessaauthor=T.+O.+Yarovinskyauthor=J.+R.+Bender&title=Ceramide-Activated+Phosphatase+Mediates+Fatty+Acid-Induced+Endothelial+Vegf+Resistance+and+Impaired+Angiogenesis&doi=10.1016%2Fj.ajpath.2014.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide-Activated Phosphatase Mediates Fatty Acid-Induced Endothelial VEGF Resistance and Impaired Angiogenesis</span></div><div class="casAuthors">Mehra, Vishal C.; Jackson, Elias; Zhang, Xian M.; Jiang, Xian-Cheng; Dobrucki, Lawrence W.; Yu, Jun; Bernatchez, Pascal; Sinusas, Albert J.; Shulman, Gerald I.; Sessa, William C.; Yarovinsky, Timur O.; Bender, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1562-1576</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Endothelial dysfunction, including endothelial hyporesponsiveness to prototypical angiogenic growth factors and eNOS agonists, underlies vascular pathol. in many dysmetabolic states.  We investigated effects of a satd. free fatty acid, palmitic acid (PA), on endothelial cell responses to VEGF.  PA-pretreated endothelial cells had markedly diminished Akt, eNOS, and ERK activation responses to VEGF, despite normal VEGFR2 phosphorylation.  PA inhibited VEGF-induced angiogenic cord formation in Matrigel, and PA-treated endothelial cells accumulated early species (C16) ceramide.  The serine palmitoyltransferase inhibitor myriocin reversed these defects.  Protein phosphatase 2A (PP2A) became more eNOS-assocd. in PA-treated cells; the PP2A inhibitor okadaic acid reversed PA-induced signaling defects.  Mice fed a diet high in satd. fat for 2 to 3 wk had impaired i) aortic Akt and eNOS phosphorylation to infused VEGF, ii) ear angiogenic responses to intradermal adenoviral-VEGF injection, and iii) vascular flow recovery to hindlimb ischemia as indicated by laser Doppler and αVβ3 SPECT imaging.  High-fat feeding did not impair VEGF-induced signaling or angiogenic responses in mice with reduced serine palmitoyltransferase expression.  Thus, de novo ceramide synthesis is required for these detrimental PA effects.  The findings demonstrate an endothelial VEGF resistance mechanism conferred by PA, which comprises ceramide-induced, PP2A-mediated dephosphorylation of crit. activation sites on enzymes central to vascular homeostasis and angiogenesis.  This study defines potential mol. targets for preservation of endothelial function in metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgG6GyltXqD7Vg90H21EOLACvtfcHk0lg8S5c5fbd_-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVemtLk%253D&md5=0ab893f099774af919a778489ba9ed35</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2014.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2014.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DMehra%26aufirst%3DV.%2BC.%26aulast%3DJackson%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%2BM.%26aulast%3DJiang%26aufirst%3DX.%2BC.%26aulast%3DDobrucki%26aufirst%3DL.%2BW.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DBernatchez%26aufirst%3DP.%26aulast%3DSinusas%26aufirst%3DA.%2BJ.%26aulast%3DShulman%26aufirst%3DG.%2BI.%26aulast%3DSessa%26aufirst%3DW.%2BC.%26aulast%3DYarovinsky%26aufirst%3DT.%2BO.%26aulast%3DBender%26aufirst%3DJ.%2BR.%26atitle%3DCeramide-Activated%2520Phosphatase%2520Mediates%2520Fatty%2520Acid-Induced%2520Endothelial%2520Vegf%2520Resistance%2520and%2520Impaired%2520Angiogenesis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2014%26volume%3D184%26spage%3D1562%26epage%3D1576%26doi%3D10.1016%2Fj.ajpath.2014.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKeage, M. J.</span></span> <span> </span><span class="NLM_article-title">New-Generation Platinum Drugs in the Treatment of Cisplatin-Resistant Cancers</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1046</span>, <span class="refDoi"> DOI: 10.1517/13543784.14.8.1033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1517%2F13543784.14.8.1033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=16050795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFelsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1033-1046&author=M.+J.+McKeage&title=New-Generation+Platinum+Drugs+in+the+Treatment+of+Cisplatin-Resistant+Cancers&doi=10.1517%2F13543784.14.8.1033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">New-generation platinum drugs in the treatment of cisplatin-resistant cancers</span></div><div class="casAuthors">McKeage, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1033-1046</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Platinum drugs with altered stable ligands, such as oxaliplatin and satraplatin, produce a different DNA-adduct profile to cisplatin.  This results in a distinct therapeutic profile, and clin. trials with these agents demonstrate significant anticancer activity in diseases with inherent or acquired resistance to cisplatin, such as colorectal and prostate cancers as well as previously treated ovarian and germ-cell cancer.  An alternative approach to increasing the efficacy assocd. with platinum therapy is to enhance tumor delivery by coupling platinum drugs with a polymer or encapsulating the agent in a liposome.  The early clin. trials of these novel delivery formulations are promising but, as yet, have not confirmed that the delivery of platinum to the tumor cell DNA is increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVke4wqJPl4bVg90H21EOLACvtfcHk0lg8S5c5fbd_-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFelsrw%253D&md5=e95d7e5cd02b5bba3e4202ebc6c77f62</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.8.1033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.8.1033%26sid%3Dliteratum%253Aachs%26aulast%3DMcKeage%26aufirst%3DM.%2BJ.%26atitle%3DNew-Generation%2520Platinum%2520Drugs%2520in%2520the%2520Treatment%2520of%2520Cisplatin-Resistant%2520Cancers%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D1033%26epage%3D1046%26doi%3D10.1517%2F13543784.14.8.1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toop, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dun, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrills, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span> <span> </span><span class="NLM_article-title">Development of Novel Pp2a Activators for Use in the Treatment of Acute Myeloid Leukaemia</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4605</span>– <span class="NLM_lpage">4616</span>, <span class="refDoi"> DOI: 10.1039/C6OB00556J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1039%2FC6OB00556J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=27102578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsF2ntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=4605-4616&author=H.+D.+Toopauthor=M.+D.+Dunauthor=B.+K.+Rossauthor=H.+M.+Flanaganauthor=N.+M.+Verrillsauthor=J.+C.+Morris&title=Development+of+Novel+Pp2a+Activators+for+Use+in+the+Treatment+of+Acute+Myeloid+Leukaemia&doi=10.1039%2FC6OB00556J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel PP2A activators for use in the treatment of acute myeloid leukemia</span></div><div class="casAuthors">Toop, Hamish D.; Dun, Matthew D.; Ross, Bryony K.; Flanagan, Hayley M.; Verrills, Nicole M.; Morris, Jonathan C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4605-4616</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">AAL(S), the chiral deoxy analog of the FDA approved drug FTY720, has been shown to inhibit proliferation and apoptosis in several cancer cell lines.  It has been suggested that it does this by activating protein phosphatase 2A (PP2A).  The authors show that these analogs activate PP2A in these cells supporting the suggested mechanism for their cytotoxic properties.  The authors' findings identify key structural motifs required for anti-cancer effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4bXSci2sQNbVg90H21EOLACvtfcHk0liyxih1goPRIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsF2ntb0%253D&md5=1804e9ffc4c08747ee59161d333aaba4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1039%2FC6OB00556J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6OB00556J%26sid%3Dliteratum%253Aachs%26aulast%3DToop%26aufirst%3DH.%2BD.%26aulast%3DDun%26aufirst%3DM.%2BD.%26aulast%3DRoss%26aufirst%3DB.%2BK.%26aulast%3DFlanagan%26aufirst%3DH.%2BM.%26aulast%3DVerrills%26aufirst%3DN.%2BM.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26atitle%3DDevelopment%2520of%2520Novel%2520Pp2a%2520Activators%2520for%2520Use%2520in%2520the%2520Treatment%2520of%2520Acute%2520Myeloid%2520Leukaemia%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D4605%26epage%3D4616%26doi%3D10.1039%2FC6OB00556J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatchwell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrills, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wark, P. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Siqueira, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooze, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett Nathan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothenberg, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, J.</span></span> <span> </span><span class="NLM_article-title">The E3 Ubiquitin Ligase Midline 1 Promotes Allergen and Rhinovirus-Induced Asthma by Inhibiting Protein Phosphatase 2a Activity</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1038/nm.3049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fnm.3049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23334847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=232-237&author=A.+Collisonauthor=L.+Hatchwellauthor=N.+Verrillsauthor=P.+A.+B.+Warkauthor=A.+P.+de%0ASiqueiraauthor=M.+Toozeauthor=H.+Carpenterauthor=A.+S.+Donauthor=J.+C.+Morrisauthor=N.+Zimmermannauthor=W.+Bartlett+Nathanauthor=M.+E.+Rothenbergauthor=S.+L.+Johnstonauthor=P.+S.+Fosterauthor=J.+Mattes&title=The+E3+Ubiquitin+Ligase+Midline+1+Promotes+Allergen+and+Rhinovirus-Induced+Asthma+by+Inhibiting+Protein+Phosphatase+2a+Activity&doi=10.1038%2Fnm.3049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity</span></div><div class="casAuthors">Collison, Adam; Hatchwell, Luke; Verrills, Nicole; Wark, Peter A. B.; de Siqueira, Ana Pereira; Tooze, Melinda; Carpenter, Helen; Don, Anthony S.; Morris, Jonathan C.; Zimmermann, Nives; Bartlett, Nathan W.; Rothenberg, Marc E.; Johnston, Sebastian L.; Foster, Paul S.; Mattes, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">232-237</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Allergic airway inflammation is assocd. with activation of innate immune pathways by allergens.  Acute exacerbations of asthma are commonly assocd. with rhinovirus infection.  Here we show that, after exposure to house dust mite (HDM) or rhinovirus infection, the E3 ubiquitin ligase midline 1 (MID1) is upregulated in mouse bronchial epithelium.  HDM regulates MID1 expression in a Toll-like receptor 4 (TLR4)- and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent manner.  MID1 decreases protein phosphatase 2A (PP2A) activity through assocn. with its catalytic subunit PP2Ac. siRNA-mediated knockdown of MID1 or pharmacol. activation of PP2A using a nonphosphorylatable FTY720 analog in mice exposed to HDM reduces airway hyperreactivity and inflammation, including the expression of interleukin-25 (IL-25), IL-33 and CCL20, IL-5 and IL-13 release, nuclear factor (NF)κB activity, p38 mitogen-activated protein kinase (MAPK) phosphorylation, accumulation of eosinophils, T lymphocytes and myeloid dendritic cells, and the no. of mucus-producing cells.  MID1 inhibition also limited rhinovirus-induced exacerbation of allergic airway disease.  We found that MID1 was upregulated in primary human bronchial epithelial cells upon HDM or rhinovirus exposure, and this correlated with TRAIL and CCL20 expression.  Together, these findings identify a key role of MID1 in allergic airway inflammation and links innate immune pathway activation to the development and exacerbation of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDuz_MDUgBT7Vg90H21EOLACvtfcHk0liyxih1goPRIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSjtLo%253D&md5=1978d6cb499352e5c91e393173d0828b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnm.3049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3049%26sid%3Dliteratum%253Aachs%26aulast%3DCollison%26aufirst%3DA.%26aulast%3DHatchwell%26aufirst%3DL.%26aulast%3DVerrills%26aufirst%3DN.%26aulast%3DWark%26aufirst%3DP.%2BA.%2BB.%26aulast%3Dde%2BSiqueira%26aufirst%3DA.%2BP.%26aulast%3DTooze%26aufirst%3DM.%26aulast%3DCarpenter%26aufirst%3DH.%26aulast%3DDon%26aufirst%3DA.%2BS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DZimmermann%26aufirst%3DN.%26aulast%3DBartlett%2BNathan%26aufirst%3DW.%26aulast%3DRothenberg%26aufirst%3DM.%2BE.%26aulast%3DJohnston%26aufirst%3DS.%2BL.%26aulast%3DFoster%26aufirst%3DP.%2BS.%26aulast%3DMattes%26aufirst%3DJ.%26atitle%3DThe%2520E3%2520Ubiquitin%2520Ligase%2520Midline%25201%2520Promotes%2520Allergen%2520and%2520Rhinovirus-Induced%2520Asthma%2520by%2520Inhibiting%2520Protein%2520Phosphatase%25202a%2520Activity%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D232%26epage%3D237%26doi%3D10.1038%2Fnm.3049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Switzer, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitek, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitek, M. P.</span></span> <span> </span><span class="NLM_article-title">Targeting Set/I(2)Pp2a Oncoprotein Functions as a Multi-Pathway Strategy for Cancer Therapy</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2504</span>– <span class="NLM_lpage">2513</span>, <span class="refDoi"> DOI: 10.1038/onc.2010.622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fonc.2010.622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=21297667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2504-2513&author=C.+H.+Switzerauthor=R.+Y.+S.+Chengauthor=T.+M.+Vitekauthor=D.+J.+Christensenauthor=D.+A.+Winkauthor=M.+P.+Vitek&title=Targeting+Set%2FI%282%29Pp2a+Oncoprotein+Functions+as+a+Multi-Pathway+Strategy+for+Cancer+Therapy&doi=10.1038%2Fonc.2010.622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy</span></div><div class="casAuthors">Switzer, C. H.; Cheng, R. Y. S.; Vitek, T. M.; Christensen, D. J.; Wink, D. A.; Vitek, M. P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2504-2513</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The SET oncoprotein participates in cancer progression by affecting multiple cellular processes, inhibiting the tumor suppressor protein phosphatase 2A (PP2A), and inhibiting the metastasis suppressor nm23-H1.  On the basis of these multiple activities, we hypothesized that targeted inhibition of SET would have multiple discrete and measurable effects on cancer cells.  Here, the effects of inhibiting SET oncoprotein function on intracellular signaling and proliferation of human cancer cell lines was investigated.  We obsd. the effects of COG112, a novel SET interacting peptide, on PP2A activity, Akt signaling, nm23-H1 activity and cellular migration/invasion in human U87 glioblastoma and MDA-MB-231 breast adenocarcinoma cancer cell lines.  We found that COG112 interacted with SET protein and inhibited the assocn. between SET and PP2A catalytic subunit (PP2A-c) and nm23-H1.  The interaction between COG112 and SET caused PP2A phosphatase and nm23-H1 exonuclease activities to increase.  COG112-mediated increases in PP2A activity resulted in the inhibition of Akt signaling and cellular proliferation.  Addnl., COG112 inhibited SET assocn. with Ras-related C3 botulinum toxin substrate 1 (Rac1), leading to decreased cellular migration and invasion.  COG112 treatment releases the SET-mediated inhibition of the tumor suppressor PP2A, as well as the metastasis suppressor nm23-H1.  These results establish SET as a novel mol. target and that the inhibition of SET may have beneficial effects in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNLfUOr4nkNrVg90H21EOLACvtfcHk0liyxih1goPRIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqtLs%253D&md5=5297b9597daa0e745fbd80ccb711872d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fonc.2010.622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2010.622%26sid%3Dliteratum%253Aachs%26aulast%3DSwitzer%26aufirst%3DC.%2BH.%26aulast%3DCheng%26aufirst%3DR.%2BY.%2BS.%26aulast%3DVitek%26aufirst%3DT.%2BM.%26aulast%3DChristensen%26aufirst%3DD.%2BJ.%26aulast%3DWink%26aufirst%3DD.%2BA.%26aulast%3DVitek%26aufirst%3DM.%2BP.%26atitle%3DTargeting%2520Set%252FI%25282%2529Pp2a%2520Oncoprotein%2520Functions%2520as%2520a%2520Multi-Pathway%2520Strategy%2520for%2520Cancer%2520Therapy%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2504%26epage%3D2513%26doi%3D10.1038%2Fonc.2010.622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saddoughi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gencer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oaks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szulc, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvam, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senkal, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett-Mayer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Palma, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedarovich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habib, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahelin, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrotti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogretmen, B.</span></span> <span> </span><span class="NLM_article-title">Sphingosine Analogue Drug Fty720 Targets I2pp2a/Set and Mediates Lung Tumour Suppression Via Activation of Pp2a-Ripk1-Dependent Necroptosis</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1002/emmm.201201283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Femmm.201201283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23180565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFWq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=105-121&author=S.+A.+Saddoughiauthor=S.+Gencerauthor=Y.+K.+Petersonauthor=K.+E.+Wardauthor=A.+Mukhopadhyayauthor=J.+Oaksauthor=J.+Bielawskiauthor=Z.+M.+Szulcauthor=R.+J.+Thomasauthor=S.+P.+Selvamauthor=C.+E.+Senkalauthor=E.+Garrett-Mayerauthor=R.+M.+De+Palmaauthor=D.+Fedarovichauthor=A.+Liuauthor=A.+A.+Habibauthor=R.+V.+Stahelinauthor=D.+Perrottiauthor=B.+Ogretmen&title=Sphingosine+Analogue+Drug+Fty720+Targets+I2pp2a%2FSet+and+Mediates+Lung+Tumour+Suppression+Via+Activation+of+Pp2a-Ripk1-Dependent+Necroptosis&doi=10.1002%2Femmm.201201283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis</span></div><div class="casAuthors">Saddoughi, Sahar A.; Gencer, Salih; Peterson, Yuri K.; Ward, Katherine E.; Mukhopadhyay, Archana; Oaks, Joshua; Bielawski, Jacek; Szulc, Zdzislaw M.; Thomas, Raquela J.; Selvam, Shanmugam P.; Senkal, Can E.; Garrett-Mayer, Elizabeth; De Palma, Ryan M.; Fedarovich, Dzmitry; Liu, Angen; Habib, Amyn A.; Stahelin, Robert V.; Perrotti, Danilo; Ogretmen, Besim</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Mechanisms that alter protein phosphatase 2A (PP2A)-dependent lung tumor suppression via the I2PP2A/SET oncoprotein are unknown.  We show here that the tumor suppressor ceramide binds I2PP2A/SET selectively in the nucleus and including its K209 and Y122 residues as detd. by mol. modeling/simulations and site-directed mutagenesis.  Because I2PP2A/SET was found overexpressed, whereas ceramide was downregulated in lung tumors, a sphingolipid analog drug, FTY720, was identified to mimick ceramide for binding and targeting I2PP2A/SET, leading to PP2A reactivation, lung cancer cell death, and tumor suppression in vivo.  Accordingly, while mol. targeting of I2PP2A/SET by stable knockdown prevented further tumor suppression by FTY720, reconstitution of WT-I2PP2A/SET expression restored this process.  Mechanistically, targeting I2PP2A/SET by FTY720 mediated PP2A/RIPK1-dependent programmed necrosis (necroptosis), but not by apoptosis.  The RIPK1 inhibitor necrostatin and knockdown or genetic loss of RIPK1 prevented growth inhibition by FTY720.  Expression of WT- or death-domain-deleted (DDD)-RIPK1, but not the kinase-domain-deleted (KDD)-RIPK1, restored FTY720-mediated necroptosis in RIPK1-/- MEFs.  Thus, these data suggest that targeting I2PP2A/SET by FTY720 suppresses lung tumor growth, at least in part, via PP2A activation and necroptosis mediated by the kinase domain of RIPK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRYK04JuK_OrVg90H21EOLACvtfcHk0lhgjS4PxGIs8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFWq&md5=d51f3eac9f81dfd3668567f9cc9de8ab</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201283%26sid%3Dliteratum%253Aachs%26aulast%3DSaddoughi%26aufirst%3DS.%2BA.%26aulast%3DGencer%26aufirst%3DS.%26aulast%3DPeterson%26aufirst%3DY.%2BK.%26aulast%3DWard%26aufirst%3DK.%2BE.%26aulast%3DMukhopadhyay%26aufirst%3DA.%26aulast%3DOaks%26aufirst%3DJ.%26aulast%3DBielawski%26aufirst%3DJ.%26aulast%3DSzulc%26aufirst%3DZ.%2BM.%26aulast%3DThomas%26aufirst%3DR.%2BJ.%26aulast%3DSelvam%26aufirst%3DS.%2BP.%26aulast%3DSenkal%26aufirst%3DC.%2BE.%26aulast%3DGarrett-Mayer%26aufirst%3DE.%26aulast%3DDe%2BPalma%26aufirst%3DR.%2BM.%26aulast%3DFedarovich%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DHabib%26aufirst%3DA.%2BA.%26aulast%3DStahelin%26aufirst%3DR.%2BV.%26aulast%3DPerrotti%26aufirst%3DD.%26aulast%3DOgretmen%26aufirst%3DB.%26atitle%3DSphingosine%2520Analogue%2520Drug%2520Fty720%2520Targets%2520I2pp2a%252FSet%2520and%2520Mediates%2520Lung%2520Tumour%2520Suppression%2520Via%2520Activation%2520of%2520Pp2a-Ripk1-Dependent%2520Necroptosis%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D105%26epage%3D121%26doi%3D10.1002%2Femmm.201201283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pippa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Miralles, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Prieto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitek, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odero, M. D.</span></span> <span> </span><span class="NLM_article-title">Effect of Fty720 on the Set-Pp2a Complex in Acute Myeloid Leukemia; Set Binding Drugs Have Antagonistic Activity</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1915</span>– <span class="NLM_lpage">1918</span>, <span class="refDoi"> DOI: 10.1038/leu.2014.141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fleu.2014.141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24781014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslCgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1915-1918&author=R.+Pippaauthor=A.+Dominguezauthor=D.+J.+Christensenauthor=I.+Moreno-Mirallesauthor=M.+J.+Blanco-Prietoauthor=M.+P.+Vitekauthor=M.+D.+Odero&title=Effect+of+Fty720+on+the+Set-Pp2a+Complex+in+Acute+Myeloid+Leukemia%3B+Set+Binding+Drugs+Have+Antagonistic+Activity&doi=10.1038%2Fleu.2014.141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity</span></div><div class="casAuthors">Pippa, R.; Dominguez, A.; Christensen, D. J.; Moreno-Miralles, I.; Blanco-Prieto, M. J.; Vitek, M. P.; Odero, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1915-1918</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To study the mechanism of FTY720 restoration of PP2A activity in AML, we first analyzed the interaction between endogenous SET and PP2Ac proteins in the AML cell line HL-60.  Treatment with FTY720 at a concn. that reduced proliferation by 50% induced PP2A activity by 30%, and effectively disrupted the assocn. between SET and PP2Ac in HL-60 cells.  In conclusion, we show that SET forms an inhibitory complex with PP2Ac in AML, impairing the activity of PP2A, and that the whole structure of SET (amino terminus and carboxy terminus) is involved in the binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYLZ7kTICdJrVg90H21EOLACvtfcHk0lhgjS4PxGIs8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslCgsLw%253D&md5=679876e36bf1316ff06502d83499438e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fleu.2014.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2014.141%26sid%3Dliteratum%253Aachs%26aulast%3DPippa%26aufirst%3DR.%26aulast%3DDominguez%26aufirst%3DA.%26aulast%3DChristensen%26aufirst%3DD.%2BJ.%26aulast%3DMoreno-Miralles%26aufirst%3DI.%26aulast%3DBlanco-Prieto%26aufirst%3DM.%2BJ.%26aulast%3DVitek%26aufirst%3DM.%2BP.%26aulast%3DOdero%26aufirst%3DM.%2BD.%26atitle%3DEffect%2520of%2520Fty720%2520on%2520the%2520Set-Pp2a%2520Complex%2520in%2520Acute%2520Myeloid%2520Leukemia%253B%2520Set%2520Binding%2520Drugs%2520Have%2520Antagonistic%2520Activity%26jtitle%3DLeukemia%26date%3D2014%26volume%3D28%26spage%3D1915%26epage%3D1918%26doi%3D10.1038%2Fleu.2014.141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a Inhibits Colorectal Cancer Proliferation Probably by Regulating Expression Levels of C-Myc, P21waf1/Cip1 and Proliferating Cell Nuclear Antigen</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2009.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.canlet.2009.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19481339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFyqs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2009&pages=66-72&author=T.+Masuoauthor=S.+Okamuraauthor=Y.+Zhangauthor=M.+Mori&title=Cyclosporine+a+Inhibits+Colorectal+Cancer+Proliferation+Probably+by+Regulating+Expression+Levels+of+C-Myc%2C+P21waf1%2FCip1+and+Proliferating+Cell+Nuclear+Antigen&doi=10.1016%2Fj.canlet.2009.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21WAF1/CIP1 and proliferating cell nuclear antigen</span></div><div class="casAuthors">Masuo, Takashige; Okamura, Shinichi; Zhang, Yajing; Mori, Masatomo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-72</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The present study investigated the role of Calcineurin (CaN) in the proliferation of human colorectal cancers.  CaN activity and protein expression were increased in human colorectal cancers.  Nuclear transcription factor NFAT, a physiol. substrate for CaN, was activated in human colon cancer specimen as well as in the human colon cancer cell lines.  CaN inhibitor cyclosporine A (CsA) reduced cell growth in these cell lines.  CsA decreased the expressions of c-Myc and the proliferating cell nuclear antigen (PCNA) but also increased p21WAF1/CIP1 expression.  These results suggest that CaN promotes colorectal cancer proliferation probably by regulating levels of c-Myc, p21WAF1/CIP1, and PCNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5x0M0PqjXjLVg90H21EOLACvtfcHk0liMvSpoexrSzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFyqs7fE&md5=0f1129621c42de2ab5aae35efed1e564</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2009.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2009.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DMasuo%26aufirst%3DT.%26aulast%3DOkamura%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26atitle%3DCyclosporine%2520a%2520Inhibits%2520Colorectal%2520Cancer%2520Proliferation%2520Probably%2520by%2520Regulating%2520Expression%2520Levels%2520of%2520C-Myc%252C%2520P21waf1%252FCip1%2520and%2520Proliferating%2520Cell%2520Nuclear%2520Antigen%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D285%26spage%3D66%26epage%3D72%26doi%3D10.1016%2Fj.canlet.2009.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, K. A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a Inhibits Breast Cancer Cell Growth by Downregulating the Expression of Pyruvate Kinase Subtype M2</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2012.989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3892%2Fijmm.2012.989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22580449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ajtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=302-308&author=K.+A.+I.+Jiangauthor=B.+Heauthor=L.+Laiauthor=Q.+Chenauthor=Y.+Liuauthor=Q.+Guoauthor=Q.+Wang&title=Cyclosporine+a+Inhibits+Breast+Cancer+Cell+Growth+by+Downregulating+the+Expression+of+Pyruvate+Kinase+Subtype+M2&doi=10.3892%2Fijmm.2012.989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2</span></div><div class="casAuthors">Jiang, Kai; He, Baoming; Lai, Lihua; Chen, Qingyun; Liu, Yang; Guo, Qingming; Wang, Qingqing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">302-308</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">The high proliferative rate of tumor cells leads to metabolic needs distinct from those of their normal counterparts.  An embryonic- and tumor-specific isoform of the enzyme pyruvate kinase M2 (PKM2) is overexpressed in cancer cells to increase the use of glycolytic intermediates for macromol. biosynthesis and tumor growth.  We report that Cyclosporin A (CsA) can regulate the expression and activity of PKM2 in breast cancer cell lines MCF-7, MDA-MB-435 and MDA-MB-231.  PKM2 was found to be highly expressed in the three breast cancer cell lines compared to normal primary breast cells.  Treatment with CsA inhibited the viability of breast cancer cells in a time- and dose-dependent manner.  CsA significantly downregulated the expression of PKM2 in breast cancer cells and decreased ATP (ATP) synthesis, which induced cancer cells to undergo necrosis.  Furthermore, the growth suppression effect of CsA was impaired in MCF-7 cells when they were transfected with the PKM2 overexpression plasmid, suggesting that CsA was an effective inhibitor of PKM2-dependent proliferation of breast cancer cells.  These results may provide new insights into the mechanism of CsA in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmv8SetAhEbVg90H21EOLACvtfcHk0liMvSpoexrSzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ajtL7K&md5=0af5ee226bcb6e821ad9a41b490d02f2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2012.989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2012.989%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DK.%2BA.%2BI.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DCyclosporine%2520a%2520Inhibits%2520Breast%2520Cancer%2520Cell%2520Growth%2520by%2520Downregulating%2520the%2520Expression%2520of%2520Pyruvate%2520Kinase%2520Subtype%2520M2%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2012%26volume%3D30%26spage%3D302%26epage%3D308%26doi%3D10.3892%2Fijmm.2012.989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawahara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwagi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netto, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, H.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a and Tacrolimus Inhibit Bladder Cancer Growth through Down-Regulation of Nfatc1</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1582</span>– <span class="NLM_lpage">1593</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.18632%2Foncotarget.2750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25638160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC2Mrht1OrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1582-1593&author=T.+Kawaharaauthor=E.+Kashiwagiauthor=H.+Ideauthor=Y.+Liauthor=Y.+Zhengauthor=Y.+Miyamotoauthor=G.+J.+Nettoauthor=H.+Ishiguroauthor=H.+Miyamoto&title=Cyclosporine+a+and+Tacrolimus+Inhibit+Bladder+Cancer+Growth+through+Down-Regulation+of+Nfatc1&doi=10.18632%2Foncotarget.2750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1</span></div><div class="casAuthors">Kawahara Takashi; Kashiwagi Eiji; Ide Hiroki; Zheng Yichun; Netto George J; Ishiguro Hitoshi; Miyamoto Hiroshi; Kawahara Takashi; Li Yi; Zheng Yichun; Miyamoto Yurina; Ishiguro Hitoshi; Miyamoto Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1582-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The functional role of nuclear factor of activated T-cells (NFAT), a key regulator of the immune response, in bladder cancer progression remains uncertain.  In this study, we assessed biological significance of NFAT in human bladder cancer.  Immunohistochemistry detected nuclear/cytoplasmic NFATc1 signals in 14 (21.5%)/34 (52.3%), respectively, of 65 muscle-invasive bladder carcinomas and showed that patients with nuclear NFATc1-positive tumor had a significantly higher risk of disease progression (P = 0.006).  In bladder cancer cell lines, cyclosporine A (CsA) and tacrolimus (FK506), immunosuppressant drugs/non-selective NFAT inhibitors, attenuated NFATc1 expression and its nuclear translocation, NFAT transcriptional activity, and the expression of cyclooxygenase-2 and c-myc, downstream targets of NFATc1.  NFAT inhibition via NFATc1-small interfering RNA (siRNA) or treatment with these NFAT inhibitors resulted in decreases in cell viability/colony formation, cell migration/invasion, and the expression/activity of MMP-2 and MMP-9, as well as an increase in apoptosis, in the parental/control lines.  No significant additional inhibition in the viability and invasion of NFATc1-siRNA cells was seen.  In xenograft-bearing mice, CsA and FK506 significantly retarded tumor growth.  These results suggest that NFATc1 plays an important role in bladder cancer outgrowth.  Thus, NFATc1 inactivation, especially using CsA and FK506, has the potential of being a therapeutic approach for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOAG3KUOIPiH6oPH0mYWL1fW6udTcc2eZJDvSbFfz5d7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mrht1OrsQ%253D%253D&md5=4ef8c68f7ed5ae66cea68e19c8877959</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2750%26sid%3Dliteratum%253Aachs%26aulast%3DKawahara%26aufirst%3DT.%26aulast%3DKashiwagi%26aufirst%3DE.%26aulast%3DIde%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DNetto%26aufirst%3DG.%2BJ.%26aulast%3DIshiguro%26aufirst%3DH.%26aulast%3DMiyamoto%26aufirst%3DH.%26atitle%3DCyclosporine%2520a%2520and%2520Tacrolimus%2520Inhibit%2520Bladder%2520Cancer%2520Growth%2520through%2520Down-Regulation%2520of%2520Nfatc1%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D1582%26epage%3D1593%26doi%3D10.18632%2Foncotarget.2750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P. T. W.</span></span> <span> </span><span class="NLM_article-title">Purification of Protein Phosphatase 4 Catalytic Subunit: Inhibition by the Antitumour Drug Fostriecin and Other Tumour Suppressors and Promoters</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>431</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(98)00775-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0014-5793%2898%2900775-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9714542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK1cXltFWrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=1998&pages=357-361&author=C.+J.+Hastieauthor=P.+T.+W.+Cohen&title=Purification+of+Protein+Phosphatase+4+Catalytic+Subunit%3A+Inhibition+by+the+Antitumour+Drug+Fostriecin+and+Other+Tumour+Suppressors+and+Promoters&doi=10.1016%2FS0014-5793%2898%2900775-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumor drug fostriecin and other tumor suppressors and promoters</span></div><div class="casAuthors">Hastie, C. James; Cohen, Patricia T. W.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">431</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-361</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Protein phosphatase 4 (PP4) is a protein serine/threonine phosphatase that predominantly localizes to centrosomes and plays a role in microtubule organization at centrosomes.  Here, PP4 catalytic subunit has been purified from porcine testis to near homogeneity and a specific activity of 680 mU/mg against phosphorylase a.  The antitumor drug, fostriecin, inhibits PP4 catalytic subunit (IC50 3 nM) with similar potency to PP2A catalytic subunit (IC50 1.5 nM).  PP4 is also inhibited in the nanomolar range by several naturally occurring tumor promoters and toxins, with similar IC50 values to those obtained for PP2A. The gene for human PP4 catalytic subunit localizes to 16p11.2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmkTsiBvA8PLVg90H21EOLACvtfcHk0lgkS0-0WF2Ebg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFWrsb0%253D&md5=6a38bd64aeddc9e73877aa73745f7dbd</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2898%2900775-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252898%252900775-3%26sid%3Dliteratum%253Aachs%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%2BT.%2BW.%26atitle%3DPurification%2520of%2520Protein%2520Phosphatase%25204%2520Catalytic%2520Subunit%253A%2520Inhibition%2520by%2520the%2520Antitumour%2520Drug%2520Fostriecin%2520and%2520Other%2520Tumour%2520Suppressors%2520and%2520Promoters%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D431%26spage%3D357%26epage%3D361%26doi%3D10.1016%2FS0014-5793%2898%2900775-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prickett, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span> <span> </span><span class="NLM_article-title">The A4 Regulatory Subunit Exerts Opposing Allosteric Effects on Protein Phosphatases Pp6 and Pp2a</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">30503</span>– <span class="NLM_lpage">30511</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601054200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M601054200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=16895907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCrsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=30503-30511&author=T.+D.+Prickettauthor=D.+L.+Brautigan&title=The+A4+Regulatory+Subunit+Exerts+Opposing+Allosteric+Effects+on+Protein+Phosphatases+Pp6+and+Pp2a&doi=10.1074%2Fjbc.M601054200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The α4 Regulatory Subunit Exerts Opposing Allosteric Effects on Protein Phosphatases PP6 and PP2A</span></div><div class="casAuthors">Prickett, Todd D.; Brautigan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">30503-30511</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protein Ser/Thr phosphatase family contains three enzymes called PP2A, PP4, and PP6 with sep. biol. functions inferred from genetics of the yeast homologues Pph21/22, Pph3, and Sit4.  These catalytic subunits assoc. with a common subunit called α4 (related to yeast Tap42).  Here, we characterized recombinant PP6 and PP2A catalytic monomers and α4·phosphatase heterodimers.  Monomeric PP6 and PP2A showed identical kinetics using either p-nitrophenyl phosphate (pNPP) or 32P-myelin basic protein (MBP) as substrates, with matching Km and Vmax values.  Using pNPP as substrate, PP6 and PP2A gave the same IC50 with active site inhibitors okadaic acid, microcystin-LR, calyculin A, and cantharidin.  However, with MBP as substrate, PP6 was inhibited at 5-fold lower concns. of toxins relative to PP2A, suggesting PP6 might be a preferred in vivo target of toxins.  Heterodimeric α4·PP6 and α4·PP2A were starkly different.  With MBP as substrate the α4·PP2A heterodimer had a 100-fold higher Vmax than α4·PP6, and neither heterodimer was active with pNPP.  Thus, these phosphatases are distinguished by their different responses to allosteric binding of the common regulatory subunit α4.  Transient expression of α4 differentially increased or decreased phosphorylation of endogenous phosphoproteins, consistent with opposing effects on PP2A and PP6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqpOx4uHDms7Vg90H21EOLACvtfcHk0lgkS0-0WF2Ebg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCrsL3K&md5=857da17a92103bf12b845e6cf4a3fe77</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601054200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601054200%26sid%3Dliteratum%253Aachs%26aulast%3DPrickett%26aufirst%3DT.%2BD.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26atitle%3DThe%2520A4%2520Regulatory%2520Subunit%2520Exerts%2520Opposing%2520Allosteric%2520Effects%2520on%2520Protein%2520Phosphatases%2520Pp6%2520and%2520Pp2a%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D30503%26epage%3D30511%26doi%3D10.1074%2Fjbc.M601054200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of Ser/Thr Protein Phosphatases: Specificity, Use and Common Forms of Abuse</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1385/1-59745-267-X:23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1385%2F1-59745-267-X%3A23" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2006&pages=23-38&author=M.+Swingleauthor=L.+Niauthor=R.+E.+Honkanen&title=Small-Molecule+Inhibitors+of+Ser%2FThr+Protein+Phosphatases%3A+Specificity%2C+Use+and+Common+Forms+of+Abuse&doi=10.1385%2F1-59745-267-X%3A23"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1385%2F1-59745-267-X%3A23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59745-267-X%253A23%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DM.%26aulast%3DNi%26aufirst%3DL.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520Ser%252FThr%2520Protein%2520Phosphatases%253A%2520Specificity%252C%2520Use%2520and%2520Common%2520Forms%2520of%2520Abuse%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2006%26volume%3D365%26spage%3D23%26epage%3D38%26doi%3D10.1385%2F1-59745-267-X%3A23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinclair, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charbonneau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossie, S.</span></span> <span> </span><span class="NLM_article-title">Purification of a Fatty Acid-Stimulated Protein-Serine/Threonine Phosphatase from Bovine Brain and Its Identification as a Homolog of Protein Phosphatase 5</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">22464</span>– <span class="NLM_lpage">22471</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.36.22464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.272.36.22464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9278397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2sXlvFGitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=22464-22471&author=J.+Skinnerauthor=C.+Sinclairauthor=C.+Romeoauthor=D.+Armstrongauthor=H.+Charbonneauauthor=S.+Rossie&title=Purification+of+a+Fatty+Acid-Stimulated+Protein-Serine%2FThreonine+Phosphatase+from+Bovine+Brain+and+Its+Identification+as+a+Homolog+of+Protein+Phosphatase+5&doi=10.1074%2Fjbc.272.36.22464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of a fatty acid-stimulated protein-serine/threonine phosphatase from bovine brain and its identification as a homolog of protein phosphatase 5</span></div><div class="casAuthors">Skinner, Jeffrey; Sinclair, Christopher; Romeo, Charles; Armstrong, David; Charbonneau, Harry; Rossie, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">22464-22471</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">An arachidonic acid-stimulated Ser/Thr phosphatase activity was detected in sol. exts. prepd. from rat pituitary clonal GH4C1 cells, rat or bovine brain, and bovine heart.  The enzyme activity was purified to homogeneity from bovine brain as a monomer with a Mr of 63,000 and a specific activity of 32 nmol of Pi released per min/mg of protein when assayed in the presence of 10 μM phosphocasein in the absence of lipid.  Arachidonic acid stimulated activity 4-14-fold, with half-maximal stimulation at 50-100 μM, when assayed in the presence of a variety of phosphosubstrates including casein, reduced carboxamidomethylated and maleylated lysozyme, myelin basic protein, and histone.  Oleic acid, linoleic acid, and palmitoleic acid also stimulated activity; however, satd. fatty acids and alc. or Me ester derivs. of fatty acids did not significantly affect activity.  The lipid-stimulated phosphatase was identified as the bovine equiv. of protein phosphatase 5 or a closely related homolog by sequence anal. of proteolytic fragments generated from the purified enzyme.  When recombinant rat protein phosphatase 5 was expressed as a cleavable glutathione S-transferase fusion protein, the affinity-purified thrombin-cleaved enzyme exhibited a specific activity and sensitivity to arachidonic acid similar to those of the purified bovine brain enzyme.  These results suggest that protein phosphatase 5 may be regulated in vivo by a lipid second messenger or another endogenous activator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEHnC4BDZiGLVg90H21EOLACvtfcHk0ljn6_mQ_eiWwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvFGitr0%253D&md5=cda30d1c70bf65da6448a27ccafeb550</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.36.22464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.36.22464%26sid%3Dliteratum%253Aachs%26aulast%3DSkinner%26aufirst%3DJ.%26aulast%3DSinclair%26aufirst%3DC.%26aulast%3DRomeo%26aufirst%3DC.%26aulast%3DArmstrong%26aufirst%3DD.%26aulast%3DCharbonneau%26aufirst%3DH.%26aulast%3DRossie%26aufirst%3DS.%26atitle%3DPurification%2520of%2520a%2520Fatty%2520Acid-Stimulated%2520Protein-Serine%252FThreonine%2520Phosphatase%2520from%2520Bovine%2520Brain%2520and%2520Its%2520Identification%2520as%2520a%2520Homolog%2520of%2520Protein%2520Phosphatase%25205%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D22464%26epage%3D22471%26doi%3D10.1074%2Fjbc.272.36.22464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Serine/Threonine Phosphatases: Mechanism through Structure</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2009.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19879837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFKltL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2009&pages=468-484&author=Y.+Shi&title=Serine%2FThreonine+Phosphatases%3A+Mechanism+through+Structure&doi=10.1016%2Fj.cell.2009.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Serine/threonine phosphatases: mechanism through structure</span></div><div class="casAuthors">Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">468-484</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The reversible phosphorylation of proteins is accomplished by opposing activities of kinases and phosphatases.  Relatively few protein serine/threonine phosphatases (PSPs) control the specific dephosphorylation of thousands of phosphoprotein substrates.  Many PSPs, exemplified by protein phosphatase 1 (PP1) and PP2A, achieve substrate specificity and regulation through combinatorial interactions between conserved catalytic subunits and a large no. of regulatory subunits.  Other PSPs, represented by PP2C and TFIIF-assocg. component of RNA polymerase II C-terminal domain (CTD) phosphatase/small CTD phosphatase (FCP/SCP), contain both catalytic and regulatory domains within the same polypeptide chain.  Here, the authors discuss biochem. and structural investigations that advance the mechanistic understanding of the 3 major classes of PSPs, with a focus on PP2A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrS0iZKM4I_bVg90H21EOLACvtfcHk0ljn6_mQ_eiWwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFKltL%252FK&md5=8a0892323688d6774c8448b69d389b8d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26atitle%3DSerine%252FThreonine%2520Phosphatases%253A%2520Mechanism%2520through%2520Structure%26jtitle%3DCell%26date%3D2009%26volume%3D139%26spage%3D468%26epage%3D484%26doi%3D10.1016%2Fj.cell.2009.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P. T. W.</span></span> <span> </span><span class="NLM_article-title">Activation of Protein Phosphatase 5 by Limited Proteolysis or the Binding of Polyunsaturated Fatty Acids to the Tpr Domain</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(96)01427-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0014-5793%2896%2901427-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9000529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK28XnsFSmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1997&pages=136-140&author=M.+X.+Chenauthor=P.+T.+W.+Cohen&title=Activation+of+Protein+Phosphatase+5+by+Limited+Proteolysis+or+the+Binding+of+Polyunsaturated+Fatty+Acids+to+the+Tpr+Domain&doi=10.1016%2FS0014-5793%2896%2901427-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of protein phosphatase 5 by limited proteolysis or the binding of polyunsaturated fatty acids to the TPR domain</span></div><div class="casAuthors">Chen, Mao Xiang; Cohen, Patricia T. W.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">136-140</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Protein phosphatase 5 (PP5) exhibits very low phosphatase activity, which can be stimulated >25-fold by proteolysis.  Since proteolysis cleaves the N-terminal tetratricopeptide repeat (TPR) domain from the catalytic domain, these results indicate that the TPR domain shields the active site.  Polyunsatd. fatty acids, such as arachidonic acid, and lipids contg. polyunsatd. fatty acids, such as phosphatidylinositol, stimulate both bacterially expressed human and native rabbit PP5 activity >25-fold toward casein and myelin basic protein.  Phosphatidylinositol binds to the TPR domain, and not to the catalytic domain, indicating that activation by polyunsatd. fatty acids is allosteric and that it may occur by movement of the TPR domain to allow substrate access.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQhPrOeuhk37Vg90H21EOLACvtfcHk0ljn6_mQ_eiWwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsFSmt7k%253D&md5=53fbece8e1449adc8cd867ea3634bd30</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2896%2901427-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252896%252901427-5%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DM.%2BX.%26aulast%3DCohen%26aufirst%3DP.%2BT.%2BW.%26atitle%3DActivation%2520of%2520Protein%2520Phosphatase%25205%2520by%2520Limited%2520Proteolysis%2520or%2520the%2520Binding%2520of%2520Polyunsaturated%2520Fatty%2520Acids%2520to%2520the%2520Tpr%2520Domain%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D400%26spage%3D136%26epage%3D140%26doi%3D10.1016%2FS0014-5793%2896%2901427-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayner, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinkers, M.</span></span> <span> </span><span class="NLM_article-title">Identification of Amino Acids in the Tetratricopeptide Repeat and C-Terminal Domains of Protein Phosphatase 5 Involved in Autoinhibition and Lipid Activation†</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">10485</span>– <span class="NLM_lpage">10490</span>, <span class="refDoi"> DOI: 10.1021/bi010999i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi010999i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFGmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10485-10490&author=H.+Kangauthor=S.+L.+Saynerauthor=K.+L.+Grossauthor=L.+C.+Russellauthor=M.+Chinkers&title=Identification+of+Amino+Acids+in+the+Tetratricopeptide+Repeat+and+C-Terminal+Domains+of+Protein+Phosphatase+5+Involved+in+Autoinhibition+and+Lipid+Activation%E2%80%A0&doi=10.1021%2Fbi010999i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Amino Acids in the Tetratricopeptide Repeat and C-Terminal Domains of Protein Phosphatase 5 Involved in Autoinhibition and Lipid Activation</span></div><div class="casAuthors">Kang, Hyeog; Sayner, Sarah L.; Gross, Katherine L.; Russell, Lance C.; Chinkers, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10485-10490</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein phosphatase 5 (PP5) exhibits low basal activity due to the autoinhibitory properties of its N-terminal and C-terminal domains but can be activated approx. 40-fold in vitro by polyunsatd. fatty acids.  To identify residues involved in regulating PP5 activity, we performed scanning mutagenesis of its N-terminal tetratricopeptide repeat (TPR) domain and deletion mutagenesis of its C-terminal domain.  Mutating residues in a groove of the TPR domain that binds to heat shock protein 90 had no effect on basal phosphatase activity.  Mutation of Glu-76, however, whose side chain projects away from this groove, resulted in a 10-fold elevation of basal activity without affecting arachidonic acid-stimulated activity.  Thus, the interface of the TPR domain involved in PP5 autoinhibition appears to be different from that involved in heat shock protein 90 binding.  We also obsd. a 10-fold elevation of basal phosphatase activity upon removing the C-terminal 13 amino acids of PP5, with a concomitant 50% decrease in arachidonic acid-stimulated activity.  These two effects were accounted for by two distinct amino acid deletions: deleting the four C-terminal residues (496-499) of PP5 had no effect on its activity, but removing Gln-495 elevated basal activity 10-fold.  Removal of a further three amino acids had no addnl. effect, but deleting Asn-491 resulted in a 50% redn. in arachidonic acid-stimulated activity.  Thus, Glu-76 in the TPR domain and Gln-495 at the C-terminus were implicated in maintaining the low basal activity of PP5.  While the TPR domain alone has been thought to mediate fatty acid activation of PP5, our data suggest that Asn-491, near its C-terminus, may also be involved in this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Ebu1Rlv0grVg90H21EOLACvtfcHk0lhdb_SljGcUDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFGmtbo%253D&md5=d0ff0800f3d8a481c43d8162dc291ed5</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fbi010999i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi010999i%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DH.%26aulast%3DSayner%26aufirst%3DS.%2BL.%26aulast%3DGross%26aufirst%3DK.%2BL.%26aulast%3DRussell%26aufirst%3DL.%2BC.%26aulast%3DChinkers%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Amino%2520Acids%2520in%2520the%2520Tetratricopeptide%2520Repeat%2520and%2520C-Terminal%2520Domains%2520of%2520Protein%2520Phosphatase%25205%2520Involved%2520in%2520Autoinhibition%2520and%2520Lipid%2520Activation%25E2%2580%25A0%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10485%26epage%3D10490%26doi%3D10.1021%2Fbi010999i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andreeva, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutuzov, M. A.</span></span> <span> </span><span class="NLM_article-title">Ppef/Pp7 Protein Ser/Thr Phosphatases</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">3103</span>– <span class="NLM_lpage">3110</span>, <span class="refDoi"> DOI: 10.1007/s00018-009-0110-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs00018-009-0110-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19662497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCitrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=3103-3110&author=A.+V.+Andreevaauthor=M.+A.+Kutuzov&title=Ppef%2FPp7+Protein+Ser%2FThr+Phosphatases&doi=10.1007%2Fs00018-009-0110-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">PPEF/PP7 protein Ser/Thr phosphatases</span></div><div class="casAuthors">Andreeva, Alexandra V.; Kutuzov, Mikhail A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3103-3110</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  PPEF/PP7 represents one of the five subfamilies of the PPP protein Ser/Thr phosphatases.  Studies published in recent years point to a role of plant PP7 at a crossroad of different pathways of light and stress signalling.  In animals, PPEFs are highly expressed in sensory neurons, and Drosophila PPEF phosphatase, rdgC, is essential for dephosphorylation of rhodopsin.  Expression profiling suggests that mammalian PPEF may play a role in stress-protective responses, cell survival, growth, proliferation, and oncogenesis.  Despite structural similarities of the catalytic domains and the fact that some of these phosphatases are involved in light perception both in animals and in plants, the plant and non-plant representatives of this group have distinct domain architecture and appear not to be orthologues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoza2FZtBa9X7Vg90H21EOLACvtfcHk0lhdb_SljGcUDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCitrvE&md5=51fcdaa7424693fa40cc9d9636584273</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-0110-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-0110-7%26sid%3Dliteratum%253Aachs%26aulast%3DAndreeva%26aufirst%3DA.%2BV.%26aulast%3DKutuzov%26aufirst%3DM.%2BA.%26atitle%3DPpef%252FPp7%2520Protein%2520Ser%252FThr%2520Phosphatases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26spage%3D3103%26epage%3D3110%26doi%3D10.1007%2Fs00018-009-0110-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rusnak, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertz, P.</span></span> <span> </span><span class="NLM_article-title">Calcineurin: Form and Function</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1521</span>, <span class="refDoi"> DOI: 10.1152/physrev.2000.80.4.1483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1152%2Fphysrev.2000.80.4.1483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11015619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVKisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2000&pages=1483-1521&author=F.+Rusnakauthor=P.+Mertz&title=Calcineurin%3A+Form+and+Function&doi=10.1152%2Fphysrev.2000.80.4.1483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Calcineurin: form and function</span></div><div class="casAuthors">Rusnak, Frank; Mertz, Pamela</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1483-1521</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review with 487 refs.  Calcineurin is a eukaryotic Ca2+/calmodulin-dependent serine/threonine phosphoprotein phosphatase.  It is a heterodimeric protein consisting of a catalytic subunit, calcineurin A, which contains an active site dinuclear metal center, and a tightly assocd., myristoylated, Ca2+-binding subunit, calcineurin B.  The primary sequence of both subunits and heterodimeric quaternary structure is highly conserved from yeast to mammals.  As a serine/threonine protein phosphatase, calcineurin participates in a no. of cellular processes and Ca2+-dependent signal transduction pathways.  Calcineurin is potently inhibited by immunosuppressant drugs, cyclosporin A and FK 506, in the presence of their resp. cytoplasmic immunophilin proteins, cyclophilin and FK 506-binding protein.  Many studies have used these immunosuppressant drugs and/or modern genetic techniques to disrupt calcineurin in model organisms such as yeast, filamentous fungi, plants, vertebrates, and mammals to explore its biol. function.  Recent advances regarding calcineurin structure include the detn. of its 3-dimensional structure.  In addn., biochem. and spectroscopic studies are beginning to unravel aspects of the mechanism of phosphate ester hydrolysis including the importance of the dinuclear metal ion cofactor and metal ion redox chem., studies which may lead to new calcineurin inhibitors.  This review provides a comprehensive examn. of the biol. roles of calcineurin and reviews aspects related to its structure and catalytic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb_f4SIemYHbVg90H21EOLACvtfcHk0ljcgQkN5o3MtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVKisLk%253D&md5=34321bdba3efaed2600666ad9fe9429b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2000.80.4.1483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2000.80.4.1483%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DF.%26aulast%3DMertz%26aufirst%3DP.%26atitle%3DCalcineurin%253A%2520Form%2520and%2520Function%26jtitle%3DPhysiol.%2520Rev.%26date%3D2000%26volume%3D80%26spage%3D1483%26epage%3D1521%26doi%3D10.1152%2Fphysrev.2000.80.4.1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kissinger, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parge, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knighton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempczyk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalish, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moomaw, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastinel, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habuka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacquet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villafranca, J. E.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of Human Calcineurin and the Human Fkbp12–Fk506–Calcineurin Complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1038/378641a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2F378641a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8524402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2MXpvVChsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=1995&pages=641-644&author=C.+R.+Kissingerauthor=H.+E.+Pargeauthor=D.+R.+Knightonauthor=C.+T.+Lewisauthor=L.+A.+Pelletierauthor=A.+Tempczykauthor=V.+J.+Kalishauthor=K.+D.+Tuckerauthor=R.+E.+Showalterauthor=E.+W.+Moomawauthor=L.+N.+Gastinelauthor=N.+Habukaauthor=X.+Chenauthor=F.+Maldonadoauthor=J.+E.+Barkerauthor=R.+Bacquetauthor=J.+E.+Villafranca&title=Crystal+Structures+of+Human+Calcineurin+and+the+Human+Fkbp12%E2%80%93Fk506%E2%80%93Calcineurin+Complex&doi=10.1038%2F378641a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex</span></div><div class="casAuthors">Kissinger, Charles R.; Parge, Hans E.; Knighton, Daniel R.; Lewis, Cristina T.; Pelletier, Laura A.; Tempczyk, Anna; Kalish, Vincent J.; Tucker, Kathleen D.; Showalter, Richard E.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">6557</span>),
    <span class="NLM_cas:pages">641-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Calcineurin (CaN) is a calcium- and calmodulin-dependent protein serine/threonine phosphatase which is crit. for several important cellular processes, including T-cell activation.  CaN is the target of the immunosuppressive drugs cyclosporin A and FK506, which inhibit CaN after forming complexes with cytoplasmic binding proteins (cyclophilin and FKBP12, resp.).  The authors report here the crystal structures of full-length human CaN at 2.1 Å resoln. and of the complex of human CaN with FKBP12-FK506 at 3.5 Å resoln.  In the native CaN structure, an autoinhibitory element binds at the Zn/Fe-contg. active site.  The site of binding of FKBP12-FK506 appears to be shared by other non-competitive inhibitors of calcineurin, including a natural anchoring protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIlai2HUv_4rVg90H21EOLACvtfcHk0ljcgQkN5o3MtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpvVChsbc%253D&md5=7410673e0cedc4bb5d12ea9961ef2153</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2F378641a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F378641a0%26sid%3Dliteratum%253Aachs%26aulast%3DKissinger%26aufirst%3DC.%2BR.%26aulast%3DParge%26aufirst%3DH.%2BE.%26aulast%3DKnighton%26aufirst%3DD.%2BR.%26aulast%3DLewis%26aufirst%3DC.%2BT.%26aulast%3DPelletier%26aufirst%3DL.%2BA.%26aulast%3DTempczyk%26aufirst%3DA.%26aulast%3DKalish%26aufirst%3DV.%2BJ.%26aulast%3DTucker%26aufirst%3DK.%2BD.%26aulast%3DShowalter%26aufirst%3DR.%2BE.%26aulast%3DMoomaw%26aufirst%3DE.%2BW.%26aulast%3DGastinel%26aufirst%3DL.%2BN.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMaldonado%26aufirst%3DF.%26aulast%3DBarker%26aufirst%3DJ.%2BE.%26aulast%3DBacquet%26aufirst%3DR.%26aulast%3DVillafranca%26aufirst%3DJ.%2BE.%26atitle%3DCrystal%2520Structures%2520of%2520Human%2520Calcineurin%2520and%2520the%2520Human%2520Fkbp12%25E2%2580%2593Fk506%25E2%2580%2593Calcineurin%2520Complex%26jtitle%3DNature%26date%3D1995%26volume%3D378%26spage%3D641%26epage%3D644%26doi%3D10.1038%2F378641a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santikarn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calder, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klee, C. B.</span></span> <span> </span><span class="NLM_article-title">Identification of the Nh2-Terminal Blocking Group of Calcineurin B as Myristic Acid</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(82)80759-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0014-5793%2882%2980759-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=7160476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL3sXht1Wqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=1982&pages=314-318&author=A.+Aitkenauthor=P.+Cohenauthor=S.+Santikarnauthor=D.+H.+Williamsauthor=A.+G.+Calderauthor=A.+Smithauthor=C.+B.+Klee&title=Identification+of+the+Nh2-Terminal+Blocking+Group+of+Calcineurin+B+as+Myristic+Acid&doi=10.1016%2F0014-5793%2882%2980759-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the amino-terminal blocking group of calcineurin B as myristic acid</span></div><div class="casAuthors">Aitken, Alastair; Cohen, Philip; Santikarn, Sitthivet; Williams, Dudley H.; Calder, A. Graham; Smith, Alistair; Klee, Claude B.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">314-18</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The N-terminal blocking group of the Ca2+-binding B-subunit of calcineurin (protein phosphatase-2B) was identified as myristic acid by fast atom bombardment mass spectrometry and gas chromatog.  The sequence, myristyl-Gly-Asn-Glu-Ala-, is very similar to that of the catalytic subunit of cAMP-dependent kinase, the only other protein known to contain this fatty acid.  This finding, and the elution of all myristyl peptides at 57% MeCN on reverse-phase high-performance liq. chromatog. may facilitate the identification of other proteins with this blocking group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDkGubhzoIGbVg90H21EOLACvtfcHk0liSWIdN4pEjRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXht1Wqu74%253D&md5=de5baba84d8c84252eca4cb1745a6f26</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2882%2980759-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252882%252980759-X%26sid%3Dliteratum%253Aachs%26aulast%3DAitken%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DSantikarn%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DCalder%26aufirst%3DA.%2BG.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DKlee%26aufirst%3DC.%2BB.%26atitle%3DIdentification%2520of%2520the%2520Nh2-Terminal%2520Blocking%2520Group%2520of%2520Calcineurin%2520B%2520as%2520Myristic%2520Acid%26jtitle%3DFEBS%2520Lett.%26date%3D1982%26volume%3D150%26spage%3D314%26epage%3D318%26doi%3D10.1016%2F0014-5793%2882%2980759-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P. T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Martin, C.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 4-from Obscurity to Vital Functions</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>579</i></span>,  <span class="NLM_fpage">3278</span>– <span class="NLM_lpage">3286</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2005.04.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.febslet.2005.04.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15913612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFSqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=3278-3286&author=P.+T.+W.+Cohenauthor=A.+Philpauthor=C.+V%C3%A1zquez-Martin&title=Protein+Phosphatase+4-from+Obscurity+to+Vital+Functions&doi=10.1016%2Fj.febslet.2005.04.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 4 - from obscurity to vital functions</span></div><div class="casAuthors">Cohen, Patricia T. W.; Philp, Amanda; Vazquez-Martin, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3278-3286</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein phosphatase 4 (Ppp4) is a ubiquitous protein serine/threonine phosphatase in the PPP family that is now recognized to regulate a variety of cellular functions independently of protein phosphatase 2A (PP2A).  Regulatory subunits (R1 and R2) have been identified in mammals that interact with the catalytic subunit of Ppp4 (Ppp4c) and control its activity.  Ppp4c-R2 complexes play roles in organelle assembly; not only are they essential for maturation of the centrosome, but they are also involved in spliceosomal assembly via interaction with the survival of motor neurons (SMNs) complex.  Several cellular signaling routes, including NF-κB and the target of rapamycin (TOR) pathways appear to be regulated by Ppp4.  Emerging evidence indicates that Ppp4 may play a role in the DNA damage response and that Ppp4c-R1 complexes decrease the activity of a histone deacetylase, implicating Ppp4 in the regulation of chromatin activities.  Antitumor agents, cantharidin and fostriecin, potently inhibit the activity of Ppp4.  Orthologs of mammalian Ppp4 subunits in Saccharomyces cerevisiae confer resistance to the anticancer, DNA-binding drugs, cisplatin and oxaliplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJh9_WaRLkXbVg90H21EOLACvtfcHk0liSWIdN4pEjRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFSqu78%253D&md5=45d31e4cd30f9616a3c1f7f86a455b94</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2005.04.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2005.04.070%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%2BT.%2BW.%26aulast%3DPhilp%26aufirst%3DA.%26aulast%3DV%25C3%25A1zquez-Martin%26aufirst%3DC.%26atitle%3DProtein%2520Phosphatase%25204-from%2520Obscurity%2520to%2520Vital%2520Functions%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D3278%26epage%3D3286%26doi%3D10.1016%2Fj.febslet.2005.04.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragusa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beullens, M.</span></span> <span> </span><span class="NLM_article-title">The Extended Pp1 Toolkit: Designed to Create Specificity</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2010.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.tibs.2010.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20399103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=450-458&author=M.+Bollenauthor=W.+Petiauthor=M.+J.+Ragusaauthor=M.+Beullens&title=The+Extended+Pp1+Toolkit%3A+Designed+to+Create+Specificity&doi=10.1016%2Fj.tibs.2010.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The extended PP1 toolkit: Designed to create specificity</span></div><div class="casAuthors">Bollen, Mathieu; Peti, Wolfgang; Ragusa, Michael J.; Beullens, Monique</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">450-458</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein Ser/Thr phosphatase-1 (PP1) catalyzes the majority of eukaryotic protein dephosphorylation reactions in a highly regulated and selective manner. Recent studies have identified an unusually diversified PP1 interactome with the properties of a regulatory toolkit.  PP1-interacting proteins (PIPs) function as targeting subunits, substrates and/or inhibitors.  As targeting subunits, PIPs contribute to substrate selection by bringing PP1 into the vicinity of specific substrates and by modulating substrate specificity via addnl. substrate docking sites or blocking substrate-binding channels.  Many of the nearly 200 established mammalian PIPs are predicted to be intrinsically disordered, a property that facilitates their binding to a large surface area of PP1 via multiple docking motifs.  These novel insights offer perspectives for the therapeutic targeting of PP1 by interfering with the binding of PIPs or substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCSyMKukyPxrVg90H21EOLACvtfcHk0liSWIdN4pEjRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKqsL4%253D&md5=960aa0dff84b136f7f3d03ed06f4b6c1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2010.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2010.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DBollen%26aufirst%3DM.%26aulast%3DPeti%26aufirst%3DW.%26aulast%3DRagusa%26aufirst%3DM.%2BJ.%26aulast%3DBeullens%26aufirst%3DM.%26atitle%3DThe%2520Extended%2520Pp1%2520Toolkit%253A%2520Designed%2520to%2520Create%2520Specificity%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2010%26volume%3D35%26spage%3D450%26epage%3D458%26doi%3D10.1016%2Fj.tibs.2010.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Wever, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derua, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beullens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Eynde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">A Substrate-Trapping Strategy for Protein Phosphatase Pp1 Holoenzymes Using Hypoactive Subunit Fusions</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">15152</span>– <span class="NLM_lpage">15162</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA118.004132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.RA118.004132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30115685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWhu7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=15152-15162&author=D.+Wuauthor=V.+De+Weverauthor=R.+Deruaauthor=C.+Winklerauthor=M.+Beullensauthor=A.+Van+Eyndeauthor=M.+Bollen&title=A+Substrate-Trapping+Strategy+for+Protein+Phosphatase+Pp1+Holoenzymes+Using+Hypoactive+Subunit+Fusions&doi=10.1074%2Fjbc.RA118.004132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A substrate-trapping strategy for protein phosphatase PP1 holoenzymes using hypoactive subunit fusions</span></div><div class="casAuthors">Wu, Dan; De Wever, Veerle; Derua, Rita; Winkler, Claudia; Beullens, Monique; Van Eynde, Aleyde; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">15152-15162</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protein Ser/Thr phosphatase PP1 catalyzes an important fraction of protein dephosphorylation events and forms highly specific holoenzymes through an assocn. with regulatory interactors of protein phosphatase one (RIPPOs).  The functional characterization of individual PP1 holoenzymes is hampered by the lack of straightforward strategies for substrate mapping.  Because efficient substrate recruitment often involves binding to both PP1 and its assocd. RIPPO, here we examd. whether PP1-RIPPO fusions can be used to trap substrates for further anal.  Fusions of an hypoactive point mutant of PP1 and either of four tested RIPPOs accumulated in HEK293T cells with their assocd. substrates and were co-immunopptd. for subsequent identification of the substrates by immunoblotting or MS anal.  Hypoactive fusions were also used to study RIPPOs themselves as substrates for assocd. PP1.  In contrast, substrate trapping was barely detected with active PP1-RIPPO fusions or with nonfused PP1 or RIPPO subunits.  Our results suggest that hypoactive fusions of PP1 subunits represent an easy-to-use tool for substrate identification of individual holoenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowtnZJ1lGt97Vg90H21EOLACvtfcHk0lj9z79eY4J5FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWhu7zP&md5=2b1c2c0e617f15785f47cd086d3e8c31</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA118.004132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA118.004132%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDe%2BWever%26aufirst%3DV.%26aulast%3DDerua%26aufirst%3DR.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DBeullens%26aufirst%3DM.%26aulast%3DVan%2BEynde%26aufirst%3DA.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DA%2520Substrate-Trapping%2520Strategy%2520for%2520Protein%2520Phosphatase%2520Pp1%2520Holoenzymes%2520Using%2520Hypoactive%2520Subunit%2520Fusions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D15152%26epage%3D15162%26doi%3D10.1074%2Fjbc.RA118.004132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 6 Subunit with Conserved Sit4-Associated Protein Domain Targets Iκbϵ</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">22624</span>– <span class="NLM_lpage">22634</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601772200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M601772200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=16769727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVWjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=22624-22634&author=B.+Stefanssonauthor=D.+L.+Brautigan&title=Protein+Phosphatase+6+Subunit+with+Conserved+Sit4-Associated+Protein+Domain+Targets+I%CE%BAb%CF%B5&doi=10.1074%2Fjbc.M601772200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IκBε</span></div><div class="casAuthors">Stefansson, Bjarki; Brautigan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">22624-22634</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Protein Ser/Thr phosphatases compose a PPP family that includes type-2 PP2A, PP4, and PP6, each with essential functions.  The human PP6 gene rescues sit4ts mutants of Saccharomyces cerevisiae, and Sit4 phosphatase function depends on multiple Sit4-assocd. protein (SAP) subunits.  The authors report here finding a SAPS sequence domain encoded in only a single gene each in Schizosaccharomyces pombe, Caenorhabditis elegans, and Drosophila but in three distinct open reading frames in Xenopus, Mus musculus, and Homo sapiens.  The SAPS proteins are more divergent in sequence than PP6.  Northern hybridization showed differential distribution of the human SAPS-related mRNA in multiple human tissues, named as PP6R1, PP6R2, and PP6R3.  Antibodies were generated, distribution of endogenous PP6, PP6R1, PP6R2, and PP6R3 proteins was examd. by immunoblotting, and the abundance of mRNA and protein in various tissues did not match.  FLAG-tagged PP6R1 and PP6R2 expressed in HEK293 cells co-pptd. endogenous PP6, but not PP2A or PP4, showing specificity for recognition of phosphatases.  The SAPS domain of PP6R1 alone was sufficient for assocn. with PP6, and this predicts that conserved sequence motifs in the SAPS domain accounts for the specificity.  FLAG-PP6R1 and FLAG-PP6R2 co-pptd. HA-IκBε.  Knockdown of PP6 or PP6R1 but not PP6R3 with siRNA significantly enhanced degrdn. of endogenous IκBε in response to tumor necrosis factor-α.  The results show SAPS domain subunits recruit substrates such as IκBε as one way to det. specific functions for PP6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUt_ittCRdGrVg90H21EOLACvtfcHk0lj9z79eY4J5FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVWjsrk%253D&md5=a737096150473184a74379499d674b17</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601772200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601772200%26sid%3Dliteratum%253Aachs%26aulast%3DStefansson%26aufirst%3DB.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26atitle%3DProtein%2520Phosphatase%25206%2520Subunit%2520with%2520Conserved%2520Sit4-Associated%2520Protein%2520Domain%2520Targets%2520I%25CE%25BAb%25CF%25B5%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D22624%26epage%3D22634%26doi%3D10.1074%2Fjbc.M601772200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugherty, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 6 Regulatory Subunits Composed of Ankyrin Repeat Domains†</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1442</span>– <span class="NLM_lpage">1451</span>, <span class="refDoi"> DOI: 10.1021/bi7022877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi7022877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksV2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1442-1451&author=B.+Stefanssonauthor=T.+Ohamaauthor=A.+E.+Daughertyauthor=D.+L.+Brautigan&title=Protein+Phosphatase+6+Regulatory+Subunits+Composed+of+Ankyrin+Repeat+Domains%E2%80%A0&doi=10.1021%2Fbi7022877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Phosphatase 6 Regulatory Subunits Composed of Ankyrin Repeat Domains</span></div><div class="casAuthors">Stefansson, Bjarki; Ohama, Takashi; Daugherty, Abbi E.; Brautigan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1442-1451</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein phosphatase 6 (PP6) is an essential Ser/Thr phosphatase conserved among eukaryotes.  The Saccharomyces cerevisiae homolog of PP6 called Sit4 depends on assocn. with SAPS domain subunits.  This study used a human SAPS domain subunit FLAG-PP6R1 to identify endogenous interacting proteins.  Mass spectrometry identified copptg. proteins as PP6 catalytic subunit and three ankyrin repeat proteins (Ankrd28, Ankrd44, and Ankrd52).  These proteins have extensive sequence identity to one another but segregate into sep. branches on a phylogenetic tree for vertebrate species, suggesting individual biol. functions.  Tagged Ankrd28 (ARS-A) copptd. with PP6, not with PP2A or PP4, and with SAPS domain subunits PP6R1 and PP6R3.  Tagged PP6 copptd. endogenous SAPS domain subunits and Ankrd28.  The C-terminal region of PP6R1 was sufficient to coppt. Ankrd28, but not PP6, demonstrating that PP6R1 acts as a scaffold with sep. regions for binding to PP6 and to Ankrd28.  Endogenous PP6 holoenzymes with PP6R1 and PP6R3 subunits were resolved by DEAE chromatog. and eluted together with Ankrd28 at Mr > 440 kDa from Superose 12.  Knockdown of PP6R1 or Ankrd28, but not PP6R3, produced equiv. enhancement of IκBε degrdn. in response to TNFα.  The results suggest that PP6 functions as a heterotrimer, composed of the PP6 catalytic subunit bound to a SAPS domain scaffold subunit that assocs. with Ankrd28.  We propose that the SAPS and ankyrin repeat regulatory subunits det. the function and specificity of PP6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfYTLHdSp5AbVg90H21EOLACvtfcHk0lh4jh1LRSGRFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksV2juw%253D%253D&md5=dc7460d9036c16a4e138e7c0a4fda704</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fbi7022877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7022877%26sid%3Dliteratum%253Aachs%26aulast%3DStefansson%26aufirst%3DB.%26aulast%3DOhama%26aufirst%3DT.%26aulast%3DDaugherty%26aufirst%3DA.%2BE.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26atitle%3DProtein%2520Phosphatase%25206%2520Regulatory%2520Subunits%2520Composed%2520of%2520Ankyrin%2520Repeat%2520Domains%25E2%2580%25A0%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D1442%26epage%3D1451%26doi%3D10.1021%2Fbi7022877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Damle, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">The Human Dephosphorylation Database Depod: 2019 Update</span>. <i>Database</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">baz133</span>, <span class="refDoi"> DOI: 10.1093/database/baz133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1093%2Fdatabase%2Fbaz133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31836896" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=baz133&author=N.+P.+Damleauthor=M.+K%C3%B6hn&title=The+Human+Dephosphorylation+Database+Depod%3A+2019+Update&doi=10.1093%2Fdatabase%2Fbaz133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1093%2Fdatabase%2Fbaz133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fdatabase%252Fbaz133%26sid%3Dliteratum%253Aachs%26aulast%3DDamle%26aufirst%3DN.%2BP.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DThe%2520Human%2520Dephosphorylation%2520Database%2520Depod%253A%25202019%2520Update%26jtitle%3DDatabase%26date%3D2019%26volume%3D2019%26spage%3Dbaz133%26doi%3D10.1093%2Fdatabase%2Fbaz133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohama, T.</span></span> <span> </span><span class="NLM_article-title">The Multiple Functions of Protein Phosphatase 6</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1866</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2018.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bbamcr.2018.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30036567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWhtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1866&publication_year=2019&pages=74-82&author=T.+Ohama&title=The+Multiple+Functions+of+Protein+Phosphatase+6&doi=10.1016%2Fj.bbamcr.2018.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The multiple functions of protein phosphatase 6</span></div><div class="casAuthors">Ohama, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1866</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-82</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review presents the accumulating evidence for the roles of protein phosphatase 6 (PP6) in cell cycle, DNA damage repair, inflammatory signaling, lymphocyte development, virus infection, tumor formation/progression, cell/tissue size, and non-coding RNA-mediated regulation.  PP6 is an evolutionarily conserved and ubiquitously expressed Ser/Thr protein phosphatase most closely related to protein phosphatase 2A (PP2A) and protein phosphatase 4 (PP4).  Although abundantly expressed in cells with multiple roles in cellular signaling, PP6 has received less attention than its close relative PP2A.  Many studies used okadaic acid as "PP2A" inhibitor, even though these toxins also inhibit PP6 activity, so effects of the inhibitor could have been due to inhibition of both phosphatases.  PP6 has its own dedicated subunits that assemble into heterotrimers that presumably fulfill its discrete functions in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwZcpMbVAD5LVg90H21EOLACvtfcHk0lh4jh1LRSGRFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWhtLvF&md5=7317d761a17efe42b0f8c27c4310b750</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2018.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2018.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DOhama%26aufirst%3DT.%26atitle%3DThe%2520Multiple%2520Functions%2520of%2520Protein%2520Phosphatase%25206%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2019%26volume%3D1866%26spage%3D74%26epage%3D82%26doi%3D10.1016%2Fj.bbamcr.2018.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naguro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span> <span> </span><span class="NLM_article-title">A Pp6-Ask3Module Coordinates the Bidirectional Cell Volume Regulation under Osmotic Stress</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2809</span>– <span class="NLM_lpage">2817</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2018.02.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.celrep.2018.02.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29539411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslSgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=2809-2817&author=K.+Watanabeauthor=T.+Umedaauthor=K.+Niwaauthor=I.+Naguroauthor=H.+Ichijo&title=A+Pp6-Ask3Module+Coordinates+the+Bidirectional+Cell+Volume+Regulation+under+Osmotic+Stress&doi=10.1016%2Fj.celrep.2018.02.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A PP6-ASK3 Module Coordinates the Bidirectional Cell Volume Regulation under Osmotic Stress</span></div><div class="casAuthors">Watanabe, Kengo; Umeda, Tsuyoshi; Niwa, Kuniyoshi; Naguro, Isao; Ichijo, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2809-2817</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cell vol. regulation is a vital system for cellular activities.  When perturbed by hypoosmotic or hyperosmotic stress, cells immediately induce the cell vol. recovery system, regulatory vol. decrease (RVD) or regulatory vol. increase (RVI), resp.  In contrast to the knowledge about effector mols., the mol. mechanisms linking osmosensing to RVD/RVI induction remain unknown.  Addnl., few reciprocal responders in the bidirectional osmotic stress response have been identified.  We previously reported that ASK3 bidirectionally switches its kinase activity under osmotic stress.  Herein we demonstrate that ASK3 controls both RVD and RVI under osmotic stress.  Using a high-content genome-wide small interfering RNA (siRNA) screen, we identify PP6 as a direct ASK3 inactivator.  Furthermore, PP6 rapidly interacts with ASK3 in an osmolality-dependent manner, and it inactivates ASK3 to induce RVI and, thereby, cell survival under hyperosmotic stress.  These findings suggest that the PP6-ASK3 interaction is a core module in the bidirectional osmotic stress response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEyvmh_hzGdrVg90H21EOLACvtfcHk0lj_nObY1-qGjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslSgtrc%253D&md5=ab1dca1377664d9478ecb133ab437e4f</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2018.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2018.02.045%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DUmeda%26aufirst%3DT.%26aulast%3DNiwa%26aufirst%3DK.%26aulast%3DNaguro%26aufirst%3DI.%26aulast%3DIchijo%26aufirst%3DH.%26atitle%3DA%2520Pp6-Ask3Module%2520Coordinates%2520the%2520Bidirectional%2520Cell%2520Volume%2520Regulation%2520under%2520Osmotic%2520Stress%26jtitle%3DCell%2520Rep.%26date%3D2018%26volume%3D22%26spage%3D2809%26epage%3D2817%26doi%3D10.1016%2Fj.celrep.2018.02.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kutuzov, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreeva, A. V.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase with Ef-Hand Domains 2 (Ppef2) Is a Potent Negative Regulator of Apoptosis Signal Regulating Kinase-1 (Ask1)</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1816</span>– <span class="NLM_lpage">1822</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2010.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.biocel.2010.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20674765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ClsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=1816-1822&author=M.+A.+Kutuzovauthor=N.+Bennettauthor=A.+V.+Andreeva&title=Protein+Phosphatase+with+Ef-Hand+Domains+2+%28Ppef2%29+Is+a+Potent+Negative+Regulator+of+Apoptosis+Signal+Regulating+Kinase-1+%28Ask1%29&doi=10.1016%2Fj.biocel.2010.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase with EF-hand domains 2 (PPEF2) is a potent negative regulator of apoptosis signal regulating kinase-1 (ASK1)</span></div><div class="casAuthors">Kutuzov, Mikhail A.; Bennett, Nelly; Andreeva, Alexandra V.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1816-1822</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The function of protein phosphatases with EF-hand domains (PPEF) in mammals is not known.  Large-scale expression profiling expts. suggest that PPEF expression may correlate with stress protective responses, cell survival, growth, proliferation, or neoplastic transformation.  Apoptosis signal regulating kinase-1 (ASK1) is a MAP kinase kinase kinase implicated in cancer, cardiovascular and neurodegenerative diseases.  ASK1 is activated by oxidative stress and induces pro-apoptotic or inflammatory signalling, largely via sustained activation of MAP kinases p38 and/or JNK.  We identify human PPEF2 as a novel interacting partner and a neg. regulator of ASK1.  In COS-7 or HEK 293A cells treated with H2O2, expression of PPEF2 abrogated sustained activation of p38 and one of the JNK p46 isoforms, and prevented ASK1-dependent caspase-3 cleavage and activation.  PPEF2 efficiently suppressed H2O2-induced activation of ASK1.  Overexpessed as well as endogenous ASK1 co-immunopptd. with PPEF2.  PPEF2 was considerably more potent both as a suppressor of ASK1 activation and as its interacting partner as compared to protein phosphatase 5 (PP5), a well-known neg. regulator of ASK1.  PPEF2 was found to form complexes with endogenous Hsp70 and to a lesser extent Hsp90, which are also known interacting partners of PP5.  These data identify, for the first time, a possible downstream signalling partner of a mammalian PPEF phosphatase, and suggest that, despite structural divergence, PPEF and PP5 phosphatases may share common interacting partners and functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3rd5CybTzMbVg90H21EOLACvtfcHk0lj_nObY1-qGjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ClsrjK&md5=7e5b8c3f1453e7d75c4551e7e63828f6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2010.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2010.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DKutuzov%26aufirst%3DM.%2BA.%26aulast%3DBennett%26aufirst%3DN.%26aulast%3DAndreeva%26aufirst%3DA.%2BV.%26atitle%3DProtein%2520Phosphatase%2520with%2520Ef-Hand%2520Domains%25202%2520%2528Ppef2%2529%2520Is%2520a%2520Potent%2520Negative%2520Regulator%2520of%2520Apoptosis%2520Signal%2520Regulating%2520Kinase-1%2520%2528Ask1%2529%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2010%26volume%3D42%26spage%3D1816%26epage%3D1822%26doi%3D10.1016%2Fj.biocel.2010.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. G.</span></span> <span> </span><span class="NLM_article-title">Protein Serine/Threonine Phosphatase Ppef-1 Suppresses Genotoxic Stress Response Via Dephosphorylation of Pdcd5</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">39222</span>, <span class="refDoi"> DOI: 10.1038/srep39222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsrep39222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28051100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=39222&author=S.+Y.+Parkauthor=J.+Seoauthor=H.+K.+Choiauthor=H.+J.+Ohauthor=G.+Gukauthor=Y.+H.+Leeauthor=J.+Leeauthor=W.+J.+Junauthor=K.+C.+Choiauthor=H.+G.+Yoon&title=Protein+Serine%2FThreonine+Phosphatase+Ppef-1+Suppresses+Genotoxic+Stress+Response+Via+Dephosphorylation+of+Pdcd5&doi=10.1038%2Fsrep39222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Protein serine/threonine phosphatase PPEF-1 suppresses genotoxic stress response via dephosphorylation of PDCD5</span></div><div class="casAuthors">Park, Soo-Yeon; Seo, Jaesung; Choi, Hyo-Kyoung; Oh, Hye-Jeong; Guk, Garam; Lee, Yoo-Hyun; Lee, Jeongmin; Jun, Woo Jin; Choi, Kyung-Chul; Yoon, Ho-Geun</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39222</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Programmed cell death 5 (PDCD5) is believed to play a crucial role in p53 activation; however, the underlying mechanism of how PDCD5 function is regulated during apoptosis remains obscure.  Here, we report that the serine/threonine phosphatase PPEF-1 interacts with and dephosphorylates PDCD5 at Ser-119, which leads to PDCD5 destabilization.  Overexpression of wild-type PPEF-1, but not inactive PPEF-1D172N, efficiently suppressed CK2α-mediated stabilization of PDCD5 and p53-mediated apoptosis in response to etoposide (ET).  Conversely, PPEF-1 knockdown further enhanced genotoxic stress responses.  Notably, PPEF-1 suppressed p53-mediated genotoxic stress response via neg. regulation of PDCD5.  We also detd. that overexpression of wild-type PPEF-1, but not inactive PPEF-1D172N, significantly increased tumorigenic growth and chemoresistance of A549 human lung carcinoma cells.  Collectively, these data demonstrate that PPEF-1 plays a pivotal role in tumorigenesis of lung cancer cells by reducing PDCD5-mediated genotoxic stress responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogWbSCz9_3rLVg90H21EOLACvtfcHk0li3FSjSE-E4DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKmsw%253D%253D&md5=b6685132f75b39ed83c6a4d9ae00d23a</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fsrep39222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep39222%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DOh%26aufirst%3DH.%2BJ.%26aulast%3DGuk%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJun%26aufirst%3DW.%2BJ.%26aulast%3DChoi%26aufirst%3DK.%2BC.%26aulast%3DYoon%26aufirst%3DH.%2BG.%26atitle%3DProtein%2520Serine%252FThreonine%2520Phosphatase%2520Ppef-1%2520Suppresses%2520Genotoxic%2520Stress%2520Response%2520Via%2520Dephosphorylation%2520of%2520Pdcd5%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D39222%26doi%3D10.1038%2Fsrep39222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ceulemans, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">Functional Diversity of Protein Phosphatase-1, a Cellular Economizer and Reset Button</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1152/physrev.00013.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1152%2Fphysrev.00013.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=14715909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotl2rtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=1-39&author=H.+Ceulemansauthor=M.+Bollen&title=Functional+Diversity+of+Protein+Phosphatase-1%2C+a+Cellular+Economizer+and+Reset+Button&doi=10.1152%2Fphysrev.00013.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Functional diversity of protein phosphatase-1, a cellular economizer and reset button</span></div><div class="casAuthors">Ceulemans, Hugo; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-39</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Protein phosphatase-1 (PP1) is a ubiquitous eukaryotic enzyme that regulates a variety of cellular processes through the dephosphorylation of dozens of substrates.  This multifunctionality of PP1 relies on its assocn. with a host of function-specific targeting and substrate-specifying proteins.  Here, the authors discuss how PP1 affects the biochem. and physiol. of eukaryotic cells.  The picture of PP1 that emerges from this anal. is that of a "green" enzyme that promotes the rational use of energy, the recycling of protein factors, and a reversal of the cell to a basal and/or energy-conserving state.  Thus, PP1 promotes a shift to more energy-efficient fuels when nutrients are abundant and stimulates the storage of energy in the form of glycogen.  PP1 also enables the relaxation of actomyosin fibers, the return to basal patterns of protein synthesis, and the recycling of transcription and splicing factors.  In addn., PP1 plays a key role in the recovery from stress, but promotes apoptosis when cells are damaged beyond repair.  Furthermore, PP1 down-regulates ion pumps and transporters in various tissues and ion channels that are involved in the excitation of neurons.  Finally, PP1 promotes the exit from mitosis and maintains cells in the G1 or G2 phases of the cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS5CZMahU7vrVg90H21EOLACvtfcHk0li3FSjSE-E4DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotl2rtw%253D%253D&md5=e3ef8c05db14f1d2d34bf9027d82b477</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00013.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00013.2003%26sid%3Dliteratum%253Aachs%26aulast%3DCeulemans%26aufirst%3DH.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DFunctional%2520Diversity%2520of%2520Protein%2520Phosphatase-1%252C%2520a%2520Cellular%2520Economizer%2520and%2520Reset%2520Button%26jtitle%3DPhysiol.%2520Rev.%26date%3D2004%26volume%3D84%26spage%3D1%26epage%3D39%26doi%3D10.1152%2Fphysrev.00013.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rebelo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Cruz e Silva, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Cruz e Silva, O. A. B.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 1 Is a Key Player in Nuclear Events</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2589</span>– <span class="NLM_lpage">2598</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2015.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cellsig.2015.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26275498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVyit7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=2589-2598&author=S.+Rebeloauthor=M.+Santosauthor=F.+Martinsauthor=E.+F.+da+Cruz+e+Silvaauthor=O.+A.+B.+da+Cruz+e+Silva&title=Protein+Phosphatase+1+Is+a+Key+Player+in+Nuclear+Events&doi=10.1016%2Fj.cellsig.2015.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 1 is a key player in nuclear events</span></div><div class="casAuthors">Rebelo, Sandra; Santos, Mariana; Martins, Filipa; da Cruz e Silva, Edgar F.; da Cruz e Silva, Odete A. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2589-2598</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Reversible protein phosphorylation at serine (Ser), threonine (Thr) and tyrosine (Tyr) residues is among the major regulatory mechanism in eukaryotic cells.  The eukaryotic genome encodes many protein kinases and protein phosphatases.  However, the localization, activity and specificity towards phosphatase substrates are dictated by a large array of phosphatase binding and regulatory subunits.  For protein phosphatase 1 (PP1) more than 200 binding subunits have been described.  The various PP1 isoforms and the binding subunits can be located throughout the cell, including in the nucleus.  It follows that several nuclear specific PP1 binding proteins (PIPs) have been described and these will be discussed.  Among them are PNUTS (phosphatase 1 nuclear targeting subunit), NIPP1 (nuclear inhibitor of PP1) and CREB (cAMP-responsive element-binding protein), which have all been assocd. with transcription.  In fact PP1 can assoc. with transcription factors fulfilling an important regulatory function, in this respect it can bind to Hox11, human factor C1 (HCF1) and myocyte enhancer factor-2 (MEF2).  PP1 also regulates cell cycle progression and centrosome maturation and splitting, again by binding to specific regulatory proteins.  Moreover, PP1 together with other protein phosphatases control the entry into mitosis by regulating the activity of mitotic kinases.  Thus, PP1, its binding proteins and/or the phosphorylation states of both, directly control a vast array of cell nucleus assocd. functions, many of which are starting to be unraveled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdEWDyzihjXrVg90H21EOLACvtfcHk0li3FSjSE-E4DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVyit7fK&md5=108d25b14f3f3245078f09016faeb14f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2015.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2015.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DRebelo%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DMartins%26aufirst%3DF.%26aulast%3Dda%2BCruz%2Be%2BSilva%26aufirst%3DE.%2BF.%26aulast%3Dda%2BCruz%2Be%2BSilva%26aufirst%3DO.%2BA.%2BB.%26atitle%3DProtein%2520Phosphatase%25201%2520Is%2520a%2520Key%2520Player%2520in%2520Nuclear%2520Events%26jtitle%3DCell.%2520Signalling%26date%3D2015%26volume%3D27%26spage%3D2589%26epage%3D2598%26doi%3D10.1016%2Fj.cellsig.2015.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenolikar, S.</span></span> <span> </span><span class="NLM_article-title">From Promiscuity to Precision: Protein Phosphatases Get a Makeover</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2009.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.molcel.2009.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19285938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=537-545&author=D.+M.+Virshupauthor=S.+Shenolikar&title=From+Promiscuity+to+Precision%3A+Protein+Phosphatases+Get+a+Makeover&doi=10.1016%2Fj.molcel.2009.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">From promiscuity to precision: protein phosphatases get a makeover</span></div><div class="casAuthors">Virshup, David M.; Shenolikar, Shirish</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">537-545</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The control of biol. events requires strict regulation using complex protein phosphorylation and dephosphorylation strategies.  The bulk of Ser/Thr residue dephosphorylations are catalyzed by a handful of protein phosphatase (PP) catalytic subunits, giving rise to the misconception that these phosphatases are promiscuous and unregulated enzymes in vivo.  The reality is much more nuanced: PP1 and PP2A, the most abundant Ser/Thr-PPs, are, in fact, families of hundreds of protein Ser/Thr-PPs, assembled from a few catalytic subunits in combination with a highly diverse array of regulators.  As recent publications illustrate, these regulatory subunits confer specificity, selectivity, localization, and regulation on these important enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpCaDeYAzyZbVg90H21EOLACvtfcHk0lj6fDkHKFtczg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSmsr4%253D&md5=db62c4123ce7b9871f2a162d556a571c</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DShenolikar%26aufirst%3DS.%26atitle%3DFrom%2520Promiscuity%2520to%2520Precision%253A%2520Protein%2520Phosphatases%2520Get%2520a%2520Makeover%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D33%26spage%3D537%26epage%3D545%26doi%3D10.1016%2Fj.molcel.2009.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lesage, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, M.</span></span> <span> </span><span class="NLM_article-title">Spindle Checkpoint Silencing: Pp1 Tips the Balance</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">R898</span>– <span class="NLM_lpage">R903</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2011.08.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cub.2011.08.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22075433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKmurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=R898-R903&author=B.+Lesageauthor=J.+Qianauthor=M.+Bollen&title=Spindle+Checkpoint+Silencing%3A+Pp1+Tips+the+Balance&doi=10.1016%2Fj.cub.2011.08.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Spindle Checkpoint Silencing: PP1 Tips the Balance</span></div><div class="casAuthors">Lesage, Bart; Qian, Junbin; Bollen, Mathieu</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">R898-R903</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The spindle checkpoint is a mitotic surveillance mechanism that delays anaphase until all sister chromatids are correctly attached to microtubules from opposite poles.  Recent studies reveal that protein kinase Aurora B is a key regulator of spindle checkpoint activation, whereas protein phosphatase PP1 antagonizes Aurora B and induces checkpoint silencing.  Chromosome biorientation stretches the kinetochores and spatially separates centromeric Aurora B from its kinetochore substrates, comprising several PP1-interacting proteins (PIPs).  The ensuing dephosphorylation of these PIPs creates docking sites for the bulk recruitment of PP1 to the kinetochores.  We propose that this tension-induced targeting of PP1 triggers checkpoint silencing by the dephosphorylation of kinetochore and checkpoint components, including Aurora B substrates.  In addn., PP1 also directly inactivates a kinetochore-assocd. pool of Aurora B and silences checkpoint signaling by opposing the centromeric targeting of Aurora B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqMytVf7Wph7Vg90H21EOLACvtfcHk0lj6fDkHKFtczg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKmurbK&md5=b98f9d817ffa9e61dbf4832782bf5208</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2011.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2011.08.063%26sid%3Dliteratum%253Aachs%26aulast%3DLesage%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DBollen%26aufirst%3DM.%26atitle%3DSpindle%2520Checkpoint%2520Silencing%253A%2520Pp1%2520Tips%2520the%2520Balance%26jtitle%3DCurr.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3DR898%26epage%3DR903%26doi%3D10.1016%2Fj.cub.2011.08.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanuma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuhashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, K.</span></span> <span> </span><span class="NLM_article-title">Analysis of Isoform Specific Function of Pp1 Catalytic Subunits in Mammalian Cells Using Sirna</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1383</span>– <span class="NLM_lpage">1388</span>, <span class="refDoi"> DOI: 10.3892/ijo.25.5.1383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3892%2Fijo.25.5.1383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15492829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSktbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1383-1388&author=T.+Okadaauthor=T.+Fujiiauthor=N.+Tanumaauthor=S.+Mitsuhashiauthor=T.+Uranoauthor=Y.+Arakiauthor=H.+Shimaauthor=K.+Kikuchi&title=Analysis+of+Isoform+Specific+Function+of+Pp1+Catalytic+Subunits+in+Mammalian+Cells+Using+Sirna&doi=10.3892%2Fijo.25.5.1383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of isoform specific function of PP1 catalytic subunits in mammalian cells using siRNA</span></div><div class="casAuthors">Okada, Tadashi; Fujii, Tsubasa; Tanuma, Nobuhiro; Mitsuhashi, Shinya; Urano, Takeshi; Araki, Yoshio; Shima, Hiroshi; Kikuchi, Kunimi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1383-1388</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Protein phosphatase type 1 (PP1) is involved in the regulation of numerous cell functions in mammalian cells.  The major isoforms of PP1 catalytic subunit (PP1C)α, γ1 and δ have nearly identical catalytic domain, but they vary in sequences at the amino and carboxyl termini.  We previously showed that PP1Cα is highly expressed in rat hepatoma cells.  To examine isoform specific function of PP1C, each isoform was depleted from HeLa cells by RNA interference.  The PP1Cα-depleted cells rounded up and showed increased cell death, indicating that PP1Cα is essential in cell proliferation.  PP1Cγ1-depleted cells slightly rounded up and have decreased G1 phase population and increased S phase population.  The PP1Cδ-depleted cells were enlarged, and appeared flat and rich in lamellipodia.  These data suggested that each PP1C isoform has non-redundant function in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSNqdgB_pE-bVg90H21EOLACvtfcHk0lj6fDkHKFtczg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSktbnP&md5=f8ec7542c6775fe49b911f68ad2afe85</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3892%2Fijo.25.5.1383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.25.5.1383%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DTanuma%26aufirst%3DN.%26aulast%3DMitsuhashi%26aufirst%3DS.%26aulast%3DUrano%26aufirst%3DT.%26aulast%3DAraki%26aufirst%3DY.%26aulast%3DShima%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DK.%26atitle%3DAnalysis%2520of%2520Isoform%2520Specific%2520Function%2520of%2520Pp1%2520Catalytic%2520Subunits%2520in%2520Mammalian%2520Cells%2520Using%2520Sirna%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2004%26volume%3D25%26spage%3D1383%26epage%3D1388%26doi%3D10.3892%2Fijo.25.5.1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. W. C.</span></span> <span> </span><span class="NLM_article-title">Pp-1α and Pp-1γ Display Antagonism and Differential Roles in Tumorigenicity of Lung Cancer Cells</span>. <i>Curr. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.2174/156652413804486205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F156652413804486205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23176181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=220-227&author=P.+C.+Chenauthor=C.+Liauthor=D.+Wangauthor=Z.+W.+Luoauthor=S.+J.+Fuauthor=X.+Liauthor=Z.+L.+Liauthor=X.+W.+Chenauthor=L.+Liauthor=Z.+X.+Huangauthor=W.+K.+Jiauthor=W.+F.+Huauthor=X.+H.+Huauthor=M.+Dengauthor=L.+Gongauthor=H.+G.+Chenauthor=J.+P.+Liuauthor=D.+W.+C.+Li&title=Pp-1%CE%B1+and+Pp-1%CE%B3+Display+Antagonism+and+Differential+Roles+in+Tumorigenicity+of+Lung+Cancer+Cells&doi=10.2174%2F156652413804486205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells</span></div><div class="casAuthors">Chen, P.-C.; Li, C.; Wang, D.; Luo, Z.-W.; Fu, S.-J.; Li, X.; Li, Z.-L.; Chen, X.-W.; Li, L.; Huang, Z.-X.; Ji, W.-K.; Hu, W.-F.; Hu, X.-H.; Deng, M.; Gong, L.; Chen, H.-G.; Liu, J.-P.; Li, D. W.-C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">220-227</span>CODEN:
                <span class="NLM_cas:coden">CMMUBP</span>;
        ISSN:<span class="NLM_cas:issn">1566-5240</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Protein serine/threonine phosphatases are important cellular signaling mols. and play major roles in regulating many different functions including cell proliferation, senescence, programmed cell death, and oncogenic cell transformation.  Among different serine/threonine phosphatases, PP-1 and PP-2A contribute to more than 90% phosphatase activities in eukaryotes.  While the functions of PP-2A in cell transformation and tumorigenesis have been well established, the role of PP-1 in carcinogenesis remains to be further explored.  Moreover, PP-1 exists in different isoforms, whether these isoforms have differential functions in tumorigenesis remains to be examd.  In the present study, we demonstrated that in lung cancer 1299 cells, PP1α and PP1γ exist in an antagonizing balance.  In the parent H1299 cells, PP-1γ is dominant, about 4-fold higher than that of PP-1α.  Overexpression of PP-1α significantly down-regulates PP-1γ at both mRNA and protein levels.  In contrast, knockdown of PP-1α leads to upregulation of PP-1γ.  Moreover, overexpression of PP-1α significantly attenuates the ability of the H1299 cells in promoting tumorigenicity as tested in immuno-deficient nude mice.  This attenuation is derived from the halted cell cycle progression, which is largely attributed by the changed RB-E2F activity.  Together, our results demonstrate that PP-1α and PP-1γ not only antagonize each other in lung cancer cells, but also display differential functions in tumorigenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWHqpOXAPAnbVg90H21EOLACvtfcHk0lgQCe_MY-va5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeqtb0%253D&md5=01e4f6b2e2b5c6d5c9f387b1091faa29</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.2174%2F156652413804486205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156652413804486205%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DZ.%2BW.%26aulast%3DFu%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%2BL.%26aulast%3DChen%26aufirst%3DX.%2BW.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%2BX.%26aulast%3DJi%26aufirst%3DW.%2BK.%26aulast%3DHu%26aufirst%3DW.%2BF.%26aulast%3DHu%26aufirst%3DX.%2BH.%26aulast%3DDeng%26aufirst%3DM.%26aulast%3DGong%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DH.%2BG.%26aulast%3DLiu%26aufirst%3DJ.%2BP.%26aulast%3DLi%26aufirst%3DD.%2BW.%2BC.%26atitle%3DPp-1%25CE%25B1%2520and%2520Pp-1%25CE%25B3%2520Display%2520Antagonism%2520and%2520Differential%2520Roles%2520in%2520Tumorigenicity%2520of%2520Lung%2520Cancer%2520Cells%26jtitle%3DCurr.%2520Mol.%2520Med.%26date%3D2013%26volume%3D13%26spage%3D220%26epage%3D227%26doi%3D10.2174%2F156652413804486205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felgueiras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerónimo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fardilha, M.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 1 in Tumorigenesis: Is It Worth a Closer Look?</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>1874</i></span>,  <span class="NLM_fpage">188433</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2020.188433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bbcan.2020.188433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=32956763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVKgtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1874&publication_year=2020&pages=188433&author=J.+Felgueirasauthor=C.+Jer%C3%B3nimoauthor=M.+Fardilha&title=Protein+Phosphatase+1+in+Tumorigenesis%3A+Is+It+Worth+a+Closer+Look%3F&doi=10.1016%2Fj.bbcan.2020.188433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 1 in tumorigenesis: is it worth a closer look?</span></div><div class="casAuthors">Felgueiras, Juliana; Jeronimo, Carmen; Fardilha, Margarida</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">1874</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188433</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cancer cells take advantage of signaling cascades to meet their requirements for sustained growth and survival.  Cell signaling is tightly controlled by reversible protein phosphorylation mechanisms, which require the counterbalanced action of protein kinases and protein phosphatases.  Imbalances on this system are assocd. with cancer development and progression.  Protein phosphatase 1 (PP1) is one of the most relevant protein phosphatases in eukaryotic cells.  Despite the widely recognized involvement of PP1 in key biol. processes, both in health and disease, its relevance in cancer has been largely neglected.  Here, we provide compelling evidence that support major roles for PP1 in tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJmrEm9Ugv07Vg90H21EOLACvtfcHk0lgQCe_MY-va5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVKgtrrE&md5=ab52757ccf2bf84b1970079687d583df</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2020.188433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2020.188433%26sid%3Dliteratum%253Aachs%26aulast%3DFelgueiras%26aufirst%3DJ.%26aulast%3DJer%25C3%25B3nimo%26aufirst%3DC.%26aulast%3DFardilha%26aufirst%3DM.%26atitle%3DProtein%2520Phosphatase%25201%2520in%2520Tumorigenesis%253A%2520Is%2520It%2520Worth%2520a%2520Closer%2520Look%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2020%26volume%3D1874%26spage%3D188433%26doi%3D10.1016%2Fj.bbcan.2020.188433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bialojan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, A.</span></span> <span> </span><span class="NLM_article-title">Inhibitory Effect of a Marine-Sponge Toxin, Okadaic Acid, on Protein Phosphatases. Specificity and Kinetics</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1042/bj2560283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1042%2Fbj2560283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2851982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL1MXitVequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1988&pages=283-290&author=C.+Bialojanauthor=A.+Takai&title=Inhibitory+Effect+of+a+Marine-Sponge+Toxin%2C+Okadaic+Acid%2C+on+Protein+Phosphatases.+Specificity+and+Kinetics&doi=10.1042%2Fbj2560283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases.  Specificity and kinetics</span></div><div class="casAuthors">Bialojan, Corinna; Takai, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-90</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">The inhibitory effect of a marine sponge toxin, okadaic acid, was examd. on type 1, type 2A, type 2B, and type 2C protein phosphatases as well as on a polycation-modulated (PCM) phosphatase.  Of the protein phosphatases examd., the catalytic subunit of type 2A phosphatase from rabbit skeletal muscle was most potently inhibited.  For the phosphorylated myosin light-chain (PMLC) phosphatase activity of the enzyme, the concn. of okadaic acid required to obtain 50% inhibition (ID50) was ∼1 nM.  The PMLC phosphatase activities of type 1 and PCM phosphatase were also strongly inhibited (ID50 0.1-0.5 μM).  The PMLC phosphatase activity of type 2B phosphatase (calcineurin) was inhibited to a lesser extent (ID50 4-5 μM).  Similar results were obtained for the phosphorylase a phosphatase activity of type 1 and PCM phosphatases and for the p-nitrophenyl phosphate phosphatase activity of calcineurin.  The following phosphatases were not affected by ≤10 μM okadaic acid: type 2C phosphatase, phosphotyrosyl phosphatase, inositol 1,4,5-trisphosphate phosphatase, acid phosphatases, and alk. phosphatases.  Thus okadaic acid had a relatively high specificity for type 2A, type 1, and PCM phosphatases.  Kinetic studies showed that okadaic acid acts as a noncompetitive or mixed inhibitor on the okadaic acid-sensitive enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDRX40cIwTiLVg90H21EOLACvtfcHk0ljs87ojYS178A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXitVequg%253D%253D&md5=0303a70deb82c0c087e4585ac180c5d8</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1042%2Fbj2560283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2560283%26sid%3Dliteratum%253Aachs%26aulast%3DBialojan%26aufirst%3DC.%26aulast%3DTakai%26aufirst%3DA.%26atitle%3DInhibitory%2520Effect%2520of%2520a%2520Marine-Sponge%2520Toxin%252C%2520Okadaic%2520Acid%252C%2520on%2520Protein%2520Phosphatases.%2520Specificity%2520and%2520Kinetics%26jtitle%3DBiochem.%2520J.%26date%3D1988%26volume%3D256%26spage%3D283%26epage%3D290%26doi%3D10.1042%2Fbj2560283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suganuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suguri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayasu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojika, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakamatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimura, T.</span></span> <span> </span><span class="NLM_article-title">Okadaic Acid: An Additional Non-Phorbol-12-Tetradecanoate-13-Acetate-Type Tumor Promoter</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">1768</span>– <span class="NLM_lpage">1771</span>, <span class="refDoi"> DOI: 10.1073/pnas.85.6.1768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.85.6.1768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=3126494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL1cXktVaitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=1768-1771&author=M.+Suganumaauthor=H.+Fujikiauthor=H.+Suguriauthor=S.+Yoshizawaauthor=M.+Hirotaauthor=M.+Nakayasuauthor=M.+Ojikaauthor=K.+Wakamatsuauthor=K.+Yamadaauthor=T.+Sugimura&title=Okadaic+Acid%3A+An+Additional+Non-Phorbol-12-Tetradecanoate-13-Acetate-Type+Tumor+Promoter&doi=10.1073%2Fpnas.85.6.1768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Okadaic acid: an additional non-phorbol-12-tetradecanoate 13-acetate-type tumor promoter</span></div><div class="casAuthors">Suganuma, Masami; Fujiki, Hirota; Suguri, Hiroko; Yoshizawa, Shigeru; Hirota, Mitsuru; Nakayasu, Michie; Ojika, Makoto; Wakamatsu, Kazumasa; Yamada, Kiyoyuki; Sugimura, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1768-71</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A 2-stage carcinogenesis expt. in mouse skin initiated by a single application of 100 μg of DMBA and followed by application of 10 μg of okadaic acid (a polyether compd. of C38 fatty acid) twice a week revealed that the latter is a potent addnl. tumor promoter: tumors developed in 93% of the mice treated with DMBA and okadaic acid by week 16.  In contrast, tumors were found in only 1 mouse each in the groups treated with DMBA alone or okadaic acid alone.  An av. of 2.6 tumors/mouse was found in week 30 in the group treated with DMBA and okadaic acid.  Unlike TPA, teleocidin, and aplysiatoxin, okadaic acid did not inhibit the specific binding of [3H]TPA to a mouse skin particulate fraction when added up to 100 μM or activate Ca-activated, phospholipid-dependent protein kinase (protein kinase C) in vitro when added up to 1.2 μM.  Therefore, the actions of okadaic acid and phorbol ester may be mediated in different ways.  These results show that okadaic acid is a non-TPA-type tumor promoter in mouse skin carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTZJGIsBydTbVg90H21EOLACvtfcHk0ljs87ojYS178A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXktVaitrw%253D&md5=9aa530e2a6fa72ef04baa1146d024417</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.6.1768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.6.1768%26sid%3Dliteratum%253Aachs%26aulast%3DSuganuma%26aufirst%3DM.%26aulast%3DFujiki%26aufirst%3DH.%26aulast%3DSuguri%26aufirst%3DH.%26aulast%3DYoshizawa%26aufirst%3DS.%26aulast%3DHirota%26aufirst%3DM.%26aulast%3DNakayasu%26aufirst%3DM.%26aulast%3DOjika%26aufirst%3DM.%26aulast%3DWakamatsu%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DSugimura%26aufirst%3DT.%26atitle%3DOkadaic%2520Acid%253A%2520An%2520Additional%2520Non-Phorbol-12-Tetradecanoate-13-Acetate-Type%2520Tumor%2520Promoter%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D1768%26epage%3D1771%26doi%3D10.1073%2Fpnas.85.6.1768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suganuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuya-Suguri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fusetani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimura, T.</span></span> <span> </span><span class="NLM_article-title">Calyculin a, an Inhibitor of Protein Phosphatases, a Potent Tumor Promoter on Cd-1 Mouse Skin</span>. <i>Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3521</span>– <span class="NLM_lpage">3525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=3521-3525&author=M.+Suganumaauthor=H.+Fujikiauthor=H.+Furuya-Suguriauthor=S.+Yoshizawaauthor=S.+Yasumotoauthor=Y.+Katoauthor=N.+Fusetaniauthor=T.+Sugimura&title=Calyculin+a%2C+an+Inhibitor+of+Protein+Phosphatases%2C+a+Potent+Tumor+Promoter+on+Cd-1+Mouse+Skin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuganuma%26aufirst%3DM.%26aulast%3DFujiki%26aufirst%3DH.%26aulast%3DFuruya-Suguri%26aufirst%3DH.%26aulast%3DYoshizawa%26aufirst%3DS.%26aulast%3DYasumoto%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DFusetani%26aufirst%3DN.%26aulast%3DSugimura%26aufirst%3DT.%26atitle%3DCalyculin%2520a%252C%2520an%2520Inhibitor%2520of%2520Protein%2520Phosphatases%252C%2520a%2520Potent%2520Tumor%2520Promoter%2520on%2520Cd-1%2520Mouse%2520Skin%26jtitle%3DCancer%2520Res.%2520Treat.%26date%3D1990%26volume%3D50%26spage%3D3521%26epage%3D3525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suganuma, M.</span></span> <span> </span><span class="NLM_article-title">Tumor Promotion by Inhibitors of Protein Phosphatases 1 and 2a: The Okadaic Acid Class of Compounds</span>. <i>Adv. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/S0065-230X(08)60958-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0065-230X%2808%2960958-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8394044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFensLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1993&pages=143-194&author=H.+Fujikiauthor=M.+Suganuma&title=Tumor+Promotion+by+Inhibitors+of+Protein+Phosphatases+1+and+2a%3A+The+Okadaic+Acid+Class+of+Compounds&doi=10.1016%2FS0065-230X%2808%2960958-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor promotion by inhibitors of protein phosphatases 1 and 2A: The okadaic acid class of compounds</span></div><div class="casAuthors">Fujiki, Hirota; Suganuma, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-94</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    </div><div class="casAbstract">A review with many refs. on okadaic acid compds., calyculins, microcystins, nodularin, tautomycin and human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokprynlqNJ3rVg90H21EOLACvtfcHk0lgpqtDFoISF3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFensLk%253D&md5=81c71b978764ef1b6d9152934c51865b</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2808%2960958-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252808%252960958-6%26sid%3Dliteratum%253Aachs%26aulast%3DFujiki%26aufirst%3DH.%26aulast%3DSuganuma%26aufirst%3DM.%26atitle%3DTumor%2520Promotion%2520by%2520Inhibitors%2520of%2520Protein%2520Phosphatases%25201%2520and%25202a%253A%2520The%2520Okadaic%2520Acid%2520Class%2520of%2520Compounds%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D1993%26volume%3D61%26spage%3D143%26epage%3D194%26doi%3D10.1016%2FS0065-230X%2808%2960958-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hein, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandquist, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshacharyulu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span> <span> </span><span class="NLM_article-title">Pr55α Regulatory Subunit of Pp2a Inhibits the Mob1/Lats Cascade and Activates Yap in Pancreatic Cancer Cells</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">63</span>, <span class="refDoi"> DOI: 10.1038/s41389-019-0172-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fs41389-019-0172-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31659153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BB3MjisVWjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=63&author=A.+L.+Heinauthor=N.+D.+Brandquistauthor=C.+Y.+Ouelletteauthor=P.+Seshacharyuluauthor=C.+A.+Enkeauthor=M.+M.+Ouelletteauthor=S.+K.+Batraauthor=Y.+Yan&title=Pr55%CE%B1+Regulatory+Subunit+of+Pp2a+Inhibits+the+Mob1%2FLats+Cascade+and+Activates+Yap+in+Pancreatic+Cancer+Cells&doi=10.1038%2Fs41389-019-0172-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells</span></div><div class="casAuthors">Hein Ashley L; Brandquist Nichole D; Ouellette Caroline Y; Enke Charles A; Yan Ying; Seshacharyulu Parthasarathy; Ouellette Michel M; Batra Surinder K; Yan Ying; Ouellette Michel M</div><div class="citationInfo"><span class="NLM_cas:title">Oncogenesis</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">63</span>
        ISSN:<span class="NLM_cas:issn">2157-9024</span>.
    </div><div class="casAbstract">PP2A holoenzyme complexes are responsible for the majority of Ser/Thr phosphatase activities in human cells.  Each PP2A consists of a catalytic subunit (C), a scaffold subunit (A), and a regulatory subunit (B).  While the A and C subunits each exists only in two highly conserved isoforms, a large number of B subunits share no homology, which determines PP2A substrate specificity and cellular localization.  It is anticipated that different PP2A holoenzymes play distinct roles in cellular signaling networks, whereas PP2A has only generally been defined as a putative tumor suppressor, which is mostly based on the loss-of-function studies using pharmacological or biological inhibitors for the highly conserved A or C subunit of PP2A.  Recent studies of specific pathways indicate that some PP2A complexes also possess tumor-promoting functions.  We have previously reported an essential role of PR55α, a PP2A regulatory subunit, in the support of oncogenic phenotypes, including in vivo tumorigenicity/metastasis of pancreatic cancer cells.  In this report, we have elucidated a novel role of PR55α-regulated PP2A in the activation of YAP oncoprotein, whose function is required for anchorage-independent growth during oncogenesis of solid tumors.  Our data show two lines of YAP regulation by PR55α: (1) PR55α inhibits the MOB1-triggered autoactivation of LATS1/2 kinases, the core member of the Hippo pathway that inhibits YAP by inducing its proteasomal degradation and cytoplasmic retention and (2) PR55α directly interacts with and regulates YAP itself.  Accordingly, PR55α is essential for YAP-promoted gene transcriptions, as well as for anchorage-independent growth, in which YAP plays a key role.  In summary, current findings demonstrate a novel YAP activation mechanism based on the PR55α-regulated PP2A phosphatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR2TUtaXPf8uKNc3HjJRoFAfW6udTcc2eY0g3V7qQnjiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjisVWjtg%253D%253D&md5=e387c69ef4990ee2a6ef1b1fc13b0b50</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fs41389-019-0172-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41389-019-0172-9%26sid%3Dliteratum%253Aachs%26aulast%3DHein%26aufirst%3DA.%2BL.%26aulast%3DBrandquist%26aufirst%3DN.%2BD.%26aulast%3DOuellette%26aufirst%3DC.%2BY.%26aulast%3DSeshacharyulu%26aufirst%3DP.%26aulast%3DEnke%26aufirst%3DC.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BM.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26aulast%3DYan%26aufirst%3DY.%26atitle%3DPr55%25CE%25B1%2520Regulatory%2520Subunit%2520of%2520Pp2a%2520Inhibits%2520the%2520Mob1%252FLats%2520Cascade%2520and%2520Activates%2520Yap%2520in%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DOncogenesis%26date%3D2019%26volume%3D8%26spage%3D63%26doi%3D10.1038%2Fs41389-019-0172-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hein, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshacharyulu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachagani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheinin, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnusamy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumby, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span> <span> </span><span class="NLM_article-title">Pr55α Subunit of Protein Phosphatase 2a Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">2243</span>– <span class="NLM_lpage">2253</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-2119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F0008-5472.CAN-15-2119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26893480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVagsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=2243-2253&author=A.+L.+Heinauthor=P.+Seshacharyuluauthor=S.+Rachaganiauthor=Y.+M.+Sheininauthor=M.+M.+Ouelletteauthor=M.+P.+Ponnusamyauthor=M.+C.+Mumbyauthor=S.+K.+Batraauthor=Y.+Yan&title=Pr55%CE%B1+Subunit+of+Protein+Phosphatase+2a+Supports+the+Tumorigenic+and+Metastatic+Potential+of+Pancreatic+Cancer+Cells+by+Sustaining+Hyperactive+Oncogenic+Signaling&doi=10.1158%2F0008-5472.CAN-15-2119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling</span></div><div class="casAuthors">Hein, Ashley L.; Seshacharyulu, Parthasarathy; Rachagani, Satyanarayana; Sheinin, Yuri M.; Ouellette, Michel M.; Ponnusamy, Moorthy P.; Mumby, Marc C.; Batra, Surinder K.; Yan, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2243-2253</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The protein phosphatase 2 (PP2A) holoenzyme consists of a catalytic subunit, a scaffold subunit, and a regulatory subunit.  Based on loss-of-function anal. using PP2A catalytic inhibitors or inhibition via tumor viral antigens, limited studies suggest that PP2A is a putative tumor suppressor.  However, PP2A has also been shown to facilitate the activation of oncogenic signaling pathways when assocd. with specific regulatory subunits.  In this study, we investigated the possible oncogenic role of PP2A in pancreatic cancer.  We found a striking increase in the expression of PR55α (PPP2R2A), a PP2A regulatory subunit, in pancreatic cancer cells compared with normal pancreatic epithelial cells.  Consistently, PR55α expression was markedly elevated in pancreatic ductal adenocarcinoma tissues compared with adjacent normal pancreatic tissues (P < 0.0001) and correlated with poor survival of pancreatic cancer patients (P < 0.0003).  RNAi-mediated depletion of PR55α in pancreatic cancer cell lines resulted in diminished phosphorylation of both AKT and ERK1/2 (MAPK3/1) and decreased protein levels of β-catenin (CTNNB1).  Accordingly, pancreatic cancer cells with reduced PR55α expression exhibited significantly impaired properties of transformation, including attenuated cell growth, clonogenicity, mobility, and anchorage-independent growth.  Moreover, orthotopic implantation of PR55α-depleted pancreatic cancer cells into nude mice resulted in markedly reduced tumorigenicity (P < 0.001) and distant metastases.  Together, these results suggest that PR55α promotes pancreatic cancer development by sustaining hyperactivity of multiple oncogenic signaling pathways, including AKT, ERK, and Wnt.  These studies also provide a basis for exploring PR55α as a diagnostic or therapeutic target in pancreatic cancer.  Cancer Res; 76(8); 2243-53. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpctfLsB_OWHbVg90H21EOLACvtfcHk0lgpqtDFoISF3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVagsr4%253D&md5=0c6e0ef27c8db5734572cdd14d4d98ba</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-2119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-2119%26sid%3Dliteratum%253Aachs%26aulast%3DHein%26aufirst%3DA.%2BL.%26aulast%3DSeshacharyulu%26aufirst%3DP.%26aulast%3DRachagani%26aufirst%3DS.%26aulast%3DSheinin%26aufirst%3DY.%2BM.%26aulast%3DOuellette%26aufirst%3DM.%2BM.%26aulast%3DPonnusamy%26aufirst%3DM.%2BP.%26aulast%3DMumby%26aufirst%3DM.%2BC.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26aulast%3DYan%26aufirst%3DY.%26atitle%3DPr55%25CE%25B1%2520Subunit%2520of%2520Protein%2520Phosphatase%25202a%2520Supports%2520the%2520Tumorigenic%2520and%2520Metastatic%2520Potential%2520of%2520Pancreatic%2520Cancer%2520Cells%2520by%2520Sustaining%2520Hyperactive%2520Oncogenic%2520Signaling%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D2243%26epage%3D2253%26doi%3D10.1158%2F0008-5472.CAN-15-2119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dohoney, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillerm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteford, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hager, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, J. N.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of P53 at Serine 37 Is Important for Transcriptional Activity and Regulation in Response to DNA Damage</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1207005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsj.onc.1207005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=14712210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=49-57&author=K.+M.+Dohoneyauthor=C.+Guillermauthor=C.+Whitefordauthor=C.+Elbiauthor=P.+F.+Lambertauthor=G.+L.+Hagerauthor=J.+N.+Brady&title=Phosphorylation+of+P53+at+Serine+37+Is+Important+for+Transcriptional+Activity+and+Regulation+in+Response+to+DNA+Damage&doi=10.1038%2Fsj.onc.1207005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage</span></div><div class="casAuthors">Dohoney, Kathleen M.; Guillerm, Claire; Whiteford, Craig; Elbi, Cem; Lambert, Paul F.; Hager, Gordon L.; Brady, John N.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-57</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The p53 tumor suppressor protein plays a crit. role in mediating cellular response to stress.  Upon DNA damage, post-translational modifications stabilize and activate this nuclear phosphoprotein.  To det. the effect of phosphorylation site mutants in the context of the whole p53 protein, we performed reporter assays in p53 and MDM2 knockout mouse embryonic fibroblasts transfected with full-length p53 constructs.  We show that mutation of S37 causes a decrease in p53 transcriptional activity compared to wild-type p53.  Our data further suggest that the dephosphorylation of p53 at S37 is a regulated event involving protein phosphatase 2A (PP2A).  Coimmunopptn. and immunofluorescence microscopy studies demonstrate that PP2A and p53 assoc. with one another in vivo following γ-irradn.  Consistent with these observations, phosphorylated S37 accumulates in cell exts. prepd. from γ-irradiated Molt-4 cells in the presence of okadaic acid.  Furthermore, in vitro phosphatase assays show that PP2A dephosphorylates p53 at S37.  These results suggest that dephosphorylation of p53 at S37 plays a role in the transcriptional regulation of the p53 protein in response to DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-PeB-y_VrLVg90H21EOLACvtfcHk0lgILHfX8lzODg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKgsg%253D%253D&md5=e191cae86f3cf566409740c505d3b830</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207005%26sid%3Dliteratum%253Aachs%26aulast%3DDohoney%26aufirst%3DK.%2BM.%26aulast%3DGuillerm%26aufirst%3DC.%26aulast%3DWhiteford%26aufirst%3DC.%26aulast%3DElbi%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DP.%2BF.%26aulast%3DHager%26aufirst%3DG.%2BL.%26aulast%3DBrady%26aufirst%3DJ.%2BN.%26atitle%3DPhosphorylation%2520of%2520P53%2520at%2520Serine%252037%2520Is%2520Important%2520for%2520Transcriptional%2520Activity%2520and%2520Regulation%2520in%2520Response%2520to%2520DNA%2520Damage%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D49%26epage%3D57%26doi%3D10.1038%2Fsj.onc.1207005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shouse, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piluso, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">A Specific Pp2a Regulatory Subunit, B56gamma, Mediates DNA Damage-Induced Dephosphorylation of P53 at Thr55</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsj.emboj.7601519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17245430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFKnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=402-411&author=H.+H.+Liauthor=X.+Caiauthor=G.+P.+Shouseauthor=L.+G.+Pilusoauthor=X.+Liu&title=A+Specific+Pp2a+Regulatory+Subunit%2C+B56gamma%2C+Mediates+DNA+Damage-Induced+Dephosphorylation+of+P53+at+Thr55&doi=10.1038%2Fsj.emboj.7601519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">A specific PP2A regulatory subunit, B56γ, mediates DNA damage-induced dephosphorylation of p53 at Thr55</span></div><div class="casAuthors">Li, Heng-Hong; Cai, Xin; Shouse, Geoffrey P.; Piluso, Landon G.; Liu, Xuan</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">402-411</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein phosphatase 2A (PP2A) has been implicated to exert its tumor suppressive function via a small subset of regulatory subunits.  In this study, we reported that the specific B regulatory subunits of PP2A B56γ1 and B56γ3 mediate dephosphorylation of p53 at Thr55.  Ablation of the B56γ protein by RNAi, which abolishes the Thr55 dephosphorylation in response to DNA damage, reduces p53 stabilization, Bax expression and cell apoptosis.  To investigate the mol. mechanisms, we have shown that the endogenous B56γ protein level and assocn. with p53 increase after DNA damage.  Finally, we demonstrate that Thr55 dephosphorylation is required for B56γ3-mediated inhibition of cell proliferation and cell transformation.  These results suggest a mol. mechanism for B56γ-mediated tumor suppression and provide a potential route for regulation of B56γ-specific PP2A complex function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogpCl1lcVVR7Vg90H21EOLACvtfcHk0lgILHfX8lzODg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFKnug%253D%253D&md5=cd8d5524ac3afc35f6aa9eed449c299f</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601519%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%2BH.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DShouse%26aufirst%3DG.%2BP.%26aulast%3DPiluso%26aufirst%3DL.%2BG.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DA%2520Specific%2520Pp2a%2520Regulatory%2520Subunit%252C%2520B56gamma%252C%2520Mediates%2520DNA%2520Damage-Induced%2520Dephosphorylation%2520of%2520P53%2520at%2520Thr55%26jtitle%3DEMBO%2520J.%26date%3D2007%26volume%3D26%26spage%3D402%26epage%3D411%26doi%3D10.1038%2Fsj.emboj.7601519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span> <span> </span><span class="NLM_article-title">Knockdown of Protein Phosphatase 4 Regulatory Subunit 1 Inhibits Growth of Lung Cancer Cells in Vitro</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">10513</span>– <span class="NLM_lpage">10520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXms1WqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=10513-10520&author=Y.+Zhuauthor=Y.+Wuauthor=J.+Wangauthor=F.+Lvauthor=X.+Shen&title=Knockdown+of+Protein+Phosphatase+4+Regulatory+Subunit+1+Inhibits+Growth+of+Lung+Cancer+Cells+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Knockdown of protein phosphatase 4 regulatory subunit 1 inhibits growth of lung cancer cells in vitro</span></div><div class="casAuthors">Zhu, Yanping; Wu, Yun; Wang, Jialei; Lv, Fanzhen; Shen, Xiaoyong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">10513-10520</span>CODEN:
                <span class="NLM_cas:coden">IJCEFA</span>;
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Lung cancer is the leading cause of death from cancer around the world.  Cancer patients undertaking chemotherapy or radiotherapy would experience a wide range of distressing side effects.  Hence, exploring a promising new and safe therapeutic strategy to fight against cancer was urgent.  Protein phosphatase 4 catalytic subunit (PP4c) is a member of the Protein phosphatase 2 (PP2A) family and play an essential role in biol. processes of microtubule (MT) growth/organization, apoptosis, and tumor necrosis factor signaling.  Protein phosphatase 4 regulatory subunit 1 (PPP4R1), a protein that co-purifying with PP4c from bovine testis exts., has been reported to be involved in tumor progression.  However, its functional role in lung cancer remains unclear.  In this study, we firstly evaluated the expression levels of PPP4R1 in three lung cancer cell lines by quant. real-time PCR (qRT-PCR) anal. and found that PPP4R1 was expressed highest in 95D cells.  Then PPP4R1 was knocked down by lentivirus-based system in 95D cells.  Proliferation and colony nos. were evaluated in lung cancer 95D cells by tetrazolium (MTT) and colony formation assay, resp.  As a result, stable knockdown of PPP4R1 led to suppression of proliferation and colony-forming ability in 95D cells.  Subsequently, the cell cycle anal. showed knockdown of PPP4R1 arrested cell cycle at G0/G1 phase in 95D cells.  Further investigation indicated that knockdown of PPP4R1 down-regulated cell-cycle activators, including CDK2, CDK4 and CDK6, as detd. by western blot.  Our results suggest that PPP4R1 knockdown inhibited lung cancer cell proliferation via down regulating cell-cycle activators.  The identification of PPP4R1 may provide a potential therapeutic strategy for lung cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyc-f7XRj_grVg90H21EOLACvtfcHk0liCq12wOdXHeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXms1WqurY%253D&md5=0c3e12202dbbe3a2976c2f61b7ea6aa2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLv%26aufirst%3DF.%26aulast%3DShen%26aufirst%3DX.%26atitle%3DKnockdown%2520of%2520Protein%2520Phosphatase%25204%2520Regulatory%2520Subunit%25201%2520Inhibits%2520Growth%2520of%2520Lung%2520Cancer%2520Cells%2520in%2520Vitro%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2016%26volume%3D9%26spage%3D10513%26epage%3D10520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Pp4r1 Accelerates Cell Growth and Proliferation in Hepg2 Hepatocellular Carcinoma</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2067</span>– <span class="NLM_lpage">2074</span>, <span class="refDoi"> DOI: 10.2147/OTT.S77709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2147%2FOTT.S77709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26300649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFegtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=2067-2074&author=G.+Wuauthor=Z.+Maauthor=J.+Qianauthor=B.+Liu&title=Pp4r1+Accelerates+Cell+Growth+and+Proliferation+in+Hepg2+Hepatocellular+Carcinoma&doi=10.2147%2FOTT.S77709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">PP4R1 accelerates cell growth and proliferation in HepG2 hepatocellular carcinoma</span></div><div class="casAuthors">Wu, Gang; Ma, Zhenyu; Qian, Jianmin; Liu, Bin</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2067-2074</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC), as the fifth most common cancer worldwide, has become the third leading cause of cancer-related deaths.  It is reported that protein phosphatase 4 (PP4) is an essential protein for nucleation, growth, and stabilization of microtubules in centrosomes/spindle bodies during cell division.  Besides, previous studies have identified protein phosphatase 4 regulatory subunit 1 (PP4R1) as a constitutive interaction partner of PP4 catalytic subunit PP4C.  The PP4C-PP4R1 PP4 complex plays a role in dephosphorylation, regulation of histone acetylation, and NF-κB activation.  However, little is known about the pathol. functions of PP4R1 in human cancers.  Thus, in order to investigate how PP4R1 functions in human HCC, two common hepatocarcinogenesis HCC cell lines HepG2 and SMMC-7721 were employed, transduced with recombinant lentivirus expressing PP4R1 short hairpin RNA.  Compared with the controls, the cells treated with Lv-shPP4R1 showed a significant decrease in cell proliferation and colony formation.  The results of flow cytometry showed that the knockdown of PP4R1 caused HepG2 cells arrest at G2/M phase in the cell cycle.  Furthermore, the transduction of Lv-shPP4R1 into HepG2 cells led to the inactivation of two major mitogen-activated protein kinase signaling cascades: p38 and c-Jun N-terminal kinase (JNK), indicating that PP4R1 could promote cell proliferation, which might be regulated by p38 and c-Jun N-terminal kinase pathways.  In a word, this study highlights the crucial role of PP4R1 in promoting HCC cell growth, which might elucidate the pathol. mechanism of HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW3WgqxNrntrVg90H21EOLACvtfcHk0liCq12wOdXHeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFegtLg%253D&md5=9b200f429892e43711a554fd7da65e63</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2147%2FOTT.S77709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S77709%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DPp4r1%2520Accelerates%2520Cell%2520Growth%2520and%2520Proliferation%2520in%2520Hepg2%2520Hepatocellular%2520Carcinoma%26jtitle%3DOncoTargets%2520Ther.%26date%3D2015%26volume%3D8%26spage%3D2067%26epage%3D2074%26doi%3D10.2147%2FOTT.S77709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisters, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbruzzese, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage Ii Pancreatic Ductal Adenocarcinoma</span>. <i>Cancer Epidemiol., Biomarkers Prev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1336</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1158/1055-9965.EPI-12-0223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1055-9965.EPI-12-0223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22665577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOhs73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=1336-1343&author=S.+Wengauthor=H.+Wangauthor=W.+Chenauthor=M.+H.+Katzauthor=D.+Chatterjeeauthor=J.+E.+Leeauthor=P.+W.+Pistersauthor=H.+F.+Gomezauthor=J.+L.+Abbruzzeseauthor=J.+B.+Flemingauthor=H.+Wang&title=Overexpression+of+Protein+Phosphatase+4+Correlates+with+Poor+Prognosis+in+Patients+with+Stage+Ii+Pancreatic+Ductal+Adenocarcinoma&doi=10.1158%2F1055-9965.EPI-12-0223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Weng, Shaofan; Wang, Hua; Chen, Weihong; Katz, Matthew H.; Chatterjee, Deyali; Lee, Jeffrey E.; Pisters, Peter W.; Gomez, Henry F.; Abbruzzese, James L.; Fleming, Jason B.; Wang, Huamin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Epidemiology, Biomarkers & Prevention</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1336-1343</span>CODEN:
                <span class="NLM_cas:coden">CEBPE4</span>;
        ISSN:<span class="NLM_cas:issn">1055-9965</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Protein phosphatase 4 (PP4) has been reported to be overexpressed in breast and lung cancers.  PP4 plays an important role in the regulation of centrosome maturation, DNA repair, NF-κB, and c-jun-NH2-kinase (JNK) signaling pathways.  However, the expression and functions of PP4 in pancreatic cancer have not been studied.  Exptl. Design: We examd. the expression of PP4 catalytic subunit (PP4C) protein in 133 patients with stage II pancreatic ductal adenocarcinoma (PDAC) and their paired benign pancreatic samples (N = 113) by immunohistochem.  To confirm the immunohistochem. results, we measured PP4C protein and mRNA levels by Western blotting and real-time reverse transcriptase PCR.  Using univariate and multivariate anal., we correlated PP4C expression with survival and other clinicopathol. features.  Results: PP4C was overexpressed in 75 of 133 (56.4%) stage II PDAC samples, which was significantly higher than the paired benign pancreatic tissue (15%, 17 of 113).  PP4C mRNA expression levels were also higher in PDAC samples than the paired benign pancreatic tissue.  Overexpression of PP4C in PDAC samples was assocd. with higher frequencies of distant metastasis (P = 0.02) and poor disease-free and overall survivals in patients with stage II PDAC (P = 0.006 and 0.02) independent of tumor size, margin status, and lymph node status (stage).  Conclusions: Our study showed that PP4C is overexpressed in PDAC.  Overexpression of PP4C in PDAC samples is assocd. with poor prognosis in patients with stage II PDAC.  Therefore, targeting PP4 signaling pathway may represent a new approach for the treatment of PDAC.  Impact: Our study showed that PP4C is an independent prognostic factor in patients with stage II PDAC.  Cancer Epidemiol Biomarkers Prev; 21(8); 1336-43. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUDVHHguAIMLVg90H21EOLACvtfcHk0lii8C423yHemA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOhs73J&md5=63a2d4d4ce6c702c9febe3b6e12cf607</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1158%2F1055-9965.EPI-12-0223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1055-9965.EPI-12-0223%26sid%3Dliteratum%253Aachs%26aulast%3DWeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DKatz%26aufirst%3DM.%2BH.%26aulast%3DChatterjee%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DPisters%26aufirst%3DP.%2BW.%26aulast%3DGomez%26aufirst%3DH.%2BF.%26aulast%3DAbbruzzese%26aufirst%3DJ.%2BL.%26aulast%3DFleming%26aufirst%3DJ.%2BB.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DOverexpression%2520of%2520Protein%2520Phosphatase%25204%2520Correlates%2520with%2520Poor%2520Prognosis%2520in%2520Patients%2520with%2520Stage%2520Ii%2520Pancreatic%2520Ductal%2520Adenocarcinoma%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2012%26volume%3D21%26spage%3D1336%26epage%3D1343%26doi%3D10.1158%2F1055-9965.EPI-12-0223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herzig, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullinger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasdogan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teleanu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rücker, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paschka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchenbauer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidel, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buske, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döhner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döhner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidzik, V. I.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 4 Regulatory Subunit 2 (Ppp4r2) Is Recurrently Deleted in Acute Myeloid Leukemia and Required for Efficient DNA Double Strand Break Repair</span>. <i>Onco Targets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">95038</span>– <span class="NLM_lpage">95053</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.21119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.18632%2Foncotarget.21119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=95038-95053&author=J.+K.+Herzigauthor=L.+Bullingerauthor=A.+Tasdoganauthor=P.+Zimmermannauthor=M.+Schlegelauthor=V.+Teleanuauthor=D.+Weberauthor=F.+G.+R%C3%BCckerauthor=P.+Paschkaauthor=A.+Dolnikauthor=E.+Schneiderauthor=F.+Kuchenbauerauthor=F.+H.+Heidelauthor=C.+Buskeauthor=H.+D%C3%B6hnerauthor=K.+D%C3%B6hnerauthor=V.+I.+Gaidzik&title=Protein+Phosphatase+4+Regulatory+Subunit+2+%28Ppp4r2%29+Is+Recurrently+Deleted+in+Acute+Myeloid+Leukemia+and+Required+for+Efficient+DNA+Double+Strand+Break+Repair&doi=10.18632%2Foncotarget.21119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.21119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.21119%26sid%3Dliteratum%253Aachs%26aulast%3DHerzig%26aufirst%3DJ.%2BK.%26aulast%3DBullinger%26aufirst%3DL.%26aulast%3DTasdogan%26aufirst%3DA.%26aulast%3DZimmermann%26aufirst%3DP.%26aulast%3DSchlegel%26aufirst%3DM.%26aulast%3DTeleanu%26aufirst%3DV.%26aulast%3DWeber%26aufirst%3DD.%26aulast%3DR%25C3%25BCcker%26aufirst%3DF.%2BG.%26aulast%3DPaschka%26aufirst%3DP.%26aulast%3DDolnik%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DKuchenbauer%26aufirst%3DF.%26aulast%3DHeidel%26aufirst%3DF.%2BH.%26aulast%3DBuske%26aufirst%3DC.%26aulast%3DD%25C3%25B6hner%26aufirst%3DH.%26aulast%3DD%25C3%25B6hner%26aufirst%3DK.%26aulast%3DGaidzik%26aufirst%3DV.%2BI.%26atitle%3DProtein%2520Phosphatase%25204%2520Regulatory%2520Subunit%25202%2520%2528Ppp4r2%2529%2520Is%2520Recurrently%2520Deleted%2520in%2520Acute%2520Myeloid%2520Leukemia%2520and%2520Required%2520for%2520Efficient%2520DNA%2520Double%2520Strand%2520Break%2520Repair%26jtitle%3DOnco%2520Targets%2520Ther.%26date%3D2017%26volume%3D8%26spage%3D95038%26epage%3D95053%26doi%3D10.18632%2Foncotarget.21119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mirna, M. M.</span>; <span class="NLM_string-name">Robert, H.</span>; <span class="NLM_string-name">Cyntura, S.</span>; <span class="NLM_string-name">Alicja, L.</span></span> <span> </span><span class="NLM_article-title">Role of Protein Phosphatase 4 Regulatory Subunits in Myeloid Leukaemia</span>. In  <i>NCRI Cancer Conference</i>, November 6–9, 2016, Liverpool, UK; <span class="NLM_publisher-name">NCRI</span>: <span class="NLM_publisher-loc">London</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+M.+Mirna&author=H.+Robert&author=S.+Cyntura&author=L.+Alicja&title=Role+of+Protein+Phosphatase+4+Regulatory+Subunits+in+Myeloid+Leukaemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMirna%26aufirst%3DM.%2BM.%26atitle%3DRole%2520of%2520Protein%2520Phosphatase%25204%2520Regulatory%2520Subunits%2520in%2520Myeloid%2520Leukaemia%26jtitle%3DNCRI%2520Cancer%2520Conference%26pub%3DNCRI%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z.</span></span> <span> </span><span class="NLM_article-title">Lentivirus-Mediated Short-Hairpin Rna Targeting Protein Phosphatase 4 Regulatory Subunit 1 Inhibits Growth in Breast Cancer</span>. <i>Journal of breast cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.4048/jbc.2015.18.3.218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.4048%2Fjbc.2015.18.3.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26472971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC28zisF2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=218-224&author=Y.+Qiauthor=T.+Huauthor=K.+Liauthor=R.+Yeauthor=Z.+Ye&title=Lentivirus-Mediated+Short-Hairpin+Rna+Targeting+Protein+Phosphatase+4+Regulatory+Subunit+1+Inhibits+Growth+in+Breast+Cancer&doi=10.4048%2Fjbc.2015.18.3.218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Lentivirus-Mediated Short-Hairpin RNA Targeting Protein Phosphatase 4 Regulatory Subunit 1 Inhibits Growth in Breast Cancer</span></div><div class="casAuthors">Qi Yuying; Ye Renqing; Ye Zuodong; Hu Tinghui; Li Kai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of breast cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">218-24</span>
        ISSN:<span class="NLM_cas:issn">1738-6756</span>.
    </div><div class="casAbstract">PURPOSE:  Protein phosphatase 4 regulatory subunit 1 (PP4R1), as an interaction partner of the catalytic serine/threonine-protein phosphatase 4 catalytic subunit has been shown to involve in cellular processes and nuclear factor κB signaling.  However, the functions of PP4R1 in human breast cancers remain unclear.  This study is designed to explore the effect of PP4R1 knockdown on the biological characteristics of breast cancer cells.  METHODS:  A lentivirus-mediated short hairpin RNA (shRNA) was designed to knockdown the expression of PP4R1 in ZR-75-30 breast cancer cells.  The efficiency of lentivirus-mediated shRNA infection was determined using fluorescence microscopy to observe lentivirus-mediated green fluorescent protein expression and confirmed to be over 80%.  PP4R1 expression in infected ZR-75-30 cells was detected by quantitative real-time polymerase chain reaction and western blot analysis.  Cell proliferation and colony formation ability were measured by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay and colony formation assay, respectively.  Flow cytometry was used to measure cell cycle progression and cell apoptosis.  In addition, apoptosis makers, including poly-ADP-ribose polymerase (PARP) and caspase-3, were investigated in PP4R1-silenced ZR-75-30 cells by western blot assay.  RESULTS:  We successfully constructed lentivirus-mediated shRNA to target PP4R1 in ZR-75-30 cells.  MTT assay and colony formation assay showed the loss of PP4R1 suppressed the proliferation of ZR-75-30 cells.  Flow cytometry analysis indicated cell cycle arrest and increased cell apoptosis in PP4R1 knockdown cells.  Further, the apoptosis response in cells depleted of PP4R1 was illustrated by downregulation of PARP and upregulation of caspase-3.  CONCLUSION:  Our results suggest that PP4R1 could promote breast cancer cell proliferation and might play a vital role in breast cancer occurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTg6XDPcrotG7jnyZkbE8yXfW6udTcc2eYKOPF0OF_LJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zisF2jsA%253D%253D&md5=cc7a755d5808686c5e092c34b934b7d8</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.4048%2Fjbc.2015.18.3.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4048%252Fjbc.2015.18.3.218%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DR.%26aulast%3DYe%26aufirst%3DZ.%26atitle%3DLentivirus-Mediated%2520Short-Hairpin%2520Rna%2520Targeting%2520Protein%2520Phosphatase%25204%2520Regulatory%2520Subunit%25201%2520Inhibits%2520Growth%2520in%2520Breast%2520Cancer%26jtitle%3DJournal%2520of%2520breast%2520cancer%26date%3D2015%26volume%3D18%26spage%3D218%26epage%3D224%26doi%3D10.4048%2Fjbc.2015.18.3.218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span> <span> </span><span class="NLM_article-title">Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1166</span>– <span class="NLM_lpage">1176</span>, <span class="refDoi"> DOI: 10.2174/1389557511313080005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F1389557511313080005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23373656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslyrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1166-1176&author=L.+P.+Dengauthor=J.+Dongauthor=W.+Wang&title=Exploiting+Protein+Phosphatase+Inhibitors+Based+on+Cantharidin+Analogues+for+Cancer+Drug+Discovery&doi=10.2174%2F1389557511313080005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting protein phosphatase inhibitors based on cantharidin analogues for cancer drug discovery</span></div><div class="casAuthors">Deng, Liping; Dong, Jian; Wang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1166-1176</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cantharidin (CTD), a natural toxin, can inhibit a variety of tumor cell lines, esp. hepatocellular carcinoma cells.  It is a strong inhibitor of protein phosphatase type 1 (PP1) and type 2A (PP2A).  Because of the cytotoxicity, the clin. application of CDT is limited.  Here, we review the structure-activity relationships of CDT analogs, including norcantharidin (NCTD), cantharimides and related derivs. of CTDs, which have more powerful antitumor activity but less cytotoxicity than CDT itself.  Important advances in the design of the CTD-based inhibitors achieved recently are outlined here in order to establish principles for synthesis, screening, and the applications of promising anti-cancer drug candidates.  In addn., efforts to ameliorate the intrinsic cytotoxicity through the use of drug carriers are also discussed.  It is conceivable that rational design of the protein phosphatase inhibitors based on cantharidin analogs can be facilitated by studies of mechanism of the protein-inhibitor interactions and the related structural biol. in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSSUpGh8KMe7Vg90H21EOLACvtfcHk0liksHfrAELkGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslyrtLY%253D&md5=1294bf70bdddc356ee08f6d061720d03</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.2174%2F1389557511313080005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557511313080005%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%2BP.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DExploiting%2520Protein%2520Phosphatase%2520Inhibitors%2520Based%2520on%2520Cantharidin%2520Analogues%2520for%2520Cancer%2520Drug%2520Discovery%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1166%26epage%3D1176%26doi%3D10.2174%2F1389557511313080005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Cantharidin, Another Natural Toxin That Inhibits the Activity of Serine/Threonine Protein Phosphatases Types 1 and 2a</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(93)80889-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0014-5793%2893%2980889-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8397101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3sXmtF2gtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=1993&pages=283-286&author=R.+E.+Honkanen&title=Cantharidin%2C+Another+Natural+Toxin+That+Inhibits+the+Activity+of+Serine%2FThreonine+Protein+Phosphatases+Types+1+and+2a&doi=10.1016%2F0014-5793%2893%2980889-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A</span></div><div class="casAuthors">Honkanen, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-6</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">Cantharidin, a natural toxicant of blister beetles, is a strong inhibitor of protein phosphatases types 1(PP1) and 2A (PP2A).  Like okadaic acid, cantharidin inhibits the activity of the purified catalytic subunit of PP2A (IC50 = 0.16 μM) at a lower concn. than that of PP1 (IC50 = 1.7 μM) and only inhibits the activity of protein phosphatase type 2B (PP2B) at high concns.  Dose-inhibition studies conducted with whole cell homogenates indicate that cantharidin also inhibits the native forms of these enzymes.  Thus, cantharidin, which is economical and readily available, may be useful as an addnl. probe for studying the functions of serine/threonine protein phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCTexjtZgU8LVg90H21EOLACvtfcHk0liksHfrAELkGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmtF2gtrk%253D&md5=fe0aed4fcaa215b56456a530316695de</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2893%2980889-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252893%252980889-3%26sid%3Dliteratum%253Aachs%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DCantharidin%252C%2520Another%2520Natural%2520Toxin%2520That%2520Inhibits%2520the%2520Activity%2520of%2520Serine%252FThreonine%2520Protein%2520Phosphatases%2520Types%25201%2520and%25202a%26jtitle%3DFEBS%2520Lett.%26date%3D1993%26volume%3D330%26spage%3D283%26epage%3D286%26doi%3D10.1016%2F0014-5793%2893%2980889-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kok, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, M. Y. P.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin-Induced Apoptosis in Oral Cancer Cells Is Associated with an Increase of Proapoptotic to Antiapoptotic Protein Ratio</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2004.07.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.canlet.2004.07.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15596295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKksbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2005&pages=43-52&author=S.+H.+Kokauthor=S.+J.+Chengauthor=C.+Y.+Hongauthor=J.+J.+Leeauthor=S.+K.+Linauthor=Y.+S.+Kuoauthor=C.+P.+Chiangauthor=M.+Y.+P.+Kuo&title=Norcantharidin-Induced+Apoptosis+in+Oral+Cancer+Cells+Is+Associated+with+an+Increase+of+Proapoptotic+to+Antiapoptotic+Protein+Ratio&doi=10.1016%2Fj.canlet.2004.07.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio</span></div><div class="casAuthors">Kok, Sang-Heng; Cheng, Shih-Jung; Hong, Chi-Yuan; Lee, Jang-Jaer; Lin, Sze-Kwan; Kuo, Ying-Shiung; Chiang, Chun-Pin; Kuo, Mark Yen-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-52</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Norcantharidin (NCTD), the demethylated analog of cantharidin, was used to treat human cancers in China since 1984.  It was recently found to be capable of inducing apoptosis in human colon carcinoma, hepatoma and glioblastoma cells by way of an elusive mechanism.  In this study, the authors demonstrated that NCTD also induces apoptosis in human oral cancer cell lines SAS (p53 wild-type phenotype) and Ca9-22 (p53 mutant) as evidenced by nuclear condensation, TUNEL labeling, DNA fragmentation and cleavage of PARP.  Apoptosis induced by NCTD was both dose- and time-dependent.  The authors found NCTD did not induce Fas and FasL, implying that it activated other apoptosis pathways.  The authors' data showed that NCTD caused accumulation of cytosolic cytochrome c and activation of caspase-9, suggesting that apoptosis occurred via the mitochondria mediated pathway.  NCTD enhanced the expression of Bax in SAS cells consistent with their p53 status.  Moreover, the authors showed that NCTD downregulated the expression of Bcl-2 in Ca9-22 and Bcl-XL in SAS.  The authors' results suggest that NCTD-induced apoptosis in oral cancer cells may be mediated by an increase in the ratios of proapoptotic to antiapoptotic proteins.  Since oral cancer cells with mutant p53 or elevated Bcl-XL levels showed resistance to multiple chemotherapeutic agents, NCTD may overcome the chemoresistance of these cells and provide potential new avenues for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0t5WMeg_eLVg90H21EOLACvtfcHk0liksHfrAELkGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKksbfJ&md5=505b03d726bd7a687c2daacc4a0d8dd2</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.07.045%26sid%3Dliteratum%253Aachs%26aulast%3DKok%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DS.%2BJ.%26aulast%3DHong%26aufirst%3DC.%2BY.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DLin%26aufirst%3DS.%2BK.%26aulast%3DKuo%26aufirst%3DY.%2BS.%26aulast%3DChiang%26aufirst%3DC.%2BP.%26aulast%3DKuo%26aufirst%3DM.%2BY.%2BP.%26atitle%3DNorcantharidin-Induced%2520Apoptosis%2520in%2520Oral%2520Cancer%2520Cells%2520Is%2520Associated%2520with%2520an%2520Increase%2520of%2520Proapoptotic%2520to%2520Antiapoptotic%2520Protein%2520Ratio%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D217%26spage%3D43%26epage%3D52%26doi%3D10.1016%2Fj.canlet.2004.07.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin: Research Advances in Pharmaceutical Activities and Derivatives in Recent Years</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">110755</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2020.110755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.biopha.2020.110755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=33152920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVClsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2020&pages=110755&author=J.+Zhouauthor=Y.+Renauthor=L.+Tanauthor=X.+Songauthor=M.+Wangauthor=Y.+Liauthor=Z.+Caoauthor=C.+Guo&title=Norcantharidin%3A+Research+Advances+in+Pharmaceutical+Activities+and+Derivatives+in+Recent+Years&doi=10.1016%2Fj.biopha.2020.110755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years</span></div><div class="casAuthors">Zhou, Jianbo; Ren, Yali; Tan, Lu; Song, Xiaominting; Wang, Miao; Li, Yuzhi; Cao, Zhixing; Guo, Chuanjie</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110755</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Cantharidin (CTD) is the main bioactive component of Cantharides, which is called Banmao in Traditional Chinese Medicine (TCM).  Norcantharidin (NCTD) is a structural modifier of CTD.  To compare with CTD, NCTD has lighter side effects and stronger bioactivity in anti-cancer through inhibiting cell proliferation, causing apoptosis and autophagy, overwhelming migration and metastasis, affecting immunity as well as lymphangiogenesis.  Examples of these effects include suppressing Protein Phosphatase 2A and modulating Wnt/beta catenin signal, with Caspase family proteins, AMPK pathway and c-Met/EGFR pathway involving resp.  Moreover, NCTD has the effects of immune enhancement, anti-platelet aggregation and inhibition of renal interstitial fibrosis with distinct signaling pathways.  The immunol. effects induced by NCTD are related to the regulation of macrophage polarization and LPS-mediated immune response.  The antiplatelet activity that NCTD induced is relevant to the inhibition of platelet signaling and the downregulation of α2 integrin.  Furthermore, some of novel derivs. designed and synthesized artificially show stronger biol. activities (e.g., anticancer effect, enzyme inhibition effect, antioxidant effect) and lower toxicity than NCTD itself.  Plenty of literatures have reported various pharmacol. effects of NCTD, particularly the anticancer effect, which has been widely concerned in clin. application and lab. research.  In this review, the pharmaceutical activities and derivs. of NCTD are discussed, which can be ref. for further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNm6z-HAVWs7Vg90H21EOLACvtfcHk0lhlNgsowzFuxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVClsbvE&md5=ed227404d8b9d59674af74cf8632a735</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2020.110755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2020.110755%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DC.%26atitle%3DNorcantharidin%253A%2520Research%2520Advances%2520in%2520Pharmaceutical%2520Activities%2520and%2520Derivatives%2520in%2520Recent%2520Years%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2020%26volume%3D131%26spage%3D110755%26doi%3D10.1016%2Fj.biopha.2020.110755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackland, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakoff, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCluskey, A.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Substituted Cantharidin and Norcantharidin Analogues—Synthesis, Protein Phosphatase (1 and 2a) Inhibition, and Anti-Cancer Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3392</span>– <span class="NLM_lpage">3397</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bmcl.2007.03.093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17451951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVals7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3392-3397&author=T.+A.+Hillauthor=S.+G.+Stewartauthor=B.+Sauerauthor=J.+Gilbertauthor=S.+P.+Acklandauthor=J.+A.+Sakoffauthor=A.+McCluskey&title=Heterocyclic+Substituted+Cantharidin+and+Norcantharidin+Analogues%E2%80%94Synthesis%2C+Protein+Phosphatase+%281+and+2a%29+Inhibition%2C+and+Anti-Cancer+Activity&doi=10.1016%2Fj.bmcl.2007.03.093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic substituted cantharidin and norcantharidin analogues-synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity</span></div><div class="casAuthors">Hill, Timothy A.; Stewart, Scott G.; Sauer, Benjamin; Gilbert, Jayne; Ackland, Stephen P.; Sakoff, Jennette A.; McCluskey, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3392-3397</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Norcantharidin is a potent PP1 (IC50 = 9.0 ± 1.4 μM) and PP2A (IC50 = 3.0 ± 0.4 μM) inhibitor with 3-fold PP2A selectivity and induces growth inhibition (GI50 ∼45 μM) across a range of human cancer cell lines including those of colorectal (HT29, SW480), breast (MCF-7), ovarian (A2780), lung (H460), skin (A431), prostate (DU145), neuroblastoma (BE2-C), and glioblastoma (SJ-G2) origin.  Until now limited modifications to the parent compd. have been tolerated.  Surprisingly, simple heterocyclic half-acid norcantharidin analogs are more active than the original lead compd., with the morphilino-substituted I being a more potent (IC50 = 2.8 ± 0.10 μM) and selective (4.6-fold) PP2A inhibitor with greater in vitro cytotoxicity (GI50 ∼9.6 μM) relative to norcantharidin.  The analogous thiomorpholine-substituted II displays increased PP1 inhibition (IC50 = 3.2 ± 0 μM) and reduced PP2A inhibition (IC50 = 5.1 ± 0.41 μM), to norcantharidin.  Synthesis of the analogous cantharidin analog III with incorporation of the amine nitrogen into the heterocycle further increases PP1 (IC50 = 5.9 ± 2.2 μM) and PP2A (IC50 = 0.79 ± 0.1 μM) inhibition and cell cytotoxicity (GI50 ∼3.3 μM).  These analogs represent the most potent cantharidin analogs thus reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7h1jE0eU50rVg90H21EOLACvtfcHk0lhlNgsowzFuxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVals7g%253D&md5=a97b9fa408a2486f1285084ed230eaff</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.093%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DT.%2BA.%26aulast%3DStewart%26aufirst%3DS.%2BG.%26aulast%3DSauer%26aufirst%3DB.%26aulast%3DGilbert%26aufirst%3DJ.%26aulast%3DAckland%26aufirst%3DS.%2BP.%26aulast%3DSakoff%26aufirst%3DJ.%2BA.%26aulast%3DMcCluskey%26aufirst%3DA.%26atitle%3DHeterocyclic%2520Substituted%2520Cantharidin%2520and%2520Norcantharidin%2520Analogues%25E2%2580%2594Synthesis%252C%2520Protein%2520Phosphatase%2520%25281%2520and%25202a%2529%2520Inhibition%252C%2520and%2520Anti-Cancer%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3392%26epage%3D3397%26doi%3D10.1016%2Fj.bmcl.2007.03.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarleton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakoff, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCluskey, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Anticancer Activity of a Series of Norcantharidin Analogues</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.ejmech.2012.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22796041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWntLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2012&pages=573-581&author=M.+Tarletonauthor=J.+Gilbertauthor=J.+A.+Sakoffauthor=A.+McCluskey&title=Synthesis+and+Anticancer+Activity+of+a+Series+of+Norcantharidin+Analogues&doi=10.1016%2Fj.ejmech.2012.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticancer activity of a series of norcantharidin analogues</span></div><div class="casAuthors">Tarleton, Mark; Gilbert, Jayne; Sakoff, Jennette A.; McCluskey, Adam</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">573-581</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Cantharidin (I) and norcantharidin (II) display high levels of anticancer activity against a broad range of tumor cell lines.  Synthetic manipulation of norcantharidin yields (3S,3aR,4S,7R,7aS)-3-hydroxyhexahydro-4,7-epoxyisobenzofuran-1(3H)-one III (R = H), which also displays a high level of anticancer activity against tumor cells but interestingly, shows selectivity towards HT29 (colon; GI50 = 14 μM) and SJ-G2 (glioblastoma; GI50 = 15 μM) cell lines.  Substitution at the hydroxyl group of the cyclic lactone within III (R = H) produces a diastereomeric pair of products that have no difference in cytotoxicity over the cell lines tested.  Incorporation of an iso-Pr tail at this position, giving III (R = OCHMe2), produced the most promising compd. of this series to date, with strong selectivity towards HT29 (colon; GI50 = 19 μM) and SJ-G2 (glioblastoma; GI50 = 21 μM) cell lines but completely void of any activity against the remaining tumor cell lines (GI50 > 100 μM), as per the parent mol.  We also discovered that the introduction of a terminal phosphate moiety, to give IV, at the same position produced a different trend in cytotoxicity with strong activity in BE2-C (neuroblastoma; GI50 = 9 μM) cells; suggestive of an alternate mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7fXI0hNBoy7Vg90H21EOLACvtfcHk0lhlNgsowzFuxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWntLfE&md5=0d00855b5afc8b1e15f5e83968fc1b82</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DTarleton%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DJ.%26aulast%3DSakoff%26aufirst%3DJ.%2BA.%26aulast%3DMcCluskey%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Anticancer%2520Activity%2520of%2520a%2520Series%2520of%2520Norcantharidin%2520Analogues%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D54%26spage%3D573%26epage%3D581%26doi%3D10.1016%2Fj.ejmech.2012.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, B.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Inhibits Il-6-Induced Epithelial-Mesenchymal Transition Via the Jak2/Stat3/Twist Signaling Pathway in Hepatocellular Carcinoma Cells</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1224</span>– <span class="NLM_lpage">1232</span>, <span class="refDoi"> DOI: 10.3892/or.2017.5775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3892%2For.2017.5775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28677802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVSnu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=1224-1232&author=Y.+Gaoauthor=W.+Liauthor=R.+Liuauthor=Q.+Guoauthor=J.+Liauthor=Y.+Baoauthor=H.+Zhengauthor=S.+Jiangauthor=B.+Hua&title=Norcantharidin+Inhibits+Il-6-Induced+Epithelial-Mesenchymal+Transition+Via+the+Jak2%2FStat3%2FTwist+Signaling+Pathway+in+Hepatocellular+Carcinoma+Cells&doi=10.3892%2For.2017.5775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin inhibits IL-6-induced epithelial-mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells</span></div><div class="casAuthors">Gao, Yebo; Li, Weidong; Liu, Rui; Guo, Qiujun; Li, Jie; Bao, Yanju; Zheng, Honggang; Jiang, Shulong; Hua, Baojin</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1224-1232</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Epithelial-mesenchymal transition (EMT), plays a vital role in hepatocellular carcinoma (HCC) development and metastasis.  Norcantharidin (NCTD; 7-oxabicyclo (2.2.1) heptane-2,3-dicarboxylic anhydride) plays anticancer roles in the regulation of tumor cell proliferation, apoptosis and migra- tion.  However, the mol. mechanism of HCC EMT and the effects of NCTD in the HCC EMT process have been either poorly elucidated or not studied.  In this study, HCC EMT was induced by the treatment of IL-6 and various concns. of NCTD (0, 30, 60 and 120 μM) were treated with HCC cell lines, HCCLM3 and SMMC-7721.  We investigated the effect of NCTD on the invasion of HCC cells by using Transwell assay.  Immunofluorescence staining, western blot anal. and quant. RT-PCR were performed to evaluate the protein and mRNA expression levels of HCC cells.  Here, using cell line models, our data demonstrated that interleukin 6 (IL-6) induced EMT through the JAK/STAT3/TWIST pathway in HCC.  Moreover, our studies revealed that NCTD markedly inhibited IL-6-induced EMT and cell invasiveness.  Signaling studies revealed that NCTD sufficiently suppressed JAK/ STAT3/TWIST signaling to reverse the IL-6-promoting effects.  Collectively, these data provide evidence for the use of NCTD as a potential anticancer drug in HCC metastatic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVlXR6BJlgLbVg90H21EOLACvtfcHk0lhyU2qLtv-ERA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVSnu7nF&md5=beb7e71b25cfa7c180e4e55462965d87</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.3892%2For.2017.5775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2017.5775%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DHua%26aufirst%3DB.%26atitle%3DNorcantharidin%2520Inhibits%2520Il-6-Induced%2520Epithelial-Mesenchymal%2520Transition%2520Via%2520the%2520Jak2%252FStat3%252FTwist%2520Signaling%2520Pathway%2520in%2520Hepatocellular%2520Carcinoma%2520Cells%26jtitle%3DOncol.%2520Rep.%26date%3D2017%26volume%3D38%26spage%3D1224%26epage%3D1232%26doi%3D10.3892%2For.2017.5775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. G.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin-Induced Apoptosis of Ags Human Gastric Cancer Cells through Reactive Oxygen Species Production, and Caspase- and Mitochondria-Dependent Signaling Pathways</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">6031</span>– <span class="NLM_lpage">6042</span>, <span class="refDoi"> DOI: 10.21873/anticanres.11192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.21873%2Fanticanres.11192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=27793930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFahsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=6031-6042&author=L.+C.+Zhengauthor=M.+D.+Yangauthor=C.+L.+Kuoauthor=C.+H.+Linauthor=M.+J.+Fanauthor=Y.+C.+Chouauthor=H.+F.+Luauthor=W.+W.+Huangauthor=S.+F.+Pengauthor=J.+G.+Chung&title=Norcantharidin-Induced+Apoptosis+of+Ags+Human+Gastric+Cancer+Cells+through+Reactive+Oxygen+Species+Production%2C+and+Caspase-+and+Mitochondria-Dependent+Signaling+Pathways&doi=10.21873%2Fanticanres.11192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin-induced apoptosis of AGS human gastric cancer cells through reactive oxygen species production, and caspase- and mitochondria-dependent signaling pathways</span></div><div class="casAuthors">Zheng, Li-Cheng; Yang, Mei-Due; Chao-Lin, Kuo; Lin, Chia-Hsin; Fan, Ming-Jen; Yu-Cheng, Chou; Lu, Hsu-Feng; Huang, Wen-Wen; Peng, Shu-Fen; Chung, Jing-Gung</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6031-6042</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Norcantharidin (NCTD) was purified from mylabris, the dried body of the Chinese blister beetle.  NCTD has been shown to exhibit anticancer activities in many human cancer cell lines, but there are no reports to show whether it induces apoptosis of human gastric cancer cells.  Therefore, in the present study, we investigated NCTD-induced cell death and assocd. protein expression in human gastric cancer AGS cells in vitro.  Cell morphol. changes, viability and cell-cycle distribution were examd. and analyzed by phase-contrast microscopy and flow cytometric assays.  Flow cytometry was also used to measure the levels of reactive oxygen species (ROS), Ca2+, mitochondrial membrane potential (Vm) and activity of caspases.  The results indicated that NCTD induced cell morphol. changes, reduced total viable cell no. and induced G0/G1 phase arrest.  NCTD also increased ROS prodn. and reduced the Vm and increased caspase-9 activity in AGS cells.  Western blotting also found that NCTD increased the pro-apoptotic proteins such as BCL2-assocd. X protein (BAX) and BH3 interacting-domain death agonist (BID) and increased the release of cytochrome c, apoptosis inducing factor (AIF) and endonuclease G (Endo G) release from mitochondria in AGS cells.  NCTD also significantly increased the expression of active forms of caspase-3 and -8 and -9 and reduced the expression of caspase-4 and -12 in AGS cells.  Based on these observations, we suggest that NCTD-induced apoptotic cell death may be through mitochondria- and caspase-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_rZz_7L6ZDrVg90H21EOLACvtfcHk0lhyU2qLtv-ERA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFahsr0%253D&md5=2bf794d0f154d2d35387b780a1cd378d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.21873%2Fanticanres.11192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fanticanres.11192%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DL.%2BC.%26aulast%3DYang%26aufirst%3DM.%2BD.%26aulast%3DKuo%26aufirst%3DC.%2BL.%26aulast%3DLin%26aufirst%3DC.%2BH.%26aulast%3DFan%26aufirst%3DM.%2BJ.%26aulast%3DChou%26aufirst%3DY.%2BC.%26aulast%3DLu%26aufirst%3DH.%2BF.%26aulast%3DHuang%26aufirst%3DW.%2BW.%26aulast%3DPeng%26aufirst%3DS.%2BF.%26aulast%3DChung%26aufirst%3DJ.%2BG.%26atitle%3DNorcantharidin-Induced%2520Apoptosis%2520of%2520Ags%2520Human%2520Gastric%2520Cancer%2520Cells%2520through%2520Reactive%2520Oxygen%2520Species%2520Production%252C%2520and%2520Caspase-%2520and%2520Mitochondria-Dependent%2520Signaling%2520Pathways%26jtitle%3DAnticancer%2520Res.%26date%3D2016%26volume%3D36%26spage%3D6031%26epage%3D6042%26doi%3D10.21873%2Fanticanres.11192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. D.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Induces Cell Cycle Arrest and Inhibits Progression of Human Leukemic Jurkat T Cells through Mitogen-Activated Protein Kinase-Mediated Regulation of Interleukin-2 Production</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2010.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.tiv.2010.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=21075198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1agsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=206-212&author=H.+F.+Liaoauthor=Y.+J.+Chenauthor=C.+H.+Chouauthor=F.+W.+Wangauthor=C.+D.+Kuo&title=Norcantharidin+Induces+Cell+Cycle+Arrest+and+Inhibits+Progression+of+Human+Leukemic+Jurkat+T+Cells+through+Mitogen-Activated+Protein+Kinase-Mediated+Regulation+of+Interleukin-2+Production&doi=10.1016%2Fj.tiv.2010.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production</span></div><div class="casAuthors">Liao, Hui-Fen; Chen, Yu-Jen; Chou, Chin-Hung; Wang, Fang-Wei; Kuo, Cheng-Deng</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology in Vitro</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">206-212</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Norcantharidin (NCTD) is a potential anti-cancer agent that inhibits proliferation and induces cell death through regulation of mitogen-activated protein kinases (MAPK).  This study examd. the effect of NCTD on tumor cells by using a model of phorbol 12-myristate 13-acetate plus ionomycin (PMAI)-activated leukemia Jurkat T cells.  The results showed that NCTD significantly inhibited the viability of cells with and without PMAI treatment.  NCTD induced cell cycle arrest at G2/M phase, down-regulated the expression of calcineurin and, by itself or in combination with Cyclosporine A, reduced calcineurin phosphatase activity.  Furthermore, NCTD up-regulates the expression of phosphorylated (p)-P38 and p-ERK1/2, but not JNK in PMAI-activated Jurkat T cells, in accordance with the alteration in viability.  Regarding major cytokine and chemokine secretion profile, NCTD attenuates PMAI-augmented prodn. of IL-2, but slightly increases or has no effect on TNF-α and IL-8.  By blockade of various MAPK, NCTD regulates PMAI-augmented IL-2 prodn. through activation of P38 and ERK1/2, in accordance with the aforementioned MAPK expression.  In conclusion, NCTD inhibited IL-2 prodn. in PMAI-activated human leukemia Jurkat T cells through activation of P38 and ERK1/2, suggesting that NCTD might have the potential of being used as a chemopreventive agent to inhibit tumor progression in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobvijPSQqGlLVg90H21EOLACvtfcHk0lgbp4mkUR_RAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1agsLnL&md5=3e8e59fd6d94d1887c4fb728785897ea</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2010.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2010.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DH.%2BF.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DChou%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DF.%2BW.%26aulast%3DKuo%26aufirst%3DC.%2BD.%26atitle%3DNorcantharidin%2520Induces%2520Cell%2520Cycle%2520Arrest%2520and%2520Inhibits%2520Progression%2520of%2520Human%2520Leukemic%2520Jurkat%2520T%2520Cells%2520through%2520Mitogen-Activated%2520Protein%2520Kinase-Mediated%2520Regulation%2520of%2520Interleukin-2%2520Production%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2011%26volume%3D25%26spage%3D206%26epage%3D212%26doi%3D10.1016%2Fj.tiv.2010.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Nanocapsules Inhibit the Invasion and Metastasis of Esophageal Cancer by Inhibiting Microrna-206 Via Igf1r-Pi3k-Akt Pathway</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">7249</span>– <span class="NLM_lpage">7256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVaqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=7249-7256&author=Z.+H.+Luauthor=K.+Guauthor=Y.+F.+Yunauthor=Y.+T.+Tangauthor=X.+J.+Luauthor=Y.+Ouauthor=X.+F.+Zhouauthor=Y.+Tian&title=Norcantharidin+Nanocapsules+Inhibit+the+Invasion+and+Metastasis+of+Esophageal+Cancer+by+Inhibiting+Microrna-206+Via+Igf1r-Pi3k-Akt+Pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin nanocapsules inhibit the invasion and metastasis of esophageal cancer by inhibiting microRNA-206 via IGF1R-PI3K-AKT pathway</span></div><div class="casAuthors">Lu, Zhonghua; Gu, Ke; Yun, Yifei; Tang, Yiting; Lu, Xujing; Ou, Yao; Zhou, Xifa; Tian, Ye</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">7249-7256</span>CODEN:
                <span class="NLM_cas:coden">IJCEFA</span>;
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">To investigate the effect of norcantharidin nanocapsules (NCTD-NPs) on the growth of esophageal cancer EC109 cells by inhibiting miR-206-mediated IGF1R-PI3K-Akt signaling pathway.  Esophageal cancer (ESCA) cell line EC109 was cultured.  Proliferative, invasive and metastatic capacities of EC109 cells were detected by cell counting kit-8 (CCK-8), would healing and transwell assay, resp.  Cell apoptosis was detected by flow cytometry.  Western blot and quant. real time-polymerase chain reaction (qRT-PCR) were conducted to det. expressions of relative genes.  The model of in situ transplantation tumor of ESCA in nude mice was established.  Meanwhile, fluorescence in vivo imaging was obsd.  Proliferative capacity of microRNA-206 overexpressing EC109 cells remarkably decreased after NCTD-NPs treatment in time- and dose-dependent manners.  NCTD-NPs treatment increased apoptotic rate of microRNA-206 overexpressing EC109 cells compared with that of EC109 cells.  After treatment with different doses of NCTD-NPs or NCTD, the migratory capacity of microRNA-206 overexpressing EC109 cells remarkably decreased than that of EC109 cells.  Transwell assay indicated that 25 nmol/L NCTD-NPs could markedly inhibit invasion of microRNA-206 overexpressing EC109 cells.  Western blot results elucidated downregulation of p-AKT (Ser473) and p-AKT (Thr308) in EC109 cells and microRNA-206 overexpressing EC109 cells.  Fluorescence in vivo imaging showed better inhibitory effect of NCTD-NPs on ESCA metastasis than NCTD in nude mice.  NCTD-NPs inhibited invasion and metastasis of ESCA both in vitro and in vivo.  The inhibitory effect of NCTD-NPs on ESCA development is related to IGF1R-PI3K-AKT pathway regulated by microRNA-206.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB0asi9JIE2bVg90H21EOLACvtfcHk0lgbp4mkUR_RAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVaqsbk%253D&md5=3430a3bb97397e5a0c488938436fa727</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DZ.%2BH.%26aulast%3DGu%26aufirst%3DK.%26aulast%3DYun%26aufirst%3DY.%2BF.%26aulast%3DTang%26aufirst%3DY.%2BT.%26aulast%3DLu%26aufirst%3DX.%2BJ.%26aulast%3DOu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%2BF.%26aulast%3DTian%26aufirst%3DY.%26atitle%3DNorcantharidin%2520Nanocapsules%2520Inhibit%2520the%2520Invasion%2520and%2520Metastasis%2520of%2520Esophageal%2520Cancer%2520by%2520Inhibiting%2520Microrna-206%2520Via%2520Igf1r-Pi3k-Akt%2520Pathway%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2019%26volume%3D12%26spage%3D7249%26epage%3D7256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Autophagy Suppression Accelerates Apoptosis Induced by Norcantharidin in Cholangiocarcinoma</span>. <i>Pathol. Oncol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1697</span>– <span class="NLM_lpage">1707</span>, <span class="refDoi"> DOI: 10.1007/s12253-019-00719-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs12253-019-00719-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31612378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFKjsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&pages=1697-1707&author=Y.+Wangauthor=W.+Jiangauthor=C.+Liauthor=X.+Xiongauthor=H.+Guoauthor=Q.+Tianauthor=X.+Li&title=Autophagy+Suppression+Accelerates+Apoptosis+Induced+by+Norcantharidin+in+Cholangiocarcinoma&doi=10.1007%2Fs12253-019-00719-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy Suppression Accelerates Apoptosis Induced by Norcantharidin in Cholangiocarcinoma</span></div><div class="casAuthors">Wang, Yun; Jiang, Wangjie; Li, Cunjiang; Xiong, Xuanxuan; Guo, Hao; Tian, Qingzhong; Li, Xiangcheng</div><div class="citationInfo"><span class="NLM_cas:title">Pathology & Oncology Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1697-1707</span>CODEN:
                <span class="NLM_cas:coden">POREFR</span>;
        ISSN:<span class="NLM_cas:issn">1219-4956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Norcantharidin is a cantharidin demethylated analog with antitumor effects in many tumors, including cholangiocarcinoma.  Autophagy suppression is known to increase chemosensitivity in cholangiocarcinoma.  This study aimed to det. whether autophagy suppression accelerates apoptosis induced by norcantharidin in human cholangiocarcinoma cells.  The human cholangiocarcinoma cell line QBC939 was incubated in RPMI 1640 medium with or without norcantharidin.  Autophagy was induced using HBSS media with Ca2+ and Mg2+ supported by 10 mM HEPES or suppressed by treatment with 3-MA or transfection with siRNA against Atg5.  The comparison was drawn between these conditions in mitochondrial membrane potential disturbance, the levels of reactive oxygen species (ROS), apoptotic proteins, and apoptosis.  Cholangiocarcinoma cell apoptosis was accelerated by norcantharidin.  Autophagy suppression up-regulated norcantharidins pro-apoptotic effect, but autophagy induction weakened it.  As apoptosis was accelerated, ROS prodn. was up-regulated.  Bax protein expression, cytochrome c levels and localization, mitochondrial membrane disturbance, and the levels of caspase-9, caspase-3, and cleaved PARP were higher when autophagy was suppressed, and all of those were down-regulated when autophagy was induced.  To sum up, it was found that norcantharidin induced cholangiocarcinoma cell death, and autophagy suppression enhanced the pro-apoptotic action of norcantharidin, which appears to involve the mitochondrial apoptosis pathway activation and ROS generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7l-1H940697Vg90H21EOLACvtfcHk0lgbp4mkUR_RAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFKjsbvK&md5=c04e46712fb3b338da0c5ee44c20d5ef</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1007%2Fs12253-019-00719-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12253-019-00719-9%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DAutophagy%2520Suppression%2520Accelerates%2520Apoptosis%2520Induced%2520by%2520Norcantharidin%2520in%2520Cholangiocarcinoma%26jtitle%3DPathol.%2520Oncol.%2520Res.%26date%3D2020%26volume%3D26%26spage%3D1697%26epage%3D1707%26doi%3D10.1007%2Fs12253-019-00719-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsi, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. K.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Induce Apoptosis in Human Nasopharyngeal Carcinoma through Caspase and Mitochondrial Pathway</span>. <i>Environ. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1002/tox.22521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Ftox.22521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29193574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOrtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=343-350&author=A.+W.+G.+Chenauthor=Y.+S.+Tsengauthor=C.+C.+Linauthor=Y.+T.+Hsiauthor=Y.+S.+Loauthor=Y.+C.+Chuangauthor=S.+H.+Linauthor=C.+Y.+Yuauthor=M.+J.+Hsiehauthor=M.+K.+Chen&title=Norcantharidin+Induce+Apoptosis+in+Human+Nasopharyngeal+Carcinoma+through+Caspase+and+Mitochondrial+Pathway&doi=10.1002%2Ftox.22521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin induce apoptosis in human nasopharyngeal carcinoma through caspase and mitochondrial pathway</span></div><div class="casAuthors">Chen, Andy Wei-Ge; Tseng, Yen-Shuo; Lin, Chia-Chieh; Hsi, Yi-Ting; Lo, Yu-Sheng; Chuang, Yi-Ching; Lin, Shu-Hui; Yu, Chia-Yun; Hsieh, Ming-Ju; Chen, Mu-Kuan</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-350</span>CODEN:
                <span class="NLM_cas:coden">ETOXFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-4081</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">While Nasopharyngeal carcinoma (NPC) is uncommon in western countries, it is endemic in Southeast Asia and Southern China.  Previous study of norcantharidin (NCTD), isolated from blister beetles, has proved its anticancer effect on various tumors.  However, the effect of NCTD in NPC has never been studied.  The purpose of this study is to inspect the suppression activity of NCTD on NPC, along with the underlying mechanism.  NPC cell line NPC-BM was treated with NCTD.  NCTD remarkably inhibited proliferation and induce apoptosis in NPC-BM cell.  Activation of caspase-3, -8, -9 was obsd. through western blotting.  The expression of antiapoptotic protein Bcl-XL was significantly reduced, but expression of proapoptotic protein Bak was increased after treatment of NCTD.  The cytotoxic effect of NCTD on NPC-BM cell is mainly due to apoptosis, mediated by caspase and mitochondrial pathway.  These results suggested that NCTD could be a potential anticancer agent for NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_k5HvygfIhrVg90H21EOLACvtfcHk0ljyU4G11avwIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOrtL%252FK&md5=39f02f149cc6ecd2702506e31890564c</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Ftox.22521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Ftox.22521%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DA.%2BW.%2BG.%26aulast%3DTseng%26aufirst%3DY.%2BS.%26aulast%3DLin%26aufirst%3DC.%2BC.%26aulast%3DHsi%26aufirst%3DY.%2BT.%26aulast%3DLo%26aufirst%3DY.%2BS.%26aulast%3DChuang%26aufirst%3DY.%2BC.%26aulast%3DLin%26aufirst%3DS.%2BH.%26aulast%3DYu%26aufirst%3DC.%2BY.%26aulast%3DHsieh%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DM.%2BK.%26atitle%3DNorcantharidin%2520Induce%2520Apoptosis%2520in%2520Human%2520Nasopharyngeal%2520Carcinoma%2520through%2520Caspase%2520and%2520Mitochondrial%2520Pathway%26jtitle%3DEnviron.%2520Toxicol.%26date%3D2018%26volume%3D33%26spage%3D343%26epage%3D350%26doi%3D10.1002%2Ftox.22521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein Phosphatase 5 Suppresses Non-Small Cell Lung Cancer through Amp-Activated Kinase Activation</span>. <i>Lung Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.lungcan.2017.07.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.lungcan.2017.07.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=29191605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC1M3msFyqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2017&pages=81-89&author=F.+S.+Hsiehauthor=M.+H.+Hungauthor=C.+Y.+Wangauthor=Y.+L.+Chenauthor=Y.+J.+Hsiaoauthor=M.+H.+Tsaiauthor=J.+R.+Liauthor=L.+J.+Chenauthor=C.+T.+Shihauthor=T.+I.+Chaoauthor=K.+F.+Chen&title=Inhibition+of+Protein+Phosphatase+5+Suppresses+Non-Small+Cell+Lung+Cancer+through+Amp-Activated+Kinase+Activation&doi=10.1016%2Fj.lungcan.2017.07.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation</span></div><div class="casAuthors">Hsieh Feng-Shu; Hsiao Yung-Jen; Tsai Ming-Hsien; Li Jia-Rong; Chen Li-Ju; Shih Chih-Ting; Hung Man-Hsin; Wang Cheng-Yi; Chen Yen-Lin; Chao Tzu-I; Chen Kuen-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Lung cancer (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-89</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Non-small cell lung cancer (NSCLC) continues to be the top cause of cancer death.  To improve the treatment of lung cancer, there is necessity to identify novel oncogenes and investigate their effects on lung carcinogenesis.  Protein phosphatase 5 (PP5) has long been known to regulate stress-induced apoptosis and cell proliferation.  Recently, PP5 has been found overexpressed and emerged as a viable therapeutic target in various human cancers, but its role in NSCLC remains elusive.  MATERIALS AND METHODS:  The expression of PP5 in NSCLC cell lines (A549, H358, and H460) and human tumor samples were examined.  Protein phosphatase inhibitors, cantharidin and norcantharidin, were used as proof-of-concept compounds to investigate the pathological function of PP5 in NSCLC.  Apoptosis and cellular signaling were analyzed.  In vivo efficacy was determined in nude mice with H460 xenograft.  RESULTS AND CONCLUSION:  We found that PP5 was more highly expressed in human lung tumor samples than in adjacent normal tissues.  Overexpression of PP5 promoted cell proliferation, colony formation, and sphere-forming ability of A549 cells.  Inhibition of PP5 phosphatase activity by cantharidin induced significant apoptosis and upregulated AMP-activated protein kinase (AMPK) signaling.  Importantly, we found that PP5-mediated dephosphorylation of AMPK determines the in vitro anti-NSCLC effects of cantharidin.  Consistent with our in vitro data, PP5 inhibition suppressed H460 tumor growth and upregulated p-AMPK in tumor samples.  Our results demonstrate that PP5 inhibition suppresses tumor growth via activating AMPK signaling.  Targeting oncogenic PP5 represents an attractive therapeutic strategy for treating lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCA6xgGlThsr9KldV63DuefW6udTcc2ebFnXdx9j1iw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3msFyqtg%253D%253D&md5=537b67e55d6c63e8ed3e4839f8cceeec</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2017.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2017.07.040%26sid%3Dliteratum%253Aachs%26aulast%3DHsieh%26aufirst%3DF.%2BS.%26aulast%3DHung%26aufirst%3DM.%2BH.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DHsiao%26aufirst%3DY.%2BJ.%26aulast%3DTsai%26aufirst%3DM.%2BH.%26aulast%3DLi%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DL.%2BJ.%26aulast%3DShih%26aufirst%3DC.%2BT.%26aulast%3DChao%26aufirst%3DT.%2BI.%26aulast%3DChen%26aufirst%3DK.%2BF.%26atitle%3DInhibition%2520of%2520Protein%2520Phosphatase%25205%2520Suppresses%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520through%2520Amp-Activated%2520Kinase%2520Activation%26jtitle%3DLung%2520Cancer%26date%3D2017%26volume%3D112%26spage%3D81%26epage%3D89%26doi%3D10.1016%2Fj.lungcan.2017.07.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Inhibits Cell Growth by Suppressing the Expression and Phosphorylation of Both Egfr and C-Met in Human Colon Cancer Cells</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">55</span>, <span class="refDoi"> DOI: 10.1186/s12885-016-3039-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1186%2Fs12885-016-3039-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28086832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs12ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=55&author=P.+Qiuauthor=S.+Wangauthor=M.+Liuauthor=H.+Maauthor=X.+Zengauthor=M.+Zhangauthor=L.+Xuauthor=Y.+Cuiauthor=H.+Xuauthor=Y.+Tangauthor=Y.+Heauthor=L.+Zhang&title=Norcantharidin+Inhibits+Cell+Growth+by+Suppressing+the+Expression+and+Phosphorylation+of+Both+Egfr+and+C-Met+in+Human+Colon+Cancer+Cells&doi=10.1186%2Fs12885-016-3039-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells</span></div><div class="casAuthors">Qiu, Peiju; Wang, Siwen; Liu, Ming; Ma, He; Zeng, Xuan; Zhang, Meng; Xu, Lingling; Cui, Yidi; Xu, Huixin; Tang, Yang; He, Yanli; Zhang, Lijuan</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55/1-55/7</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Norcantharidin (NCTD) is a Chinese FDA approved, chem. synthesized drug for cancer treatment.  The effect of NCTD on signaling proteins of EGFR and c-Met was systematically elucidated in current study.  Methods: Two human colon cancer cell lines, HCT116 and HT29, were used as model systems to investigate the anti-cancer mol. mechanism of NCTD.  Cell cycle arrest and early/late apoptosis were analyzed by flow cytometry.  The levels of EGFR, phospho-EGFR, c-Met, phospho-c-Met and other related proteins were quantified by western blot anal.  Results: NCTD induced cell cycle arrest at G2/M phase in both cell lines.  The early and late apoptosis was also obsd.  Further investigation indicated that NCTD suppressed not only the expression of the total EGFR and the phosphorylated EGFR but also the expression of the total c-Met and the phosphorylated c-Met in colon cancer cells.  Moreover, EGFR expression could be mostly restored by co-treatment with MG132, a proteasome inhibitor.  In addn., NCTD-induced cell death was comparable to that of the anti-cancer drug gefitinib, a tyrosine kinase inhibitor for EGFR, based on the immunoblot anal. of the expressed proteins after the drug treatment.  Conclusions: NCTD might be a useful and inexpensive drug candidate to substitute for gefitinib to serve the treatment needs of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolo43L-3UDf7Vg90H21EOLACvtfcHk0ljyU4G11avwIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs12ntbo%253D&md5=b903120dc626f56b9961f876b1de0896</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1186%2Fs12885-016-3039-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-016-3039-x%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DNorcantharidin%2520Inhibits%2520Cell%2520Growth%2520by%2520Suppressing%2520the%2520Expression%2520and%2520Phosphorylation%2520of%2520Both%2520Egfr%2520and%2520C-Met%2520in%2520Human%2520Colon%2520Cancer%2520Cells%26jtitle%3DBMC%2520Cancer%26date%3D2017%26volume%3D17%26spage%3D55%26doi%3D10.1186%2Fs12885-016-3039-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, B.</span></span> <span> </span><span class="NLM_article-title">Norcantharidin Regulates Erα Signaling and Tamoxifen Resistance Via Targeting Mir-873/Cdk3 in Breast Cancer Cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">e0217181</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0217181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1371%2Fjournal.pone.0217181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31120927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht12jsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=e0217181&author=X.+Zhangauthor=B.+Zhangauthor=P.+Zhangauthor=L.+Lianauthor=L.+Liauthor=Z.+Qiuauthor=K.+Qianauthor=A.+Chenauthor=Q.+Liuauthor=Y.+Jiangauthor=J.+Cuiauthor=B.+Qi&title=Norcantharidin+Regulates+Er%CE%B1+Signaling+and+Tamoxifen+Resistance+Via+Targeting+Mir-873%2FCdk3+in+Breast+Cancer+Cells&doi=10.1371%2Fjournal.pone.0217181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells</span></div><div class="casAuthors">Zhang, Xiumei; Zhang, Bingfeng; Zhang, Panhong; Lian, Lihui; Li, Lianlian; Qiu, Zhihong; Qian, Kai; Chen, An; Liu, Qiongqing; Jiang, Yinjie; Cui, Jiajun; Qi, Bing</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0217181</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">MiR-873/CDK3 has been shown to play a crit. role in ERα signaling and tamoxifen resistance.  Thus, targeting this pathway may be a potential therapeutic approach for the treatment of ER pos. breast cancer esp. tamoxifen resistant subtype.  Here we report that Norcantharidin (NCTD), currently used clin. as an ani-cancer drug in China, regulates miR-873/CDK3 axis in breast cancer cells.  NCTD decreases the transcriptional activity of ERα but not ERβ through the modulation of miR-873/CDK3 axis.  We also found that NCTD inhibits cell proliferation and tumor growth and miR-873/CDK3 axis mediates cell proliferation suppression of NCTD.  More important, we found that NCTD sensitizes resistant cells to tamoxifen.  NCTD inhibits tamoxifen induced the transcriptional activity as well ERα downstream gene expressions in tamoxifen resistant breast cancer cells.  In addn., we found that NCTD restores tamoxifen induced recruitments of ERα co-repressors N-CoR and SMRT.  Knockdown of miR-873 and overexpression of CDK3 diminish the effect of NCTD on tamoxifen resistance.  Our data shows that NCTD regulates ERα signaling and tamoxifen resistance by targeting miR-873/CDK3 axis in breast cancer cells.  This study may provide an alternative therapy strategy for tamoxifen resistant breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorKXr5qYN-YLVg90H21EOLACvtfcHk0lglwUjwerjwHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht12jsbbK&md5=303c872eddd1b83478811e8584642962</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0217181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0217181%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DLian%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DZ.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DB.%26atitle%3DNorcantharidin%2520Regulates%2520Er%25CE%25B1%2520Signaling%2520and%2520Tamoxifen%2520Resistance%2520Via%2520Targeting%2520Mir-873%252FCdk3%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DPLoS%2520One%26date%3D2019%26volume%3D14%26spage%3De0217181%26doi%3D10.1371%2Fjournal.pone.0217181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. F.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 5 Promotes Hepatocarcinogenesis through Interaction with Amp-Activated Protein Kinase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bcp.2017.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28528695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotF2qsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=49-60&author=Y.+L.+Chenauthor=M.+H.+Hungauthor=P.+Y.+Chuauthor=T.+I.+Chaoauthor=M.+H.+Tsaiauthor=L.+J.+Chenauthor=Y.+J.+Hsiaoauthor=C.+T.+Shihauthor=F.+S.+Hsiehauthor=K.+F.+Chen&title=Protein+Phosphatase+5+Promotes+Hepatocarcinogenesis+through+Interaction+with+Amp-Activated+Protein+Kinase&doi=10.1016%2Fj.bcp.2017.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase</span></div><div class="casAuthors">Chen, Yao-Li; Hung, Man-Hsin; Chu, Pei-Yi; Chao, Tzu-I.; Tsai, Ming-Hsien; Chen, Li-Ju; Hsiao, Yung-Jen; Shih, Chih-Ting; Hsieh, Feng-Shu; Chen, Kuen-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The serine-threonine protein phosphatase family members are known as crit. regulators of various cellular functions, such as survival and transformation.  Growing evidence suggests that pharmacol. manipulation of phosphatase activity exhibits therapeutic benefits.  Ser/Thr protein phosphatase 5 (PP5) is known to participate in glucocorticoid receptor (GR) and stress-induced signaling cascades that regulate cell growth and apoptosis, and has been shown to be overexpressed in various human malignant diseases.  However, the role of PP5 in hepatocellular carcinoma (HCC) and whether PP5 may be a viable therapeutic target for HCC treatment are unknown.  Here, by analyzing HCC clin. samples obtained from 215 patients, we found that overexpression of PP5 is tumor specific and assocd. with worse clin. outcomes.  We further characterized the oncogenic properties of PP5 in HCC cells.  Importantly, both silencing of PP5 with lentiviral-mediated short hairpin RNA (shRNA) and chem. inhibition of PP5 phosphatase activity using the natural compd. cantharidin/norcantharidin markedly suppressed the growth of HCC cells and tumors in vitro and in vivo.  Moreover, we identified AMP-activated protein kinase (AMPK) as a novel downstream target of oncogenic PP5 and demonstrated that the antitumor mechanisms underlying PP5 inhibition involve activation of AMPK signaling.  Overall, our results establish a pathol. function of PP5 in hepatocarcinogenesis via affecting AMPK signaling and suggest that PP5 inhibition is an attractive therapeutic approach for HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopo4vKvhpeebVg90H21EOLACvtfcHk0lglwUjwerjwHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotF2qsbo%253D&md5=c5c7dff475271b7986de3cfeb1d25e2d</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DHung%26aufirst%3DM.%2BH.%26aulast%3DChu%26aufirst%3DP.%2BY.%26aulast%3DChao%26aufirst%3DT.%2BI.%26aulast%3DTsai%26aufirst%3DM.%2BH.%26aulast%3DChen%26aufirst%3DL.%2BJ.%26aulast%3DHsiao%26aufirst%3DY.%2BJ.%26aulast%3DShih%26aufirst%3DC.%2BT.%26aulast%3DHsieh%26aufirst%3DF.%2BS.%26aulast%3DChen%26aufirst%3DK.%2BF.%26atitle%3DProtein%2520Phosphatase%25205%2520Promotes%2520Hepatocarcinogenesis%2520through%2520Interaction%2520with%2520Amp-Activated%2520Protein%2520Kinase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2017%26volume%3D138%26spage%3D49%26epage%3D60%26doi%3D10.1016%2Fj.bcp.2017.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papke, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abney, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">The Antitumor Drug Lb-100 Is a Catalytic Inhibitor of Protein Phosphatase 2a (Ppp2ca) and 5 (Ppp5c) Coordinating with the Active-Site Catalytic Metals in Ppp5c</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-1143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1535-7163.MCT-17-1143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30679389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFGgs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=556-566&author=B.+M.+D%E2%80%99Arcyauthor=M.+R.+Swingleauthor=C.+M.+Papkeauthor=K.+A.+Abneyauthor=E.+S.+Bouskaauthor=A.+Prakashauthor=R.+E.+Honkanen&title=The+Antitumor+Drug+Lb-100+Is+a+Catalytic+Inhibitor+of+Protein+Phosphatase+2a+%28Ppp2ca%29+and+5+%28Ppp5c%29+Coordinating+with+the+Active-Site+Catalytic+Metals+in+Ppp5c&doi=10.1158%2F1535-7163.MCT-17-1143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">The antitumor drug LB-100 is a catalytic inhibitor of protein phosphatase 2A (PPP2CA) and 5 (PPP5C) coordinating with the active-site catalytic metals in PPP5C</span></div><div class="casAuthors">D'Arcy, Brandon M.; Swingle, Mark R.; Papke, Cinta M.; Abney, Kevin A.; Bouska, Erin S.; Prakash, Aishwarya; Honkanen, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">556-566</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The first phase I trial (NCT01837667) evaluating LB-100 recently concluded that safety and efficacy parameters are favorable for further clin. testing.  Although LB-100 is widely reported as a specific inhibitor of serine/threonine phosphatase 2A (PP2AC/PPP2CA:PPP2CB), we could find no exptl. evidence in the published literature demonstrating the specific engagement of LB-100 with PP2A in vitro, in cultured cells, or in animals.  Rather, the premise for LB-100 targeting PP2AC is derived from studies that measure phosphate released from a phosphopeptide (K-R-pT-I-R-R) or inferred from the ability of LB-100 to mimic activity previously reported to result from the inhibition of PP2AC by other means.  PP2AC and PPP5C share a common catalytic mechanism.  Here, we demonstrate that the phosphopeptide used to ascribe LB-100 specificity for PP2A is also a substrate for PPP5C.  Inhibition assays using purified enzymes demonstrate that LB-100 is a catalytic inhibitor of both PP2AC and PPP5C.  The structure of PPP5C cocrystd. with LB-100 was solved to a resoln. of 1.65Å, revealing that the 7-oxabicyclo[2.2.1]heptane-2,3-dicarbonyl moiety coordinates with the metal ions and key residues that are conserved in both PP2AC and PPP5C.  These data demonstrate that LB-100 is a catalytic inhibitor of both PP2AC and PPP5C and suggest that the obsd. antitumor activity might be due to an additive effect achieved by suppressing both PP2A and PPP5C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnejVjep6twLVg90H21EOLACvtfcHk0lglwUjwerjwHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFGgs7bL&md5=d0abf7737094643ebf06547cecce574d</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-1143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-1143%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DB.%2BM.%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DPapke%26aufirst%3DC.%2BM.%26aulast%3DAbney%26aufirst%3DK.%2BA.%26aulast%3DBouska%26aufirst%3DE.%2BS.%26aulast%3DPrakash%26aufirst%3DA.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DThe%2520Antitumor%2520Drug%2520Lb-100%2520Is%2520a%2520Catalytic%2520Inhibitor%2520of%2520Protein%2520Phosphatase%25202a%2520%2528Ppp2ca%2529%2520and%25205%2520%2528Ppp5c%2529%2520Coordinating%2520with%2520the%2520Active-Site%2520Catalytic%2520Metals%2520in%2520Ppp5c%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2019%26volume%3D18%26spage%3D556%26epage%3D566%26doi%3D10.1158%2F1535-7163.MCT-17-1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golden, T.</span></span> <span> </span><span class="NLM_article-title">Regulators of Serine/Threonine Protein Phosphatases at the Dawn of a Clinical Era?</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2055</span>– <span class="NLM_lpage">2075</span>, <span class="refDoi"> DOI: 10.2174/0929867023368836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F0929867023368836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=12369870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlCnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=2055-2075&author=R.+E.+Honkanenauthor=T.+Golden&title=Regulators+of+Serine%2FThreonine+Protein+Phosphatases+at+the+Dawn+of+a+Clinical+Era%3F&doi=10.2174%2F0929867023368836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Regulators of serine/threonine protein phosphatases at the dawn of a clinical era?</span></div><div class="casAuthors">Honkanen, R. E.; Golden, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2055-2075</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Reversible phosphorylation is a key mechanism for regulating the biol. activity of many human proteins that affect a diverse array of cellular processes, including protein-protein interactions, gene transcription, cell-cycle progression and apoptosis.  Once viewed as simple house keeping enzymes, recent studies have made it eminently clear that, like their kinase counterparts, protein phosphatases are dynamic and highly regulated enzymes.  Therefore, the development of compds. that alter the activity of specific phosphatases is rapidly emerging as an important area in drug discovery.  Because >98% of protein phosphorylation occurs on serine and threonine residues, the identification of agents that alter the activity of specific serine/threonine phosphatases seems esp. promising for drug development in the future.  This review is focused on the enzymes encoded by the PPP-gene family, which includes PP1, PP2A, PP2B, PP4, PP5, PP6 and PP7.  The structure/functions of human phosphatases will be addressed briefly, as will the natural product inhibitors of PP1-PP6 (e.g. okadaic acid, microcystins, nodularin, cantharidin, calyculin A, tautomycin, and fostriecin).  The development of chimeric antisense oligonucleotides that support RNase H mediated degrdn. of the targeted mRNA has resulted in compds. capable of specifically suppressing the expression of PP5 (ISIS 15534) and PP1gamma 1 (ISIS 14435) in human cells.  Such compds. have already proven useful for the validation of drug targets, and if difficulties assocd. with systemic delivery of antisense oligonucleotides can be overcome, antisense is poised to have a major impact on the clin. management of many human disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjDFkVtCb1obVg90H21EOLACvtfcHk0ljs2hNzAYAtag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlCnsbc%253D&md5=ea4cd9c1cee79fb1e43d2e64e333755b</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.2174%2F0929867023368836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867023368836%26sid%3Dliteratum%253Aachs%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DGolden%26aufirst%3DT.%26atitle%3DRegulators%2520of%2520Serine%252FThreonine%2520Protein%2520Phosphatases%2520at%2520the%2520Dawn%2520of%2520a%2520Clinical%2520Era%253F%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D2055%26epage%3D2075%26doi%3D10.2174%2F0929867023368836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of Ser/Thr Protein Phosphatases: Specificity, Use and Common Forms of Abuse</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1385/1-59745-267-X:23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1385%2F1-59745-267-X%3A23" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2006&pages=23-38&author=M.+Swingleauthor=L.+Niauthor=R.+E.+Honkanen&title=Small-Molecule+Inhibitors+of+Ser%2FThr+Protein+Phosphatases%3A+Specificity%2C+Use+and+Common+Forms+of+Abuse&doi=10.1385%2F1-59745-267-X%3A23"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1385%2F1-59745-267-X%3A23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59745-267-X%253A23%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DM.%26aulast%3DNi%26aufirst%3DL.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520Ser%252FThr%2520Protein%2520Phosphatases%253A%2520Specificity%252C%2520Use%2520and%2520Common%2520Forms%2520of%2520Abuse%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2006%26volume%3D365%26spage%3D23%26epage%3D38%26doi%3D10.1385%2F1-59745-267-X%3A23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R E</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwiller, J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, R E</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daily, S L</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatra, B S</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukelow, M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boynton, A L</span></span> <span> </span><span class="NLM_article-title">Characterization of Microcystin-Lr, a Potent Inhibitor of Type 1 and Type 2a Protein Phosphatases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>265</i></span>,  <span class="NLM_fpage">19401</span>– <span class="NLM_lpage">19404</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(17)45384-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0021-9258%2817%2945384-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2174036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXlvVOisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=19401-19404&author=R+E+Honkanenauthor=J+Zwillerauthor=R+E+Mooreauthor=S+L+Dailyauthor=B+S+Khatraauthor=M+Dukelowauthor=A+L+Boynton&title=Characterization+of+Microcystin-Lr%2C+a+Potent+Inhibitor+of+Type+1+and+Type+2a+Protein+Phosphatases&doi=10.1016%2FS0021-9258%2817%2945384-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases</span></div><div class="casAuthors">Honkanen, Richard E.; Zwiller, Jean; Moore, Richard E.; Daily, Sharon L.; Khatra, Balwant S.; Dukelow, Michael; Boynton, Alton L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">19401-4</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The level of protein phosphorylation is dependent on the relative activities of both protein kinases and protein phosphatases.  By comparison with protein kinases, however, there have been considerably fewer studies on the functions of serine/threonine protein phosphatases.  This is partly due to a lack of specific protein phosphatase inhibitors that can be used as probes.  The present study is a characterization of the inhibitory effects of microcystin-LR, a hepatotoxic cyclic peptide assocd. with most strains of the blue-green algae Microcystis aeruginosa found in the Northern hemisphere, that proves to be a potent inhibitor of type 1 (IC50 = 1.7 nM) and type 2A (IC50 = 0.04 nM) protein phosphatases.  Microcystin-LR inhibited the activity of both type 1 and type 2A phosphatases >10-fold more potently than okadaic acid under the same conditions.  Type 2A protein phosphatases in dil. mammalian cell exts. were found to be completely inhibited by 0.5 nM microcystin-LR while type I protein phosphatases were only slightly affected at this concn.  Thus, microcystin-LR may prove to be a useful probe for the study and identification of cellular processes which are mediated by protein phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTSf9UHioQjLVg90H21EOLACvtfcHk0ljs2hNzAYAtag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlvVOisrc%253D&md5=dca914b3af519bf6d0e97d2e5415184b</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2817%2945384-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252817%252945384-1%26sid%3Dliteratum%253Aachs%26aulast%3DHonkanen%26aufirst%3DR%2BE%26aulast%3DZwiller%26aufirst%3DJ%26aulast%3DMoore%26aufirst%3DR%2BE%26aulast%3DDaily%26aufirst%3DS%2BL%26aulast%3DKhatra%26aufirst%3DB%2BS%26aulast%3DDukelow%26aufirst%3DM%26aulast%3DBoynton%26aufirst%3DA%2BL%26atitle%3DCharacterization%2520of%2520Microcystin-Lr%252C%2520a%2520Potent%2520Inhibitor%2520of%2520Type%25201%2520and%2520Type%25202a%2520Protein%2520Phosphatases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D19401%26epage%3D19404%26doi%3D10.1016%2FS0021-9258%2817%2945384-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacKintosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beattie, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klumpp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codd, G. A.</span></span> <span> </span><span class="NLM_article-title">Cyanobacterial Microcystin-Lr Is a Potent and Specific Inhibitor of Protein Phosphatases 1 and 2a from Both Mammals and Higher Plants</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(90)80245-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0014-5793%2890%2980245-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2162782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXlsVOjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1990&pages=187-192&author=C.+MacKintoshauthor=K.+A.+Beattieauthor=S.+Klumppauthor=P.+Cohenauthor=G.+A.+Codd&title=Cyanobacterial+Microcystin-Lr+Is+a+Potent+and+Specific+Inhibitor+of+Protein+Phosphatases+1+and+2a+from+Both+Mammals+and+Higher+Plants&doi=10.1016%2F0014-5793%2890%2980245-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants</span></div><div class="casAuthors">MacKintosh, Carol; Beattie, Kenneth A.; Klumpp, Susanne; Cohen, Philip; Codd, Geoffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-92</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The cyclic heptapeptide, microcystin-LR (I), inhibits protein phosphatases 1 (PP1) and 2A (PP2A) with Ki values >0.1 nM.  Protein phosphatase 2B is inhibited 1000-fold less potently, whereas 6 other phosphatases and 8 protein kinases tested are unaffected.  These results are strikingly similar to those obtained with the tumor promoter okadaic acid.  Okadaic acid prevents the binding of microcystin-LR to PP2A, and the protein inhibitors 1 and 2 prevent the binding of microcystin-LR to PP1.  The possibility that inhibition of PP1 and PP2A accounts for the extreme toxicity of microcystin-LR, and indicate its potential value in the detection and anal. of protein kinases and phosphatases was also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY9x8OhseK07Vg90H21EOLACvtfcHk0lhSRUMGHj5CpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlsVOjs74%253D&md5=ba374e02bd0233ca76986bd375bc7ae7</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2890%2980245-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252890%252980245-E%26sid%3Dliteratum%253Aachs%26aulast%3DMacKintosh%26aufirst%3DC.%26aulast%3DBeattie%26aufirst%3DK.%2BA.%26aulast%3DKlumpp%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCodd%26aufirst%3DG.%2BA.%26atitle%3DCyanobacterial%2520Microcystin-Lr%2520Is%2520a%2520Potent%2520and%2520Specific%2520Inhibitor%2520of%2520Protein%2520Phosphatases%25201%2520and%25202a%2520from%2520Both%2520Mammals%2520and%2520Higher%2520Plants%26jtitle%3DFEBS%2520Lett.%26date%3D1990%26volume%3D264%26spage%3D187%26epage%3D192%26doi%3D10.1016%2F0014-5793%2890%2980245-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppeck, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlin, A. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the Ser-Thr Phosphatases Pp1 and Pp2a by Naturally Occurring Toxins</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(97)00146-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0968-0896%2897%2900146-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9354230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2sXntVOmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=1739-1750&author=J.+E.+Sheppeckauthor=C.+M.+Gaussauthor=A.+R.+Chamberlin&title=Inhibition+of+the+Ser-Thr+Phosphatases+Pp1+and+Pp2a+by+Naturally+Occurring+Toxins&doi=10.1016%2FS0968-0896%2897%2900146-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins</span></div><div class="casAuthors">Sheppeck, James E., II; Gauss, Carla-Maria; Chamberlin, A. Richard</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1739-1750</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 112 refs., of PP1 and PP2A phosphatases and their inhibition by endogenous protein inhibitors and okadaic acid class inhibitors.  Site-directed mutagenesis studies of the enzymes are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJAM7FgXBGdrVg90H21EOLACvtfcHk0lhSRUMGHj5CpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXntVOmtbo%253D&md5=6ab1a2f7c9cbee2f0434e6d3e93d3627</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2897%2900146-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252897%252900146-6%26sid%3Dliteratum%253Aachs%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DChamberlin%26aufirst%3DA.%2BR.%26atitle%3DInhibition%2520of%2520the%2520Ser-Thr%2520Phosphatases%2520Pp1%2520and%2520Pp2a%2520by%2520Naturally%2520Occurring%2520Toxins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1997%26volume%3D5%26spage%3D1739%26epage%3D1750%26doi%3D10.1016%2FS0968-0896%2897%2900146-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adler, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitt, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunnimalaiyaan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Tautomycetin and Tautomycin Suppress the Growth of Medullary Thyroid Cancer Cells Via Inhibition of Glycogen Synthase Kinase-3β</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">914</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1535-7163.MCT-08-0712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19372564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1amtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=914-920&author=J.+T.+Adlerauthor=M.+Cookauthor=Y.+Luoauthor=S.+C.+Pittauthor=J.+Juauthor=W.+Liauthor=B.+Shenauthor=M.+Kunnimalaiyaanauthor=H.+Chen&title=Tautomycetin+and+Tautomycin+Suppress+the+Growth+of+Medullary+Thyroid+Cancer+Cells+Via+Inhibition+of+Glycogen+Synthase+Kinase-3%CE%B2&doi=10.1158%2F1535-7163.MCT-08-0712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3β</span></div><div class="casAuthors">Adler, Joel T.; Cook, Mackenzie; Luo, Yinggang; Pitt, Susan C.; Ju, Jianhua; Li, Wenli; Shen, Ben; Kunnimalaiyaan, Muthusamy; Chen, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">914-920</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Medullary thyroid cancer (MTC) is a relatively uncommon neuroendocrine tumor that arises from the calcitonin-secreting parafollicular cells of the thyroid gland.  Unfortunately, MTC frequently metastasizes, precluding curative surgical resection and causing significant morbidity.  Thus, there is an urgent need for new treatment modalities.  Tautomycin and tautomycetin are antifungal antibiotics isolated from Streptomyces spiroverticillatus and Streptomyces griseochromogens, resp.  Glycogen synthase kinase-3β is a serine/threonine protein kinase that regulates multiple cellular processes and is important in various cancers, including MTC.  Treatment with tautomycin and tautomycetin decreased neuroendocrine markers, suppressed hormonal secretion, and inhibited growth through apoptosis in MTC cells.  Importantly, we describe a novel action of these compds.: inhibition of glycogen synthase kinase-3β.[Mol Cancer Ther 2009;8(4):914-20].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsbyEBzq3K-rVg90H21EOLACvtfcHk0lhSRUMGHj5CpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1amtrc%253D&md5=8c61808108510fcd0d675ba54ba3ca4d</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0712%26sid%3Dliteratum%253Aachs%26aulast%3DAdler%26aufirst%3DJ.%2BT.%26aulast%3DCook%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DPitt%26aufirst%3DS.%2BC.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DKunnimalaiyaan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DTautomycetin%2520and%2520Tautomycin%2520Suppress%2520the%2520Growth%2520of%2520Medullary%2520Thyroid%2520Cancer%2520Cells%2520Via%2520Inhibition%2520of%2520Glycogen%2520Synthase%2520Kinase-3%25CE%25B2%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D914%26epage%3D920%26doi%3D10.1158%2F1535-7163.MCT-08-0712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choy, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettenbach, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span> <span> </span><span class="NLM_article-title">Pp1:Tautomycetin Complex Reveals a Path toward the Development of Pp1-Specific Inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">17703</span>– <span class="NLM_lpage">17706</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b09368</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b09368" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=17703-17706&author=M.+S.+Choyauthor=M.+Swingleauthor=B.+D%E2%80%99Arcyauthor=K.+Abneyauthor=S.+F.+Rusinauthor=A.+N.+Kettenbachauthor=R.+Pageauthor=R.+E.+Honkanenauthor=W.+Peti&title=Pp1%3ATautomycetin+Complex+Reveals+a+Path+toward+the+Development+of+Pp1-Specific+Inhibitors&doi=10.1021%2Fjacs.7b09368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">PP1:Tautomycetin Complex Reveals a Path toward the Development of PP1-Specific Inhibitors</span></div><div class="casAuthors">Choy, Meng S.; Swingle, Mark; D'Arcy, Brandon; Abney, Kevin; Rusin, Scott F.; Kettenbach, Arminja N.; Page, Rebecca; Honkanen, Richard E.; Peti, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17703-17706</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors for each serine/threonine phosphatase (PPP) are essential to investigate the biol. actions of PPPs and to guide drug development.  Biol. diverse organisms (e.g., cyanobacteria, dinoflagellates, beetles) produce structurally distinct toxins that are catalytic inhibitors of PPPs.  However, most toxins exhibit little selectivity, typically inhibiting multiple family members with similar potencies.  Thus, the use of these toxins as chem. tools to study the relationship between individual PPPs and their biol. substrates, and how disruptions in these relationships contributes to human disease, is severely limited.  Here, the authors show that tautomycetin (TTN) is highly selective for a single PPP, protein phosphatase 1 (PP1/PPP1C).  The structure of the PP1:TTN complex reveals that PP1 selectivity is defined by a covalent bond between TTN and a PP1-specific cysteine residue, Cys127.  Together, these data provide key mol. insights needed for the development of novel probes targeting single PPPs, esp. PP1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpALzQw5bYdb7Vg90H21EOLACvtfcHk0lhSRUMGHj5CpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbI&md5=d84b7f918040f64c3733e61383b3240c</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b09368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b09368%26sid%3Dliteratum%253Aachs%26aulast%3DChoy%26aufirst%3DM.%2BS.%26aulast%3DSwingle%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DB.%26aulast%3DAbney%26aufirst%3DK.%26aulast%3DRusin%26aufirst%3DS.%2BF.%26aulast%3DKettenbach%26aufirst%3DA.%2BN.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DPeti%26aufirst%3DW.%26atitle%3DPp1%253ATautomycetin%2520Complex%2520Reveals%2520a%2520Path%2520toward%2520the%2520Development%2520of%2520Pp1-Specific%2520Inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D17703%26epage%3D17706%26doi%3D10.1021%2Fjacs.7b09368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuhashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubukata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oikawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, K.</span></span> <span> </span><span class="NLM_article-title">Tautomycetin Is a Novel and Specific Inhibitor of Serine/Threonine Protein Phosphatase Type 1, Pp1</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2001.5596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1006%2Fbbrc.2001.5596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11554729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms12rtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2001&pages=328-331&author=S.+Mitsuhashiauthor=N.+Matsuuraauthor=M.+Ubukataauthor=H.+Oikawaauthor=H.+Shimaauthor=K.+Kikuchi&title=Tautomycetin+Is+a+Novel+and+Specific+Inhibitor+of+Serine%2FThreonine+Protein+Phosphatase+Type+1%2C+Pp1&doi=10.1006%2Fbbrc.2001.5596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Tautomycetin Is a Novel and Specific Inhibitor of Serine/Threonine Protein Phosphatase Type 1, PP1</span></div><div class="casAuthors">Mitsuhashi, Shinya; Matsuura, Nobuyasu; Ubukata, Makoto; Oikawa, Hideaki; Shima, Hiroshi; Kikuchi, Kunimi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-331</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Here we isolated tautomycetin, TC, and examd. its phosphatase inhibitory activity.  Recently we have reported that the left-hand moiety of tautomycin, TM, and the right one contg. the spiroketal are essentially required for inhibition of protein phosphatase, PP, and induction of apoptosis, resp.  TC is structurally almost identical to TM except that TC is lacking the spiroketal, which has the potential apoptosis-inducing activity.  TC specifically inhibited PP1 activity, IC50 values for purified PP1 and PP2A enzymes being 1.6 and 62 nM, resp., whereas the IC50 values of TM were 0.21 and 0.94 nM, resp.  These results demonstrate that TC is the most specific PP1 inhibitor out of over 40 species of natural phosphatase inhibitors reported, strongly suggesting that TC is a novel powerful tool to elucidate the physiol. roles of PP1 in various biol. events.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriOZircsC4mbVg90H21EOLACvtfcHk0ljlHM5ukClWXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms12rtLk%253D&md5=71a0e3a172f3da73003d35f2c0f0d992</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.5596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.5596%26sid%3Dliteratum%253Aachs%26aulast%3DMitsuhashi%26aufirst%3DS.%26aulast%3DMatsuura%26aufirst%3DN.%26aulast%3DUbukata%26aufirst%3DM.%26aulast%3DOikawa%26aufirst%3DH.%26aulast%3DShima%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DK.%26atitle%3DTautomycetin%2520Is%2520a%2520Novel%2520and%2520Specific%2520Inhibitor%2520of%2520Serine%252FThreonine%2520Protein%2520Phosphatase%2520Type%25201%252C%2520Pp1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D287%26spage%3D328%26epage%3D331%26doi%3D10.1006%2Fbbrc.2001.5596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velmurugan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, Y. C.</span></span> <span> </span><span class="NLM_article-title">Combination of Celecoxib and Calyculin-a Inhibits Epithelial-Mesenchymal Transition in Human Oral Cancer Cells</span>. <i>Biotech. Histochem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1080/10520295.2019.1700429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1080%2F10520295.2019.1700429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31937145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2nsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2020&pages=341-348&author=B.+K.+Velmuruganauthor=C.+H.+Huaauthor=M.+H.+Tsaiauthor=C.+P.+Leeauthor=C.+M.+Chungauthor=Y.+C.+Ko&title=Combination+of+Celecoxib+and+Calyculin-a+Inhibits+Epithelial-Mesenchymal+Transition+in+Human+Oral+Cancer+Cells&doi=10.1080%2F10520295.2019.1700429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of celecoxib and calyculin-A inhibits epithelial-mesenchymal transition in human oral cancer cells</span></div><div class="casAuthors">Velmurugan, Bharath Kumar; Hua, Chun-Hung; Tsai, Ming-Hsui; Lee, Chi-Pin; Chung, Chia-Min; Ko, Ying-Chin</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnic & Histochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">341-348</span>CODEN:
                <span class="NLM_cas:coden">BIHIEU</span>;
        ISSN:<span class="NLM_cas:issn">1052-0295</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Expression of cyclo-oxygenase-2 (COX-2) and protein phosphatase 2A (PP2A) deactivation occurs frequently in oral squamous cell carcinoma (OSCC).  We initially assessed COX-2 and PP2A protein expression in OSCC specimens using immunohistochem. (IHC) staining and western blot anal.  We found strong COX-2 and phosphorylated PP2A (p-PP2A) expression in OSCC samples.  No significant difference in total PP2A expression was obsd. between cancer and nontumor tissues.  The effect of combining COX-2 inhibitor and celecoxib (CXB) with the PP2A inhibitor, calyculin-A (CLA) on the OSCC cell line, HSC3, was evaluated in vitro.  We found that a combination of 1 nM CLA and 50μM CXB significantly inhibited cell viability, and migration and invasion of HSC3 cells.  Western blots for AKT, p-AKT, ERK, p-ERK, E-cadherin, vimentin and β-catenin were conducted after treatment with CXB and/or CLA.  Increased E-cadherin and decreased β-catenin expression were found in CXB or CLA treated hsc-3 cells, whereas the combined CXB and CLA treatment showed no difference in E-cadherin or β-catenin expression.  Our findings suggest that CLA alone was more effective than CXB alone, but not in the combined drug treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmKsicr0G907Vg90H21EOLACvtfcHk0ljlHM5ukClWXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2nsr4%253D&md5=894bf17776e9a22aaf5e08d58e38eff4</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1080%2F10520295.2019.1700429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10520295.2019.1700429%26sid%3Dliteratum%253Aachs%26aulast%3DVelmurugan%26aufirst%3DB.%2BK.%26aulast%3DHua%26aufirst%3DC.%2BH.%26aulast%3DTsai%26aufirst%3DM.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BP.%26aulast%3DChung%26aufirst%3DC.%2BM.%26aulast%3DKo%26aufirst%3DY.%2BC.%26atitle%3DCombination%2520of%2520Celecoxib%2520and%2520Calyculin-a%2520Inhibits%2520Epithelial-Mesenchymal%2520Transition%2520in%2520Human%2520Oral%2520Cancer%2520Cells%26jtitle%3DBiotech.%2520Histochem.%26date%3D2020%26volume%3D95%26spage%3D341%26epage%3D348%26doi%3D10.1080%2F10520295.2019.1700429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edelson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span> <span> </span><span class="NLM_article-title">The Discodermia Calyx Toxin Calyculin a Enhances Cyclin D1 Phosphorylation and Degradation, and Arrests Cell Cycle Progression in Human Breast Cancer Cells</span>. <i>Toxins</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.3390/toxins3010105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3390%2Ftoxins3010105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22069692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVSqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=105-119&author=J.+R.+Edelsonauthor=D.+L.+Brautigan&title=The+Discodermia+Calyx+Toxin+Calyculin+a+Enhances+Cyclin+D1+Phosphorylation+and+Degradation%2C+and+Arrests+Cell+Cycle+Progression+in+Human+Breast+Cancer+Cells&doi=10.3390%2Ftoxins3010105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">The Discodermia calyx toxin calyculin A enhances cyclin D1 phosphorylation and degradation, and arrests cell cycle progression in human breast cancer cells</span></div><div class="casAuthors">Edelson, Jessica R.; Brautigan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Toxins</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-119</span>CODEN:
                <span class="NLM_cas:coden">TOXIB7</span>;
        ISSN:<span class="NLM_cas:issn">2072-6651</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Cyclin D1 is a key regulator of the cell cycle that is over expressed in more than half of breast cancer patients.  The levels of cyclin D1 are controlled primarily through post-translational mechanisms and phosphorylation of cyclin D1 at T286 induces its proteasomal degrdn.  To date, no studies have explored the involvement of phosphatases in this process.  Here we treated human breast cancer cells with the structurally distinct toxins calyculin A, okadaic acid, and cantharidin, which are known to inhibit Ser/Thr phosphatases of the PPP family.  At low nanomolar concns. calyculin A induced T286 phosphorylation and degrdn. of cyclin D1 via the proteosome in MDA-MB-468 and MDA-MB-231 cells.  Cyclin D1 degrdn. also was dose-dependently induced by okadaic acid and catharidin, implicating a neg. regulatory role for type-2A phosphatases.  These effects occurred without increasing phosphorylation of p70S6K, cyclin D3, or myosin light chain that were used as endogenous reporters of cellular PP2A and PP1 activity.  A reverse phase phosphoprotein array anal. revealed increased phosphorylation of only 6 out of 33 Ser/Thr phosphosites, indicating selective inhibition of phosphatases by calyculin A.  Calyculin A treatment induced cell cycle arrest in MDA-MB-468 and MCF-7 breast cancer cells.  These findings suggest that a specific pool of type-2A phosphatase is inhibited by calyculin A leading to the degrdn. of cyclin D1 in human breast cancer cells.  The results highlight the utility of toxins as pharmacol. probes and points to the T286 cyclin D1 phosphatase inhibited by calyculin A as a possible target for chemotherapy to treat triple neg. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8BWDOyU65SbVg90H21EOLACvtfcHk0lgKajhtwqVHug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVSqsL0%253D&md5=be584d29f5225f6f219bca8cfa94ef46</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.3390%2Ftoxins3010105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Ftoxins3010105%26sid%3Dliteratum%253Aachs%26aulast%3DEdelson%26aufirst%3DJ.%2BR.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Discodermia%2520Calyx%2520Toxin%2520Calyculin%2520a%2520Enhances%2520Cyclin%2520D1%2520Phosphorylation%2520and%2520Degradation%252C%2520and%2520Arrests%2520Cell%2520Cycle%2520Progression%2520in%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DToxins%26date%3D2011%26volume%3D3%26spage%3D105%26epage%3D119%26doi%3D10.3390%2Ftoxins3010105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lê, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlichman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiessen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhauer, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M. J.</span></span> <span> </span><span class="NLM_article-title">Phase I and Pharmacokinetic Study of Fostriecin Given as an Intravenous Bolus Daily for Five Consecutive Days</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1023/B:DRUG.0000011792.13160.b0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1023%2FB%3ADRUG.0000011792.13160.b0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=14739664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisleisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=159-167&author=L.+H.+L%C3%AAauthor=C.+Erlichmanauthor=L.+Pillonauthor=J.+J.+Thiessenauthor=A.+Dayauthor=N.+Wainmanauthor=E.+A.+Eisenhauerauthor=M.+J.+Moore&title=Phase+I+and+Pharmacokinetic+Study+of+Fostriecin+Given+as+an+Intravenous+Bolus+Daily+for+Five+Consecutive+Days&doi=10.1023%2FB%3ADRUG.0000011792.13160.b0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and Pharmacokinetic Study of Fostriecin given as an Intravenous Bolus Daily for Five Consecutive Days</span></div><div class="casAuthors">Le, Lyly H.; Erlichman, Charles; Pillon, Linda; Thiessen, Jake J.; Day, Andrew; Wainman, Nancy; Eisenhauer, Elizabeth A.; Moore, Malcolm J.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-167</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Fostriecin (CI-920) is a potent inhibitor of protein phosphatase 2A (PP2A) and protein phosphatase 4(PP4) found to have anticancer activity in preclin. testing.  A phase I study was conducted to evaluate the max.-tolerated dose (MTD), toxicity profile, and pharmacokinetics (PK) of this drug.  Forty-six patients were treated with escalating doses of fostriecin (2-47 mg/m2) administered as a daily bolus infusion for five consecutive days.  PK studies were performed at different time points following administration of fostriecin.  Dose-limiting toxicities included: elevation of creatinine, bilirubin, and hepatic transaminases; nausea, anorexia, lethargy, and hypotension.  PK studies were compatible with a two-compartment model.  Regression anal. revealed a significant relationship between dose and clearance; however, the r2 value was only 0.168 indicating a low predictive value for the model.  No significant difference was seen in PK parameters with repeated dosing during the same cycle.  Although no tumor responses were seen, 16 patients had stable disease with a median duration response of 2.6 mo.  The study was closed before reaching MTD due to problems with the supply of fostriecin from the National Cancer Institute of the United States (NCI US).  New methods for synthesizing fostriecin have recently been described and therefore further development of this unique anticancer agent may be warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGCDycMl34ErVg90H21EOLACvtfcHk0lgKajhtwqVHug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisleisQ%253D%253D&md5=1439c0b7a0c9d9a072a15e1573163c8a</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1023%2FB%3ADRUG.0000011792.13160.b0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253ADRUG.0000011792.13160.b0%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25AA%26aufirst%3DL.%2BH.%26aulast%3DErlichman%26aufirst%3DC.%26aulast%3DPillon%26aufirst%3DL.%26aulast%3DThiessen%26aufirst%3DJ.%2BJ.%26aulast%3DDay%26aufirst%3DA.%26aulast%3DWainman%26aufirst%3DN.%26aulast%3DEisenhauer%26aufirst%3DE.%2BA.%26aulast%3DMoore%26aufirst%3DM.%2BJ.%26atitle%3DPhase%2520I%2520and%2520Pharmacokinetic%2520Study%2520of%2520Fostriecin%2520Given%2520as%2520an%2520Intravenous%2520Bolus%2520Daily%2520for%2520Five%2520Consecutive%2520Days%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2004%26volume%3D22%26spage%3D159%26epage%3D167%26doi%3D10.1023%2FB%3ADRUG.0000011792.13160.b0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tunac, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, W. E.</span></span> <span> </span><span class="NLM_article-title">Novel Antitumor Agents Ci-920, Pd113,270 and Pd113,271. I. Taxonomy, Fermentation and Biological Properties</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1595</span>– <span class="NLM_lpage">1600</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.36.1595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.7164%2Fantibiotics.36.1595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=6689323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL2cXhtlOhur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1983&pages=1595-1600&author=J.+B.+Tunacauthor=B.+D.+Grahamauthor=W.+E.+Dobson&title=Novel+Antitumor+Agents+Ci-920%2C+Pd113%2C270+and+Pd113%2C271.+I.+Taxonomy%2C+Fermentation+and+Biological+Properties&doi=10.7164%2Fantibiotics.36.1595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Novel antitumor agents CI-920, PD 113,270 and PD 113,271.  I.  Taxonomy, fermentation and biological properties</span></div><div class="casAuthors">Tunac, J. B.; Graham, B. D.; Dobson, W. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1595-600</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">CI-920 (PD 110,161)  [87810-56-8] and 2 analogs (PD 113,270  [87860-37-5] and PD 113,271  [87810-56-8]) are novel antitumor compds. produced by a new actinomycete characterized as Streptomyces pulveraceus subspecies fostreus ATCC 31906.  The antitumor compds. are predominantly produced during the stationary (idiophase) growth phase of the organism.  CI-920 is active against the murine P388 lymphocytic and L1210 lymphoid leukemia with T/C values of 246 and 207, resp.  This compd. has no significant antimicrobial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJnwOMEqsDLrVg90H21EOLACvtfcHk0lgocDP0A0rhmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtlOhur8%253D&md5=4eea14d04a03e9c44325f3b30dced9a1</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.36.1595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.36.1595%26sid%3Dliteratum%253Aachs%26aulast%3DTunac%26aufirst%3DJ.%2BB.%26aulast%3DGraham%26aufirst%3DB.%2BD.%26aulast%3DDobson%26aufirst%3DW.%2BE.%26atitle%3DNovel%2520Antitumor%2520Agents%2520Ci-920%252C%2520Pd113%252C270%2520and%2520Pd113%252C271.%2520I.%2520Taxonomy%252C%2520Fermentation%2520and%2520Biological%2520Properties%26jtitle%3DJ.%2520Antibiot.%26date%3D1983%26volume%3D36%26spage%3D1595%26epage%3D1600%26doi%3D10.7164%2Fantibiotics.36.1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stampwala, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunge, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willmer, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brankiewicz, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smitka, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, J. C.</span></span> <span> </span><span class="NLM_article-title">Novel Antitumor Agents Ci-920, Pd113,270 and Pd113,271. Ii. Isolation and Characterization</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1605</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.36.1601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.7164%2Fantibiotics.36.1601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=6689324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL2cXhtlGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1983&pages=1601-1605&author=S.+S.+Stampwalaauthor=R.+H.+Bungeauthor=T.+R.+Hurleyauthor=N.+E.+Willmerauthor=A.+J.+Brankiewiczauthor=C.+E.+Steinmanauthor=T.+A.+Smitkaauthor=J.+C.+French&title=Novel+Antitumor+Agents+Ci-920%2C+Pd113%2C270+and+Pd113%2C271.+Ii.+Isolation+and+Characterization&doi=10.7164%2Fantibiotics.36.1601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Novel antitumor agents CI-920, PD 113,270 and PD 113,271.  II.  Isolation and characterization</span></div><div class="casAuthors">Stampwala, S. S.; Bunge, R. H.; Hurley, T. R.; Willmer, N. E.; Brankiewicz, A. J.; Steinman, C. E.; Smitka, T. A.; French, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1601-5</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">A complex of structurally related compds. that exhibit in vivo antileukemic activity was isolated from fermn. broths of a new streptomycete.  The components of this complex are water sol. phosphate esters contg. a conjugated triene system.  The isolation and characterization of 3 of these components are described: CI-920 (I), PD 113,270 (II), and PD 11,271 (III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxZWINg6gZLVg90H21EOLACvtfcHk0lgocDP0A0rhmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtlGltL8%253D&md5=513f2bc9f77918073e5636c743bd0ab5</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.36.1601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.36.1601%26sid%3Dliteratum%253Aachs%26aulast%3DStampwala%26aufirst%3DS.%2BS.%26aulast%3DBunge%26aufirst%3DR.%2BH.%26aulast%3DHurley%26aufirst%3DT.%2BR.%26aulast%3DWillmer%26aufirst%3DN.%2BE.%26aulast%3DBrankiewicz%26aufirst%3DA.%2BJ.%26aulast%3DSteinman%26aufirst%3DC.%2BE.%26aulast%3DSmitka%26aufirst%3DT.%2BA.%26aulast%3DFrench%26aufirst%3DJ.%2BC.%26atitle%3DNovel%2520Antitumor%2520Agents%2520Ci-920%252C%2520Pd113%252C270%2520and%2520Pd113%252C271.%2520Ii.%2520Isolation%2520and%2520Characterization%26jtitle%3DJ.%2520Antibiot.%26date%3D1983%26volume%3D36%26spage%3D1601%26epage%3D1605%26doi%3D10.7164%2Fantibiotics.36.1601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haslbeck, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drazic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckl, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alte, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popowicz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemmecker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Striggow, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, K.</span></span> <span> </span><span class="NLM_article-title">Selective Activators of Protein Phosphatase 5 Target the Auto-Inhibitory Mechanism</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">e00210</span>, <span class="refDoi"> DOI: 10.1042/BSR20150042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1042%2FBSR20150042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26182372" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=e00210&author=V.+Haslbeckauthor=A.+Drazicauthor=J.+M.+Ecklauthor=F.+Alteauthor=M.+Helmuthauthor=G.+Popowiczauthor=W.+Schmidtauthor=F.+Braunauthor=M.+Weiwadauthor=G.+Fischerauthor=G.+Gemmeckerauthor=M.+Sattlerauthor=F.+Striggowauthor=M.+Grollauthor=K.+Richter&title=Selective+Activators+of+Protein+Phosphatase+5+Target+the+Auto-Inhibitory+Mechanism&doi=10.1042%2FBSR20150042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1042%2FBSR20150042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20150042%26sid%3Dliteratum%253Aachs%26aulast%3DHaslbeck%26aufirst%3DV.%26aulast%3DDrazic%26aufirst%3DA.%26aulast%3DEckl%26aufirst%3DJ.%2BM.%26aulast%3DAlte%26aufirst%3DF.%26aulast%3DHelmuth%26aufirst%3DM.%26aulast%3DPopowicz%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DW.%26aulast%3DBraun%26aufirst%3DF.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DGemmecker%26aufirst%3DG.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DStriggow%26aufirst%3DF.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DK.%26atitle%3DSelective%2520Activators%2520of%2520Protein%2520Phosphatase%25205%2520Target%2520the%2520Auto-Inhibitory%2520Mechanism%26jtitle%3DBiosci.%2520Rep.%26date%3D2015%26volume%3D35%26spage%3De00210%26doi%3D10.1042%2FBSR20150042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, J. S.</span></span> <span> </span><span class="NLM_article-title">Ro 90-7501 Inhibits Pp5 through a Novel, Tpr-Dependent Mechanism</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>482</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.11.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bbrc.2016.11.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=27840051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKgtrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2017&pages=215-220&author=T.+J.+Hongauthor=K.+Parkauthor=E.+W.+Choiauthor=J.+S.+Hahn&title=Ro+90-7501+Inhibits+Pp5+through+a+Novel%2C+Tpr-Dependent+Mechanism&doi=10.1016%2Fj.bbrc.2016.11.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Ro 90-7501 inhibits PP5 through a novel, TPR-dependent mechanism</span></div><div class="casAuthors">Hong, Tae-Joon; Park, Kwanghyun; Choi, Eun-Wook; Hahn, Ji-Sook</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein phosphatase 5 (PP5) is a serine/threonine phosphatase that belongs to the PPP family phosphatases.  PP5 and the other phosphatases of the PPP family share significantly similar catalytic domain structure.  Due to this structural similarity, natural competitive inhibitors such as okadaic acid and cantharidin exhibit broad specificity over the PPP family phosphatases.  In this study, we report the identification of three PP5 inhibitors, Ro 90-7501, aurothioglucose, and N-oleoyldopamine, along with a novel inhibitory mechanism of Ro 90-7501.  Unlike other inhibitors binding to the phosphatase domain, Ro 90-7501 inhibited PP5 in a TPR-dependent manner.  This TPR-dependent PP5 inhibition shown by Ro 90-7501 is a unique and novel inhibitory mechanism, which might be a useful tool for studies of PP5 on both regulatory mechanism and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7kSCE7SCq4bVg90H21EOLACvtfcHk0liLuEXC5PMG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKgtrfO&md5=e6145b85c9ecfe377f05340331625b94</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.11.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.11.043%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DT.%2BJ.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DE.%2BW.%26aulast%3DHahn%26aufirst%3DJ.%2BS.%26atitle%3DRo%252090-7501%2520Inhibits%2520Pp5%2520through%2520a%2520Novel%252C%2520Tpr-Dependent%2520Mechanism%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D482%26spage%3D215%26epage%3D220%26doi%3D10.1016%2Fj.bbrc.2016.11.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung
Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">Identification of Chaulmoogric Acid as a Small Molecule Activator of Protein Phosphatase 5</span>. <i>Appl. Biochem. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">1450</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.1007/s12010-009-8647-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs12010-009-8647-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19404779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivVSmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=1450-1459&author=C.+Cherauthor=M.-H.+Tremblayauthor=J.+R.+Barberauthor=S.+Chung%0ANgauthor=B.+Zhang&title=Identification+of+Chaulmoogric+Acid+as+a+Small+Molecule+Activator+of+Protein+Phosphatase+5&doi=10.1007%2Fs12010-009-8647-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of chaulmoogric acid as a small molecule activator of protein phosphatase 5</span></div><div class="casAuthors">Cher, Charmian; Tremblay, Marie-Helene; Barber, Jack R.; Ng, Shi Chung; Zhang, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Applied Biochemistry and Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1450-1459</span>CODEN:
                <span class="NLM_cas:coden">ABIBDL</span>;
        ISSN:<span class="NLM_cas:issn">0273-2289</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protein phosphatase 5 (PP5) is an important protein phosphatase that is abundantly expressed in the central nervous system.  Recent studies showed that PP5 activity in the neocortex from patients with Alzheimer's disease (AD) is decreased significantly, suggesting that small mol. PP5 activators may have therapeutic potential for AD.  Here, the authors performed a biochem. screening for PP5 activators with the microsource compd. library.  Chaulmoogric acid (I) was identified to be an effective activator with EC50 value of 134.5 μM.  Importantly, results from CD and limited proteolysis studies showed that I bound to a region of the tetratricopeptide repeat (TPR) domain of PP5 resulting in complete loss of helical content.  These results demonstrated a different mechanism of action from that of arachidonic acid, a known activator for PP5 dephosphorylation activity.  Synergistic activation of PP5 enzymic activity was also obsd. with combined application of both compds. at relatively low concns.  Therefore, a further structure-activity relation study of I may facilitate the discovery of small mols. that can synergize with endogenous arachidonic acid for PP5 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8yRVAxHEbELVg90H21EOLACvtfcHk0liLuEXC5PMG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivVSmtbs%253D&md5=3d4afccc38de95524d20fe77d34b3e18</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1007%2Fs12010-009-8647-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12010-009-8647-3%26sid%3Dliteratum%253Aachs%26aulast%3DCher%26aufirst%3DC.%26aulast%3DTremblay%26aufirst%3DM.-H.%26aulast%3DBarber%26aufirst%3DJ.%2BR.%26aulast%3DChung%2BNg%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520Chaulmoogric%2520Acid%2520as%2520a%2520Small%2520Molecule%2520Activator%2520of%2520Protein%2520Phosphatase%25205%26jtitle%3DAppl.%2520Biochem.%2520Biotechnol.%26date%3D2010%26volume%3D160%26spage%3D1450%26epage%3D1459%26doi%3D10.1007%2Fs12010-009-8647-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikekita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinomiya, T.</span></span> <span> </span><span class="NLM_article-title">A Novel Immunosuppressive Agent Fty720 Induced Akt Dephosphorylation in Leukemia Cells</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1312</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0705182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsj.bjp.0705182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=12711631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFGiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2003&pages=1303-1312&author=Y.+Matsuokaauthor=Y.+Nagaharaauthor=M.+Ikekitaauthor=T.+Shinomiya&title=A+Novel+Immunosuppressive+Agent+Fty720+Induced+Akt+Dephosphorylation+in+Leukemia+Cells&doi=10.1038%2Fsj.bjp.0705182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells</span></div><div class="casAuthors">Matsuoka, Yumiko; Nagahara, Yukitoshi; Ikekita, Masahiko; Shinomiya, Takahisa</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1303-1312</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Our previous studies revealed that the immunosuppressive agent, FTY720, mainly induces mitochondria-involved apoptosis in some types of cancer cells, since Bcl-2 overexpression prevents the FTY720-induction of apoptotic stimuli.  Furthermore, FTY720 induces G0/G1 cell cycle arrest.  The present study further examines the correlation between intracellular signaling kinases with FTY720-induced mitochondria-involved apoptosis.  Human T cell leukemia Jurkat was exposed to FTY720.  Dephosphorylation of Akt occurred in a time- and concn.-dependent manner.  FTY720 also induced Bad (Ser136) and ribosomal p70S6 kinase (p7056k) (Thr389) dephosphorylation.  FTY720-induced Akt dephosphorylation was not because of Akt upstream phosphatidylinositol 3'-kinase (PI 3-kinase) pathway inhibition.  FTY720 also induced Akt dephosphorylation in human B cell leukemia BALL-1.  BALL-1 cells were resistant to FTY720-induced apoptosis.  Okadaic acid (OA) inhibited the FTY720-induced dephosphorylation of Akt and p70S6k, suggesting that FTY720 promotes Ser/Thr protein phosphatase (PP) activity.  OA partially inhibited FTY720-induced caspase-3 activation.  PP2A or PP2A-like phosphatase was temporarily activated in cells exposed to FTY720.  In addn., FTY720 activated purified PP2A (ABC).  Overall, the results suggest that FTY720 activated PP2A or PP2A-like phosphatase and dephosphorylated Akt pathway factors resulting in the enhancement of apoptosis via mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB5BFOyJHN8rVg90H21EOLACvtfcHk0lhblip9PrLDIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFGiu74%253D&md5=b49a304112e81d5c254f5803f5c70cac</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705182%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DY.%26aulast%3DNagahara%26aufirst%3DY.%26aulast%3DIkekita%26aufirst%3DM.%26aulast%3DShinomiya%26aufirst%3DT.%26atitle%3DA%2520Novel%2520Immunosuppressive%2520Agent%2520Fty720%2520Induced%2520Akt%2520Dephosphorylation%2520in%2520Leukemia%2520Cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D138%26spage%3D1303%26epage%3D1312%26doi%3D10.1038%2Fsj.bjp.0705182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mudhakir, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalil, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harashima, H.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic Analysis of the Tissue Distribution of Octaarginine Modified Liposomes in Mice</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.2133/dmpk.20.275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2133%2Fdmpk.20.275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=16141607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWitrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=275-281&author=D.+Mudhakirauthor=H.+Akitaauthor=I.+A.+Khalilauthor=S.+Futakiauthor=H.+Harashima&title=Pharmacokinetic+Analysis+of+the+Tissue+Distribution+of+Octaarginine+Modified+Liposomes+in+Mice&doi=10.2133%2Fdmpk.20.275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic analysis of the tissue distribution of octaarginine modified liposomes in mice</span></div><div class="casAuthors">Mudhakir, Diky; Akita, Hidetaka; Khalil, Ikramy A.; Futaki, Shiroh; Harashima, Hideyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">275-281</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">We recently found that octaarginine modified liposomes (R8-Lip) can be efficiently internalized by cultured cells.  The purpose of the present study was to quant. det. the effect of R8-d. on the tissue distribution of R8-Lip in mice, using their clearance as an index.  R8 was introduced in the form of stearylated R8 (STR-R8).  The liposomes were composed of cholesterol and egg phosphatidylcholine and were labeled with [3H]cholesteryl hexadecyl ether.  Various densities of R8 (3%, 10% and 30%) contg. liposomes were prepd. with a diam. of approx. 70-80 nm.  The tissue distribution of R8-Lip was detd. after their i.v. administration into mice and the effect of R8-d. on tissue distribution was compared with uptake clearance, the calcd. tissue distribution divided by the area under the blood concn.-time course.  As results, R8-Lip were more rapidly eliminated from circulating blood and distributed to many tissues, esp. liver depending on the R8-d.  However, the tissue uptake clearance represented similar value to that of pos. charge liposomes.  Based on these results, we conclude that the R8-dependent increase in R8-Lip in various tissues tested indicates that pos. charge, but not PTD function derived from R8 predominantly responsible for the enhancement of tissue distribution.  Therefore, it is suggested that topol. control of R8 is important to exhibit the PTD function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWHEEeoxWEWrVg90H21EOLACvtfcHk0lhblip9PrLDIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWitrnF&md5=3423e90977c4c239f214ac2e33bad919</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.20.275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.20.275%26sid%3Dliteratum%253Aachs%26aulast%3DMudhakir%26aufirst%3DD.%26aulast%3DAkita%26aufirst%3DH.%26aulast%3DKhalil%26aufirst%3DI.%2BA.%26aulast%3DFutaki%26aufirst%3DS.%26aulast%3DHarashima%26aufirst%3DH.%26atitle%3DPharmacokinetic%2520Analysis%2520of%2520the%2520Tissue%2520Distribution%2520of%2520Octaarginine%2520Modified%2520Liposomes%2520in%2520Mice%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2005%26volume%3D20%26spage%3D275%26epage%3D281%26doi%3D10.2133%2Fdmpk.20.275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Permpongkosol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumiya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongkanand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuyama, A.</span></span> <span> </span><span class="NLM_article-title">Anticarcinogenic Effect of Fty720 in Human Prostate Carcinoma Du145 Cells: Modulation of Mitogenic Signaling, Fak, Cell-Cycle Entry and Apoptosis</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1002/ijc.10178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fijc.10178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11857403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2002&pages=167-172&author=S.+Permpongkosolauthor=J.+D.+Wangauthor=S.+Takaharaauthor=K.+Matsumiyaauthor=N.+Nonomuraauthor=K.+Nishimuraauthor=A.+Tsujimuraauthor=A.+Kongkanandauthor=A.+Okuyama&title=Anticarcinogenic+Effect+of+Fty720+in+Human+Prostate+Carcinoma+Du145+Cells%3A+Modulation+of+Mitogenic+Signaling%2C+Fak%2C+Cell-Cycle+Entry+and+Apoptosis&doi=10.1002%2Fijc.10178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis</span></div><div class="casAuthors">Permpongkosol, Sompol; Wang, Jing-Ding; Takahara, Shiro; Matsumiya, Kiyomi; Nonomura, Norio; Nishimura, Kazuo; Tsujimura, Akira; Kongkanand, Apichat; Okuyama, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-172</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Despite the high frequency of prostate cancer, therapeutic options for advanced disease are limited to chemotherapy, radiation or hormonal therapy and eventually fail in all patients.  Therefore, alternative approaches need to be developed.  We previously reported that FTY720, a metabolite from Isaria sinclairii, is a unique antitumor agent for an androgen-independent prostate cancer cell line and requires caspase-3 activation in apoptosis.  In our study, we have evaluated the effect of FTY720 on a family of mitogen-activated protein kinases (MAPKs), focal adhesion kinase (FAK), mitochondrial transmembrane potential, caspase-9 and caspase-8 and analyzed the expression of some cell-cycle regulator proteins in DU145 cells to understand the various antitumor effects of FTY720.  Apoptosis was quantified by phosphatidylserine exposure.  Activation of MAPKs, cleavage of caspase-9 and caspase-8, status of cyclin-dependent kinases (CDKs) and Cip1/p21, a cyclin-dependent kinase inhibitor, were evaluated by Western blot anal., in addn. to FAK and phospho-FAK immunopptn. and cell-cycle anal. by FAC Scan.  We found that in DU145 cells, 40 μM FTY720 caused activation of p38 MAPK and the upstream kinase MKK3/MKK6 but not SAPK/JNK.  Mitochondrial transmembrane potential, FAK and ERK1/2 were reduced while caspase-9 and caspase-8 were cleaved.  The p38-specific inhibitor had no effect on apoptosis induced by FTY720, whereas z-VAD.FMK, a broad-spectrum caspase inhibitor, did not inhibit the p38 MAPK activation.  An amt. of 20 μM FTY720 resulted in G1 arrest and a decrease of CDK2 as well as CDK4, whereas it induced Cip1/p21.  FTY720 may exert anticarcinogenic effects against prostate cancer cells possibly involving modulation of mitogenic signaling, cell-cycle regulators, induction of G1 arrest and apoptotic death in DU145 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYNohycZVKrrVg90H21EOLACvtfcHk0lhblip9PrLDIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVSktb8%253D&md5=18bac0de77ae125c2fdca91164b0f9c5</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2Fijc.10178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.10178%26sid%3Dliteratum%253Aachs%26aulast%3DPermpongkosol%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BD.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DMatsumiya%26aufirst%3DK.%26aulast%3DNonomura%26aufirst%3DN.%26aulast%3DNishimura%26aufirst%3DK.%26aulast%3DTsujimura%26aufirst%3DA.%26aulast%3DKongkanand%26aufirst%3DA.%26aulast%3DOkuyama%26aufirst%3DA.%26atitle%3DAnticarcinogenic%2520Effect%2520of%2520Fty720%2520in%2520Human%2520Prostate%2520Carcinoma%2520Du145%2520Cells%253A%2520Modulation%2520of%2520Mitogenic%2520Signaling%252C%2520Fak%252C%2520Cell-Cycle%2520Entry%2520and%2520Apoptosis%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2002%26volume%3D98%26spage%3D167%26epage%3D172%26doi%3D10.1002%2Fijc.10178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otsuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuoka, Y.</span></span> <span> </span><span class="NLM_article-title">Induction of Apoptosis in Human Bladder Cancer Cells in Vitro and in Vivo Caused by Fty720 Treatment</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">2372</span>– <span class="NLM_lpage">2377</span>, <span class="refDoi"> DOI: 10.1097/01.ju.0000064938.32318.91</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1097%2F01.ju.0000064938.32318.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=12771800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlOisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2003&pages=2372-2377&author=H.+Azumaauthor=S.+Takaharaauthor=S.+Horieauthor=S.+Mutoauthor=Y.+Otsukiauthor=Y.+Katsuoka&title=Induction+of+Apoptosis+in+Human+Bladder+Cancer+Cells+in+Vitro+and+in+Vivo+Caused+by+Fty720+Treatment&doi=10.1097%2F01.ju.0000064938.32318.91"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of Apoptosis in Human Bladder Cancer Cells In Vitro and In Vivo Caused by FTY720 Treatment</span></div><div class="casAuthors">Azuma, Haruhito; Takahara, Shiro; Horie, Shigeo; Muto, Satoru; Otsuki, Yoshinori; Katsuoka, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2372-2377</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">FTY720 is a unique immunosuppressant that induces apoptosis in activated lymphocytes but not in other hematopoietic cells.  We examd. whether FTY720 has anticancer effects on human bladder cancer cells by inducing apoptosis and we investigated its mol. pathway.  MATERIALS AND METHODS We used the 3 human bladder cancer cell lines T24, UMUC3 and HT1197, and the human fibroblast derived cell line CRL-2096 (American Type Tissue Collection, Rockville, Maryland) in this study.  The difference in drug susceptibility to FTY720 in cancer cells and fibroblasts was examd. by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and cell growth assays.  FTY720 induced apoptosis was detd. by morphol. anal. under light and electron microscopy, and DNA electrophoresis, and its mol. pathway was evaluated by Western blot anal. focusing on the p42/p44 mitogen activated protein kinase pathway.  We then tested the in vivo effect of this agent using 2 mouse models of human bladder cancer xenograft.  RESULTS FTY720 treatment in vitro induced selective apoptosis in cancer cells at a concn. of less than 10 μM. Morphol. anal. revealed features characteristic of apoptosis, including small cytoplasm with fragmented nuclei and condensed chromatin.  DNA electrophoresis confirmed apoptosis, as evidenced by a distinct oligosomal ladder.  Western blot anal. revealed that the agent significantly inhibited hepatocyte growth factor induced p42/p44 mitogen activated protein kinase activity.  The in vivo anticancer effect was clearly confirmed by significantly decreased tumor growth without notable side effects in the 2 xenograft models.  CONCLUSIONS FTY720 treatment may induce selective apoptosis in vitro as well as in vivo in cancer cells.  We suggest that FTY720 is a potent and clin. applicable anticancer agent for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLUVoMc3LO8rVg90H21EOLACvtfcHk0li4beLmRrMOWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlOisLY%253D&md5=48b7aff671b4fcb1f64117dd3b62614c</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1097%2F01.ju.0000064938.32318.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.ju.0000064938.32318.91%26sid%3Dliteratum%253Aachs%26aulast%3DAzuma%26aufirst%3DH.%26aulast%3DTakahara%26aufirst%3DS.%26aulast%3DHorie%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DS.%26aulast%3DOtsuki%26aufirst%3DY.%26aulast%3DKatsuoka%26aufirst%3DY.%26atitle%3DInduction%2520of%2520Apoptosis%2520in%2520Human%2520Bladder%2520Cancer%2520Cells%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Caused%2520by%2520Fty720%2520Treatment%26jtitle%3DJ.%2520Urol.%26date%3D2003%26volume%3D169%26spage%3D2372%26epage%3D2377%26doi%3D10.1097%2F01.ju.0000064938.32318.91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sonoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizu-Yokota, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momoi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, T.</span></span> <span> </span><span class="NLM_article-title">Fty720, a Novel Immunosuppressive Agent, Induces Apoptosis in Human Glioma Cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2001.4352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1006%2Fbbrc.2001.4352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11181042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1aitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2001&pages=282-288&author=Y.+Sonodaauthor=D.+Yamamotoauthor=S.+Sakuraiauthor=M.+Hasegawaauthor=E.+Aizu-Yokotaauthor=T.+Momoiauthor=T.+Kasahara&title=Fty720%2C+a+Novel+Immunosuppressive+Agent%2C+Induces+Apoptosis+in+Human+Glioma+Cells&doi=10.1006%2Fbbrc.2001.4352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720, a Novel Immunosuppressive Agent, Induces Apoptosis in Human Glioma Cells</span></div><div class="casAuthors">Sonoda, Yoshiko; Yamamoto, Daisuke; Sakurai, Shinya; Hasegawa, Maki; Aizu-Yokota, Eriko; Momoi, Takashi; Kasahara, Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">282-288</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">FTY720, a metabolite from Isaria sinclairii, has been developed to be a potent immunosuppressive drug with induction of apoptosis in T cells and several cell lines.  We investigated whether FTY720 induces apoptosis in human glioma cell lines, since they are relatively resistant to multiple apoptotic stimuli.  In human glioma cells including T98G, FTY720 induced apoptosis with ED50 between 1 to 10 μg/mL, while etoposide did not induce apoptosis at the same doses.  Among the caspase family proteases, mainly caspase-6 was activated during the apoptosis by FTY720 but not etoposide.  In addn., FTY720 caused tyrosine dephosphorylation of FAK and did not activate a FAK-PI3-kinase survival pathway.  This was confirmed also by the observation that orthovanadate prevented FTY720-induced dephosphorylation of FAK and inhibited FTY720-induced cell death.  We assumed that FTY720 induced FAK dephosphorylation and cut off the FAK-PI3-kinase pathway resulting in the induction of apoptosis via caspase-6 activation in these glioma cells.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgnarZ8uvwVbVg90H21EOLACvtfcHk0li4beLmRrMOWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1aitLY%253D&md5=54a9a89c87911ee6f4e6a0f3d701b4ff</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.4352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.4352%26sid%3Dliteratum%253Aachs%26aulast%3DSonoda%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DD.%26aulast%3DSakurai%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DAizu-Yokota%26aufirst%3DE.%26aulast%3DMomoi%26aufirst%3DT.%26aulast%3DKasahara%26aufirst%3DT.%26atitle%3DFty720%252C%2520a%2520Novel%2520Immunosuppressive%2520Agent%252C%2520Induces%2520Apoptosis%2520in%2520Human%2520Glioma%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D281%26spage%3D282%26epage%3D288%26doi%3D10.1006%2Fbbrc.2001.4352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrestha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, E.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baek, D. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Fty720 (Fingolimod) Derivatives with Aromatic Head Group as Anticancer Agents</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1015</span>– <span class="NLM_lpage">1018</span>, <span class="refDoi"> DOI: 10.1248/cpb.c18-00065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1248%2Fcpb.c18-00065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30270236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltF2qtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=1015-1018&author=T.+Leeauthor=H.+S.+Moonauthor=S.+W.+Kimauthor=J.+Shresthaauthor=S.+M.+Shinauthor=J.-Y.+Leeauthor=S.+Kimauthor=E.-Y.+Parkauthor=D.+J.+Baek&title=Synthesis+and+Biological+Evaluation+of+Fty720+%28Fingolimod%29+Derivatives+with+Aromatic+Head+Group+as+Anticancer+Agents&doi=10.1248%2Fcpb.c18-00065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of FTY720 (fingolimod) derivatives with aromatic head group as anticancer agents</span></div><div class="casAuthors">Lee, Taeho; Moon, Hong Seop; Kim, Seon Woong; Shrestha, Jitendra; Shin, Sang Mi; Lee, Joo-Youn; Kim, Sanghee; Park, Eun-Young; Baek, Dong Jae</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1015-1018</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">FTY720 is employed for the treatment of multiple sclerosis and exerts apoptotic effects on various cancers through protein phosphatase 2A (PP2A) activation.  In compd. I (R = 2,6-(OH)2C6H3), the dihydroxy head group of FTY720 was modified into dihydroxy Ph group.  The cell survival in I treated colorectal and gastric cancer cells was significantly reduced as compared with control, 34.6 and 25.1%, resp.  The docking study of I showed that the arom. head group effectively binds to PP2A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKotwPi-v_LVg90H21EOLACvtfcHk0liwJGgXwJGA2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltF2qtrg%253D&md5=ef00753b12ce5459fe936d7e76cfc29f</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c18-00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c18-00065%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%26aulast%3DMoon%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DShrestha%26aufirst%3DJ.%26aulast%3DShin%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DJ.-Y.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DE.-Y.%26aulast%3DBaek%26aufirst%3DD.%2BJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Fty720%2520%2528Fingolimod%2529%2520Derivatives%2520with%2520Aromatic%2520Head%2520Group%2520as%2520Anticancer%2520Agents%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2018%26volume%3D66%26spage%3D1015%26epage%3D1018%26doi%3D10.1248%2Fcpb.c18-00065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S. S.</span></span> <span> </span><span class="NLM_article-title">Fty720, a Synthetic Compound from Isaria Sinclairii, Inhibits Proliferation and Induces Apoptosis in Pancreatic Cancer Cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2007.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.canlet.2007.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17462818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFKjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2007&pages=288-297&author=Y.+Shenauthor=M.+X.+Caiauthor=W.+L.+Xiaauthor=J.+W.+Liuauthor=Q.+Y.+Zhangauthor=H.+Y.+Xieauthor=C.+Wangauthor=X.+H.+Wangauthor=S.+S.+Zheng&title=Fty720%2C+a+Synthetic+Compound+from+Isaria+Sinclairii%2C+Inhibits+Proliferation+and+Induces+Apoptosis+in+Pancreatic+Cancer+Cells&doi=10.1016%2Fj.canlet.2007.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells</span></div><div class="casAuthors">Shen, Yan; Cai, Minxia; Xia, Weiliang; Liu, Junwei; Zhang, Qiyi; Xie, Haiyang; Wang, Chen; Wang, Xiaohui; Zheng, Shusen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">288-297</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">FTY720, a synthetic compd. produced by modification of a metabolite from Isaria sinclairii, is known as a unique immunosuppressive agent that exerts its activity by inducing apoptosis of lymphocytes [S. Suzuki, FTY720: Mechanisms of action and its effect on organ transplantation, Transplant. Proc. 31 (1999) 2779-2782].  Addnl., it has been found that FTY720 has inhibitory effects on various cancer growth and metastasis [J.D. Wang, S. Takahara, N. Nonomura, Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation, Prostate 40 (1999) 50-55].  To investigate its effect on the growth and metastasis of pancreatic cancer, FTY720 was used to treat three pancreatic cancer cell lines (BxPC-3, AsPC-1, and PANC-1).  The MTT assay and flow cytometry were used to evaluate the cell death after FTY720 treatment; the wound closure assay, three-dimensional (3D) Matrigel assay, and invasive assay were used to evaluate the migration, colony formation and invasion abilities after FTY720 treatment, resp.  Protein expression in BxPC-3, AsPC-1, and PANC-1 cells after FTY720 treatment was detected by Western blotting.  The MTT assay indicated that the growth of pancreatic cancer cells could be inhibited by FTY720 at various concns. between 0 and 17 μM in a dose-dependent manner, which was also confirmed by flow cytometry.  The wound closure assay, 3D Matrigel assay and cell invasion assay all showed that FTY720 significantly suppressed migration, colony formation and invasion ability of cancer cells at concns. from 5 to 17 μM.  After FTY720 treatment, the phospho-Akt, Bcl-2, pro-caspase-3 expression were down-regulated while the caspase-9 protein expression was increased.  In conclusion, FTY720 can inhibit the growth, migration and invasion of pancreatic cancer cells.  Our study provides a preclin. support for chemotherapeutic approach with FTY720 for the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq91TuouUYBILVg90H21EOLACvtfcHk0liwJGgXwJGA2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFKjsLw%253D&md5=d89f995c7acbd5fae6256468734008bc</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2007.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2007.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DM.%2BX.%26aulast%3DXia%26aufirst%3DW.%2BL.%26aulast%3DLiu%26aufirst%3DJ.%2BW.%26aulast%3DZhang%26aufirst%3DQ.%2BY.%26aulast%3DXie%26aufirst%3DH.%2BY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%2BH.%26aulast%3DZheng%26aufirst%3DS.%2BS.%26atitle%3DFty720%252C%2520a%2520Synthetic%2520Compound%2520from%2520Isaria%2520Sinclairii%252C%2520Inhibits%2520Proliferation%2520and%2520Induces%2520Apoptosis%2520in%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D254%26spage%3D288%26epage%3D297%26doi%3D10.1016%2Fj.canlet.2007.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groen, R. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baleydier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kentsis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marineau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grebliunaite, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozakewich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pflumio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poglio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VerPlank, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolliday, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aster, J. C.</span></span> <span> </span><span class="NLM_article-title">Phenothiazines Induce Pp2a-Mediated Apoptosis in T Cell Acute Lymphoblastic Leukemia</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1172/JCI65093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1172%2FJCI65093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24401270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1ertLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=644-655&author=A.+Gutierrezauthor=L.+Panauthor=R.+W.+J.+Groenauthor=F.+Baleydierauthor=A.+Kentsisauthor=J.+Marineauauthor=R.+Grebliunaiteauthor=E.+Kozakewichauthor=C.+Reedauthor=F.+Pflumioauthor=S.+Poglioauthor=B.+Uzanauthor=P.+Clemonsauthor=L.+VerPlankauthor=F.+Anauthor=J.+Burbankauthor=S.+Nortonauthor=N.+Tollidayauthor=H.+Steenauthor=A.+P.+Wengauthor=H.+Yuanauthor=J.+E.+Bradnerauthor=C.+Mitsiadesauthor=A.+T.+Lookauthor=J.+C.+Aster&title=Phenothiazines+Induce+Pp2a-Mediated+Apoptosis+in+T+Cell+Acute+Lymphoblastic+Leukemia&doi=10.1172%2FJCI65093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia</span></div><div class="casAuthors">Gutierrez, Alejandro; Pan, Li; Groen, Richard W. J.; Baleydier, Frederic; Kentsis, Alex; Marineau, Jason; Grebliunaite, Ruta; Kozakewich, Elena; Reed, Casie; Pflumio, Francoise; Poglio, Sandrine; Uzan, Benjamin; Clemons, Paul; VerPlank, Lynn; An, Frank; Burbank, Jason; Norton, Stephanie; Tolliday, Nicola; Steen, Hanno; Weng, Andrew P.; Yuan, Huipin; Bradner, James E.; Mitsiades, Constantine; Look, A. Thomas; Aster, Jon C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">644-655</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">T cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer that is frequently assocd. with activating mutations in NOTCH1 and dysregulation of MYC.  Here, we performed 2 complementary screens to identify FDA-approved drugs and drug-like small mols. with activity against T-ALL.  We developed a zebrafish system to screen small mols. for toxic activity toward MYC-overexpressing thymocytes and used a human T-ALL cell line to screen for small mols. that synergize with Notch inhibitors.  We identified the antipsychotic drug perphenazine in both screens due to its ability to induce apoptosis in fish, mouse, and human T-ALL cells.  Using ligand-affinity chromatog. coupled with mass spectrometry, we identified protein phosphatase 2A (PP2A) as a perphenazine target.  T-ALL cell lines treated with perphenazine exhibited rapid dephosphorylation of multiple PP2A substrates and subsequent apoptosis.  Moreover, shRNA knockdown of specific PP2A subunits attenuated perphenazine activity, indicating that PP2A mediates the drug's antileukemic activity.  Finally, human T-ALLs treated with perphenazine exhibited suppressed cell growth and dephosphorylation of PP2A targets in vitro and in vivo.  Our findings provide a mechanistic explanation for the recurring identification of phenothiazines as a class of drugs with anticancer effects.  Furthermore, these data suggest that pharmacol. PP2A activation in T-ALL and other cancers driven by hyperphosphorylated PP2A substrates has therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9Qi2TciNj57Vg90H21EOLACvtfcHk0lhZ02ughLH4gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1ertLo%253D&md5=5f1136790da37d215708aeae37af3085</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1172%2FJCI65093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI65093%26sid%3Dliteratum%253Aachs%26aulast%3DGutierrez%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DGroen%26aufirst%3DR.%2BW.%2BJ.%26aulast%3DBaleydier%26aufirst%3DF.%26aulast%3DKentsis%26aufirst%3DA.%26aulast%3DMarineau%26aufirst%3DJ.%26aulast%3DGrebliunaite%26aufirst%3DR.%26aulast%3DKozakewich%26aufirst%3DE.%26aulast%3DReed%26aufirst%3DC.%26aulast%3DPflumio%26aufirst%3DF.%26aulast%3DPoglio%26aufirst%3DS.%26aulast%3DUzan%26aufirst%3DB.%26aulast%3DClemons%26aufirst%3DP.%26aulast%3DVerPlank%26aufirst%3DL.%26aulast%3DAn%26aufirst%3DF.%26aulast%3DBurbank%26aufirst%3DJ.%26aulast%3DNorton%26aufirst%3DS.%26aulast%3DTolliday%26aufirst%3DN.%26aulast%3DSteen%26aufirst%3DH.%26aulast%3DWeng%26aufirst%3DA.%2BP.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DLook%26aufirst%3DA.%2BT.%26aulast%3DAster%26aufirst%3DJ.%2BC.%26atitle%3DPhenothiazines%2520Induce%2520Pp2a-Mediated%2520Apoptosis%2520in%2520T%2520Cell%2520Acute%2520Lymphoblastic%2520Leukemia%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D644%26epage%3D655%26doi%3D10.1172%2FJCI65093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kauko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulesskiy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangodkar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aakula, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yetukuri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padzik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laajala, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haapaniemi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momeny, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varila, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aittokallio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennerberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westermarck, J.</span></span> <span> </span><span class="NLM_article-title">Pp2a Inhibition Is a Druggable Mek Inhibitor Resistance Mechanism in Kras-Mutant Lung Cancer Cells</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">eaaq1093</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aaq1093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1126%2Fscitranslmed.aaq1093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30021885" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=eaaq1093&author=O.+Kaukoauthor=C.+M.+O%E2%80%99Connorauthor=E.+Kulesskiyauthor=J.+Sangodkarauthor=A.+Aakulaauthor=S.+Izadmehrauthor=L.+Yetukuriauthor=B.+Yadavauthor=A.+Padzikauthor=T.+D.+Laajalaauthor=P.+Haapaniemiauthor=M.+Momenyauthor=T.+Varilaauthor=M.+Ohlmeyerauthor=T.+Aittokallioauthor=K.+Wennerbergauthor=G.+Narlaauthor=J.+Westermarck&title=Pp2a+Inhibition+Is+a+Druggable+Mek+Inhibitor+Resistance+Mechanism+in+Kras-Mutant+Lung+Cancer+Cells&doi=10.1126%2Fscitranslmed.aaq1093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaq1093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaq1093%26sid%3Dliteratum%253Aachs%26aulast%3DKauko%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DC.%2BM.%26aulast%3DKulesskiy%26aufirst%3DE.%26aulast%3DSangodkar%26aufirst%3DJ.%26aulast%3DAakula%26aufirst%3DA.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DYetukuri%26aufirst%3DL.%26aulast%3DYadav%26aufirst%3DB.%26aulast%3DPadzik%26aufirst%3DA.%26aulast%3DLaajala%26aufirst%3DT.%2BD.%26aulast%3DHaapaniemi%26aufirst%3DP.%26aulast%3DMomeny%26aufirst%3DM.%26aulast%3DVarila%26aufirst%3DT.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DAittokallio%26aufirst%3DT.%26aulast%3DWennerberg%26aufirst%3DK.%26aulast%3DNarla%26aufirst%3DG.%26aulast%3DWestermarck%26aufirst%3DJ.%26atitle%3DPp2a%2520Inhibition%2520Is%2520a%2520Druggable%2520Mek%2520Inhibitor%2520Resistance%2520Mechanism%2520in%2520Kras-Mutant%2520Lung%2520Cancer%2520Cells%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2018%26volume%3D10%26spage%3Deaaq1093%26doi%3D10.1126%2Fscitranslmed.aaq1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Calcineurin Is a Common Target of Cyclophilin-Cyclosporin a and Fkbp-Fk506 Complexes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(91)90124-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0092-8674%2891%2990124-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1715244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1991&pages=807-815&author=J.+Liuauthor=J.+D.+Farmerauthor=W.+S.+Laneauthor=J.+Friedmanauthor=I.+Weissmanauthor=S.+L.+Schreiber&title=Calcineurin+Is+a+Common+Target+of+Cyclophilin-Cyclosporin+a+and+Fkbp-Fk506+Complexes&doi=10.1016%2F0092-8674%2891%2990124-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</span></div><div class="casAuthors">Liu, Jun; Farmer, Jesse D., Jr.; Lane, Willam S.; Friedman, Jeff; Weissman, Irving; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">807-15</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Although the immediate receptors (immunophilins) of the immunosuppressants cyclosporin A (CsA) and FK506 are distinct, their similar mechanisms of inhibition of cell signaling suggest that their assocd. immunophilin complexes interact with a common target.  The authors report that the complexes cyclophilin-CsA and FKBP-FK506 (but not cyclophilin, FKBP, FKBP-rapamycin, or FKBP-506BD) competitively bind to and inhibit the Ca2+- and calmodulin-dependent phosphatase calcineurin, although the binding and inhibition of calcineurin do not require calmodulin.  These results suggest that calcineurin is involved in a common step assocd. with T cell receptor and IgE receptor signaling pathways and that cyclophilin and FKBP mediate the actions of CsA and FK506, resp., by forming drug-dependent complexes with and altering the activity of calcineurin-calmodulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfN8mg-hNhLVg90H21EOLACvtfcHk0liYqyzEHkEQZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D&md5=00c4883ea86e6b2c554f8f72ed717ac9</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2891%2990124-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252891%252990124-H%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFarmer%26aufirst%3DJ.%2BD.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DWeissman%26aufirst%3DI.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DCalcineurin%2520Is%2520a%2520Common%2520Target%2520of%2520Cyclophilin-Cyclosporin%2520a%2520and%2520Fkbp-Fk506%2520Complexes%26jtitle%3DCell%26date%3D1991%26volume%3D66%26spage%3D807%26epage%3D815%26doi%3D10.1016%2F0092-8674%2891%2990124-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fruman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burakoff, S.</span></span> <span> </span><span class="NLM_article-title">Calcineurin Phosphatase Activity in T Lymphocytes Is Inhibited by Fk 506 and Cyclosporin A</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">3686</span>– <span class="NLM_lpage">3690</span>, <span class="refDoi"> DOI: 10.1073/pnas.89.9.3686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.89.9.3686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1373887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1SisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=3686-3690&author=D.+Frumanauthor=C.+Kleeauthor=B.+Biererauthor=S.+Burakoff&title=Calcineurin+Phosphatase+Activity+in+T+Lymphocytes+Is+Inhibited+by+Fk+506+and+Cyclosporin+A&doi=10.1073%2Fpnas.89.9.3686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A</span></div><div class="casAuthors">Fruman, David A.; Klee, Claude B.; Bierer, Barbara E.; Burakoff, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3686-90</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The immunosuppressive agents cyclosporin A (CsA) and FK 506 bind to distinct families of intracellular proteins (immunophilins) termed cyclophilins and FK 506-binding proteins (FKBPs).  Recently, it has been shown that, in vitro, the complexes of CsA-cyclophilin and FK 506-FKBP-12 bind to and inhibit the activity of calcineurin, a calcium-dependent serine/threonine phosphatase.  The authors have investigated the effects of drug treatment on phosphatase activity in T lymphocytes.  Calcineurin is expressed in T cells, and its activity can be measured in cell lysates.  Both CsA and FK 506 specifically inhibit cellular calcineurin at drug concns. that inhibit interleukin 2 prodn. in activated T cells.  Rapamycin, which binds to FKBPs but exhibits different activities than FK 506, has no effect on calcineurin activity.  Furthermore, excess concns. of rapamycin prevent the effects of FK 506, apparently by displacing FK 506 from FKBPs.  These results show that calcineurin is a target of drug-immunophilin complexes in vivo and establish a physiol. role for calcineurin in T-cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnX1PJSpEhorVg90H21EOLACvtfcHk0liYqyzEHkEQZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1SisLo%253D&md5=c0c5457bc8f333a2d0efd6bfd99994d2</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.9.3686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.9.3686%26sid%3Dliteratum%253Aachs%26aulast%3DFruman%26aufirst%3DD.%26aulast%3DKlee%26aufirst%3DC.%26aulast%3DBierer%26aufirst%3DB.%26aulast%3DBurakoff%26aufirst%3DS.%26atitle%3DCalcineurin%2520Phosphatase%2520Activity%2520in%2520T%2520Lymphocytes%2520Is%2520Inhibited%2520by%2520Fk%2520506%2520and%2520Cyclosporin%2520A%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26spage%3D3686%26epage%3D3690%26doi%3D10.1073%2Fpnas.89.9.3686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelker, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of Protein Phosphatase-1 Bound to Nodularin-R and Tautomycin: A Novel Scaffold for Structure-Based Drug Design of Serine/Threonine Phosphatase Inhibitors</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>385</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.10.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.jmb.2008.10.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=18992256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=11-21&author=M.+S.+Kelkerauthor=R.+Pageauthor=W.+Peti&title=Crystal+Structures+of+Protein+Phosphatase-1+Bound+to+Nodularin-R+and+Tautomycin%3A+A+Novel+Scaffold+for+Structure-Based+Drug+Design+of+Serine%2FThreonine+Phosphatase+Inhibitors&doi=10.1016%2Fj.jmb.2008.10.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Protein Phosphatase-1 Bound to Nodularin-R and Tautomycin: A Novel Scaffold for Structure-based Drug Design of Serine/Threonine Phosphatase Inhibitors</span></div><div class="casAuthors">Kelker, Matthew S.; Page, Rebecca; Peti, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-21</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Protein phosphatase 1 (PP1) occurs in all tissues and regulates many pathways, ranging from cell-cycle progression to carbohydrate metab.  Many naturally occurring, mol. toxins modulate PP1 activity, though the exact mechanism of this differential regulation is not understood.  A detailed elucidation of these interactions is crucial for understanding the cellular basis of phosphatase function and signaling pathways but more importantly, they can serve as the basis for highly specific therapeutics, e.g. against cancer.  We report the crystal structures of PP1 in complex with nodularin-R at 1.63 Å and tautomycin at 1.70 Å resoln.  The PP1:nodularin-R complex was used to demonstrate the utility of our improved PP1 prodn. technique, which produces highly active, sol. PP1.  Tautomycin is one of the few toxins that reportedly preferentially binds PP1 > PP2A.  Therefore, the PP1:tautomycin structure is the first complex structure with a toxin with preferred PP1 specificity.  Furthermore, since tautomycin is a linear non-peptide-based toxin, our reported structure will aid the design of lead compds. for novel PP1-specific pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6lYsXVoX1jrVg90H21EOLACvtfcHk0lgNP1RoTXjunQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsbrF&md5=c6d5fb0be88de9ea584aecfa5e04d57b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.10.053%26sid%3Dliteratum%253Aachs%26aulast%3DKelker%26aufirst%3DM.%2BS.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DPeti%26aufirst%3DW.%26atitle%3DCrystal%2520Structures%2520of%2520Protein%2520Phosphatase-1%2520Bound%2520to%2520Nodularin-R%2520and%2520Tautomycin%253A%2520A%2520Novel%2520Scaffold%2520for%2520Structure-Based%2520Drug%2520Design%2520of%2520Serine%252FThreonine%2520Phosphatase%2520Inhibitors%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D385%26spage%3D11%26epage%3D21%26doi%3D10.1016%2Fj.jmb.2008.10.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwiller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daily, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatra, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukelow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boynton, A. L.</span></span> <span> </span><span class="NLM_article-title">Characterization of Microcystin-Lr, a Potent Inhibitor of Type 1 and Type 2a Protein Phosphatases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>265</i></span>,  <span class="NLM_fpage">19401</span>– <span class="NLM_lpage">19404</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(17)45384-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0021-9258%2817%2945384-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2174036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXlvVOisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=19401-19404&author=R.+E.+Honkanenauthor=J.+Zwillerauthor=R.+E.+Mooreauthor=S.+L.+Dailyauthor=B.+S.+Khatraauthor=M.+Dukelowauthor=A.+L.+Boynton&title=Characterization+of+Microcystin-Lr%2C+a+Potent+Inhibitor+of+Type+1+and+Type+2a+Protein+Phosphatases&doi=10.1016%2FS0021-9258%2817%2945384-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases</span></div><div class="casAuthors">Honkanen, Richard E.; Zwiller, Jean; Moore, Richard E.; Daily, Sharon L.; Khatra, Balwant S.; Dukelow, Michael; Boynton, Alton L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">19401-4</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The level of protein phosphorylation is dependent on the relative activities of both protein kinases and protein phosphatases.  By comparison with protein kinases, however, there have been considerably fewer studies on the functions of serine/threonine protein phosphatases.  This is partly due to a lack of specific protein phosphatase inhibitors that can be used as probes.  The present study is a characterization of the inhibitory effects of microcystin-LR, a hepatotoxic cyclic peptide assocd. with most strains of the blue-green algae Microcystis aeruginosa found in the Northern hemisphere, that proves to be a potent inhibitor of type 1 (IC50 = 1.7 nM) and type 2A (IC50 = 0.04 nM) protein phosphatases.  Microcystin-LR inhibited the activity of both type 1 and type 2A phosphatases >10-fold more potently than okadaic acid under the same conditions.  Type 2A protein phosphatases in dil. mammalian cell exts. were found to be completely inhibited by 0.5 nM microcystin-LR while type I protein phosphatases were only slightly affected at this concn.  Thus, microcystin-LR may prove to be a useful probe for the study and identification of cellular processes which are mediated by protein phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTSf9UHioQjLVg90H21EOLACvtfcHk0lgNP1RoTXjunQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlvVOisrc%253D&md5=dca914b3af519bf6d0e97d2e5415184b</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2817%2945384-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252817%252945384-1%26sid%3Dliteratum%253Aachs%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DZwiller%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DR.%2BE.%26aulast%3DDaily%26aufirst%3DS.%2BL.%26aulast%3DKhatra%26aufirst%3DB.%2BS.%26aulast%3DDukelow%26aufirst%3DM.%26aulast%3DBoynton%26aufirst%3DA.%2BL.%26atitle%3DCharacterization%2520of%2520Microcystin-Lr%252C%2520a%2520Potent%2520Inhibitor%2520of%2520Type%25201%2520and%2520Type%25202a%2520Protein%2520Phosphatases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D19401%26epage%3D19404%26doi%3D10.1016%2FS0021-9258%2817%2945384-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bialojan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, A.</span></span> <span> </span><span class="NLM_article-title">Inhibitory Effect of a Marine-Sponge Toxin, Okadaic Acid, on Protein Phosphatases. Specificity and Kinetics</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1042/bj2560283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1042%2Fbj2560283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2851982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL1MXitVequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1988&pages=283-290&author=C.+Bialojanauthor=A.+Takai&title=Inhibitory+Effect+of+a+Marine-Sponge+Toxin%2C+Okadaic+Acid%2C+on+Protein+Phosphatases.+Specificity+and+Kinetics&doi=10.1042%2Fbj2560283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases.  Specificity and kinetics</span></div><div class="casAuthors">Bialojan, Corinna; Takai, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-90</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">The inhibitory effect of a marine sponge toxin, okadaic acid, was examd. on type 1, type 2A, type 2B, and type 2C protein phosphatases as well as on a polycation-modulated (PCM) phosphatase.  Of the protein phosphatases examd., the catalytic subunit of type 2A phosphatase from rabbit skeletal muscle was most potently inhibited.  For the phosphorylated myosin light-chain (PMLC) phosphatase activity of the enzyme, the concn. of okadaic acid required to obtain 50% inhibition (ID50) was ∼1 nM.  The PMLC phosphatase activities of type 1 and PCM phosphatase were also strongly inhibited (ID50 0.1-0.5 μM).  The PMLC phosphatase activity of type 2B phosphatase (calcineurin) was inhibited to a lesser extent (ID50 4-5 μM).  Similar results were obtained for the phosphorylase a phosphatase activity of type 1 and PCM phosphatases and for the p-nitrophenyl phosphate phosphatase activity of calcineurin.  The following phosphatases were not affected by ≤10 μM okadaic acid: type 2C phosphatase, phosphotyrosyl phosphatase, inositol 1,4,5-trisphosphate phosphatase, acid phosphatases, and alk. phosphatases.  Thus okadaic acid had a relatively high specificity for type 2A, type 1, and PCM phosphatases.  Kinetic studies showed that okadaic acid acts as a noncompetitive or mixed inhibitor on the okadaic acid-sensitive enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDRX40cIwTiLVg90H21EOLACvtfcHk0lgNP1RoTXjunQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXitVequg%253D%253D&md5=0303a70deb82c0c087e4585ac180c5d8</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1042%2Fbj2560283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2560283%26sid%3Dliteratum%253Aachs%26aulast%3DBialojan%26aufirst%3DC.%26aulast%3DTakai%26aufirst%3DA.%26atitle%3DInhibitory%2520Effect%2520of%2520a%2520Marine-Sponge%2520Toxin%252C%2520Okadaic%2520Acid%252C%2520on%2520Protein%2520Phosphatases.%2520Specificity%2520and%2520Kinetics%26jtitle%3DBiochem.%2520J.%26date%3D1988%26volume%3D256%26spage%3D283%26epage%3D290%26doi%3D10.1042%2Fbj2560283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span> <span> </span><span class="NLM_article-title">Calyculin a, Protein Phosphatase Inhibitor, Enhances Capacitation of Human Sperm*</span>. <i>Fertil. Steril.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1016/S0015-0282(16)55642-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0015-0282%2816%2955642-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8380391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADyaK3s7it1ahtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1993&pages=216-222&author=S.+Furuyaauthor=Y.+Endoauthor=K.+Osumiauthor=M.+Obaauthor=S.+Nozawaauthor=S.+Suzuki&title=Calyculin+a%2C+Protein+Phosphatase+Inhibitor%2C+Enhances+Capacitation+of+Human+Sperm*&doi=10.1016%2FS0015-0282%2816%2955642-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Calyculin A, protein phosphatase inhibitor, enhances capacitation of human sperm</span></div><div class="casAuthors">Furuya S; Endo Y; Osumi K; Oba M; Nozawa S; Suzuki S</div><div class="citationInfo"><span class="NLM_cas:title">Fertility and sterility</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">216-22</span>
        ISSN:<span class="NLM_cas:issn">0015-0282</span>.
    </div><div class="casAbstract">OBJECTIVE:  To examine the effects of protein phosphatase inhibitors on capacitation and protein phosphorylation in human sperm.  DESIGN:  The chlortetracycline (CTC) fluorescence assay was used to monitor capacitated sperm treated with or without protein phosphatase inhibitors.  Capacitation was confirmed by the ability of sperm to undergo the acrosome reaction in response to Ca++ ionophore A23187 or mouse zonae pellucidae. 32P-labeled sperm phosphoproteins were analyzed by one-dimensional gel electrophoresis to detect the effects of protein phosphatase inhibitors on protein phosphorylation.  RESULTS:  The treatment of sperm with calyculin A resulted in the following: [1] the rapid appearance of the clear perimeter pattern, specifically, distribution of fluorescence over the entire head exhibiting a bright perimeter and bright midpiece, in a dose-dependent manner in the 1 to 100 nM range; [2] an accelerated ability to undergo the acrosome reaction; and [3] an enhanced phosphorylation of sperm phosphoproteins in a dose-related fashion in the 1 to 100 nM range.  A similar stimulatory effect was observed only with a 100-fold higher concentrations of okadaic acid, another protein phosphatase inhibitor.  CONCLUSION:  Our results strongly suggest that protein phosphorylation and dephosphorylation may be involved in the regulation of human sperm capacitation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSh7hPk4cJ4JjAEfvC7EH1LfW6udTcc2eaTMYT2VLBWKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s7it1ahtA%253D%253D&md5=c2743bf5364f67aa2e493b3726b8baa6</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2FS0015-0282%2816%2955642-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0015-0282%252816%252955642-8%26sid%3Dliteratum%253Aachs%26aulast%3DFuruya%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DOsumi%26aufirst%3DK.%26aulast%3DOba%26aufirst%3DM.%26aulast%3DNozawa%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26atitle%3DCalyculin%2520a%252C%2520Protein%2520Phosphatase%2520Inhibitor%252C%2520Enhances%2520Capacitation%2520of%2520Human%2520Sperm%252A%26jtitle%3DFertil.%2520Steril.%26date%3D1993%26volume%3D59%26spage%3D216%26epage%3D222%26doi%3D10.1016%2FS0015-0282%2816%2955642-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Fostriecin, an Antitumor Antibiotic with Inhibitory Activity against Serine/Threonine Protein Phosphatases Types 1 (Pp1) and 2a (Pp2a), Is Highly Selective for Pp2a</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>416</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(97)01210-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0014-5793%2897%2901210-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9373158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2sXmvFWjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=1997&pages=230-234&author=A.+H.+Walshauthor=A.+Chengauthor=R.+E.+Honkanen&title=Fostriecin%2C+an+Antitumor+Antibiotic+with+Inhibitory+Activity+against+Serine%2FThreonine+Protein+Phosphatases+Types+1+%28Pp1%29+and+2a+%28Pp2a%29%2C+Is+Highly+Selective+for+Pp2a&doi=10.1016%2FS0014-5793%2897%2901210-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A</span></div><div class="casAuthors">Walsh, Aimee H.; Cheng, Aiyang; Honkanen, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">416</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-234</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Fostriecin, an antitumor antibiotic produced by Streptomyces pulveraceus, is a strong inhibitor of type 2A (PP2A; IC50 3.2 nM) and a weak inhibitor of type 1 (PP1; IC50 131 μM) serine/threonine protein phosphatases.  Fostriecin has no apparent effect on the activity of PP2B, and dose-inhibition studies conducted with whole cell homogenates indicate that fostriecin also inhibits the native forms of PP1 and PP2A.  Studies with recombinant PP1/PP2A chimeras indicate that okadaic acid and fostriecin have different binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdJTXuBKPEvbVg90H21EOLACvtfcHk0lgcg5-Nx7EK7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvFWjsLs%253D&md5=c1d1b15eda708b2f87e5dee740214827</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2897%2901210-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252897%252901210-6%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DA.%2BH.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DFostriecin%252C%2520an%2520Antitumor%2520Antibiotic%2520with%2520Inhibitory%2520Activity%2520against%2520Serine%252FThreonine%2520Protein%2520Phosphatases%2520Types%25201%2520%2528Pp1%2529%2520and%25202a%2520%2528Pp2a%2529%252C%2520Is%2520Highly%2520Selective%2520for%2520Pp2a%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D416%26spage%3D230%26epage%3D234%26doi%3D10.1016%2FS0014-5793%2897%2901210-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackintosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 2a and Its [3h]Cantharidin/[3h] Endothall Thioanhydride Binding Site</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1443</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(93)90109-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0006-2952%2893%2990109-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8240393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2cXpvVKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=1435-1443&author=Y.+M.+Liauthor=C.+Mackintoshauthor=J.+E.+Casida&title=Protein+Phosphatase+2a+and+Its+%5B3h%5DCantharidin%2F%5B3h%5D+Endothall+Thioanhydride+Binding+Site&doi=10.1016%2F0006-2952%2893%2990109-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogs</span></div><div class="casAuthors">Li, Yue Ming; Mackintosh, Carol; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1435-43</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The target site for cantharidin (CA) (I) and its analogs was isolated recently from mouse liver and identified as protein phosphatase 2A (PP2A) in the heterodimeric form known as PP2A2.  The most toxic CA analog, endothall thioanhydride (ETA) (mouse i.p. LD50 0.3 mg/kg), appears to have the same binding site in mouse liver and brain based on studies comparing [3H]ETA and [3H]CA.  ATP and its nonhydrolyzable analogs and pyrophosphate and related compds. including phosphonoformic acid inhibited both [3H]CA and [3H]ETA binding with IC50 values ranging from 2 to 81 μM.  As with CA itself, the most potent inhibitors have two neg. charged groups in close proximity to each other.  Inhibition of [3H]CA binding by 5,5'-dithiobis(2-nitrobenzoic acid) and stimulation by N-ethylmaleimide indicated the involvement of a thiol site in the CA-binding domain.  CA and three analogs (cantharidic acid, palasonin and endothall) inhibited PP2A and protein phosphatase 1 (PP1) but not PP2B or PP2C.  The catalytic subunit of PP2A was 5- to 12-fold more sensitive to these CA analogs than the catalytic subunit of PP1.  CA and the herbicide endothall also inhibited spinach leaf PP1 and PP2A and, at 50 μM, decreased the PP2A-mediated light-induced activation of nitrate reductase in intact spinach leaves by 62 and 56%, resp.  This is consistent with PP2A as their site of action in plants, and indicates that potential use of CA analogs as pharmacol. probes to investigate cellular processes that are regulated by reversible protein phosphorylation in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjHd2be-nKP7Vg90H21EOLACvtfcHk0lhX2QR3F7E6FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXpvVKlsg%253D%253D&md5=357fb1e34a8c6943f61f8348cd0e5889</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2893%2990109-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252893%252990109-A%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DMackintosh%26aufirst%3DC.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DProtein%2520Phosphatase%25202a%2520and%2520Its%2520%255B3h%255DCantharidin%252F%255B3h%255D%2520Endothall%2520Thioanhydride%2520Binding%2520Site%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D46%26spage%3D1435%26epage%3D1443%26doi%3D10.1016%2F0006-2952%2893%2990109-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciszak, E. M.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for the Catalytic Activity of Human Serine/Threonine Protein Phosphatase-5</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">33992</span>– <span class="NLM_lpage">33999</span>, <span class="refDoi"> DOI: 10.1074/jbc.M402855200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M402855200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15155720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=33992-33999&author=M.+R.+Swingleauthor=R.+E.+Honkanenauthor=E.+M.+Ciszak&title=Structural+Basis+for+the+Catalytic+Activity+of+Human+Serine%2FThreonine+Protein+Phosphatase-5&doi=10.1074%2Fjbc.M402855200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Catalytic Activity of Human Serine/Threonine Protein Phosphatase-5</span></div><div class="casAuthors">Swingle, Mark R.; Honkanen, Richard E.; Ciszak, Ewa M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">33992-33999</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Serine/threonine protein phosphatase-5 (PP5) affects many signaling networks that regulate cell growth and cellular responses to stress.  Here we report the crystal structure of the PP5 catalytic domain (PP5c) at a resoln. of 1.6 Å.  From this structure we propose a mechanism for PP5-mediated hydrolysis of phosphoprotein substrates, which requires the precise positioning of two metal ions within a conserved Asp271-M1:M2-W1-His427-His304-Asp274 catalytic motif (where M1 and M2 are metals and W1 is a water mol.).  The structure of PP5c provides a structural basis for explaining the exceptional catalytic proficiency of protein phosphatases, which are among the most powerful known catalysts.  Resoln. of the entire C terminus revealed a novel subdomain, and the structure of the PP5c should also aid development of type-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg1iBbzyxsibVg90H21EOLACvtfcHk0lhX2QR3F7E6FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs7Y%253D&md5=7e302ecc9f581181f7e52d766cf78b7e</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M402855200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M402855200%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DCiszak%26aufirst%3DE.%2BM.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Catalytic%2520Activity%2520of%2520Human%2520Serine%252FThreonine%2520Protein%2520Phosphatase-5%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D33992%26epage%3D33999%26doi%3D10.1074%2Fjbc.M402855200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. S.</span></span> <span> </span><span class="NLM_article-title">Medical Uses of Mylabris in Ancient China and Recent Studies</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/0378-8741(89)90062-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0378-8741%2889%2990062-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2689797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXptFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1989&pages=147-162&author=G.+S.+Wang&title=Medical+Uses+of+Mylabris+in+Ancient+China+and+Recent+Studies&doi=10.1016%2F0378-8741%2889%2990062-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Medical uses of Mylabris in ancient China and recent studies</span></div><div class="casAuthors">Wang, Guangsheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-62</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    </div><div class="casAbstract">A review with 56 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtR_mIS1cynLVg90H21EOLACvtfcHk0liU3CNt7pniAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXptFSitg%253D%253D&md5=ac51dbf89c0fbb622bb0939b7d4a9f27</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2F0378-8741%2889%2990062-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-8741%252889%252990062-7%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BS.%26atitle%3DMedical%2520Uses%2520of%2520Mylabris%2520in%2520Ancient%2520China%2520and%2520Recent%2520Studies%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D1989%26volume%3D26%26spage%3D147%26epage%3D162%26doi%3D10.1016%2F0378-8741%2889%2990062-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casida, J. E.</span></span> <span> </span><span class="NLM_article-title">Cantharidin-Binding Protein: Identification as Protein Phosphatase 2a</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">11867</span>– <span class="NLM_lpage">11870</span>, <span class="refDoi"> DOI: 10.1073/pnas.89.24.11867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.89.24.11867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1334551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3sXps12isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=11867-11870&author=Y.+M.+Liauthor=J.+E.+Casida&title=Cantharidin-Binding+Protein%3A+Identification+as+Protein+Phosphatase+2a&doi=10.1073%2Fpnas.89.24.11867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Cantharidin-binding protein:  Identification as protein phosphatase 2A</span></div><div class="casAuthors">Li, Yue Ming; Casida, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11867-70</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The toxic effects of cantharidin from blister beetles and its analogs, including the herbicide endothall, are attributable to their high affinity and specificity for a cantharidin-binding protein (CBP).  An ammonium sulfate ppt. of mouse liver cytosol was purified by five chromatog. steps to isolate CBP in 14% yield and >99% purity as monitored by [3H]cantharidin-binding activity.  The purifn. factor of 2230-fold corresponds to a CBP content of 0.045% of the liver cytosolic protein.  CBP is a heterodimer consisting of a 61-kDa α subunit and a 30-kDa β subunit.  Amino acid sequences of four peptides from CBP-α and three peptides from CBP-β are identical with deduced amino acid sequences for the Aα regulatory and Cβ catalytic subunits, resp., of protein phosphatase 2A (PP2A).  This assignment of CBP as PP2A-AC from structural evidence is supported by biochem. studies with selective substrates and inhibitors.  CBP dephosphorylation of phosphorylase a is sensitive not only to okadaic acid, as with PP2A, but also to cantharidin and its analogs, consistent with their potency in blocking the radioligand binding site of CBP.  Okadaic acid is a potent inhibitor of [3H]cantharidin binding to CBP.  PP2A is present in many mammalian tissues and in plants and is involved in regulatory phosphorylation-dephosphorylation events which modulate multiple cellular functions.  Inhibition of PP2A activity may account for the diverse effects and toxicity of cantharidin and its analogs, including the herbicide endothall, in mammals and possibly plants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_hQQbwUrdybVg90H21EOLACvtfcHk0liU3CNt7pniAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXps12isg%253D%253D&md5=ed879675d31ff91e40123a9821695e6c</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.24.11867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.24.11867%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DCasida%26aufirst%3DJ.%2BE.%26atitle%3DCantharidin-Binding%2520Protein%253A%2520Identification%2520as%2520Protein%2520Phosphatase%25202a%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26spage%3D11867%26epage%3D11870%26doi%3D10.1073%2Fpnas.89.24.11867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norbury, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span> <span> </span><span class="NLM_article-title">DNA Damage-Induced Apoptosis</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2797</span>– <span class="NLM_lpage">2808</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1207532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsj.onc.1207532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15077143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=2797-2808&author=C.+J.+Norburyauthor=B.+Zhivotovsky&title=DNA+Damage-Induced+Apoptosis&doi=10.1038%2Fsj.onc.1207532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">DNA damage-induced apoptosis</span></div><div class="casAuthors">Norbury, Chris J.; Zhivotovsky, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2797-2808</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Unicellular organisms respond to the presence of DNA lesions by activating cell cycle checkpoint and repair mechanisms, while multi-cellular animals have acquired the further option of eliminating damaged cells by triggering apoptosis.  Defects in DNA damage-induced apoptosis contribute to tumorigenesis and to the resistance of cancer cells to a variety of therapeutic agents.  The intranuclear mechanisms that signal apoptosis after DNA damage overlap with those that initiate cell cycle arrest and DNA repair, and the early events in these pathways are highly conserved.  In addn., multiple independent routes have recently been traced by which nuclear DNA damage can be signaled to the mitochondria, tipping the balance in favor of cell death rather than repair and survival.  Here, we review current knowledge of nuclear DNA damage signaling, giving particular attention to interactions between these nuclear events and apoptotic processes in other intracellular compartments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlYE0yPuxqDbVg90H21EOLACvtfcHk0liU3CNt7pniAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLY%253D&md5=f7e5152debef32edeaee0bed090eff8b</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207532%26sid%3Dliteratum%253Aachs%26aulast%3DNorbury%26aufirst%3DC.%2BJ.%26aulast%3DZhivotovsky%26aufirst%3DB.%26atitle%3DDNA%2520Damage-Induced%2520Apoptosis%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D2797%26epage%3D2808%26doi%3D10.1038%2Fsj.onc.1207532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomicic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böchzelt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tome, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briehl, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaina, B.</span></span> <span> </span><span class="NLM_article-title">Molecular Modes of Action of Cantharidin in Tumor Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">811</span>– <span class="NLM_lpage">818</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2004.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bcp.2004.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15710358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2005&pages=811-818&author=T.+Efferthauthor=R.+Rauhauthor=S.+Kahlauthor=M.+Tomicicauthor=H.+B%C3%B6chzeltauthor=M.+E.+Tomeauthor=M.+M.+Briehlauthor=R.+Bauerauthor=B.+Kaina&title=Molecular+Modes+of+Action+of+Cantharidin+in+Tumor+Cells&doi=10.1016%2Fj.bcp.2004.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modes of action of cantharidin in tumor cells</span></div><div class="casAuthors">Efferth, Thomas; Rauh, Rolf; Kahl, Stefan; Tomicic, Maja; Boechzelt, Herbert; Tome, Margaret E.; Briehl, Margaret M.; Bauer, Rudolf; Kaina, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">811-818</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer chemotherapy is often limited by patient's toxicity and tumor drug resistance indicating that new drug development and modification of existing drugs is crit. for improving the therapeutic response.  Traditional Chinese medicine is a rich source of potential anticancer agents.  In particular, cantharidin (CAN), the active principle ingredient from the blister beetle, Mylabris, has antitumor activity, but the cytotoxic mechanism is unknown.  In leukemia cells, cantharidin induces apoptosis by a p53-dependent mechanism.  Cantharidin causes both DNA single- and double-strand breaks.  Colony-forming assays with knockout and transfectant cells lines showed that DNA polymerase β, but not ERCC1, conferred increased cell survival after cantharidin treatment, indicating that base excision repair (BER), rather than nucleotide excision repair (NER), is important for CAN-induced DNA lesions.  Oxidative stress-resistant thymic lymphoma-derived WEHI7.2 variants are also more resistant to cantharidin.  These data suggest that cantharidin treatment causes oxidative stress that provokes DNA damage and p53-dependent apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6EwUQMINvirVg90H21EOLACvtfcHk0liU3CNt7pniAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCrsb0%253D&md5=7765e60d2ea2140273645730d420da65</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DEfferth%26aufirst%3DT.%26aulast%3DRauh%26aufirst%3DR.%26aulast%3DKahl%26aufirst%3DS.%26aulast%3DTomicic%26aufirst%3DM.%26aulast%3DB%25C3%25B6chzelt%26aufirst%3DH.%26aulast%3DTome%26aufirst%3DM.%2BE.%26aulast%3DBriehl%26aufirst%3DM.%2BM.%26aulast%3DBauer%26aufirst%3DR.%26aulast%3DKaina%26aufirst%3DB.%26atitle%3DMolecular%2520Modes%2520of%2520Action%2520of%2520Cantharidin%2520in%2520Tumor%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D69%26spage%3D811%26epage%3D818%26doi%3D10.1016%2Fj.bcp.2004.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadioglu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kermani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiebig, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span> <span> </span><span class="NLM_article-title">Pharmacogenomics of Cantharidin in Tumor Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2013.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bcp.2013.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=24231507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlGr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=399-409&author=O.+Kadiogluauthor=N.+S.+Kermaniauthor=G.+Kelterauthor=U.+Schumacherauthor=H.-H.+Fiebigauthor=H.+J.+Gretenauthor=T.+Efferth&title=Pharmacogenomics+of+Cantharidin+in+Tumor+Cells&doi=10.1016%2Fj.bcp.2013.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenomics of cantharidin in tumor cells</span></div><div class="casAuthors">Kadioglu, Onat; Kermani, Navid Salehi; Kelter, Gerhard; Schumacher, Udo; Fiebig, Heinz-Herbert; Greten, Henry Johannes; Efferth, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-409</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cantharis vesicatoria (blister beetle) is used in Chinese medicine and has been categorized as highly toxic in the Chinese pharmacopeia.  In Europe, Cantharis patches have been used since ages to treat various skin-related diseases.  We investigated the cytotoxicity of the Cantharis ingredient, cantharidin, in 41 tumor cell lines (Oncotest panel) and compared the results with those of 60 cell lines of the National Cancer Institute, USA.  We found profound activity at low micromolar concns. (log10IC50 values between -6.980 and 5.009 M).  Cantharidin bound to protein phosphatase 2A (PP2A) with higher affinity (-8.12 kcal/mol) than to PP1 (-6.25 kcal/mol) in mol. docking analyses.  Using a PCR array for 84 apoptosis genes, cantharidin treatment upregulated gene expression of caspase-1 and nerve growth factor receptor, but downregulated mRNA expression of Bcl-2 like protein 10, Fas ligand, and tumor necrosis factor-α.  By using COMPARE anal. of microarray-based transcriptome-wide mRNA expressions, 21 genes were found to significantly correlate with response of 60 tumor cell lines to cantharidin.  As shown by hierarchical cluster anal. and chi-squared test, the distribution of cell lines in the dendrogram according to their gene expression profiles predicted sensitivity or resistance to cantharidin (P = 6.482 × 10-5).  The compassionate use of Cantharis patches in two patients suffering from basalioma and Mycosis fungoides, resp., considerably improved the diseases without signs of toxicity.  In conclusion, these results indicate that cantharidin may be a useful candidate to develop novel strategies for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5v3KSTltV77Vg90H21EOLACvtfcHk0ljt2ctujhQeRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlGr&md5=6253a9c33e6ca5cee8f85a076ace1ce4</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DKadioglu%26aufirst%3DO.%26aulast%3DKermani%26aufirst%3DN.%2BS.%26aulast%3DKelter%26aufirst%3DG.%26aulast%3DSchumacher%26aufirst%3DU.%26aulast%3DFiebig%26aufirst%3DH.-H.%26aulast%3DGreten%26aufirst%3DH.%2BJ.%26aulast%3DEfferth%26aufirst%3DT.%26atitle%3DPharmacogenomics%2520of%2520Cantharidin%2520in%2520Tumor%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2014%26volume%3D87%26spage%3D399%26epage%3D409%26doi%3D10.1016%2Fj.bcp.2013.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span> <span> </span><span class="NLM_article-title">Overview of Cantharidin and Its Analogues</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2034</span>– <span class="NLM_lpage">2044</span>, <span class="refDoi"> DOI: 10.2174/0929867324666170414165253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F0929867324666170414165253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28413963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVGns7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=2034-2044&author=G.+Wangauthor=J.+Dongauthor=L.+Deng&title=Overview+of+Cantharidin+and+Its+Analogues&doi=10.2174%2F0929867324666170414165253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of Cantharidin and its Analogues</span></div><div class="casAuthors">Wang, Guofang; Dong, Jian; Deng, Liping</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2034-2044</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Cantharidin has been categorized as highly toxicant in Chinese medicine.  But cantharidin can efficiently treat different types of diseases, such as molluscum contagiosum.  While cantharidin is quite useful, unfortunately, due to its side effects, increasing regulations have limited access to this useful therapeutic option.  Cantharidin&#39;s toxic effects have caused it to fall into disuse for most legitimate medical purposes.  Although cantharidin generates effects and its advantages must be realized.  Recently, cancer affects people's life more and more.  Because cantharidin can treat some cancers, so solns. must be used to reduce side effects.  This review aims to describe some its analogs, several efficient methods to inhibit the side effects of cantharidin and pharmacogenomics of cantharidin.  Methods: We searched for research about cantharidin by entering the database.  Then evaluated these papers and analyzed their founding, soln., mechanism, etc., and targeted to screen the papers related to the content of our research, and then sorted them out in accordance with the soln., mechanism research and other content.  Finally, these content was unified into a framework.  Results: Some cantharidin&#39;s analogs were found that they show some similar functions to cantharidin and we found that norcantharidin, acylthiourea derivs., cantharidinamides, anhydride-modified derivs. and other derivs. have less side effects.  The modified cantharidin analogs reduce toxicity in hepatocytes.  Cantharidin consists of a six-ring and a five-ring, the moiety of oxygen on the six-ring and the anhydride section exhibit biochem. activity.  Protein phosphatases are assocd. with many cellular processes including apoptosis, cell cycle progression and so on.  Cantharidin can cause apoptosis and double-stand breakage of DNA.  Cantharidin and norcantharidin can efficiently inhibit the activity of mammalian and plant protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) in vivo.  Cantharidin inhibits PP5 at the nanomolar level with an IC50 value of 600 nM.  PP5 can manage the cellular survival, death, proliferation and other some intracellular biol. activities in mammals.  After cantharidin's treatment, the level of EtPP5 mRNA expression was downregulated.  Their also can be used to inhibit the Glutathione S-transferases (GSTs), angiogenesis and the expression of A549 human lung cancer cells, trigger eryptosis and induced bladder cancer cell apoptosis.  We found that using Vitamin C and ginsenosides and translating cantharidin into nanoparticles can minimize the cantharidin side effects in the patients.  Conclusion: Cantharidin can inhibit various tumor cell lines.  Cantharidin causes both DNA single- and double- strand breaks and induces apoptosis.  Although cantharidin shows some toxicity for human, its anti-cancer effects should be taken seriously.  Several viable methods can help solve this problem.  The most important pharmacogenomics of cantharidin is that cantharidin can inhibit PPs, because PPs are assocd. with many cellular processes.  This prospect is very broad and needs to continue studying.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLehivCxkC5rVg90H21EOLACvtfcHk0ljt2ctujhQeRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVGns7nO&md5=527b7f06d39155cf19ca27c346a23319</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.2174%2F0929867324666170414165253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867324666170414165253%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DL.%26atitle%3DOverview%2520of%2520Cantharidin%2520and%2520Its%2520Analogues%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2018%26volume%3D25%26spage%3D2034%26epage%3D2044%26doi%3D10.2174%2F0929867324666170414165253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elder, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span> <span> </span><span class="NLM_article-title">Lb100, a Small Molecule Inhibitor of Pp2a with Potent Chemo- and Radio-Sensitizing Potential</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">833</span>, <span class="refDoi"> DOI: 10.1080/15384047.2015.1040961</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1080%2F15384047.2015.1040961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25897893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWlsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=821-833&author=C.+S.+Hongauthor=W.+Hoauthor=C.+Zhangauthor=C.+Yangauthor=J.+B.+Elderauthor=Z.+Zhuang&title=Lb100%2C+a+Small+Molecule+Inhibitor+of+Pp2a+with+Potent+Chemo-+and+Radio-Sensitizing+Potential&doi=10.1080%2F15384047.2015.1040961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential</span></div><div class="casAuthors">Hong, Christopher S.; Ho, Winson; Zhang, Chao; Yang, Chunzhang; Elder, J. Bradley; Zhuang, Zhengping</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">821-833</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1555-8576</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase that plays a significant role in mitotic progression and cellular responses to DNA damage.  While traditionally viewed as a tumor suppressor, inhibition of PP2A has recently come to attention as a novel therapeutic means of driving senescent cancer cells into mitosis and promoting cell death via mitotic catastrophe.  These findings have been corroborated in numerous studies utilizing naturally produced compds. that selectively inhibit PP2A.  To overcome the known human toxicities assocd. with these compds., a water-sol. small mol. inhibitor, LB100, was recently developed to competitively inhibit the PP2A protein.  This review summarizes the pre-clin. studies to date that have demonstrated the anti-cancer activity of LB100 via its chemo- and radio-sensitizing properties.  These studies demonstrate the tremendous therapeutic potential of LB100 in a variety of cancer types.  The results of an ongoing phase 1 trial are eagerly anticipated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmlFnabEiiRrVg90H21EOLACvtfcHk0ljt2ctujhQeRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWlsL%252FI&md5=dea6b6f986027fdfa49f51efa60a12f6</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1080%2F15384047.2015.1040961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15384047.2015.1040961%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DC.%2BS.%26aulast%3DHo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DElder%26aufirst%3DJ.%2BB.%26aulast%3DZhuang%26aufirst%3DZ.%26atitle%3DLb100%252C%2520a%2520Small%2520Molecule%2520Inhibitor%2520of%2520Pp2a%2520with%2520Potent%2520Chemo-%2520and%2520Radio-Sensitizing%2520Potential%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2015%26volume%3D16%26spage%3D821%26epage%3D833%26doi%3D10.1080%2F15384047.2015.1040961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansfield, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braiteh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durivage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ungerleider, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovach, J. S.</span></span> <span> </span><span class="NLM_article-title">Safety, Tolerability, and Preliminary Activity of Lb-100, an Inhibitor of Protein Phosphatase 2a, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3277</span>– <span class="NLM_lpage">3284</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-2299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1078-0432.CCR-16-2299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28039265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=3277-3284&author=V.+Chungauthor=A.+S.+Mansfieldauthor=F.+Braitehauthor=D.+Richardsauthor=H.+Durivageauthor=R.+S.+Ungerleiderauthor=F.+Johnsonauthor=J.+S.+Kovach&title=Safety%2C+Tolerability%2C+and+Preliminary+Activity+of+Lb-100%2C+an+Inhibitor+of+Protein+Phosphatase+2a%2C+in+Patients+with+Relapsed+Solid+Tumors%3A+An+Open-Label%2C+Dose+Escalation%2C+First-in-Human%2C+Phase+I+Trial&doi=10.1158%2F1078-0432.CCR-16-2299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial</span></div><div class="casAuthors">Chung, Vincent; Mansfield, Aaron S.; Braiteh, Fadi; Richards, Donald; Durivage, Henry; Ungerleider, Richard S.; Johnson, Francis; Kovach, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3277-3284</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To det. the MTD and to assess the safety, tolerability, and potential activity of LB-100, a first-in-class small-mol. inhibitor of protein phosphatase 2A (PP2A) in adult patients with progressive solid tumors.  Exptl. Design: LB-100 was administered i.v. daily for 3 days in 21-day cycles in a 3 + 3 dose escalation design.  Results: There were 29 patient entries over 7 dose escalations.  One patient stopped treatment after one dose because of an acute infection and was reenrolled after recovery; each course was analyzed as a sep. patient entry.  Two patients had dose-limiting toxicity (reversible increases in serum creatinine or calcd. serum creatinine clearance) at the 3.1 mg/m2 level.  Probable or possible study drug-related grade 3 adverse events occurred in 6 (20.7%) patients [anemia (n = 2), decreased creatinine clearance, dyspnea, hyponatremia, and lymphopenia].  Ten (50%) of 20 response-evaluable patients had stable disease for four or more cycles.  One patient with pancreatic adenocarcinoma had a partial response noted after 10 cycles, which was maintained for five addnl. cycles.  The other patients achieving stable disease had one of the following: fibrosarcoma, chondrosarcoma, thymoma, atypical carcinoid of lung, or ovarian, testicular, breast (n = 2), and prostate cancer.  The recommended phase II dose of LB-100 is 2.33 mg/m2 daily for 3 days every 3 wk.  Conclusions: The safety, tolerability, preliminary evidence of antitumor activity, and novel mechanism of action of LB-100 support its continued development alone and in combination with other therapies.  Clin Cancer Res; 23(13); 3277-84. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmfD_3Ttra_bVg90H21EOLACvtfcHk0lh8MN_kHMC1pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurfM&md5=9df8e258b2a7034e268dc07db1eec751</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-2299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-2299%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DV.%26aulast%3DMansfield%26aufirst%3DA.%2BS.%26aulast%3DBraiteh%26aufirst%3DF.%26aulast%3DRichards%26aufirst%3DD.%26aulast%3DDurivage%26aufirst%3DH.%26aulast%3DUngerleider%26aufirst%3DR.%2BS.%26aulast%3DJohnson%26aufirst%3DF.%26aulast%3DKovach%26aufirst%3DJ.%2BS.%26atitle%3DSafety%252C%2520Tolerability%252C%2520and%2520Preliminary%2520Activity%2520of%2520Lb-100%252C%2520an%2520Inhibitor%2520of%2520Protein%2520Phosphatase%25202a%252C%2520in%2520Patients%2520with%2520Relapsed%2520Solid%2520Tumors%253A%2520An%2520Open-Label%252C%2520Dose%2520Escalation%252C%2520First-in-Human%252C%2520Phase%2520I%2520Trial%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D3277%26epage%3D3284%26doi%3D10.1158%2F1078-0432.CCR-16-2299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span> <span> </span><span class="NLM_article-title">A Synthetic Cantharidin Analog for the Enhancement of Doxorubicin Suppression of Stem Cell-Derived Aggressive Sarcoma</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">9535</span>– <span class="NLM_lpage">9543</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2010.08.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.biomaterials.2010.08.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20875681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlygt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=9535-9543&author=C.+Zhangauthor=Y.+Pengauthor=F.+Wangauthor=X.+Tanauthor=N.+Liuauthor=S.+Fanauthor=D.+Wangauthor=L.+Zhangauthor=D.+Liuauthor=T.+Wangauthor=S.+Wangauthor=Y.+Zhouauthor=Y.+Suauthor=T.+Chengauthor=Z.+Zhuangauthor=C.+Shi&title=A+Synthetic+Cantharidin+Analog+for+the+Enhancement+of+Doxorubicin+Suppression+of+Stem+Cell-Derived+Aggressive+Sarcoma&doi=10.1016%2Fj.biomaterials.2010.08.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">A synthetic cantharidin analog for the enhancement of doxorubicin suppression of stem cell-derived aggressive sarcoma</span></div><div class="casAuthors">Zhang, Chao; Peng, Yi; Wang, Fengchao; Tan, Xu; Liu, Nan; Fan, Song; Wang, Dechun; Zhang, Lilong; Liu, Dengqun; Wang, Tao; Wang, Shaojun; Zhou, Yue; Su, Yongping; Cheng, Tianmin; Zhuang, Zhengping; Shi, Chunmeng</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">9535-9543</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Failure to cure many cancers once they are disseminated has been attributed to the presence of resistant cancer stem cells.  Cantharidin, a natural compd. isolated from the beetles and other insects has been traditionally used as anticancer agent, but limited by its significant toxicity.  It has shown that cantharidin can force cancer cells prematurely into cell cycle and subsequently induce apoptotic cell death through the inhibition of protein phosphatase 2A (PP2A).  In this study, we showed that a synthesized analog of cantharidin, LB1, with significant PP2A inhibition activity but without apparent toxicity, greatly enhanced the effectiveness of the std. anti-sarcoma chemotherapeutic agent, doxorubicin (DOX), in the xenograft growth inhibition and lung metastases prevention of an aggressive sarcoma derived from transformed mesenchymal stem cells in syngeneic rats.  We report here on the possibility of, pharmacol. inhibition of PP2A with low toxicity cantharidin derivs. may be a useful strategy to enhance the effectiveness of DNA-damaged chemotherapeutic drugs against stem cell-derived cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNZMdCeWHDGLVg90H21EOLACvtfcHk0lh8MN_kHMC1pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlygt77P&md5=b1555bdcbdbc50ca86dadcf3cc25a3b2</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2010.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2010.08.059%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DShi%26aufirst%3DC.%26atitle%3DA%2520Synthetic%2520Cantharidin%2520Analog%2520for%2520the%2520Enhancement%2520of%2520Doxorubicin%2520Suppression%2520of%2520Stem%2520Cell-Derived%2520Aggressive%2520Sarcoma%26jtitle%3DBiomaterials%26date%3D2010%26volume%3D31%26spage%3D9535%26epage%3D9543%26doi%3D10.1016%2Fj.biomaterials.2010.08.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y.-X.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein Phosphatase 2a with a Small Molecule Lb100 Radiosensitizes Nasopharyngeal Carcinoma Xenografts by Inducing Mitotic Catastrophe and Blocking DNA Damage Repair</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">7512</span>– <span class="NLM_lpage">7524</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.18632%2Foncotarget.2258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25245035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC2M7js1agsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=7512-7524&author=P.+Lvauthor=Y.+Wangauthor=J.+Maauthor=Z.+Wangauthor=J.-L.+Liauthor=C.+S.+Hongauthor=Z.+Zhuangauthor=Y.-X.+Zeng&title=Inhibition+of+Protein+Phosphatase+2a+with+a+Small+Molecule+Lb100+Radiosensitizes+Nasopharyngeal+Carcinoma+Xenografts+by+Inducing+Mitotic+Catastrophe+and+Blocking+DNA+Damage+Repair&doi=10.18632%2Foncotarget.2258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair</span></div><div class="casAuthors">Lv Peng; Wang Yue; Li Jing-Li; Ma Jie; Wang Zheng; Hong Christopher S; Zhuang Zhengping; Zeng Yi-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7512-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nasopharyngeal carcinoma (NPC), while uncommon worldwide, is a major health problem in China.  Although local radiation and surgery provide good control of NPC, better treatments that permit reductions in radiation dosing are needed.  Inhibition of protein phosphatase 2A (PP2A), a ubiquitous multifunctional enzyme with critical roles in cell cycle regulation and DNA-damage response, reportedly sensitizes cancer cells to radiation and chemotherapy.  We studied PP2A inhibition with LB100, a small molecule currently in a Phase I clinical trial, on radiosensitization of two human nasopharyngeal cell lines: CNE1, which is reportedly radioresistant, and CNE2.  In both cell lines, LB100 exposure increased intracellular p-Plk1, TCTP, and Cdk1 and decreased p53, changes associated with cell cycle arrest, mitotic catastrophe and radio-inhibition of cell proliferation.  Mice bearing subcutaneous xenografts of either cell line were administered 1.5 mg/kg LB100 daily for three days and a single dose of 20 Gy radiation (day 3), which produced marked and prolonged tumor mass regression (dose enhancement factors of 2.98 and 2.27 for CNE1 and CNE2 xenografts, respectively).  Treatment with either LB100 or radiation alone only transiently inhibited xenograft growth.  Our results support further exploration of PP2A inhibition as part of radiotherapy regimens for NPC and potentially other solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2-dNSOMXQvuxsqfvU0ziafW6udTcc2eZ8cGyaizXxvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7js1agsw%253D%253D&md5=44d7ff0a78dd6fa95ae62b81fea3c972</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2258%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.-L.%26aulast%3DHong%26aufirst%3DC.%2BS.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DZeng%26aufirst%3DY.-X.%26atitle%3DInhibition%2520of%2520Protein%2520Phosphatase%25202a%2520with%2520a%2520Small%2520Molecule%2520Lb100%2520Radiosensitizes%2520Nasopharyngeal%2520Carcinoma%2520Xenografts%2520by%2520Inducing%2520Mitotic%2520Catastrophe%2520and%2520Blocking%2520DNA%2520Damage%2520Repair%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D7512%26epage%3D7524%26doi%3D10.18632%2Foncotarget.2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein Phosphatase 2a Sensitizes Pancreatic Cancer to Chemotherapy by Increasing Drug Perfusion Via Hif-1α-Vegf Mediated Angiogenesis</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.canlet.2014.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25304380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslCisbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2014&pages=281-287&author=X.+Baiauthor=X.+Zhiauthor=Q.+Zhangauthor=F.+Liangauthor=W.+Chenauthor=C.+Liangauthor=Q.+Huauthor=X.+Sunauthor=Z.+Zhuangauthor=T.+Liang&title=Inhibition+of+Protein+Phosphatase+2a+Sensitizes+Pancreatic+Cancer+to+Chemotherapy+by+Increasing+Drug+Perfusion+Via+Hif-1%CE%B1-Vegf+Mediated+Angiogenesis&doi=10.1016%2Fj.canlet.2014.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis</span></div><div class="casAuthors">Bai, Xueli; Zhi, Xiao; Zhang, Qi; Liang, Feng; Chen, Wei; Liang, Chao; Hu, Qida; Sun, Xu; Zhuang, Zhengping; Liang, Tingbo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-287</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Pancreatic cancer is a malignant disease without efficient treatment.  Improved treatments are urgently needed to enhance or replace chemotherapy.  Here we used a small mol. compd. LB-100 to assess the effect of pharmacol. inhibition of protein phosphatase 2A (PP2A) in combination with doxorubicin on the proliferation of pancreatic cancer in cell lines and a xenograft model.  LB-100 moderately reduced PP2A activity and the growth of the cell lines but did not show chemosensitization in vitro.  In vivo, however, LB-100 synergistically enhanced the activity of doxorubicin.  This effect was assocd. with increased microvessel d., blood perfusion, and doxorubicin concns. within the xenografts.  Mech., LB-100 induced expression of hypoxia-induced factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF).  In an umbilical vein endothelial cell monolayer model for measuring changes in vascular permeability, increased VEGF secretion following exposure to LB-100 and doxorubicin was accompanied by increased amts. of doxorubicin penetrating the endothelial barrier.  In conclusion, PP2A inhibition by LB-100 enhanced the cytotoxicity of doxorubicin in vivo but not in vitro potentially via HIF-1α-VEGF mediated angiogenesis.  Combining inhibition of PP2A with chemotherapeutic regimens may enhance their effectiveness against pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXdjMXoSXSw7Vg90H21EOLACvtfcHk0lj1XRMCBH3B0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslCisbfE&md5=a2930a35970d9f6e0aa9fc113868453f</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.09.048%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DX.%26aulast%3DZhi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DZhuang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520Protein%2520Phosphatase%25202a%2520Sensitizes%2520Pancreatic%2520Cancer%2520to%2520Chemotherapy%2520by%2520Increasing%2520Drug%2520Perfusion%2520Via%2520Hif-1%25CE%25B1-Vegf%2520Mediated%2520Angiogenesis%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D355%26spage%3D281%26epage%3D287%26doi%3D10.1016%2Fj.canlet.2014.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalev, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simicek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablina, A.</span></span> <span> </span><span class="NLM_article-title">Loss of Ppp2r2a Inhibits Homologous Recombination DNA Repair and Predicts Tumor Sensitivity to Parp Inhibition</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">6414</span>– <span class="NLM_lpage">6424</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-1667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F0008-5472.CAN-12-1667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23087057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyns7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=6414-6424&author=P.+Kalevauthor=M.+Simicekauthor=I.+Vazquezauthor=S.+Munckauthor=L.+Chenauthor=T.+Soinauthor=N.+Dandaauthor=W.+Chenauthor=A.+Sablina&title=Loss+of+Ppp2r2a+Inhibits+Homologous+Recombination+DNA+Repair+and+Predicts+Tumor+Sensitivity+to+Parp+Inhibition&doi=10.1158%2F0008-5472.CAN-12-1667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of PPP2R2A Inhibits Homologous Recombination DNA Repair and Predicts Tumor Sensitivity to PARP Inhibition</span></div><div class="casAuthors">Kalev, Peter; Simicek, Michal; Vazquez, Iria; Munck, Sebastian; Chen, Liping; Soin, Thomas; Danda, Natasha; Chen, Wen; Sablina, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6414-6424</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Findings suggest that downregulation of a PP2A family phosphatase in tumors may predict therapeutic responses to a promising new class of anticancer agents currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3mqXzgrVh4LVg90H21EOLACvtfcHk0lj1XRMCBH3B0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyns7rK&md5=b93954d366c436b42e61d924466bc717</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-1667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-1667%26sid%3Dliteratum%253Aachs%26aulast%3DKalev%26aufirst%3DP.%26aulast%3DSimicek%26aufirst%3DM.%26aulast%3DVazquez%26aufirst%3DI.%26aulast%3DMunck%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSoin%26aufirst%3DT.%26aulast%3DDanda%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSablina%26aufirst%3DA.%26atitle%3DLoss%2520of%2520Ppp2r2a%2520Inhibits%2520Homologous%2520Recombination%2520DNA%2520Repair%2520and%2520Predicts%2520Tumor%2520Sensitivity%2520to%2520Parp%2520Inhibition%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D6414%26epage%3D6424%26doi%3D10.1158%2F0008-5472.CAN-12-1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsels, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsels, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maybaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein Phosphatase 2a Radiosensitizes Pancreatic Cancers by Modulating Cdc25c/Cdk1 and Homologous Recombination Repair</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4422</span>– <span class="NLM_lpage">4432</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-0788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1158%2F1078-0432.CCR-13-0788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23780887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSitr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4422-4432&author=D.+Weiauthor=L.+A.+Parselsauthor=D.+Karnakauthor=M.+A.+Davisauthor=J.+D.+Parselsauthor=A.+C.+Marshauthor=L.+Zhaoauthor=J.+Maybaumauthor=T.+S.+Lawrenceauthor=Y.+Sunauthor=M.+A.+Morgan&title=Inhibition+of+Protein+Phosphatase+2a+Radiosensitizes+Pancreatic+Cancers+by+Modulating+Cdc25c%2FCdk1+and+Homologous+Recombination+Repair&doi=10.1158%2F1078-0432.CCR-13-0788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair</span></div><div class="casAuthors">Wei, Dongping; Parsels, Leslie A.; Karnak, David; Davis, Mary A.; Parsels, Joshua D.; Marsh, Amanda C.; Zhao, Lili; Maybaum, Jonathan; Lawrence, Theodore S.; Sun, Yi; Morgan, Meredith A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4422-4432</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To identify targets whose inhibition may enhance the efficacy of chemoradiation in pancreatic cancer and thus improve survival, we conducted an siRNA library screen in pancreatic cancer cells.  We investigated PPP2R1A, a scaffolding subunit of protein phosphatase 2A (PP2A) as a lead radiosensitizing target.  Exptl. Design: We detd. the effect of PP2A inhibition by genetic (PPP2R1A siRNA) and pharmacol. (LB100, a small mol. entering phase I clin. trials) approaches on radiosensitization of Panc-1 and MiaPaCa-2 pancreatic cancer cells both in vitro and in vivo.  Results: PPP2R1A depletion by siRNA radiosensitized Panc-1 and MiaPaCa-2 cells, with radiation enhancement ratios of 1.4 (P < 0.05).  Likewise, LB100 produced similar radiosensitization in pancreatic cancer cells, but minimal radiosensitization in normal small intestinal cells.  Mechanistically, PPP2R1A siRNA or LB100 caused aberrant CDK1 activation, likely resulting from accumulation of the active forms of PLK1 (pPLK1 T210) and CDC25C (pCDC25C T130).  Furthermore, LB100 inhibited radiation-induced Rad51 focus formation and homologous recombination repair (HRR), ultimately leading to persistent radiation-induced DNA damage, as reflected by γ-H2AX expression.  Finally, we identified CDC25C as a key PP2A substrate involved in LB100-mediated radiosensitization as depletion of CDC25C partially reversed LB100-mediated radiosensitization.  In a mouse xenograft model of human pancreatic cancer, LB100 produced significant radiosensitization with minimal wt. loss.  Conclusions: Collectively, our data show that PP2A inhibition radiosensitizes pancreatic cancer both in vitro and in vivo via activation of CDC25C/CDK1 and inhibition of HRR, and provide proof-of-concept evidence that PP2A is a promising target for the improvement of local therapy in pancreatic cancer.  Clin Cancer Res; 19(16); 4422-32. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB8m2W4oU8G7Vg90H21EOLACvtfcHk0ligjheP-fhpfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSitr%252FL&md5=e85c871a61505ec2480fbc00a9d002c1</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0788%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DD.%26aulast%3DParsels%26aufirst%3DL.%2BA.%26aulast%3DKarnak%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DM.%2BA.%26aulast%3DParsels%26aufirst%3DJ.%2BD.%26aulast%3DMarsh%26aufirst%3DA.%2BC.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DMaybaum%26aufirst%3DJ.%26aulast%3DLawrence%26aufirst%3DT.%2BS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26atitle%3DInhibition%2520of%2520Protein%2520Phosphatase%25202a%2520Radiosensitizes%2520Pancreatic%2520Cancers%2520by%2520Modulating%2520Cdc25c%252FCdk1%2520and%2520Homologous%2520Recombination%2520Repair%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D4422%26epage%3D4432%26doi%3D10.1158%2F1078-0432.CCR-13-0788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structure of Protein Phosphatase 2a Core Enzyme Bound to Tumor-Inducing Toxins</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.09.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.cell.2006.09.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17055435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=341-353&author=Y.+Xingauthor=Y.+Xuauthor=Y.+Chenauthor=P.+D.+Jeffreyauthor=Y.+Chaoauthor=Z.+Linauthor=Z.+Liauthor=S.+Strackauthor=J.+B.+Stockauthor=Y.+Shi&title=Structure+of+Protein+Phosphatase+2a+Core+Enzyme+Bound+to+Tumor-Inducing+Toxins&doi=10.1016%2Fj.cell.2006.09.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins</span></div><div class="casAuthors">Xing, Yongna; Xu, Yanhui; Chen, Yu; Jeffrey, Philip D.; Chao, Yang; Lin, Zheng; Li, Zhu; Strack, Stefan; Stock, Jeffry B.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">341-353</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The serine/threonine phosphatase protein phosphatase 2A (PP2A) plays an essential role in many aspects of cellular functions and has been shown to be an important tumor suppressor.  The core enzyme of PP2A comprises a 65 kDa scaffolding subunit and a 36 kDa catalytic subunit.  Here we report the crystal structures of the PP2A core enzyme bound to two of its inhibitors, the tumor-inducing agents okadaic acid and microcystin-LR, at 2.6 and 2.8 Å resoln., resp.  The catalytic subunit recognizes one end of the elongated scaffolding subunit by interacting with the conserved ridges of HEAT repeats 11-15.  Formation of the core enzyme forces the scaffolding subunit to undergo pronounced structural rearrangement.  The scaffolding subunit exhibits considerable conformational flexibility, which is proposed to play an essential role in PP2A function.  These structures, together with biochem. analyses, reveal significant insights into PP2A function and serve as a framework for deciphering the diverse roles of PP2A in cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaeKKPHPHlPbVg90H21EOLACvtfcHk0ligjheP-fhpfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73K&md5=b6bef7b8fbff156a1deda69e4443d338</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.09.025%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DChao%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DStrack%26aufirst%3DS.%26aulast%3DStock%26aufirst%3DJ.%2BB.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructure%2520of%2520Protein%2520Phosphatase%25202a%2520Core%2520Enzyme%2520Bound%2520to%2520Tumor-Inducing%2520Toxins%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D341%26epage%3D353%26doi%3D10.1016%2Fj.cell.2006.09.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uges, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleijfer, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höppener, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groen, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemse, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Graaf, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, E. G.</span></span> <span> </span><span class="NLM_article-title">Phase I and Pharmacokinetic Study of the Topoisomerase Ii Catalytic Inhibitor Fostriecin</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">882</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6690141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fsj.bjc.6690141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10070885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK1MXhslCnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1999&pages=882-887&author=R.+S.+de+Jongauthor=N.+H.+Mulderauthor=D.+R.+Ugesauthor=D.+T.+Sleijferauthor=F.+J.+H%C3%B6ppenerauthor=H.+J.+Groenauthor=P.+H.+Willemseauthor=W.+T.+van+der%0AGraafauthor=E.+G.+de+Vries&title=Phase+I+and+Pharmacokinetic+Study+of+the+Topoisomerase+Ii+Catalytic+Inhibitor+Fostriecin&doi=10.1038%2Fsj.bjc.6690141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin</span></div><div class="casAuthors">De Jong, R. S.; Mulder, N. H.; Uges, D. R. A.; Sleijfer, D. Th; Hoppener, F. J. P.; Groen, H. J. M.; Willemse, P. H. B.; Van der Graaf, W. T. A.; De Vries, E. G. E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">882-887</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">We conducted a phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.  Fostriecin was administered i.v. over 60 min on days 1-5 at 4-wk intervals.  Dose was escalated from 2 mg m-2 day-1 to 20 mg m-2 day-1 in 20 patients.  Drug pharmacokinetics was analyzed with high performance liq. chromatog. with UV-detection.  Plasma collected during drug administration was tested in vitro for growth inhibition of a teniposide-resistant small-cell lung cancer (SCLC) cell line.  The predominant toxicities were elevated liver transaminases (max. common toxicity criteria (CTC) grade 4) and serum creatinine (max. CTC grade 2).  These showed only a limited increase with increasing doses, often recovered during drug administration and were fully reversible.  Duration of elevated alanine-amino transferase (ALT) was dose-limiting in one patient at 20 mg m-2.  Other frequent toxicities were grade 1-2 nausea/vomiting, fever and mild fatigue.  Mean fostriecin plasma half-life was 0.36 h (initial; 95% Cl, 0-0.76 h) and 1.51 h (terminal; 95% Cl, 0.41-2.61 h).  A metabolite, most probably dephosphorylated fostriecin, was detected in plasma and urine.  No tumor responses were obsd., but the plasma concns. reached in the patients were insufficient to induce significant growth inhibition in vitro.  The max. tolerated dose (MTD) has not been reached, because drug supply was stopped at the 20 mg m-2 dose level.  However, further escalation seems possible and is warranted to achieve potentially effective drug levels.  Fostriecin has a short plasma half-life and longer duration of infusion should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQHIU_LDw9QLVg90H21EOLACvtfcHk0ligjheP-fhpfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhslCnsbs%253D&md5=aeb49bb8bdc77cc495eade5a905eb0d0</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6690141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6690141%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJong%26aufirst%3DR.%2BS.%26aulast%3DMulder%26aufirst%3DN.%2BH.%26aulast%3DUges%26aufirst%3DD.%2BR.%26aulast%3DSleijfer%26aufirst%3DD.%2BT.%26aulast%3DH%25C3%25B6ppener%26aufirst%3DF.%2BJ.%26aulast%3DGroen%26aufirst%3DH.%2BJ.%26aulast%3DWillemse%26aufirst%3DP.%2BH.%26aulast%3Dvan%2Bder%2BGraaf%26aufirst%3DW.%2BT.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BG.%26atitle%3DPhase%2520I%2520and%2520Pharmacokinetic%2520Study%2520of%2520the%2520Topoisomerase%2520Ii%2520Catalytic%2520Inhibitor%2520Fostriecin%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1999%26volume%3D79%26spage%3D882%26epage%3D887%26doi%3D10.1038%2Fsj.bjc.6690141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buck, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardouin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichikawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soenen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonness, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Fundamental Role of the Fostriecin Unsaturated Lactone and Implications for Selective Protein Phosphatase Inhibition</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">15694</span>– <span class="NLM_lpage">15695</span>, <span class="refDoi"> DOI: 10.1021/ja038672n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja038672n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=15694-15695&author=S.+B.+Buckauthor=C.+Hardouinauthor=S.+Ichikawaauthor=D.+R.+Soenenauthor=C.+M.+Gaussauthor=I.+Hwangauthor=M.+R.+Swingleauthor=K.+M.+Bonnessauthor=R.+E.+Honkanenauthor=D.+L.+Boger&title=Fundamental+Role+of+the+Fostriecin+Unsaturated+Lactone+and+Implications+for+Selective+Protein+Phosphatase+Inhibition&doi=10.1021%2Fja038672n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Fundamental Role of the Fostriecin Unsaturated Lactone and Implications for Selective Protein Phosphatase Inhibition</span></div><div class="casAuthors">Buck, Suzanne B.; Hardouin, Christophe; Ichikawa, Satoshi; Soenen, Danielle R.; Gauss, C.-M.; Hwang, Inkyu; Swingle, Mark R.; Bonness, Kathy M.; Honkanen, Richard E.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">15694-15695</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Key derivs. and analogs of fostriecin were prepd. and examd. that revealed a fundamental role for the unsatd. lactone and confirmed the essential nature of the phosphate monoester.  Thus, an identical 200-fold redn. in protein phosphatase 2A (PP2A) inhibition is obsd. with either the satd. lactone (7) or with an analog that lacks the entire lactone (15).  This 200-fold increase in PP2A inhibition attributable to the unsatd. lactone may be due to reversible C269 alkylation within the PP β12-β13 active site loop accounting for PP2A/4 potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruIuvHRt3367Vg90H21EOLACvtfcHk0lhlUpQlL58aXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGqurg%253D&md5=34d2fe8f857cb1d045111b45c96dfc46</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1021%2Fja038672n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja038672n%26sid%3Dliteratum%253Aachs%26aulast%3DBuck%26aufirst%3DS.%2BB.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DIchikawa%26aufirst%3DS.%26aulast%3DSoenen%26aufirst%3DD.%2BR.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DBonness%26aufirst%3DK.%2BM.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DFundamental%2520Role%2520of%2520the%2520Fostriecin%2520Unsaturated%2520Lactone%2520and%2520Implications%2520for%2520Selective%2520Protein%2520Phosphatase%2520Inhibition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D15694%26epage%3D15695%26doi%3D10.1021%2Fja038672n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amable, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationship Studies of Fostriecin, Cytostatin, and Key Analogs, with Pp1, Pp2a, Pp5, and (B12–B13)-Chimeras (Pp1/Pp2a and Pp5/Pp2a), Provide Further Insight into the Inhibitory Actions of Fostriecin Family Inhibitors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.155630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1124%2Fjpet.109.155630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19592665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Gjt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=45-53&author=M.+R.+Swingleauthor=L.+Amableauthor=B.+G.+Lawhornauthor=S.+B.+Buckauthor=C.+P.+Burkeauthor=P.+Rattiauthor=K.+L.+Fischerauthor=D.+L.+Bogerauthor=R.+E.+Honkanen&title=Structure-Activity+Relationship+Studies+of+Fostriecin%2C+Cytostatin%2C+and+Key+Analogs%2C+with+Pp1%2C+Pp2a%2C+Pp5%2C+and+%28B12%E2%80%93B13%29-Chimeras+%28Pp1%2FPp2a+and+Pp5%2FPp2a%29%2C+Provide+Further+Insight+into+the+Inhibitory+Actions+of+Fostriecin+Family+Inhibitors&doi=10.1124%2Fjpet.109.155630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and (β12-β13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors</span></div><div class="casAuthors">Swingle, Mark R.; Amable, Lauren; Lawhorn, Brian G.; Buck, Suzanne B.; Burke, Christopher P.; Ratti, Pukar; Fischer, Kimberly L.; Boger, Dale L.; Honkanen, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-53</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Fostriecin and cytostatin are structurally related natural inhibitors of serine/threonine phosphatases, with promising antitumor activity.  The total synthesis of these antitumor agents has enabled the prodn. of structural analogs, which are useful to explore the biol. significance of features contained in the parent compds.  Here, the inhibitory activity of fostriecin, cytostatin, and 10 key structural analogs were tested in side-by-side phosphatase assays to further characterize their inhibitory activity against PP1c (Ser/Thr protein phosphatase 1 catalytic subunit), PP2Ac (Ser/Thr protein phosphatase 2A catalytic subunit), PP5c (Ser/Thr protein phosphatase 5 catalytic subunit), and chimeras of PP1 (Ser/Thr protein phosphatase 1) and PP5 (Ser/Thr protein phosphatase 5), in which key residues predicted for inhibitor contact with PP2A (Ser/Thr protein phosphatase 2A) were introduced into PP1 and PP5 using site-directed mutagenesis.  The data confirm the importance of the C9-phosphate and C11-alc. for general inhibition and further demonstrate the importance of a predicted C3 interaction with a unique cysteine (Cys269) in the β12-β13 loop of PP2A.  The data also indicate that addnl. features beyond the unsatd. lactone contribute to inhibitory potency and selectivity.  Notably, a deriv. of fostriecin lacking the entire lactone subunit demonstrated marked potency and selectivity for PP2A, while having substantially reduced and similar activity against PP1 and PP1/PP2A- PP5/PP2A-chimeras that have greatly increased sensitivity to both fostriecin and cytostatin.  This suggests that other features [e.g., the (Z,Z,E)-triene] also contribute to inhibitory selectivity.  When considered together with previous data, these studies suggest that, despite the high structural conservation of the catalytic site in PP1, PP2A and PP5, the development of highly selective catalytic inhibitors should be feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofSHvvUev4N7Vg90H21EOLACvtfcHk0lhlUpQlL58aXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Gjt7fP&md5=632aa6f446f9c964048ce9b6badc9573</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.155630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.155630%26sid%3Dliteratum%253Aachs%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DAmable%26aufirst%3DL.%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DBuck%26aufirst%3DS.%2BB.%26aulast%3DBurke%26aufirst%3DC.%2BP.%26aulast%3DRatti%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DK.%2BL.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26atitle%3DStructure-Activity%2520Relationship%2520Studies%2520of%2520Fostriecin%252C%2520Cytostatin%252C%2520and%2520Key%2520Analogs%252C%2520with%2520Pp1%252C%2520Pp2a%252C%2520Pp5%252C%2520and%2520%2528B12%25E2%2580%2593B13%2529-Chimeras%2520%2528Pp1%252FPp2a%2520and%2520Pp5%252FPp2a%2529%252C%2520Provide%2520Further%2520Insight%2520into%2520the%2520Inhibitory%2520Actions%2520of%2520Fostriecin%2520Family%2520Inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D45%26epage%3D53%26doi%3D10.1124%2Fjpet.109.155630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Doherty, G. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Dehydro-Dephospho-Fostriecin and Formal Total Synthesis of Fostriecin</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">8334</span>– <span class="NLM_lpage">8338</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.9b03120</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.9b03120" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFShsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=8334-8338&author=D.+Gaoauthor=B.+Liauthor=G.+A.+O%E2%80%99Doherty&title=Synthesis+of+Dehydro-Dephospho-Fostriecin+and+Formal+Total+Synthesis+of+Fostriecin&doi=10.1021%2Facs.orglett.9b03120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Dehydro-Dephospho-Fostriecin and Formal Total Synthesis of Fostriecin</span></div><div class="casAuthors">Gao, Dong; Li, Bohui; O'Doherty, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8334-8338</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A formal synthesis of fostriecin and a total synthesis of its related congener dihydro-dephospho-fostriecin (I) have been achieved.  The route relies upon the use of the Sharpless dihydroxylation to set the abs. stereochem. at C-8/9 and Noyori transfer hydrogenation and Leighton allylation to set the C-11 and C-5 relative stereochem., resp.  Finally, the divergent functionalization of a C-12/13 alkyne was used to establish the Z,E-dienyne of dehydro-dephospho-fostriecin I and the Z,Z,E-triene of fostriecin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqae8JRXnq3rVg90H21EOLACvtfcHk0lhlUpQlL58aXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFShsbnO&md5=1692837e9d0eb16cf2a7ad0b29c4d10c</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.9b03120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.9b03120%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Doherty%26aufirst%3DG.%2BA.%26atitle%3DSynthesis%2520of%2520Dehydro-Dephospho-Fostriecin%2520and%2520Formal%2520Total%2520Synthesis%2520of%2520Fostriecin%26jtitle%3DOrg.%2520Lett.%26date%3D2019%26volume%3D21%26spage%3D8334%26epage%3D8338%26doi%3D10.1021%2Facs.orglett.9b03120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoshima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okado, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, M.</span></span> <span> </span><span class="NLM_article-title">Formal Total Synthesis of Fostriecin by 1,4-Asymmetric Induction with an Alkyne-Cobalt Complex</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">10150</span>– <span class="NLM_lpage">10159</span>, <span class="refDoi"> DOI: 10.1002/chem.201000795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fchem.201000795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20645347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2qsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=10150-10159&author=Y.+Hayashiauthor=H.+Yamaguchiauthor=M.+Toyoshimaauthor=K.+Okadoauthor=T.+Toyoauthor=M.+Shoji&title=Formal+Total+Synthesis+of+Fostriecin+by+1%2C4-Asymmetric+Induction+with+an+Alkyne-Cobalt+Complex&doi=10.1002%2Fchem.201000795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Formal Total Synthesis of Fostriecin by 1,4-Asymmetric Induction with an Alkyne-Cobalt Complex</span></div><div class="casAuthors">Hayashi, Yujiro; Yamaguchi, Hirofumi; Toyoshima, Maya; Okado, Kotaro; Toyo, Takumi; Shoji, Mitsuru</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">10150-10159, S10150/1-S10150/134</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The synthesis of a protected dephosphofostriecin, I, and thereby a formal synthesis of fostriecin, has been accomplished.  The synthetic challenges were the construction of four stereogenic centers and the conformationally labile cis-cis-trans-triene moiety.  Previous total syntheses have employed at least two asym. reactions that required the use of an external chiral auxiliary.  Although remote stereoinduction in a 1,4-relationship is considered difficult, we have developed a notable 1,4-asym. induction that utilizes an alkyne-cobalt complex for the control of C5 stereochem. by the C8 stereogenic center.  The stereochem. at C11 was established by 1,3-asym. induction with a higher-order alkynyl-zinc reagent.  Thus, only one asym. reaction requiring an external chiral auxiliary was employed in this route.  The labile cis-cis-trans-triene unit was constructed at a late stage of the synthesis by diastereoselective coupling of a dienyne and an aldehyde unit, followed by redn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6ws1u-rVjC7Vg90H21EOLACvtfcHk0lhr7LoWgMYe9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2qsb%252FI&md5=61a25f41da7ee45ee6e924f2b0506a2b</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1002%2Fchem.201000795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201000795%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DToyoshima%26aufirst%3DM.%26aulast%3DOkado%26aufirst%3DK.%26aulast%3DToyo%26aufirst%3DT.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DFormal%2520Total%2520Synthesis%2520of%2520Fostriecin%2520by%25201%252C4-Asymmetric%2520Induction%2520with%2520an%2520Alkyne-Cobalt%2520Complex%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2010%26volume%3D16%26spage%3D10150%26epage%3D10159%26doi%3D10.1002%2Fchem.201000795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Doherty, G.</span></span> <span> </span><span class="NLM_article-title">Total and Formal Syntheses of Fostriecin</span>. <i>Org. Chem. Front.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3608</span>– <span class="NLM_lpage">3615</span>, <span class="refDoi"> DOI: 10.1039/D0QO01121E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1039%2FD0QO01121E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=33184589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVKgsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2020&pages=3608-3615&author=G.+Dongauthor=B.+Liauthor=G.+O%E2%80%99Doherty&title=Total+and+Formal+Syntheses+of+Fostriecin&doi=10.1039%2FD0QO01121E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Total and formal syntheses of fostriecin</span></div><div class="casAuthors">Dong, Gao; Li, Bohui; O'Doherty, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Chemistry Frontiers</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3608-3615</span>CODEN:
                <span class="NLM_cas:coden">OCFRA8</span>;
        ISSN:<span class="NLM_cas:issn">2052-4129</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Two formal syntheses and one total synthesis of fostriecin (1) have been achieved, as well as, the synthesis of its related congener dihydro-dephospho-fostriecin.  All the routes use the Sharpless dihydroxylation to set the abs. stereochem. at C-8/9 positions and a Leighton allylation to set the C-5 position of the natural product.  In the formal syntheses a Noyori transfer hydrogenation of an ynone was used to set the C-11 position while the total synthesis employed a combination of asym. dihydroxylation and Pd-π-allyl redn. to set the C-11 position.  Finally in the total synthesis, a trans-hydroboration of the C-12/13 alkyne was used in combination with a Suzuki cross coupling to establish the Z,Z,E-triene of fostriecin (1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxXBN_YFF83LVg90H21EOLACvtfcHk0lhr7LoWgMYe9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVKgsr3M&md5=7c6f6db293bf26f6f744f93306ff81c3</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1039%2FD0QO01121E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0QO01121E%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Doherty%26aufirst%3DG.%26atitle%3DTotal%2520and%2520Formal%2520Syntheses%2520of%2520Fostriecin%26jtitle%3DOrg.%2520Chem.%2520Front.%26date%3D2020%26volume%3D7%26spage%3D3608%26epage%3D3615%26doi%3D10.1039%2FD0QO01121E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, M.</span></span> <span> </span><span class="NLM_article-title">Fostriecin Potentiates Genome Instability and Anti-Tumor Immunity in Ovarian Cancer</span>. <i>J. Immunother. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">A593</span>– <span class="NLM_lpage">A593</span>, <span class="refDoi"> DOI: 10.1136/jitc-2020-SITC2020.0559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1136%2Fjitc-2020-SITC2020.0559" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=A593-A593&author=R.+Rajaauthor=C.+Wuauthor=K.+Butlerauthor=M.+Curtis&title=Fostriecin+Potentiates+Genome+Instability+and+Anti-Tumor+Immunity+in+Ovarian+Cancer&doi=10.1136%2Fjitc-2020-SITC2020.0559"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1136%2Fjitc-2020-SITC2020.0559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjitc-2020-SITC2020.0559%26sid%3Dliteratum%253Aachs%26aulast%3DRaja%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DK.%26aulast%3DCurtis%26aufirst%3DM.%26atitle%3DFostriecin%2520Potentiates%2520Genome%2520Instability%2520and%2520Anti-Tumor%2520Immunity%2520in%2520Ovarian%2520Cancer%26jtitle%3DJ.%2520Immunother.%2520Cancer%26date%3D2020%26volume%3D8%26spage%3DA593%26epage%3DA593%26doi%3D10.1136%2Fjitc-2020-SITC2020.0559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusayanagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuramochi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, F.</span></span> <span> </span><span class="NLM_article-title">Antitumor Antibiotic Fostriecin Covalently Binds to Cysteine-269 Residue of Protein Phosphatase 2a Catalytic Subunit in Mammalian Cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">8113</span>– <span class="NLM_lpage">8122</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.09.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bmc.2009.09.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19857968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2js7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=8113-8122&author=T.+Takeuchiauthor=N.+Takahashiauthor=K.+Ishiauthor=T.+Kusayanagiauthor=K.+Kuramochiauthor=F.+Sugawara&title=Antitumor+Antibiotic+Fostriecin+Covalently+Binds+to+Cysteine-269+Residue+of+Protein+Phosphatase+2a+Catalytic+Subunit+in+Mammalian+Cells&doi=10.1016%2Fj.bmc.2009.09.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor antibiotic fostriecin covalently binds to cysteine-269 residue of protein phosphatase 2A catalytic subunit in mammalian cells</span></div><div class="casAuthors">Takeuchi, Toshifumi; Takahashi, Noriyuki; Ishi, Kazutomo; Kusayanagi, Tomoe; Kuramochi, Kouji; Sugawara, Fumio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8113-8122</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fostriecin is a phosphate monoester with excellent antitumor activity against mouse leukemia, and it is a potent inhibitor of protein phosphatase (PP) 2A.  This compd. has been predicted to covalently bind to the Cys269 residue of the PP2A catalytic subunit (PP2Ac) at the α,β-unsatd. lactone via a conjugate addn. reaction.  However, this binding has not yet been exptl. proven.  To confirm such binding, we synthesized biotin-labeled fostriecin (bio-Fos), which has an inhibitory activity against the proliferation of mouse leukemia cells.  We showed that fostriecin directly binds to PP2Ac in HeLa S3 cells by pull-down assays using bio-Fos.  Moreover, we directly demonstrated that fostriecin covalently binds to the Cys269 residue of PP2Ac by matrix assisted laser desorption/ionization time-of-flight mass spectrometry anal.  From these results, the inhibitory mechanism of fostriecin on PP2A activity is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFAMdpXt3_arVg90H21EOLACvtfcHk0lhr7LoWgMYe9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2js7fL&md5=7cd55788624efa257f9f635fd154976f</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.09.050%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DIshi%26aufirst%3DK.%26aulast%3DKusayanagi%26aufirst%3DT.%26aulast%3DKuramochi%26aufirst%3DK.%26aulast%3DSugawara%26aufirst%3DF.%26atitle%3DAntitumor%2520Antibiotic%2520Fostriecin%2520Covalently%2520Binds%2520to%2520Cysteine-269%2520Residue%2520of%2520Protein%2520Phosphatase%25202a%2520Catalytic%2520Subunit%2520in%2520Mammalian%2520Cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D8113%26epage%3D8122%26doi%3D10.1016%2Fj.bmc.2009.09.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greengard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nairn, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span> <span> </span><span class="NLM_article-title">Three-Dimensional Structure of the Catalytic Subunit of Protein Serine/Threonine Phosphatase-1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>376</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">753</span>, <span class="refDoi"> DOI: 10.1038/376745a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2F376745a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=7651533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFChs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=745-753&author=J.+Goldbergauthor=H.+B.+Huangauthor=Y.+G.+Kwonauthor=P.+Greengardauthor=A.+C.+Nairnauthor=J.+Kuriyan&title=Three-Dimensional+Structure+of+the+Catalytic+Subunit+of+Protein+Serine%2FThreonine+Phosphatase-1&doi=10.1038%2F376745a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1</span></div><div class="casAuthors">Goldberg, Jonathan; Huang, Hsien-bin; Kwon, Young-guen; Greengard, Paul; Nairn, Angus C.; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">6543</span>),
    <span class="NLM_cas:pages">745-53</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The crystal structure of mammalian (rabbit muscle) phosphoprotein phosphatase 1, complexed with the toxin, microcystin, and detd. at 2.1 Å resoln., revealed that it is a metalloenzyme unrelated in architecture to the phosphoprotein tyrosine phosphatases.  Two metal cations were positioned by a central β-α-β-α-β scaffold at the active site, from which emanate 3 surface grooves that are potential binding sites for substrates and inhibitors.  The C-terminus was positioned at the end of one of the grooves such that regulatory sequences following the domain might modulate function.  The fold of the catalytic domain was expected to be closely preserved in phosphoprotein phosphatases 2A and 2B (calcineurin).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3Ox1khdGU7Vg90H21EOLACvtfcHk0liN0QRSgath-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFChs7w%253D&md5=05f1a525b89cb35161fde5af5edac860</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1038%2F376745a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376745a0%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DH.%2BB.%26aulast%3DKwon%26aufirst%3DY.%2BG.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DThree-Dimensional%2520Structure%2520of%2520the%2520Catalytic%2520Subunit%2520of%2520Protein%2520Serine%252FThreonine%2520Phosphatase-1%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D745%26epage%3D753%26doi%3D10.1038%2F376745a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Apeldoorn, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Egmond, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speijers, G. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, G. J. I.</span></span> <span> </span><span class="NLM_article-title">Toxins of Cyanobacteria</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1002/mnfr.200600185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fmnfr.200600185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17195276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFCrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=7-60&author=M.+E.+van%0AApeldoornauthor=H.+P.+van+Egmondauthor=G.+J.+A.+Speijersauthor=G.+J.+I.+Bakker&title=Toxins+of+Cyanobacteria&doi=10.1002%2Fmnfr.200600185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Toxins of cyanobacteria</span></div><div class="casAuthors">van Apeldoorn, Marian E.; van Egmond, Hans P.; Speijers, Gerrit J. A.; Bakker, Guido J. I.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Nutrition & Food Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-60</span>CODEN:
                <span class="NLM_cas:coden">MNFRCV</span>;
        ISSN:<span class="NLM_cas:issn">1613-4125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Blue-green algae are found in lakes, ponds, rivers and brackish waters throughout the world.  In case of excessive growth such as bloom formation, these bacteria can produce inherent toxins in quantities causing toxicity in mammals, including humans.  These cyanotoxins include cyclic peptides and alkaloids.  Among the cyclic peptides are the microcystins and the nodularins.  The alkaloids include anatoxin-a, anatoxin-a(S), cylindrospermopsin, saxitoxins (STXs), aplysiatoxins and lyngbyatoxin.  Both biol. and chem. methods are used to det. cyanotoxins.  Bioassays and biochem. assays are nonspecific, so they can only be used as screening methods.  HPLC has some good prospects.  For the subsequent detection of these toxins different detectors may be used, ranging from simple UV-spectrometry via fluorescence detection to various types of MS.  The main problem in the detn. of cyanobacterial toxins is the lack of ref. materials of all relevant toxins.  In general, toxicity data on cyanotoxins are rather scarce.  A majority of toxicity data are known to be of microcystin-LR.  For nodularins, data from a few animal studies are available.  For the alkaloids, limited toxicity data exist for anatoxin-a, cylindrospermopsin and STX.  Risk assessment for acute exposure could be relevant for some types of exposure.  Nevertheless, no acute ref. doses have formally been derived thus far.  For STX(s), many countries have established tolerance levels in bivalves, but these limits were set in view of STX(s) as biotoxins, accumulating in marine shellfish.  Official regulations for other cyanotoxins were not established, although some (provisional) guideline values were derived for microcystins in drinking water by WHO and several countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdcVqkbkPfb7Vg90H21EOLACvtfcHk0liN0QRSgath-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFCrur8%253D&md5=a9ab88d7d63f4de718f1392f83b87b25</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.200600185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.200600185%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BApeldoorn%26aufirst%3DM.%2BE.%26aulast%3Dvan%2BEgmond%26aufirst%3DH.%2BP.%26aulast%3DSpeijers%26aufirst%3DG.%2BJ.%2BA.%26aulast%3DBakker%26aufirst%3DG.%2BJ.%2BI.%26atitle%3DToxins%2520of%2520Cyanobacteria%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2007%26volume%3D51%26spage%3D7%26epage%3D60%26doi%3D10.1002%2Fmnfr.200600185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwaghe, M. J.</span></span> <span> </span><span class="NLM_article-title">Microcystins Contamination of Surface Water Supply Sources in Zaria-Nigeria</span>. <i>Environ. Monit. Assess.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">606</span>, <span class="refDoi"> DOI: 10.1007/s10661-015-4829-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs10661-015-4829-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26329267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC287otlarug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2015&pages=606&author=M.+A.+Chiaauthor=M.+J.+Kwaghe&title=Microcystins+Contamination+of+Surface+Water+Supply+Sources+in+Zaria-Nigeria&doi=10.1007%2Fs10661-015-4829-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Microcystins contamination of surface water supply sources in Zaria-Nigeria</span></div><div class="casAuthors">Chia Mathias Ahii; Kwaghe Mndepawe Jonah</div><div class="citationInfo"><span class="NLM_cas:title">Environmental monitoring and assessment</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">606</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cyanobacterial contamination of public water supply systems is a worldwide problem.  The present study investigated water quality and microcystins (MCs) contamination of four public water supply systems in Zaria, Nigeria.  The water bodies were eutrophic in the rainy and dry season and supported high phytoplankton biomass with chlorophyll a concentrations generally higher than 20.0 μg/L.  The biomass of the predominant species (Microcystis aeruginosa and Anabaena subcylindrica) of cyanobacteria had a significant positive correlation with particulate and dissolved MCs.  Dissolved MCs concentrations were higher (>1.0 μg/L) than the maximum permissible limits for drinking water in all the water bodies in the dry season and three of them in the rainy season.  These results suggest that there is the need to have a regular monitoring program for these water bodies to prevent acute and chronic health hazards associated with MCs contamination of drinking and irrigation water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4DbdyGL01oNK0qsdY6Nc1fW6udTcc2eYjzVrpieqE1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287otlarug%253D%253D&md5=4687b954c4cf8e229b14033d4bc26e48</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1007%2Fs10661-015-4829-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10661-015-4829-3%26sid%3Dliteratum%253Aachs%26aulast%3DChia%26aufirst%3DM.%2BA.%26aulast%3DKwaghe%26aufirst%3DM.%2BJ.%26atitle%3DMicrocystins%2520Contamination%2520of%2520Surface%2520Water%2520Supply%2520Sources%2520in%2520Zaria-Nigeria%26jtitle%3DEnviron.%2520Monit.%2520Assess.%26date%3D2015%26volume%3D187%26spage%3D606%26doi%3D10.1007%2Fs10661-015-4829-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bittencourt-Oliveira, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hereman, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordeiro-Araújo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo-Silva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, F. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, A. N.</span></span> <span> </span><span class="NLM_article-title">Phytotoxicity Associated to Microcystins: A Review</span>. <i>Braz. J. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.1590/1519-6984.06213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1590%2F1519-6984.06213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25627583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC2Mrgt1OhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=753-760&author=M.+C.+Bittencourt-Oliveiraauthor=T.+C.+Heremanauthor=M.+K.+Cordeiro-Ara%C3%BAjoauthor=I.+Macedo-Silvaauthor=C.+T.+Diasauthor=F.+F.+C.+Sasakiauthor=A.+N.+Moura&title=Phytotoxicity+Associated+to+Microcystins%3A+A+Review&doi=10.1590%2F1519-6984.06213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Phytotoxicity associated to microcystins: a review</span></div><div class="casAuthors">Bittencourt-Oliveira M C; Hereman T C; Cordeiro-Araujo M K; Sasaki F F C; Macedo-Silva I; Dias C T; Moura A N</div><div class="citationInfo"><span class="NLM_cas:title">Brazilian journal of biology = Revista brasleira de biologia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Microcystins (MC) are the most studied toxins of cyanobacteria since they are widely distributed and account for several cases of human and animal poisoning, being potent inhibitors of the serine/threonine protein phosphatases 1 (PP1) and 2A (PP2A).  The phosphatases PP1 and PP2A are also present in plants, which may also suffer adverse effects due to the inhibition of these enzymes.  In aquatic plants, biomass reduction is usually observed after absorption of cyanotoxins, which can bioaccumulate in its tissues.  In terrestrial plants, the effects caused by microcystins vary from inhibition to stimulation as the individuals develop from seedling to adult, and include reduction of protein phosphatases 1 and 2A, oxidative stress, decreased photosynthetic activity and even cell apoptosis, as well as bioaccumulation in plant tissues.  Thus, the irrigation of crop plants by water contaminated with microcystins is not only an economic problem but becomes a public health issue because of the possibility of food contamination, and this route of exposure requires careful monitoring by the responsible authorities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdcE3_BMw2imhHGZei4OW9fW6udTcc2eYjzVrpieqE1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mrgt1OhtA%253D%253D&md5=41256c6643c5f17aed200e938f71df11</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1590%2F1519-6984.06213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252F1519-6984.06213%26sid%3Dliteratum%253Aachs%26aulast%3DBittencourt-Oliveira%26aufirst%3DM.%2BC.%26aulast%3DHereman%26aufirst%3DT.%2BC.%26aulast%3DCordeiro-Ara%25C3%25BAjo%26aufirst%3DM.%2BK.%26aulast%3DMacedo-Silva%26aufirst%3DI.%26aulast%3DDias%26aufirst%3DC.%2BT.%26aulast%3DSasaki%26aufirst%3DF.%2BF.%2BC.%26aulast%3DMoura%26aufirst%3DA.%2BN.%26atitle%3DPhytotoxicity%2520Associated%2520to%2520Microcystins%253A%2520A%2520Review%26jtitle%3DBraz.%2520J.%2520Biol.%26date%3D2014%26volume%3D74%26spage%3D753%26epage%3D760%26doi%3D10.1590%2F1519-6984.06213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Funari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testai, E.</span></span> <span> </span><span class="NLM_article-title">Human Health Risk Assessment Related to Cyanotoxins Exposure</span>. <i>Crit. Rev. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1080/10408440701749454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1080%2F10408440701749454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=18259982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Wlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=97-125&author=E.+Funariauthor=E.+Testai&title=Human+Health+Risk+Assessment+Related+to+Cyanotoxins+Exposure&doi=10.1080%2F10408440701749454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Human health risk assessment related to cyanotoxins exposure</span></div><div class="casAuthors">Funari, Enzo; Testai, Emanuela</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-125</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">1040-8444</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  This review focuses on the risk assessment assocd. with human exposure to cyanotoxins, secondary metabolites of an ubiquitous group of photosynthetic procariota.  Cyanobacteria occurr esp. in eutrophic inland and coastal surface waters, where under favorable conditions they attain high densities and may form blooms and scums.  Cyanotoxins can be grouped according to their biol. effects into hepatotoxins, neurotoxins, cytotoxins, and toxins with irritating potential, also acting on the gastrointestinal system.  The chem. and toxicol. properties of the main cyanotoxins, relevant for the evaluation of possible risks for human health, are presented.  Humans may be exposed to cyanotoxins via several routes, with the oral one being by far the most important, occurring by ingesting contaminated drinking water, food, some dietary supplements, or water during recreational activities.  Acute and short-term toxic effects have been assocd. in humans with exposure to high levels of cyanotoxins in drinking and bathing waters.  However, the chronic exposure to low cyanotoxin levels remains a crit. issue.  This article identifies the actual risky exposure scenarios, provides toxicol. derived ref. values, and discusses open issues and research needs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj3AszvQxfR7Vg90H21EOLACvtfcHk0lgiKTxloknp4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Wlurk%253D&md5=dbe83c9af6215b25af04b3b01fa13528</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1080%2F10408440701749454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408440701749454%26sid%3Dliteratum%253Aachs%26aulast%3DFunari%26aufirst%3DE.%26aulast%3DTestai%26aufirst%3DE.%26atitle%3DHuman%2520Health%2520Risk%2520Assessment%2520Related%2520to%2520Cyanotoxins%2520Exposure%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D2008%26volume%3D38%26spage%3D97%26epage%3D125%26doi%3D10.1080%2F10408440701749454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jochimsen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmichael, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardo, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cookson, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filho, D. A. d. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyra, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreto, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azevedo, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, W. R.</span></span> <span> </span><span class="NLM_article-title">Liver Failure and Death after Exposure to Microcystins at a Hemodialysis Center in Brazil</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">878</span>, <span class="refDoi"> DOI: 10.1056/NEJM199803263381304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1056%2FNEJM199803263381304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9516222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADyaK1c7mslyisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1998&pages=873-878&author=E.+M.+Jochimsenauthor=W.+W.+Carmichaelauthor=J.+S.+Anauthor=D.+M.+Cardoauthor=S.+T.+Cooksonauthor=C.+E.+Holmesauthor=M.+B.+Antunesauthor=D.+A.+d.+M.+Filhoauthor=T.+M.+Lyraauthor=V.+S.+Barretoauthor=S.+M.+Azevedoauthor=W.+R.+Jarvis&title=Liver+Failure+and+Death+after+Exposure+to+Microcystins+at+a+Hemodialysis+Center+in+Brazil&doi=10.1056%2FNEJM199803263381304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil</span></div><div class="casAuthors">Jochimsen E M; Carmichael W W; An J S; Cardo D M; Cookson S T; Holmes C E; Antunes M B; de Melo Filho D A; Lyra T M; Barreto V S; Azevedo S M; Jarvis W R</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">873-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Hemodialysis is a common but potentially hazardous procedure.  From February 17 to 20, 1996, 116 of 130 patients (89 percent) at a dialysis center (dialysis center A) in Caruaru, Brazil, had visual disturbances, nausea, and vomiting associated with hemodialysis.  By March 24, 26 of the patients had died of acute liver failure.  METHODS:  A case patient was defined as any patient undergoing dialysis at dialysis center A or Caruaru's other dialysis center (dialysis center B) during February 1996 who had acute liver failure.  To determine the risk factors for and the source of the outbreak, we conducted a cohort study of the 130 patients at dialysis center A and the 47 patients at dialysis center B, reviewed the centers' water supplies, and collected water, patients' serum, and postmortem liver tissue for microcystin assays.  RESULTS:  One hundred one patients (all at dialysis center A) met the case definition, and 50 died.  Affected patients who died were older than those who survived (median age, 47 vs. 35 years, P<0.001).  Furthermore, all 17 patients undergoing dialysis on the Tuesday-, Thursday-, and Saturday-night schedule became ill, and 13 of them (76 percent) died.  Both centers received water from a nearby reservoir.  However, the water supplied to dialysis center B was treated, filtered, and chlorinated, whereas the water supplied to dialysis center A was not.  Microcystins produced by cyanobacteria were detected in water from the reservoir and from dialysis center A and in serum and liver tissue of case patients.  CONCLUSIONS:  Water used for hemodialysis can contain toxic materials, and its quality should therefore be carefully monitored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6uVwzPlrzozUE-swuRqsHfW6udTcc2eaYVnxuRvWicbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7mslyisA%253D%253D&md5=02e75c15621b4a4946060f0a8ab2a958</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1056%2FNEJM199803263381304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199803263381304%26sid%3Dliteratum%253Aachs%26aulast%3DJochimsen%26aufirst%3DE.%2BM.%26aulast%3DCarmichael%26aufirst%3DW.%2BW.%26aulast%3DAn%26aufirst%3DJ.%2BS.%26aulast%3DCardo%26aufirst%3DD.%2BM.%26aulast%3DCookson%26aufirst%3DS.%2BT.%26aulast%3DHolmes%26aufirst%3DC.%2BE.%26aulast%3DAntunes%26aufirst%3DM.%2BB.%26aulast%3DFilho%26aufirst%3DD.%2BA.%2Bd.%2BM.%26aulast%3DLyra%26aufirst%3DT.%2BM.%26aulast%3DBarreto%26aufirst%3DV.%2BS.%26aulast%3DAzevedo%26aufirst%3DS.%2BM.%26aulast%3DJarvis%26aufirst%3DW.%2BR.%26atitle%3DLiver%2520Failure%2520and%2520Death%2520after%2520Exposure%2520to%2520Microcystins%2520at%2520a%2520Hemodialysis%2520Center%2520in%2520Brazil%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D338%26spage%3D873%26epage%3D878%26doi%3D10.1056%2FNEJM199803263381304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshikata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. C.</span></span> <span> </span><span class="NLM_article-title">Detection and Identification of Microcystins in the Drinking Water of Haimen City, China</span>. <i>Nat. Toxins</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1002/(SICI)(1996)4:6<277::AID-NT5>3.0.CO;2-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2F%28SICI%29%281996%294%3A6%3C277%3A%3AAID-NT5%3E3.0.CO%3B2-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=9029553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2sXhsFeqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=277-283&author=K.+Haradaauthor=M.+Oshikataauthor=H.+Uchidaauthor=M.+Suzukiauthor=F.+Kondoauthor=K.+Satoauthor=Y.+Uenoauthor=S.+Z.+Yuauthor=G.+Chenauthor=G.+C.+Chen&title=Detection+and+Identification+of+Microcystins+in+the+Drinking+Water+of+Haimen+City%2C+China&doi=10.1002%2F%28SICI%29%281996%294%3A6%3C277%3A%3AAID-NT5%3E3.0.CO%3B2-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Detection and identification of microcystins in the drinking water of Haimen City, China</span></div><div class="casAuthors">Harada, Ken-Ichi; Oshikata, Motoji; Uchida, Hideaki; Suzuki, Makoto; Kondo, Fumio; Sato, Katsuhiko; Ueno, Yoshio; Yu, Shun-Zhang; Chen, Gang; Chen, Gong-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Natural Toxins</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">277-283</span>CODEN:
                <span class="NLM_cas:coden">NATOEE</span>;
        ISSN:<span class="NLM_cas:issn">1056-9014</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">Cyanobacterial toxins, microcystins, have a potent tumor-promoting activity.  We investigated the level of microcystins in drinking water collected from 1992 to 1994 in Haimen City, China, where people who drink pond ditch water usually incurred a high incidence rate of hepatocellular carcinoma as compared with those who drink well water.  HPLC, liq. chromatog./mass spectrometry (LC/MS), and protein phosphatase inhibition assay (pp assay) were used to identify and quantify the microcystins.  Microcystin LR and [D-Asp3]microcystin LR were detected in 2 of 50 samples at a concn. of less than 100 ng/L by LC/MS in 1992.  Although no microcystins were found by the chem. method in 1993, 6 of 7 samples, except for 3 tap water samples, showed approx. 100 ng/L by using the pp assay in 1994.  The results obtained supported the epidemiol. results reported by S. Z. Yu (1989, 1995).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Cen8oCjfB7Vg90H21EOLACvtfcHk0lgiKTxloknp4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsFeqtbg%253D&md5=374fa77175f43b4dfbd698e9b5461a38</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%29%281996%294%3A6%3C277%3A%3AAID-NT5%3E3.0.CO%3B2-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%2529%25281996%25294%253A6%253C277%253A%253AAID-NT5%253E3.0.CO%253B2-1%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DOshikata%26aufirst%3DM.%26aulast%3DUchida%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DKondo%26aufirst%3DF.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DS.%2BZ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DG.%2BC.%26atitle%3DDetection%2520and%2520Identification%2520of%2520Microcystins%2520in%2520the%2520Drinking%2520Water%2520of%2520Haimen%2520City%252C%2520China%26jtitle%3DNat.%2520Toxins%26date%3D1996%26volume%3D4%26spage%3D277%26epage%3D283%26doi%3D10.1002%2F%28SICI%29%281996%294%3A6%3C277%3A%3AAID-NT5%3E3.0.CO%3B2-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svircev, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krstic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miladinov-Mikov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidovic, M.</span></span> <span> </span><span class="NLM_article-title">Freshwater Cyanobacterial Blooms and Primary Liver Cancer Epidemiological Studies in Serbia</span>. <i>J. Environ. Sci. Heal C</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1080/10590500802668016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1080%2F10590500802668016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslShtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=36-55&author=Z.+Svircevauthor=S.+Krsticauthor=M.+Miladinov-Mikovauthor=V.+Balticauthor=M.+Vidovic&title=Freshwater+Cyanobacterial+Blooms+and+Primary+Liver+Cancer+Epidemiological+Studies+in+Serbia&doi=10.1080%2F10590500802668016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Freshwater Cyanobacterial Blooms and Primary Liver Cancer Epidemiological Studies in Serbia</span></div><div class="casAuthors">Svircev, Zorica; Krstic, Svetislav; Miladinov-Mokov, Marica; Baltic, Vladimir; Vidovic, Milka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis & Ecotoxicology Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-55</span>CODEN:
                <span class="NLM_cas:coden">JESHA2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A large part of Central Serbia experiences continual shortage of sufficient ground water resources.  For that reason, more than 20 reservoirs serve as drinking water suppliers.  Significant and persistent cyanobacterial "blooms" have been recognized in nine of them.  Samples for cyanotoxin analyses were taken during and after "blooms" in Celije Reservoir and from Krusevac town-supplied tap water from that reservoir two days later.  Concn. of microcystin-LR was 650 μ gL-1 in the reservoir, while the tap water contained 2.5 μ gL-1.  In the two investigated periods, the high primary liver cancer (PLC) mortality of 11.6 from 1980-1990 and extremely high PLC incidence of 34.7 from 2000-2002 were obsd. in the regions affected by heavy cyanobacterial blooms.  In contrast, PLC mortality and incidence rates were substantially lower in the regions not affected by cyanobacterial blooms: in 1980-1990 the rate of PLC mortality amounted to 2.7 in Kosovo, 7.6 in Vojvodina, and 8.3 in the non-affected regions of Central Serbia; while in 2000-2002 PLC incidence amounted to 4.1 in Kosovo, 5.2 in Vojvodina, and 13.6 in the non- or less-affected regions of Central Serbia.  Keeping in mind that the most affected PLC regions in Central Serbia (Toplicki, Niski, and Sumadijski regions) have the water supply systems based on six reservoirs found regularly in bloom during summer months and that some of the regions are also connected with two boundary "blooming" reservoirs, representing a total of eight of nine blooming reservoirs, it is easy to presume that the PLC incidence could be related to drinking water quality.  The uneven geog. distribution of liver cancer in Serbia is conspicuous and hot spots could be related to drinking water supply.  It is very clear that the high-risk regions for PLC occurrence correspond with drinking water reservoirs continually found with cyanobacterial blooms, and the low risk regions correspond with water supplies not affected by cyanobacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo27-h0lS6n2LVg90H21EOLACvtfcHk0lgOp-JHJGwIGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslShtrY%253D&md5=7899e2a89e6aa270cd6151a2df56ea87</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1080%2F10590500802668016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10590500802668016%26sid%3Dliteratum%253Aachs%26aulast%3DSvircev%26aufirst%3DZ.%26aulast%3DKrstic%26aufirst%3DS.%26aulast%3DMiladinov-Mikov%26aufirst%3DM.%26aulast%3DBaltic%26aufirst%3DV.%26aulast%3DVidovic%26aufirst%3DM.%26atitle%3DFreshwater%2520Cyanobacterial%2520Blooms%2520and%2520Primary%2520Liver%2520Cancer%2520Epidemiological%2520Studies%2520in%2520Serbia%26jtitle%3DJ.%2520Environ.%2520Sci.%2520Heal%2520C%26date%3D2009%26volume%3D27%26spage%3D36%26epage%3D55%26doi%3D10.1080%2F10590500802668016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. Z.</span></span> <span> </span><span class="NLM_article-title">Detection of Microcystins, a Blue-Green Algal Hepatotoxin, in Drinking Water Sampled in Haimen and Fusui, Endemic Areas of Primary Liver Cancer in China, by Highly Sensitive Immunoassay</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1317</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1093/carcin/17.6.1317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1093%2Fcarcin%2F17.6.1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=8681449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK28XjvFegurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=1317-1321&author=Y.+Uenoauthor=S.+Nagataauthor=T.+Tsutsumiauthor=A.+Hasegawaauthor=M.+F.+Watanabeauthor=H.+D.+Parkauthor=G.+C.+Chenauthor=G.+Chenauthor=S.+Z.+Yu&title=Detection+of+Microcystins%2C+a+Blue-Green+Algal+Hepatotoxin%2C+in+Drinking+Water+Sampled+in+Haimen+and+Fusui%2C+Endemic+Areas+of+Primary+Liver+Cancer+in+China%2C+by+Highly+Sensitive+Immunoassay&doi=10.1093%2Fcarcin%2F17.6.1317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay</span></div><div class="casAuthors">Ueno, Yoshio; Nagata, Satoshi; Tsutsumi, Tomoaki; Hasegawa, Akihiro; Watanabe, Mariyo F.; Park, Ho-Dong; Chen, Gong-Chao; Chen, Gang; Yu, Shun-Zhang</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1317-1321</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">An epidemiol. survey to identify causes of a high incidence of primary liver cancer (PLC) in Haimen City, Jian-Su Province and Fusui County, Guangxi Province, China, found a close correlation between the incidence of PLC and consumption of pond and ditch water.  To clarify whether microcystin (MC), a hepatotoxic peptide produced by water bloom algae, pollute drinking water in PLC endemic areas in China, a highly sensitive ELISA with a detection limit of 50 pg/mL, was introduced to monitor MC.  Three drinking water surveys were conducted in 1993-1994.  A total of 1135 samples were collected from ponds, ditches, rivers, shallow wells, and deep wells in Haimen City.  The first survey, in Sept. 1993, found that 3 of 14 ditch water specimens were pos. for MC, in concns. of 90-460 pg/mL.  Several toxic algae such as Oscillatoria agardhii were present in some ditches.  In the second trial, samples were collected from 5 ponds/ditches, 2 rivers, 2 shallow wells, and 2 deep wells on a monthly basis throughout 1994.  These data showed that MC was highest in June-Sept., at concns. of 62-296 pg/mL.  A third trial of 989 samples collected from water sources in July 1994 showed that 17% of pond/ditch water, 32% of river water, and 4% of shallow well water were pos. for MC, with avs. of 101, 160, and 68 pg/mL, resp.  No MC was detected in deep well water.  A similar survey on 26 drinking water samples in Fusui, demonstrated a high MC contamination frequency in pond/ditch and river waters, but no MC in shallow and deep wells.  These data support a hypothesis that the blue-green algal toxin, MC, in pond/ditch and river waters used as drinking water is a risk factor for the high incidence of PLC in China.  Based on previous PLC epidemiol. findings and MC drinking water screening surveys, an advisory level of MC in drinking water of <0.01 μg/L was proposed.  The combined effect of a potent hepatocarcinogen, AFB1, and an intermittent intake of MC in drinking water in summer was discussed as an etiol. of PLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJLNHTWjvoULVg90H21EOLACvtfcHk0lgOp-JHJGwIGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvFegurg%253D&md5=aa950c022ada24c2f88480b2735af1c5</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2F17.6.1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252F17.6.1317%26sid%3Dliteratum%253Aachs%26aulast%3DUeno%26aufirst%3DY.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DM.%2BF.%26aulast%3DPark%26aufirst%3DH.%2BD.%26aulast%3DChen%26aufirst%3DG.%2BC.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DS.%2BZ.%26atitle%3DDetection%2520of%2520Microcystins%252C%2520a%2520Blue-Green%2520Algal%2520Hepatotoxin%252C%2520in%2520Drinking%2520Water%2520Sampled%2520in%2520Haimen%2520and%2520Fusui%252C%2520Endemic%2520Areas%2520of%2520Primary%2520Liver%2520Cancer%2520in%2520China%252C%2520by%2520Highly%2520Sensitive%2520Immunoassay%26jtitle%3DCarcinogenesis%26date%3D1996%26volume%3D17%26spage%3D1317%26epage%3D1321%26doi%3D10.1093%2Fcarcin%2F17.6.1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Figueiredo, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azeiteiro, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteves, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, F. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, M. J.</span></span> <span> </span><span class="NLM_article-title">Microcystin-Producing Blooms—a Serious Global Public Health Issue</span>. <i>Ecotoxicol. Environ. Saf.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/j.ecoenv.2004.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.ecoenv.2004.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=15327870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFCltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=151-163&author=D.+R.+de+Figueiredoauthor=U.+M.+Azeiteiroauthor=S.+M.+Estevesauthor=F.+J.+M.+Gon%C3%A7alvesauthor=M.+J.+Pereira&title=Microcystin-Producing+Blooms%E2%80%94a+Serious+Global+Public+Health+Issue&doi=10.1016%2Fj.ecoenv.2004.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Microcystin-producing blooms-a serious global public health issue</span></div><div class="casAuthors">de Figueiredo, Daniela R.; Azeiteiro, Ulisses M.; Esteves, Sonia M.; Goncalves, Fernando J. M.; Pereira, Mario J.</div><div class="citationInfo"><span class="NLM_cas:title">Ecotoxicology and Environmental Safety</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-163</span>CODEN:
                <span class="NLM_cas:coden">EESADV</span>;
        ISSN:<span class="NLM_cas:issn">0147-6513</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The investigation on microcystin topics is increasing due to the related ecol. and public health risks.  Recent investigation confirms a gap in establishing global patterns relating a particular environment to the bloom occurrence of a species and the prodn. of certain microcystin variants.  All the results concerning the environmental effects on the microcystin synthesis of one species must be checked in the light of genome diversity.  Thus, the poisoning risks of a bloom depend on the strain causing toxicity.  To be more effective, specific water treatment methods are required for blooms of different microcystin-producing species (such as colonial and filamentous cyanobacteria found in stratified and unstratified water bodies, resp.).  With the increasing no. of new microcystin variants discovered, the development of new rapid, inexpensive, and sensitive enough monitoring methods to promptly screen simultaneously a great diversity of toxins and also check their toxic effects is becoming necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNhcNFNBcdpLVg90H21EOLACvtfcHk0lgOp-JHJGwIGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFCltbY%253D&md5=2d3079a71d6d4e13d869299fefc4d1ff</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2Fj.ecoenv.2004.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ecoenv.2004.04.006%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BFigueiredo%26aufirst%3DD.%2BR.%26aulast%3DAzeiteiro%26aufirst%3DU.%2BM.%26aulast%3DEsteves%26aufirst%3DS.%2BM.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DF.%2BJ.%2BM.%26aulast%3DPereira%26aufirst%3DM.%2BJ.%26atitle%3DMicrocystin-Producing%2520Blooms%25E2%2580%2594a%2520Serious%2520Global%2520Public%2520Health%2520Issue%26jtitle%3DEcotoxicol.%2520Environ.%2520Saf.%26date%3D2004%26volume%3D59%26spage%3D151%26epage%3D163%26doi%3D10.1016%2Fj.ecoenv.2004.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vareli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frillingos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briasoulis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sainis, I.</span></span> <span> </span><span class="NLM_article-title">Hepatotoxic Seafood Poisoning (Hsp) Due to Microcystins: A Threat from the Ocean?</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2751</span>– <span class="NLM_lpage">2768</span>, <span class="refDoi"> DOI: 10.3390/md11082751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3390%2Fmd11082751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23921721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSms7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=2751-2768&author=K.+Vareliauthor=W.+Jaegerauthor=A.+Toukaauthor=S.+Frillingosauthor=E.+Briasoulisauthor=I.+Sainis&title=Hepatotoxic+Seafood+Poisoning+%28Hsp%29+Due+to+Microcystins%3A+A+Threat+from+the+Ocean%3F&doi=10.3390%2Fmd11082751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatotoxic Seafood Poisoning (HSP) due to microcystins: a threat from the ocean?</span></div><div class="casAuthors">Vareli, Katerina; Jaeger, Walter; Touka, Anastasia; Frillingos, Stathis; Briasoulis, Evangelos; Sainis, Ioannis</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2751-2768, 18 pp.</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Cyanobacterial blooms are a major and growing problem for freshwater ecosystems worldwide that increasingly concerns public health, with an av. of 60% of blooms known to be toxic.  The most studied cyanobacterial toxins belong to a family of cyclic heptapeptide hepatotoxins, called microcystins.  The microcystins are stable hydrophilic cyclic heptapeptides with a potential to cause cell damage following cellular uptake via org. anion-transporting proteins (OATP).  Their intracellular biol. effects presumably involve inhibition of catalytic subunits of protein phosphatases (PP1 and PP2A) and glutathione depletion.  The microcystins produced by cyanobacteria pose a serious problem to human health, if they contaminate drinking water or food.  These toxins are collectively responsible for human fatalities, as well as continued and widespread poisoning of wild and domestic animals.  Although intoxications of aquatic organisms by microcystins have been widely documented for freshwater ecosystems, such poisonings in marine environments have only occasionally been reported.  Moreover, these poisonings have been attributed to freshwater cyanobacterial species invading seas of lower salinity (e.g., the Baltic) or to the discharge of freshwater microcystins into the ocean.  However, recent data suggest that microcystins are also being produced in the oceans by a no. of cosmopolitan marine species, so that Hepatotoxic Seafood Poisoning (HSP) is increasingly recognized as a major health risk that follows consumption of contaminated seafood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz2rT3uysozLVg90H21EOLACvtfcHk0lgtUiRVFUhFKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSms7bO&md5=136df3b9e7408a9d6259962bfcab56b1</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.3390%2Fmd11082751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd11082751%26sid%3Dliteratum%253Aachs%26aulast%3DVareli%26aufirst%3DK.%26aulast%3DJaeger%26aufirst%3DW.%26aulast%3DTouka%26aufirst%3DA.%26aulast%3DFrillingos%26aufirst%3DS.%26aulast%3DBriasoulis%26aufirst%3DE.%26aulast%3DSainis%26aufirst%3DI.%26atitle%3DHepatotoxic%2520Seafood%2520Poisoning%2520%2528Hsp%2529%2520Due%2520to%2520Microcystins%253A%2520A%2520Threat%2520from%2520the%2520Ocean%253F%26jtitle%3DMar.%2520Drugs%26date%3D2013%26volume%3D11%26spage%3D2751%26epage%3D2768%26doi%3D10.3390%2Fmd11082751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prickett, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span> <span> </span><span class="NLM_article-title">The A4 Regulatory Subunit Exerts Opposing Allosteric Effects on Protein Phosphatases Pp6 and Pp2a</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">30503</span>– <span class="NLM_lpage">30511</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601054200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M601054200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=16895907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCrsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=30503-30511&author=T.+D.+Prickettauthor=D.+L.+Brautigan&title=The+A4+Regulatory+Subunit+Exerts+Opposing+Allosteric+Effects+on+Protein+Phosphatases+Pp6+and+Pp2a&doi=10.1074%2Fjbc.M601054200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">The α4 Regulatory Subunit Exerts Opposing Allosteric Effects on Protein Phosphatases PP6 and PP2A</span></div><div class="casAuthors">Prickett, Todd D.; Brautigan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">30503-30511</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protein Ser/Thr phosphatase family contains three enzymes called PP2A, PP4, and PP6 with sep. biol. functions inferred from genetics of the yeast homologues Pph21/22, Pph3, and Sit4.  These catalytic subunits assoc. with a common subunit called α4 (related to yeast Tap42).  Here, we characterized recombinant PP6 and PP2A catalytic monomers and α4·phosphatase heterodimers.  Monomeric PP6 and PP2A showed identical kinetics using either p-nitrophenyl phosphate (pNPP) or 32P-myelin basic protein (MBP) as substrates, with matching Km and Vmax values.  Using pNPP as substrate, PP6 and PP2A gave the same IC50 with active site inhibitors okadaic acid, microcystin-LR, calyculin A, and cantharidin.  However, with MBP as substrate, PP6 was inhibited at 5-fold lower concns. of toxins relative to PP2A, suggesting PP6 might be a preferred in vivo target of toxins.  Heterodimeric α4·PP6 and α4·PP2A were starkly different.  With MBP as substrate the α4·PP2A heterodimer had a 100-fold higher Vmax than α4·PP6, and neither heterodimer was active with pNPP.  Thus, these phosphatases are distinguished by their different responses to allosteric binding of the common regulatory subunit α4.  Transient expression of α4 differentially increased or decreased phosphorylation of endogenous phosphoproteins, consistent with opposing effects on PP2A and PP6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqpOx4uHDms7Vg90H21EOLACvtfcHk0lgtUiRVFUhFKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCrsL3K&md5=857da17a92103bf12b845e6cf4a3fe77</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601054200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601054200%26sid%3Dliteratum%253Aachs%26aulast%3DPrickett%26aufirst%3DT.%2BD.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26atitle%3DThe%2520A4%2520Regulatory%2520Subunit%2520Exerts%2520Opposing%2520Allosteric%2520Effects%2520on%2520Protein%2520Phosphatases%2520Pp6%2520and%2520Pp2a%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D30503%26epage%3D30511%26doi%3D10.1074%2Fjbc.M601054200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maude, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Donnell, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehrotra, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gani, D.</span></span> <span> </span><span class="NLM_article-title">Design and Preparation of Serine–Threonine Protein Phosphatase Inhibitors Based Upon the Nodularin and Microcystin Toxin Structures. Part 3</span>. <i>J. Chem. Soc. Perkin Trans. 1</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1695</span>, <span class="refDoi"> DOI: 10.1039/b100401h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1039%2Fb100401h" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=1673-1695&author=K.+L.+Websterauthor=A.+B.+Maudeauthor=M.+E.+O%27Donnellauthor=A.+P.+Mehrotraauthor=D.+Gani&title=Design+and+Preparation+of+Serine%E2%80%93Threonine+Protein+Phosphatase+Inhibitors+Based+Upon+the+Nodularin+and+Microcystin+Toxin+Structures.+Part+3&doi=10.1039%2Fb100401h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1039%2Fb100401h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb100401h%26sid%3Dliteratum%253Aachs%26aulast%3DWebster%26aufirst%3DK.%2BL.%26aulast%3DMaude%26aufirst%3DA.%2BB.%26aulast%3DO%2527Donnell%26aufirst%3DM.%2BE.%26aulast%3DMehrotra%26aufirst%3DA.%2BP.%26aulast%3DGani%26aufirst%3DD.%26atitle%3DDesign%2520and%2520Preparation%2520of%2520Serine%25E2%2580%2593Threonine%2520Protein%2520Phosphatase%2520Inhibitors%2520Based%2520Upon%2520the%2520Nodularin%2520and%2520Microcystin%2520Toxin%2520Structures.%2520Part%25203%26jtitle%3DJ.%2520Chem.%2520Soc.%2520Perkin%2520Trans.%25201%26date%3D2001%26volume%3D1%26spage%3D1673%26epage%3D1695%26doi%3D10.1039%2Fb100401h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maynes, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, C. F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. N. G.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Tumor-Promoter Okadaic Acid Bound to Protein Phosphatase-1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">44078</span>– <span class="NLM_lpage">44082</span>, <span class="refDoi"> DOI: 10.1074/jbc.M107656200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M107656200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11535607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos12ntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=44078-44082&author=J.+T.+Maynesauthor=K.+S.+Batemanauthor=M.+M.+Cherneyauthor=A.+K.+Dasauthor=H.+A.+Luuauthor=C.+F.+B.+Holmesauthor=M.+N.+G.+James&title=Crystal+Structure+of+the+Tumor-Promoter+Okadaic+Acid+Bound+to+Protein+Phosphatase-1&doi=10.1074%2Fjbc.M107656200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tumor-promoter okadaic acid bound to protein phosphatase-1</span></div><div class="casAuthors">Maynes, Jason T.; Bateman, Katherine S.; Cherney, Maia M.; Das, Amit K.; Luu, Hue Anh; Holmes, Charles F. B.; James, Michael N. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">44078-44082</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Protein phosphatase-1 (PP1) plays a key role in dephosphorylation in numerous biol. processes such as glycogen metab., cell cycle regulation, smooth muscle contraction, and protein synthesis.  Microorganisms produce a variety of inhibitors of PP1, which include the microcystin class of inhibitors and okadaic acid, the latter being the major cause of diarrhetic shellfish poisoning and a powerful tumor promoter.  The authors have detd. the crystal structure of the mol. complex of okadaic acid bound to PP1 to a resoln. of 1.9 Å.  This structure reveals that the acid binds in a hydrophobic groove adjacent to the active site of the protein and interacts with basic residues within the active site.  Okadaic acid exhibits a cyclic structure, which is maintained via an intramol. hydrogen bond.  This is reminiscent of other macrocyclic protein phosphatase inhibitors.  The inhibitor-bound enzyme shows very little conformational change when compared with two other PP1 structures, except in the inhibitor-sensitive β12-β13 loop region.  The selectivity of okadaic acid for protein phosphatases-1 and -2A but not PP-2B (calcineurin) may be reassessed in light of this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7AMLpTLsFbbVg90H21EOLACvtfcHk0lgtUiRVFUhFKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos12ntb8%253D&md5=8b41e617072a2dde062fac26b42ec1da</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M107656200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M107656200%26sid%3Dliteratum%253Aachs%26aulast%3DMaynes%26aufirst%3DJ.%2BT.%26aulast%3DBateman%26aufirst%3DK.%2BS.%26aulast%3DCherney%26aufirst%3DM.%2BM.%26aulast%3DDas%26aufirst%3DA.%2BK.%26aulast%3DLuu%26aufirst%3DH.%2BA.%26aulast%3DHolmes%26aufirst%3DC.%2BF.%2BB.%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Tumor-Promoter%2520Okadaic%2520Acid%2520Bound%2520to%2520Protein%2520Phosphatase-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D44078%26epage%3D44082%26doi%3D10.1074%2Fjbc.M107656200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawhorn, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boga, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colby, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swingle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amable, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honkanen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis and Evaluation of Cytostatin, Its C10-C11 Diastereomers, and Additional Key Analogues: Impact on Pp2a Inhibition</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">16720</span>– <span class="NLM_lpage">16732</span>, <span class="refDoi"> DOI: 10.1021/ja066477d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja066477d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSrsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=16720-16732&author=B.+G.+Lawhornauthor=S.+B.+Bogaauthor=S.+E.+Wolkenbergauthor=D.+A.+Colbyauthor=C.-M.+Gaussauthor=M.+R.+Swingleauthor=L.+Amableauthor=R.+E.+Honkanenauthor=D.+L.+Boger&title=Total+Synthesis+and+Evaluation+of+Cytostatin%2C+Its+C10-C11+Diastereomers%2C+and+Additional+Key+Analogues%3A+Impact+on+Pp2a+Inhibition&doi=10.1021%2Fja066477d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis and Evaluation of Cytostatin, Its C10-C11 Diastereomers, and Additional Key Analogues: Impact on PP2A Inhibition</span></div><div class="casAuthors">Lawhorn, Brian G.; Boga, Sobhana B.; Wolkenberg, Scott E.; Colby, David A.; Gauss, Carla-Maria; Swingle, Mark R.; Amable, Lauren; Honkanen, Richard E.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">16720-16732</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The total synthesis of cytostatin (I, R = H, R1 = OH), an antitumor agent belonging to the fostriecin family of natural products, is described in full detail.  The convergent approach relied on a key epoxide-opening reaction to join the two stereotriad units and a single-step late-stage stereoselective installation of the sensitive (Z,Z,E)-triene through a β-chelation-controlled nucleophilic addn.  The synthetic route provided rapid access to the C4-C6 stereoisomers of the cytostatin lactone, which were prepd. and used to define the C4-C6 relative stereochem. of the natural product.  In addn. to the natural product, each of the C10-C11 diastereomers of cytostatin was divergently prepd., e.g. I (R = OH, R1 = H), (11 steps from key convergence step) by this route and used to unequivocally confirm the relative and abs. stereochem. of cytostatin.  Each of the cytostatin diastereomers exhibited a reduced activity toward inhibition of PP2A (>100-fold), demonstrating the importance of the presence and stereochem. of the C10-Me and C11-hydroxy groups for potent PP2A inhibition.  Extensions of the studies provided dephosphocytostatin, sulfocytostatin (a key analog related to the natural product sultriecin), 11-deshydroxycytostatin, and an analog lacking the entire C12-C18 (Z,Z,E)-triene segment, which were used to define the magnitude of the C9-phosphate (>4000-fold), C11-alc. (250-fold), and triene (220-fold) contribution to PP2A inhibition.  A model of cytostatin bound to the active site of PP2A is presented, compared to that of fostriecin, which is also presented in detail for the first time, and used to provide insights into the role of the key substituents.  Notably, the α,β-unsatd. lactone of cytostatin, like that of fostriecin, is projected to serve as a key electrophile, providing a covalent adduct with Cys269 unique to PP2A, contributing to its potency (≥200-fold for fostriecin) and accounting for its selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeS-CWIkStBrVg90H21EOLACvtfcHk0lgKfV_VGYgGOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSrsr%252FO&md5=e2be848f74cd7b13dce3568d0ef8588c</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1021%2Fja066477d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja066477d%26sid%3Dliteratum%253Aachs%26aulast%3DLawhorn%26aufirst%3DB.%2BG.%26aulast%3DBoga%26aufirst%3DS.%2BB.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DColby%26aufirst%3DD.%2BA.%26aulast%3DGauss%26aufirst%3DC.-M.%26aulast%3DSwingle%26aufirst%3DM.%2BR.%26aulast%3DAmable%26aufirst%3DL.%26aulast%3DHonkanen%26aufirst%3DR.%2BE.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DTotal%2520Synthesis%2520and%2520Evaluation%2520of%2520Cytostatin%252C%2520Its%2520C10-C11%2520Diastereomers%252C%2520and%2520Additional%2520Key%2520Analogues%253A%2520Impact%2520on%2520Pp2a%2520Inhibition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D16720%26epage%3D16732%26doi%3D10.1021%2Fja066477d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambrecht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haesen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sents, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssens, V.</span></span> <span> </span><span class="NLM_article-title">Structure, Regulation, and Pharmacological Modulation of Pp2a Phosphatases</span>. <i>Methods Mol. Biol. (N. Y., NY, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1053</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1007/978-1-62703-562-0_17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2F978-1-62703-562-0_17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23860660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvVSjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1053&publication_year=2013&pages=283-305&author=C.+Lambrechtauthor=D.+Haesenauthor=W.+Sentsauthor=E.+Ivanovaauthor=V.+Janssens&title=Structure%2C+Regulation%2C+and+Pharmacological+Modulation+of+Pp2a+Phosphatases&doi=10.1007%2F978-1-62703-562-0_17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, Regulation, and Pharmacological Modulation of PP2A Phosphatases</span></div><div class="casAuthors">Lambrecht, Caroline; Haesen, Dorien; Sents, Ward; Ivanova, Elitsa; Janssens, Veerle</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1053</span>
        (<span class="NLM_cas:issue">Phosphatase Modulators</span>),
    <span class="NLM_cas:pages">283-305</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Protein phosphatases of the type 2A family (PP2A) represent a major fraction of cellular Ser/Thr phosphatase activity in any given human tissue.  In this review, we describe how the holoenzymic nature of PP2A and the existence of several distinct PP2A composing subunits allow for the generation of multiple structurally and functionally different PP2A complexes, explaining why PP2A is involved in the regulation of so many diverse cell biol. and physiol. processes.  Moreover, in human disease, most notably in several cancers and Alzheimer's Disease, PP2A expression and/or activity have been found significantly decreased, underscoring its important functions as a major tumor suppressor and tau phosphatase.  Hence, several recent preclin. studies have demonstrated that pharmacol. restoration of PP2A activity, as well as pharmacol. PP2A inhibition, under certain conditions, may be of significant future therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFqaa-GHtxarVg90H21EOLACvtfcHk0lgKfV_VGYgGOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvVSjsLY%253D&md5=7c84b163ba402ff91d9806ccdf345b98</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-562-0_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-562-0_17%26sid%3Dliteratum%253Aachs%26aulast%3DLambrecht%26aufirst%3DC.%26aulast%3DHaesen%26aufirst%3DD.%26aulast%3DSents%26aufirst%3DW.%26aulast%3DIvanova%26aufirst%3DE.%26aulast%3DJanssens%26aufirst%3DV.%26atitle%3DStructure%252C%2520Regulation%252C%2520and%2520Pharmacological%2520Modulation%2520of%2520Pp2a%2520Phosphatases%26jtitle%3DMethods%2520Mol.%2520Biol.%2520%2528N.%2520Y.%252C%2520NY%252C%2520U.%2520S.%2529%26date%3D2013%26volume%3D1053%26spage%3D283%26epage%3D305%26doi%3D10.1007%2F978-1-62703-562-0_17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aggen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nairn, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlin, A. R.</span></span> <span> </span><span class="NLM_article-title">The Design, Synthesis, and Biological Evaluation of Analogues of the Serine-Threonine Protein Phosphatase 1 and 2a Selective Inhibitor Microcystin La: Rational Modifications Imparting Pp1 Selectivity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(98)00254-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0968-0896%2898%2900254-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10220039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK1MXitlGktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=543-564&author=J.+B.+Aggenauthor=J.+M.+Humphreyauthor=C.+M.+Gaussauthor=H.+B.+Huangauthor=A.+C.+Nairnauthor=A.+R.+Chamberlin&title=The+Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Analogues+of+the+Serine-Threonine+Protein+Phosphatase+1+and+2a+Selective+Inhibitor+Microcystin+La%3A+Rational+Modifications+Imparting+Pp1+Selectivity&doi=10.1016%2FS0968-0896%2898%2900254-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">The design, synthesis, and biological evaluation of analogs of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivity</span></div><div class="casAuthors">Aggen, James B.; Humphrey, John M.; Gauss, Carla-Maria; Huang, Hsien-Bin; Nairn, Angus C.; Chamberlin, A. Richard</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">543-564</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Based on the results from previously reported mol. modeling analyses of the interactions between the inhibitor microcystin and the serine-threonine protein phosphatases 1 and 2A, the authors have designed analogs of microcystin LA (I) with structural modifications intended to impart PP1 selectivity.  The synthesis of several first generation analogs followed by inhibition assays revealed that all three are PP1-selective, as predicted.  Although the obsd. selectivities are modest, one of the designed analogs is more selective for PP1 than any known small mol. inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoirJVeATZ49bVg90H21EOLACvtfcHk0lgKfV_VGYgGOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitlGktbg%253D&md5=45a6a03ed8f3c9e11c9dc4f7e20297e2</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2898%2900254-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252898%252900254-5%26sid%3Dliteratum%253Aachs%26aulast%3DAggen%26aufirst%3DJ.%2BB.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DHuang%26aufirst%3DH.%2BB.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DChamberlin%26aufirst%3DA.%2BR.%26atitle%3DThe%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Analogues%2520of%2520the%2520Serine-Threonine%2520Protein%2520Phosphatase%25201%2520and%25202a%2520Selective%2520Inhibitor%2520Microcystin%2520La%253A%2520Rational%2520Modifications%2520Imparting%2520Pp1%2520Selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1999%26volume%3D7%26spage%3D543%26epage%3D564%26doi%3D10.1016%2FS0968-0896%2898%2900254-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontanillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemskov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhrig, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Highly Selective Submicromolar Microcystin-Based Inhibitors of Protein Phosphatase (Pp)2a over Pp1</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">13985</span>– <span class="NLM_lpage">13989</span>, <span class="refDoi"> DOI: 10.1002/anie.201606449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fanie.201606449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1CgtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=13985-13989&author=M.+Fontanilloauthor=I.+Zemskovauthor=M.+Hafnerauthor=U.+Uhrigauthor=F.+Salviauthor=B.+Simonauthor=V.+Wittmannauthor=M.+Kohn&title=Synthesis+of+Highly+Selective+Submicromolar+Microcystin-Based+Inhibitors+of+Protein+Phosphatase+%28Pp%292a+over+Pp1&doi=10.1002%2Fanie.201606449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of highly selective submicromolar microcystin-based inhibitors of protein phosphatase (PP)2A over PP1</span></div><div class="casAuthors">Fontanillo, Miriam; Zemskov, Ivan; Haefner, Maximilian; Uhrig, Ulrike; Salvi, Francesca; Simon, Bernd; Wittmann, Valentin; Koehn, Maja</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">13985-13989</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Research and therapeutic targeting of the phosphoserine/threonine phosphatases PP1 and PP2A is hindered by the lack of selective inhibitors.  The microcystin (MC) natural toxins target both phosphatases with equal potency, and their complex synthesis has complicated structure-activity relationship studies in the past.  We report herein the synthesis and biochem. evaluation of 11 MC analogs, which was accomplished through an efficient strategy combining solid- and soln.-phase approaches.  Our approach led to the first MC analog with submicromolar inhibitory potency that is strongly selective for PP2A over PP1 and does not require the complex lipophilic Adda group.  Through mutational and structural analyses, we identified a new key element for binding, as well as reasons for the selectivity.  This work gives unprecedented insight into how selectivity between these phosphatases can be achieved with MC analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9YGP8xoSFCbVg90H21EOLACvtfcHk0lgkM16ug8ZHmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1CgtLfI&md5=58eb29f37742812e41be89fd1918065f</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1002%2Fanie.201606449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201606449%26sid%3Dliteratum%253Aachs%26aulast%3DFontanillo%26aufirst%3DM.%26aulast%3DZemskov%26aufirst%3DI.%26aulast%3DHafner%26aufirst%3DM.%26aulast%3DUhrig%26aufirst%3DU.%26aulast%3DSalvi%26aufirst%3DF.%26aulast%3DSimon%26aufirst%3DB.%26aulast%3DWittmann%26aufirst%3DV.%26aulast%3DKohn%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520Highly%2520Selective%2520Submicromolar%2520Microcystin-Based%2520Inhibitors%2520of%2520Protein%2520Phosphatase%2520%2528Pp%25292a%2520over%2520Pp1%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D13985%26epage%3D13989%26doi%3D10.1002%2Fanie.201606449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontanillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Microcystins: Synthesis and Structure–Activity Relationship Studies toward Pp1 and Pp2a</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1118</span>– <span class="NLM_lpage">1126</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.08.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bmc.2017.08.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28893598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKlurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=1118-1126&author=M.+Fontanilloauthor=M.+K%C3%B6hn&title=Microcystins%3A+Synthesis+and+Structure%E2%80%93Activity+Relationship+Studies+toward+Pp1+and+Pp2a&doi=10.1016%2Fj.bmc.2017.08.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Microcystins: Synthesis and structure-activity relationship studies toward PP1 and PP2A</span></div><div class="casAuthors">Fontanillo, Miriam; Koehn, Maja</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1118-1126</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Microcystins are highly toxic cyanotoxins responsible for plant, animal and human poisoning.  Exposure to microcystins, mainly through drinkable water and contaminated food, is a current world health concern.  Although it is quite challenging, the synthesis of these potent cyanotoxins, analogs and derivs. helps to evaluate their toxicol. properties and to elucidate their binding mechanisms to their main targets Protein Phosphatase-1 (PP1) and -2A (PP2A).  This review focuses on synthetic approaches to prep. microcystins and analogs and compiles structure-activity relationship (SAR) studies that describe the unique features of microcystins that make them so potent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdqsA88KlWTbVg90H21EOLACvtfcHk0lgkM16ug8ZHmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKlurfF&md5=f0a944727d4103bd4c57e4f29dd827ce</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.08.040%26sid%3Dliteratum%253Aachs%26aulast%3DFontanillo%26aufirst%3DM.%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DMicrocystins%253A%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Studies%2520toward%2520Pp1%2520and%2520Pp2a%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D1118%26epage%3D1126%26doi%3D10.1016%2Fj.bmc.2017.08.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snen, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isono, K.</span></span> <span> </span><span class="NLM_article-title">A New Antibiotic, Tautomycetin</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.42.141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.7164%2Fantibiotics.42.141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2921220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaL1MXhsVOhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1989&pages=141-144&author=Y.+Kobayashiauthor=K.+Koauthor=I.+Yamaguchiauthor=Y.-C.+Snenauthor=K.+Isono&title=A+New+Antibiotic%2C+Tautomycetin&doi=10.7164%2Fantibiotics.42.141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">A new antibiotic, tautomycetin</span></div><div class="casAuthors">Cheng, Xing Chun; Kihara, Tsuyoshi; Ying, Xing; Uramoto, Masakazu; Osada, Hiroyuki; Kusakabe, Hiroo; Wang, Bao Nu; Kobayashi, Yumiko; Ko, Keido; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-4</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">The new antibiotic tautomycetin was isolated from Streptomyces griseochromogenes.  This compd. appeared as a tautomeric mixt. and had inhibitory activity against a series of fungi, but not against Gram pos. or neg. bacteria.  In human erythroid leukemia cells, the antibiotic at 3-100 μg/mL induced bleb formation, but it reversed the bleb formation induced by phorbol 12,13-dibutyrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTw_hyGXGm8rVg90H21EOLACvtfcHk0lgkM16ug8ZHmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhsVOhtrc%253D&md5=ebec46dd250df88956cb75554068e571</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.42.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.42.141%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKo%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DI.%26aulast%3DSnen%26aufirst%3DY.-C.%26aulast%3DIsono%26aufirst%3DK.%26atitle%3DA%2520New%2520Antibiotic%252C%2520Tautomycetin%26jtitle%3DJ.%2520Antibiot.%26date%3D1989%26volume%3D42%26spage%3D141%26epage%3D144%26doi%3D10.7164%2Fantibiotics.42.141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ubukata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isono, a. K.</span></span> <span> </span><span class="NLM_article-title">The Structure of Tautomycin, a Regulator of Eukaryotic Cell Growth</span>. <i>J. Chem. Soc., Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1039/c39900000244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1039%2Fc39900000244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXkslOqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=244-246&author=M.+Ubukataauthor=X.+C.+Chengauthor=a.+K.+Isono&title=The+Structure+of+Tautomycin%2C+a+Regulator+of+Eukaryotic+Cell+Growth&doi=10.1039%2Fc39900000244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of tautomycin, a regulator of eukaryotic cell growth</span></div><div class="casAuthors">Ubukata, Makoto; Cheng, Xing Chun; Isono, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Chemical Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">244-6</span>CODEN:
                <span class="NLM_cas:coden">JCCCAT</span>;
        ISSN:<span class="NLM_cas:issn">0022-4936</span>.
    </div><div class="casAbstract">Structure I is proposed for tautomycin produced by Streptomyces spiroverticillatus, on the basis of chem. degrdn. and spectroscopic evidences including 2D INADEQUATE of tautomycin labeled with [1,2-13C]acetate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18QToO9qtibVg90H21EOLACvtfcHk0lgYy8PHqtuYSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslOqtbg%253D&md5=7bda344594d976ba2b9e659e8e98966d</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1039%2Fc39900000244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39900000244%26sid%3Dliteratum%253Aachs%26aulast%3DUbukata%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DX.%2BC.%26aulast%3DIsono%26aufirst%3Da.%2BK.%26atitle%3DThe%2520Structure%2520of%2520Tautomycin%252C%2520a%2520Regulator%2520of%2520Eukaryotic%2520Cell%2520Growth%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1990%26spage%3D244%26epage%3D246%26doi%3D10.1039%2Fc39900000244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myles, D. C.</span></span> <span> </span><span class="NLM_article-title">Novel Biologically Active Natural and Unnatural Products</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">633</span>, <span class="refDoi"> DOI: 10.1016/j.copbio.2003.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.copbio.2003.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=14662393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1OqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=627-633&author=D.+C.+Myles&title=Novel+Biologically+Active+Natural+and+Unnatural+Products&doi=10.1016%2Fj.copbio.2003.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Novel biologically active natural and unnatural products</span></div><div class="casAuthors">Myles, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-633</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Natural products have been used as medicinal agents for many years.  In addn., these compds. have served as the starting points for semisynthetic analogs with improved properties.  This review highlights work on several classes of natural products and their derivs., including both well established and emerging structural classes that are in, or nearing, clin. use for a variety of important indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXZqb8I12KtrVg90H21EOLACvtfcHk0lgYy8PHqtuYSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1OqtLs%253D&md5=a1f2171645fc3383b60bd2039b04da76</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2003.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2003.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DMyles%26aufirst%3DD.%2BC.%26atitle%3DNovel%2520Biologically%2520Active%2520Natural%2520and%2520Unnatural%2520Products%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2003%26volume%3D14%26spage%3D627%26epage%3D633%26doi%3D10.1016%2Fj.copbio.2003.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubukata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isono, K.</span></span> <span> </span><span class="NLM_article-title">The Structure of Tautomycin, a Dialkylmaleic Anhydride Antibiotic</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">819</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.43.809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.7164%2Fantibiotics.43.809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=2387775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3cXmtlWjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1990&pages=809-819&author=X.+C.+Chengauthor=M.+Ubukataauthor=K.+Isono&title=The+Structure+of+Tautomycin%2C+a+Dialkylmaleic+Anhydride+Antibiotic&doi=10.7164%2Fantibiotics.43.809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of tautomycin, a dialkylmaleic anhydride antibiotic</span></div><div class="casAuthors">Cheng, Xing Chun; Ubukata, Makoto; Isono, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">809-19</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">The chem. structure of tautomycin (C41H66O13) was detd. to be I by chem. degrdn., spectroscopic anal. and 2D INADEQUATE of tautomycin labeled with [1,2-13C]acetate.  Tautomycin exists in methanol-buffer soln. (1% Et2NH-HCO2H, pH 7.3) as an equil. mixt. of 2,3-dialkylmaleic anhydride and its dicarboxylic acid in a ratio of ∼5:4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrABMMVSDe5mLVg90H21EOLACvtfcHk0lgYy8PHqtuYSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtlWjtrs%253D&md5=dd3defa0557b4506c05ac0d734c01d64</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.43.809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.43.809%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%2BC.%26aulast%3DUbukata%26aufirst%3DM.%26aulast%3DIsono%26aufirst%3DK.%26atitle%3DThe%2520Structure%2520of%2520Tautomycin%252C%2520a%2520Dialkylmaleic%2520Anhydride%2520Antibiotic%26jtitle%3DJ.%2520Antibiot.%26date%3D1990%26volume%3D43%26spage%3D809%26epage%3D819%26doi%3D10.7164%2Fantibiotics.43.809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkhof, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalban, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izquierdo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiel-Wilck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stites, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aradhye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappos, L.</span></span> <span> </span><span class="NLM_article-title">Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>362</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0907839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1056%2FNEJMoa0907839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=20089954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVWrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=402-415&author=J.+A.+Cohenauthor=F.+Barkhofauthor=G.+Comiauthor=H.+P.+Hartungauthor=B.+O.+Khatriauthor=X.+Montalbanauthor=J.+Pelletierauthor=R.+Capraauthor=P.+Galloauthor=G.+Izquierdoauthor=K.+Tiel-Wilckauthor=A.+de+Veraauthor=J.+Jinauthor=T.+Stitesauthor=S.+Wuauthor=S.+Aradhyeauthor=L.+Kappos&title=Oral+Fingolimod+or+Intramuscular+Interferon+for+Relapsing+Multiple+Sclerosis&doi=10.1056%2FNEJMoa0907839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis</span></div><div class="casAuthors">Cohen, Jeffrey A.; Barkhof, Frederik; Comi, Giancarlo; Hartung, Hans-Peter; Khatri, Bhupendra O.; Montalban, Xavier; Pelletier, Jean; Capra, Ruggero; Gallo, Paolo; Izquierdo, Guillermo; Tiel-Wilck, Klaus; de Vera, Ana; Jin, James; Stites, Tracy; Wu, Stacy; Aradhye, Shreeram; Kappos, Ludwig</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">402-415</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyte egress from lymph nodes, showed clin. efficacy and improvement on imaging in a phase 2 study involving patients with multiple sclerosis.  METHODS: In this 12-mo, double-blind, double-dummy study, we randomly assigned 1292 patients with relapsing-remitting multiple sclerosis who had a recent history of at least one relapse to receive either oral fingolimod at a daily dose of either 1.25 or 0.5 mg or i.m. interferon beta-1a (an established therapy for multiple sclerosis) at a weekly dose of 30 μg.  The primary end point was the annualized relapse rate.  Key secondary end points were the no. of new or enlarged lesions on T2-weighted magnetic resonance imaging (MRI) scans at 12 mo and progression of disability that was sustained for at least 3 mo.  RESULTS: A total of 1153 patients (89%) completed the study.  The annualized relapse rate was significantly lower in both groups receiving fingolimod - 0.20 (95% confidence interval [CI], 0.16 to 0.26) in the 1.25-mg group and 0.16 (95% CI, 0.12 to 0.21) in the 0.5-mg group - than in the interferon group (0.33; 95% CI, 0.26 to 0.42; P < 0.001 for both comparisons).  MRI findings supported the primary results.  No significant differences were seen among the study groups with respect to progression of disability.  Two fatal infections occurred in the group that received the 1.25-mg dose of fingolimod: disseminated primary varicella zoster and herpes simplex encephalitis.  Other adverse events among patients receiving fingolimod were nonfatal herpesvirus infections, bradycardia and atrioventricular block, hypertension, macular edema, skin cancer, and elevated liver-enzyme levels.  CONCLUSIONS: This trial showed the superior efficacy of oral fingolimod with respect to relapse rates and MRI outcomes in patients with multiple sclerosis, as compared with i.m. interferon beta-1a.  Longer studies are needed to assess the safety and efficacy of treatment beyond 1 yr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2xFo108Gd0bVg90H21EOLACvtfcHk0lgYy8PHqtuYSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVWrsbk%253D&md5=13b88619c4c0460c8920f0fb15a14fe7</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0907839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0907839%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%2BA.%26aulast%3DBarkhof%26aufirst%3DF.%26aulast%3DComi%26aufirst%3DG.%26aulast%3DHartung%26aufirst%3DH.%2BP.%26aulast%3DKhatri%26aufirst%3DB.%2BO.%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DCapra%26aufirst%3DR.%26aulast%3DGallo%26aufirst%3DP.%26aulast%3DIzquierdo%26aufirst%3DG.%26aulast%3DTiel-Wilck%26aufirst%3DK.%26aulast%3Dde%2BVera%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DStites%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DKappos%26aufirst%3DL.%26atitle%3DOral%2520Fingolimod%2520or%2520Intramuscular%2520Interferon%2520for%2520Relapsing%2520Multiple%2520Sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D402%26epage%3D415%26doi%3D10.1056%2FNEJMoa0907839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heise, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hof, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prieschl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumruker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiestand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span> <span> </span><span class="NLM_article-title">The Immune Modulator Fty720 Targets Sphingosine 1-Phosphate Receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">21453</span>– <span class="NLM_lpage">21457</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200176200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+Immune+Modulator+Fty720+Targets+Sphingosine+1-Phosphate+Receptors&doi=10.1074%2Fjbc.C200176200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lijDkO-u2iJYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520Immune%2520Modulator%2520Fty720%2520Targets%2520Sphingosine%25201-Phosphate%2520Receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457%26doi%3D10.1074%2Fjbc.C200176200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proia, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, H.</span></span> <span> </span><span class="NLM_article-title">Essential Requirement for Sphingosine Kinase 2 in a Sphingolipid Apoptosis Pathway Activated by Fty720 Analogues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">15833</span>– <span class="NLM_lpage">15842</span>, <span class="refDoi"> DOI: 10.1074/jbc.M609124200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1074%2Fjbc.M609124200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=17400555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=15833-15842&author=A.+S.+Donauthor=C.+Martinez-Lamencaauthor=W.+R.+Webbauthor=R.+L.+Proiaauthor=E.+Robertsauthor=H.+Rosen&title=Essential+Requirement+for+Sphingosine+Kinase+2+in+a+Sphingolipid+Apoptosis+Pathway+Activated+by+Fty720+Analogues&doi=10.1074%2Fjbc.M609124200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Essential Requirement for Sphingosine Kinase 2 in a Sphingolipid Apoptosis Pathway Activated by FTY720 Analogues</span></div><div class="casAuthors">Don, Anthony S.; Martinez-Lamenca, Carolina; Webb, William R.; Proia, Richard L.; Roberts, Ed; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">15833-15842</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The clin. immunosuppressant FTY720 is a sphingosine analog that, once phosphorylated by sphingosine kinase 2 (Sphk2), is an agonist of multiple receptor subtypes for sphingosine 1-phosphate.  Short exposures to FTY720 afford long term protection in lymphoproliferative and autoimmune disease models, presumably by inducing apoptosis in subsets of cells essential for pathogenesis.  Sphingosine itself is pro-apoptotic, and apoptosis induced with FTY720 or sphingosine is thought to proceed independently of their phosphorylation.  Following chem. mutagenesis of Jurkat cells we isolated mutants that are selectively resistant to FTY720 analog AAL(R), as well as natural sphingolipid bases, including sphingosine.  Cells lacking functional Sphk2 were resistant to apoptosis induced with AAL(R), indicating that apoptosis proceeds through AAL(R) phosphorylation.  Phosphorylation of AAL(R) was also required for induction of lymphocyte apoptosis in mice, as apoptosis was not induced with the non-phosphorylatable chiral analog, AAL(S).  Apoptosis was induced in the spleen but not the thymus of mice administered 1 mg/kg AAL(R), correlating with levels of AAL(R)-phosphate (AFD(R)) in organ exts.  AFD(R) did not induce apoptosis when added to the cell culture medium, indicating that it induces apoptosis through an intracellular target.  NBD-labeled AAL(R) localized to the endoplasmic reticulum, and AAL(R) treatment resulted in elevated cytosolic calcium, Bax redistribution from cytosol to mitochondrial and endoplasmic reticulum membranes, and caspase-independent mitochondrial permeabilization in Jurkat cells.  We therefore describe an apoptotic pathway triggered by intracellular accumulation of sphingolipid base phosphates and suggest that sphingoid base substrates for Sphk2 acting intracellularly could be useful in the treatment of lymphoproliferative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvCAjaLgvWeLVg90H21EOLACvtfcHk0lijDkO-u2iJYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7c%253D&md5=2c44863428e98ebc5e338b447b5d99c8</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609124200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609124200%26sid%3Dliteratum%253Aachs%26aulast%3DDon%26aufirst%3DA.%2BS.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DWebb%26aufirst%3DW.%2BR.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DEssential%2520Requirement%2520for%2520Sphingosine%2520Kinase%25202%2520in%2520a%2520Sphingolipid%2520Apoptosis%2520Pathway%2520Activated%2520by%2520Fty720%2520Analogues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D15833%26epage%3D15842%26doi%3D10.1074%2Fjbc.M609124200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung
Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">Identification of Chaulmoogric Acid as a Small Molecule Activator of Protein Phosphatase 5</span>. <i>Appl. Biochem. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">1450</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.1007/s12010-009-8647-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs12010-009-8647-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=19404779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivVSmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=1450-1459&author=C.+Cherauthor=M.+H.+Tremblayauthor=J.+R.+Barberauthor=S.+Chung%0ANgauthor=B.+Zhang&title=Identification+of+Chaulmoogric+Acid+as+a+Small+Molecule+Activator+of+Protein+Phosphatase+5&doi=10.1007%2Fs12010-009-8647-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of chaulmoogric acid as a small molecule activator of protein phosphatase 5</span></div><div class="casAuthors">Cher, Charmian; Tremblay, Marie-Helene; Barber, Jack R.; Ng, Shi Chung; Zhang, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Applied Biochemistry and Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1450-1459</span>CODEN:
                <span class="NLM_cas:coden">ABIBDL</span>;
        ISSN:<span class="NLM_cas:issn">0273-2289</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protein phosphatase 5 (PP5) is an important protein phosphatase that is abundantly expressed in the central nervous system.  Recent studies showed that PP5 activity in the neocortex from patients with Alzheimer's disease (AD) is decreased significantly, suggesting that small mol. PP5 activators may have therapeutic potential for AD.  Here, the authors performed a biochem. screening for PP5 activators with the microsource compd. library.  Chaulmoogric acid (I) was identified to be an effective activator with EC50 value of 134.5 μM.  Importantly, results from CD and limited proteolysis studies showed that I bound to a region of the tetratricopeptide repeat (TPR) domain of PP5 resulting in complete loss of helical content.  These results demonstrated a different mechanism of action from that of arachidonic acid, a known activator for PP5 dephosphorylation activity.  Synergistic activation of PP5 enzymic activity was also obsd. with combined application of both compds. at relatively low concns.  Therefore, a further structure-activity relation study of I may facilitate the discovery of small mols. that can synergize with endogenous arachidonic acid for PP5 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8yRVAxHEbELVg90H21EOLACvtfcHk0lijDkO-u2iJYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivVSmtbs%253D&md5=3d4afccc38de95524d20fe77d34b3e18</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1007%2Fs12010-009-8647-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12010-009-8647-3%26sid%3Dliteratum%253Aachs%26aulast%3DCher%26aufirst%3DC.%26aulast%3DTremblay%26aufirst%3DM.%2BH.%26aulast%3DBarber%26aufirst%3DJ.%2BR.%26aulast%3DChung%2BNg%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520Chaulmoogric%2520Acid%2520as%2520a%2520Small%2520Molecule%2520Activator%2520of%2520Protein%2520Phosphatase%25205%26jtitle%3DAppl.%2520Biochem.%2520Biotechnol.%26date%3D2010%26volume%3D160%26spage%3D1450%26epage%3D1459%26doi%3D10.1007%2Fs12010-009-8647-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sager, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dushukyan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodford, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of the Co-Chaperone Protein Phosphatase 5 in Cancer</span>. <i>Cell Stress Chaperones</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1007/s12192-020-01091-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2Fs12192-020-01091-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=32239474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtFygs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=383-394&author=R.+A.+Sagerauthor=N.+Dushukyanauthor=M.+Woodfordauthor=M.+Mollapour&title=Structure+and+Function+of+the+Co-Chaperone+Protein+Phosphatase+5+in+Cancer&doi=10.1007%2Fs12192-020-01091-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of the co-chaperone protein phosphatase 5 in cancer</span></div><div class="casAuthors">Sager, Rebecca A.; Dushukyan, Natela; Woodford, Mark; Mollapour, Mehdi</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress & Chaperones</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-394</span>CODEN:
                <span class="NLM_cas:coden">CSCHFG</span>;
        ISSN:<span class="NLM_cas:issn">1355-8145</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Abstr.: Protein phosphatase 5 (PP5) is a serine/threonine protein phosphatase that regulates many cellular functions including steroid hormone signaling, stress response, proliferation, apoptosis, and DNA repair.  PP5 is also a co-chaperone of the heat shock protein 90 mol. chaperone machinery that assists in regulation of cellular signaling pathways essential for cell survival and growth.  PP5 plays a significant role in survival and propagation of multiple cancers, which makes it a promising target for cancer therapy.  Though there are several naturally occurring PP5 inhibitors, none is specific for PP5.  Here, we review the roles of PP5 in cancer progression and survival and discuss the unique features of the PP5 structure that differentiate it from other phosphoprotein phosphatase (PPP) family members and make it an attractive therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrevQjbIKpaPLVg90H21EOLACvtfcHk0lhEluQk_TwTQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtFygs78%253D&md5=88975ea4fa2a889c5dce3d826660b6d1</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1007%2Fs12192-020-01091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12192-020-01091-3%26sid%3Dliteratum%253Aachs%26aulast%3DSager%26aufirst%3DR.%2BA.%26aulast%3DDushukyan%26aufirst%3DN.%26aulast%3DWoodford%26aufirst%3DM.%26aulast%3DMollapour%26aufirst%3DM.%26atitle%3DStructure%2520and%2520Function%2520of%2520the%2520Co-Chaperone%2520Protein%2520Phosphatase%25205%2520in%2520Cancer%26jtitle%3DCell%2520Stress%2520Chaperones%26date%3D2020%26volume%3D25%26spage%3D383%26epage%3D394%26doi%3D10.1007%2Fs12192-020-01091-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaszczyszyn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ga̧siorowski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Świa̧tek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malinka, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieślik-Boczula, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarnik-Matusewicz, B.</span></span> <span> </span><span class="NLM_article-title">Chemical Structure of Phenothiazines and Their Biological Activity</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/S1734-1140(12)70726-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS1734-1140%2812%2970726-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=22580516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOqurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=16-23&author=A.+Jaszczyszynauthor=K.+Ga%CC%A7siorowskiauthor=P.+%C5%9Awia%CC%A7tekauthor=W.+Malinkaauthor=K.+Cie%C5%9Blik-Boczulaauthor=J.+Petrusauthor=B.+Czarnik-Matusewicz&title=Chemical+Structure+of+Phenothiazines+and+Their+Biological+Activity&doi=10.1016%2FS1734-1140%2812%2970726-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical structure of phenothiazines and their biological activity</span></div><div class="casAuthors">Jaszczyszyn, Agata; Gasiorowski, Kazimierz; Swiatek, Piotr; Malinka, Wieslaw; Cieslik-Boczula, Katarzyna; Petrus, Joanna; Czarnik-Matusewicz, Boguslawa</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-23</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">A review.  Phenothiazines belong to the oldest, synthetic antipsychotic drugs, which do not have their precursor in the world of natural compds.  Apart from their fundamental neuroleptic action connected with the dopaminergic receptors blockade, phenothiazine derivs. also exert diverse biol. activities, which account for their cancer chemopreventive-effect, as: calmodulin- and protein kinase C inhibitory-actions, anti-proliferative effect, inhibition of P-glycoprotein transport function and reversion of multidrug resistance.  According to literature data on relations between chem. structure of phenothiazines and their biol. effects, the main directions for further chem. modifications have been established.  They are provided and discussed in this review paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMdmAHZF4qbrVg90H21EOLACvtfcHk0lhEluQk_TwTQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOqurnF&md5=6430e4be4856ee62dc8eaa9dc79731e9</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2812%2970726-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252812%252970726-0%26sid%3Dliteratum%253Aachs%26aulast%3DJaszczyszyn%26aufirst%3DA.%26aulast%3DGa%25CC%25A7siorowski%26aufirst%3DK.%26aulast%3D%25C5%259Awia%25CC%25A7tek%26aufirst%3DP.%26aulast%3DMalinka%26aufirst%3DW.%26aulast%3DCie%25C5%259Blik-Boczula%26aufirst%3DK.%26aulast%3DPetrus%26aufirst%3DJ.%26aulast%3DCzarnik-Matusewicz%26aufirst%3DB.%26atitle%3DChemical%2520Structure%2520of%2520Phenothiazines%2520and%2520Their%2520Biological%2520Activity%26jtitle%3DPharmacol.%2520Rep.%26date%3D2012%26volume%3D64%26spage%3D16%26epage%3D23%26doi%3D10.1016%2FS1734-1140%2812%2970726-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kastrinsky, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangodkar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaware, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhawan, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M.</span></span> <span> </span><span class="NLM_article-title">Reengineered Tricyclic Anti-Cancer Agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6528</span>– <span class="NLM_lpage">6534</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.bmc.2015.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=26372073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSitLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6528-6534&author=D.+B.+Kastrinskyauthor=J.+Sangodkarauthor=N.+Zawareauthor=S.+Izadmehrauthor=N.+S.+Dhawanauthor=G.+Narlaauthor=M.+Ohlmeyer&title=Reengineered+Tricyclic+Anti-Cancer+Agents&doi=10.1016%2Fj.bmc.2015.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Reengineered tricyclic anti-cancer agents</span></div><div class="casAuthors">Kastrinsky, David B.; Sangodkar, Jaya; Zaware, Nilesh; McClinch, Kimberly; Farrington, Caroline C.; Giannini, Heather M.; Izadmehr, Sudeh; Dhawan, Neil S.; Narla, Goutham; Ohlmeyer, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6528-6534</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The phenothiazine and dibenzazepine tricyclics are potent neurotropic drugs with a documented but underutilized anti-cancer side effect.  Reengineering these agents (TFP, CPZ, CIP) by replacing the basic amine with a neutral polar functional group (e.g., RTC-1, RTC-2) abrogated their CNS effects as demonstrated by in vitro pharmacol. assays and in vivo behavioral models.  Further optimization generated several phenothiazines and dibenzazepines with improved anti-cancer potency, exemplified by RTC-5.  This new lead demonstrated efficacy against a xenograft model of an EGFR driven cancer without the neurotropic effects exhibited by the parent mols.  Its effects were attributed to concomitant neg. regulation of PI3K-AKT and RAS-ERK signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF-IPrpK7hDLVg90H21EOLACvtfcHk0lhEluQk_TwTQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSitLbI&md5=a76922484503f3651d39688139e8178b</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DKastrinsky%26aufirst%3DD.%2BB.%26aulast%3DSangodkar%26aufirst%3DJ.%26aulast%3DZaware%26aufirst%3DN.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DDhawan%26aufirst%3DN.%2BS.%26aulast%3DNarla%26aufirst%3DG.%26aulast%3DOhlmeyer%26aufirst%3DM.%26atitle%3DReengineered%2520Tricyclic%2520Anti-Cancer%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6528%26epage%3D6534%26doi%3D10.1016%2Fj.bmc.2015.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sangodkar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tohme, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastrinsky, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaware, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiredja, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhawan, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatzer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borczuk, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokulrangan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrington, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avelar, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gidwani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQuaid, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClinch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma’ayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiFeo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galsky, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brautigan, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannou, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chance, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, G.</span></span> <span> </span><span class="NLM_article-title">Activation of Tumor Suppressor Protein Pp2a Inhibits Kras-Driven Tumor Growth</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">2081</span>– <span class="NLM_lpage">2090</span>, <span class="refDoi"> DOI: 10.1172/JCI89548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1172%2FJCI89548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=28504649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC1crntlagtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=2081-2090&author=J.+Sangodkarauthor=A.+Perlauthor=R.+Tohmeauthor=J.+Kiselarauthor=D.+B.+Kastrinskyauthor=N.+Zawareauthor=S.+Izadmehrauthor=S.+Mazharauthor=D.+D.+Wiredjaauthor=C.+M.+O%E2%80%99Connorauthor=D.+Hoonauthor=N.+S.+Dhawanauthor=D.+Schlatzerauthor=S.+Yaoauthor=D.+Leonardauthor=A.+C.+Borczukauthor=G.+Gokulranganauthor=L.+Wangauthor=E.+Svensonauthor=C.+C.+Farringtonauthor=E.+Yuanauthor=R.+A.+Avelarauthor=A.+Stachnikauthor=B.+Smithauthor=V.+Gidwaniauthor=H.+M.+Gianniniauthor=D.+McQuaidauthor=K.+McClinchauthor=Z.+Wangauthor=A.+C.+Levineauthor=R.+C.+Searsauthor=E.+Y.+Chenauthor=Q.+Duanauthor=M.+Dattauthor=S.+Haiderauthor=A.+Ma%E2%80%99ayanauthor=A.+DiFeoauthor=N.+Sharmaauthor=M.+D.+Galskyauthor=D.+L.+Brautiganauthor=Y.+A.+Ioannouauthor=W.+Xuauthor=M.+R.+Chanceauthor=M.+Ohlmeyerauthor=G.+Narla&title=Activation+of+Tumor+Suppressor+Protein+Pp2a+Inhibits+Kras-Driven+Tumor+Growth&doi=10.1172%2FJCI89548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth</span></div><div class="casAuthors">Sangodkar Jaya; Kastrinsky David B; Zaware Nilesh; Izadmehr Sudeh; Hoon Divya; Dhawan Neil S; Yao Shen; Stachnik Agnes; Smith Blake; Gidwani Vickram; Giannini Heather M; McQuaid Daniel; McClinch Kimberly; Levine Alice C; Chen Edward Y; Duan Qiaonan; Ma'ayan Avi; Galsky Matthew D; Ioannou Yiannis A; Ohlmeyer Michael; Perl Abbey; Tohme Rita; Kiselar Janna; Mazhar Sahar; Wiredja Danica D; O'Connor Caitlin M; Schlatzer Daniela; Leonard Daniel; Gokulrangan Giridharan; Svenson Elena; Farrington Caroline C; Yuan Eric; Avelar Rita A; DiFeo Analisa; Sharma Neelesh; Chance Mark R; Narla Goutham; Tohme Rita; Borczuk Alain C; Wang Lifu; Brautigan David L; Wang Zhizhi; Haider Shozeb; Xu Wenqing; Sears Rosalie C; Datt Manish; Haider Shozeb</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2081-2090</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Targeted cancer therapies, which act on specific cancer-associated molecular targets, are predominantly inhibitors of oncogenic kinases.  While these drugs have achieved some clinical success, the inactivation of kinase signaling via stimulation of endogenous phosphatases has received minimal attention as an alternative targeted approach.  Here, we have demonstrated that activation of the tumor suppressor protein phosphatase 2A (PP2A), a negative regulator of multiple oncogenic signaling proteins, is a promising therapeutic approach for the treatment of cancers.  Our group previously developed a series of orally bioavailable small molecule activators of PP2A, termed SMAPs.  We now report that SMAP treatment inhibited the growth of KRAS-mutant lung cancers in mouse xenografts and transgenic models.  Mechanistically, we found that SMAPs act by binding to the PP2A Aα scaffold subunit to drive conformational changes in PP2A.  These results show that PP2A can be activated in cancer cells to inhibit proliferation.  Our strategy of reactivating endogenous PP2A may be applicable to the treatment of other diseases and represents an advancement toward the development of small molecule activators of tumor suppressor proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSu8vjXvEHeHDAEfvC7EH1LfW6udTcc2eYgns2idMsRkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crntlagtg%253D%253D&md5=38e48e3438d12d2c2091f2eafdfc9a83</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1172%2FJCI89548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI89548%26sid%3Dliteratum%253Aachs%26aulast%3DSangodkar%26aufirst%3DJ.%26aulast%3DPerl%26aufirst%3DA.%26aulast%3DTohme%26aufirst%3DR.%26aulast%3DKiselar%26aufirst%3DJ.%26aulast%3DKastrinsky%26aufirst%3DD.%2BB.%26aulast%3DZaware%26aufirst%3DN.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DMazhar%26aufirst%3DS.%26aulast%3DWiredja%26aufirst%3DD.%2BD.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DC.%2BM.%26aulast%3DHoon%26aufirst%3DD.%26aulast%3DDhawan%26aufirst%3DN.%2BS.%26aulast%3DSchlatzer%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DLeonard%26aufirst%3DD.%26aulast%3DBorczuk%26aufirst%3DA.%2BC.%26aulast%3DGokulrangan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSvenson%26aufirst%3DE.%26aulast%3DFarrington%26aufirst%3DC.%2BC.%26aulast%3DYuan%26aufirst%3DE.%26aulast%3DAvelar%26aufirst%3DR.%2BA.%26aulast%3DStachnik%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DGidwani%26aufirst%3DV.%26aulast%3DGiannini%26aufirst%3DH.%2BM.%26aulast%3DMcQuaid%26aufirst%3DD.%26aulast%3DMcClinch%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLevine%26aufirst%3DA.%2BC.%26aulast%3DSears%26aufirst%3DR.%2BC.%26aulast%3DChen%26aufirst%3DE.%2BY.%26aulast%3DDuan%26aufirst%3DQ.%26aulast%3DDatt%26aufirst%3DM.%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DMa%25E2%2580%2599ayan%26aufirst%3DA.%26aulast%3DDiFeo%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DGalsky%26aufirst%3DM.%2BD.%26aulast%3DBrautigan%26aufirst%3DD.%2BL.%26aulast%3DIoannou%26aufirst%3DY.%2BA.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DChance%26aufirst%3DM.%2BR.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DNarla%26aufirst%3DG.%26atitle%3DActivation%2520of%2520Tumor%2520Suppressor%2520Protein%2520Pp2a%2520Inhibits%2520Kras-Driven%2520Tumor%2520Growth%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2017%26volume%3D127%26spage%3D2081%26epage%3D2090%26doi%3D10.1172%2FJCI89548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrington, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen-Petersen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janghorban, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolczanski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangodkar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, G.</span></span> <span> </span><span class="NLM_article-title">Protein Phosphatase 2a Activation as a Therapeutic Strategy for Managing Myc-Driven Cancers</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>295</i></span>,  <span class="NLM_fpage">757</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(17)49933-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2FS0021-9258%2817%2949933-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31822503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BB3MXmslKlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2020&pages=757-770&author=C.+C.+Farringtonauthor=E.+Yuanauthor=S.+Mazharauthor=S.+Izadmehrauthor=L.+Hurstauthor=B.+L.+Allen-Petersenauthor=M.+Janghorbanauthor=E.+Chungauthor=G.+Wolczanskiauthor=M.+Galskyauthor=R.+Searsauthor=J.+Sangodkarauthor=G.+Narla&title=Protein+Phosphatase+2a+Activation+as+a+Therapeutic+Strategy+for+Managing+Myc-Driven+Cancers&doi=10.1016%2FS0021-9258%2817%2949933-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers</span></div><div class="casAuthors">Farrington, Caroline C.; Yuan, Eric; Mazhar, Sahar; Izadmehr, Sudeh; Hurst, Lauren; Allen-Petersen, Brittany L.; Janghorban, Mahnaz; Chung, Eric; Wolczanski, Grace; Galsky, Matthew; Sears, Rosalie; Sangodkar, Jaya; Narla, Goutham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">757-770</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The tumor suppressor protein phosphatase 2A (PP2A) is a serine/threonine phosphatase whose activity is inhibited in most human cancers.  One of the best-characterized PP2A substrates is MYC proto-oncogene basic helix-loop-helix transcription factor (MYC), whose overexpression is commonly assocd. with aggressive forms of this disease.  PP2A directly dephosphorylates MYC, resulting in its degrdn.  To explore the therapeutic potential of direct PP2A activation in a diverse set of MYC-driven cancers, here we used biochem. assays, recombinant cell lines, gene expression analyses, and immunohistochem. to evaluate a series of first-in-class small-mol. activators of PP2A (SMAPs) in Burkitt lymphoma, KRAS-driven non-small cell lung cancer, and triple-neg. breast cancer.  In all tested models of MYC-driven cancer, the SMAP treatment rapidly and persistently inhibited MYC expression through proteasome-mediated degrdn., inhibition of MYC transcriptional activity, decreased cancer cell proliferation, and tumor growth inhibition.  Importantly, we generated a series of cell lines expressing PP2A-dependent phosphodegron variants of MYC and demonstrated that the antitumorigenic activity of SMAPs depends on MYC degrdn.  Collectively, the findings presented here indicate a pharmacol. tractable approach to drive MYC degrdn. by using SMAPs for the management of a broad range of MYC-driven cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK-i1WvbxTi7Vg90H21EOLACvtfcHk0ljToYlP3kk5Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXmslKlsLk%253D&md5=df2645d79fa6375819e19ad0c099c921</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2817%2949933-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252817%252949933-9%26sid%3Dliteratum%253Aachs%26aulast%3DFarrington%26aufirst%3DC.%2BC.%26aulast%3DYuan%26aufirst%3DE.%26aulast%3DMazhar%26aufirst%3DS.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DHurst%26aufirst%3DL.%26aulast%3DAllen-Petersen%26aufirst%3DB.%2BL.%26aulast%3DJanghorban%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DE.%26aulast%3DWolczanski%26aufirst%3DG.%26aulast%3DGalsky%26aufirst%3DM.%26aulast%3DSears%26aufirst%3DR.%26aulast%3DSangodkar%26aufirst%3DJ.%26aulast%3DNarla%26aufirst%3DG.%26atitle%3DProtein%2520Phosphatase%25202a%2520Activation%2520as%2520a%2520Therapeutic%2520Strategy%2520for%2520Managing%2520Myc-Driven%2520Cancers%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2020%26volume%3D295%26spage%3D757%26epage%3D770%26doi%3D10.1016%2FS0021-9258%2817%2949933-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, S. C.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of Human Calcineurin Complexed with Cyclosporin a and Human Cyclophilin</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">13522</span>– <span class="NLM_lpage">13526</span>, <span class="refDoi"> DOI: 10.1073/pnas.212504399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.212504399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=12357034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVKms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=13522-13526&author=L.+Jinauthor=S.+C.+Harrison&title=Crystal+Structure+of+Human+Calcineurin+Complexed+with+Cyclosporin+a+and+Human+Cyclophilin&doi=10.1073%2Fpnas.212504399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin</span></div><div class="casAuthors">Jin, Lei; Harrison, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13522-13526</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Calcineurin (Cn; protein phosphatase 2B), is an important participant in signaling pathways that activate T cells.  It is the target of the immunosuppressive drugs, cyclosporin A (CsA) and FK 506.  These drugs bind proteins known as cyclophilin (Cyp) and FK 506-binding protein, resp., and the drug-protein complexes in turn inhibit Cn.  Here, the authors report the crystal structure of a Cyp/CsA/Cn ternary complex, detd. to a resoln. of 3.1 Å.  Residues 3-9 of CsA, particularly N-methylleucine (Mle)-4 and Mle-6, and Trp-121 of Cyp were found to form a composite surface for interaction with Cn.  The hydrophobic interface buried 2 H-bonds.  The structure accounted clearly for the effects of mutations in Cn on CsA-resistance and for the way modifications of CsA alter immunosuppressive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqspopSI-iZLLVg90H21EOLACvtfcHk0ljkfnJT5Jw-jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVKms7c%253D&md5=cff5598bce80f7a372582156f9e8619b</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1073%2Fpnas.212504399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.212504399%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DL.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26atitle%3DCrystal%2520Structure%2520of%2520Human%2520Calcineurin%2520Complexed%2520with%2520Cyclosporin%2520a%2520and%2520Human%2520Cyclophilin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D13522%26epage%3D13526%26doi%3D10.1073%2Fpnas.212504399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazáry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stähelin, H.</span></span> <span> </span><span class="NLM_article-title">Immunosuppressive and Specific Antimitotic Effects of Ovalicin</span>. <i>Experientia</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1171</span>– <span class="NLM_lpage">1173</span>, <span class="refDoi"> DOI: 10.1007/BF02147835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1007%2FBF02147835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=4889119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaF1MXhtVagsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1968&pages=1171-1173&author=S.+Laz%C3%A1ryauthor=H.+St%C3%A4helin&title=Immunosuppressive+and+Specific+Antimitotic+Effects+of+Ovalicin&doi=10.1007%2FBF02147835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppressive and specific antimitotic effects of ovalicin</span></div><div class="casAuthors">Lazary, S.; Staehelin, H.</div><div class="citationInfo"><span class="NLM_cas:title">Experientia</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1171-3</span>CODEN:
                <span class="NLM_cas:coden">EXPEAM</span>;
        ISSN:<span class="NLM_cas:issn">0014-4754</span>.
    </div><div class="casAbstract">The primary hemagglutinin response in mice 7 or 14 days after immunization with sheep red blood cells (SRBC) was strongly inhibited by ovalicin (600 and 1200 mg./kg., orally).  Partial tolerance to the standard secondary challenge with SRBC was found when the primary response was inhibited with 1200 mg./kg.  When animals were treated with the drug on the day of the 2nd challenge with SRBC only, there was but a slight inhibition of the response.  Survival of skin grafts in mice was prolonged by a single dose of ovalicin (300 mg./kg., i.p.), with max. effect 3-4 days after grafting.  High doses (300 mg./kg.) of ovalicin reduced the spleen wt. in immunized animals to a level close to that of nonimmunized mice.  Similarly, spleen wt. increased due to infiltration, and multiplication of leukemia L-1210 cells was repressed by ovalicin, in a hybrid host as well as in the isologous host.  High doses of ovalicin were required to depress the mitotic index in the spleens in nonstimulated mice, while in immunized mice lower doses were quite active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowsFIh4n5a_rVg90H21EOLACvtfcHk0ljkfnJT5Jw-jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXhtVagsw%253D%253D&md5=52f6a314f42179017874f605c24dae91</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1007%2FBF02147835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02147835%26sid%3Dliteratum%253Aachs%26aulast%3DLaz%25C3%25A1ry%26aufirst%3DS.%26aulast%3DSt%25C3%25A4helin%26aufirst%3DH.%26atitle%3DImmunosuppressive%2520and%2520Specific%2520Antimitotic%2520Effects%2520of%2520Ovalicin%26jtitle%3DExperientia%26date%3D1968%26volume%3D24%26spage%3D1171%26epage%3D1173%26doi%3D10.1007%2FBF02147835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Twentyman, P. R.</span></span> <span> </span><span class="NLM_article-title">Cyclosporins as Drug Resistance Modifiers</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(92)90668-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0006-2952%2892%2990668-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1346494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK38Xht1Shtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1992&pages=109-117&author=P.+R.+Twentyman&title=Cyclosporins+as+Drug+Resistance+Modifiers&doi=10.1016%2F0006-2952%2892%2990668-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporins as drug resistance modifiers</span></div><div class="casAuthors">Twentyman, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-17</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A review with 74 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYudtkPoUSN7Vg90H21EOLACvtfcHk0ljkfnJT5Jw-jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht1Shtrc%253D&md5=bebd650b92118463a5d91f4953cfa252</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2892%2990668-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252892%252990668-9%26sid%3Dliteratum%253Aachs%26aulast%3DTwentyman%26aufirst%3DP.%2BR.%26atitle%3DCyclosporins%2520as%2520Drug%2520Resistance%2520Modifiers%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1992%26volume%3D43%26spage%3D109%26epage%3D117%26doi%3D10.1016%2F0006-2952%2892%2990668-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÖLler, E.</span></span> <span> </span><span class="NLM_article-title">Evidence That the Immunosuppressive Effects of Fk506 and Cyclosporine Are Identical</span>. <i>Transplantation</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1001</span>– <span class="NLM_lpage">1007</span>, <span class="refDoi"> DOI: 10.1097/00007890-199012000-00021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1097%2F00007890-199012000-00021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1701570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3MXhvF2htbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=1001-1007&author=A.+Johanssonauthor=E.+M%C3%96Ller&title=Evidence+That+the+Immunosuppressive+Effects+of+Fk506+and+Cyclosporine+Are+Identical&doi=10.1097%2F00007890-199012000-00021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical</span></div><div class="casAuthors">Johansson, Anette; Moeller, Erna</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1001-7</span>CODEN:
                <span class="NLM_cas:coden">TRPLAU</span>;
        ISSN:<span class="NLM_cas:issn">0041-1337</span>.
    </div><div class="casAbstract">The in vitro immunol. properties of FK506 were studied in comparison and in combination with cyclosporin A (CsA), to evaluate the possibility that their mechanisms of action were identical or similar, in spite of their different mol. structures.  The ability to inhibit several responses of human peripheral blood lymphocytes to mitogenic and alloantigenic stimulation was explored.  Synergistic effects of the 2 drugs were extensively studied.  FK506 and CsA had very similar mechanisms of action and additive effects were recorded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDNeLAgMfRaLVg90H21EOLACvtfcHk0ljw1q3GMXCzBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhvF2htbs%253D&md5=879f12c44dae74bec8fb7d0eda1b0b9b</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1097%2F00007890-199012000-00021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007890-199012000-00021%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DM%25C3%2596Ller%26aufirst%3DE.%26atitle%3DEvidence%2520That%2520the%2520Immunosuppressive%2520Effects%2520of%2520Fk506%2520and%2520Cyclosporine%2520Are%2520Identical%26jtitle%3DTransplantation%26date%3D1990%26volume%3D50%26spage%3D1001%26epage%3D1007%26doi%3D10.1097%2F00007890-199012000-00021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltz, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siekierka, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigal, N. H.</span></span> <span> </span><span class="NLM_article-title">Fk-506 and Cyclosporin a Inhibit Highly Similar Signal Transduction Pathways in Human T Lymphocytes</span>. <i>Cell. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1016/0008-8749(91)90103-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0008-8749%2891%2990103-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1707760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK3MXhslyjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1991&pages=269-284&author=C.+S.+Linauthor=R.+C.+Boltzauthor=J.+J.+Siekierkaauthor=N.+H.+Sigal&title=Fk-506+and+Cyclosporin+a+Inhibit+Highly+Similar+Signal+Transduction+Pathways+in+Human+T+Lymphocytes&doi=10.1016%2F0008-8749%2891%2990103-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes</span></div><div class="casAuthors">Lin, C. Shirley; Boltz, Robert C.; Siekierka, John J.; Sigal, Nolan H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-84</span>CODEN:
                <span class="NLM_cas:coden">CLIMB8</span>;
        ISSN:<span class="NLM_cas:issn">0008-8749</span>.
    </div><div class="casAbstract">This report compares the ability of cyclosporin A and FK-506 to inhibit human T cell activation triggered via cell surface mols. that utilize different intracellular processes.  The authors stimulated highly purified peripheral blood T lymphocytes with mitogens (Con A and PHA), ionomycin + PMA, or monoclonal antibodies specific for cell surface antigens involved in activation (CD2, CD3, CD28) either in combination with each other or in conjunction with PMA.  Using measurements of the proliferative response, IL-2 prodn., and changes in intracellular Ca2+ ([Ca2+]i), the authors demonstrate that FK-506 exerts its inhibitory effect on early events of T-cell activation in a manner indistinguishable from that of CsA.  An important finding in this study is the strict correlation between those activation pathways that are inhibited by FK-506 and CsA and the requirement that the sensitive pathways induce a measurable rise in [Ca2+]i.  This correlation held even for the CD28/CD2 pathway which was previously shown to be calcium-independent; however by employing FACS anal. of [Ca2+]i within individual cells, a subset of cells activated via CD28/CD2 was found to respond with a measurable rise in [Ca2+]i.  The authors also noted that the proliferative response induced by certain stimuli, such as ionomycin + PMA and PHA + PMA, was partially resistant to FK-506 and CsA, while IL-2 prodn. was completely suppressed.  The partial FK-506/CsA-resistance of these responses was shown to be detd. by the amt. of PMA added to the cultures.  FK-506 and CsA inhibit highly similar signal transduction pathways in human T lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS11XBY_VeN7Vg90H21EOLACvtfcHk0ljw1q3GMXCzBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslyjsbc%253D&md5=05eab8b7b126287ca9a386b72e517ca3</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2F0008-8749%2891%2990103-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0008-8749%252891%252990103-I%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%2BS.%26aulast%3DBoltz%26aufirst%3DR.%2BC.%26aulast%3DSiekierka%26aufirst%3DJ.%2BJ.%26aulast%3DSigal%26aufirst%3DN.%2BH.%26atitle%3DFk-506%2520and%2520Cyclosporin%2520a%2520Inhibit%2520Highly%2520Similar%2520Signal%2520Transduction%2520Pathways%2520in%2520Human%2520T%2520Lymphocytes%26jtitle%3DCell.%2520Immunol.%26date%3D1991%26volume%3D133%26spage%3D269%26epage%3D284%26doi%3D10.1016%2F0008-8749%2891%2990103-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondragon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of Calcineurin-Cyclophilin-Cyclosporin Shows Common but Distinct Recognition of Immunophilin-Drug Complexes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">12037</span>– <span class="NLM_lpage">12042</span>, <span class="refDoi"> DOI: 10.1073/pnas.192206699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1073%2Fpnas.192206699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=12218175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlCltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=12037-12042&author=Q.+Huaiauthor=H.+Y.+Kimauthor=Y.+Liuauthor=Y.+Zhaoauthor=A.+Mondragonauthor=J.+O.+Liuauthor=H.+Ke&title=Crystal+Structure+of+Calcineurin-Cyclophilin-Cyclosporin+Shows+Common+but+Distinct+Recognition+of+Immunophilin-Drug+Complexes&doi=10.1073%2Fpnas.192206699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes</span></div><div class="casAuthors">Huai, Qing; Kim, Hwa-Young; Liu, Yudong; Zhao, Yingdong; Mondragon, Angelo; Liu, Jun O.; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">12037-12042</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the common target for two immunophilin-immunosuppressant complexes, cyclophilin A-cyclosporin A (CyPA-CsA) and FKBP-FK506.  How the two structurally distinct immunophilin-drug complexes bind the same target has remained unknown.  We report the crystal structure of calcineurin (CN) in complex with CyPA-CsA at 2.8-Å resoln.  The CyPA-CsA complex binds to a composite surface formed by the catalytic and regulatory subunits of CN, where the complex of FK506 and its binding protein FKBP also binds.  While the majority of the CN residues involved in the binding are common for both immunophilin-immunosuppressant complexes, a significant no. of the residues are distinct.  Unlike FKBP-FK506, CyPA-CsA interacts with Arg-122 at the active site of CN, implying direct involvement of CyPA-CsA in the regulation of CN catalysis.  The simultaneous interaction of CyPA with both the composite surface and the active site of CN suggests that the composite surface may serve as a substrate recognition site responsible for the narrow substrate specificity of CN.  The comparison of CyPA-CsA-CN with FKBP-FK506-CN significantly contributes to understanding the mol. basis of regulation of CN activity by the immunophilin-immunosuppressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSjhnlTGw4urVg90H21EOLACvtfcHk0ljw1q3GMXCzBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlCltbk%253D&md5=9cc518ce524b0e84963cc891a9d1415d</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1073%2Fpnas.192206699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.192206699%26sid%3Dliteratum%253Aachs%26aulast%3DHuai%26aufirst%3DQ.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMondragon%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DCrystal%2520Structure%2520of%2520Calcineurin-Cyclophilin-Cyclosporin%2520Shows%2520Common%2520but%2520Distinct%2520Recognition%2520of%2520Immunophilin-Drug%2520Complexes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D12037%26epage%3D12042%26doi%3D10.1073%2Fpnas.192206699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sintchak, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgibbon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navia, M. A.</span></span> <span> </span><span class="NLM_article-title">X-Ray Structure of Calcineurin Inhibited by the Immunophilin-Immunosuppressant Fkbp12-Fk506 Complex</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(95)90439-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2F0092-8674%2895%2990439-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=7543369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFSgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1995&pages=507-522&author=J.+P.+Griffithauthor=J.+L.+Kimauthor=E.+E.+Kimauthor=M.+D.+Sintchakauthor=J.+A.+Thomsonauthor=M.+J.+Fitzgibbonauthor=M.+A.+Flemingauthor=P.+R.+Caronauthor=K.+Hsiaoauthor=M.+A.+Navia&title=X-Ray+Structure+of+Calcineurin+Inhibited+by+the+Immunophilin-Immunosuppressant+Fkbp12-Fk506+Complex&doi=10.1016%2F0092-8674%2895%2990439-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex</span></div><div class="casAuthors">Griffith, James P.; Kim, Joseph L.; Kim, Eunice E.; Sintchak, Michael D.; Thomson, John A.; Fitzgibbon, Matthew J.; Fleming, Mark A.; Caron, Paul R.; Hsiao, Kathy; Navia, Manuel A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">507-22</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The x-ray structure of the ternary complex of a calcineurin A fragment, calcineurin B, FKBP12, and the immunosuppressant drug FK506 (also known as tacrolimus) has been detd. at 2.5 Å resoln., providing a description of how FK506 functions at the at. level.  In the structure, FKBP-12-KF506 binary complex does not contact the phosphatase active site on calcineurin A that is more than 10 Å removed.  Instead, FKBP-12-FK506 is so positioned that it can inhibit the dephosphorylation of its macromol. substrates by phys. hindering their approach to the active site.  The ternary complex described here represents the three-dimensional structure of a Ser/Thr protein phosphatase and provides a structural basis for understanding calcineurin inhibition by FKBP-12-FK506.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLqpO9MqIX57Vg90H21EOLACvtfcHk0ljw1q3GMXCzBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFSgtrY%253D&md5=bcb0f597be68fbb42888776700591d14</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990439-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990439-5%26sid%3Dliteratum%253Aachs%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DKim%26aufirst%3DE.%2BE.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DFitzgibbon%26aufirst%3DM.%2BJ.%26aulast%3DFleming%26aufirst%3DM.%2BA.%26aulast%3DCaron%26aufirst%3DP.%2BR.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DNavia%26aufirst%3DM.%2BA.%26atitle%3DX-Ray%2520Structure%2520of%2520Calcineurin%2520Inhibited%2520by%2520the%2520Immunophilin-Immunosuppressant%2520Fkbp12-Fk506%2520Complex%26jtitle%3DCell%26date%3D1995%26volume%3D82%26spage%3D507%26epage%3D522%26doi%3D10.1016%2F0092-8674%2895%2990439-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harikishore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sup Yoon, H.</span></span> <span> </span><span class="NLM_article-title">Immunophilins: Structures, Mechanisms and Ligands</span>. <i>Curr. Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.2174/1874467208666150519113427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F1874467208666150519113427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25986569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BC2MfltVKitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=37-47&author=A.+Harikishoreauthor=H.+Sup+Yoon&title=Immunophilins%3A+Structures%2C+Mechanisms+and+Ligands&doi=10.2174%2F1874467208666150519113427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Immunophilins: Structures, Mechanisms and Ligands</span></div><div class="casAuthors">Harikishore Amaravadhi; Yoon Ho Sup</div><div class="citationInfo"><span class="NLM_cas:title">Current molecular pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Immunophilins consist of a family of highly conserved proteins which possess binding abilities to immunosuppressive drugs.  Cyclophilins (Cyps) and FK506-binding proteins (FKBP) are family proteins collectively referred as immunophilins.  Most Cyps and FKBP family members catalyse peptidyl-prolyl cis/trans isomerase (PPIase) mediated reactions and form binary complexes with their ligands cyclosporine A and FK506.  Immunophilins are also involved in key biochemical processes including protein folding, receptor signalling, protein trafficking, and transcription and exhibit versatile biological functions, when complexed with their ligands.  Therapeutic implications of immunophilins and effects of their ligands in neurodegenerative disorders, cancer, and infectious diseases have been accumulating in recent years.  This review focuses on molecular characteristics of the canonical and non-canonical immunophilin family members from human and Plasmodium falciparum and P. vivax, recent progress on immunophilin inhibitor development, and future perspectives of structure-based design of non-immunosuppressive immunophilin ligands with potential pharmacological activities against infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzpKzaquF5abJzI8owOhpDfW6udTcc2ebDto47KRraurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfltVKitQ%253D%253D&md5=7bfe974952c55aac2dfd3da051158e97</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.2174%2F1874467208666150519113427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1874467208666150519113427%26sid%3Dliteratum%253Aachs%26aulast%3DHarikishore%26aufirst%3DA.%26aulast%3DSup%2BYoon%26aufirst%3DH.%26atitle%3DImmunophilins%253A%2520Structures%252C%2520Mechanisms%2520and%2520Ligands%26jtitle%3DCurr.%2520Mol.%2520Pharmacol.%26date%3D2015%26volume%3D9%26spage%3D37%26epage%3D47%26doi%3D10.2174%2F1874467208666150519113427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grigoriu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cossio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hummer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cyert, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span> <span> </span><span class="NLM_article-title">The Molecular Mechanism of Substrate Engagement and Immunosuppressant Inhibition of Calcineurin</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e1001492</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1001492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1371%2Fjournal.pbio.1001492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=23468591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt1Wnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=e1001492&author=S.+Grigoriuauthor=R.+Bondauthor=P.+Cossioauthor=J.+A.+Chenauthor=N.+Lyauthor=G.+Hummerauthor=R.+Pageauthor=M.+S.+Cyertauthor=W.+Peti&title=The+Molecular+Mechanism+of+Substrate+Engagement+and+Immunosuppressant+Inhibition+of+Calcineurin&doi=10.1371%2Fjournal.pbio.1001492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanism of substrate engagement and immunosuppressant inhibition of calcineurin</span></div><div class="casAuthors">Grigoriu, Simina; Bond, Rachel; Cossio, Pilar; Chen, Jennifer A.; Ly, Nina; Hummer, Gerhard; Page, Rebecca; Cyert, Martha S.; Peti, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1001492</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Ser/Thr phosphatases dephosphorylate their targets with high specificity, yet the structural and sequence determinants of phosphosite recognition are poorly understood.  Calcineurin (CN) is a conserved Ca2+/calmodulin-dependent Ser/Thr phosphatase and the target of immunosuppressants, FK506 and cyclosporin A (CSA).  To investigate CN substrate recognition we used X-ray crystallog., biochem., modeling, and in vivo expts. to study A238L, a viral protein inhibitor of CN.  We show that A238L competitively inhibits CN by occupying a crit. substrate recognition site, while leaving the catalytic center fully accessible.  Critically, the 1.7 Å structure of the A238L-CN complex reveals how CN recognizes residues in A238L that are analogous to a substrate motif, "LxVP".  The structure enabled modeling of a peptide substrate bound to CN, which predicts substrate interactions beyond the catalytic center.  Finally, this study establishes that "LxVP" sequences and immunosuppressants bind to the identical site on CN.  Thus, FK506, CSA, and A238L all prevent "LxVP"-mediated substrate recognition by CN, highlighting the importance of this interaction for substrate dephosphorylation.  Collectively, this work presents the first integrated structural model for substrate selection and dephosphorylation by CN and lays the groundwork for structure-based development of new CN inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPKK_IkJPw7LVg90H21EOLACvtfcHk0lgB89iep4ccNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt1Wnu7s%253D&md5=2f0fd8d26bafc562c50a323648d23fb3</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1001492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1001492%26sid%3Dliteratum%253Aachs%26aulast%3DGrigoriu%26aufirst%3DS.%26aulast%3DBond%26aufirst%3DR.%26aulast%3DCossio%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%2BA.%26aulast%3DLy%26aufirst%3DN.%26aulast%3DHummer%26aufirst%3DG.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DCyert%26aufirst%3DM.%2BS.%26aulast%3DPeti%26aufirst%3DW.%26atitle%3DThe%2520Molecular%2520Mechanism%2520of%2520Substrate%2520Engagement%2520and%2520Immunosuppressant%2520Inhibition%2520of%2520Calcineurin%26jtitle%3DPLoS%2520Biol.%26date%3D2013%26volume%3D11%26spage%3De1001492%26doi%3D10.1371%2Fjournal.pbio.1001492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a Sensitizes Human Non-Small Cell Lung Cancer Cells to Gefitinib through Inhibition of Stat3</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.canlet.2016.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=27264264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC28Xptl2msbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2016&pages=124-133&author=J.+Shouauthor=L.+Youauthor=J.+Yaoauthor=J.+Xieauthor=J.+Jingauthor=Z.+Jingauthor=L.+Jiangauthor=X.+Suiauthor=H.+Panauthor=W.+Han&title=Cyclosporine+a+Sensitizes+Human+Non-Small+Cell+Lung+Cancer+Cells+to+Gefitinib+through+Inhibition+of+Stat3&doi=10.1016%2Fj.canlet.2016.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3</span></div><div class="casAuthors">Shou, Jiawei; You, Liangkun; Yao, Junlin; Xie, Jiansheng; Jing, Jing; Jing, Zhao; Jiang, Liming; Sui, Xinbing; Pan, Hongming; Han, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-133</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have dramatically prolonged the overall survival of non-small cell lung cancer (NSCLC) patients with EGFR-activating mutation, but the presence of primary or acquired resistance eventually leads to therapeutic failure.  Thus, how to improve the efficacy and reverse the resistance to EGFR-TKIs remains a significant challenge.  In this study, we found that CsA significantly augmented the anti-cancer effect of gefitinib in EGFR-TKI-sensitive and -resistant NSCLC cells.  Mechanistically, CsA promoted gefitinib-induced apoptosis through inhibition of the STAT3 pathway.  Similar with the function of CsA, siRNAs against STAT3 also enhanced gefitinib-induced apoptosis in multiple lung cancer cells.  Xenograft studies further demonstrated that CsA promoted the anti-cancer activity of gefitinib on lung cancer cells through inhibition of STAT3.  Moreover, NSCLC patients with high levels of phosphorylated STAT3 (Y705) showed a significantly poorer therapeutic response to EGFR-TKIs.  This study provides preclin. evidence that the combination of CsA or a STAT3 inhibitor with EGFR-TKIs is a promising approach to improve the efficacy of EGFR-TKIs for the treatment of patients with advanced NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDFcLL-N9pZrVg90H21EOLACvtfcHk0lgB89iep4ccNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xptl2msbo%253D&md5=b77ae3609cbe1ba3612a4b3c01c08537</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DShou%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DJing%26aufirst%3DJ.%26aulast%3DJing%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSui%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DW.%26atitle%3DCyclosporine%2520a%2520Sensitizes%2520Human%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Cells%2520to%2520Gefitinib%2520through%2520Inhibition%2520of%2520Stat3%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D379%26spage%3D124%26epage%3D133%26doi%3D10.1016%2Fj.canlet.2016.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a Sensitizes Lung Cancer Cells to Crizotinib through Inhibition of the Ca2+/Calcineurin/Erk Pathway</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2019.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1016%2Fj.ebiom.2019.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30879923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BB3cbkvFygsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2019&pages=326-339&author=Z.+Liuauthor=L.+Jiangauthor=Y.+Liauthor=B.+Xieauthor=J.+Xieauthor=Z.+Wangauthor=X.+Zhouauthor=H.+Jiangauthor=Y.+Fangauthor=H.+Panauthor=W.+Han&title=Cyclosporine+a+Sensitizes+Lung+Cancer+Cells+to+Crizotinib+through+Inhibition+of+the+Ca2%2B%2FCalcineurin%2FErk+Pathway&doi=10.1016%2Fj.ebiom.2019.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2(+)/calcineurin/Erk pathway</span></div><div class="casAuthors">Liu Zhen; Jiang Liming; Li Yiran; Xie Binbin; Fang Yong; Xie Jiansheng; Wang Zhanggui; Zhou Xiaoyun; Jiang Hanliang; Pan Hongming; Han Weidong</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">326-339</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Crizotinib has potent anti-tumor activity in patients with advanced MET-amplified non-small cell lung cancer (NSCLC).  However, the therapeutic effect is still not satisfying.  Thus, developing approaches that improve the efficacy of crizotinib remains a significant challenge.  METHODS:  MET-amplified NSCLC cell lines were treated with crizotinib and cyclosporine A (CsA).  Cell viability was determined by MTS assay.  The changes of apoptosis, cell cycle and calcineurin-Erk pathways were assessed by western blot.  Xenograft mouse model, primary human NSCLC cells and hollow fiber assays were utilized to confirm the effects of CsA.  FINDINGS:  We demonstrated that CsA significantly increased the anti-tumor effect of crizotinib on multiple MET-amplified NSCLC cells in vitro and in vivo.  Mechanistically, crizotinib treatment led to the activation of Ca(2+)-calcineurin (CaN)-Kinase suppressor of Ras 2 (KSR2) signaling, resulting in Erk1/2 activation and enhanced survival of cancer cells.  CsA effectively blocked CaN-KSR2-Erk1/2 signaling, promoting crizotinib-induced apoptosis and G2/M arrest.  Similarly, pharmacologic or genetic inhibition of Erk1/2 also enhanced crizotinib-induced growth inhibition in vitro.  Xenograft studies further confirmed that CsA or Erk1/2 inhibitor PD98059 enhanced the anti-cancer activity of crizotinib through inhibition of CaN-Erk1/2 axis.  The results were also validated by primary human NSCLC cells in vitro and hollow fiber assays in vivo.  INTERPRETATION:  This study provides preclinical evidences that combination therapy of CsA and crizotinib is a promising approach for targeted treatment of MET-amplified lung cancer patients.  FUND: This work was supported by the National Natural Science Foundation of China, the Key Projects of Natural Foundation of Zhejiang Province, the Ten thousand plan youth talent support program of Zhejiang Province, the Zhejiang Natural Sciences Foundation Grant, and the Zhejiang medical innovative discipline construction project-2016.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgn64dfaI-xP6xYuD7tu2XfW6udTcc2eZ31-0NkTFSkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbkvFygsA%253D%253D&md5=f3adbefaac0ecde03500f13d45b1b9d8</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2019.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2019.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DB.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DW.%26atitle%3DCyclosporine%2520a%2520Sensitizes%2520Lung%2520Cancer%2520Cells%2520to%2520Crizotinib%2520through%2520Inhibition%2520of%2520the%2520Ca2%252B%252FCalcineurin%252FErk%2520Pathway%26jtitle%3DEBioMedicine%26date%3D2019%26volume%3D42%26spage%3D326%26epage%3D339%26doi%3D10.1016%2Fj.ebiom.2019.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, K.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in Vitro</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.2174/1871520618666181029170605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.2174%2F1871520618666181029170605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30378503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVKns77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=248-255&author=L.+Gaoauthor=J.+Dongauthor=N.+Zhangauthor=Z.+Leauthor=W.+Renauthor=S.+Liauthor=F.+Liauthor=J.+Songauthor=Q.+Wangauthor=Z.+Douauthor=S.+Y.+Parkauthor=K.+Zhi&title=Cyclosporine+a+Suppresses+the+Malignant+Progression+of+Oral+Squamous+Cell+Carcinoma+in+Vitro&doi=10.2174%2F1871520618666181029170605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro</span></div><div class="casAuthors">Gao, Ling; Dong, Jianwei; Zhang, Nanyang; Le, Zhanxian; Ren, Wenhao; Li, Shaoming; Li, Fan; Song, Jianzhong; Wang, Qibo; Dou, Zhichao; Park, Soo Y.; Zhi, Keqian</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">248-255</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The Oral Squamous Cell Carcinoma (OSCC) is one of the most frequent cancer types.  Failure of treatment of OSCC is potentially lethal because of local recurrence, regional lymph node metastasis, and distant metastasis.  Chemotherapy plays a vital role through suppression of tumorigenesis.  Cyclosporine A (CsA), an immunosuppressant drug, has been efficiently used in allograft organ transplant recipients to prevent rejection, and also has been used in a subset of patients with autoimmunity related disorders.  The present study aims to investigate novel and effective chemotherapeutic drugs to overcome drug-resistance in the treatment of OSCC.  Cells were incubated in the std. way.  Cell viability was assayed using the MTT assay.  Cell proliferation was detd. using colony formation assay.  The cell cycle assay was performed using flow cytometry.  Apoptosis was assessed using fluorescence-activated cell sorting after stained by the Annexin V-fluorescein isothiocyanate (FITC).  Cell migration and invasion were analyzed using wound healing assay and tranwell.  The effect of COX-2, c-Myc, MMP-9, MMP-2, and NFATc1 protein expression was detd. using Western blot anal. while NFATc1 mRNA expression was detd. by RT-PCR.  In vitro studies indicated that CsA inhibited partial OSCC growth by inducing cell cycle arrest, apoptosis, and the migration and invasion of OSCC cells.  We also demonstrated that CsA could inhibit the expression of NFATc1 and its downstream genes COX-2, c-Myc, MMP-9, and MMP-2 in OSCC cells.  Furthermore, we analyzed the expression of NFATc1 in head and neck cancer through the Oncomine database.  The data was consistent with the exptl. findings.  The present study initially demonstrated that CsA could inhibit the progression of OSCC cells and can mediate the signal mols. of NFATc1 signaling pathway, which has strong relationship with cancer development.  That explains us CsA has potential to explore the possibilities as a novel chemotherapeutic drug for the treatment of OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryTfyBLTiuA7Vg90H21EOLACvtfcHk0ljGoe9zVpyGew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVKns77F&md5=f75a707fc004fb95f5c0cfd11f299ed3</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.2174%2F1871520618666181029170605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520618666181029170605%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLe%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DDou%26aufirst%3DZ.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DZhi%26aufirst%3DK.%26atitle%3DCyclosporine%2520a%2520Suppresses%2520the%2520Malignant%2520Progression%2520of%2520Oral%2520Squamous%2520Cell%2520Carcinoma%2520in%2520Vitro%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2019%26volume%3D19%26spage%3D248%26epage%3D255%26doi%3D10.2174%2F1871520618666181029170605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Metabolic Dependence of Cyclosporinea on Cell Proliferation of Human Non-Small Cell Lung Cancer A549 Cells and Its Implication in Post-Transplant Malignancy</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2997</span>– <span class="NLM_lpage">3004</span>, <span class="refDoi"> DOI: 10.3892/or.2019.7076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.3892%2For.2019.7076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=30896878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKitrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2019&pages=2997-3004&author=X.+Qinauthor=Z.+Chen&title=Metabolic+Dependence+of+Cyclosporinea+on+Cell+Proliferation+of+Human+Non-Small+Cell+Lung+Cancer+A549+Cells+and+Its+Implication+in+Post-Transplant+Malignancy&doi=10.3892%2For.2019.7076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic dependence of cyclosporine A on cell proliferation of human non-small cell lung cancer A549 cells and its implication in post-transplant malignancy</span></div><div class="casAuthors">Qin, Xinghua; Chen, Ziwei</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2997-3004</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Cyclosporine A (CsA), a widely used immunosuppressant to prevent organ transplant rejection, is assocd. with an increased cancer risk following transplantation, particularly in the lung.  However, the underlying mechanisms remain unclear.  In the present study, using human non-small cell lung cancer A549 cells, it was detd. that CsA (0.1 or 1μM) promoted cell proliferation with glucose alone as the energy source.  CsA treatment increased the phosphorylation of protein kinase B (Akt) and consequently the expression of Cyclin D1.  Inhibiting Akt signaling with the phosphatidylinositol 3-kinase inhibitor wortmannin prevented this effect.  Mechanistically, CsA treatment increased reactive oxygen species (ROS) generation, and the intracellular ROS scavenger N-acetyl-cysteine (NAC) attenuated CsA-induced cell proliferation as well as the activation of Akt/Cyclin D1 signaling.  However, notably, it was demonstrated that CsA treatment decreased cell proliferation and Akt phosphorylation under normal lipid loading.  Further investigation indicated that palmitic acid induced excessive generation of ROS, while CsA treatment further stimulated this ROS prodn.  Scavenging intracellular ROS with NAC attenuated the CsA-mediated inhibition of cell proliferation.  Collectively, the results indicated a pleiotropic effect of CsA in the regulation of A549 cell proliferation under different metabolic conditions.  This indicated that CsA administration may contribute to increased post-transplant cancer risk in organ recipients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEcyvtTsnL4rVg90H21EOLACvtfcHk0ljGoe9zVpyGew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKitrzF&md5=05f37b2c45f7341a742d56f1e3e61c79</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.3892%2For.2019.7076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2019.7076%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DMetabolic%2520Dependence%2520of%2520Cyclosporinea%2520on%2520Cell%2520Proliferation%2520of%2520Human%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520A549%2520Cells%2520and%2520Its%2520Implication%2520in%2520Post-Transplant%2520Malignancy%26jtitle%3DOncol.%2520Rep.%26date%3D2019%26volume%3D41%26spage%3D2997%26epage%3D3004%26doi%3D10.3892%2For.2019.7076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawahara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwagi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netto, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, H.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine a and Tacrolimus Inhibit Urothelial Tumorigenesis</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1002/mc.22265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1002%2Fmc.22265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=25594762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvV2isQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=161-169&author=T.+Kawaharaauthor=E.+Kashiwagiauthor=Y.+Liauthor=Y.+Zhengauthor=Y.+Miyamotoauthor=G.+J.+Nettoauthor=H.+Ishiguroauthor=H.+Miyamoto&title=Cyclosporine+a+and+Tacrolimus+Inhibit+Urothelial+Tumorigenesis&doi=10.1002%2Fmc.22265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis</span></div><div class="casAuthors">Kawahara, Takashi; Kashiwagi, Eiji; Li, Yi; Zheng, Yichun; Miyamoto, Yurina; Netto, George J.; Ishiguro, Hitoshi; Miyamoto, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-169</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The functional role of nuclear factor of activated T-cells (NFAT), while it has been extensively investigated in the immune system, remains uncertain in bladder cancer development.  We here aim to assess the effects of cyclosporine A (CsA) and tacrolimus (FK506), immunosuppressants known to specifically inactivate the NFAT pathway in immune cells, on neoplastic transformation of urothelial cells.  Immunohistochem. revealed that the expression levels of NFATc1, a NFAT isoform shown to function as an oncogene in a sarcoma model, were elevated in urothelial neoplasms, compared with non-neoplastic urothelial tissues, and in low-grade and high-grade papillary urothelial carcinomas, compared with papillary urothelial neoplasms of low malignant potential.  In an immortalized normal urothelial cell line SVHUC, CsA and FK506 reduced NFATc1 expression, NFAT transcriptional activity, and the expression of c-myc, a downstream target of NFATc1 signals.  Treatment with CsA or FK506 in the SVHUC cells undergoing neoplastic transformation induced by exposure to a chem. carcinogen 3-methylcholanthrene resulted in strong inhibition in colony formation in vitro as well as tumor formation in NOD-SCID mice.  CsA and FK506 were addnl. found to up-regulate the expression of several mols. that play a protective role in bladder tumorigenesis, including p53, p21, and p27, and down-regulate that of oncogenic genes, such as cyclin D1, cyclin D3, and cyclin E, in SVHUC cells with the carcinogen challenge.  Thus, CsA and FK506 likely inhibit urothelial tumorigenesis.  These findings offer a potential chemopreventive approach for urothelial tumors using NFAT inhibitors. © 2015 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_VwswJdNilrVg90H21EOLACvtfcHk0liKEAuYYoyM8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvV2isQ%253D%253D&md5=63927dc291af434d9d72c81e7de1bfc4</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1002%2Fmc.22265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22265%26sid%3Dliteratum%253Aachs%26aulast%3DKawahara%26aufirst%3DT.%26aulast%3DKashiwagi%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DNetto%26aufirst%3DG.%2BJ.%26aulast%3DIshiguro%26aufirst%3DH.%26aulast%3DMiyamoto%26aufirst%3DH.%26atitle%3DCyclosporine%2520a%2520and%2520Tacrolimus%2520Inhibit%2520Urothelial%2520Tumorigenesis%26jtitle%3DMol.%2520Carcinog.%26date%3D2016%26volume%3D55%26spage%3D161%26epage%3D169%26doi%3D10.1002%2Fmc.22265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juvvadi, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobay, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobeil, S. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venters, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Averette, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrington, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheaton, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciofani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spicer, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, W. J.</span></span> <span> </span><span class="NLM_article-title">Harnessing Calcineurin-Fk506-Fkbp12 Crystal Structures from Invasive Fungal Pathogens to Develop Antifungal Agents</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4275</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-12199-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=10.1038%2Fs41467-019-12199-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=31537789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BB3MngsVaqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4275&author=P.+R.+Juvvadiauthor=D.+Foxauthor=B.+G.+Bobayauthor=M.+J.+Hoyauthor=S.+M.+C.+Gobeilauthor=R.+A.+Ventersauthor=Z.+Changauthor=J.+J.+Linauthor=A.+F.+Averetteauthor=D.+C.+Coleauthor=B.+C.+Barringtonauthor=J.+D.+Wheatonauthor=M.+Ciofaniauthor=M.+Trzossauthor=X.+M.+Liauthor=S.+C.+Leeauthor=Y.+L.+Chenauthor=M.+Mutzauthor=L.+D.+Spicerauthor=M.+A.+Schumacherauthor=J.+Heitmanauthor=W.+J.+Steinbach&title=Harnessing+Calcineurin-Fk506-Fkbp12+Crystal+Structures+from+Invasive+Fungal+Pathogens+to+Develop+Antifungal+Agents&doi=10.1038%2Fs41467-019-12199-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents</span></div><div class="casAuthors">Juvvadi Praveen R; Cole D Christopher; Barrington Blake C; Steinbach William J; Fox David 3rd; Fox David 3rd; Fox David 3rd; Bobay Benjamin G; Venters Ronald A; Spicer Leonard D; Bobay Benjamin G; Gobeil Sophie M C; Venters Ronald A; Spicer Leonard D; Schumacher Maria A; Bobay Benjamin G; Gobeil Sophie M C; Venters Ronald A; Spicer Leonard D; Hoy Michael J; Chang Zanetta; Lin Jackie J; Averette Anna Floyd; Heitman Joseph; Steinbach William J; Wheaton Joshua D; Ciofani Maria; Trzoss Michael; Li Xiaoming; Mutz Mitchell; Li Xiaoming; Lee Soo Chan; Chen Ying-Lien; Mutz Mitchell</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4275</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Calcineurin is important for fungal virulence and a potential antifungal target, but compounds targeting calcineurin, such as FK506, are immunosuppressive.  Here we report the crystal structures of calcineurin catalytic (CnA) and regulatory (CnB) subunits complexed with FK506 and the FK506-binding protein (FKBP12) from human fungal pathogens (Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans and Coccidioides immitis).  Fungal calcineurin complexes are similar to the mammalian complex, but comparison of fungal and human FKBP12 (hFKBP12) reveals conformational differences in the 40s and 80s loops.  NMR analysis, molecular dynamic simulations, and mutations of the A. fumigatus CnA/CnB-FK506-FKBP12-complex identify a Phe88 residue, not conserved in hFKBP12, as critical for binding and inhibition of fungal calcineurin.  These differences enable us to develop a less immunosuppressive FK506 analog, APX879, with an acetohydrazine substitution of the C22-carbonyl of FK506.  APX879 exhibits reduced immunosuppressive activity and retains broad-spectrum antifungal activity and efficacy in a murine model of invasive fungal infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAI0aDOrgWeKNc3HjJRoFAfW6udTcc2ebkfq6-eNWkoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MngsVaqtA%253D%253D&md5=c660da6ed31639ea01cee2910afd57e6</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-12199-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-12199-1%26sid%3Dliteratum%253Aachs%26aulast%3DJuvvadi%26aufirst%3DP.%2BR.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DBobay%26aufirst%3DB.%2BG.%26aulast%3DHoy%26aufirst%3DM.%2BJ.%26aulast%3DGobeil%26aufirst%3DS.%2BM.%2BC.%26aulast%3DVenters%26aufirst%3DR.%2BA.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DJ.%2BJ.%26aulast%3DAverette%26aufirst%3DA.%2BF.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DBarrington%26aufirst%3DB.%2BC.%26aulast%3DWheaton%26aufirst%3DJ.%2BD.%26aulast%3DCiofani%26aufirst%3DM.%26aulast%3DTrzoss%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DMutz%26aufirst%3DM.%26aulast%3DSpicer%26aufirst%3DL.%2BD.%26aulast%3DSchumacher%26aufirst%3DM.%2BA.%26aulast%3DHeitman%26aufirst%3DJ.%26aulast%3DSteinbach%26aufirst%3DW.%2BJ.%26atitle%3DHarnessing%2520Calcineurin-Fk506-Fkbp12%2520Crystal%2520Structures%2520from%2520Invasive%2520Fungal%2520Pathogens%2520to%2520Develop%2520Antifungal%2520Agents%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D4275%26doi%3D10.1038%2Fs41467-019-12199-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Köhn, M.</span></span> <span> </span><span class="NLM_article-title">Turn and Face the Strange: A New View on Phosphatases</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1021/acscentsci.9b00909</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.9b00909" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;key=1%3ACAS%3A280%3ADC%252BB38vgtlGlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=467-477&author=M.+K%C3%B6hn&title=Turn+and+Face+the+Strange%3A+A+New+View+on+Phosphatases&doi=10.1021%2Facscentsci.9b00909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Turn and Face the Strange: A New View on Phosphatases</span></div><div class="casAuthors">Kohn Maja; Kohn Maja</div><div class="citationInfo"><span class="NLM_cas:title">ACS central science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-477</span>
        ISSN:<span class="NLM_cas:issn">2374-7943</span>.
    </div><div class="casAbstract">Phosphorylation as a post-translational modification is critical for cellular homeostasis.  Kinases and phosphatases regulate phosphorylation levels by adding or removing, respectively, a phosphate group from proteins or other biomolecules.  Imbalances in phosphorylation levels are involved in a multitude of diseases.  Phosphatases are often thought of as the black sheep, the strangers, of phosphorylation-mediated signal transduction, particularly when it comes to drug discovery and development.  This is due to past difficulties to study them and unsuccessful attempts to target them; however, phosphatases have regained strong attention and are actively pursued now in clinical trials.  By giving examples for current hot topics in phosphatase biology and for new approaches to target them, it is illustrated here how and why phosphatases made their comeback, and what is envisioned to come in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuvWjnAOzzqBgd2Wuil24tfW6udTcc2ebkfq6-eNWkoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38vgtlGlsw%253D%253D&md5=2911d30a74e11a6fd18246c0d3350414</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.9b00909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.9b00909%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hn%26aufirst%3DM.%26atitle%3DTurn%2520and%2520Face%2520the%2520Strange%253A%2520A%2520New%2520View%2520on%2520Phosphatases%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2020%26volume%3D6%26spage%3D467%26epage%3D477%26doi%3D10.1021%2Facscentsci.9b00909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WG8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WG8','PDB','5WG8'); return false;">PDB: 5WG8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1S95" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1S95','PDB','1S95'); return false;">PDB: 1S95</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IE3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IE3','PDB','2IE3'); return false;">PDB: 2IE3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FJM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FJM','PDB','1FJM'); return false;">PDB: 1FJM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ALZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ALZ','PDB','6ALZ'); return false;">PDB: 6ALZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7B','PDB','3E7B'); return false;">PDB: 3E7B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA9','PDB','4JA9'); return false;">PDB: 4JA9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JA7','PDB','4JA7'); return false;">PDB: 4JA7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NTS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NTS','PDB','6NTS'); return false;">PDB: 6NTS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MF8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MF8','PDB','1MF8'); return false;">PDB: 1MF8</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00631&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00631%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-13%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00631" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                10MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a8e1c8fe83c88","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
